data_2l3f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l3f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -87.61 117.51 26.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -100.12 134.04 43.62 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.366 0.667 . . . . 0.0 110.558 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.512 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.2 -174.03 17.55 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.384 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -117.03 144.23 33.16 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 122.948 0.499 . . . . 0.0 110.281 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.42 145.42 16.13 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.024 2.483 . . . . 0.0 112.003 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.11 128.85 38.46 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.825 0.703 . . . . 0.0 111.124 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.518 HG13 HD22 ' A' ' 62' ' ' LEU . 48.7 t -93.75 78.88 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.9 tp -128.71 154.07 46.69 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 112.164 -161.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.51 154.92 37.21 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 9.9 pt-20 -65.13 -10.68 32.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.15 0.58 . . . . 0.0 112.222 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.428 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 20.7 m-80 -120.08 97.38 5.57 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' HG12 ' A' ' 104' ' ' VAL . 52.6 m -144.04 112.93 6.71 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.387 0.675 . . . . 0.0 110.205 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.56 -36.21 29.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.053 . . . . 0.0 110.75 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.16 116.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.241 0.616 . . . . 0.0 109.484 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -104.95 115.51 30.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.515 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.0 mt -98.38 109.32 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.736 0.814 . . . . 0.0 109.046 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 73' ' ' TRP . 80.8 mt -98.08 108.93 21.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 109.026 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.72 -177.9 11.99 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 166.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 p -89.61 -82.17 0.27 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -136.12 114.92 10.88 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.5 Cg_exo -52.89 136.77 60.62 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.958 2.438 . . . . 0.0 112.846 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 m -61.22 145.64 50.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.105 0.878 . . . . 0.0 109.634 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.542 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 7.8 p-10 -61.89 -31.26 71.53 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.158 0.436 . . . . 0.0 110.73 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.75 -36.24 76.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.87 0.868 . . . . 0.0 110.793 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.1 m -66.5 -47.08 74.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.45 -26.57 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.763 1.225 . . . . 0.0 112.832 -171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 18.7 mmt85 -69.4 -36.36 76.68 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 110.089 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.64 -16.12 35.33 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.281 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 65.38 21.59 11.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.695 1.598 . . . . 0.0 111.597 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.89 135.9 40.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.842 1.257 . . . . 0.0 108.873 -173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -57.98 -40.49 80.79 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 122.936 0.495 . . . . 0.0 110.817 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.98 -13.33 45.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.512 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.89 16.41 Favored Glycine 0 C--N 1.362 1.984 0 C-N-CA 124.02 0.819 . . . . 0.0 113.523 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -109.78 112.29 58.39 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 165.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.07 0.56 3.1 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.794 2.996 . . . . 0.0 114.273 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.29 -14.2 80.89 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -72.82 97.64 2.28 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 168.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -80.07 -1.65 40.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.971 0.909 . . . . 0.0 110.885 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -36.03 -41.91 0.26 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.916 2.087 . . . . 0.0 113.443 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.36 -28.9 64.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.57 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -84.11 -37.84 21.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.106 0.562 . . . . 0.0 111.117 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.68 -48.24 80.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 0.0 110.224 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -74.02 -37.26 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.416 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.08 -41.11 99.88 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.071 0.388 . . . . 0.0 114.071 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -71.41 -30.63 66.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.745 0.418 . . . . 0.0 110.363 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.82 -36.91 59.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.807 0.843 . . . . 0.0 112.465 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 pt -91.11 -10.46 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.396 0.678 . . . . 0.0 111.143 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.18 19.81 79.75 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.588 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -135.7 112.64 10.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -71.53 96.44 1.53 Allowed 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.588 0.709 . . . . 0.0 111.696 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.68 -35.87 81.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.013 0.925 . . . . 0.0 110.917 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -53.29 -50.44 64.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.627 1.171 . . . . 0.0 112.626 -170.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -81.96 -6.31 59.02 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.275 0.63 . . . . 0.0 112.097 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtt -86.11 139.62 30.95 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 151.35 33.56 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.081 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.513 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 53.6 t80 -50.0 -42.94 50.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -167.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 42.5 mt-10 -60.31 -46.2 90.73 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.305 0.378 . . . . 0.0 110.758 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -68.53 -45.13 73.02 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -59.71 -32.99 71.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.14 0.427 . . . . 0.0 110.885 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.518 HD22 HG13 ' A' ' 9' ' ' VAL . 47.2 mt -66.77 -43.15 84.8 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.81 172.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 74.7 mmtt -57.06 -41.17 78.27 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.216 0.606 . . . . 0.0 110.233 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -65.27 -39.25 92.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.498 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.05 -46.25 85.22 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.851 0.461 . . . . 0.0 110.228 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 28.6 mmtp -59.88 -39.77 86.43 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.104 0.561 . . . . 0.0 109.882 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.05 -45.65 90.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.992 1.317 . . . . 0.0 111.335 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -86.25 7.78 23.86 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.328 0.251 . . . . 0.0 111.035 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 67.85 38.5 2.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.479 1.111 . . . . 0.0 110.988 171.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.63 132.92 57.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.15 1.38 . . . . 0.0 109.504 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.5 151.6 18.03 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 46.5 mt -119.84 141.06 49.87 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.341 0.656 . . . . 0.0 109.29 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.423 ' HB3' HD22 ' A' ' 19' ' ' LEU . 4.9 t90 -165.09 -168.96 1.53 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -133.54 177.91 7.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.956 0.902 . . . . 0.0 109.888 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.498 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.7 t -95.64 -56.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.675 0.79 . . . . 0.0 109.647 172.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.455 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 57.3 m-85 -84.21 107.98 16.84 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.095 0.558 . . . . 0.0 110.607 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.492 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 3.7 tmtm? -66.82 -31.14 71.57 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.813 0.845 . . . . 0.0 109.044 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -152.86 130.87 11.81 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.061 0.544 . . . . 0.0 109.742 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' A' ' 91' ' ' ASP . . . -151.03 144.21 11.49 Favored Glycine 0 C--O 1.238 0.4 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.825 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.059 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.37 -70.1 1.3 Allowed Glycine 0 C--N 1.344 0.989 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.759 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.508 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 1.1 m-20 -38.88 133.41 1.12 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.873 1.269 . . . . 0.0 113.349 173.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -114.62 25.87 10.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.438 -165.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 8.4 tp10 -78.88 111.96 15.57 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.72 144.07 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.88 0.872 . . . . 0.0 109.134 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -68.95 149.61 48.65 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.233 1.013 . . . . 0.0 110.796 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -78.27 130.94 36.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.498 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 35.3 m-85 -120.67 3.88 10.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.252 0.621 . . . . 0.0 111.395 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.0 t -74.63 -14.69 60.79 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.007 0.523 . . . . 0.0 109.817 173.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.88 -4.04 61.87 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.148 -0.807 . . . . 0.0 113.094 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 mt -52.8 -32.88 46.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 117.732 0.766 . . . . 0.0 112.879 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -68.59 -27.19 65.82 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.779 0.323 . . . . 0.0 111.444 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -83.31 -53.0 6.07 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.696 0.799 . . . . 0.0 111.466 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.516 ' HG3' HG23 ' A' ' 104' ' ' VAL . 25.4 ptm -73.32 -29.41 62.66 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.305 0.642 . . . . 0.0 111.341 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -139.24 86.96 14.12 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.449 0.7 . . . . 0.0 111.209 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.69 -25.97 8.78 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.469 2.113 . . . . 0.0 112.554 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -77.8 -10.13 59.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.4 0.68 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.594 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 36.2 tp -54.39 131.09 41.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.81 0.694 . . . . 0.0 110.673 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.41 ' HD2' ' NE2' ' A' ' 158' ' ' HIS . 18.0 ptp180 -128.56 -37.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.004 0.921 . . . . 0.0 108.707 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 tp -132.29 125.34 30.75 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.255 0.622 . . . . 0.0 110.432 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.496 HG12 HD23 ' A' ' 107' ' ' LEU . 32.9 mt -101.69 109.53 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.515 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.5 m -95.12 112.98 24.62 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.165 0.507 . . . . 0.0 109.928 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.1 114.49 25.75 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.189 0.996 . . . . 0.0 109.396 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -90.51 107.16 18.98 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.34 28.45 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.327 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -56.07 -50.7 70.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 112.851 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 76' ' ' PHE . 26.3 mmmt -50.26 -37.22 34.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.41 -46.03 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.018 0.527 . . . . 0.0 110.103 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.73 -14.59 70.25 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 114.736 -1.12 . . . . 0.0 114.705 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.64 -28.38 69.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.974 0.51 . . . . 0.0 110.837 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.19 19.99 12.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.271 1.028 . . . . 0.0 111.227 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 41.2 tt0 -61.6 -54.71 49.36 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.627 170.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 125' ' ' ARG . 32.2 Cg_endo -59.23 -20.59 55.78 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 122.262 1.975 . . . . 0.0 113.438 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.56 -50.31 70.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.932 0.893 . . . . 0.0 110.163 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.482 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 9.8 mt -89.46 -6.67 56.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 29.3 mtp180 -69.62 -20.04 63.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.966 0.507 . . . . 0.0 109.944 168.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.35 -16.74 80.15 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.402 -0.666 . . . . 0.0 113.42 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.2 mpt? -85.73 9.97 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.702 0.751 . . . . 0.0 112.183 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.96 17.28 71.45 Favored Glycine 0 C--N 1.352 1.441 0 C-N-CA 122.869 0.271 . . . . 0.0 113.633 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -111.07 134.34 52.74 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.548 0.739 . . . . 0.0 109.611 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.99 143.28 56.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.4 p -127.85 139.59 52.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.706 0.802 . . . . 0.0 110.16 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -132.14 118.7 19.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.668 1.187 . . . . 0.0 108.928 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.96 95.11 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.9 mt -75.42 150.99 85.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 73.0 Cg_endo -72.5 163.88 37.25 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.084 1.856 . . . . 0.0 110.359 171.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -63.4 133.09 53.43 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.7 p -79.31 -3.97 48.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.264 0.626 . . . . 0.0 112.026 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -66.68 159.52 27.55 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 111.059 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.43 -28.93 62.77 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.501 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.9 76.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.837 0.855 . . . . 0.0 112.002 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.484 ' ND2' ' HB2' ' A' ' 135' ' ' PRO . 49.1 t30 -89.94 -33.76 16.29 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.063 0.545 . . . . 0.0 110.982 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.534 HH21 ' HA ' ' A' ' 146' ' ' LYS . 6.5 tpm_? -51.61 -44.42 62.88 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.089 1.356 . . . . 0.0 112.458 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -60.87 -12.88 12.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.745 1.218 . . . . 0.0 113.317 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -121.06 -40.63 2.59 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.155 0.982 . . . . 0.0 110.823 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 65.4 m -93.3 85.64 5.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.697 0.799 . . . . 0.0 110.407 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.534 ' HA ' HH21 ' A' ' 142' ' ' ARG . 34.0 mmtp -93.99 -50.64 5.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.51 0.724 . . . . 0.0 111.475 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -86.05 -4.15 59.1 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.932 0.493 . . . . 0.0 111.506 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.412 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.3 tpt180 -78.31 -24.62 46.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.675 0.39 . . . . 0.0 110.097 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 11.3 pt-20 -62.12 -13.46 27.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 m -65.68 -30.5 71.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.37 0.668 . . . . 0.0 112.194 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.42 ' O ' HG22 ' A' ' 155' ' ' VAL . 14.7 pt-20 -72.61 -29.6 63.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.795 0.438 . . . . 0.0 109.925 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -67.35 -37.65 83.56 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.55 -37.69 83.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.978 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.48 72.63 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.793 0.683 . . . . 0.0 111.168 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 151' ' ' GLU . 80.2 t -71.87 -60.39 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.567 0.747 . . . . 0.0 111.03 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -88.09 -7.56 56.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.77 -28.57 66.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.1 0.409 . . . . 0.0 110.86 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.41 ' NE2' ' HD2' ' A' ' 108' ' ' ARG . 0.6 OUTLIER -67.88 -21.66 65.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.596 0.758 . . . . 0.0 111.219 -175.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.4 mt -64.85 -14.28 58.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.428 1.091 . . . . 0.0 113.277 -170.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -98.48 -62.52 1.23 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 166.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 124.565 1.146 . . . . 0.0 108.179 178.132 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.402 HD13 ' HB3' ' A' ' 80' ' ' SER . 40.5 mm . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.525 ' HZ3' ' HB2' ' A' ' 25' ' ' ASP . 34.5 mmtp -97.21 111.95 23.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -95.15 133.8 38.58 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.579 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.67 -166.66 9.71 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.948 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -117.97 147.77 41.99 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.384 0.674 . . . . 0.0 109.318 -172.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.06 162.16 27.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.196 1.931 . . . . 0.0 110.668 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.55 120.43 10.54 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.24 0.616 . . . . 0.0 111.486 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.518 HG13 HD23 ' A' ' 62' ' ' LEU . 41.0 t -94.56 84.6 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.503 HD12 HG11 ' A' ' 104' ' ' VAL . 48.8 tp -129.47 154.56 46.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.246 -159.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -123.62 159.31 29.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.936 0.894 . . . . 0.0 108.623 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.417 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 11.4 pt-20 -59.57 -28.12 66.85 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 43.7 m-80 -111.18 86.84 2.4 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -131.1 112.11 12.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.692 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.464 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.1 tt0 -91.56 -31.97 15.71 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.748 1.219 . . . . 0.0 110.091 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 69.1 mt -125.58 122.16 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.796 0.838 . . . . 0.0 109.465 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.2 tp -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -95.41 106.35 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 75.7 mt -95.79 108.5 20.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 108.85 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.84 178.32 9.13 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 166.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 15.5 t -89.81 -75.59 0.45 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 tp -130.58 124.01 20.69 Favored Pre-proline 0 C--O 1.244 0.8 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.76 155.18 11.06 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -59.32 124.12 18.96 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.525 ' HB2' ' HZ3' ' A' ' 3' ' ' LYS . 9.3 p-10 -61.88 -22.37 65.49 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.121 0.568 . . . . 0.0 112.157 -171.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.29 -51.48 56.97 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.646 0.591 . . . . 0.0 110.111 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 t -55.04 -30.74 60.22 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.728 0.811 . . . . 0.0 111.872 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.8 mt -77.56 -26.75 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.893 0.877 . . . . 0.0 110.873 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -61.84 -27.63 68.92 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.256 0.623 . . . . 0.0 111.45 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -102.71 -3.48 26.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.474 0.71 . . . . 0.0 110.396 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 50.34 28.0 3.01 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.837 1.255 . . . . 0.0 113.168 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -149.09 141.78 24.5 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.001 0.521 . . . . 0.0 110.708 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.454 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 66.1 m-85 -67.62 -6.03 18.43 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 123.94 0.896 . . . . 0.0 112.437 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 90.9 t80 -82.07 -24.85 35.02 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 109.357 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.3 -31.39 79.08 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.877 0.736 . . . . 0.0 114.84 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -123.24 111.98 30.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.995 0.398 . . . . 0.0 110.462 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -88.35 -0.94 6.86 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.445 2.764 . . . . 0.0 112.566 170.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.57 -6.39 89.35 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.568 ' HB3' ' HD2' ' A' ' 41' ' ' PHE . 11.7 m120 -76.19 126.21 30.57 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.52 4.94 50.25 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 124.246 1.018 . . . . 0.0 110.027 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.568 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 86.6 m-85 -50.1 -36.56 30.07 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 109.674 163.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -73.56 -26.75 60.98 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.616 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -79.28 -44.84 20.89 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.727 0.811 . . . . 0.0 111.736 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.95 -38.64 57.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 0.0 111.473 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.25 -30.31 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.49 -53.29 36.51 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.559 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.508 ' CE1' ' HB2' ' A' ' 149' ' ' GLU . 14.4 p-80 -65.84 -30.3 70.9 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.006 0.431 . . . . 0.0 110.356 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 156' ' ' PHE . . . -68.88 -34.44 75.43 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.093 0.957 . . . . 0.0 112.145 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 pt -96.33 -10.39 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.987 0.915 . . . . 0.0 110.405 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.62 39.15 22.36 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 115.039 0.776 . . . . 0.0 115.039 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.92 127.68 1.31 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.425 1.09 . . . . 0.0 108.769 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -72.0 102.78 3.04 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.043 0.937 . . . . 0.0 112.556 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.3 mt -61.03 -25.55 66.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.478 1.111 . . . . 0.0 111.809 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -68.78 -31.24 70.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.657 0.783 . . . . 0.0 111.238 -172.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.36 -11.04 53.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.973 0.909 . . . . 0.0 110.962 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 56.8 mtt -85.08 137.66 32.9 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 152.4 38.4 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.327 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 34.4 t80 -40.28 -51.12 2.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.259 1.424 . . . . 0.0 113.331 -171.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.53 -52.17 62.32 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.1 0.96 . . . . 0.0 111.311 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.92 -42.71 90.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.591 0.756 . . . . 0.0 110.797 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -56.5 -53.34 58.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.829 1.252 . . . . 0.0 110.911 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.518 HD23 HG13 ' A' ' 9' ' ' VAL . 84.5 mt -65.48 -41.69 93.05 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.814 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -71.89 -28.14 63.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.698 0.399 . . . . 0.0 111.769 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.3 m -60.9 -42.32 97.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.109 0.48 . . . . 0.0 109.755 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.4 -50.29 66.05 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.013 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 30.8 mmtp -57.01 -44.78 83.13 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.454 0.702 . . . . 0.0 109.932 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -53.75 -41.29 66.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.243 1.417 . . . . 0.0 112.226 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -84.1 0.88 46.65 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.92 0.888 . . . . 0.0 111.746 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.464 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 66.9 42.73 2.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.852 1.261 . . . . 0.0 110.387 -178.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.38 136.92 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.806 1.242 . . . . 0.0 109.191 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.25 163.17 14.06 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 170.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -124.39 144.4 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.929 0.892 . . . . 0.0 109.162 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.4 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.1 t90 -165.29 -169.14 1.54 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -134.8 170.33 16.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.439 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 61.4 t -97.05 -35.39 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.478 0.711 . . . . 0.0 110.549 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -111.43 105.2 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 50.7 tptt -64.97 -26.98 68.53 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.362 1.065 . . . . 0.0 111.748 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.28 138.53 25.15 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.7 114.39 0.86 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.402 ' HB3' HD13 ' A' ' 2' ' ' ILE . 87.3 p . . . . . 0 C--O 1.239 0.543 0 CA-C-N 117.562 0.681 . . . . 0.0 109.925 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 mt . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.06 54.99 0.8 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.432 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 16.7 t70 -176.45 150.44 0.88 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -172.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.92 17.85 14.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.309 0.644 . . . . 0.0 112.623 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' A' ' 77' ' ' LYS . 24.6 tt0 -77.76 105.67 9.08 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 mm -89.71 147.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.113 0.965 . . . . 0.0 109.392 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -74.6 143.92 44.17 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 168.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -82.88 127.4 33.46 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.439 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 64.2 m-85 -114.92 10.97 16.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.369 0.667 . . . . 0.0 110.998 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.1 t -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.696 0.398 . . . . 0.0 110.818 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.26 -4.76 86.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.738 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 104' ' ' VAL . 16.6 mt -49.41 -53.11 24.36 Favored 'General case' 0 C--N 1.368 1.392 0 C-N-CA 123.676 0.79 . . . . 0.0 111.212 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -59.35 -18.7 40.63 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.467 0.707 . . . . 0.0 112.58 -168.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.38 -42.74 13.41 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.501 1.121 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -94.97 -16.02 23.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 17.1 m -122.35 88.12 48.8 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.168 0.587 . . . . 0.0 110.48 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.1 -39.12 3.3 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.184 1.923 . . . . 0.0 112.101 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -86.2 -6.12 59.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.765 0.826 . . . . 0.0 113.117 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.534 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.1 tp -61.85 117.45 5.91 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.611 0.569 . . . . 0.0 111.073 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -111.47 -40.53 4.35 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.941 0.896 . . . . 0.0 109.52 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 56.2 tp -129.35 133.08 47.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.925 0.89 . . . . 0.0 110.875 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.4 mt -112.7 146.31 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.463 ' HB3' HD13 ' A' ' 134' ' ' LEU . 81.7 m -125.69 113.51 17.44 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.598 0.759 . . . . 0.0 110.317 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.64 107.93 19.59 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.595 1.158 . . . . 0.0 109.086 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -98.79 88.24 3.98 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.65 139.1 3.96 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.625 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.0 -50.84 65.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 111.695 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.48 -38.43 69.1 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.461 1.104 . . . . 0.0 112.008 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 21' ' ' SER . . . -65.57 -36.19 83.04 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.996 0.518 . . . . 0.0 110.823 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.85 -16.37 59.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 115.099 -0.955 . . . . 0.0 114.556 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.59 -29.73 70.75 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.11 0.481 . . . . 0.0 110.947 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -111.31 25.33 11.83 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.722 0.809 . . . . 0.0 111.084 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.52 -44.22 24.48 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.066 0.946 . . . . 0.0 112.543 170.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.401 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 71.9 Cg_endo -70.72 -13.77 32.53 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 121.8 1.667 . . . . 0.0 112.828 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 tp -58.91 -41.03 86.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.562 1.145 . . . . 0.0 110.191 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -96.98 -10.55 26.01 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.489 -174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 122' ' ' PRO . 19.6 mtm180 -63.93 -34.91 79.03 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.078 0.466 . . . . 0.0 110.244 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.93 -12.26 70.95 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.446 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.3 mtt -94.94 9.67 38.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 0.0 111.708 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.01 17.87 77.7 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 113.878 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -110.0 133.59 53.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.437 0.695 . . . . 0.0 110.071 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.68 143.74 55.82 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.0 p -132.93 149.73 52.22 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.707 0.803 . . . . 0.0 110.351 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -145.5 129.23 17.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.353 1.061 . . . . 0.0 109.369 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.64 97.07 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 111' ' ' CYS . 39.6 mt -77.62 144.34 69.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.951 176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.432 ' HD2' ' HE1' ' A' ' 152' ' ' TRP . 44.7 Cg_exo -59.3 154.82 44.14 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.521 2.814 . . . . 0.0 113.269 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.5 m -68.91 108.88 3.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 m -84.69 21.03 1.61 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.422 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.1 t -59.73 154.14 18.76 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.454 0.702 . . . . 0.0 110.522 171.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.19 69.69 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.149 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.48 -15.37 61.32 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.962 0.905 . . . . 0.0 111.452 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.476 ' HA ' ' HD2' ' A' ' 144' ' ' PHE . 9.5 t30 -132.51 8.55 4.25 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.324 0.65 . . . . 0.0 111.204 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -65.77 -36.22 82.92 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.899 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -66.03 -25.88 67.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.725 1.21 . . . . 0.0 111.47 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.476 ' HD2' ' HA ' ' A' ' 141' ' ' ASN . 56.2 m-85 -92.56 -35.89 13.33 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.595 0.758 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 t -86.85 30.08 0.77 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.36 1.064 . . . . 0.0 111.425 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -67.71 -70.57 0.25 Allowed 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.79 -4.69 17.03 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 17.0 mmt180 -73.2 -22.92 60.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.167 0.587 . . . . 0.0 110.41 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 47' ' ' HIS . 12.7 pt-20 -55.54 -24.59 33.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.824 0.85 . . . . 0.0 112.592 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.7 t -67.53 -46.97 71.27 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 111.724 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 10.9 pt-20 -66.47 -31.97 73.05 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.432 ' HE1' ' HD2' ' A' ' 135' ' ' PRO . 35.8 m95 -68.66 -46.73 68.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 27.2 tt0 -62.47 -37.87 87.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.762 -173.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.29 82.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.153 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.41 -35.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.901 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 45.9 m-85 -104.62 -1.73 26.03 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.489 -0.757 . . . . 0.0 112.648 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -81.17 -36.82 29.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.928 0.491 . . . . 0.0 110.768 170.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -67.23 -17.74 64.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.034 0.209 . . . . 0.0 110.648 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.46 -30.75 71.78 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.523 0.729 . . . . 0.0 110.38 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.68 -44.92 95.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.563 0.745 . . . . 0.0 110.228 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.56 1.338 0 C-N-CA 124.415 1.086 . . . . 0.0 109.997 -179.652 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 80' ' ' SER . 39.2 mm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -124.39 123.72 40.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.648 1.179 . . . . 0.0 108.88 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -89.64 139.35 30.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 122.755 0.422 . . . . 0.0 110.893 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.455 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -72.73 166.39 54.26 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.663 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -95.21 139.94 22.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.952 0.501 . . . . 0.0 111.174 -172.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.86 134.26 54.13 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.719 2.279 . . . . 0.0 110.251 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.73 143.35 54.54 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.005 0.816 . . . . 0.0 112.257 -169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.538 HG12 HD22 ' A' ' 62' ' ' LEU . 34.5 t -97.92 61.35 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.445 HD12 ' CG1' ' A' ' 104' ' ' VAL . 64.4 tp -104.13 145.75 29.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.837 -171.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.651 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 5.2 t70 -116.38 158.42 23.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.401 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 9.8 pt-20 -63.86 -21.87 66.65 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.406 0.622 . . . . 0.0 111.084 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 42.0 m-80 -110.46 84.12 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.755 1.622 . . . . 0.0 107.754 174.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -135.56 123.73 23.02 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.515 0.726 . . . . 0.0 110.282 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 38.9 tt0 -106.36 -29.69 9.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.734 1.214 . . . . 0.0 110.677 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.642 HD12 HD12 ' A' ' 159' ' ' LEU . 37.9 mt -131.82 125.18 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.963 0.905 . . . . 0.0 109.628 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.0 tp -110.86 124.82 52.81 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.348 1.059 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 111' ' ' CYS . 47.1 mt -102.45 111.27 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.211 0.604 . . . . 0.0 109.66 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 73' ' ' TRP . 97.4 mt -99.07 127.94 45.1 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.2 -175.13 49.77 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 162.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -94.64 -71.78 0.65 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -134.82 124.59 16.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.455 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 71.0 Cg_exo -52.09 137.26 54.02 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.593 2.195 . . . . 0.0 112.442 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.405 ' O ' HG13 ' A' ' 28' ' ' ILE . 30.1 m -61.01 146.17 48.07 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.775 0.672 . . . . 0.0 110.537 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.6 t70 -58.07 -41.72 84.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.799 0.44 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -47.63 -40.54 19.89 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.973 1.309 . . . . 0.0 111.72 171.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -78.34 -39.67 38.81 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.137 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 24' ' ' SER . 74.8 mt -68.12 -25.62 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 124.365 1.066 . . . . 0.0 111.691 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 23.7 mmt180 -65.29 -28.01 69.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.475 0.31 . . . . 0.0 111.349 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -114.62 0.25 13.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.962 0.505 . . . . 0.0 111.393 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 62.69 24.96 14.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.901 1.28 . . . . 0.0 112.878 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -129.63 134.37 47.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.286 1.034 . . . . 0.0 108.806 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -56.51 -46.1 80.71 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.418 0.687 . . . . 0.0 110.513 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -64.15 -0.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.229 1.412 . . . . 0.0 112.889 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.24 -26.45 9.37 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.743 0.687 . . . . 0.0 113.609 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -102.74 108.85 59.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 163.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -26.75 41.21 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.68 2.253 . . . . 0.0 112.019 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.33 -6.53 40.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.791 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.86 129.21 38.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.61 -6.73 59.52 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.396 0.679 . . . . 0.0 111.723 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -37.91 -41.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.555 1.542 . . . . 0.0 113.541 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.603 0.761 . . . . 0.0 112.216 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.3 mtp-105 -75.63 -40.9 55.53 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.403 0.281 . . . . 0.0 110.797 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.77 -55.22 15.96 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.62 -34.32 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.496 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.77 88.42 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.346 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.77 -37.91 89.19 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.769 0.828 . . . . 0.0 109.754 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.547 ' HA ' ' HG2' ' A' ' 153' ' ' GLU . . . -65.02 -47.78 76.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.296 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.401 HD13 ' ND2' ' A' ' 68' ' ' ASN . 26.8 pt -89.48 -14.79 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.536 -174.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.99 39.45 20.04 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.034 0.374 . . . . 0.0 114.034 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -133.0 146.27 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.317 1.047 . . . . 0.0 109.361 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -85.15 91.46 8.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.43 -1.29 49.69 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.228 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.15 -48.99 11.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.32 -30.22 60.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.485 1.114 . . . . 0.0 112.307 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.3 mtt -61.23 156.43 18.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.973 0.509 . . . . 0.0 111.001 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.66 162.45 20.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.567 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 31.3 t80 -49.42 -55.37 13.32 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.929 0.892 . . . . 0.0 112.765 -173.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.59 -40.31 82.86 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.7 0.8 . . . . 0.0 111.526 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -66.56 -53.62 32.67 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.971 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -64.86 -30.34 71.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.676 0.61 . . . . 0.0 112.074 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 80.8 mt -61.48 -49.56 76.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.124 0.57 . . . . 0.0 110.612 171.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -64.59 -28.59 69.73 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.447 0.467 . . . . 0.0 111.356 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -68.93 -39.23 79.72 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.371 0.668 . . . . 0.0 110.671 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 72.0 mt -65.15 -49.58 69.3 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 122.913 0.485 . . . . 0.0 110.479 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.651 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 4.5 mtpp -68.65 -27.4 65.96 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.945 0.898 . . . . 0.0 112.671 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -58.37 -40.9 83.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.623 0.769 . . . . 0.0 110.349 165.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 87.0 m-20 -93.6 19.28 8.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.397 1.079 . . . . 0.0 110.078 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 64.99 32.89 10.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.124 0.97 . . . . 0.0 111.693 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 72.3 mt -108.59 126.08 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.86 0.864 . . . . 0.0 109.514 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.8 156.04 16.22 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.4 mt -120.98 133.25 55.26 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.453 ' HB3' HD22 ' A' ' 19' ' ' LEU . 6.9 t90 -162.62 -169.16 2.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -145.64 165.25 29.25 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.287 1.035 . . . . 0.0 110.34 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.484 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.9 t -80.77 -47.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.644 0.778 . . . . 0.0 110.805 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -98.14 110.86 23.37 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.355 0.662 . . . . 0.0 111.711 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.09 -24.64 65.06 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.027 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.12 135.0 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.492 0.717 . . . . 0.0 109.609 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.68 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.29 146.46 15.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.496 ' HB3' HD12 ' A' ' 2' ' ' ILE . 79.1 p . . . . . 0 N--CA 1.477 0.887 0 CA-C-N 117.87 0.835 . . . . 0.0 110.344 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 80' ' ' SER . 51.2 mt . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.78 54.81 4.98 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.42 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.68 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.2 t70 -170.42 148.98 3.25 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.51 17.38 12.1 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.474 0.71 . . . . 0.0 112.434 -166.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -89.71 118.13 29.09 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.312 0.577 . . . . 0.0 109.49 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.1 mt -122.55 146.73 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 109.248 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -64.38 147.33 52.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.921 0.888 . . . . 0.0 110.173 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -81.52 117.48 21.96 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.484 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 59.9 m-85 -105.65 0.65 26.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.509 0.724 . . . . 0.0 111.107 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.9 p -75.4 -16.81 60.33 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.98 -5.82 70.27 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.385 -0.675 . . . . 0.0 112.396 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.489 HD23 ' HE1' ' A' ' 103' ' ' MET . 15.3 mt -48.16 -55.08 11.25 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 123.857 0.863 . . . . 0.0 111.107 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -60.29 -26.99 66.92 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.334 0.653 . . . . 0.0 111.77 -167.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -76.16 -41.12 50.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.084 0.954 . . . . 0.0 111.881 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.489 ' HE1' HD23 ' A' ' 100' ' ' LEU . 22.7 ptt? -91.4 -23.15 20.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.445 ' CG1' HD12 ' A' ' 10' ' ' LEU . 15.0 m -122.08 107.95 34.81 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.363 0.529 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.98 -36.49 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.32 2.013 . . . . 0.0 111.961 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -86.35 -10.06 55.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -170.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.35 116.49 5.56 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 121.147 0.499 . . . . 0.0 110.756 -171.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.414 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 5.9 ptm180 -111.06 -43.63 3.72 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.338 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' A' ' 16' ' ' ILE . 47.5 tp -126.11 127.58 46.0 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 122.933 0.493 . . . . 0.0 110.009 -167.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.8 mt -110.99 114.15 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.6 m -96.55 115.8 28.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.952 0.901 . . . . 0.0 110.993 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.05 116.26 28.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.655 1.182 . . . . 0.0 109.04 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -93.75 119.35 32.62 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.43 143.05 11.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.103 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 57.2 ttp180 -50.98 -48.75 61.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.45 1.1 . . . . 0.0 112.068 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -49.21 -36.01 18.8 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.73 1.212 . . . . 0.0 112.761 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.88 -42.7 23.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.174 0.59 . . . . 0.0 109.9 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.58 -10.13 47.82 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.54 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 76.4 mt-10 -68.24 -34.59 76.5 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.041 0.536 . . . . 0.0 110.701 172.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -100.71 19.49 16.97 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.931 0.893 . . . . 0.0 110.885 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.531 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.1 tm-20 -63.07 -49.34 81.55 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.344 1.058 . . . . 0.0 112.933 170.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.85 -16.27 49.48 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.73 1.62 . . . . 0.0 112.887 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.09 -52.13 67.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.278 1.031 . . . . 0.0 110.868 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.0 -5.06 58.95 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.011 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -66.55 -32.62 74.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.7 0.4 . . . . 0.0 110.331 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.59 -12.6 61.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.536 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.425 ' HE3' ' HB2' ' A' ' 97' ' ' PHE . 59.2 mtt -96.17 11.97 32.46 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.175 0.99 . . . . 0.0 111.433 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.33 73.77 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.323 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -105.49 136.18 45.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.301 0.641 . . . . 0.0 110.325 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.67 140.07 57.88 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 167.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 29.3 p -128.82 141.86 51.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.252 0.548 . . . . 0.0 110.816 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -135.28 126.85 28.85 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.765 1.226 . . . . 0.0 108.83 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.94 106.81 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.63 153.33 50.18 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.109 0.964 . . . . 0.0 109.516 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.566 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 49.0 Cg_exo -58.63 164.48 9.32 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.131 2.554 . . . . 0.0 113.195 172.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.7 t -65.69 110.7 2.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 p -80.66 25.16 0.44 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.031 0.932 . . . . 0.0 112.088 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.8 t -63.0 147.79 49.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.967 0.907 . . . . 0.0 110.337 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.21 -20.88 75.42 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.343 -0.389 . . . . 0.0 113.343 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.73 -8.45 56.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.018 0.527 . . . . 0.0 111.129 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.02 13.19 10.51 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.391 1.076 . . . . 0.0 109.598 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.471 ' HA ' ' OG ' ' A' ' 145' ' ' SER . 48.9 ttp180 -66.77 -31.9 72.84 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.493 0.717 . . . . 0.0 110.558 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -57.3 -32.71 66.94 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.091 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.63 -22.92 16.21 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.491 1.117 . . . . 0.0 110.674 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.579 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 84.0 p -90.43 11.64 20.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.024 0.529 . . . . 0.0 112.092 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.07 -69.79 0.18 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.112 0.965 . . . . 0.0 111.949 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -90.4 -2.97 57.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.298 0.639 . . . . 0.0 111.134 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 13.1 tpt180 -72.61 -18.36 61.6 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.744 0.818 . . . . 0.0 109.499 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -25.24 0.79 Allowed 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.58 1.152 . . . . 0.0 113.079 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.5 t -60.89 -44.95 96.41 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.089 0.955 . . . . 0.0 111.928 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 155' ' ' VAL . 9.5 pt-20 -72.95 -32.25 65.13 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -67.01 -40.19 87.26 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 4.7 tm-20 -71.15 -33.3 69.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.45 63.95 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.153 0.581 . . . . 0.0 111.531 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 151' ' ' GLU . 71.5 t -81.64 -57.62 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.877 0.471 . . . . 0.0 110.746 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -92.78 1.6 57.2 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -166.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -61.76 -41.46 97.71 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -77.69 -10.75 59.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.419 0.687 . . . . 0.0 111.831 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 16' ' ' ILE . 38.7 mt -78.99 -25.21 43.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.586 -168.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.39 -45.08 89.2 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 166.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 CA--C 1.556 1.193 0 C-N-CA 124.985 1.314 . . . . 0.0 111.578 174.607 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.1 mm . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.482 ' HB2' HD22 ' A' ' 22' ' ' LEU . 56.9 mtpt -84.91 125.69 32.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.61 0.764 . . . . 0.0 109.975 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.75 135.27 35.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.281 0.633 . . . . 0.0 111.69 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.484 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -76.43 -177.01 43.13 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.986 165.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.75 144.67 37.64 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.225 -172.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.96 151.72 32.42 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.83 2.353 . . . . 0.0 112.254 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 139.33 58.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.644 0.778 . . . . 0.0 112.65 -172.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.611 HG13 HD22 ' A' ' 62' ' ' LEU . 65.9 t -104.84 88.59 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.482 HD12 HG11 ' A' ' 104' ' ' VAL . 54.1 tp -138.46 153.37 48.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.808 -160.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.07 165.23 19.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.306 1.042 . . . . 0.0 110.189 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 8.9 pt-20 -65.72 -17.66 64.78 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.99 0.916 . . . . 0.0 111.957 171.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 46.2 m-80 -120.55 91.57 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.2 m -141.07 118.8 11.68 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.059 0.944 . . . . 0.0 109.074 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.24 -37.75 19.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.685 0.794 . . . . 0.0 110.659 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 66.4 mt -125.83 124.44 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.246 0.618 . . . . 0.0 109.889 -174.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.52 115.25 29.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.447 HG21 ' ND2' ' A' ' 113' ' ' ASN . 47.8 mt -94.2 102.98 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 73' ' ' TRP . 98.2 mt -94.67 119.15 32.85 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.034 0.933 . . . . 0.0 110.233 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.62 -178.78 37.52 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -93.94 -78.55 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 3' ' ' LYS . 64.1 tp -134.3 116.34 13.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 170.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.7 Cg_exo -53.63 148.39 35.75 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.207 2.605 . . . . 0.0 113.584 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' ILE . 29.0 t -61.55 150.7 35.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.623 1.169 . . . . 0.0 111.918 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 10.4 m-20 -55.03 -43.49 73.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.877 0.871 . . . . 0.0 110.71 175.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.584 ' HB3' HD22 ' A' ' 36' ' ' ASN . 15.2 tp10 -66.55 -26.06 66.95 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.454 1.096 . . . . 0.0 111.0 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.579 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 69.4 m -73.54 -40.91 63.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 24' ' ' SER . 64.1 mt -71.32 -21.69 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.501 1.12 . . . . 0.0 111.413 -176.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 20.3 mmt85 -61.31 -33.12 73.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.035 0.534 . . . . 0.0 110.915 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.565 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 80.6 mttt -110.46 -2.47 16.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.011 0.924 . . . . 0.0 111.116 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 58.57 27.73 16.1 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.639 1.576 . . . . 0.0 112.748 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -138.27 156.35 47.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.959 0.904 . . . . 0.0 110.231 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -71.35 -5.51 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.597 0.759 . . . . 0.0 110.288 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -77.34 -16.93 58.66 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.969 1.708 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.83 -30.72 73.6 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 0.0 114.307 -175.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.584 HD22 ' HB3' ' A' ' 26' ' ' GLU . 36.8 m-80 -124.09 99.38 37.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.334 0.654 . . . . 0.0 110.437 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.08 -7.51 15.28 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.676 164.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.404 ' HA2' HH12 ' A' ' 43' ' ' ARG . . . -85.13 -15.76 66.3 Favored Glycine 0 C--N 1.357 1.741 0 O-C-N 123.525 0.516 . . . . 0.0 112.214 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -73.79 125.76 28.86 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 137' ' ' SER . 1.3 t0 -79.43 -4.88 53.19 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.926 0.891 . . . . 0.0 112.088 -158.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 113' ' ' ASN . 38.0 m-85 -48.48 -36.19 14.61 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.193 0.997 . . . . 0.0 111.663 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -73.25 -32.36 64.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.432 0.693 . . . . 0.0 112.192 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.582 ' HD2' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -88.48 -23.51 23.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.754 0.422 . . . . 0.0 111.511 177.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HB2' ' A' ' 149' ' ' GLU . 49.4 mt -86.38 -45.67 10.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.939 0.496 . . . . 0.0 111.051 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.95 -32.48 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.54 94.49 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.476 0.485 . . . . 0.0 112.971 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -61.81 -43.59 98.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.75 0.82 . . . . 0.0 109.809 171.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 156' ' ' PHE . . . -71.61 -33.32 68.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.596 -1.183 . . . . 0.0 113.978 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -94.43 -11.37 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.991 0.517 . . . . 0.0 111.146 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 27.54 63.61 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.423 0.452 . . . . 0.0 113.314 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.14 113.0 6.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.3 99.82 0.97 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.202 0.601 . . . . 0.0 111.086 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.463 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 77.0 mt -67.66 -27.89 67.24 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.303 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.582 ' HG3' ' HD2' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -65.17 -37.85 88.69 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.443 0.697 . . . . 0.0 111.438 -173.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.5 -36.9 63.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.02 0.528 . . . . 0.0 112.081 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.9 mtt -62.83 149.15 44.97 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -171.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 153.92 40.61 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.208 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.49 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 t80 -44.34 -50.57 9.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.144 0.978 . . . . 0.0 113.501 -171.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 43.1 mt-10 -61.83 -54.17 45.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.504 0.722 . . . . 0.0 111.44 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -58.06 -37.2 73.97 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.639 0.776 . . . . 0.0 111.127 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 35.5 ttmt -62.54 -45.97 90.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.11 0.964 . . . . 0.0 110.132 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.611 HD22 HG13 ' A' ' 9' ' ' VAL . 25.8 mt -61.73 -47.28 85.97 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.134 0.896 . . . . 0.0 110.957 175.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 66.9 mttm -55.02 -38.05 67.42 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -66.79 -51.46 55.46 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.156 0.91 . . . . 0.0 110.238 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.438 HD11 ' HA ' ' A' ' 62' ' ' LEU . 57.2 mt -52.8 -56.72 13.67 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.936 0.894 . . . . 0.0 111.395 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.514 ' HE3' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.14 -30.54 71.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.315 0.646 . . . . 0.0 111.947 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.28 -36.89 85.17 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.272 0.629 . . . . 0.0 111.175 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -90.94 6.51 44.35 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.385 0.674 . . . . 0.0 110.959 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 65.57 37.44 5.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 111.359 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.24 132.37 56.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 109.46 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.3 154.02 17.24 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -121.26 132.38 54.77 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 95' ' ' ASN . 4.2 t90 -156.08 -169.76 3.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -143.24 165.54 27.18 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.54 0.736 . . . . 0.0 110.2 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 72.5 t -82.23 -62.29 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.468 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.66 107.7 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.326 0.584 . . . . 0.0 111.374 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.414 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.2 ttmt -64.31 -31.92 73.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.032 170.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 93' ' ' GLU . . . -152.55 126.85 9.23 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.14 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.527 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -134.3 135.45 7.99 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 123.171 0.588 . . . . 0.0 110.052 -176.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.25 -23.57 77.2 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.312 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.527 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 7.0 t70 -84.07 157.8 21.64 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.123 0.487 . . . . 0.0 110.744 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.3 24.13 8.84 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.904 -170.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' HB3' ' HB1' ' A' ' 78' ' ' ALA . 10.8 tp10 -85.75 111.48 20.18 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.36 155.38 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.112 0.965 . . . . 0.0 109.056 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 73' ' ' TRP . 59.0 m-80 -76.63 149.31 36.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.169 0.988 . . . . 0.0 110.484 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.26 116.48 19.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 0.0 110.494 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.446 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.4 m-85 -103.6 4.05 35.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.652 0.781 . . . . 0.0 111.351 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.1 m -74.48 -29.95 61.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.698 0.399 . . . . 0.0 110.746 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.88 -10.79 85.27 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.014 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.6 mt -47.4 -54.15 12.02 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.133 0.973 . . . . 0.0 111.592 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.1 mtpt -61.43 -18.76 60.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -167.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.05 -39.15 17.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.282 0.633 . . . . 0.0 111.485 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -96.26 -15.49 21.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 11.1 m -126.95 91.16 47.68 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-N 118.758 0.708 . . . . 0.0 111.023 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.88 -28.78 3.79 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.387 2.058 . . . . 0.0 113.251 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 106' ' ' LYS . 11.4 mmpt? -94.73 -0.5 54.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.1 tp -60.89 104.42 0.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.518 0.675 . . . . 0.0 111.395 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -93.42 -49.36 5.96 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.841 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 42.7 tp -131.58 133.41 44.99 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.276 0.63 . . . . 0.0 110.056 -173.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.494 HG12 HD23 ' A' ' 107' ' ' LEU . 38.4 mt -105.12 115.67 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 92.4 m -96.09 113.25 24.84 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.448 0.299 . . . . 0.0 110.336 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -90.35 107.74 19.33 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.447 ' ND2' HG21 ' A' ' 18' ' ' ILE . 7.6 p30 -86.12 110.48 19.58 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.58 134.62 7.56 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.496 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.449 ' HA ' HG11 ' A' ' 133' ' ' VAL . 33.4 ttm180 -72.11 -3.25 22.04 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.231 1.012 . . . . 0.0 113.421 -175.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.54 -29.85 41.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.827 0.451 . . . . 0.0 110.307 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.373 0.669 . . . . 0.0 109.664 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.8 -16.02 58.65 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 114.925 -1.034 . . . . 0.0 115.194 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -56.34 -29.58 61.52 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.522 0.729 . . . . 0.0 111.789 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -116.51 20.29 14.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.815 0.846 . . . . 0.0 111.247 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.36 -53.85 54.3 Favored Pre-proline 0 CA--C 1.567 1.622 0 C-N-CA 123.302 0.641 . . . . 0.0 112.23 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.75 -15.49 33.37 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 121.851 1.701 . . . . 0.0 112.727 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.08 -44.87 91.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 10.0 mt -82.4 -5.38 58.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.244 -172.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -72.43 -22.5 61.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.93 -21.52 67.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.628 0.58 . . . . 0.0 113.197 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.6 mpt? -86.66 7.62 25.81 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.76 0.824 . . . . 0.0 111.026 175.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.63 20.94 70.25 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.153 0.406 . . . . 0.0 113.959 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.453 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 35.5 m-85 -110.62 145.51 37.76 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.193 0.597 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.26 143.62 40.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.3 p -130.32 151.12 51.18 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.531 0.732 . . . . 0.0 110.131 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.44 121.82 4.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 109.313 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 115' ' ' ARG . 52.2 t -85.84 130.56 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.132 0.492 . . . . 0.0 110.084 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.6 mt -101.09 152.74 37.96 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.961 1.304 . . . . 0.0 108.274 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.14 153.03 78.79 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.434 2.09 . . . . 0.0 112.575 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 m -59.52 114.46 2.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.411 1.084 . . . . 0.0 110.339 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 40' ' ' ASP . 19.4 m -86.34 49.12 1.73 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.556 0.693 . . . . 0.0 111.894 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 p -68.96 139.44 55.04 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 154.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.82 57.88 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 123.474 0.484 . . . . 0.0 113.445 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.56 86.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.108 0.563 . . . . 0.0 110.567 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.82 -41.66 67.95 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.108 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -53.93 -34.02 58.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.692 0.62 . . . . 0.0 111.76 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -69.0 -29.83 68.11 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -98.82 22.49 10.04 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.987 1.315 . . . . 0.0 110.697 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 66.6 m -157.32 34.98 0.28 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.096 0.959 . . . . 0.0 109.697 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -66.8 -35.09 79.27 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.799 1.036 . . . . 0.0 113.799 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.28 -13.86 26.05 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.586 0.355 . . . . 0.0 110.249 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.433 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.9 tpt180 -79.73 -38.7 32.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.302 0.641 . . . . 0.0 109.776 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.447 ' HB2' HD23 ' A' ' 44' ' ' LEU . 12.5 pt-20 -62.68 -18.19 61.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.479 1.112 . . . . 0.0 112.212 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.1 t -58.88 -23.05 60.49 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.42 0.688 . . . . 0.0 111.651 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 155' ' ' VAL . 9.4 pt-20 -65.6 -32.14 73.56 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 122.996 0.518 . . . . 0.0 110.654 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -65.62 -43.11 90.57 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.44 -37.72 88.38 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.695 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.13 -14.36 59.81 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.072 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 151' ' ' GLU . 48.5 t -87.13 -54.58 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.411 0.685 . . . . 0.0 110.601 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 71.9 m-85 -91.77 2.87 56.21 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -168.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -72.62 -28.18 62.6 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.271 0.487 . . . . 0.0 112.163 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -74.6 -6.87 51.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.419 HD13 HD11 ' A' ' 16' ' ' ILE . 95.4 mt -76.08 -22.6 55.41 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.98 0.512 . . . . 0.0 111.603 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.58 -15.39 62.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.871 0.468 . . . . 0.0 111.129 166.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 125.594 1.558 . . . . 0.0 110.252 175.266 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 80' ' ' SER . 46.1 mm . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -94.81 131.88 40.2 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -91.61 130.82 37.36 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 110.305 171.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 158.96 53.62 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 162.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -82.72 143.5 47.03 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 117.779 0.789 . . . . 0.0 110.084 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 162.44 1.55 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.206 2.604 . . . . 0.0 112.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.22 125.74 26.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.37 0.605 . . . . 0.0 110.513 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.562 HG13 HD23 ' A' ' 62' ' ' LEU . 21.2 t -91.03 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.448 HD12 ' CG1' ' A' ' 104' ' ' VAL . 49.9 tp -110.27 143.94 39.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.982 -162.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -125.89 163.62 22.55 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.8 -22.17 66.55 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.194 0.521 . . . . 0.0 110.968 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.619 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 45.1 m-80 -103.43 77.64 1.53 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.5 m -133.53 104.68 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.03 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.475 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 84.3 mt-10 -89.72 -30.15 18.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.549 1.14 . . . . 0.0 109.827 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.8 mt -126.68 118.18 50.13 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 123.886 0.874 . . . . 0.0 109.023 174.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -103.72 117.05 33.47 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 HG12 ' HB2' ' A' ' 111' ' ' CYS . 44.1 mt -99.54 110.33 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.79 118.14 35.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.47 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -72.94 -168.59 12.89 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 164.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -103.99 -72.46 0.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 tp -147.31 124.62 5.79 Favored Pre-proline 0 C--O 1.243 0.763 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.58 150.31 70.18 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.935 2.423 . . . . 0.0 112.452 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.0 t -68.92 163.41 24.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.981 0.912 . . . . 0.0 110.758 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 m-20 -53.77 -48.28 69.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.417 0.687 . . . . 0.0 110.46 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.18 -39.91 80.12 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.316 1.01 . . . . 0.0 111.361 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -67.35 -45.76 75.42 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.14 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.1 mt -71.6 -19.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.298 1.039 . . . . 0.0 111.976 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 28.5 mmm180 -70.39 -46.76 63.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -90.76 -6.54 54.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.447 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 65.97 22.08 11.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.175 1.39 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -129.32 142.92 50.7 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 109.377 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -60.79 -44.24 97.08 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.027 0.918 . . . . 0.0 108.569 165.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.87 -8.62 5.22 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.389 171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.98 -31.69 58.84 Favored Glycine 0 C--N 1.351 1.397 0 C-N-CA 123.54 0.59 . . . . 0.0 112.979 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -100.79 104.8 33.94 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.66 -10.92 29.77 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.404 2.736 . . . . 0.0 112.719 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.75 -6.84 64.11 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.06 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -79.7 116.81 20.1 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -83.24 -0.5 49.78 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.262 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -42.47 -42.66 3.35 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.454 1.901 . . . . 0.0 112.974 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -74.36 -21.71 59.55 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.697 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.54 -37.12 17.17 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.763 0.825 . . . . 0.0 111.222 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.41 -52.61 15.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.79 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.05 -39.11 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.051 0.54 . . . . 0.0 109.557 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.76 99.6 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.911 0.757 . . . . 0.0 113.982 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -69.02 -34.91 76.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.654 . . . . 0.0 110.24 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 153' ' ' GLU . . . -71.6 -38.78 70.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.045 0.938 . . . . 0.0 112.81 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.47 HD12 ' ND2' ' A' ' 68' ' ' ASN . 13.8 pt -89.72 -9.98 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.952 0.501 . . . . 0.0 111.563 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.3 29.55 66.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.211 0.32 . . . . 0.0 113.022 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -133.71 112.97 11.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -66.27 93.07 0.2 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.283 0.563 . . . . 0.0 110.298 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.17 -39.42 89.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.78 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -57.12 -46.5 82.59 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.581 1.152 . . . . 0.0 111.709 -166.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -69.59 -37.47 76.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.392 0.677 . . . . 0.0 112.195 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.13 145.74 49.95 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.497 0.719 . . . . 0.0 112.369 -172.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.18 138.82 55.91 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.29 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.525 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 57.1 t80 -43.94 -46.49 8.19 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.532 1.133 . . . . 0.0 113.529 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.13 -47.99 80.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 111.857 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -63.93 -37.99 89.45 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.251 1.021 . . . . 0.0 110.701 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 58' ' ' TYR . 19.5 ttmm -60.45 -43.15 97.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.707 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.562 HD23 HG13 ' A' ' 9' ' ' VAL . 72.7 mt -65.88 -42.53 90.18 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.015 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -61.21 -33.38 73.38 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.6 m -64.22 -45.08 89.82 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.225 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.8 mt -57.59 -47.83 81.06 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.476 0.485 . . . . 0.0 110.371 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HE2' HG12 ' A' ' 9' ' ' VAL . 26.3 mmtp -61.95 -37.68 85.62 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.204 0.602 . . . . 0.0 110.417 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -58.21 -40.83 82.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.159 0.983 . . . . 0.0 111.456 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.47 ' ND2' HD12 ' A' ' 49' ' ' ILE . 64.3 m-80 -89.88 3.5 52.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.141 0.576 . . . . 0.0 110.868 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 1.1 mpp_? 65.68 45.65 2.59 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.218 1.407 . . . . 0.0 111.592 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.8 mt -114.09 131.86 64.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 109.168 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.15 160.33 13.29 Favored Glycine 0 N--CA 1.462 0.411 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 169.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.5 mt -124.49 145.34 49.59 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -165.88 -168.9 1.38 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -128.43 170.16 13.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.077 0.551 . . . . 0.0 109.639 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 77.3 t -83.0 -45.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -95.77 112.28 24.04 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.179 0.591 . . . . 0.0 109.79 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -67.37 -24.52 65.71 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.777 0.831 . . . . 0.0 110.462 171.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.94 140.64 19.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.96 0.904 . . . . 0.0 109.854 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.525 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -150.03 134.14 4.69 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.505 ' HB3' HD12 ' A' ' 2' ' ' ILE . 47.4 p . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.241 0.642 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.32 59.01 4.89 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.525 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.4 t70 179.05 154.56 0.44 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.126 0.971 . . . . 0.0 110.26 -173.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.02 28.91 6.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.816 1.246 . . . . 0.0 112.237 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.2 100.01 6.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.716 0.689 . . . . 0.0 109.256 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.3 mt -101.86 147.76 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.346 1.059 . . . . 0.0 110.354 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.93 151.17 46.88 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.643 0.777 . . . . 0.0 110.166 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.96 103.66 10.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.444 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 54.8 m-85 -93.54 1.85 56.6 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.606 0.762 . . . . 0.0 111.032 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.3 m -74.76 -9.45 58.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.658 0.383 . . . . 0.0 111.752 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.31 -5.28 70.06 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.739 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.43 HD12 ' SD ' ' A' ' 127' ' ' MET . 17.2 mt -47.38 -58.01 4.64 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 123.898 0.879 . . . . 0.0 113.252 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -63.63 -14.52 52.54 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -164.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.21 -46.88 8.14 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.179 0.992 . . . . 0.0 111.168 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -83.23 -23.41 32.78 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 9.8 m -123.67 90.51 50.53 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 123.08 0.552 . . . . 0.0 110.629 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.06 -34.84 4.65 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.462 2.108 . . . . 0.0 111.695 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.619 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.1 mmpt? -73.41 -17.9 61.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.138 0.975 . . . . 0.0 113.471 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 33.2 tp -62.16 133.32 55.07 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 123.518 0.511 . . . . 0.0 111.445 -170.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -142.64 -28.93 0.58 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.882 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 58.1 tp -134.62 138.87 44.88 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.642 0.777 . . . . 0.0 109.715 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.564 ' HB ' HG22 ' A' ' 131' ' ' THR . 72.2 mt -113.98 143.64 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.469 ' SG ' HG13 ' A' ' 155' ' ' VAL . 72.3 m -126.64 130.31 50.2 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.492 0.717 . . . . 0.0 109.521 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.435 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 92.3 m-85 -105.04 130.18 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.191 0.596 . . . . 0.0 111.09 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.428 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 94.4 m-20 -85.29 88.81 7.53 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.141 0.576 . . . . 0.0 109.943 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 170.82 26.22 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.153 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 65.1 ttt180 -53.48 -63.65 1.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.112 0.965 . . . . 0.0 112.064 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -61.17 -12.41 12.56 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -84.65 -50.04 8.0 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.12 -9.77 72.43 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.962 -1.017 . . . . 0.0 115.108 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.1 mt-10 -64.62 -18.46 64.94 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.833 0.816 . . . . 0.0 111.762 176.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.36 25.15 12.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.199 1.0 . . . . 0.0 110.664 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.5 -52.32 73.7 Favored Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 123.628 0.771 . . . . 0.0 112.738 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' ' 125' ' ' ARG . 71.1 Cg_endo -67.17 -19.19 51.07 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.082 1.855 . . . . 0.0 112.845 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.58 -46.02 87.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.054 0.942 . . . . 0.0 110.34 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.487 ' HB2' HG23 ' A' ' 131' ' ' THR . 18.7 mt -86.65 -9.69 55.46 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.461 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 122' ' ' PRO . 95.1 mtt-85 -69.66 -26.29 64.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.123 0.569 . . . . 0.0 110.782 169.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.37 -10.56 70.32 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.964 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.43 ' SD ' HD12 ' A' ' 100' ' ' LEU . 59.9 mtt -94.99 12.11 29.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.983 0.913 . . . . 0.0 110.696 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.79 -4.39 74.82 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -91.23 144.8 25.23 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.946 0.498 . . . . 0.0 110.921 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -74.32 145.85 43.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.564 HG22 ' HB ' ' A' ' 110' ' ' ILE . 18.6 p -134.98 148.61 50.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.066 0.946 . . . . 0.0 108.901 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -142.0 127.48 18.92 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.092 0.957 . . . . 0.0 108.697 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.74 110.87 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 111' ' ' CYS . 92.9 mt -95.11 154.68 39.53 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.87 154.29 58.47 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.936 1.757 . . . . 0.0 111.586 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -66.64 113.77 5.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.8 t -79.33 36.34 0.3 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -167.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -74.67 159.6 31.87 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.286 0.634 . . . . 0.0 110.559 172.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.62 47.05 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.96 14.67 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.583 0.692 . . . . 0.0 110.737 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -74.14 -23.8 59.32 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.139 0.576 . . . . 0.0 110.923 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.586 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 37.8 ptt180 -66.88 -25.74 66.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.805 0.336 . . . . 0.0 110.625 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -63.2 -26.22 68.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.234 1.014 . . . . 0.0 110.965 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -99.13 -24.85 14.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.621 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 49.5 m -82.97 22.55 0.93 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.809 0.844 . . . . 0.0 112.59 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.95 -61.06 2.06 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.56 -30.89 67.49 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 167.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.621 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 48.0 mtp180 -83.71 -11.3 57.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.37 0.268 . . . . 0.0 111.288 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.1 -34.35 30.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.059 0.544 . . . . 0.0 111.05 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.3 m -60.25 -39.55 87.13 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.925 0.89 . . . . 0.0 112.466 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -72.31 -36.28 68.85 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -64.59 -47.51 78.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 26.7 tt0 -64.12 -37.35 87.14 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.883 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.75 -37.3 62.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.903 0.752 . . . . 0.0 111.276 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.469 HG13 ' SG ' ' A' ' 111' ' ' CYS . 20.9 t -61.88 -39.22 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.701 0.801 . . . . 0.0 111.362 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -106.36 1.21 25.57 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 122.12 -0.362 . . . . 0.0 110.44 -171.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 ttm180 -71.88 -40.11 69.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.486 0.715 . . . . 0.0 110.108 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -76.67 -4.77 44.86 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.73 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.7 -30.19 62.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.002 0.521 . . . . 0.0 109.717 172.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -94.92 -55.37 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.942 -176.107 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -92.06 113.81 26.18 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -87.37 123.08 31.94 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 122.613 0.365 . . . . 0.0 111.126 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.71 166.57 54.85 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.256 168.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -94.18 145.94 30.68 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 119.284 -0.389 . . . . 0.0 111.195 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.84 159.68 32.4 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.821 2.347 . . . . 0.0 111.439 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.15 130.08 41.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.262 0.554 . . . . 0.0 111.532 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.528 HG11 HD21 ' A' ' 62' ' ' LEU . 46.5 t -95.7 60.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.42 HD13 HD11 ' A' ' 17' ' ' LEU . 42.0 tp -106.58 153.95 21.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.339 -161.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.636 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 22.7 t0 -126.07 154.83 42.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.89 1.276 . . . . 0.0 108.056 170.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.07 -11.22 60.59 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.853 0.461 . . . . 0.0 111.667 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.447 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . 23.8 m-80 -108.83 17.92 21.3 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.869 0.467 . . . . 0.0 110.79 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -72.78 117.73 14.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.194 0.598 . . . . 0.0 111.154 -174.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.07 -36.29 17.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.073 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.1 mt -126.1 112.1 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 10' ' ' LEU . 59.9 tp -103.43 118.61 37.15 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.533 HG12 ' HB2' ' A' ' 111' ' ' CYS . 41.9 mt -104.18 110.17 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 109.178 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 82.8 mt -100.27 124.77 46.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.337 1.055 . . . . 0.0 109.901 -177.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -78.84 -171.86 40.75 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 164.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.4 p -100.39 -68.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 tp -149.35 116.96 3.73 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 173.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.48 166.02 23.14 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.004 2.469 . . . . 0.0 113.423 -167.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -65.39 147.2 53.84 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.327 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.8 m-20 -57.63 -39.15 76.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.137 0.975 . . . . 0.0 111.358 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.81 -28.35 69.8 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 124.142 0.901 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.535 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 39.2 m -84.73 -38.28 19.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.584 0.753 . . . . 0.0 110.401 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.2 -29.19 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.832 0.853 . . . . 0.0 111.158 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.2 mmt180 -54.16 -38.17 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 170.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -94.25 -16.34 23.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.096 0.958 . . . . 0.0 110.514 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 56.46 24.96 9.11 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.927 1.291 . . . . 0.0 111.729 -170.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -144.16 151.49 39.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.032 0.933 . . . . 0.0 110.208 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.449 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 87.8 m-85 -70.41 -0.38 8.16 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.983 1.313 . . . . 0.0 114.52 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 2.5 p90 -96.94 -12.06 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.64 -33.07 80.72 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.845 0.715 . . . . 0.0 113.143 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -103.25 100.01 16.53 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.38 0.672 . . . . 0.0 109.525 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.25 -21.07 23.83 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.189 2.593 . . . . 0.0 111.638 171.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.57 -1.75 66.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.435 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -79.38 112.49 16.66 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -87.64 -1.36 57.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.837 0.855 . . . . 0.0 110.806 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' HE1' HG22 ' A' ' 18' ' ' ILE . 82.3 t80 -39.83 -45.08 1.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.979 1.711 . . . . 0.0 112.602 172.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.464 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 80.3 m95 -70.74 -27.78 64.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.311 -173.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -74.81 -48.4 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.414 0.286 . . . . 0.0 110.255 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.34 -47.07 83.69 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.936 0.773 . . . . 0.0 110.83 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.25 -40.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.43 0.692 . . . . 0.0 109.96 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.58 85.42 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.922 0.764 . . . . 0.0 113.636 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -73.52 -44.11 58.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.695 0.798 . . . . 0.0 110.146 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . . . -64.35 -38.99 92.99 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.541 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.9 pt -88.29 -15.25 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.34 28.43 63.88 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 116.477 -0.329 . . . . 0.0 113.828 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -143.65 96.97 2.99 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.9 105.95 0.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.011 0.924 . . . . 0.0 111.971 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.27 -23.31 40.86 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.408 0.683 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.36 -38.27 86.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.461 0.705 . . . . 0.0 111.474 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -94.13 6.13 49.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.542 0.737 . . . . 0.0 111.108 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.5 mtt -95.41 146.01 24.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.124 0.569 . . . . 0.0 110.567 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.9 158.45 35.54 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.071 170.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.566 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 32.8 t80 -47.76 -63.4 1.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.851 0.86 . . . . 0.0 113.141 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 29.8 mt-10 -59.89 -32.85 71.12 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.191 0.597 . . . . 0.0 111.095 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -54.98 12.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.925 0.89 . . . . 0.0 111.692 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HE2' ' CD2' ' A' ' 42' ' ' TRP . 8.2 ptmt -59.99 -29.75 68.67 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.473 -176.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 39.6 mt -64.95 -47.87 76.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.705 0.802 . . . . 0.0 111.476 173.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.9 mmmm -55.57 -38.16 68.99 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.234 0.54 . . . . 0.0 110.358 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.1 m -69.63 -39.53 77.09 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.355 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 62' ' ' LEU . 89.8 mt -57.4 -50.09 74.1 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.926 0.49 . . . . 0.0 110.529 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.636 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 1.8 mptm? -60.98 -37.07 81.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.72 0.637 . . . . 0.0 110.833 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -64.36 -42.09 96.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.877 0.871 . . . . 0.0 111.154 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.415 ' O ' HD12 ' A' ' 159' ' ' LEU . 59.7 m-80 -88.79 3.32 51.46 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.067 0.547 . . . . 0.0 110.903 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HD2' ' HB2' ' A' ' 13' ' ' ASN . 24.3 mmt180 67.05 35.13 4.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.356 1.062 . . . . 0.0 111.394 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -106.22 134.05 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.55 1.14 . . . . 0.0 108.797 174.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.16 151.15 18.01 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 172.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 mt -124.38 131.9 53.52 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 117.862 0.831 . . . . 0.0 109.833 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 2.8 t90 -152.74 -175.99 5.54 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -130.93 158.18 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.513 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.3 t -70.85 -44.33 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 173.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -101.79 108.28 19.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.432 0.634 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.537 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.7 ptmt -65.63 -24.71 67.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.528 167.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.94 137.52 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.919 0.888 . . . . 0.0 109.208 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.582 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -154.79 150.76 22.39 Favored Glycine 0 C--O 1.212 -1.234 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.479 0.977 0 CA-C-N 118.17 0.985 . . . . 0.0 109.544 -179.598 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.02 59.99 0.4 Allowed Glycine 0 N--CA 1.461 0.307 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.582 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 23.1 t70 -177.14 158.5 1.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.111 -1.544 . . . . 0.0 107.698 -164.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.27 20.71 11.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -167.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.537 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.7 tp10 -89.58 98.93 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 mt -110.53 150.0 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.867 0.867 . . . . 0.0 109.54 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -71.32 148.53 46.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.001 0.92 . . . . 0.0 110.632 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -79.0 96.78 5.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.822 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.513 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 31.6 m-85 -80.23 -8.45 59.46 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.23 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -72.12 -18.85 61.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.898 0.479 . . . . 0.0 110.753 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 -5.88 62.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.467 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.492 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 21.9 mt -52.57 -51.34 60.24 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.241 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.475 ' HZ1' ' HB3' ' A' ' 101' ' ' LYS . 6.8 mtpm? -58.94 -26.2 64.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.134 0.574 . . . . 0.0 112.268 -171.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.72 -35.9 65.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.5 0.72 . . . . 0.0 111.332 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -106.98 -14.56 14.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -172.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 19.2 m -125.29 86.64 56.73 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.211 0.914 . . . . 0.0 111.443 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.83 -33.13 4.01 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.714 2.276 . . . . 0.0 112.211 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.39 -7.72 58.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.107 0.563 . . . . 0.0 112.235 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 56.9 tp -58.67 104.12 0.2 Allowed 'General case' 0 C--N 1.355 0.805 0 O-C-N 123.659 0.6 . . . . 0.0 111.282 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.95 -47.2 7.13 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.5 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 49.7 tp -128.45 133.79 48.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.232 0.613 . . . . 0.0 110.967 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mt -108.46 126.39 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.533 ' HB2' HG12 ' A' ' 18' ' ' ILE . 78.9 m -109.46 115.99 30.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.513 0.725 . . . . 0.0 110.327 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.51 122.02 37.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.648 0.779 . . . . 0.0 110.549 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.533 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 84.5 m-20 -76.58 89.57 3.31 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 110.283 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.22 172.46 45.93 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.532 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 88.9 mtm180 -55.62 -50.93 68.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.467 1.107 . . . . 0.0 113.127 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 62.9 mmtt -62.32 -17.33 58.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.32 -37.76 13.82 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.65 -9.98 75.32 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.904 -1.044 . . . . 0.0 115.23 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.3 mt-10 -61.03 -26.07 67.36 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.455 0.645 . . . . 0.0 110.786 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -99.55 10.07 42.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.638 1.175 . . . . 0.0 111.405 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.472 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 35.9 tt0 -55.11 -54.06 54.57 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.698 171.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.25 -25.18 36.96 Favored 'Trans proline' 0 C--N 1.397 3.095 0 CA-C-N 121.075 1.42 . . . . 0.0 111.805 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.17 -41.74 98.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.67 0.788 . . . . 0.0 110.385 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 mt -96.34 -15.05 22.1 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.819 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -69.54 -32.07 70.65 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.456 0.646 . . . . 0.0 109.59 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.1 -5.0 64.6 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.454 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.433 ' HE3' ' HB2' ' A' ' 97' ' ' PHE . 59.5 mtt -93.98 13.03 24.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.693 0.797 . . . . 0.0 111.25 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.51 10.62 84.63 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.415 0.526 . . . . 0.0 114.415 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.07 145.75 27.58 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 122.869 0.468 . . . . 0.0 110.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.88 135.76 49.91 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.472 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 16.0 p -128.9 139.3 52.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.911 0.884 . . . . 0.0 109.531 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -146.36 131.12 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.15 104.37 15.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 111' ' ' CYS . 54.6 mt -82.29 147.43 56.82 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.399 172.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.645 ' HG3' ' HG3' ' A' ' 148' ' ' ARG . 42.5 Cg_endo -63.6 152.12 81.83 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 122.583 2.189 . . . . 0.0 111.727 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.0 m -60.08 123.24 16.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 m -86.16 12.4 9.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.944 0.498 . . . . 0.0 111.645 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p -60.85 149.0 37.44 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.13 0.572 . . . . 0.0 109.528 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.66 -28.72 60.35 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.328 0.393 . . . . 0.0 112.975 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.08 -35.22 79.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.909 0.884 . . . . 0.0 112.195 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -98.74 5.66 47.42 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.538 0.735 . . . . 0.0 111.43 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.409 ' HG2' ' HG ' ' A' ' 145' ' ' SER . 25.5 ttt-85 -73.93 -10.56 59.77 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.3 0.572 . . . . 0.0 110.699 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -52.29 -26.11 11.19 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.042 0.937 . . . . 0.0 112.994 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -96.47 2.82 52.87 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.599 0.76 . . . . 0.0 111.949 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.642 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 97.8 p -73.27 15.37 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -162.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.39 -74.21 0.17 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.284 0.947 . . . . 0.0 109.39 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.88 -25.21 63.59 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 112.002 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.645 ' HG3' ' HG3' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -69.42 -49.62 53.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.73 0.812 . . . . 0.0 110.158 -177.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -60.52 -36.53 78.62 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.264 0.626 . . . . 0.0 110.632 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -63.95 -40.78 97.21 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.535 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 6.9 pt-20 -70.06 -28.05 65.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.331 0.253 . . . . 0.0 110.715 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -71.63 -35.76 70.53 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.321 0.648 . . . . 0.0 109.745 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.1 -37.03 83.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.12 -17.62 64.94 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.456 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 151' ' ' GLU . 87.7 t -89.72 -61.94 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.316 0.646 . . . . 0.0 110.798 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 62.9 m-85 -86.51 2.45 47.91 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -164.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -75.55 -21.24 58.08 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -77.14 -10.86 59.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.775 0.43 . . . . 0.0 111.493 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 68' ' ' ASN . 81.2 mt -69.34 -14.78 63.11 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.639 0.775 . . . . 0.0 112.695 -170.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.64 -34.4 60.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.989 0.516 . . . . 0.0 111.003 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 124.944 1.298 . . . . 0.0 110.29 -173.235 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.473 HG22 ' HB3' ' A' ' 78' ' ' ALA . 41.0 mm . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 2.9 mptp? -94.64 111.57 23.33 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -86.6 143.41 27.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.97 -131.31 0.04 OUTLIER Glycine 0 CA--C 1.532 1.151 0 CA-C-O 121.281 0.379 . . . . 0.0 113.434 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -136.76 145.01 49.19 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.964 -0.727 . . . . 0.0 110.234 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.04 135.81 65.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.163 1.909 . . . . 0.0 108.956 166.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 135.44 57.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.655 0.597 . . . . 0.0 110.992 -170.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.566 HG11 HD23 ' A' ' 62' ' ' LEU . 74.9 t -96.32 88.31 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.478 HD11 ' CG1' ' A' ' 104' ' ' VAL . 16.8 tp -140.0 150.41 44.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -161.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.686 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 13.6 t70 -127.17 160.17 32.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.524 1.13 . . . . 0.0 108.396 171.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -67.28 -16.86 64.52 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.972 0.509 . . . . 0.0 111.88 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -102.37 17.57 23.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.986 0.914 . . . . 0.0 110.734 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -79.22 122.84 26.8 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.938 0.495 . . . . 0.0 110.167 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.574 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 30.7 tt0 -97.21 -32.23 12.04 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.546 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 159' ' ' LEU . 42.1 mt -130.25 123.91 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.416 HD13 HD12 ' A' ' 10' ' ' LEU . 58.7 tp -110.11 121.26 44.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -96.42 113.1 29.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.3 mt -99.91 111.64 23.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 109.384 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.4 177.36 21.31 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 167.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 t -90.57 -89.96 0.16 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.15 0.975 . . . . 0.0 108.789 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.77 112.31 14.93 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.93 149.11 83.01 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.172 1.915 . . . . 0.0 111.705 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.67 135.78 50.29 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.5 p-10 -61.75 -19.6 62.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -171.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -52.66 -36.57 57.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.719 1.208 . . . . 0.0 111.921 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 p -90.33 -33.97 15.88 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.294 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 81.7 mt -64.32 -37.66 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.224 1.01 . . . . 0.0 112.923 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 26.5 mmt180 -61.4 -28.59 69.36 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.204 0.526 . . . . 0.0 110.042 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -89.93 -23.28 21.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 111.131 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.08 28.02 14.27 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.994 1.317 . . . . 0.0 111.913 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.88 137.82 49.53 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.457 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.656 ' HB3' ' HZ2' ' A' ' 42' ' ' TRP . 93.5 m-85 -77.03 -2.96 36.67 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.699 167.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.695 ' HD1' ' HZ3' ' A' ' 61' ' ' LYS . 82.6 t80 -97.38 -18.68 18.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.424 1.09 . . . . 0.0 110.927 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.85 -108.44 0.03 OUTLIER Glycine 0 C--N 1.344 0.994 0 O-C-N 123.307 0.379 . . . . 0.0 112.331 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.69 93.22 46.55 Favored Pre-proline 0 N--CA 1.484 1.23 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HG2' ' HE1' ' A' ' 42' ' ' TRP . 7.7 Cg_exo -75.02 -52.43 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.916 2.411 . . . . 0.0 111.494 175.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.23 34.33 5.91 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -131.59 135.61 47.12 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.298 1.039 . . . . 0.0 111.838 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.99 0.28 28.24 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 124.946 1.299 . . . . 0.0 109.998 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -39.3 -50.3 2.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.254 2.222 . . . . 0.0 113.533 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.656 ' HZ2' ' HB3' ' A' ' 33' ' ' TYR . 72.9 m95 -69.11 -20.87 64.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.279 0.631 . . . . 0.0 112.21 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.458 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 4.6 mpt_? -86.77 -39.85 15.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.931 0.892 . . . . 0.0 110.339 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.76 -51.8 30.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.063 0.545 . . . . 0.0 111.053 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 t -73.16 -35.55 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.059 0.944 . . . . 0.0 109.61 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.74 -38.58 95.79 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.67 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -69.16 -40.6 78.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.245 0.618 . . . . 0.0 109.943 173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.77 -42.69 97.96 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.737 0.815 . . . . 0.0 112.925 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -95.15 -10.0 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.211 0.604 . . . . 0.0 112.162 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.55 59.19 Favored Glycine 0 C--N 1.353 1.496 0 O-C-N 123.266 0.354 . . . . 0.0 113.44 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.48 117.64 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.12 1.368 . . . . 0.0 108.389 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -68.47 88.73 0.34 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.597 0.713 . . . . 0.0 111.345 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.159 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -55.35 -50.94 68.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.226 1.01 . . . . 0.0 112.524 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.43 -5.78 59.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.713 0.805 . . . . 0.0 111.366 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.5 mtt -80.42 141.32 35.42 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.9 154.42 12.32 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.336 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.628 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 39.8 t80 -39.02 -50.65 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.824 0.85 . . . . 0.0 112.205 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 39.0 mt-10 -54.55 -55.72 26.34 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.154 0.909 . . . . 0.0 111.596 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.36 -39.49 74.59 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.695 ' HZ3' ' HD1' ' A' ' 34' ' ' TYR . 0.7 OUTLIER -61.18 -41.56 97.01 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.018 0.372 . . . . 0.0 110.575 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 17.0 mt -63.68 -43.94 95.2 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.887 0.742 . . . . 0.0 110.714 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 34.6 mmtp -56.76 -41.51 77.7 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.6 m -68.57 -39.55 80.97 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.042 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 61' ' ' LYS . 91.9 mt -57.35 -50.32 73.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 123.055 0.542 . . . . 0.0 109.942 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.686 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -56.79 -41.57 77.96 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 111.306 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.701 0.8 . . . . 0.0 111.278 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 56.7 m-80 -97.34 17.56 17.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.23 0.612 . . . . 0.0 110.784 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.72 29.39 16.78 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.452 1.101 . . . . 0.0 111.308 169.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.95 134.87 42.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.327 1.051 . . . . 0.0 108.626 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.46 157.57 15.39 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.17 131.74 53.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.569 0.748 . . . . 0.0 109.459 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -161.8 -168.07 1.85 Allowed 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.65 162.91 33.97 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.687 0.676 . . . . 0.0 111.569 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.472 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 68.9 t -88.21 -45.46 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.438 1.095 . . . . 0.0 110.222 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -100.56 109.69 21.8 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.3 ttmt -64.37 -39.96 94.9 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 124.368 1.043 . . . . 0.0 110.294 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.473 ' HB3' HG22 ' A' ' 2' ' ' ILE . . . -150.21 133.48 16.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.899 -176.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.687 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -155.15 144.22 10.8 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.48 1.06 0 CA-C-N 117.452 0.626 . . . . 0.0 110.127 -175.893 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 mt . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.65 58.6 0.41 Allowed Glycine 0 C--O 1.244 0.737 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.887 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.687 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 15.2 t70 -178.78 146.68 0.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 107.964 -174.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -105.18 16.82 25.11 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -167.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 15.4 tp10 -82.47 101.01 10.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.787 0.803 . . . . 0.0 109.785 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.38 145.71 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.575 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.8 156.27 34.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.867 0.467 . . . . 0.0 110.37 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.91 110.71 13.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.898 0.879 . . . . 0.0 110.367 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.472 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.7 m-85 -106.05 -9.42 17.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.281 0.632 . . . . 0.0 112.488 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.2 p -68.19 -13.49 62.27 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.62 0.368 . . . . 0.0 111.797 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -2.14 56.72 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 118.806 -0.997 . . . . 0.0 113.695 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -49.76 -37.4 29.59 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.445 0.698 . . . . 0.0 112.572 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.476 ' HA ' ' HH ' ' A' ' 129' ' ' TYR . 95.7 mttt -62.26 -31.5 72.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.52 0.328 . . . . 0.0 111.739 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.26 -50.95 8.92 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.033 0.933 . . . . 0.0 111.748 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.408 ' HG3' HG23 ' A' ' 104' ' ' VAL . 21.2 ptm -72.67 -33.54 66.6 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.302 0.641 . . . . 0.0 111.948 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.564 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -128.85 87.19 55.4 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.803 0.841 . . . . 0.0 109.64 176.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.09 -28.03 13.28 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.709 2.273 . . . . 0.0 112.501 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 0.24 56.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.316 0.646 . . . . 0.0 111.753 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 44.7 tp -57.23 110.18 0.8 Allowed 'General case' 0 C--N 1.354 0.762 0 O-C-N 123.806 0.691 . . . . 0.0 111.222 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.574 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 12.2 ptm180 -101.59 -43.47 5.88 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.67 170.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.476 ' HB3' HG12 ' A' ' 16' ' ' ILE . 59.8 tp -131.05 128.55 40.51 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.786 0.835 . . . . 0.0 110.245 -168.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.74 113.93 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.453 1.101 . . . . 0.0 108.501 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.413 ' SG ' HG13 ' A' ' 155' ' ' VAL . 73.3 m -96.48 113.73 25.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.858 0.463 . . . . 0.0 110.405 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.24 109.25 19.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.073 0.949 . . . . 0.0 110.088 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.434 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 7.2 t30 -81.85 90.4 6.41 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.95 143.25 7.32 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.768 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -54.86 -49.04 72.12 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.314 1.046 . . . . 0.0 112.141 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -49.26 -38.33 26.58 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.583 1.153 . . . . 0.0 112.744 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.77 -42.98 66.5 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.663 0.785 . . . . 0.0 110.102 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.7 -9.33 69.63 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 114.601 -1.181 . . . . 0.0 114.451 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.98 -28.99 70.47 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.138 0.469 . . . . 0.0 110.855 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.6 22.86 12.86 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.454 1.102 . . . . 0.0 110.937 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.14 -55.15 46.92 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.427 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.79 -19.18 66.61 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 122.014 1.809 . . . . 0.0 111.979 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.65 -49.04 74.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.384 1.074 . . . . 0.0 109.389 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 mt -87.59 -15.97 35.88 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.081 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -66.73 -31.71 72.53 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.24 -12.07 60.11 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.639 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.0 mtt -96.25 16.79 17.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.837 0.855 . . . . 0.0 111.338 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.94 22.51 78.75 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.04 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.476 ' HH ' ' HA ' ' A' ' 101' ' ' LYS . 33.0 m-85 -111.26 138.38 47.79 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.9 0.48 . . . . 0.0 111.225 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -62.85 142.85 58.07 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.7 p -132.46 142.07 49.08 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.988 0.515 . . . . 0.0 110.85 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -130.36 114.19 15.29 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.582 1.153 . . . . 0.0 108.325 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.0 94.44 2.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.85 140.39 88.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.013 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HG3' ' HD3' ' A' ' 148' ' ' ARG . 21.2 Cg_endo -57.97 158.08 22.46 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.424 2.083 . . . . 0.0 111.57 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.3 m -56.29 113.58 1.63 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -80.28 18.41 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.556 0.343 . . . . 0.0 111.837 -175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.0 m -57.95 149.63 22.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.108 0.963 . . . . 0.0 110.603 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.45 -24.35 65.71 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.584 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.07 70.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.384 0.673 . . . . 0.0 111.497 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -87.5 4.85 41.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.648 0.779 . . . . 0.0 111.615 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.529 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 12.7 ttm180 -62.69 -25.5 68.19 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.419 0.554 . . . . 0.0 111.984 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.53 -23.59 27.39 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.026 0.531 . . . . 0.0 111.811 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -108.04 5.94 26.55 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.105 0.962 . . . . 0.0 112.111 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 142' ' ' ARG . 41.0 t -64.23 -35.54 81.17 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -164.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -62.88 -62.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.428 0.558 . . . . 0.0 111.733 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.68 -39.91 78.22 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.428 0.691 . . . . 0.0 111.127 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.49 ' HD3' ' HG3' ' A' ' 135' ' ' PRO . 72.0 mtt-85 -74.78 -27.42 60.32 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.579 -175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.38 -35.52 79.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.985 0.514 . . . . 0.0 109.997 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.4 t -72.0 -30.08 64.87 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.984 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 4.3 pt-20 -76.66 -34.37 58.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -70.54 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.577 0.751 . . . . 0.0 109.126 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.413 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 25.0 tt0 -66.52 -37.63 85.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.658 0.783 . . . . 0.0 109.332 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.96 -13.73 62.4 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.413 HG13 ' SG ' ' A' ' 111' ' ' CYS . 85.7 t -89.48 -52.76 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.523 0.729 . . . . 0.0 110.581 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -96.09 -1.41 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -164.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 18.7 mtp180 -68.34 -38.85 81.89 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.823 0.738 . . . . 0.0 112.175 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -74.93 -9.9 58.97 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.705 0.402 . . . . 0.0 111.355 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.582 HD11 HD11 ' A' ' 16' ' ' ILE . 88.2 mt -82.51 -35.65 27.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.209 1.004 . . . . 0.0 110.221 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.04 -49.99 11.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.4 t60 . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.163 1.385 . . . . 0.0 112.384 170.554 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 80' ' ' SER . 32.8 mm . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -95.07 118.47 31.94 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -93.57 142.72 27.03 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 110.552 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -69.97 171.59 41.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.419 167.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.79 145.78 31.19 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 122.262 -0.552 . . . . 0.0 110.561 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.45 132.52 49.06 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.312 2.008 . . . . 0.0 109.654 170.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.9 147.72 45.85 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.299 1.0 . . . . 0.0 112.755 -166.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.565 HG13 HD22 ' A' ' 62' ' ' LEU . 26.2 t -92.4 47.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.482 HD13 HD11 ' A' ' 17' ' ' LEU . 35.6 tp -89.67 147.6 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.898 -167.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.13 151.86 41.69 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.73 -16.61 64.22 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.832 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.549 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 30.3 m-80 -105.88 21.05 17.93 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -70.53 109.95 5.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.485 0.66 . . . . 0.0 110.238 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.04 -38.86 26.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.257 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.416 HD13 HD13 ' A' ' 159' ' ' LEU . 55.2 mt -124.72 120.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.691 0.796 . . . . 0.0 108.995 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.482 HD11 HD13 ' A' ' 10' ' ' LEU . 59.7 tp -103.41 117.41 34.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' A' ' 111' ' ' CYS . 50.0 mt -95.99 108.69 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 73' ' ' TRP . 88.9 mt -95.52 108.7 20.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 109.147 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.42 -174.54 7.28 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 167.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 m -87.77 -82.02 0.23 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.419 HD12 ' HD2' ' A' ' 23' ' ' PRO . 51.5 tp -148.28 124.64 5.36 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.4 Cg_exo -43.26 135.35 6.06 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.897 3.065 . . . . 0.0 114.194 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 m -72.2 169.58 15.84 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 111.107 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.92 -49.18 69.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.747 0.819 . . . . 0.0 111.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.19 -31.44 67.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.322 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.7 p -70.71 -38.89 73.69 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.7 mt -68.57 -24.85 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.138 0.975 . . . . 0.0 111.746 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.32 -44.67 87.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.017 0.436 . . . . 0.0 109.905 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -95.26 -1.54 51.31 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.019 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 64.04 24.65 13.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.692 1.197 . . . . 0.0 113.123 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.86 144.12 30.03 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.933 0.893 . . . . 0.0 109.574 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -58.27 -47.51 83.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.686 0.794 . . . . 0.0 110.334 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -60.86 -16.48 41.92 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.625 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -14.17 65.21 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 122.694 0.188 . . . . 0.0 113.438 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.03 101.5 11.15 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.697 0.799 . . . . 0.0 108.856 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.4 148.63 89.87 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.806 2.337 . . . . 0.0 111.42 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.18 -21.08 25.17 Favored Glycine 0 N--CA 1.464 0.535 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.48 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -73.15 102.13 3.51 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.845 0.831 . . . . 0.0 109.408 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -79.98 -3.97 50.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.827 1.651 . . . . 0.0 110.133 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -35.21 -53.92 0.62 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.871 2.069 . . . . 0.0 113.628 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -69.73 -28.33 65.72 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.331 0.652 . . . . 0.0 111.766 -172.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -68.21 -43.82 77.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 110.412 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.0 mt -72.31 -52.64 15.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.696 1.198 . . . . 0.0 111.225 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.97 -43.28 92.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 C-N-CA 124.048 0.939 . . . . 0.0 109.336 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.74 94.56 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.151 0.907 . . . . 0.0 113.469 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -69.41 -39.76 77.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.994 0.518 . . . . 0.0 110.318 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -69.94 -38.24 76.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.89 0.876 . . . . 0.0 112.811 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.05 -11.72 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.072 0.549 . . . . 0.0 110.938 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.94 19.15 79.06 Favored Glycine 0 C--N 1.36 1.909 0 O-C-N 123.807 0.692 . . . . 0.0 113.787 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.68 110.7 11.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 108.318 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -69.55 101.22 1.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.86 0.838 . . . . 0.0 111.553 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.48 -34.08 47.83 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.025 0.93 . . . . 0.0 111.897 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -62.7 -31.0 71.83 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -168.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -83.15 -5.86 59.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.083 0.553 . . . . 0.0 112.393 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.4 mtt -86.42 154.98 20.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.213 0.605 . . . . 0.0 109.455 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.5 152.52 45.52 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 165.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.508 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 70.0 t80 -51.08 -42.21 60.44 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.003 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.92 -45.07 93.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.946 0.898 . . . . 0.0 111.486 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -67.98 -38.09 82.29 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.637 0.775 . . . . 0.0 110.569 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -53.53 -49.48 67.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.722 0.809 . . . . 0.0 109.902 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 9' ' ' VAL . 19.2 mt -61.98 -45.41 93.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 124.655 1.222 . . . . 0.0 110.986 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -57.12 -40.61 77.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.89 0.476 . . . . 0.0 111.421 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.2 m -66.37 -36.82 83.83 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.75 -37.13 84.03 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.13 0.572 . . . . 0.0 111.085 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -57.46 -44.3 84.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -65.06 -35.39 80.99 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.413 1.085 . . . . 0.0 111.555 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -85.14 -8.59 58.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.782 0.833 . . . . 0.0 111.018 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 62.87 38.05 11.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.669 1.188 . . . . 0.0 110.462 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.78 134.17 48.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.78 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.64 142.24 17.44 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.0 128.8 54.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.439 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.1 t90 -153.26 -169.93 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.96 176.83 8.33 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.702 0.801 . . . . 0.0 109.187 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.562 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.8 t -90.87 -46.76 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.137 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -94.29 118.31 31.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.866 0.467 . . . . 0.0 110.385 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.452 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 36.9 ttmt -64.77 -41.91 95.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.322 1.049 . . . . 0.0 110.45 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.86 131.04 12.73 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.348 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.61 138.63 6.64 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.512 ' HB3' HD12 ' A' ' 2' ' ' ILE . 31.2 p . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 123.114 0.566 . . . . 0.0 111.063 -171.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.4 mt . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.92 71.65 2.16 Favored Glycine 0 C--O 1.242 0.642 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.64 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.7 t70 176.48 158.31 0.29 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 108.61 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.28 23.74 8.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.861 0.864 . . . . 0.0 111.866 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 16.4 tp10 -83.06 102.56 11.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 54.9 mt -102.59 155.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.682 1.193 . . . . 0.0 109.728 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -74.26 145.19 44.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.437 1.095 . . . . 0.0 110.168 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.01 101.16 1.34 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.356 0.662 . . . . 0.0 110.377 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.562 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 22.7 m-85 -91.95 -10.27 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.065 0.546 . . . . 0.0 112.04 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.6 p -67.67 -21.73 65.33 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.134 0.174 . . . . 0.0 110.622 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.08 -3.7 75.77 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.369 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.8 mt -48.96 -46.23 43.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -64.27 -23.78 67.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.101 0.41 . . . . 0.0 111.471 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.03 -58.3 3.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.922 0.889 . . . . 0.0 111.029 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.4 ptm -71.0 -33.77 70.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.066 0.947 . . . . 0.0 112.508 -168.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.3 m -124.32 84.04 56.54 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.698 0.799 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.76 -32.38 14.49 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.889 2.393 . . . . 0.0 111.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.549 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.6 mmpt? -87.87 -0.94 57.62 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.884 0.874 . . . . 0.0 112.482 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.6 tp -59.28 107.97 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -99.27 -41.75 7.32 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.829 0.852 . . . . 0.0 109.79 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.3 tp -136.91 132.82 35.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 110.64 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.498 HG12 HD21 ' A' ' 107' ' ' LEU . 15.7 mt -104.61 123.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.509 ' HB2' HG12 ' A' ' 18' ' ' ILE . 70.9 m -101.7 114.4 28.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.977 0.511 . . . . 0.0 110.508 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.403 ' HZ ' HD12 ' A' ' 124' ' ' LEU . 95.8 m-85 -93.49 109.45 21.05 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.886 0.875 . . . . 0.0 110.225 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.531 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 22.7 t-20 -82.96 94.33 7.72 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.61 149.8 13.05 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.069 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -57.51 -43.17 84.04 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.866 1.267 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -51.41 -44.06 62.14 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.708 0.803 . . . . 0.0 112.73 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.78 85.91 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.149 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.5 -11.76 60.23 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.259 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.74 -27.89 69.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.99 0.895 . . . . 0.0 111.908 172.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -108.54 16.12 23.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.247 0.619 . . . . 0.0 111.253 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.531 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.8 tm-20 -66.4 -47.36 59.2 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.461 167.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.5 -35.29 75.78 Favored 'Trans proline' 0 C--N 1.403 3.418 0 C-N-CA 122.49 2.127 . . . . 0.0 113.18 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.54 -52.6 64.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.352 1.061 . . . . 0.0 112.014 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.403 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 15.9 mt -79.45 -6.12 56.2 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -65.6 -36.18 82.97 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.91 -17.55 71.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.214 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 62.8 mtt -86.58 9.35 18.78 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.61 0.764 . . . . 0.0 111.268 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.19 16.03 70.48 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.413 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -99.67 143.18 30.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 120.745 0.307 . . . . 0.0 110.777 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -75.84 133.2 40.67 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 161.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 36.1 p -127.62 141.1 51.72 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.999 0.92 . . . . 0.0 108.619 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -142.77 125.64 16.11 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.62 1.168 . . . . 0.0 108.17 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.31 112.82 24.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.476 HD23 HG22 ' A' ' 155' ' ' VAL . 62.8 mt -89.21 131.69 39.95 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.86 147.02 33.82 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.513 2.809 . . . . 0.0 112.772 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.6 t -54.79 116.95 3.0 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.149 0.905 . . . . 0.0 110.072 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.2 p -72.37 0.15 10.87 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.544 0.738 . . . . 0.0 112.546 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 m -60.43 143.18 53.91 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.969 0.908 . . . . 0.0 110.273 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.61 69.84 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.796 0.685 . . . . 0.0 114.368 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.54 -42.85 98.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.209 0.604 . . . . 0.0 110.436 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -81.56 -32.3 32.25 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.346 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -59.99 -23.66 63.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.42 0.45 . . . . 0.0 111.262 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -71.26 -48.9 48.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.848 0.859 . . . . 0.0 110.092 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.23 23.73 3.2 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.457 1.103 . . . . 0.0 110.382 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -169.37 70.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -91.96 -51.48 5.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.625 1.17 . . . . 0.0 108.016 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -66.0 -6.34 12.44 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.363 1.065 . . . . 0.0 112.666 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -71.43 -20.06 62.16 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.763 0.825 . . . . 0.0 110.732 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.38 -30.88 67.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.338 0.655 . . . . 0.0 111.118 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.1 t -64.52 -44.29 91.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.253 1.021 . . . . 0.0 112.445 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.2 pt-20 -75.26 -30.62 60.52 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.351 0.26 . . . . 0.0 110.485 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.59 -40.58 88.95 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 4.0 tm-20 -67.06 -39.81 86.98 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.702 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.13 64.59 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.412 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.476 HG22 HD23 ' A' ' 134' ' ' LEU . 73.1 t -84.72 -53.88 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.009 0.523 . . . . 0.0 111.001 177.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.61 2.96 52.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -168.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.41 -32.28 73.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.276 0.489 . . . . 0.0 111.137 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.405 ' CE1' HD11 ' A' ' 16' ' ' ILE . 15.4 p-80 -73.74 -12.36 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.623 0.369 . . . . 0.0 111.155 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 16' ' ' ILE . 86.7 mt -78.3 -26.06 46.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -82.7 -39.49 21.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.456 0.702 . . . . 0.0 109.121 167.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 19.9 t60 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 125.403 1.481 . . . . 0.0 110.596 -179.262 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 80' ' ' SER . 46.5 mm . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 120.764 0.316 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -93.22 111.0 22.52 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -79.33 125.62 29.74 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.486 0.315 . . . . 0.0 110.739 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.23 170.74 51.92 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 124.234 0.959 . . . . 0.0 111.629 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.416 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 8.0 m-30 -89.36 141.74 29.2 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.451 -168.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.32 164.23 29.04 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.726 2.284 . . . . 0.0 111.104 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.33 128.93 37.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.358 0.663 . . . . 0.0 111.867 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.52 HG12 HD21 ' A' ' 62' ' ' LEU . 58.7 t -100.03 72.86 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.511 HD12 ' CG1' ' A' ' 104' ' ' VAL . 60.4 tp -124.86 149.56 47.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.02 -162.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.7 160.6 25.53 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 109.194 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.15 -20.19 62.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.462 1.105 . . . . 0.0 111.882 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -122.53 91.07 3.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' HG11 ' A' ' 104' ' ' VAL . 99.5 m -131.8 114.28 14.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.925 0.89 . . . . 0.0 108.769 175.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -87.75 -33.84 18.55 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.278 1.031 . . . . 0.0 110.9 -176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.481 HD13 HD11 ' A' ' 159' ' ' LEU . 60.4 mt -128.57 125.66 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.079 0.552 . . . . 0.0 109.6 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.01 123.51 49.79 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.401 HG23 ' HE1' ' A' ' 41' ' ' PHE . 20.3 mt -100.13 115.63 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 73' ' ' TRP . 97.8 mt -103.74 124.42 48.85 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.946 0.898 . . . . 0.0 110.181 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.3 -178.61 39.51 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 123.3 0.375 . . . . 0.0 112.365 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 116' ' ' LYS . 6.9 p -100.43 -71.43 0.7 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.9 119.46 2.78 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.35 167.84 8.88 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.689 2.26 . . . . 0.0 112.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.6 p -63.69 154.42 33.13 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.801 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 33.7 t70 -57.84 -37.61 74.16 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.275 0.359 . . . . 0.0 110.837 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.89 -36.0 64.71 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.187 0.995 . . . . 0.0 111.516 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.589 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 8.7 t -86.9 -39.71 15.53 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.27 -174.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HA ' ' HE1' ' A' ' 6' ' ' PHE . 70.8 mt -66.55 -38.53 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.079 0.951 . . . . 0.0 112.0 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 24.9 mmm180 -66.73 -16.59 64.35 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.543 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 93.2 mttt -106.49 -1.5 23.02 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.662 0.785 . . . . 0.0 111.566 175.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 56.16 18.24 3.15 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.436 1.494 . . . . 0.0 114.693 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -145.05 161.92 38.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.951 0.501 . . . . 0.0 110.98 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -76.6 -1.56 28.21 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.894 1.278 . . . . 0.0 112.723 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -90.54 -14.24 32.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -52.34 -40.98 54.2 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.566 1.166 . . . . 0.0 115.717 -162.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -122.11 98.01 45.05 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.979 0.512 . . . . 0.0 110.309 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.03 2.44 4.24 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.568 2.845 . . . . 0.0 113.352 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.64 -17.73 79.98 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 120.357 -0.135 . . . . 0.0 112.898 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.97 127.47 33.58 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.34 0.591 . . . . 0.0 109.983 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.446 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 6.9 m-20 -81.01 0.32 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.61 1.164 . . . . 0.0 112.304 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.401 ' HE1' HG23 ' A' ' 18' ' ' ILE . 82.0 t80 -38.94 -47.47 1.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.819 1.248 . . . . 0.0 112.649 173.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -74.85 -26.78 59.93 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.918 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -79.31 -28.23 42.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.231 0.612 . . . . 0.0 111.594 175.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 33.4 mt -85.93 -48.54 8.62 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.818 0.447 . . . . 0.0 110.432 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.08 -30.96 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.275 0.63 . . . . 0.0 109.505 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.68 -44.52 70.49 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.573 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -60.72 -37.28 81.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.476 0.71 . . . . 0.0 110.298 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 156' ' ' PHE . . . -63.58 -45.96 88.02 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.183 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.457 HD11 HD21 ' A' ' 53' ' ' LEU . 19.9 pt -91.37 -4.79 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.684 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.43 36.22 69.18 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.546 0.529 . . . . 0.0 112.838 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -149.3 105.91 3.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.675 1.59 . . . . 0.0 107.423 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -68.42 110.84 4.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.779 0.799 . . . . 0.0 109.506 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.457 HD21 HD11 ' A' ' 49' ' ' ILE . 85.1 mt -82.3 -30.72 30.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.042 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -60.32 -38.84 84.99 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.73 3.92 52.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.136 0.574 . . . . 0.0 111.337 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.553 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 66.6 mtt -85.25 150.4 24.81 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.39 45.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.751 0.657 . . . . 0.0 109.402 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.483 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 35.0 t80 -43.15 -48.99 6.48 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.362 1.065 . . . . 0.0 113.695 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 -61.31 -49.91 75.12 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 122.577 0.351 . . . . 0.0 111.322 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.25 -48.72 80.56 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.69 0.796 . . . . 0.0 112.662 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 7.6 ptmt -62.18 -36.52 82.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.489 0.316 . . . . 0.0 111.619 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.52 HD21 HG12 ' A' ' 9' ' ' VAL . 77.5 mt -68.99 -40.34 78.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.082 0.553 . . . . 0.0 111.557 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 30.3 mmmt -55.89 -44.72 78.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.386 0.674 . . . . 0.0 110.805 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -64.07 -40.06 95.44 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.285 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.98 -55.11 36.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.407 0.683 . . . . 0.0 111.688 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -22.49 64.27 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.092 0.245 . . . . 0.0 111.449 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -62.87 -33.91 76.28 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.692 0.397 . . . . 0.0 111.757 167.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -88.94 1.94 54.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.232 0.613 . . . . 0.0 110.977 172.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 64.59 46.51 3.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.683 1.193 . . . . 0.0 110.514 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.08 133.19 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.359 1.063 . . . . 0.0 108.697 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.35 17.86 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.62 132.15 56.55 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.42 0.688 . . . . 0.0 109.15 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.428 ' HB3' HD21 ' A' ' 19' ' ' LEU . 3.6 t90 -158.13 -170.2 3.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -134.32 162.74 31.34 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.477 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 48.4 t -79.09 -51.84 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 42.0 m-85 -82.2 126.66 32.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 0.0 110.58 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.576 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.3 tmtp? -68.01 -32.17 72.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.76 149.67 16.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.039 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.92 135.71 7.86 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.471 ' HB2' HD13 ' A' ' 2' ' ' ILE . 27.9 t . . . . . 0 N--CA 1.468 0.439 0 C-N-CA 123.575 0.75 . . . . 0.0 109.537 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.7 mt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.79 57.12 5.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.38 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -173.69 154.66 2.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.492 1.117 . . . . 0.0 108.759 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -124.25 25.92 7.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.212 1.005 . . . . 0.0 111.394 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.576 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.3 tp10 -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.468 0.707 . . . . 0.0 109.26 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 77.2 mt -127.0 140.62 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.418 1.087 . . . . 0.0 109.192 -168.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -62.39 151.54 36.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.792 0.837 . . . . 0.0 110.869 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.17 130.65 36.59 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.477 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.8 m-85 -118.94 -2.23 10.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.058 0.543 . . . . 0.0 111.091 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 86.2 p -63.99 -31.11 72.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.13 -3.97 90.58 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 118.775 -1.014 . . . . 0.0 113.878 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 mt -49.8 -49.9 46.96 Favored 'General case' 0 C--N 1.369 1.444 0 C-N-CA 123.796 0.838 . . . . 0.0 111.711 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -60.77 -16.0 35.59 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -102.92 -41.41 6.15 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.306 1.042 . . . . 0.0 112.443 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -83.09 -24.65 32.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.511 ' CG1' HD12 ' A' ' 10' ' ' LEU . 9.0 m -127.75 84.88 62.13 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.608 0.763 . . . . 0.0 110.384 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 -34.07 22.04 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.628 2.219 . . . . 0.0 111.712 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.28 -12.31 59.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.947 0.899 . . . . 0.0 112.536 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 52.7 tp -62.1 130.52 45.85 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 123.713 0.633 . . . . 0.0 110.545 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -136.68 -34.5 0.75 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.246 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.4 tp -128.48 131.23 48.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.618 0.767 . . . . 0.0 109.576 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.521 ' HB ' HG23 ' A' ' 131' ' ' THR . 61.3 mt -115.94 138.01 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.522 1.129 . . . . 0.0 108.422 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.565 ' SG ' HG12 ' A' ' 155' ' ' VAL . 83.8 m -120.57 116.95 26.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.861 0.864 . . . . 0.0 109.926 -174.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 95.7 m-85 -93.91 114.74 27.03 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -98.03 76.69 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.493 1.139 . . . . 0.0 108.851 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.19 135.61 2.71 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.265 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -52.1 -52.73 49.53 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.083 0.953 . . . . 0.0 112.382 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 28.8 mmmt -48.81 -37.44 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.039 0.936 . . . . 0.0 113.054 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.61 -34.46 77.04 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.283 0.633 . . . . 0.0 110.839 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.89 73.73 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 114.778 -1.101 . . . . 0.0 115.004 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -103.87 14.89 29.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.498 1.119 . . . . 0.0 111.097 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.7 tt0 -58.74 -49.27 94.33 Favored Pre-proline 0 CA--C 1.565 1.535 0 CA-C-O 118.049 -0.977 . . . . 0.0 112.244 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 125' ' ' ARG . 31.1 Cg_endo -57.84 -23.29 58.17 Favored 'Trans proline' 0 C--N 1.409 3.742 0 C-N-CA 122.579 2.186 . . . . 0.0 113.32 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.27 -40.02 95.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.73 0.812 . . . . 0.0 110.26 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 mt -95.22 -19.43 20.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.365 0.666 . . . . 0.0 111.248 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 122' ' ' PRO . 27.5 mtp180 -63.05 -40.16 96.87 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.052 0.541 . . . . 0.0 109.911 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.28 -19.6 66.5 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.39 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.453 ' HE1' ' HB2' ' A' ' 97' ' ' PHE . 61.3 mtt -89.8 11.75 19.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.15 73.97 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -106.8 137.82 44.13 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.371 0.585 . . . . 0.0 110.248 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.77 134.72 53.73 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 167.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.521 HG23 ' HB ' ' A' ' 110' ' ' ILE . 14.7 p -137.6 152.03 48.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 123.707 0.803 . . . . 0.0 108.968 -174.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -154.04 131.73 11.48 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.131 0.572 . . . . 0.0 109.8 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 17.2 t -90.31 93.85 4.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.52 149.53 95.55 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.203 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.11 152.66 81.54 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.619 1.546 . . . . 0.0 110.908 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.3 p -59.19 119.23 6.97 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.2 p -76.97 33.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.969 1.308 . . . . 0.0 113.994 -167.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.9 m -85.0 151.56 24.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.014 0.925 . . . . 0.0 109.204 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -20.34 58.76 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.792 0.682 . . . . 0.0 114.349 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.77 91.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.641 0.776 . . . . 0.0 111.103 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.27 -25.26 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.569 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -74.27 -25.58 59.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 123.753 0.658 . . . . 0.0 110.539 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -66.46 -27.38 67.76 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.173 0.511 . . . . 0.0 111.383 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.26 -42.41 8.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.666 0.786 . . . . 0.0 109.559 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -103.73 45.59 0.95 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.233 1.413 . . . . 0.0 110.25 -171.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -73.5 -27.47 61.4 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.333 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -86.57 -6.15 58.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.574 0.75 . . . . 0.0 111.804 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -86.14 -26.82 24.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.728 . . . . 0.0 110.399 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.79 -14.56 61.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.491 0.716 . . . . 0.0 112.171 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -34.63 77.7 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.39 0.676 . . . . 0.0 110.67 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.507 ' O ' HG22 ' A' ' 155' ' ' VAL . 4.1 pt-20 -72.16 -31.11 65.65 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 119.195 -0.431 . . . . 0.0 110.072 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -65.47 -38.01 88.51 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.58 -42.81 98.26 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.522 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.32 -9.67 58.83 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.77 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.565 HG12 ' SG ' ' A' ' 111' ' ' CYS . 75.7 t -83.87 -50.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 110.243 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 47.5 m-85 -103.2 0.82 32.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -77.36 -26.83 52.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 119.156 0.889 . . . . 0.0 112.298 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.402 ' HE1' HD11 ' A' ' 16' ' ' ILE . 15.9 p-80 -74.95 -10.85 59.87 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.444 0.698 . . . . 0.0 111.326 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.481 HD11 HD13 ' A' ' 16' ' ' ILE . 95.0 mt -73.38 -10.99 60.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.7 0.8 . . . . 0.0 111.001 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -45.96 -39.51 9.02 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.824 1.249 . . . . 0.0 111.359 164.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.689 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.509 HD12 ' HB3' ' A' ' 80' ' ' SER . 22.7 mm . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.59 119.6 25.39 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 169.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -84.56 132.11 34.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.671 0.389 . . . . 0.0 111.013 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.98 -179.92 26.24 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.207 0.317 . . . . 0.0 112.585 167.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -108.87 135.0 20.16 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 122.355 -0.497 . . . . 0.0 109.726 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 157.72 33.12 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.531 2.154 . . . . 0.0 110.941 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.81 127.02 29.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.314 0.645 . . . . 0.0 112.071 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.46 HG12 HD21 ' A' ' 62' ' ' LEU . 21.6 t -91.76 88.32 2.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.558 HD12 HD13 ' A' ' 17' ' ' LEU . 34.5 tp -140.14 155.73 46.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.393 -158.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.51 159.99 27.93 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.86 -14.5 63.01 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.107 0.479 . . . . 0.0 110.945 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -111.75 84.69 2.0 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.502 ' HB ' HG13 ' A' ' 104' ' ' VAL . 98.7 m -138.92 121.43 16.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.349 0.66 . . . . 0.0 110.003 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.02 -41.45 15.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.551 1.54 . . . . 0.0 109.69 -173.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.453 HG12 ' HB3' ' A' ' 109' ' ' LEU . 34.2 mt -129.52 128.9 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.638 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.558 HD13 HD12 ' A' ' 10' ' ' LEU . 56.8 tp -109.89 124.91 52.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -95.67 118.26 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.0 mt -102.43 118.96 38.0 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.581 0.752 . . . . 0.0 109.557 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -75.66 -166.09 19.2 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 165.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -108.78 -73.57 0.68 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -147.68 119.98 4.65 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 161.03 46.97 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.444 2.096 . . . . 0.0 111.933 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.5 t -85.7 158.22 20.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.199 0.599 . . . . 0.0 110.399 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 5.1 p-10 -57.67 -29.97 65.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.363 0.665 . . . . 0.0 112.638 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.14 -38.17 67.88 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.381 0.673 . . . . 0.0 111.59 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.649 ' HB3' HD21 ' A' ' 36' ' ' ASN . 32.4 p -86.63 -38.01 17.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.042 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.2 mt -64.91 -38.76 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.921 0.889 . . . . 0.0 113.282 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 30.2 mmm180 -61.41 -30.78 70.77 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 0.0 110.375 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -97.29 -6.03 35.34 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.322 1.049 . . . . 0.0 112.082 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 62.1 22.39 13.08 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.813 1.245 . . . . 0.0 113.571 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.76 144.01 35.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.939 0.496 . . . . 0.0 110.453 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -55.3 -46.91 76.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.326 1.05 . . . . 0.0 110.107 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.29 -13.11 4.47 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 114.003 -1.453 . . . . 0.0 113.582 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.72 -19.91 73.65 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 114.346 0.498 . . . . 0.0 114.346 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.649 HD21 ' HB3' ' A' ' 27' ' ' SER . 4.5 p30 -110.77 135.16 20.78 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.27 -10.85 30.07 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.053 2.502 . . . . 0.0 113.018 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.14 -8.81 65.93 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.478 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.409 ' ND2' HD22 ' A' ' 36' ' ' ASN . 0.9 OUTLIER -94.29 82.02 4.06 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.685 0.755 . . . . 0.0 109.434 173.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -99.62 4.76 45.87 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.349 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -42.46 -30.06 0.32 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.094 1.357 . . . . 0.0 112.44 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.435 ' CE3' ' HD3' ' A' ' 61' ' ' LYS . 63.7 m95 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.713 1.205 . . . . 0.0 113.103 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -77.89 -32.54 51.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.818 0.447 . . . . 0.0 111.1 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 149' ' ' GLU . 43.3 mt -86.87 -47.78 8.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.798 0.839 . . . . 0.0 110.354 -170.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 -35.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.839 0.856 . . . . 0.0 109.035 172.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.34 -39.35 95.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.042 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.59 -36.32 83.4 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.947 0.899 . . . . 0.0 110.033 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . . . -63.99 -53.64 46.86 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.728 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.4 pt -84.45 -7.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.032 0.533 . . . . 0.0 111.809 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.48 73.24 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.574 0.546 . . . . 0.0 112.713 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -133.57 106.66 7.54 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -63.31 97.11 0.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 110.667 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.2 mt -75.6 -19.45 59.24 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -70.03 -27.56 64.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.804 0.842 . . . . 0.0 112.369 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -95.62 -3.15 46.8 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.73 -0.606 . . . . 0.0 110.832 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtt -88.66 159.18 17.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.005 0.522 . . . . 0.0 111.207 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.46 151.22 47.13 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.524 0.73 . . . . 0.0 109.344 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.567 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 30.3 t80 -51.91 -49.78 62.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 47.1 mt-10 -63.6 -37.04 85.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.025 0.375 . . . . 0.0 111.08 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.81 -53.32 33.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.435 ' HD3' ' CE3' ' A' ' 42' ' ' TRP . 17.3 ptpt -58.44 -32.13 68.41 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.307 0.643 . . . . 0.0 111.648 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 94.0 mt -66.83 -43.04 84.8 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.196 0.598 . . . . 0.0 111.318 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 33.8 mmtp -64.55 -31.61 72.9 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.005 0.431 . . . . 0.0 110.615 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.5 m -67.16 -39.41 86.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.145 173.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.97 -49.96 70.48 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.609 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 29.7 mmtp -57.28 -40.93 78.77 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 123.299 0.64 . . . . 0.0 110.546 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -60.82 -42.83 98.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.304 1.041 . . . . 0.0 111.11 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -87.52 5.46 39.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.773 0.829 . . . . 0.0 110.634 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 64.93 39.74 5.69 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 125.232 1.413 . . . . 0.0 110.92 171.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.03 135.96 48.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 124.917 1.287 . . . . 0.0 108.793 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.39 162.19 14.42 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 173.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.68 142.36 50.76 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -162.98 -170.74 2.43 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -131.53 166.38 21.51 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 0.0 109.379 172.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 54.2 t -78.1 -38.88 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.97 123.97 48.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.543 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -71.61 -24.0 61.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 170.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.83 140.43 14.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -152.16 155.7 26.28 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.509 ' HB3' HD12 ' A' ' 2' ' ' ILE . 40.7 p . . . . . 0 N--CA 1.474 0.763 0 CA-C-N 117.587 0.693 . . . . 0.0 109.998 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.26 65.23 3.88 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.673 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.468 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 8.2 t70 -169.86 160.29 8.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.972 0.509 . . . . 0.0 110.005 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.04 7.19 10.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.648 0.779 . . . . 0.0 112.591 -168.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.56 99.79 12.58 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.119 0.872 . . . . 0.0 109.467 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.36 152.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 109.617 -171.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -72.65 149.02 44.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.514 0.726 . . . . 0.0 110.042 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.51 114.6 16.51 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 29.0 m-85 -100.37 -5.44 27.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.592 0.757 . . . . 0.0 111.869 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.3 p -75.92 -10.92 59.82 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.71 0.29 . . . . 0.0 110.299 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.8 -5.44 62.84 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.803 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.457 HD23 ' SD ' ' A' ' 103' ' ' MET . 40.3 mt -50.42 -33.42 20.75 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.191 0.596 . . . . 0.0 112.371 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -62.58 -33.49 75.07 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.061 0.544 . . . . 0.0 112.298 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.25 -47.71 8.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.807 0.843 . . . . 0.0 112.266 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HG3' HG22 ' A' ' 104' ' ' VAL . 22.9 ptm -71.64 -32.34 67.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.546 0.739 . . . . 0.0 112.461 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' A' ' 103' ' ' MET . 0.7 OUTLIER -134.39 95.0 16.73 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.49 0.716 . . . . 0.0 110.438 177.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.8 -30.24 14.53 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.623 2.216 . . . . 0.0 111.778 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -87.3 -2.31 58.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.745 0.818 . . . . 0.0 111.758 -173.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 41.5 tp -56.09 104.34 0.13 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.798 0.839 . . . . 0.0 111.541 -175.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 18.7 ptp180 -101.87 -41.98 6.3 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.396 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.453 ' HB3' HG12 ' A' ' 16' ' ' ILE . 29.9 tp -130.73 139.57 50.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.675 0.39 . . . . 0.0 110.349 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.412 HG12 HD12 ' A' ' 107' ' ' LEU . 24.2 mt -112.75 115.99 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.489 ' SG ' HG12 ' A' ' 155' ' ' VAL . 83.6 m -98.71 118.74 36.12 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.456 0.703 . . . . 0.0 110.871 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -95.75 120.72 36.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.655 0.782 . . . . 0.0 110.227 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.482 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 95.2 m-20 -75.24 80.74 2.35 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.655 0.782 . . . . 0.0 109.815 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.93 162.94 21.23 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.474 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.5 ttp85 -64.31 -23.61 67.36 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.18 1.392 . . . . 0.0 113.056 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -74.37 -42.4 59.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.506 . . . . 0.0 110.057 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.26 75.89 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.696 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.08 -10.66 62.39 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.933 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -69.36 -20.08 63.84 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 117.402 0.601 . . . . 0.0 110.859 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -108.0 10.17 28.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.386 1.074 . . . . 0.0 111.086 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.565 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.2 tm-20 -67.58 -49.31 41.15 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.979 0.912 . . . . 0.0 111.666 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.08 -24.6 79.72 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.028 1.818 . . . . 0.0 112.685 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.92 -50.39 73.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.078 0.951 . . . . 0.0 111.287 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.31 -5.23 55.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -66.54 -31.93 72.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.038 0.535 . . . . 0.0 110.57 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.1 -17.59 70.07 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.69 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 63.7 mtt -88.07 2.17 52.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.847 0.859 . . . . 0.0 111.216 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.45 23.16 63.32 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.56 -0.291 . . . . 0.0 113.333 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -107.4 137.26 45.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 110.668 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 19.6 mm-40 -70.0 136.37 50.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.565 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 33.5 p -132.5 140.5 48.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.773 0.829 . . . . 0.0 109.504 -173.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -143.02 132.04 22.99 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.389 1.076 . . . . 0.0 109.302 -173.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.7 t -97.99 122.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 155' ' ' VAL . 96.3 mt -102.34 144.61 28.95 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 171.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.8 150.7 75.82 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.042 2.495 . . . . 0.0 112.078 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.5 t -62.14 94.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.824 0.703 . . . . 0.0 109.728 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -87.97 21.17 2.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.5 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.1 t -66.08 156.02 35.1 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.293 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 142' ' ' ARG . . . -62.75 -22.17 63.89 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 123.18 0.419 . . . . 0.0 113.787 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.36 -28.91 70.02 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 111.708 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -126.37 19.12 7.52 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.686 0.795 . . . . 0.0 111.134 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 139' ' ' GLY . 8.9 ptm85 -66.98 -27.63 67.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.011 0.525 . . . . 0.0 111.364 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -55.01 -31.07 60.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.464 1.106 . . . . 0.0 111.384 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.86 -18.26 13.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.001 0.92 . . . . 0.0 110.184 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -97.73 8.31 44.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.617 0.767 . . . . 0.0 112.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -63.23 -64.0 1.03 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.512 0.725 . . . . 0.0 109.356 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.07 -7.47 23.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.16 0.984 . . . . 0.0 112.845 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -82.08 -12.84 58.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.393 0.677 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.479 ' HB3' HD23 ' A' ' 44' ' ' LEU . 11.1 pt-20 -54.87 -25.41 28.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.523 0.729 . . . . 0.0 112.316 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -41.17 62.87 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.061 0.944 . . . . 0.0 112.209 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -72.92 -34.02 66.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -66.57 -33.4 75.58 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.987 0.915 . . . . 0.0 109.437 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.8 -42.19 98.69 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.482 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.93 87.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.897 -171.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.489 HG12 ' SG ' ' A' ' 111' ' ' CYS . 74.3 t -68.15 -30.83 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.929 -173.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 30.9 m-85 -118.15 -10.47 10.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.379 -0.825 . . . . 0.0 113.166 -173.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.0 -29.69 65.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.115 0.416 . . . . 0.0 111.107 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -81.05 -13.58 58.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.949 0.5 . . . . 0.0 111.2 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.403 HD12 HD13 ' A' ' 16' ' ' ILE . 62.7 mt -72.1 -41.06 67.71 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 122.829 0.452 . . . . 0.0 111.077 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -87.79 -53.73 4.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 CA--C 1.554 1.1 0 C-N-CA 125.313 1.445 . . . . 0.0 110.944 -179.396 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 mm . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HB3' HD13 ' A' ' 28' ' ' ILE . 50.4 mtmt -93.4 117.98 30.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.301 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -80.38 126.8 31.64 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 123.743 0.652 . . . . 0.0 110.868 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.77 156.22 53.41 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.408 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 7.3 m-85 -80.62 134.93 53.39 Favored Pre-proline 0 N--CA 1.473 0.68 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.581 -165.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.2 141.59 48.46 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.887 2.391 . . . . 0.0 111.265 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.12 128.61 37.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.571 0.748 . . . . 0.0 111.275 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.527 HG11 HD22 ' A' ' 62' ' ' LEU . 24.1 t -95.65 79.77 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 174.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.426 HD13 ' CG1' ' A' ' 104' ' ' VAL . 38.5 tp -117.18 149.86 39.69 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.517 -163.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -128.02 164.21 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.803 0.841 . . . . 0.0 109.46 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.2 -26.66 67.88 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.348 1.059 . . . . 0.0 112.462 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.497 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 61.7 m-80 -95.32 16.17 17.46 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.262 0.625 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' HG11 ' A' ' 104' ' ' VAL . 78.1 m -72.05 104.76 3.67 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.637 0.732 . . . . 0.0 110.544 -175.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG2' ' HG3' ' A' ' 108' ' ' ARG . 30.1 tt0 -88.32 -30.21 19.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.286 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.597 HD13 HD11 ' A' ' 159' ' ' LEU . 39.4 mt -127.66 120.35 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.148 0.979 . . . . 0.0 108.624 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.3 tp -106.97 116.97 32.85 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 111' ' ' CYS . 55.1 mt -91.7 108.27 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 94.9 mt -99.67 108.17 20.46 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 109.071 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.05 177.34 8.66 Favored Glycine 0 N--CA 1.47 0.932 0 O-C-N 123.002 0.189 . . . . 0.0 113.053 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB2' HD12 ' A' ' 89' ' ' ILE . 10.7 p -90.79 -72.42 0.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.492 HD21 ' HA3' ' A' ' 79' ' ' GLY . 19.0 tp -151.14 124.68 4.3 Favored Pre-proline 0 C--O 1.246 0.894 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 159.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.5 157.6 30.92 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.118 1.879 . . . . 0.0 111.67 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -62.95 150.29 42.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.605 0.762 . . . . 0.0 110.459 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 6.6 p-10 -58.88 -34.07 71.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.573 0.225 . . . . 0.0 110.452 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.1 -37.96 78.42 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.363 1.065 . . . . 0.0 111.947 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.6 p -81.23 -30.74 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.411 HD13 ' HB3' ' A' ' 3' ' ' LYS . 73.1 mt -74.66 -16.0 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 110.882 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 79.1 mtt180 -64.38 -38.3 90.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.569 0.347 . . . . 0.0 110.569 170.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -86.87 -16.22 36.7 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.624 0.77 . . . . 0.0 109.899 177.31 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.9 23.83 4.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.075 1.35 . . . . 0.0 113.206 -172.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -126.09 160.2 30.78 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.386 0.674 . . . . 0.0 109.561 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -72.43 -2.5 19.72 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.607 0.763 . . . . 0.0 110.746 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -70.13 -45.36 67.0 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.448 1.099 . . . . 0.0 108.294 174.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 31.76 -112.66 0.06 OUTLIER Glycine 0 C--N 1.374 2.678 0 O-C-N 125.086 1.491 . . . . 0.0 114.546 -172.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.65 129.59 23.99 Favored Pre-proline 0 C--O 1.246 0.886 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.06 9.3 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.968 2.446 . . . . 0.0 113.953 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.85 0.28 78.55 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 122.906 0.289 . . . . 0.0 112.566 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -84.08 130.15 34.87 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.88 3.4 29.93 Favored 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 123.852 0.861 . . . . 0.0 111.189 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -42.94 -56.42 3.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.683 0.793 . . . . 0.0 112.126 172.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.404 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 75.8 m95 -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.856 0.862 . . . . 0.0 111.897 -177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -80.99 -42.07 21.74 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.442 1.097 . . . . 0.0 111.415 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.27 -47.54 34.35 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.113 0.965 . . . . 0.0 109.2 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.91 -37.68 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.264 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.8 96.1 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.67 0.606 . . . . 0.0 113.184 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.19 -41.36 85.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.438 0.695 . . . . 0.0 109.961 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.61 87.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.358 1.063 . . . . 0.0 112.769 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 pt -89.44 -6.57 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.112 0.565 . . . . 0.0 111.645 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.86 22.99 78.61 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 113.178 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -139.87 96.47 3.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.99 109.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.881 0.872 . . . . 0.0 111.083 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.409 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 53.6 mt -75.21 -19.93 59.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.837 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -53.42 -54.53 35.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.724 0.809 . . . . 0.0 112.806 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -83.57 6.25 21.26 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.051 0.54 . . . . 0.0 112.427 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.564 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.1 mtt -88.81 139.6 30.29 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 154.64 40.04 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.501 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 36.9 t80 -48.37 -50.67 29.78 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 41.7 mt-10 -60.37 -38.85 85.18 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.609 0.364 . . . . 0.0 111.155 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -68.26 -53.46 24.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.94 0.896 . . . . 0.0 112.29 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 5.5 ptmt -59.89 -29.98 68.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.527 HD22 HG11 ' A' ' 9' ' ' VAL . 86.4 mt -65.1 -42.56 93.91 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.252 0.621 . . . . 0.0 111.231 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 43.7 mmtm -59.49 -39.71 84.64 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.673 0.389 . . . . 0.0 110.192 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.462 HG21 ' HE3' ' A' ' 56' ' ' MET . 31.3 m -66.96 -38.23 85.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.536 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.22 -59.25 5.61 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 111.231 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -22.2 61.74 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.224 0.328 . . . . 0.0 111.842 -174.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -58.87 -43.68 90.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.64 0.776 . . . . 0.0 110.374 164.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -89.74 19.82 4.47 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.729 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.47 ' HB2' HD23 ' A' ' 159' ' ' LEU . 15.1 mmt180 70.28 27.15 4.16 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.289 1.036 . . . . 0.0 111.58 169.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.7 mt -109.63 123.79 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.055 0.942 . . . . 0.0 109.883 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.17 158.45 14.3 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.45 140.93 49.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.435 0.694 . . . . 0.0 109.252 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.466 ' HB3' HD21 ' A' ' 19' ' ' LEU . 8.8 t90 -165.03 -177.27 4.55 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -131.5 161.93 31.42 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.44 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 53.3 t -75.73 -48.34 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.72 128.78 41.65 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.258 0.551 . . . . 0.0 110.626 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.663 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 10.2 ptmm? -84.19 -17.56 39.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.733 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.68 134.88 11.26 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.055 0.455 . . . . 0.0 110.463 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -147.78 147.66 18.53 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.485 1.275 0 CA-C-N 117.912 0.856 . . . . 0.0 111.774 -173.223 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 21' ' ' SER . 7.8 mt . . . . . 0 C--O 1.24 0.572 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.92 60.47 0.63 Allowed Glycine 0 N--CA 1.465 0.58 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.555 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.2 t70 -174.72 160.05 2.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.161 0.984 . . . . 0.0 108.908 -172.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.37 18.15 13.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 111.302 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.663 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 11.8 tp10 -85.06 97.46 9.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.4 mt -106.26 150.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.653 1.181 . . . . 0.0 109.54 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -75.1 153.39 38.34 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.45 0.7 . . . . 0.0 109.847 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.42 135.55 35.65 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.44 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 45.7 m-85 -121.55 3.43 10.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.204 0.601 . . . . 0.0 111.435 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.2 p -67.77 -18.16 64.78 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.05 0.386 . . . . 0.0 111.674 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.65 -2.73 64.98 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 118.828 -0.985 . . . . 0.0 113.582 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.401 HD22 ' SD ' ' A' ' 103' ' ' MET . 40.0 mt -52.0 -36.15 48.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 117.898 0.849 . . . . 0.0 112.958 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.7 mtpt -67.7 -17.55 64.61 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -98.46 -50.57 4.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.062 0.945 . . . . 0.0 111.772 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.401 ' SD ' HD22 ' A' ' 100' ' ' LEU . 25.5 ptm -71.32 -35.14 71.12 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.218 0.607 . . . . 0.0 111.271 -173.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.1 m -126.01 84.61 60.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.708 0.803 . . . . 0.0 109.922 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.39 -29.04 5.11 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.857 2.371 . . . . 0.0 111.82 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.497 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 11.2 mmpt? -74.55 -12.69 60.53 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.241 0.616 . . . . 0.0 111.564 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -56.54 126.65 27.51 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.1 0.875 . . . . 0.0 111.179 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.533 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -134.98 -18.01 1.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.808 174.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.533 ' HB2' HH11 ' A' ' 108' ' ' ARG . 59.1 tp -143.66 131.92 21.99 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.192 0.597 . . . . 0.0 110.367 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.409 HD11 HG21 ' A' ' 131' ' ' THR . 49.4 mt -107.37 143.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.205 1.002 . . . . 0.0 108.496 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.535 ' SG ' HG13 ' A' ' 155' ' ' VAL . 74.9 m -125.54 116.23 21.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.182 0.593 . . . . 0.0 110.13 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 96.7 m-85 -93.0 111.54 23.2 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.268 0.627 . . . . 0.0 110.394 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -84.53 93.24 8.3 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.15 127.37 3.18 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -50.53 -45.06 56.55 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.382 1.473 . . . . 0.0 113.417 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -58.13 -24.0 57.15 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 112' ' ' PHE . . . -73.16 -18.33 61.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.068 0.461 . . . . 0.0 111.075 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.43 -16.9 67.95 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.28 -0.873 . . . . 0.0 114.573 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.63 -26.68 67.93 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.919 0.488 . . . . 0.0 110.018 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.78 8.26 24.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.28 1.032 . . . . 0.0 111.334 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.451 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 38.7 tt0 -60.79 -51.08 82.1 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.169 169.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.43 -17.42 57.6 Favored 'Trans proline' 0 C--N 1.401 3.321 0 C-N-CA 121.83 1.686 . . . . 0.0 113.252 -175.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.09 -41.63 99.44 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.558 1.143 . . . . 0.0 110.755 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.0 -4.98 55.99 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.171 -171.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -66.0 -31.29 72.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.036 0.534 . . . . 0.0 110.226 172.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.21 -1.46 69.41 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.084 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 56.6 mtt -103.87 11.92 35.03 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.459 1.104 . . . . 0.0 110.451 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.33 78.15 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.934 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 29.8 m-85 -110.72 141.16 44.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.263 0.625 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 13.4 mm-40 -68.43 133.68 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.451 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 41.5 p -126.3 136.91 53.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 109.172 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -141.62 130.97 23.63 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.146 0.978 . . . . 0.0 109.358 -176.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 61.0 t -101.81 130.4 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.406 0.682 . . . . 0.0 109.643 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -115.89 154.59 48.27 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.324 1.45 . . . . 0.0 108.202 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.5 170.1 14.36 Favored 'Trans proline' 0 C--N 1.367 1.539 0 C-N-CA 122.613 2.209 . . . . 0.0 112.187 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.3 m -60.86 127.44 31.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.9 m -77.63 27.68 0.17 Allowed 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.3 m -87.71 159.61 18.43 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.827 0.851 . . . . 0.0 110.369 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 142' ' ' ARG . . . -64.5 -20.78 66.1 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.411 0.925 . . . . 0.0 115.411 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.48 -43.17 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.02 0.528 . . . . 0.0 110.833 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -69.89 -39.81 76.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.516 0.326 . . . . 0.0 110.407 171.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.45 ' HB3' ' HA2' ' A' ' 139' ' ' GLY . 7.3 tmm_? -60.01 -34.11 72.9 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.218 1.007 . . . . 0.0 111.561 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.21 -23.69 37.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.386 1.074 . . . . 0.0 112.047 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -117.76 -23.13 7.69 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.026 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 53.4 m -84.41 39.69 0.74 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.758 1.223 . . . . 0.0 113.012 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 146' ' ' LYS . 71.6 mmtt -76.54 -53.89 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.582 0.353 . . . . 0.0 110.599 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -64.16 -23.14 67.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.386 0.274 . . . . 0.0 111.141 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 55.7 ttm-85 -84.5 -18.83 34.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.0 0.92 . . . . 0.0 110.475 -176.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.03 -27.53 63.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.568 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.0 t -60.36 -43.98 96.01 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.885 0.874 . . . . 0.0 111.585 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -75.9 -27.85 57.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -63.32 -44.89 93.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.73 -35.93 77.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.777 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.28 72.4 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.866 0.466 . . . . 0.0 110.369 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.535 HG13 ' SG ' ' A' ' 111' ' ' CYS . 53.1 t -68.12 -55.49 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.036 0.934 . . . . 0.0 111.083 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -94.39 -5.73 45.77 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -71.91 -38.45 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 118.255 0.48 . . . . 0.0 110.917 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.462 ' HE1' HD11 ' A' ' 16' ' ' ILE . 7.5 p-80 -76.85 -7.14 54.94 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.148 0.579 . . . . 0.0 110.751 -174.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.597 HD11 HD13 ' A' ' 16' ' ' ILE . 81.7 mt -74.17 -20.91 60.05 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.554 0.742 . . . . 0.0 111.967 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.78 -29.07 60.99 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 169.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 CA--C 1.561 1.366 0 C-N-CA 124.896 1.279 . . . . 0.0 111.753 171.05 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.7 mm . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.418 ' HZ3' ' HB2' ' A' ' 25' ' ' ASP . 65.7 mttm -107.53 133.72 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.258 1.023 . . . . 0.0 109.858 -174.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -101.5 135.92 42.2 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.541 0.736 . . . . 0.0 110.848 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.57 174.73 47.68 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.412 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.84 148.77 69.4 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 117.098 0.449 . . . . 0.0 111.228 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.88 163.6 9.16 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.584 2.189 . . . . 0.0 110.741 159.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.75 113.5 3.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.175 0.512 . . . . 0.0 110.585 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.492 HG12 HD22 ' A' ' 62' ' ' LEU . 13.8 t -87.08 74.71 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.54 HD22 HG13 ' A' ' 104' ' ' VAL . 28.0 tp -129.38 154.38 46.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -154.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -127.43 162.12 27.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.596 1.158 . . . . 0.0 110.073 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -66.29 -24.49 66.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.054 0.942 . . . . 0.0 112.243 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.459 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 48.7 m-80 -96.27 14.28 24.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.04 0.536 . . . . 0.0 111.056 -175.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -70.16 111.09 5.55 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.419 0.628 . . . . 0.0 110.834 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -89.88 -35.66 15.5 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.038 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 63.1 mt -121.45 114.0 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.555 0.742 . . . . 0.0 109.205 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.466 HD13 HD11 ' A' ' 10' ' ' LEU . 61.1 tp -103.47 111.9 24.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.9 mt -92.62 116.43 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.1 mt -102.99 125.78 49.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.55 0.74 . . . . 0.0 109.82 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.17 -161.52 24.22 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 163.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 p -106.45 -64.3 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.2 tp -150.67 133.47 8.46 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.1 154.81 71.62 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.524 2.149 . . . . 0.0 110.663 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -60.77 150.58 32.1 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.907 0.483 . . . . 0.0 109.733 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.418 ' HB2' ' HZ3' ' A' ' 3' ' ' LYS . 7.7 p-10 -59.06 -37.31 76.74 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.61 -30.36 68.08 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.357 0.663 . . . . 0.0 110.493 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -67.07 -45.93 75.84 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.846 0.858 . . . . 0.0 109.693 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.82 -39.34 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.582 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 29' ' ' ARG . 2.8 mmp_? -61.91 -37.85 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.914 0.486 . . . . 0.0 112.163 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.63 ' HZ3' ' HB3' ' A' ' 30' ' ' LYS . 0.9 OUTLIER -100.32 -7.86 24.03 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.023 0.529 . . . . 0.0 111.836 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 67.63 18.47 9.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.442 1.097 . . . . 0.0 113.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -113.67 127.47 56.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.772 0.829 . . . . 0.0 109.056 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.494 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 84.4 m-85 -59.77 -59.77 4.91 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -55.47 -27.13 46.4 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.619 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.36 -21.13 66.17 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 123.065 0.228 . . . . 0.0 112.863 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.44 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 4.3 t30 -86.92 108.33 18.07 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.474 1.11 . . . . 0.0 108.406 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.33 142.37 78.94 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.463 2.776 . . . . 0.0 112.412 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.23 -19.3 40.48 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.376 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.44 ' ND2' ' HB3' ' A' ' 36' ' ' ASN . 95.4 m-20 -68.87 98.98 0.99 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.515 0.674 . . . . 0.0 109.572 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -86.39 -6.89 58.82 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 126.538 1.935 . . . . 0.0 110.952 -170.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.454 ' HE1' ' HB3' ' A' ' 113' ' ' ASN . 65.1 m-85 -41.63 -43.83 2.9 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 125.221 1.408 . . . . 0.0 112.681 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.494 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 74.6 m95 -71.5 -24.13 61.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.186 0.994 . . . . 0.0 112.065 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -81.48 -36.36 29.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.873 0.869 . . . . 0.0 110.902 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.09 -45.63 17.91 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.865 0.466 . . . . 0.0 111.385 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.03 -36.65 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.49 -32.67 75.48 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.889 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.15 -42.91 79.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.452 0.701 . . . . 0.0 110.053 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 156' ' ' PHE . . . -67.75 -38.02 82.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.298 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.7 pt -96.68 -11.73 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.841 0.456 . . . . 0.0 111.137 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.66 32.42 61.64 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.438 0.461 . . . . 0.0 113.579 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -133.35 111.92 11.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -66.99 89.68 0.17 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.939 0.876 . . . . 0.0 111.579 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.37 -30.98 69.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.09 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -73.41 -10.69 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.924 -173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -98.93 -9.17 24.48 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.947 -0.471 . . . . 0.0 111.68 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.463 ' HE3' HG23 ' A' ' 64' ' ' THR . 60.0 mtt -87.44 159.28 18.74 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.228 0.611 . . . . 0.0 110.76 -172.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 159.4 31.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.526 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 17.0 t80 -52.12 -54.48 29.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.43 -36.7 83.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.644 0.378 . . . . 0.0 111.214 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -67.91 -51.77 44.0 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.852 0.861 . . . . 0.0 111.654 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 8.9 ptpp? -61.32 -34.43 75.23 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.184 0.303 . . . . 0.0 111.096 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 78.0 mt -65.18 -44.18 89.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 122.657 0.383 . . . . 0.0 111.039 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -55.79 -43.15 76.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.988 0.515 . . . . 0.0 110.624 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.463 HG23 ' HE3' ' A' ' 56' ' ' MET . 25.6 m -68.4 -41.8 79.94 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.817 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 62' ' ' LEU . 78.5 mt -56.13 -62.33 1.78 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.719 0.808 . . . . 0.0 110.591 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -23.55 64.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.772 0.67 . . . . 0.0 111.752 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -63.53 -39.14 93.64 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.987 0.515 . . . . 0.0 111.024 167.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.428 ' O ' HD12 ' A' ' 159' ' ' LEU . 60.7 m-80 -85.61 14.92 5.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.042 0.537 . . . . 0.0 110.111 173.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mmt-85 69.37 25.17 5.59 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.298 1.439 . . . . 0.0 111.032 173.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.19 118.77 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.652 0.781 . . . . 0.0 109.352 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.52 161.28 15.33 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 85.7 mt -123.35 145.89 48.38 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.9 -170.29 1.72 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -130.65 163.44 27.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.583 0.753 . . . . 0.0 110.117 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.421 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 58.4 t -79.43 -54.49 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 0.0 109.89 172.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.12 128.62 35.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.576 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -78.31 -35.81 47.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.337 0.655 . . . . 0.0 110.209 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 93' ' ' GLU . . . -144.01 140.82 29.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 110.88 178.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.35 160.41 33.43 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.592 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.476 ' O ' ' HA3' ' A' ' 90' ' ' GLY . 58.8 p . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 122.922 0.489 . . . . 0.0 109.83 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.9 tp . . . . . 0 CA--C 1.555 1.151 0 CA-C-O 121.211 0.529 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . 117.53 9.43 10.24 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.232 -175.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -171.74 177.17 3.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.829 1.251 . . . . 0.0 108.185 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.6 12.4 11.48 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.163 0.585 . . . . 0.0 111.864 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.576 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 9.1 tp10 -86.73 119.13 26.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.8 mt -124.77 138.97 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.759 1.223 . . . . 0.0 108.731 -173.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -60.76 137.38 58.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.371 0.668 . . . . 0.0 109.677 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -86.07 127.31 34.65 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.929 0.492 . . . . 0.0 109.759 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.537 ' HB2' ' HE2' ' A' ' 127' ' ' MET . 67.0 m-85 -112.82 7.77 18.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.452 0.701 . . . . 0.0 111.35 -176.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.3 m -63.52 -26.5 68.74 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.838 0.455 . . . . 0.0 111.648 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -3.04 89.36 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.706 -1.052 . . . . 0.0 115.044 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.468 HD22 ' SD ' ' A' ' 103' ' ' MET . 29.5 mt -49.02 -38.57 23.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -55.78 -39.38 71.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.429 0.558 . . . . 0.0 111.197 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -85.06 -50.52 7.37 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.236 1.015 . . . . 0.0 112.267 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.529 ' HG3' HG23 ' A' ' 104' ' ' VAL . 24.1 ptm -68.58 -35.26 77.12 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.494 0.718 . . . . 0.0 111.874 -175.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.1 m -132.74 94.55 21.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.104 0.562 . . . . 0.0 110.871 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.48 -30.99 4.7 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.55 2.167 . . . . 0.0 111.742 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.4 mmmm -88.3 -7.35 56.88 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.167 -174.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.3 tp -58.53 107.72 0.54 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.48 0.657 . . . . 0.0 111.497 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -96.52 -51.43 4.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.335 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.6 tp -126.13 132.53 51.84 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.324 0.65 . . . . 0.0 110.775 -171.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.9 mt -102.95 144.26 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.51 ' HB3' HD11 ' A' ' 134' ' ' LEU . 80.1 m -124.9 113.31 17.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.807 0.443 . . . . 0.0 110.701 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.61 111.12 22.6 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.454 ' HB3' ' HE1' ' A' ' 41' ' ' PHE . 86.7 m-20 -91.39 79.49 5.59 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.4 153.39 5.86 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.343 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -62.58 -45.27 93.67 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.17 0.588 . . . . 0.0 110.148 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -31.13 69.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.809 0.843 . . . . 0.0 112.988 172.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.53 -39.57 62.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.116 0.484 . . . . 0.0 110.016 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.68 -11.14 68.56 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.392 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.31 -38.4 65.91 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.908 0.883 . . . . 0.0 112.351 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -107.92 25.3 11.73 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.543 0.737 . . . . 0.0 111.177 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 70.6 tt0 -55.78 -53.09 66.67 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.564 165.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.44 -22.22 73.77 Favored 'Trans proline' 0 C--N 1.403 3.426 0 C-N-CA 122.313 2.009 . . . . 0.0 112.906 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.402 ' HG ' ' HE3' ' A' ' 127' ' ' MET . 59.2 tp -62.79 -47.63 82.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.213 0.605 . . . . 0.0 109.661 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.97 -20.02 29.53 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.363 -174.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 34.1 mtp85 -66.65 -42.2 87.03 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.45 -21.07 68.36 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.091 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.537 ' HE2' ' HB2' ' A' ' 97' ' ' PHE . 63.9 mtt -79.04 -19.35 51.66 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.787 0.435 . . . . 0.0 111.441 175.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.51 30.59 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.523 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 142.94 27.5 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.215 0.507 . . . . 0.0 110.824 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -65.72 135.13 54.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 170.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 54.6 p -123.57 139.51 53.93 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.257 0.623 . . . . 0.0 110.161 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.442 ' HB2' HD12 ' A' ' 109' ' ' LEU . 53.1 tptt -134.12 116.75 15.79 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 107.89 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.6 110.63 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 111' ' ' CYS . 93.6 mt -95.71 150.92 38.06 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.226 1.411 . . . . 0.0 109.124 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.422 ' HB2' HD22 ' A' ' 141' ' ' ASN . 94.1 Cg_endo -74.45 130.74 14.19 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.557 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.0 p -54.46 107.91 0.33 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.728 0.811 . . . . 0.0 110.974 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.5 m -79.59 50.28 1.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.214 1.006 . . . . 0.0 112.05 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -73.29 160.45 31.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 109.804 163.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.74 59.73 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 114.758 0.663 . . . . 0.0 114.758 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.0 -37.83 78.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.795 0.438 . . . . 0.0 111.405 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.422 HD22 ' HB2' ' A' ' 135' ' ' PRO . 49.2 t30 -70.65 -20.06 62.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.481 0.712 . . . . 0.0 111.646 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.419 ' O ' ' HD3' ' A' ' 142' ' ' ARG . 12.5 tpp180 -57.22 -29.04 63.42 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.082 0.553 . . . . 0.0 110.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -53.27 -36.53 61.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.41 1.084 . . . . 0.0 111.084 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -107.33 -22.88 12.42 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.674 1.189 . . . . 0.0 111.697 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.509 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 8.2 t -87.47 13.29 10.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -165.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -72.79 -61.12 1.92 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.415 0.286 . . . . 0.0 110.478 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -24.24 64.13 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.123 0.569 . . . . 0.0 112.052 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 0.7 OUTLIER -74.99 -22.24 58.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.713 0.805 . . . . 0.0 111.225 -174.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.61 -23.19 49.64 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 t -63.84 -41.32 97.84 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.798 0.839 . . . . 0.0 111.166 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.4 pt-20 -70.78 -35.64 72.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -65.76 -41.85 91.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.099 0.559 . . . . 0.0 109.995 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -66.86 -34.55 78.04 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.985 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.05 -9.73 59.27 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.982 0.913 . . . . 0.0 111.887 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 151' ' ' GLU . 37.9 t -90.29 -43.3 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.801 0.84 . . . . 0.0 111.171 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 80.0 m-85 -102.81 4.83 38.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -168.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -86.62 -14.4 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.198 0.908 . . . . 0.0 112.384 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -84.29 -4.9 59.15 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 118.205 0.457 . . . . 0.0 111.669 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 68' ' ' ASN . 71.5 mt -61.27 -10.01 6.15 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.98 0.912 . . . . 0.0 113.113 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -51.36 -41.21 60.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.865 0.866 . . . . 0.0 111.538 164.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 C--O 1.255 1.378 0 C-N-CA 123.991 0.917 . . . . 0.0 109.015 173.622 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 78' ' ' ALA . 47.3 mm . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 120.816 0.341 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.7 125.8 45.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.324 1.05 . . . . 0.0 108.255 171.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -97.14 141.27 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.039 0.447 . . . . 0.0 111.835 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.4 171.14 51.77 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.977 163.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -107.95 125.48 31.99 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.514 1.157 . . . . 0.0 110.211 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.48 155.16 0.47 Allowed 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 124.178 3.252 . . . . 0.0 113.881 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.46 122.46 14.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.876 0.87 . . . . 0.0 113.042 -167.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.529 HG12 HD21 ' A' ' 62' ' ' LEU . 25.3 t -94.34 81.84 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.481 HD22 ' HE1' ' A' ' 103' ' ' MET . 28.7 tp -123.35 153.35 40.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -159.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.543 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 9.8 t70 -124.88 157.46 35.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.411 170.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.66 -18.62 65.01 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.097 0.559 . . . . 0.0 112.125 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.525 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 52.0 m-80 -97.04 13.64 28.35 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.914 0.886 . . . . 0.0 111.628 -176.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.0 m -77.39 116.22 17.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.922 0.489 . . . . 0.0 111.432 -171.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -99.4 -26.2 14.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.459 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.481 HD12 HD22 ' A' ' 159' ' ' LEU . 42.8 mt -121.45 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -104.16 111.09 23.55 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 111' ' ' CYS . 47.3 mt -93.62 113.23 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.8 mt -103.72 110.99 23.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.885 0.874 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.36 175.44 25.26 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.018 -0.433 . . . . 0.0 112.018 169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -87.14 -77.57 0.33 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -140.99 123.35 9.52 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -55.14 156.74 15.47 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.745 2.297 . . . . 0.0 112.445 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.452 ' O ' HG13 ' A' ' 28' ' ' ILE . 42.2 t -60.38 145.26 48.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.102 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.46 -39.85 70.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.239 0.616 . . . . 0.0 110.782 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.83 -23.71 62.4 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.355 1.062 . . . . 0.0 111.437 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.9 m -77.68 -37.4 49.81 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 24' ' ' SER . 43.6 mt -74.31 -19.25 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.599 0.76 . . . . 0.0 110.992 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.72 -33.26 75.54 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 120.953 0.406 . . . . 0.0 110.357 172.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.88 -8.43 30.88 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.203 1.001 . . . . 0.0 111.183 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 60.14 30.28 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 111.366 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -146.51 132.91 19.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.925 0.89 . . . . 0.0 110.148 -168.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -64.4 -44.96 89.64 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.384 0.612 . . . . 0.0 109.753 173.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.01 -4.42 7.13 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.227 172.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.96 -37.2 53.08 Favored Glycine 0 C--N 1.361 1.958 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -103.23 102.09 26.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.0 0.92 . . . . 0.0 108.873 165.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.17 -10.44 28.93 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.969 2.446 . . . . 0.0 112.61 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.58 -9.66 86.08 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -71.51 117.89 13.64 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.27 -4.17 37.51 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.647 0.779 . . . . 0.0 112.139 -167.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -43.94 -44.84 7.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.104 1.762 . . . . 0.0 112.847 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.431 ' HZ3' HD11 ' A' ' 65' ' ' LEU . 54.4 m95 -72.25 -22.35 61.24 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.443 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -86.91 -32.81 19.98 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 124.169 0.988 . . . . 0.0 111.697 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.9 mt -75.9 -53.95 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.391 0.676 . . . . 0.0 110.016 -174.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.38 -36.05 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.402 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.1 -36.98 91.3 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.024 0.828 . . . . 0.0 112.678 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -67.68 -41.88 83.0 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.596 0.759 . . . . 0.0 109.93 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.19 86.19 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.652 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 pt -96.52 -11.72 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.097 0.559 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.97 -59.26 2.8 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -50.24 111.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.367 1.067 . . . . 0.0 112.966 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -70.64 116.87 11.46 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.53 -30.75 57.26 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.428 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -60.24 -52.38 65.55 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -164.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.89 -22.17 63.25 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.361 0.413 . . . . 0.0 111.708 -170.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.1 mtt -60.25 152.02 25.9 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.313 0.645 . . . . 0.0 110.823 174.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.38 152.77 44.38 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.542 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 52.4 t80 -46.22 -52.27 12.75 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 0.0 112.589 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.88 -34.81 78.17 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.92 0.488 . . . . 0.0 111.704 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -73.38 -47.33 42.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.842 0.457 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -32.27 72.9 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.853 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 42.1 mt -63.24 -49.07 75.61 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.437 0.461 . . . . 0.0 110.377 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -55.54 -38.89 69.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 123.803 0.689 . . . . 0.0 111.313 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -63.78 -46.34 85.66 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.862 0.726 . . . . 0.0 109.625 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.431 HD11 ' HZ3' ' A' ' 42' ' ' TRP . 95.4 mt -59.79 -43.28 94.51 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.738 0.815 . . . . 0.0 110.889 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.543 ' HD2' ' HB2' ' A' ' 11' ' ' ASP . 28.6 mmtp -61.32 -38.09 85.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.865 0.466 . . . . 0.0 110.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -74.86 -23.11 58.37 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.228 1.011 . . . . 0.0 110.966 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' HD11 ' A' ' 159' ' ' LEU . 18.5 m120 -88.74 0.04 56.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.612 0.765 . . . . 0.0 110.256 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 65.34 32.92 9.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.777 1.231 . . . . 0.0 110.67 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.76 136.64 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 0.0 109.405 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.72 154.32 16.68 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.3 mt -120.13 129.26 54.07 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.483 0.642 . . . . 0.0 109.81 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -155.97 -168.88 2.9 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -133.25 170.38 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.206 1.003 . . . . 0.0 109.306 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.54 -61.2 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.414 ' HE1' ' HH ' ' A' ' 120' ' ' TYR . 70.9 m-85 -74.18 102.07 4.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -65.08 -28.89 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.663 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 93' ' ' GLU . . . -149.15 141.79 24.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.957 172.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.44 134.39 6.05 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.328 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.524 ' HB2' HD13 ' A' ' 2' ' ' ILE . 39.8 t . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 123.756 0.822 . . . . 0.0 109.275 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.4 HG23 ' CD1' ' A' ' 76' ' ' PHE . 3.4 mp . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.15 61.68 4.11 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.116 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.575 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 11.8 t70 -176.04 153.44 1.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.445 1.098 . . . . 0.0 108.218 -172.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -125.27 26.37 6.9 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 78' ' ' ALA . 8.3 tp10 -80.3 102.82 9.76 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.5 149.9 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.047 0.939 . . . . 0.0 108.699 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.44 ' OD1' ' HD2' ' A' ' 77' ' ' LYS . 88.8 m-20 -66.7 141.03 57.91 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.794 0.684 . . . . 0.0 110.117 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.79 116.63 26.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.521 ' HB2' ' HE1' ' A' ' 127' ' ' MET . 76.2 m-85 -101.45 18.48 20.03 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.167 0.587 . . . . 0.0 112.087 -171.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.4 p -69.61 -18.34 63.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.37 -3.34 63.19 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.361 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.95 -38.5 36.85 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.982 0.891 . . . . 0.0 113.139 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.75 -24.27 67.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.842 0.457 . . . . 0.0 111.571 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -93.56 -50.28 5.49 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.691 0.797 . . . . 0.0 111.835 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.537 ' HG3' HG23 ' A' ' 104' ' ' VAL . 24.1 ptm -70.86 -38.74 73.16 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.575 0.75 . . . . 0.0 111.942 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -122.57 89.1 49.7 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 123.375 0.67 . . . . 0.0 110.262 178.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.24 -29.5 17.14 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.826 2.351 . . . . 0.0 111.997 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.8 mmpt? -82.7 -8.65 59.58 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.832 0.853 . . . . 0.0 112.708 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.0 tp -57.54 127.95 34.61 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.604 0.565 . . . . 0.0 111.698 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -134.76 -37.48 0.82 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.639 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 26.0 tp -129.57 125.34 35.99 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.054 0.542 . . . . 0.0 110.057 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.499 ' HB ' HG23 ' A' ' 131' ' ' THR . 57.0 mt -107.2 110.82 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.517 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.9 m -96.69 115.23 27.07 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 122.612 0.365 . . . . 0.0 110.606 -175.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.11 123.03 33.0 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.403 0.681 . . . . 0.0 109.726 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -90.99 99.27 12.34 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.05 138.88 8.13 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.447 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -52.71 -42.1 64.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.753 1.221 . . . . 0.0 112.19 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 116' ' ' LYS . 5.1 mtpm? -59.8 -30.65 69.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.59 -38.97 64.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.286 0.565 . . . . 0.0 109.943 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.77 -9.45 62.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.707 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.12 -26.29 67.57 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.562 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.414 ' HH ' ' HE1' ' A' ' 76' ' ' PHE . 73.5 m-85 -102.55 14.03 33.0 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.034 1.334 . . . . 0.0 111.373 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.5 -53.19 68.7 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.242 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.65 -18.09 53.36 Favored 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 121.742 1.628 . . . . 0.0 113.15 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 tp -66.93 -46.35 75.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.501 0.72 . . . . 0.0 109.705 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.92 -18.98 31.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.168 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -69.2 -33.0 72.66 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.124 0.569 . . . . 0.0 109.966 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.68 -22.92 64.63 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.741 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.521 ' HE1' ' HB2' ' A' ' 97' ' ' PHE . 49.3 mtt -90.21 10.7 23.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.056 0.942 . . . . 0.0 111.401 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.3 25.56 75.22 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.899 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -109.56 132.65 53.94 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.282 0.633 . . . . 0.0 110.82 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -70.2 142.5 52.41 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.499 HG23 ' HB ' ' A' ' 110' ' ' ILE . 32.2 p -133.65 150.67 51.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.524 1.13 . . . . 0.0 110.159 -173.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -142.12 119.22 11.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.704 1.201 . . . . 0.0 108.866 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.9 t -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.642 0.735 . . . . 0.0 109.765 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.86 154.39 94.29 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.711 1.204 . . . . 0.0 110.287 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.96 165.51 27.87 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.277 1.985 . . . . 0.0 112.191 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.1 t -67.35 143.74 56.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.0 t -74.02 5.92 3.85 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.125 0.97 . . . . 0.0 113.513 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -64.26 140.35 58.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.139 0.576 . . . . 0.0 110.371 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.95 -28.98 73.56 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.212 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.04 98.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.555 0.742 . . . . 0.0 110.29 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -65.93 -22.9 66.52 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.003 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.486 HH12 ' HB3' ' A' ' 149' ' ' GLU . 18.7 mmm180 -81.99 -16.74 49.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.644 0.778 . . . . 0.0 111.504 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -67.0 -36.58 82.47 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -91.54 -34.14 14.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.659 0.783 . . . . 0.0 110.397 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.1 m -101.43 29.76 4.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.509 1.123 . . . . 0.0 112.038 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.31 -62.02 2.07 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.3 -4.93 32.62 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.252 1.021 . . . . 0.0 112.464 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 64.6 mtm-85 -88.91 -8.14 54.77 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.631 0.773 . . . . 0.0 111.84 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.486 ' HB3' HH12 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -59.64 -23.99 63.5 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.589 0.632 . . . . 0.0 110.665 172.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -61.19 -32.24 72.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.851 1.26 . . . . 0.0 111.481 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.5 pt-20 -74.34 -27.03 60.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -70.82 -37.91 73.23 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.93 -36.71 84.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.618 0.767 . . . . 0.0 110.168 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.6 -12.55 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.342 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 151' ' ' GLU . 41.6 t -95.1 -44.93 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.435 1.094 . . . . 0.0 111.157 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -99.37 3.12 45.83 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -69.75 -34.6 74.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.437 ' HE1' HD13 ' A' ' 16' ' ' ILE . 11.5 p-80 -82.1 -9.73 59.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.481 HD22 HD12 ' A' ' 16' ' ' ILE . 99.3 mt -51.21 -61.79 2.02 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 124.164 0.915 . . . . 0.0 111.979 -168.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.85 -60.8 2.24 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 172.502 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.424 ' HA ' ' HB2' ' A' ' 80' ' ' SER . 34.2 mm . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.259 0.552 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HB2' HD22 ' A' ' 22' ' ' LEU . 33.5 mtmm -95.51 118.79 32.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.744 -1.116 . . . . 0.0 107.989 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -87.82 134.19 33.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.203 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.18 171.8 48.16 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.953 170.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -98.26 143.85 27.02 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 117.353 0.576 . . . . 0.0 110.031 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.78 150.11 79.2 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.219 1.946 . . . . 0.0 110.449 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.96 143.32 56.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 112.325 -174.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.495 HG13 ' HE2' ' A' ' 66' ' ' LYS . 11.8 t -101.21 61.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 168.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.48 HD13 ' CG1' ' A' ' 104' ' ' VAL . 42.3 tp -98.18 146.36 25.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.162 -165.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.517 ' HB2' ' HZ3' ' A' ' 66' ' ' LYS . 2.3 t70 -124.06 159.73 29.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.85 -19.32 63.45 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.773 0.429 . . . . 0.0 111.696 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -95.49 6.99 47.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.642 0.377 . . . . 0.0 111.792 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 m -66.84 114.58 5.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.227 0.611 . . . . 0.0 111.223 -171.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 40.6 tt0 -94.23 -35.44 12.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.384 1.474 . . . . 0.0 110.223 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.9 mt -121.42 118.47 56.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 10' ' ' LEU . 63.7 tp -105.01 116.5 32.05 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.517 HG23 ' HE1' ' A' ' 41' ' ' PHE . 52.6 mt -92.84 107.63 19.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' A' ' 73' ' ' TRP . 96.0 mt -99.24 108.45 21.02 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.065 0.946 . . . . 0.0 109.152 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.83 179.66 12.78 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 123.281 0.363 . . . . 0.0 112.26 170.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 m -86.89 -69.04 0.7 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.506 HD21 ' HA3' ' A' ' 79' ' ' GLY . 27.6 tp -146.21 131.81 9.31 Favored Pre-proline 0 C--O 1.246 0.917 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 163.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HD2' HD11 ' A' ' 22' ' ' LEU . 18.4 Cg_endo -56.96 159.28 15.03 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.087 1.858 . . . . 0.0 112.075 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 m -60.37 136.94 58.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.893 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.66 -29.09 58.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.682 0.393 . . . . 0.0 110.927 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.46 -63.1 1.27 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.934 1.293 . . . . 0.0 110.549 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.466 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 51.0 p -57.24 -28.2 62.73 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.626 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.8 mt -73.28 -28.02 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -59.9 -29.13 68.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.888 0.475 . . . . 0.0 111.095 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 67.0 mttm -111.69 -0.55 15.98 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.115 0.966 . . . . 0.0 111.318 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 51.09 34.16 10.48 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.416 1.486 . . . . 0.0 113.832 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 27' ' ' SER . 13.3 pt20 -138.67 151.64 47.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.706 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -70.27 -2.51 13.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.836 0.854 . . . . 0.0 111.433 174.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -103.11 -4.85 23.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.428 1.091 . . . . 0.0 109.843 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -72.91 -25.43 73.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.996 0.358 . . . . 0.0 113.996 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -106.83 103.27 46.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.254 0.622 . . . . 0.0 109.662 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.03 -19.71 29.76 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.724 2.283 . . . . 0.0 111.791 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.36 31.07 5.61 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.655 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -115.5 116.33 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.776 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 37.0 m-20 -85.11 3.51 38.61 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.658 0.783 . . . . 0.0 112.299 -175.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.517 ' HE1' HG23 ' A' ' 18' ' ' ILE . 86.0 t80 -40.95 -51.08 3.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.282 1.033 . . . . 0.0 112.899 172.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.411 ' HE3' ' HB3' ' A' ' 53' ' ' LEU . 86.1 m95 -71.66 -23.21 61.63 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.236 -175.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.776 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 2.9 mpt_? -79.12 -42.63 25.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.957 0.903 . . . . 0.0 110.219 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.14 -49.78 16.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.957 0.903 . . . . 0.0 110.649 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.1 -31.54 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.329 0.652 . . . . 0.0 109.655 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.03 -40.54 88.58 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.485 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -62.72 -39.68 94.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.833 0.853 . . . . 0.0 109.753 172.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . . . -72.62 -30.06 64.01 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.892 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.5 pt -102.75 -4.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.58 38.59 86.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.314 0.384 . . . . 0.0 113.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -137.15 136.26 38.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.111 1.364 . . . . 0.0 108.265 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 56' ' ' MET . 14.8 p-10 -74.38 87.07 2.02 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.307 0.575 . . . . 0.0 109.866 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.411 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 92.0 mt -68.14 -51.85 41.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -46.87 -39.34 11.91 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.528 1.531 . . . . 0.0 113.258 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.45 -33.15 48.62 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.434 1.093 . . . . 0.0 111.343 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.523 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.0 mtt -66.01 151.58 46.51 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 123.103 0.561 . . . . 0.0 111.842 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.15 157.39 37.69 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.491 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.498 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 21.2 t80 -43.63 -56.43 3.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.968 1.307 . . . . 0.0 113.862 -171.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.07 -31.49 72.74 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.923 0.489 . . . . 0.0 111.668 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -72.53 -52.15 16.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 0.0 111.439 -175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 6.4 ptmt -61.54 -32.6 72.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.528 0.731 . . . . 0.0 112.491 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 89.8 mt -64.84 -42.99 94.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.438 0.695 . . . . 0.0 111.504 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.25 -40.75 95.2 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.936 0.495 . . . . 0.0 110.853 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.404 ' HA ' ' CD2' ' A' ' 67' ' ' HIS . 17.8 m -60.8 -41.23 95.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.105 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 90.4 mt -61.35 -46.93 88.16 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.828 0.705 . . . . 0.0 110.782 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 11' ' ' ASP . 23.0 mttm -65.77 -28.0 68.7 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.016 0.926 . . . . 0.0 112.617 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 64' ' ' THR . 12.2 m-70 -57.54 -43.28 84.26 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.319 0.581 . . . . 0.0 111.061 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -90.69 11.41 22.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.417 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER 66.66 39.28 3.7 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.09 1.356 . . . . 0.0 111.26 174.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 69.1 mt -109.72 131.56 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.01 152.83 17.15 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 171.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.5 mt -116.98 137.58 52.12 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.494 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.6 t90 -165.6 -169.1 1.47 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -140.59 171.92 13.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.741 0.816 . . . . 0.0 110.852 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 78.9 t -88.15 -56.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 123.841 0.857 . . . . 0.0 109.616 176.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.67 104.37 16.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.113 0.565 . . . . 0.0 110.22 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.72 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.6 ptmt -71.34 -14.74 62.29 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.758 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 93' ' ' GLU . . . -149.89 123.91 9.39 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.506 ' HA3' HD21 ' A' ' 22' ' ' LEU . . . -128.7 125.8 5.09 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 2' ' ' ILE . 30.3 t . . . . . 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 110.315 -174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.93 -59.05 1.82 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.89 142.51 1.32 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.097 1.359 . . . . 0.0 114.124 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -111.01 24.27 13.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.167 -161.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.72 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.5 tp10 -80.83 102.76 10.22 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.6 153.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.126 0.971 . . . . 0.0 110.622 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -80.56 151.9 28.89 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.37 1.068 . . . . 0.0 110.161 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.94 119.87 24.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.547 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.5 m-85 -104.28 -19.48 14.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.655 0.782 . . . . 0.0 111.582 -175.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 p -62.89 -19.89 64.61 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.29 -19.24 53.45 Favored Glycine 0 C--N 1.356 1.648 0 CA-C-O 119.773 -0.46 . . . . 0.0 112.484 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -38.89 -45.98 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.996 1.318 . . . . 0.0 113.727 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -65.87 -20.79 66.36 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -163.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -74.25 -45.21 49.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.515 0.726 . . . . 0.0 110.85 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -90.77 -18.16 25.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 13.6 m -130.12 90.06 43.32 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 121.348 0.594 . . . . 0.0 110.566 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.92 -36.59 2.53 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.116 1.878 . . . . 0.0 111.17 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 13.4 mmmm -81.1 -9.15 59.86 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 123.895 0.878 . . . . 0.0 112.551 -171.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 38.2 tp -58.36 104.28 0.2 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.848 0.718 . . . . 0.0 110.791 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 106' ' ' LYS . 23.6 mtp180 -98.33 -42.89 7.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.604 0.762 . . . . 0.0 110.019 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 37.9 tp -128.93 139.77 51.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.133 0.573 . . . . 0.0 110.531 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.45 127.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.3 m -106.98 115.56 30.4 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.291 0.636 . . . . 0.0 109.717 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 95.6 m-85 -89.16 114.61 25.92 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.451 0.7 . . . . 0.0 109.819 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.53 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 11.8 t-20 -83.11 89.54 6.95 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.87 144.56 8.82 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.335 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.45 -37.66 81.68 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.052 0.941 . . . . 0.0 112.358 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -60.06 -31.63 70.17 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.17 -43.56 56.86 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.323 0.582 . . . . 0.0 109.512 170.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -9.73 52.79 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.281 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.9 -35.64 66.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.326 0.65 . . . . 0.0 111.113 171.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.07 23.79 12.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.72 1.208 . . . . 0.0 110.945 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.52 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -65.29 -55.96 22.58 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.386 0.675 . . . . 0.0 111.29 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.6 -16.35 34.01 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.714 1.61 . . . . 0.0 112.035 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.53 -43.76 88.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.971 0.909 . . . . 0.0 109.977 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.551 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 8.1 mt -82.27 -9.88 59.32 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.813 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 75.5 mtt180 -67.56 -22.07 65.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.312 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.28 69.29 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.823 0.702 . . . . 0.0 113.481 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.551 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -84.18 7.09 20.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.462 0.705 . . . . 0.0 111.094 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.1 28.33 68.57 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 116.876 -0.147 . . . . 0.0 112.738 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 21.0 m-85 -108.43 145.46 34.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.602 0.761 . . . . 0.0 110.866 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -79.72 139.12 37.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.52 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 51.4 p -134.85 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.914 0.486 . . . . 0.0 110.57 -174.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -140.32 130.59 25.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 -174.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.13 113.02 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 111' ' ' CYS . 85.5 mt -96.49 150.8 37.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 166.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.35 167.42 23.96 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.118 1.879 . . . . 0.0 111.277 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.9 t -62.52 115.03 3.9 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.3 p -75.21 5.9 4.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.286 0.634 . . . . 0.0 112.359 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.9 p -62.23 152.58 33.01 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.854 0.862 . . . . 0.0 110.919 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.29 65.72 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.737 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.07 -23.64 51.94 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.814 0.846 . . . . 0.0 111.705 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -110.23 4.51 21.01 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.97 0.908 . . . . 0.0 110.314 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -59.95 -34.67 73.58 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.325 0.65 . . . . 0.0 111.152 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.85 -37.4 63.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 111.595 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.26 -25.51 15.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.699 0.8 . . . . 0.0 111.009 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -80.45 22.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.545 ' HZ3' ' HB2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -61.98 -67.84 0.38 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.021 0.928 . . . . 0.0 110.952 177.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.48 -10.74 27.51 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.084 0.954 . . . . 0.0 113.142 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.421 ' O ' ' HD1' ' A' ' 152' ' ' TRP . 35.1 mmt180 -86.34 -18.75 31.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.301 0.64 . . . . 0.0 110.489 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -54.39 -36.52 64.01 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.244 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -62.19 -46.35 89.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.418 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.35 -30.67 63.48 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 119.462 -0.304 . . . . 0.0 110.471 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.421 ' HD1' ' O ' ' A' ' 148' ' ' ARG . 44.3 m95 -66.29 -43.3 86.74 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -59.13 -42.72 91.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.083 0.864 . . . . 0.0 109.512 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.33 77.45 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 124.242 0.963 . . . . 0.0 111.522 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.411 HG23 HD21 ' A' ' 134' ' ' LEU . 36.6 t -62.5 -34.6 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.959 0.903 . . . . 0.0 111.936 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 83.6 m-85 -110.24 2.42 19.24 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -65.7 -40.91 92.78 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.368 1.067 . . . . 0.0 110.793 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.414 ' CE1' HD11 ' A' ' 16' ' ' ILE . 19.5 p-80 -69.84 -6.79 34.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 112.424 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.4 -18.11 60.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.907 0.483 . . . . 0.0 111.051 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -89.43 -3.39 58.43 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 122.434 0.294 . . . . 0.0 110.237 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 . . . . . 0 N--CA 1.484 1.262 0 C-N-CA 126.123 1.769 . . . . 0.0 111.048 177.657 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.3 mm . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 121.062 0.458 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -110.11 116.28 31.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.398 1.079 . . . . 0.0 108.701 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -83.26 135.38 34.77 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 122.704 0.402 . . . . 0.0 110.233 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.4 150.17 44.8 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.817 0.698 . . . . 0.0 112.952 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -79.17 132.42 63.22 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 147.83 22.1 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.287 2.658 . . . . 0.0 112.275 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.95 133.19 50.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.039 0.536 . . . . 0.0 111.597 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG13 HD21 ' A' ' 62' ' ' LEU . 94.6 t -95.59 88.07 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.524 HD12 HD11 ' A' ' 17' ' ' LEU . 18.0 tp -136.58 149.54 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -163.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -128.99 163.79 24.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.407 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.16 -12.44 61.19 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.943 0.897 . . . . 0.0 112.567 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.3 12.44 37.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.217 0.607 . . . . 0.0 111.42 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -75.79 118.75 18.93 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 108' ' ' ARG . 56.7 mt-10 -93.49 -33.75 13.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.366 1.067 . . . . 0.0 111.366 -177.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mt -126.72 120.22 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.524 HD11 HD12 ' A' ' 10' ' ' LEU . 63.0 tp -104.57 121.77 44.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 111' ' ' CYS . 48.6 mt -99.55 109.65 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.659 0.784 . . . . 0.0 109.378 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.59 118.49 31.44 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -74.38 0.32 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.895 0.747 . . . . 0.0 113.121 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' A' ' 117' ' ' ALA . 10.8 p 151.25 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -165.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.7 136.23 14.27 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 164.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 129.75 36.47 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.078 1.852 . . . . 0.0 111.917 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.7 p -69.04 140.21 54.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -49.84 -42.77 48.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.214 1.005 . . . . 0.0 112.848 -174.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 11.8 tp10 -63.38 -29.53 70.82 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -74.39 -33.26 62.99 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.5 mt -74.47 -14.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.064 0.946 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.502 ' HG2' ' HA ' ' A' ' 26' ' ' GLU . 2.5 mmp_? -66.18 -35.28 80.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.62 -3.28 26.91 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.759 0.824 . . . . 0.0 111.484 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.48 18.98 9.91 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.008 1.323 . . . . 0.0 114.034 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -146.18 161.14 40.89 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -71.61 -12.95 61.61 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.524 1.129 . . . . 0.0 110.91 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.514 ' HD1' ' HZ2' ' A' ' 61' ' ' LYS . 85.0 t80 -87.2 -9.16 55.89 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.831 1.252 . . . . 0.0 109.731 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.3 -44.3 20.53 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 124.499 1.124 . . . . 0.0 115.589 -170.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -125.95 115.53 24.23 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -63.06 99.26 0.22 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.484 2.123 . . . . 0.0 108.196 154.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.7 -38.1 0.57 Allowed Glycine 0 C--O 1.241 0.541 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.575 -164.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -72.77 105.5 4.36 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 167.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.85 6.92 14.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.951 0.9 . . . . 0.0 111.938 -168.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -44.11 -43.09 6.71 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.857 0.863 . . . . 0.0 111.975 166.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -75.16 -21.96 58.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 112.158 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.71 -53.53 8.4 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.758 0.823 . . . . 0.0 110.471 170.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -69.84 -47.94 60.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.861 0.864 . . . . 0.0 111.535 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.45 -31.93 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.083 0.553 . . . . 0.0 109.876 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.39 -38.26 93.43 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.323 0.389 . . . . 0.0 112.689 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -72.22 -36.71 69.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.305 1.042 . . . . 0.0 110.198 174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 156' ' ' PHE . . . -63.54 -42.28 98.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.573 0.749 . . . . 0.0 112.52 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -94.08 -15.17 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.642 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 35.31 61.12 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -136.14 127.69 28.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -70.0 89.76 0.62 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.014 0.911 . . . . 0.0 110.98 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -74.68 -0.44 18.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.76 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -84.6 -39.22 18.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.646 0.379 . . . . 0.0 111.18 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -99.12 0.37 43.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.693 0.797 . . . . 0.0 112.089 -166.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -90.78 141.77 28.46 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.033 0.533 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.51 147.23 53.59 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.715 0.634 . . . . 0.0 109.373 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.474 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 56.0 t80 -45.28 -51.62 10.67 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.539 1.135 . . . . 0.0 113.776 -169.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.78 -46.15 90.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.826 0.851 . . . . 0.0 111.63 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -66.04 -38.89 89.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.652 0.781 . . . . 0.0 110.572 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.514 ' HZ2' ' HD1' ' A' ' 34' ' ' TYR . 30.9 ttmt -59.94 -40.42 88.9 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.523 1.129 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.582 HD21 HG13 ' A' ' 9' ' ' VAL . 27.0 mt -61.13 -49.03 78.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.355 174.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.16 -29.2 70.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.757 0.823 . . . . 0.0 111.516 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.481 ' HA ' ' HD2' ' A' ' 67' ' ' HIS . 85.1 m -62.19 -50.02 73.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 0.0 109.985 170.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.78 -40.34 79.61 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.046 0.841 . . . . 0.0 109.961 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HE3' HG12 ' A' ' 9' ' ' VAL . 2.3 mptm? -59.39 -39.04 82.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.71 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.481 ' HD2' ' HA ' ' A' ' 64' ' ' THR . 79.8 m-70 -55.44 -41.18 72.48 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 122.72 0.408 . . . . 0.0 111.367 173.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -90.12 2.18 55.58 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.983 0.913 . . . . 0.0 111.05 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.32 36.76 8.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.847 1.259 . . . . 0.0 110.868 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -104.05 132.93 49.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.795 1.238 . . . . 0.0 108.66 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.05 159.88 13.77 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 172.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 87.6 mt -122.53 143.87 49.45 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.839 0.856 . . . . 0.0 108.872 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -163.71 -168.59 1.68 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 171.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -125.84 179.88 4.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.276 0.63 . . . . 0.0 110.34 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 92.4 t -90.66 -44.49 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 109.884 175.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -99.26 133.19 43.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.874 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 88.4 tttt -78.56 -25.11 45.29 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.671 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.24 136.43 11.9 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.297 0.639 . . . . 0.0 110.025 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.648 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -145.73 130.17 3.68 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 N--CA 1.467 0.421 0 CA-C-N 118.367 1.083 . . . . 0.0 109.535 -174.232 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.508 HD13 ' HD2' ' A' ' 116' ' ' LYS . 37.1 mt . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.16 62.63 4.31 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.247 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.648 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.4 t70 -175.25 156.57 2.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -120.73 21.44 11.48 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 0.0 111.062 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.9 tp10 -85.39 109.14 18.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.49 137.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.077 0.951 . . . . 0.0 109.741 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -59.72 142.11 53.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 111.177 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.23 91.78 0.74 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.52 0.728 . . . . 0.0 111.295 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.52 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 21.6 m-85 -80.18 -13.14 59.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.244 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.1 p -57.03 -31.64 65.35 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.736 0.815 . . . . 0.0 111.154 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.94 -4.24 69.51 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.134 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -51.67 -39.5 58.33 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.181 0.991 . . . . 0.0 112.749 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.543 ' HA ' ' HH ' ' A' ' 129' ' ' TYR . 46.4 mtpt -56.8 -34.77 68.01 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.419 0.688 . . . . 0.0 111.894 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.79 -46.71 8.39 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.822 0.849 . . . . 0.0 112.031 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptm -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.482 0.713 . . . . 0.0 111.804 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.7 m -121.22 85.92 42.38 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 123.527 0.731 . . . . 0.0 109.189 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.77 -32.54 7.33 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.56 2.173 . . . . 0.0 112.3 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.606 ' HA ' ' HZ2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -86.15 1.9 48.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 -177.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 42.6 tp -58.14 115.13 2.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.698 0.799 . . . . 0.0 112.223 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.424 ' HD3' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -107.6 -40.06 5.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.651 168.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.06 131.95 37.61 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.118 0.567 . . . . 0.0 110.496 -171.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.436 ' HB ' HG21 ' A' ' 131' ' ' THR . 54.3 mt -102.54 145.08 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.595 ' HB2' HG12 ' A' ' 18' ' ' ILE . 76.9 m -124.56 116.22 22.1 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.346 0.521 . . . . 0.0 110.425 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.417 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 97.9 m-85 -96.72 128.07 43.31 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.646 1.178 . . . . 0.0 110.377 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -97.25 78.86 2.76 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.448 0.642 . . . . 0.0 110.412 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.1 152.48 5.76 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.052 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -65.76 -40.25 91.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.241 0.616 . . . . 0.0 110.604 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.508 ' HD2' HD13 ' A' ' 89' ' ' ILE . 4.7 tmtm? -60.07 -37.12 78.95 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.163 175.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -67.82 -41.75 82.59 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.98 172.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.7 -9.85 59.78 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 114.815 -1.084 . . . . 0.0 114.232 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.61 -33.12 74.9 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.069 0.548 . . . . 0.0 110.566 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -98.87 13.59 31.95 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.968 . . . . 0.0 111.359 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -67.34 -54.64 18.11 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.57 0.748 . . . . 0.0 111.629 177.274 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.94 -15.61 43.94 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.713 1.609 . . . . 0.0 113.143 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.43 -48.64 76.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.453 0.701 . . . . 0.0 110.886 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.513 ' HB2' HG22 ' A' ' 131' ' ' THR . 17.2 mt -82.12 -9.41 59.54 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.386 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -68.03 -28.59 67.53 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.812 0.445 . . . . 0.0 110.332 165.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.51 -19.35 64.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.53 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.4 mtt -94.07 12.15 27.39 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.098 0.959 . . . . 0.0 111.369 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.98 18.23 79.0 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.727 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.543 ' HH ' ' HA ' ' A' ' 101' ' ' LYS . 23.7 m-85 -110.88 131.52 54.98 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.919 0.488 . . . . 0.0 110.706 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.61 140.97 51.76 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 16.3 p -132.8 151.78 51.93 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.952 0.901 . . . . 0.0 109.848 -172.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -134.94 123.58 23.6 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.044 0.538 . . . . 0.0 110.266 -175.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.6 t -83.11 98.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' A' ' 111' ' ' CYS . 69.8 mt -90.88 156.88 44.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.456 ' HD3' ' CZ ' ' A' ' 148' ' ' ARG . 84.2 Cg_endo -71.02 165.03 33.71 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.985 1.79 . . . . 0.0 110.616 177.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 40.6 t -63.93 117.39 6.93 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 170.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.9 p -77.74 19.03 0.41 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.346 0.658 . . . . 0.0 112.578 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.7 p -77.26 153.1 34.29 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.895 0.878 . . . . 0.0 108.905 170.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -9.89 51.2 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.635 0.614 . . . . 0.0 114.635 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.06 -6.85 56.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 111.795 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -123.05 -2.64 8.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.696 0.798 . . . . 0.0 110.59 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -75.6 -10.01 59.08 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 120.996 0.427 . . . . 0.0 111.727 -169.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.38 -26.85 13.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.674 1.189 . . . . 0.0 113.463 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -103.29 -5.37 23.12 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 0.0 110.911 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.622 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 66.3 m -88.14 0.36 56.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.654 0.781 . . . . 0.0 111.968 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.26 -70.96 0.09 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.63 0.772 . . . . 0.0 109.906 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.9 -12.05 59.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.112 0.565 . . . . 0.0 111.535 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 74.4 ttt180 -87.51 -11.71 48.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.395 0.678 . . . . 0.0 110.58 -172.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.49 -23.76 64.77 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.009 0.524 . . . . 0.0 111.298 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.8 t -66.96 -36.33 81.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.031 0.932 . . . . 0.0 109.85 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -67.42 -44.69 78.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.554 0.742 . . . . 0.0 110.223 175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -60.06 -44.35 94.79 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.115 0.884 . . . . 0.0 109.184 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -60.6 -42.25 96.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.489 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.59 -37.95 70.95 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.4 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 52.4 t -59.06 -34.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.115 0.966 . . . . 0.0 111.286 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 57.1 m-85 -107.98 -8.75 15.81 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -75.16 -48.59 22.91 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.1 0.409 . . . . 0.0 110.317 172.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -62.27 -14.56 40.08 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.03 -13.05 22.19 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.706 1.202 . . . . 0.0 112.329 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.23 -7.31 35.48 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.018 0.927 . . . . 0.0 112.304 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.9 t60 . . . . . 0 C--N 1.362 1.132 0 C-N-CA 125.972 1.709 . . . . 0.0 109.375 -175.165 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' A' ' 80' ' ' SER . 44.1 mm . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -104.53 116.56 32.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.467 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.1 mmt85 -84.73 133.39 34.37 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.498 0.719 . . . . 0.0 110.027 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.32 -179.79 34.84 Favored Glycine 0 C--O 1.247 0.96 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.739 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.439 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 20.4 m-30 -93.91 139.12 22.56 Favored Pre-proline 0 N--CA 1.47 0.548 0 O-C-N 122.504 -0.41 . . . . 0.0 110.495 -177.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.97 162.34 26.18 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.482 2.122 . . . . 0.0 110.752 163.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.74 133.59 47.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.33 0.652 . . . . 0.0 112.606 -172.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.589 HG12 HD21 ' A' ' 62' ' ' LEU . 84.2 t -93.24 80.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 167.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.459 HD13 ' CG1' ' A' ' 104' ' ' VAL . 37.3 tp -128.24 149.41 50.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.23 -161.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.674 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 34.4 t70 -111.5 153.2 26.53 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -53.66 -48.61 69.27 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.283 0.633 . . . . 0.0 112.305 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -105.8 59.83 0.66 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.779 0.799 . . . . 0.0 111.817 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.49 ' HG1' ' HB3' ' A' ' 11' ' ' ASP . 27.6 m -85.9 135.2 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.37 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.94 -39.57 11.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.836 0.855 . . . . 0.0 111.809 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.408 HD11 ' CE1' ' A' ' 158' ' ' HIS . 44.3 mt -122.31 123.99 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.437 HD12 HD11 ' A' ' 10' ' ' LEU . 51.2 tp -109.37 117.18 33.37 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.489 HG12 ' HB2' ' A' ' 111' ' ' CYS . 43.9 mt -98.56 113.35 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 73' ' ' TRP . 88.2 mt -106.08 122.52 46.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.846 0.858 . . . . 0.0 110.176 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 -154.71 10.84 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 164.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.6 p -119.16 -66.88 1.03 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.067 0.933 . . . . 0.0 108.825 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.8 tp -146.72 119.33 4.92 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.63 158.24 56.85 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.116 1.877 . . . . 0.0 111.053 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -67.94 146.46 53.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.16 0.584 . . . . 0.0 109.436 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.529 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 36.5 t70 -61.81 -27.04 68.48 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.14 0.275 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.91 -31.48 62.91 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.555 0.742 . . . . 0.0 111.249 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 m -86.6 -41.27 14.4 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.744 0.818 . . . . 0.0 110.489 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 72.3 mt -63.73 -32.09 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 124.107 0.963 . . . . 0.0 112.974 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -62.7 -27.43 69.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.495 0.318 . . . . 0.0 111.283 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -91.02 -26.37 19.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.714 0.806 . . . . 0.0 110.596 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 61.51 34.5 17.94 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 125.25 1.42 . . . . 0.0 110.728 -165.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -135.7 133.25 37.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 109.672 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -60.59 -54.83 40.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.751 0.82 . . . . 0.0 110.547 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.429 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 83.7 t80 -65.41 -15.16 62.31 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.618 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.48 -30.33 49.61 Favored Glycine 0 C--N 1.359 1.859 0 O-C-N 123.249 0.343 . . . . 0.0 112.854 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -99.47 106.98 42.87 Favored Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.14 179.61 6.05 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.303 2.002 . . . . 0.0 110.644 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.18 -11.53 65.03 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -170.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 41' ' ' PHE . 28.8 t-20 -80.77 122.78 27.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.893 1.277 . . . . 0.0 109.5 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.06 -3.9 50.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.543 0.737 . . . . 0.0 111.986 -170.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 87.6 t80 -48.07 -45.24 32.24 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.306 1.042 . . . . 0.0 112.451 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -60.97 -37.03 81.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.482 0.713 . . . . 0.0 111.374 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.62 -41.64 71.96 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.616 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.03 -55.04 25.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.725 0.81 . . . . 0.0 111.057 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 49' ' ' ILE . 63.2 t -66.48 -44.73 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.68 -177.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -34.44 88.61 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.179 0.924 . . . . 0.0 113.975 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -68.33 -43.22 78.02 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.544 0.738 . . . . 0.0 110.313 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 153' ' ' GLU . . . -70.52 -41.35 72.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.005 0.922 . . . . 0.0 112.474 -174.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.464 HD11 ' ND2' ' A' ' 68' ' ' ASN . 17.1 pt -85.12 -14.88 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.23 0.612 . . . . 0.0 110.141 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.14 78.42 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.661 0.601 . . . . 0.0 113.933 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.486 ' HG3' HD22 ' A' ' 68' ' ' ASN . 11.6 mm-40 -115.65 142.81 46.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.012 0.925 . . . . 0.0 109.282 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.82 88.83 6.3 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.25 -47.47 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.88 -48.58 81.1 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.747 1.279 . . . . 0.0 112.248 -165.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.37 -32.44 64.5 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.7 137.0 57.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.507 0.323 . . . . 0.0 110.733 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.92 31.51 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.397 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.548 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 42.9 t80 -44.1 -43.75 7.12 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.82 -49.1 78.97 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.816 0.846 . . . . 0.0 111.101 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.1 -34.75 76.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.862 1.265 . . . . 0.0 111.473 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.33 -45.5 94.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.764 1.226 . . . . 0.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.589 HD21 HG12 ' A' ' 9' ' ' VAL . 80.7 mt -63.14 -42.78 99.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 110.816 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -63.08 -31.21 72.3 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.707 0.403 . . . . 0.0 111.339 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -74.4 -28.05 60.91 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.954 0.502 . . . . 0.0 110.948 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.27 -48.36 80.25 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.674 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -57.11 -39.28 74.78 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.617 0.767 . . . . 0.0 111.019 176.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -57.68 -40.58 79.74 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.295 1.038 . . . . 0.0 112.15 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.486 HD22 ' HG3' ' A' ' 51' ' ' GLU . 52.8 m-80 -92.15 4.76 52.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.644 0.378 . . . . 0.0 111.671 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 63.39 40.6 8.32 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.18 1.392 . . . . 0.0 111.15 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.86 138.69 29.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 125.066 1.346 . . . . 0.0 109.065 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.08 154.77 16.41 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 170.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -126.33 134.19 51.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.692 0.797 . . . . 0.0 108.866 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.415 ' HB3' HD22 ' A' ' 19' ' ' LEU . 4.8 t90 -160.71 -170.27 2.69 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -134.75 162.88 31.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.345 1.058 . . . . 0.0 109.236 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.403 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 56.0 t -73.39 -48.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 52.6 m-85 -87.45 133.75 33.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.525 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.7 tmmm? -75.17 -32.64 61.33 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.467 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -159.82 152.93 21.89 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.695 0.798 . . . . 0.0 110.817 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.504 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -146.54 128.44 3.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.458 ' HB3' HD13 ' A' ' 2' ' ' ILE . 43.5 p . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -173.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.03 55.32 0.4 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.504 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 18.7 t70 174.77 158.57 0.17 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.577 1.151 . . . . 0.0 108.813 -167.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.86 25.56 10.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.953 0.901 . . . . 0.0 111.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.525 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 6.1 tp10 -79.82 102.81 9.31 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 87.5 mt -114.81 146.81 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.744 1.218 . . . . 0.0 109.735 -173.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -68.26 141.82 55.78 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.833 0.853 . . . . 0.0 108.981 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.17 114.56 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.403 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 62.3 m-85 -100.78 6.37 43.83 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.86 0.464 . . . . 0.0 112.124 -175.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.1 t -63.73 -26.05 68.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 0.0 111.615 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.83 -1.88 84.7 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 118.898 -0.946 . . . . 0.0 114.302 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.453 HD23 ' SD ' ' A' ' 103' ' ' MET . 35.9 mt -50.03 -34.84 22.65 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 117.87 0.835 . . . . 0.0 113.071 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -65.42 -22.43 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -99.33 -45.97 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.515 ' HG3' HG22 ' A' ' 104' ' ' VAL . 17.4 ptm -69.81 -35.85 75.17 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.874 0.87 . . . . 0.0 111.314 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 2.0 m -132.87 88.11 38.49 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.336 0.654 . . . . 0.0 109.698 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.455 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 94.9 Cg_endo -72.59 -25.3 17.76 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.013 2.475 . . . . 0.0 111.771 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.2 mmmt -91.72 -6.65 51.61 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.553 1.141 . . . . 0.0 111.537 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.548 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -58.82 109.62 0.85 Allowed 'General case' 0 C--N 1.356 0.861 0 O-C-N 123.771 0.669 . . . . 0.0 110.253 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -108.38 -40.14 5.23 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.659 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 130' ' ' GLU . 47.7 tp -125.45 130.12 51.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -174.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.6 mt -110.2 116.59 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.909 0.884 . . . . 0.0 108.793 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.492 ' HB3' HD11 ' A' ' 134' ' ' LEU . 68.1 m -97.9 117.33 31.99 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 123.417 0.687 . . . . 0.0 109.699 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 91.2 m-85 -93.34 123.05 36.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.206 0.602 . . . . 0.0 110.57 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -79.95 79.62 6.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.166 0.586 . . . . 0.0 109.564 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.64 175.3 19.98 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.379 -0.828 . . . . 0.0 115.02 169.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 73.5 ttt180 -57.31 -61.04 2.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.709 1.204 . . . . 0.0 111.52 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.24 -27.66 36.22 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.86 0.864 . . . . 0.0 113.316 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.16 -50.74 15.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.443 0.697 . . . . 0.0 109.914 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.17 -10.53 84.26 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.63 -1.168 . . . . 0.0 114.789 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 96.1 mt-10 -66.24 -22.58 66.33 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.667 0.734 . . . . 0.0 110.265 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -103.53 19.63 19.41 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.347 1.059 . . . . 0.0 110.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.513 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 37.2 tt0 -60.68 -51.54 78.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 118.146 -0.931 . . . . 0.0 112.0 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -54.99 -27.56 55.11 Favored 'Trans proline' 0 C--N 1.406 3.563 0 C-N-CA 122.76 2.307 . . . . 0.0 113.571 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -62.2 -42.84 99.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.299 1.04 . . . . 0.0 110.444 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.5 -15.04 25.94 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.633 -172.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.6 mtp85 -66.85 -34.3 77.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.863 0.465 . . . . 0.0 109.975 171.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.44 -13.02 70.5 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.758 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.5 mtt -93.36 12.25 25.43 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.154 0.982 . . . . 0.0 111.292 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.0 27.83 69.68 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.387 0.429 . . . . 0.0 114.028 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.86 137.96 45.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.715 0.406 . . . . 0.0 111.306 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 28.1 mt-10 -65.1 129.83 41.12 Favored 'General case' 0 C--N 1.345 0.406 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 165.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.513 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.9 p -130.66 144.45 51.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.88 0.472 . . . . 0.0 110.16 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -139.64 125.56 19.69 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.095 0.958 . . . . 0.0 109.835 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 46.3 t -87.13 104.62 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 111' ' ' CYS . 74.3 mt -90.14 154.08 46.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.4 145.14 70.33 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 111.164 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.5 t -59.91 107.39 0.61 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.71 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.5 p -57.97 85.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 O-C-N 124.447 1.092 . . . . 0.0 111.04 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.7 t -129.81 161.0 31.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.616 1.566 . . . . 0.0 108.395 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -42.92 95.84 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.414 0.446 . . . . 0.0 112.865 167.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.0 82.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.41 0.684 . . . . 0.0 111.23 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -65.02 -44.4 89.3 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.979 172.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -67.9 -23.54 65.11 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.417 1.073 . . . . 0.0 110.309 -172.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -56.94 -28.34 62.01 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.819 1.247 . . . . 0.0 111.684 171.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -118.17 -20.04 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.301 1.04 . . . . 0.0 111.496 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.2 t -98.28 31.71 2.7 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.834 0.853 . . . . 0.0 110.973 -173.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -65.35 0.68 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.77 -6.94 59.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.642 0.777 . . . . 0.0 111.965 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -85.85 -14.22 45.62 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.318 0.647 . . . . 0.0 110.042 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -51.76 -23.52 4.72 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.862 0.865 . . . . 0.0 112.57 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -63.63 -29.6 70.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.619 0.768 . . . . 0.0 111.376 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 155' ' ' VAL . 8.3 pt-20 -73.22 -35.2 66.27 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -68.03 -35.9 79.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 2.1 tm-20 -70.8 -33.12 70.4 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.751 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.72 -11.95 60.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.858 0.863 . . . . 0.0 112.307 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 151' ' ' GLU . 53.2 t -89.61 -49.17 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.002 0.521 . . . . 0.0 110.29 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 68.4 m-85 -99.36 2.17 45.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -71.19 -35.03 71.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.651 0.66 . . . . 0.0 111.469 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.408 ' CE1' HD11 ' A' ' 16' ' ' ILE . 31.7 p-80 -69.44 -11.77 61.1 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.803 0.441 . . . . 0.0 111.441 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.39 -35.71 71.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.38 -45.81 24.78 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.601 0.761 . . . . 0.0 109.273 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 . . . . . 0 CA--C 1.563 1.468 0 C-N-CA 126.077 1.751 . . . . 0.0 112.518 -176.506 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HB2' HD22 ' A' ' 22' ' ' LEU . 3.4 mptp? -100.1 117.55 34.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -93.38 130.94 38.98 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.974 0.51 . . . . 0.0 111.766 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.87 165.05 45.63 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.942 0.776 . . . . 0.0 112.502 172.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.45 149.23 38.54 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.295 0.638 . . . . 0.0 111.544 -165.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -56.74 137.29 80.64 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.519 2.146 . . . . 0.0 110.311 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 142.99 56.6 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.87 0.731 . . . . 0.0 112.419 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.45 HG13 HD22 ' A' ' 62' ' ' LEU . 59.9 t -91.06 86.61 2.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.25 139.76 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.839 -162.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.89 162.26 23.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.426 1.091 . . . . 0.0 108.353 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.65 -24.39 67.59 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.761 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -104.14 36.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.128 0.571 . . . . 0.0 111.075 -175.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 m -89.53 106.63 18.58 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.268 0.556 . . . . 0.0 110.334 -176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.63 -29.98 17.44 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.95 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.44 HD13 HD13 ' A' ' 159' ' ' LEU . 43.2 mt -123.95 121.49 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 tp -107.98 115.12 29.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.41 HG12 ' HB2' ' A' ' 111' ' ' CYS . 39.9 mt -97.31 119.91 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.328 0.651 . . . . 0.0 109.268 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.414 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 60.7 mt -111.0 115.87 30.22 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.669 0.788 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -70.99 178.32 33.57 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 167.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 p -86.24 -80.28 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 3' ' ' LYS . 45.9 tp -131.68 122.39 18.67 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 171.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.12 149.42 44.13 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.901 2.4 . . . . 0.0 113.25 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.504 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.9 m -60.78 152.2 27.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.693 1.197 . . . . 0.0 111.12 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 54.2 m-20 -58.98 -40.56 85.18 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.185 0.594 . . . . 0.0 111.35 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.04 -25.54 67.88 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.838 1.255 . . . . 0.0 110.506 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.2 m -83.36 -38.59 21.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.718 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 24' ' ' SER . 48.6 mm -61.34 -41.03 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.346 1.058 . . . . 0.0 110.795 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.5 mmm180 -58.68 -30.95 67.77 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.717 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -106.73 -7.51 17.23 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.896 0.878 . . . . 0.0 112.33 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 58.74 30.95 20.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.814 1.246 . . . . 0.0 113.421 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -145.9 141.67 28.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.97 0.908 . . . . 0.0 109.554 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -59.69 -42.73 93.62 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.688 0.795 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -62.14 -12.63 20.72 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.404 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.45 -21.94 55.29 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.277 0.465 . . . . 0.0 113.615 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -115.77 96.69 47.26 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.65 131.87 4.05 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.38 2.72 . . . . 0.0 110.032 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.14 -13.38 5.48 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -171.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -75.17 126.44 31.03 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 171.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -82.18 1.88 34.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.326 0.512 . . . . 0.0 111.025 -169.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -46.52 -44.21 17.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.161 0.984 . . . . 0.0 112.179 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -71.55 -26.42 62.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.813 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -76.58 -40.12 50.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.233 1.013 . . . . 0.0 111.495 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 149' ' ' GLU . 80.3 mt -79.56 -46.71 16.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.59 0.756 . . . . 0.0 110.9 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 49' ' ' ILE . 98.7 t -72.64 -32.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.75 -40.97 93.95 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.804 0.69 . . . . 0.0 112.325 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -67.22 -36.07 80.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.421 0.689 . . . . 0.0 110.113 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . . . -70.95 -32.33 69.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 45' ' ' VAL . 18.5 pt -103.09 -10.93 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.241 0.617 . . . . 0.0 111.732 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.7 40.99 44.33 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.37 0.419 . . . . 0.0 113.76 177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HB3' ' HE1' ' A' ' 56' ' ' MET . 20.2 mm-40 -134.02 142.63 47.69 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.668 1.187 . . . . 0.0 108.794 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -86.48 87.8 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.522 0.677 . . . . 0.0 109.976 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.8 -31.94 67.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.831 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -62.13 -39.19 91.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.639 0.776 . . . . 0.0 112.399 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.38 -36.76 66.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.856 0.462 . . . . 0.0 110.638 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.447 ' HE1' ' HB3' ' A' ' 51' ' ' GLU . 65.3 mtt -57.67 130.39 46.17 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.19 -173.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.63 151.79 19.96 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.479 166.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.475 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 69.1 t80 -48.11 -49.58 31.47 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.501 0.72 . . . . 0.0 112.524 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.24 -40.65 94.32 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.767 0.827 . . . . 0.0 112.249 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.47 -39.49 92.04 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.573 0.702 . . . . 0.0 110.567 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -62.2 -40.59 96.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.011 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 28.8 mt -57.91 -52.33 65.94 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.012 0.82 . . . . 0.0 109.398 174.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -52.52 -46.62 66.78 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.18 0.992 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.42 HG22 ' HE1' ' A' ' 56' ' ' MET . 89.7 m -63.19 -54.74 32.75 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.058 0.943 . . . . 0.0 112.304 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.24 -50.37 70.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.498 0.719 . . . . 0.0 110.739 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -66.0 -32.24 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 112.105 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -60.34 -42.39 95.59 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.546 0.738 . . . . 0.0 110.628 168.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.43 ' O ' HD11 ' A' ' 159' ' ' LEU . 92.0 m-20 -81.32 8.08 9.99 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.984 0.914 . . . . 0.0 110.83 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 68.51 31.57 4.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 0.0 111.161 176.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.7 mt -111.09 136.85 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.489 1.115 . . . . 0.0 109.349 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.55 160.63 19.14 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 74.5 mt -123.6 144.18 49.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.462 0.705 . . . . 0.0 109.187 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.414 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.5 t90 -167.07 -169.27 1.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -137.68 -177.89 5.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.424 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 97.1 t -98.67 -55.48 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.522 0.729 . . . . 0.0 110.289 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -80.46 107.82 13.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.986 0.514 . . . . 0.0 111.552 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -64.53 -36.4 84.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.194 0.998 . . . . 0.0 110.519 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.44 122.95 10.41 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.713 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.89 116.26 1.94 Allowed Glycine 0 C--N 1.33 0.236 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.236 0.375 0 C-N-CA 123.196 0.598 . . . . 0.0 110.878 -170.664 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.5 mt . . . . . 0 CA--C 1.549 0.908 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.44 -75.9 1.13 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -38.96 137.79 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.214 1.406 . . . . 0.0 114.208 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.24 28.08 7.65 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.491 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -75.64 106.09 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.2 mm -97.4 155.27 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.22 0.608 . . . . 0.0 110.013 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -78.7 158.33 28.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.868 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.6 121.69 24.97 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.424 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 58.9 m-85 -117.71 -0.01 11.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.2 p -74.96 -19.59 60.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.13 79.1 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.575 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 69.2 mt -52.93 -29.43 28.63 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 123.444 0.698 . . . . 0.0 112.855 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.492 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 36.8 mtpt -65.09 -27.6 68.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -85.59 -55.28 4.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.196 0.998 . . . . 0.0 111.405 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 ptm -74.52 -33.82 62.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.21 0.604 . . . . 0.0 112.594 -169.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.1 m -127.08 90.77 48.46 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.221 0.608 . . . . 0.0 110.933 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.93 -32.54 2.55 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.512 2.141 . . . . 0.0 112.325 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.761 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 8.1 mmpt? -76.51 -9.49 58.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 112.241 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.2 tp -59.97 112.46 1.88 Allowed 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.687 0.617 . . . . 0.0 111.218 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -101.71 -45.38 5.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.413 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 132' ' ' LYS . 40.8 tp -134.39 133.49 40.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.2 mt -105.53 115.76 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.161 0.984 . . . . 0.0 108.487 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.475 ' HB3' HD12 ' A' ' 134' ' ' LEU . 80.0 m -98.97 116.15 30.55 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.022 0.529 . . . . 0.0 110.466 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.22 127.98 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.702 0.801 . . . . 0.0 110.195 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.494 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 14.4 m120 -90.2 102.28 15.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.59 155.05 29.89 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.586 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 78.6 ttt180 -55.84 -48.05 76.17 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.4 1.08 . . . . 0.0 112.359 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.25 -29.61 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.45 27.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 173.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.82 -9.55 62.8 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.874 -1.057 . . . . 0.0 114.597 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 115' ' ' ARG . 15.2 mm-40 -62.13 -19.97 63.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.56 0.744 . . . . 0.0 111.703 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -110.13 22.11 15.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 110.674 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.8 tt0 -59.02 -55.84 42.34 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.367 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.29 -17.71 23.98 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.458 1.438 . . . . 0.0 111.801 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.5 -48.1 78.97 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 109.83 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.502 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 6.7 mt -84.17 -16.64 42.75 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.533 -176.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 7.9 ttt180 -73.54 -17.81 61.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 176.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.88 -16.66 78.19 Favored Glycine 0 C--N 1.355 1.637 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.021 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.502 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -83.38 4.55 26.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.633 0.773 . . . . 0.0 111.197 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.97 14.56 72.07 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.542 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 36.2 m-85 -110.95 130.43 55.59 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.305 0.642 . . . . 0.0 111.222 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.42 139.1 58.74 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 15.2 p -128.13 147.01 50.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.553 0.741 . . . . 0.0 109.967 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.499 ' HB2' HD13 ' A' ' 109' ' ' LEU . 51.9 tptt -140.38 124.72 17.76 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 109.164 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.0 t -90.39 118.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.6 mt -102.9 147.79 34.62 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.19 167.45 16.31 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.328 2.019 . . . . 0.0 112.87 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.7 m -65.46 126.55 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.48 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.6 m -77.12 12.75 1.31 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.028 0.931 . . . . 0.0 112.94 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 m -72.93 145.8 46.54 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.862 0.865 . . . . 0.0 109.975 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.57 -26.9 71.2 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-O 121.298 0.388 . . . . 0.0 112.185 173.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.97 -10.87 54.04 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.501 1.121 . . . . 0.0 112.667 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -119.17 -15.85 9.15 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.764 0.826 . . . . 0.0 109.216 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.695 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 39.6 ttp85 -83.54 -17.74 40.8 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.629 0.772 . . . . 0.0 110.705 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.7 mtp-105 -61.14 -27.12 68.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.701 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -106.46 -28.92 10.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.233 1.013 . . . . 0.0 110.12 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.695 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 23.1 t -81.49 37.73 0.47 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.176 0.991 . . . . 0.0 111.501 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 54.0 mtmt -69.82 -54.11 15.11 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.744 0.818 . . . . 0.0 110.626 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.39 -15.04 57.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 5.0 mpt_? -88.44 -13.73 39.69 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.107 0.563 . . . . 0.0 111.459 -174.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.514 ' HB2' HD23 ' A' ' 44' ' ' LEU . 12.9 pt-20 -80.42 -22.66 40.97 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 120.654 0.264 . . . . 0.0 110.605 172.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -66.5 -28.49 68.61 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.426 0.69 . . . . 0.0 111.309 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.8 pt-20 -71.27 -21.37 62.1 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 122.848 0.459 . . . . 0.0 110.819 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -67.52 -42.09 83.33 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.724 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.63 -36.45 78.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.7 63.65 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.782 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.437 HG12 ' SG ' ' A' ' 111' ' ' CYS . 45.8 t -89.54 -45.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.583 0.753 . . . . 0.0 111.195 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 72.0 m-85 -96.46 -20.36 18.47 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -166.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -76.18 -6.13 49.9 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.85 1.205 . . . . 0.0 113.156 -171.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -73.54 -5.83 42.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.986 -0.447 . . . . 0.0 110.632 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.44 HD13 HD13 ' A' ' 16' ' ' ILE . 39.1 mt -87.57 -17.41 32.03 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.44 1.096 . . . . 0.0 108.787 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.59 -44.29 10.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.625 1.17 . . . . 0.0 109.904 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 70.4 m80 . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 125.46 1.504 . . . . 0.0 110.771 -175.769 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.789 0.328 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -107.97 114.18 27.9 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 168.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.49 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.3 mmt85 -78.69 129.73 35.03 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.821 0.701 . . . . 0.0 109.995 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.62 151.03 52.23 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -80.6 145.32 58.37 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.787 0.294 . . . . 0.0 111.269 -167.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.5 149.17 68.18 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.322 2.015 . . . . 0.0 110.248 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 131.93 50.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.247 0.619 . . . . 0.0 112.58 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 57.7 t -89.92 86.15 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.49 HD23 HG13 ' A' ' 104' ' ' VAL . 19.9 tp -144.41 153.67 42.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -160.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -128.27 168.32 15.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.433 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.47 -13.65 61.1 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.446 0.698 . . . . 0.0 112.277 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.86 38.09 2.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.616 . . . . 0.0 111.464 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.591 ' HB ' HG11 ' A' ' 104' ' ' VAL . 94.9 m -101.61 130.96 48.05 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.458 0.303 . . . . 0.0 110.899 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -98.2 -39.7 8.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.258 1.023 . . . . 0.0 111.21 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.609 HD13 HD12 ' A' ' 159' ' ' LEU . 51.9 mt -120.21 119.81 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 tp -106.94 118.21 36.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -94.43 109.94 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -98.0 109.3 22.08 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.8 -168.92 3.4 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 169.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 p -103.76 -76.12 0.6 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.518 HD22 HG22 ' A' ' 89' ' ' ILE . 31.1 tp -155.34 121.78 2.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 22' ' ' LEU . 9.8 Cg_exo -72.23 151.59 54.93 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.949 2.433 . . . . 0.0 112.707 -174.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 28' ' ' ILE . 18.3 m -67.31 157.77 33.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.088 0.955 . . . . 0.0 111.092 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.17 -24.57 67.95 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.14 -45.33 95.08 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.549 0.74 . . . . 0.0 110.437 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 m -68.53 -41.13 80.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.307 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 24' ' ' SER . 19.2 mm -57.35 -34.96 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 124.265 0.978 . . . . 0.0 111.647 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -58.11 -38.0 75.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.116 0.566 . . . . 0.0 112.258 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -94.77 -17.01 22.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.252 0.621 . . . . 0.0 111.168 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 64.19 30.34 13.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.514 1.125 . . . . 0.0 111.264 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -145.68 143.64 29.91 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.784 0.834 . . . . 0.0 109.851 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.32 -41.68 97.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.181 0.992 . . . . 0.0 110.113 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.25 -24.16 62.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.733 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.5 -14.4 41.97 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.368 0.418 . . . . 0.0 113.725 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.25 104.59 30.7 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.851 0.86 . . . . 0.0 109.468 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.42 97.79 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.27 2.646 . . . . 0.0 109.539 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.08 -30.14 0.72 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -170.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -67.45 103.65 1.36 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.049 0.94 . . . . 0.0 108.467 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -84.83 -0.94 55.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.418 0.687 . . . . 0.0 112.01 -166.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -42.78 -46.1 5.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.22 1.408 . . . . 0.0 113.135 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -79.4 -18.66 51.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.87 0.868 . . . . 0.0 111.254 -170.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -72.72 -47.71 44.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.114 0.565 . . . . 0.0 110.12 167.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.7 -46.63 71.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.962 0.905 . . . . 0.0 111.413 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.9 t -73.68 -41.46 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.66 0.784 . . . . 0.0 109.685 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.92 91.2 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.793 0.683 . . . . 0.0 112.453 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -66.77 -45.1 79.57 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.288 1.035 . . . . 0.0 109.83 174.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 153' ' ' GLU . . . -67.03 -36.64 82.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.815 0.846 . . . . 0.0 112.816 -173.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.2 pt -93.78 -11.26 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.164 0.585 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.61 78.8 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.25 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.33 117.4 18.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.48 96.56 2.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.359 0.664 . . . . 0.0 110.432 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.34 -22.16 61.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.285 1.034 . . . . 0.0 113.035 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -19.87 59.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -168.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -85.18 -36.18 21.2 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.425 0.557 . . . . 0.0 110.325 169.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.1 mtt -63.18 120.55 11.73 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.553 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 160.07 2.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.087 0.555 . . . . 0.0 110.884 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.589 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 47.5 t80 -42.23 -53.59 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.708 0.803 . . . . 0.0 112.85 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 37.2 mt-10 -60.05 -35.78 75.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.635 0.774 . . . . 0.0 112.295 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.02 -48.88 13.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.944 0.897 . . . . 0.0 112.092 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -59.6 -34.96 73.4 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.837 0.455 . . . . 0.0 112.203 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 15.3 mt -64.94 -41.35 95.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.54 0.336 . . . . 0.0 110.492 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 47.7 mmtm -56.83 -37.37 71.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.273 0.629 . . . . 0.0 110.835 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -64.35 -44.16 92.32 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 123.754 0.658 . . . . 0.0 110.741 177.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.65 -57.33 13.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.56 0.744 . . . . 0.0 111.538 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -21.77 60.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -60.07 -40.29 89.01 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 110.442 165.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -86.59 7.57 25.8 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.99 0.916 . . . . 0.0 110.676 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 68.69 29.89 5.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.495 1.518 . . . . 0.0 110.864 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.5 mt -102.29 133.95 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.518 1.127 . . . . 0.0 108.838 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.81 158.15 18.33 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 66.6 mt -126.39 143.3 51.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.681 0.792 . . . . 0.0 108.995 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.65 -171.54 2.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.13 169.71 10.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.403 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 52.8 t -83.93 -34.97 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.268 0.627 . . . . 0.0 109.534 169.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 55.2 m-85 -101.92 141.65 34.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.846 0.458 . . . . 0.0 111.153 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.639 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 6.7 tmtm? -81.1 -41.87 21.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.953 0.901 . . . . 0.0 108.898 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.49 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -156.47 150.82 25.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.937 0.895 . . . . 0.0 109.768 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -160.23 139.7 6.28 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 121.527 0.679 . . . . 0.0 111.935 -168.483 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.518 HG22 HD22 ' A' ' 22' ' ' LEU . 16.0 mt . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.9 57.5 4.29 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.605 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.669 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 10.2 t70 174.17 159.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -119.38 23.82 11.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.612 0.765 . . . . 0.0 112.058 -173.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.639 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 14.9 tp10 -80.4 101.85 9.26 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 54.8 mt -105.97 149.12 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.669 1.188 . . . . 0.0 110.033 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -69.51 147.18 51.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.922 0.889 . . . . 0.0 110.008 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.62 131.8 34.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.418 ' HB2' ' HE3' ' A' ' 127' ' ' MET . 50.3 m-85 -110.0 9.72 24.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.529 0.731 . . . . 0.0 111.779 -175.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 t -69.21 -20.62 63.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.682 0.393 . . . . 0.0 110.843 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -4.52 63.87 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 118.941 -0.921 . . . . 0.0 113.714 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.402 HD23 ' SD ' ' A' ' 103' ' ' MET . 31.1 mt -50.04 -37.3 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -63.73 -31.28 72.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.591 0.356 . . . . 0.0 111.165 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -82.01 -53.12 6.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.817 0.847 . . . . 0.0 111.42 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.472 ' HG3' HG22 ' A' ' 104' ' ' VAL . 23.4 ptm -67.24 -34.95 78.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.534 0.733 . . . . 0.0 111.527 -173.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.591 HG11 ' HB ' ' A' ' 14' ' ' THR . 1.6 m -129.25 84.98 60.77 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.003 0.921 . . . . 0.0 108.857 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.4 -23.74 20.11 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.736 2.29 . . . . 0.0 112.79 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 7.45 38.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.42 0.688 . . . . 0.0 111.827 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 40.2 tp -61.4 125.44 23.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.833 0.349 . . . . 0.0 111.397 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -132.09 -30.58 1.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.13 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.7 tp -130.98 129.61 42.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.047 0.539 . . . . 0.0 110.039 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.56 122.16 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.3 1.04 . . . . 0.0 108.245 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.464 ' HB2' HG12 ' A' ' 18' ' ' ILE . 77.4 m -100.41 114.26 27.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.827 0.451 . . . . 0.0 109.881 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -89.88 115.5 27.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.983 0.913 . . . . 0.0 109.902 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.58 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 23.3 t30 -89.11 99.98 12.85 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.92 0.888 . . . . 0.0 109.124 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.89 156.43 20.8 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.811 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.54 -50.39 72.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.717 1.207 . . . . 0.0 111.681 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -55.06 -31.47 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.0 -43.91 51.14 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.037 0.535 . . . . 0.0 109.757 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.43 -11.43 64.85 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.007 -0.997 . . . . 0.0 114.149 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -60.43 -34.32 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.038 0.535 . . . . 0.0 110.955 170.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -107.16 18.26 21.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.12 0.968 . . . . 0.0 110.743 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.566 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.9 tm-20 -70.4 -48.79 17.71 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.631 0.772 . . . . 0.0 111.197 170.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.23 -28.77 72.88 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 122.322 2.014 . . . . 0.0 113.192 172.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.7 -48.95 79.47 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.645 0.778 . . . . 0.0 111.12 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.0 mt -85.61 -5.23 59.3 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -171.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -65.21 -34.44 78.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.75 -14.36 67.45 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.156 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.418 ' HE3' ' HB2' ' A' ' 97' ' ' PHE . 54.9 mtt -90.59 8.0 36.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.806 0.842 . . . . 0.0 111.4 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.48 0.75 89.58 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.33 0.492 . . . . 0.0 114.33 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -92.22 137.4 32.4 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 117.105 0.453 . . . . 0.0 110.331 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.43 131.31 45.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.566 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 49.5 p -120.69 136.83 54.74 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.303 0.641 . . . . 0.0 109.403 -176.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -134.51 115.79 14.34 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.304 1.042 . . . . 0.0 109.173 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.7 94.79 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.445 HD11 ' HB3' ' A' ' 111' ' ' CYS . 73.6 mt -77.11 139.07 64.81 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 169.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.01 159.46 29.62 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.522 2.148 . . . . 0.0 112.505 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t -65.39 104.15 0.92 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.427 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.8 p -73.29 77.21 1.33 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.162 0.982 . . . . 0.0 109.037 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.8 p -129.1 159.77 34.94 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.98 29.7 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.04 -45.42 8.32 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.206 0.602 . . . . 0.0 112.143 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.82 -9.88 52.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.626 0.37 . . . . 0.0 111.896 -169.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -65.15 -33.18 75.41 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 0.0 110.369 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.13 -30.88 70.99 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.836 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.37 23.3 6.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.182 . . . . 0.0 110.596 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.5 t -139.42 24.4 2.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.294 1.038 . . . . 0.0 108.818 -170.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 49.2 tptt -66.8 -55.93 12.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 -175.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.53 -25.55 52.19 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.244 0.618 . . . . 0.0 112.355 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.564 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -88.54 -17.52 30.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.597 0.759 . . . . 0.0 111.146 -168.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 10.9 pt-20 -65.8 -19.91 66.06 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.21 0.459 . . . . 0.0 110.424 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.6 t -67.98 -44.86 75.69 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.075 0.95 . . . . 0.0 111.172 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.8 pt-20 -73.77 -29.42 62.19 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -62.68 -48.54 78.84 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.447 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 1.2 tm-20 -60.89 -38.01 84.19 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.782 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.88 -19.89 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.088 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 151' ' ' GLU . 43.7 t -68.77 -47.14 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.443 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 33.7 m-85 -91.82 2.74 56.31 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -174.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -60.78 -55.51 32.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.475 0.71 . . . . 0.0 112.128 177.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -70.3 -9.73 56.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.609 HD12 HD13 ' A' ' 16' ' ' ILE . 93.8 mt -73.53 -31.18 63.54 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.995 0.518 . . . . 0.0 109.896 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.4 -52.21 3.57 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 . . . . . 0 CA--C 1.554 1.134 0 C-N-CA 125.456 1.502 . . . . 0.0 111.167 177.28 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.495 HD11 ' HB3' ' A' ' 80' ' ' SER . 38.0 mm . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.447 ' HZ2' ' HB3' ' A' ' 25' ' ' ASP . 55.2 mttm -91.31 112.41 24.31 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.06 138.03 35.21 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.019 0.527 . . . . 0.0 111.367 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.18 152.44 49.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.536 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -84.53 138.56 38.41 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.029 0.531 . . . . 0.0 110.267 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.61 154.94 11.05 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 123.046 2.497 . . . . 0.0 112.22 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 129.75 40.92 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.573 HG11 HD21 ' A' ' 62' ' ' LEU . 97.4 t -91.12 76.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 17' ' ' LEU . 26.9 tp -135.6 153.64 51.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -158.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.559 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 9.2 t70 -126.5 167.46 15.58 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.595 0.758 . . . . 0.0 109.09 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.26 -12.77 61.63 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.799 0.84 . . . . 0.0 111.085 170.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -119.45 73.72 0.96 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.513 ' HB ' HG13 ' A' ' 104' ' ' VAL . 99.9 m -125.15 122.63 37.66 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.508 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.471 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.0 tt0 -93.34 -39.27 11.04 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.966 1.306 . . . . 0.0 110.283 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 52.5 mt -120.11 113.67 41.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.522 HD11 HD12 ' A' ' 10' ' ' LEU . 52.3 tp -103.84 116.18 31.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.491 ' HB ' HD23 ' A' ' 72' ' ' LEU . 46.2 mt -94.38 114.1 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.288 0.635 . . . . 0.0 109.372 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -104.25 113.7 27.43 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.552 0.741 . . . . 0.0 110.424 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -67.54 174.09 28.55 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.9 m -86.91 -79.8 0.26 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 tp -136.46 122.34 13.53 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.422 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.7 Cg_exo -58.04 135.3 67.75 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.073 1.849 . . . . 0.0 111.371 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.3 t -60.89 146.12 47.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.765 0.665 . . . . 0.0 109.58 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 4.9 p-10 -58.08 -34.3 69.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.431 0.292 . . . . 0.0 111.339 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.06 -43.01 69.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.272 1.029 . . . . 0.0 111.722 172.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.546 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 26.3 t -68.99 -39.19 79.5 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.011 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 24' ' ' SER . 40.3 mt -76.97 -15.62 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.27 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 13.7 mmt180 -60.63 -36.27 78.25 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.353 0.597 . . . . 0.0 109.599 176.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.76 -0.14 40.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.204 1.002 . . . . 0.0 111.288 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 61.93 21.87 12.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.35 1.06 . . . . 0.0 112.737 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.54 HE21 ' HB3' ' A' ' 34' ' ' TYR . 18.4 pt20 -146.52 158.69 43.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.491 0.316 . . . . 0.0 111.689 -173.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.565 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 83.5 m-85 -68.6 -0.88 5.68 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.745 1.218 . . . . 0.0 112.564 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.54 ' HB3' HE21 ' A' ' 32' ' ' GLN . 63.3 t80 -105.41 1.77 28.08 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.689 1.196 . . . . 0.0 110.024 -176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -38.22 -42.42 1.24 Allowed Glycine 0 C--N 1.361 1.961 0 C-N-CA 124.917 1.246 . . . . 0.0 116.083 -174.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -126.78 146.38 56.97 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.5 2.133 . . . . 0.0 112.762 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.9 -6.36 85.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.02 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -67.58 104.78 1.68 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.58 6.39 41.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.267 0.627 . . . . 0.0 111.131 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -42.77 -43.24 3.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.898 0.879 . . . . 0.0 111.045 164.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.565 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 57.3 m95 -82.71 -28.13 30.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.868 0.867 . . . . 0.0 111.966 -177.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -68.79 -45.81 70.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.812 0.845 . . . . 0.0 111.071 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 mt -87.03 -39.03 16.01 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.133 0.573 . . . . 0.0 111.96 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.3 t -71.39 -36.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 -39.72 95.61 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.891 0.745 . . . . 0.0 112.471 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -67.96 -39.29 83.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.15 0.58 . . . . 0.0 110.496 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.93 72.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.022 0.929 . . . . 0.0 113.07 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 pt -94.74 -11.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.929 0.492 . . . . 0.0 111.151 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.78 72.83 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 0.0 113.574 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -142.98 104.26 4.29 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.09 99.91 0.19 Allowed 'General case' 0 C--N 1.352 0.703 0 CA-C-O 121.453 0.644 . . . . 0.0 110.993 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 73.2 mt -67.06 -34.49 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -66.17 -21.21 66.32 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.227 1.011 . . . . 0.0 112.539 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -95.39 -31.55 13.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.87 0.468 . . . . 0.0 111.229 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.4 mtt -58.1 141.09 51.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.236 0.614 . . . . 0.0 111.176 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.41 137.69 57.1 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.141 -0.933 . . . . 0.0 109.395 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.48 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 38.4 t80 -45.66 -38.82 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -167.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 40.3 mt-10 -58.79 -59.93 4.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.534 0.734 . . . . 0.0 110.923 175.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -60.11 -34.15 73.1 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.971 0.908 . . . . 0.0 111.729 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HG3' ' HB3' ' A' ' 53' ' ' LEU . 2.3 ttmp? -60.17 -47.5 85.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.875 1.27 . . . . 0.0 110.006 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.573 HD21 HG11 ' A' ' 9' ' ' VAL . 46.0 mt -67.5 -40.35 85.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.001 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 57.7 mtpt -60.2 -31.34 70.06 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.574 0.35 . . . . 0.0 111.736 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -67.88 -34.52 76.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.072 0.549 . . . . 0.0 110.58 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.55 -57.31 11.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.559 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -58.73 -36.78 74.87 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.137 0.575 . . . . 0.0 111.264 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -53.51 -46.58 70.13 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 111.9 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -87.06 8.41 23.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.0 0.92 . . . . 0.0 111.852 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.471 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 60.53 37.3 19.67 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.595 1.158 . . . . 0.0 110.353 -178.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.81 140.41 21.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.383 1.073 . . . . 0.0 109.225 174.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 9' ' ' VAL . . . -123.35 162.88 17.07 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 170.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.491 HD23 ' HB ' ' A' ' 18' ' ' ILE . 98.0 mt -128.76 138.95 52.38 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -164.69 -168.74 1.55 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -131.29 160.98 33.35 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.61 0.641 . . . . 0.0 111.553 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.498 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.6 t -94.04 -48.28 13.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 124.204 1.002 . . . . 0.0 110.809 175.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -93.78 113.35 25.38 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 87.9 tttt -64.28 -37.29 86.95 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.252 0.97 . . . . 0.0 110.513 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.86 134.97 17.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.849 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -143.66 136.26 6.81 Favored Glycine 0 C--O 1.218 -0.892 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.495 ' HB3' HD11 ' A' ' 2' ' ' ILE . 23.9 p . . . . . 0 N--CA 1.473 0.69 0 CA-C-N 117.958 0.879 . . . . 0.0 110.594 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.36 65.05 4.07 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.802 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.58 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.0 t70 -177.87 153.85 0.87 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.075 0.95 . . . . 0.0 108.577 -169.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -121.62 22.07 10.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.574 0.75 . . . . 0.0 111.746 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.0 tp10 -80.28 101.32 8.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.0 mt -94.61 153.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.18 0.992 . . . . 0.0 110.162 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.97 156.33 19.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.947 0.899 . . . . 0.0 109.429 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.01 122.12 34.22 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.515 0.726 . . . . 0.0 110.312 -174.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.498 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 48.2 m-85 -109.0 6.85 25.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.52 0.728 . . . . 0.0 112.007 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -70.45 -17.14 62.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.63 0.372 . . . . 0.0 111.048 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.94 -5.19 77.69 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.657 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -47.89 -49.06 31.02 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.561 0.745 . . . . 0.0 112.666 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -62.0 -27.8 69.12 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -82.91 -54.36 5.14 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.444 0.698 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -75.45 -27.72 59.02 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 4.1 m -132.54 92.61 27.04 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.285 0.634 . . . . 0.0 110.851 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 71.5 Cg_endo -74.19 -36.89 2.95 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.907 2.405 . . . . 0.0 111.781 172.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.3 mmmt -79.83 -5.93 56.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.095 0.958 . . . . 0.0 111.392 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.3 tp -57.84 128.91 39.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.842 0.857 . . . . 0.0 111.316 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.521 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -137.7 -22.61 1.09 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.328 171.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.521 ' HB2' HH11 ' A' ' 108' ' ' ARG . 23.6 tp -129.64 126.57 38.72 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.883 0.473 . . . . 0.0 110.577 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.535 ' HB ' HG21 ' A' ' 131' ' ' THR . 33.7 mt -113.78 110.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.454 ' HB3' HD13 ' A' ' 134' ' ' LEU . 76.8 m -96.12 114.21 25.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 110.509 -175.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.47 116.19 28.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.023 0.929 . . . . 0.0 110.742 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.527 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 83.1 m-20 -82.92 102.39 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.75 138.32 9.48 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -58.83 -32.1 69.08 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.144 0.578 . . . . 0.0 111.513 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -53.31 -42.89 67.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.892 0.877 . . . . 0.0 112.303 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.29 -38.72 71.8 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.426 0.631 . . . . 0.0 110.314 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.57 -9.53 55.7 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.561 -1.2 . . . . 0.0 114.44 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -24.64 66.91 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 117.374 0.587 . . . . 0.0 110.547 172.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.4 21.5 16.59 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.198 0.999 . . . . 0.0 111.215 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 1.3 tm-20 -66.24 -52.16 39.79 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.17 0.988 . . . . 0.0 112.405 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.46 -14.61 30.89 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.608 1.539 . . . . 0.0 112.357 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -66.1 -44.98 82.82 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.905 0.882 . . . . 0.0 109.668 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 -20.49 29.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 50.5 ttt180 -72.24 -29.13 63.63 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.06 -22.28 75.87 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 58.4 mtt -76.66 -9.9 59.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.195 0.598 . . . . 0.0 111.719 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.89 14.75 16.4 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 120.175 -0.236 . . . . 0.0 113.412 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.2 m-85 -109.12 145.72 35.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 0.0 109.734 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 mm-40 -70.55 137.11 49.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 163.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.535 HG21 ' HB ' ' A' ' 110' ' ' ILE . 25.8 p -128.43 138.4 52.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -129.33 117.99 21.54 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.785 1.234 . . . . 0.0 108.849 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.41 103.33 9.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 111' ' ' CYS . 48.0 mt -88.53 131.92 40.53 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 148' ' ' ARG . 45.8 Cg_exo -59.57 136.3 70.24 Favored 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.687 2.258 . . . . 0.0 111.133 176.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.6 t -50.24 118.99 3.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.261 0.975 . . . . 0.0 111.013 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 p -83.65 30.17 0.5 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.901 0.881 . . . . 0.0 111.529 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 p -61.05 149.52 36.73 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.715 0.806 . . . . 0.0 110.576 165.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -53.14 -42.97 62.89 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.729 0.643 . . . . 0.0 114.4 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.01 93.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.329 0.652 . . . . 0.0 111.782 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -78.27 -28.51 47.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.168 0.587 . . . . 0.0 110.065 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.98 -36.62 77.55 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.322 0.649 . . . . 0.0 110.952 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -57.02 -20.78 26.19 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.118 0.967 . . . . 0.0 112.565 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -112.5 -33.69 6.08 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.243 0.617 . . . . 0.0 110.847 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.7 m -69.5 83.12 0.41 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -95.8 -57.18 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.396 1.079 . . . . 0.0 110.586 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.05 -32.41 69.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.182 0.593 . . . . 0.0 110.399 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.532 ' HB3' ' HG2' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -86.95 -31.81 20.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.908 -172.599 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.75 -28.85 67.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.006 0.821 . . . . 0.0 109.01 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -65.87 -42.91 89.74 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.1 pt-20 -71.9 -26.96 62.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -67.52 -43.21 81.38 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.69 -39.12 84.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.401 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.497 -175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 151' ' ' GLU . 54.8 t -80.73 -62.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.003 0.521 . . . . 0.0 110.407 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.08 2.45 43.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -165.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -25.62 62.84 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -78.21 -8.15 57.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.558 0.343 . . . . 0.0 111.814 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.81 -38.8 76.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.815 0.446 . . . . 0.0 111.312 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.25 -41.68 40.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 C--O 1.243 0.733 0 C-N-CA 125.566 1.547 . . . . 0.0 106.89 175.552 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.2 mm . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -88.34 110.14 20.54 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.2 mmt-85 -84.25 136.42 33.94 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.182 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -68.22 162.46 49.32 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 123.634 0.584 . . . . 0.0 112.052 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -101.47 146.14 31.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.05 137.09 17.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.741 2.294 . . . . 0.0 111.866 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.4 138.79 58.27 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.94 0.896 . . . . 0.0 111.625 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.63 81.29 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.479 HD12 ' CG1' ' A' ' 104' ' ' VAL . 40.8 tp -128.0 145.36 51.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.358 -163.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -123.41 159.67 28.46 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.603 1.161 . . . . 0.0 107.909 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.13 -26.73 64.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.987 0.515 . . . . 0.0 111.202 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -111.46 89.53 3.08 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -135.48 107.64 7.21 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.303 0.641 . . . . 0.0 109.61 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.493 ' HG2' ' HB3' ' A' ' 69' ' ' ARG . 59.7 mm-40 -80.47 -35.74 34.39 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.396 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 24.3 mt -129.09 124.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 123.461 0.704 . . . . 0.0 109.857 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.79 117.4 34.02 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mt -94.15 112.83 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.52 119.66 39.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.727 0.811 . . . . 0.0 109.981 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.24 177.11 46.39 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 164.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 116' ' ' LYS . 47.4 t -90.16 -75.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 tp -129.59 125.2 22.26 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 175.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 50.6 Cg_exo -59.28 125.0 16.78 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.033 1.822 . . . . 0.0 110.509 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -78.76 173.07 12.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.8 -37.28 78.69 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.046 0.539 . . . . 0.0 111.578 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.57 -42.95 89.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.871 0.868 . . . . 0.0 111.475 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.5 m -65.4 -41.9 93.15 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.024 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.02 -26.78 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.852 1.261 . . . . 0.0 112.304 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -63.37 -39.56 94.86 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.892 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -5.18 22.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.149 0.58 . . . . 0.0 111.186 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 62.5 31.22 17.13 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.688 1.195 . . . . 0.0 111.253 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -127.68 139.34 52.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.908 1.283 . . . . 0.0 108.887 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -57.56 -40.48 78.99 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.378 0.609 . . . . 0.0 109.535 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -47.71 -44.76 27.98 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.422 169.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.39 -107.29 0.1 Allowed Glycine 0 C--N 1.362 2.012 0 O-C-N 124.043 0.839 . . . . 0.0 113.301 -170.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -122.72 146.6 48.44 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.294 1.037 . . . . 0.0 109.794 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -40.54 119.04 0.67 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.821 3.68 . . . . 0.0 114.216 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.29 -33.12 0.09 OUTLIER Glycine 0 N--CA 1.472 1.071 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.431 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -93.46 126.9 38.85 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.52 0.728 . . . . 0.0 109.245 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -81.64 1.49 33.81 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.399 1.08 . . . . 0.0 111.017 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -37.51 -49.48 1.06 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.918 1.687 . . . . 0.0 113.073 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -73.37 -24.21 60.3 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.402 -173.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 ttm-85 -88.29 -27.17 21.88 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 111.117 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.35 -51.36 9.52 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 110.569 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.96 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.27 -36.79 85.55 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.069 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -64.23 -40.97 97.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.631 . . . . 0.0 109.498 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.409 ' CB ' ' HB2' ' A' ' 156' ' ' PHE . . . -62.81 -50.32 71.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.585 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.3 pt -88.19 -4.98 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.49 0.316 . . . . 0.0 111.212 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.3 28.99 64.93 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.147 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -146.15 92.28 2.17 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.01 101.16 0.14 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.243 0.617 . . . . 0.0 109.868 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.415 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 54.3 mt -68.73 -17.43 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.401 1.081 . . . . 0.0 112.229 -167.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.02 -41.93 93.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.543 0.737 . . . . 0.0 112.044 -169.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.38 -32.64 71.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.58 0.752 . . . . 0.0 112.459 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -60.37 148.85 35.73 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.307 0.643 . . . . 0.0 112.55 -175.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 153.72 32.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 167.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.51 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 33.5 t80 -54.45 -45.61 73.12 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -164.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -63.8 -45.2 90.75 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.044 0.538 . . . . 0.0 111.271 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -34.59 78.74 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.06 0.944 . . . . 0.0 110.333 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 29.7 ttmt -65.46 -41.44 93.37 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.814 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 29.2 mt -58.06 -48.46 80.04 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.07 0.856 . . . . 0.0 109.625 173.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -55.92 -45.23 78.78 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.237 0.96 . . . . 0.0 111.693 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -67.41 -45.64 75.57 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 123.543 0.527 . . . . 0.0 110.691 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.7 mt -55.84 -56.56 19.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.752 0.821 . . . . 0.0 110.527 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -67.95 -30.65 70.0 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.296 1.039 . . . . 0.0 111.58 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -63.45 -35.94 82.1 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.815 0.846 . . . . 0.0 110.884 170.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -84.82 5.13 29.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.388 0.675 . . . . 0.0 111.254 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.493 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 2.0 mpt_? 65.36 34.47 8.19 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-O 122.25 1.024 . . . . 0.0 110.197 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.06 135.65 49.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 108.731 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.61 169.04 13.66 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.0 mt -126.73 147.42 49.97 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.759 0.824 . . . . 0.0 109.127 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -166.18 -169.02 1.34 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.33 164.34 30.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.312 0.645 . . . . 0.0 110.565 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.408 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.7 t -86.14 -42.38 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.037 0.935 . . . . 0.0 111.074 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -100.22 115.78 30.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.095 0.558 . . . . 0.0 110.625 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 1.6 tmtp? -66.47 -34.75 78.64 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -144.82 135.26 24.35 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.684 -0.635 . . . . 0.0 110.614 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.524 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -157.26 148.72 18.78 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.547 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.476 0.84 0 C-N-CA 124.303 1.041 . . . . 0.0 109.119 177.444 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.376 0.608 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.38 58.09 4.18 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.519 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.524 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.9 t0 -171.19 144.05 2.0 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -110.43 17.67 20.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.887 0.875 . . . . 0.0 111.59 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 45.8 tt0 -85.01 103.01 13.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.488 0.661 . . . . 0.0 109.376 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.55 154.01 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.809 1.244 . . . . 0.0 109.451 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -79.58 157.2 27.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.686 0.794 . . . . 0.0 109.748 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.22 139.78 30.14 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.408 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 80.8 m-85 -130.48 11.58 5.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.713 0.805 . . . . 0.0 110.951 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 99.2 p -77.62 -12.1 59.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.969 -0.457 . . . . 0.0 110.469 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.03 -4.87 68.55 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.532 -0.593 . . . . 0.0 112.307 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 mt -51.23 -49.47 61.02 Favored 'General case' 0 C--N 1.37 1.494 0 C-N-CA 123.729 0.812 . . . . 0.0 111.362 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.541 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 44.6 mtpt -64.92 -16.18 62.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -171.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.94 -40.13 9.04 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 111.611 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -85.44 -26.61 26.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 2.2 m -129.02 89.5 48.46 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 122.868 0.467 . . . . 0.0 110.04 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.64 -28.7 20.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.296 1.997 . . . . 0.0 110.969 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -84.61 -11.95 54.97 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 112.864 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 32.3 tp -57.69 101.85 0.08 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.033 0.833 . . . . 0.0 110.665 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -93.21 -43.97 8.57 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.588 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.7 tp -134.19 135.66 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.555 0.742 . . . . 0.0 109.894 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.4 mt -105.08 136.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 86.3 m -117.75 115.39 24.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.14 0.427 . . . . 0.0 110.251 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -93.56 123.06 36.62 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -101.81 111.35 23.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.18 134.99 8.62 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -53.17 -47.17 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.304 1.042 . . . . 0.0 112.18 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -60.22 -20.83 60.53 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.805 0.842 . . . . 0.0 112.641 -178.13 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.56 -46.36 17.47 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.372 0.606 . . . . 0.0 109.476 170.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.26 -9.76 68.33 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.95 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -68.35 -17.52 64.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.009 0.524 . . . . 0.0 110.636 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.79 21.47 17.45 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.183 0.993 . . . . 0.0 110.988 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.44 -51.48 59.96 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.15 -0.928 . . . . 0.0 112.357 171.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.28 -24.44 67.7 Favored 'Trans proline' 0 C--N 1.405 3.551 0 C-N-CA 122.084 1.856 . . . . 0.0 112.698 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.81 -57.21 8.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.914 0.886 . . . . 0.0 110.181 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.474 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 12.2 mt -79.18 -21.03 46.96 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 6.9 ptm180 -75.22 -11.65 60.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 120.703 0.287 . . . . 0.0 110.715 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.59 -15.14 81.44 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.405 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -81.94 10.71 5.98 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 174.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.24 19.74 79.76 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 122.749 0.214 . . . . 0.0 112.716 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 18.3 m-85 -108.79 139.59 43.39 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.304 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -73.48 142.42 46.8 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -129.99 148.15 51.82 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -139.37 123.54 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.215 1.006 . . . . 0.0 108.864 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.04 122.81 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.505 HD22 HG23 ' A' ' 155' ' ' VAL . 90.4 mt -113.02 150.15 42.44 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.58 177.37 4.08 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.772 2.314 . . . . 0.0 111.561 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 m -66.02 130.29 42.74 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -83.89 14.91 3.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.834 0.854 . . . . 0.0 112.044 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -69.88 156.26 39.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.147 0.979 . . . . 0.0 111.78 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.17 -18.61 69.38 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.693 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.22 83.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.362 0.665 . . . . 0.0 111.056 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -76.56 -2.59 33.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.7 0.8 . . . . 0.0 112.477 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 20.1 ttm-85 -56.13 -33.68 65.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.039 0.935 . . . . 0.0 113.317 -172.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -33.38 72.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.643 0.589 . . . . 0.0 110.606 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.01 5.94 20.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.774 0.829 . . . . 0.0 111.994 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 13.7 t -91.07 14.8 13.05 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.151 0.58 . . . . 0.0 112.195 -175.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.98 -58.06 5.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.425 ' HB2' ' NH1' ' A' ' 148' ' ' ARG . 17.4 m120 -59.21 -15.06 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.425 ' NH1' ' HB2' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -74.96 -23.65 58.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.974 0.51 . . . . 0.0 110.101 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.36 -55.63 32.27 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.26 0.624 . . . . 0.0 110.695 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -73.93 -32.34 63.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 111.161 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.41 ' O ' HG21 ' A' ' 155' ' ' VAL . 19.3 tt0 -67.37 -56.75 8.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.165 0.586 . . . . 0.0 110.224 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -69.58 -25.91 64.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.52 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 32.4 tt0 -59.35 -49.61 77.14 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 123.821 0.7 . . . . 0.0 109.442 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.53 77.69 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.553 -171.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.505 HG23 HD22 ' A' ' 134' ' ' LEU . 92.6 t -61.91 -32.64 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 124.173 0.989 . . . . 0.0 112.673 -174.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.409 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 44.0 m-85 -115.55 -11.99 11.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 112.909 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.52 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 14.4 ptm180 -74.1 -26.56 60.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.555 0.616 . . . . 0.0 111.591 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -73.84 -8.8 57.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.571 0.348 . . . . 0.0 111.906 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.26 -12.21 61.43 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.338 0.655 . . . . 0.0 112.732 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -90.37 -1.99 57.94 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.036 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 . . . . . 0 CA--C 1.555 1.148 0 C-N-CA 125.561 1.544 . . . . 0.0 110.435 -175.01 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptp . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.812 0.339 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.89 139.75 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -87.61 117.51 26.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -100.12 134.04 43.62 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.366 0.667 . . . . 0.0 110.558 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.512 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.2 -174.03 17.55 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.384 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -117.03 144.23 33.16 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 122.948 0.499 . . . . 0.0 110.281 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.42 145.42 16.13 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.024 2.483 . . . . 0.0 112.003 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.11 128.85 38.46 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.825 0.703 . . . . 0.0 111.124 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.518 HG13 HD22 ' A' ' 62' ' ' LEU . 48.7 t -93.75 78.88 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.9 tp -128.71 154.07 46.69 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 112.164 -161.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.51 154.92 37.21 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 9.9 pt-20 -65.13 -10.68 32.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.15 0.58 . . . . 0.0 112.222 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.428 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 20.7 m-80 -120.08 97.38 5.57 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' HG12 ' A' ' 104' ' ' VAL . 52.6 m -144.04 112.93 6.71 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.387 0.675 . . . . 0.0 110.205 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.56 -36.21 29.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.053 . . . . 0.0 110.75 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.16 116.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.241 0.616 . . . . 0.0 109.484 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -104.95 115.51 30.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.515 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.0 mt -98.38 109.32 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.736 0.814 . . . . 0.0 109.046 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 73' ' ' TRP . 80.8 mt -98.08 108.93 21.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 109.026 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.72 -177.9 11.99 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 166.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 p -89.61 -82.17 0.27 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -136.12 114.92 10.88 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.5 Cg_exo -52.89 136.77 60.62 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.958 2.438 . . . . 0.0 112.846 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 m -61.22 145.64 50.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.105 0.878 . . . . 0.0 109.634 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.542 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 7.8 p-10 -61.89 -31.26 71.53 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.158 0.436 . . . . 0.0 110.73 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.75 -36.24 76.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.87 0.868 . . . . 0.0 110.793 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.1 m -66.5 -47.08 74.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.45 -26.57 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.763 1.225 . . . . 0.0 112.832 -171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 18.7 mmt85 -69.4 -36.36 76.68 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 110.089 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.64 -16.12 35.33 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.281 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 65.38 21.59 11.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.695 1.598 . . . . 0.0 111.597 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.89 135.9 40.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.842 1.257 . . . . 0.0 108.873 -173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -57.98 -40.49 80.79 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 122.936 0.495 . . . . 0.0 110.817 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.98 -13.33 45.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.512 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.89 16.41 Favored Glycine 0 C--N 1.362 1.984 0 C-N-CA 124.02 0.819 . . . . 0.0 113.523 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -109.78 112.29 58.39 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 165.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.07 0.56 3.1 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.794 2.996 . . . . 0.0 114.273 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.29 -14.2 80.89 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -72.82 97.64 2.28 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 168.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -80.07 -1.65 40.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.971 0.909 . . . . 0.0 110.885 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -36.03 -41.91 0.26 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.916 2.087 . . . . 0.0 113.443 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.36 -28.9 64.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.57 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -84.11 -37.84 21.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.106 0.562 . . . . 0.0 111.117 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.68 -48.24 80.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 0.0 110.224 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -74.02 -37.26 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.416 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.08 -41.11 99.88 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.071 0.388 . . . . 0.0 114.071 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -71.41 -30.63 66.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.745 0.418 . . . . 0.0 110.363 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.82 -36.91 59.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.807 0.843 . . . . 0.0 112.465 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 pt -91.11 -10.46 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.396 0.678 . . . . 0.0 111.143 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.18 19.81 79.75 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.588 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -135.7 112.64 10.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -71.53 96.44 1.53 Allowed 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.588 0.709 . . . . 0.0 111.696 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.68 -35.87 81.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.013 0.925 . . . . 0.0 110.917 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -53.29 -50.44 64.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.627 1.171 . . . . 0.0 112.626 -170.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -81.96 -6.31 59.02 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.275 0.63 . . . . 0.0 112.097 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtt -86.11 139.62 30.95 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 151.35 33.56 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.081 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.513 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 53.6 t80 -50.0 -42.94 50.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -167.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 42.5 mt-10 -60.31 -46.2 90.73 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.305 0.378 . . . . 0.0 110.758 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -68.53 -45.13 73.02 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -59.71 -32.99 71.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.14 0.427 . . . . 0.0 110.885 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.518 HD22 HG13 ' A' ' 9' ' ' VAL . 47.2 mt -66.77 -43.15 84.8 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.81 172.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 74.7 mmtt -57.06 -41.17 78.27 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.216 0.606 . . . . 0.0 110.233 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -65.27 -39.25 92.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.498 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.05 -46.25 85.22 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.851 0.461 . . . . 0.0 110.228 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 28.6 mmtp -59.88 -39.77 86.43 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.104 0.561 . . . . 0.0 109.882 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.05 -45.65 90.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.992 1.317 . . . . 0.0 111.335 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -86.25 7.78 23.86 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.328 0.251 . . . . 0.0 111.035 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 67.85 38.5 2.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.479 1.111 . . . . 0.0 110.988 171.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.63 132.92 57.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.15 1.38 . . . . 0.0 109.504 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.5 151.6 18.03 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 46.5 mt -119.84 141.06 49.87 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.341 0.656 . . . . 0.0 109.29 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.423 ' HB3' HD22 ' A' ' 19' ' ' LEU . 4.9 t90 -165.09 -168.96 1.53 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -133.54 177.91 7.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.956 0.902 . . . . 0.0 109.888 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.498 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.7 t -95.64 -56.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.675 0.79 . . . . 0.0 109.647 172.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.455 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 57.3 m-85 -84.21 107.98 16.84 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.095 0.558 . . . . 0.0 110.607 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.492 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 3.7 tmtm? -66.82 -31.14 71.57 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.813 0.845 . . . . 0.0 109.044 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -152.86 130.87 11.81 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.061 0.544 . . . . 0.0 109.742 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' A' ' 91' ' ' ASP . . . -151.03 144.21 11.49 Favored Glycine 0 C--O 1.238 0.4 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.825 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -90.04 105.37 17.76 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -119.06 92.72 3.87 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 170.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -133.24 168.37 18.67 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.859 -0.525 . . . . 0.0 109.964 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.61 92.88 0.36 Allowed Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.572 -175.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 p -143.9 -171.02 3.46 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.012 0.925 . . . . 0.0 109.904 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -68.04 -62.41 1.41 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.388 0.675 . . . . 0.0 109.973 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 4.1 m-20 -72.87 -46.44 52.83 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.702 -175.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.2 m 56.07 36.36 27.26 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.582 1.153 . . . . 0.0 111.161 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 86' ' ' ASP . 31.9 mmmt -92.29 153.2 19.38 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.007 0.923 . . . . 0.0 110.097 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -70.04 97.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.37 -70.1 1.3 Allowed Glycine 0 C--N 1.344 0.989 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.759 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.508 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 1.1 m-20 -38.88 133.41 1.12 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.873 1.269 . . . . 0.0 113.349 173.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -114.62 25.87 10.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.438 -165.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 8.4 tp10 -78.88 111.96 15.57 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.72 144.07 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.88 0.872 . . . . 0.0 109.134 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -68.95 149.61 48.65 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.233 1.013 . . . . 0.0 110.796 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -78.27 130.94 36.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.498 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 35.3 m-85 -120.67 3.88 10.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.252 0.621 . . . . 0.0 111.395 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.0 t -74.63 -14.69 60.79 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.007 0.523 . . . . 0.0 109.817 173.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.88 -4.04 61.87 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.148 -0.807 . . . . 0.0 113.094 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 mt -52.8 -32.88 46.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 117.732 0.766 . . . . 0.0 112.879 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -68.59 -27.19 65.82 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.779 0.323 . . . . 0.0 111.444 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -83.31 -53.0 6.07 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.696 0.799 . . . . 0.0 111.466 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.516 ' HG3' HG23 ' A' ' 104' ' ' VAL . 25.4 ptm -73.32 -29.41 62.66 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.305 0.642 . . . . 0.0 111.341 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -139.24 86.96 14.12 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.449 0.7 . . . . 0.0 111.209 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.69 -25.97 8.78 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.469 2.113 . . . . 0.0 112.554 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -77.8 -10.13 59.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.4 0.68 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.594 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 36.2 tp -54.39 131.09 41.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.81 0.694 . . . . 0.0 110.673 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.41 ' HD2' ' NE2' ' A' ' 158' ' ' HIS . 18.0 ptp180 -128.56 -37.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.004 0.921 . . . . 0.0 108.707 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 tp -132.29 125.34 30.75 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.255 0.622 . . . . 0.0 110.432 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.496 HG12 HD23 ' A' ' 107' ' ' LEU . 32.9 mt -101.69 109.53 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.515 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.5 m -95.12 112.98 24.62 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.165 0.507 . . . . 0.0 109.928 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.1 114.49 25.75 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.189 0.996 . . . . 0.0 109.396 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -90.51 107.16 18.98 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.34 28.45 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.327 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -56.07 -50.7 70.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 112.851 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 76' ' ' PHE . 26.3 mmmt -50.26 -37.22 34.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.41 -46.03 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.018 0.527 . . . . 0.0 110.103 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.73 -14.59 70.25 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 114.736 -1.12 . . . . 0.0 114.705 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.64 -28.38 69.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.974 0.51 . . . . 0.0 110.837 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.19 19.99 12.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.271 1.028 . . . . 0.0 111.227 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 41.2 tt0 -61.6 -54.71 49.36 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.627 170.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 125' ' ' ARG . 32.2 Cg_endo -59.23 -20.59 55.78 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 122.262 1.975 . . . . 0.0 113.438 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.56 -50.31 70.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.932 0.893 . . . . 0.0 110.163 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.482 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 9.8 mt -89.46 -6.67 56.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 29.3 mtp180 -69.62 -20.04 63.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.966 0.507 . . . . 0.0 109.944 168.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.35 -16.74 80.15 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.402 -0.666 . . . . 0.0 113.42 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.2 mpt? -85.73 9.97 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.702 0.751 . . . . 0.0 112.183 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.96 17.28 71.45 Favored Glycine 0 C--N 1.352 1.441 0 C-N-CA 122.869 0.271 . . . . 0.0 113.633 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -111.07 134.34 52.74 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.548 0.739 . . . . 0.0 109.611 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.99 143.28 56.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.4 p -127.85 139.59 52.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.706 0.802 . . . . 0.0 110.16 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -132.14 118.7 19.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.668 1.187 . . . . 0.0 108.928 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.96 95.11 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.9 mt -75.42 150.99 85.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 73.0 Cg_endo -72.5 163.88 37.25 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.084 1.856 . . . . 0.0 110.359 171.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -63.4 133.09 53.43 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.7 p -79.31 -3.97 48.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.264 0.626 . . . . 0.0 112.026 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -66.68 159.52 27.55 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 111.059 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.43 -28.93 62.77 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.501 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.9 76.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.837 0.855 . . . . 0.0 112.002 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.484 ' ND2' ' HB2' ' A' ' 135' ' ' PRO . 49.1 t30 -89.94 -33.76 16.29 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.063 0.545 . . . . 0.0 110.982 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.534 HH21 ' HA ' ' A' ' 146' ' ' LYS . 6.5 tpm_? -51.61 -44.42 62.88 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.089 1.356 . . . . 0.0 112.458 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -60.87 -12.88 12.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.745 1.218 . . . . 0.0 113.317 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -121.06 -40.63 2.59 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.155 0.982 . . . . 0.0 110.823 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.412 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 65.4 m -93.3 85.64 5.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.697 0.799 . . . . 0.0 110.407 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.534 ' HA ' HH21 ' A' ' 142' ' ' ARG . 34.0 mmtp -93.99 -50.64 5.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.51 0.724 . . . . 0.0 111.475 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -86.05 -4.15 59.1 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.932 0.493 . . . . 0.0 111.506 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.412 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.3 tpt180 -78.31 -24.62 46.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.675 0.39 . . . . 0.0 110.097 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 11.3 pt-20 -62.12 -13.46 27.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 m -65.68 -30.5 71.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.37 0.668 . . . . 0.0 112.194 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.42 ' O ' HG22 ' A' ' 155' ' ' VAL . 14.7 pt-20 -72.61 -29.6 63.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.795 0.438 . . . . 0.0 109.925 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -67.35 -37.65 83.56 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.55 -37.69 83.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.978 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.48 72.63 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.793 0.683 . . . . 0.0 111.168 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 151' ' ' GLU . 80.2 t -71.87 -60.39 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.567 0.747 . . . . 0.0 111.03 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -88.09 -7.56 56.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.77 -28.57 66.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.1 0.409 . . . . 0.0 110.86 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.41 ' NE2' ' HD2' ' A' ' 108' ' ' ARG . 0.6 OUTLIER -67.88 -21.66 65.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.596 0.758 . . . . 0.0 111.219 -175.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.4 mt -64.85 -14.28 58.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.428 1.091 . . . . 0.0 113.277 -170.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -98.48 -62.52 1.23 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 166.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 124.565 1.146 . . . . 0.0 108.179 178.132 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.402 HD13 ' HB3' ' A' ' 80' ' ' SER . 40.5 mm -72.91 108.03 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.179 0.592 . . . . 0.0 109.967 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' HZ3' ' HB2' ' A' ' 25' ' ' ASP . 34.5 mmtp -97.21 111.95 23.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -95.15 133.8 38.58 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.579 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.67 -166.66 9.71 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.948 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -117.97 147.77 41.99 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.384 0.674 . . . . 0.0 109.318 -172.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.06 162.16 27.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.196 1.931 . . . . 0.0 110.668 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.55 120.43 10.54 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.24 0.616 . . . . 0.0 111.486 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.518 HG13 HD23 ' A' ' 62' ' ' LEU . 41.0 t -94.56 84.6 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.503 HD12 HG11 ' A' ' 104' ' ' VAL . 48.8 tp -129.47 154.56 46.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.246 -159.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -123.62 159.31 29.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.936 0.894 . . . . 0.0 108.623 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.417 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 11.4 pt-20 -59.57 -28.12 66.85 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.417 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 43.7 m-80 -111.18 86.84 2.4 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -131.1 112.11 12.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.692 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.464 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.1 tt0 -91.56 -31.97 15.71 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.748 1.219 . . . . 0.0 110.091 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 69.1 mt -125.58 122.16 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.796 0.838 . . . . 0.0 109.465 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.2 tp -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -95.41 106.35 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 75.7 mt -95.79 108.5 20.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 108.85 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.84 178.32 9.13 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 166.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 15.5 t -89.81 -75.59 0.45 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 tp -130.58 124.01 20.69 Favored Pre-proline 0 C--O 1.244 0.8 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.76 155.18 11.06 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -59.32 124.12 18.96 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' HB2' ' HZ3' ' A' ' 3' ' ' LYS . 9.3 p-10 -61.88 -22.37 65.49 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.121 0.568 . . . . 0.0 112.157 -171.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.29 -51.48 56.97 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.646 0.591 . . . . 0.0 110.111 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 t -55.04 -30.74 60.22 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.728 0.811 . . . . 0.0 111.872 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.8 mt -77.56 -26.75 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.893 0.877 . . . . 0.0 110.873 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -61.84 -27.63 68.92 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.256 0.623 . . . . 0.0 111.45 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -102.71 -3.48 26.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.474 0.71 . . . . 0.0 110.396 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 50.34 28.0 3.01 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.837 1.255 . . . . 0.0 113.168 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -149.09 141.78 24.5 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.001 0.521 . . . . 0.0 110.708 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.454 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 66.1 m-85 -67.62 -6.03 18.43 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 123.94 0.896 . . . . 0.0 112.437 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 90.9 t80 -82.07 -24.85 35.02 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 109.357 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.3 -31.39 79.08 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.877 0.736 . . . . 0.0 114.84 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -123.24 111.98 30.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.995 0.398 . . . . 0.0 110.462 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -88.35 -0.94 6.86 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.445 2.764 . . . . 0.0 112.566 170.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.57 -6.39 89.35 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.568 ' HB3' ' HD2' ' A' ' 41' ' ' PHE . 11.7 m120 -76.19 126.21 30.57 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.52 4.94 50.25 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 124.246 1.018 . . . . 0.0 110.027 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.568 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 86.6 m-85 -50.1 -36.56 30.07 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 109.674 163.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -73.56 -26.75 60.98 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.616 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -79.28 -44.84 20.89 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.727 0.811 . . . . 0.0 111.736 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.95 -38.64 57.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 0.0 111.473 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.25 -30.31 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.49 -53.29 36.51 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.559 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.508 ' CE1' ' HB2' ' A' ' 149' ' ' GLU . 14.4 p-80 -65.84 -30.3 70.9 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.006 0.431 . . . . 0.0 110.356 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 156' ' ' PHE . . . -68.88 -34.44 75.43 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.093 0.957 . . . . 0.0 112.145 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 pt -96.33 -10.39 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.987 0.915 . . . . 0.0 110.405 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.62 39.15 22.36 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 115.039 0.776 . . . . 0.0 115.039 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.92 127.68 1.31 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.425 1.09 . . . . 0.0 108.769 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -72.0 102.78 3.04 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.043 0.937 . . . . 0.0 112.556 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.3 mt -61.03 -25.55 66.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.478 1.111 . . . . 0.0 111.809 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -68.78 -31.24 70.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.657 0.783 . . . . 0.0 111.238 -172.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.36 -11.04 53.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.973 0.909 . . . . 0.0 110.962 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 56.8 mtt -85.08 137.66 32.9 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 152.4 38.4 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.327 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 34.4 t80 -40.28 -51.12 2.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.259 1.424 . . . . 0.0 113.331 -171.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.53 -52.17 62.32 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.1 0.96 . . . . 0.0 111.311 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.92 -42.71 90.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.591 0.756 . . . . 0.0 110.797 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -56.5 -53.34 58.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.829 1.252 . . . . 0.0 110.911 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.518 HD23 HG13 ' A' ' 9' ' ' VAL . 84.5 mt -65.48 -41.69 93.05 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.814 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -71.89 -28.14 63.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.698 0.399 . . . . 0.0 111.769 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.3 m -60.9 -42.32 97.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.109 0.48 . . . . 0.0 109.755 169.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.4 -50.29 66.05 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.013 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 30.8 mmtp -57.01 -44.78 83.13 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.454 0.702 . . . . 0.0 109.932 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -53.75 -41.29 66.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.243 1.417 . . . . 0.0 112.226 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -84.1 0.88 46.65 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.92 0.888 . . . . 0.0 111.746 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.464 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 66.9 42.73 2.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.852 1.261 . . . . 0.0 110.387 -178.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.38 136.92 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.806 1.242 . . . . 0.0 109.191 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.25 163.17 14.06 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 170.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -124.39 144.4 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.929 0.892 . . . . 0.0 109.162 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.4 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.1 t90 -165.29 -169.14 1.54 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -134.8 170.33 16.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.439 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 61.4 t -97.05 -35.39 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.478 0.711 . . . . 0.0 110.549 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -111.43 105.2 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 50.7 tptt -64.97 -26.98 68.53 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.362 1.065 . . . . 0.0 111.748 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.28 138.53 25.15 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.7 114.39 0.86 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.402 ' HB3' HD13 ' A' ' 2' ' ' ILE . 87.3 p -93.97 123.95 37.67 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.562 0.681 . . . . 0.0 109.925 -171.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -85.69 96.47 9.71 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -17.34 20.42 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.511 1.124 . . . . 0.0 111.649 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.51 -15.62 1.26 Allowed Glycine 0 C--N 1.353 1.477 0 CA-C-O 119.738 -0.479 . . . . 0.0 114.131 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.7 t -69.28 133.91 48.48 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.177 0.591 . . . . 0.0 111.251 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -88.55 138.61 31.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.125 0.97 . . . . 0.0 110.203 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 73.24 -24.82 0.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 126.441 1.896 . . . . 0.0 113.154 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 m -74.42 96.23 2.85 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -77.58 -42.29 35.71 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.542 0.737 . . . . 0.0 109.788 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 mt -104.54 97.86 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.444 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.06 54.99 0.8 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.432 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 16.7 t70 -176.45 150.44 0.88 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -172.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.92 17.85 14.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.309 0.644 . . . . 0.0 112.623 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' A' ' 77' ' ' LYS . 24.6 tt0 -77.76 105.67 9.08 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 mm -89.71 147.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.113 0.965 . . . . 0.0 109.392 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -74.6 143.92 44.17 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 168.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -82.88 127.4 33.46 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.439 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 64.2 m-85 -114.92 10.97 16.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.369 0.667 . . . . 0.0 110.998 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.1 t -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.696 0.398 . . . . 0.0 110.818 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.26 -4.76 86.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.738 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 104' ' ' VAL . 16.6 mt -49.41 -53.11 24.36 Favored 'General case' 0 C--N 1.368 1.392 0 C-N-CA 123.676 0.79 . . . . 0.0 111.212 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -59.35 -18.7 40.63 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.467 0.707 . . . . 0.0 112.58 -168.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.38 -42.74 13.41 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.501 1.121 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -94.97 -16.02 23.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 17.1 m -122.35 88.12 48.8 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.168 0.587 . . . . 0.0 110.48 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.1 -39.12 3.3 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.184 1.923 . . . . 0.0 112.101 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -86.2 -6.12 59.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.765 0.826 . . . . 0.0 113.117 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.534 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.1 tp -61.85 117.45 5.91 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.611 0.569 . . . . 0.0 111.073 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -111.47 -40.53 4.35 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.941 0.896 . . . . 0.0 109.52 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 56.2 tp -129.35 133.08 47.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.925 0.89 . . . . 0.0 110.875 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.4 mt -112.7 146.31 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.463 ' HB3' HD13 ' A' ' 134' ' ' LEU . 81.7 m -125.69 113.51 17.44 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.598 0.759 . . . . 0.0 110.317 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.64 107.93 19.59 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.595 1.158 . . . . 0.0 109.086 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -98.79 88.24 3.98 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.65 139.1 3.96 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.625 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.0 -50.84 65.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 111.695 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.48 -38.43 69.1 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.461 1.104 . . . . 0.0 112.008 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 21' ' ' SER . . . -65.57 -36.19 83.04 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.996 0.518 . . . . 0.0 110.823 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.85 -16.37 59.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 115.099 -0.955 . . . . 0.0 114.556 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.59 -29.73 70.75 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.11 0.481 . . . . 0.0 110.947 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -111.31 25.33 11.83 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.722 0.809 . . . . 0.0 111.084 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.52 -44.22 24.48 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.066 0.946 . . . . 0.0 112.543 170.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.401 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 71.9 Cg_endo -70.72 -13.77 32.53 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 121.8 1.667 . . . . 0.0 112.828 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 tp -58.91 -41.03 86.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.562 1.145 . . . . 0.0 110.191 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -96.98 -10.55 26.01 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.489 -174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 122' ' ' PRO . 19.6 mtm180 -63.93 -34.91 79.03 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.078 0.466 . . . . 0.0 110.244 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.93 -12.26 70.95 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.446 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.3 mtt -94.94 9.67 38.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 0.0 111.708 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.01 17.87 77.7 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 113.878 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -110.0 133.59 53.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.437 0.695 . . . . 0.0 110.071 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.68 143.74 55.82 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.0 p -132.93 149.73 52.22 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.707 0.803 . . . . 0.0 110.351 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -145.5 129.23 17.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.353 1.061 . . . . 0.0 109.369 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.64 97.07 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 111' ' ' CYS . 39.6 mt -77.62 144.34 69.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.951 176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.432 ' HD2' ' HE1' ' A' ' 152' ' ' TRP . 44.7 Cg_exo -59.3 154.82 44.14 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.521 2.814 . . . . 0.0 113.269 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.5 m -68.91 108.88 3.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 m -84.69 21.03 1.61 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.422 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.1 t -59.73 154.14 18.76 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.454 0.702 . . . . 0.0 110.522 171.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.19 69.69 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.149 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.48 -15.37 61.32 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.962 0.905 . . . . 0.0 111.452 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.476 ' HA ' ' HD2' ' A' ' 144' ' ' PHE . 9.5 t30 -132.51 8.55 4.25 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.324 0.65 . . . . 0.0 111.204 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -65.77 -36.22 82.92 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.899 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -66.03 -25.88 67.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.725 1.21 . . . . 0.0 111.47 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.476 ' HD2' ' HA ' ' A' ' 141' ' ' ASN . 56.2 m-85 -92.56 -35.89 13.33 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.595 0.758 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 t -86.85 30.08 0.77 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.36 1.064 . . . . 0.0 111.425 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -67.71 -70.57 0.25 Allowed 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.79 -4.69 17.03 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 17.0 mmt180 -73.2 -22.92 60.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.167 0.587 . . . . 0.0 110.41 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 47' ' ' HIS . 12.7 pt-20 -55.54 -24.59 33.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.824 0.85 . . . . 0.0 112.592 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.7 t -67.53 -46.97 71.27 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 111.724 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 10.9 pt-20 -66.47 -31.97 73.05 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.432 ' HE1' ' HD2' ' A' ' 135' ' ' PRO . 35.8 m95 -68.66 -46.73 68.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 27.2 tt0 -62.47 -37.87 87.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.762 -173.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.29 82.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.153 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.41 -35.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.901 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 45.9 m-85 -104.62 -1.73 26.03 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.489 -0.757 . . . . 0.0 112.648 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -81.17 -36.82 29.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.928 0.491 . . . . 0.0 110.768 170.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -67.23 -17.74 64.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.034 0.209 . . . . 0.0 110.648 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.46 -30.75 71.78 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.523 0.729 . . . . 0.0 110.38 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.68 -44.92 95.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.563 0.745 . . . . 0.0 110.228 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.56 1.338 0 C-N-CA 124.415 1.086 . . . . 0.0 109.997 -179.652 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 111.05 0.019 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.496 HD12 ' HB3' ' A' ' 80' ' ' SER . 39.2 mm -75.26 135.3 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.849 0.459 . . . . 0.0 110.063 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -124.39 123.72 40.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.648 1.179 . . . . 0.0 108.88 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -89.64 139.35 30.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 122.755 0.422 . . . . 0.0 110.893 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.455 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -72.73 166.39 54.26 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.663 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -95.21 139.94 22.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.952 0.501 . . . . 0.0 111.174 -172.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.86 134.26 54.13 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.719 2.279 . . . . 0.0 110.251 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.73 143.35 54.54 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.005 0.816 . . . . 0.0 112.257 -169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.538 HG12 HD22 ' A' ' 62' ' ' LEU . 34.5 t -97.92 61.35 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.445 HD12 ' CG1' ' A' ' 104' ' ' VAL . 64.4 tp -104.13 145.75 29.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.837 -171.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.651 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 5.2 t70 -116.38 158.42 23.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.401 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 9.8 pt-20 -63.86 -21.87 66.65 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.406 0.622 . . . . 0.0 111.084 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 42.0 m-80 -110.46 84.12 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.755 1.622 . . . . 0.0 107.754 174.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -135.56 123.73 23.02 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.515 0.726 . . . . 0.0 110.282 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 38.9 tt0 -106.36 -29.69 9.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.734 1.214 . . . . 0.0 110.677 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.642 HD12 HD12 ' A' ' 159' ' ' LEU . 37.9 mt -131.82 125.18 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.963 0.905 . . . . 0.0 109.628 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.0 tp -110.86 124.82 52.81 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.348 1.059 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 111' ' ' CYS . 47.1 mt -102.45 111.27 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.211 0.604 . . . . 0.0 109.66 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 73' ' ' TRP . 97.4 mt -99.07 127.94 45.1 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.2 -175.13 49.77 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 162.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -94.64 -71.78 0.65 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -134.82 124.59 16.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.455 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 71.0 Cg_exo -52.09 137.26 54.02 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.593 2.195 . . . . 0.0 112.442 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.405 ' O ' HG13 ' A' ' 28' ' ' ILE . 30.1 m -61.01 146.17 48.07 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.775 0.672 . . . . 0.0 110.537 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.6 t70 -58.07 -41.72 84.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.799 0.44 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -47.63 -40.54 19.89 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.973 1.309 . . . . 0.0 111.72 171.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -78.34 -39.67 38.81 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.137 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 24' ' ' SER . 74.8 mt -68.12 -25.62 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 124.365 1.066 . . . . 0.0 111.691 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 23.7 mmt180 -65.29 -28.01 69.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.475 0.31 . . . . 0.0 111.349 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -114.62 0.25 13.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.962 0.505 . . . . 0.0 111.393 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 62.69 24.96 14.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.901 1.28 . . . . 0.0 112.878 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -129.63 134.37 47.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.286 1.034 . . . . 0.0 108.806 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -56.51 -46.1 80.71 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.418 0.687 . . . . 0.0 110.513 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -64.15 -0.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.229 1.412 . . . . 0.0 112.889 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.24 -26.45 9.37 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.743 0.687 . . . . 0.0 113.609 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -102.74 108.85 59.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 163.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -26.75 41.21 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.68 2.253 . . . . 0.0 112.019 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.33 -6.53 40.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.791 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.86 129.21 38.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.61 -6.73 59.52 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.396 0.679 . . . . 0.0 111.723 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -37.91 -41.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.555 1.542 . . . . 0.0 113.541 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.603 0.761 . . . . 0.0 112.216 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.3 mtp-105 -75.63 -40.9 55.53 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.403 0.281 . . . . 0.0 110.797 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.77 -55.22 15.96 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.62 -34.32 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.496 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.77 88.42 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.346 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.77 -37.91 89.19 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.769 0.828 . . . . 0.0 109.754 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.547 ' HA ' ' HG2' ' A' ' 153' ' ' GLU . . . -65.02 -47.78 76.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.296 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.401 HD13 ' ND2' ' A' ' 68' ' ' ASN . 26.8 pt -89.48 -14.79 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.536 -174.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.99 39.45 20.04 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.034 0.374 . . . . 0.0 114.034 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -133.0 146.27 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.317 1.047 . . . . 0.0 109.361 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -85.15 91.46 8.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.43 -1.29 49.69 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.228 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.15 -48.99 11.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.32 -30.22 60.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.485 1.114 . . . . 0.0 112.307 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.3 mtt -61.23 156.43 18.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.973 0.509 . . . . 0.0 111.001 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.66 162.45 20.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.567 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 31.3 t80 -49.42 -55.37 13.32 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.929 0.892 . . . . 0.0 112.765 -173.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.59 -40.31 82.86 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.7 0.8 . . . . 0.0 111.526 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -66.56 -53.62 32.67 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.971 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -64.86 -30.34 71.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.676 0.61 . . . . 0.0 112.074 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 80.8 mt -61.48 -49.56 76.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.124 0.57 . . . . 0.0 110.612 171.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -64.59 -28.59 69.73 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.447 0.467 . . . . 0.0 111.356 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -68.93 -39.23 79.72 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.371 0.668 . . . . 0.0 110.671 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 72.0 mt -65.15 -49.58 69.3 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 122.913 0.485 . . . . 0.0 110.479 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.651 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 4.5 mtpp -68.65 -27.4 65.96 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.945 0.898 . . . . 0.0 112.671 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -58.37 -40.9 83.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.623 0.769 . . . . 0.0 110.349 165.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 87.0 m-20 -93.6 19.28 8.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.397 1.079 . . . . 0.0 110.078 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 64.99 32.89 10.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.124 0.97 . . . . 0.0 111.693 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 72.3 mt -108.59 126.08 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.86 0.864 . . . . 0.0 109.514 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.8 156.04 16.22 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.4 mt -120.98 133.25 55.26 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.453 ' HB3' HD22 ' A' ' 19' ' ' LEU . 6.9 t90 -162.62 -169.16 2.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -145.64 165.25 29.25 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.287 1.035 . . . . 0.0 110.34 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.484 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.9 t -80.77 -47.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.644 0.778 . . . . 0.0 110.805 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -98.14 110.86 23.37 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.355 0.662 . . . . 0.0 111.711 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.09 -24.64 65.06 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.027 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.12 135.0 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.492 0.717 . . . . 0.0 109.609 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.68 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.29 146.46 15.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.496 ' HB3' HD12 ' A' ' 2' ' ' ILE . 79.1 p -115.06 168.9 9.52 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 117.87 0.835 . . . . 0.0 110.344 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -137.15 97.11 3.41 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -134.51 -72.92 0.48 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.44 0.462 . . . . 0.0 110.998 -171.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.31 91.35 0.13 Allowed Glycine 0 C--N 1.345 1.042 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.7 p -153.72 168.41 26.35 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.811 0.845 . . . . 0.0 109.97 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -121.6 156.16 33.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.706 1.203 . . . . 0.0 109.796 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 66.57 -72.44 0.08 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.282 1.433 . . . . 0.0 110.914 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 t -98.48 118.42 35.13 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 167.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -81.39 -5.63 58.08 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.005 0.922 . . . . 0.0 111.584 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 80' ' ' SER . 51.2 mt -72.81 90.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.78 54.81 4.98 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.42 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.68 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.2 t70 -170.42 148.98 3.25 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.51 17.38 12.1 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.474 0.71 . . . . 0.0 112.434 -166.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -89.71 118.13 29.09 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.312 0.577 . . . . 0.0 109.49 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.1 mt -122.55 146.73 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 109.248 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -64.38 147.33 52.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.921 0.888 . . . . 0.0 110.173 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -81.52 117.48 21.96 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.484 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 59.9 m-85 -105.65 0.65 26.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.509 0.724 . . . . 0.0 111.107 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.9 p -75.4 -16.81 60.33 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.98 -5.82 70.27 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.385 -0.675 . . . . 0.0 112.396 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.489 HD23 ' HE1' ' A' ' 103' ' ' MET . 15.3 mt -48.16 -55.08 11.25 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 123.857 0.863 . . . . 0.0 111.107 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -60.29 -26.99 66.92 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.334 0.653 . . . . 0.0 111.77 -167.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -76.16 -41.12 50.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.084 0.954 . . . . 0.0 111.881 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.489 ' HE1' HD23 ' A' ' 100' ' ' LEU . 22.7 ptt? -91.4 -23.15 20.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.445 ' CG1' HD12 ' A' ' 10' ' ' LEU . 15.0 m -122.08 107.95 34.81 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.363 0.529 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.98 -36.49 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.32 2.013 . . . . 0.0 111.961 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -86.35 -10.06 55.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -170.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.35 116.49 5.56 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 121.147 0.499 . . . . 0.0 110.756 -171.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.414 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 5.9 ptm180 -111.06 -43.63 3.72 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.338 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.469 ' HB3' HG12 ' A' ' 16' ' ' ILE . 47.5 tp -126.11 127.58 46.0 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 122.933 0.493 . . . . 0.0 110.009 -167.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.8 mt -110.99 114.15 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.6 m -96.55 115.8 28.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.952 0.901 . . . . 0.0 110.993 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.05 116.26 28.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.655 1.182 . . . . 0.0 109.04 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -93.75 119.35 32.62 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.43 143.05 11.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.103 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 57.2 ttp180 -50.98 -48.75 61.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.45 1.1 . . . . 0.0 112.068 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -49.21 -36.01 18.8 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.73 1.212 . . . . 0.0 112.761 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.88 -42.7 23.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.174 0.59 . . . . 0.0 109.9 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.58 -10.13 47.82 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.54 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 76.4 mt-10 -68.24 -34.59 76.5 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.041 0.536 . . . . 0.0 110.701 172.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -100.71 19.49 16.97 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.931 0.893 . . . . 0.0 110.885 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.531 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.1 tm-20 -63.07 -49.34 81.55 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.344 1.058 . . . . 0.0 112.933 170.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.85 -16.27 49.48 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.73 1.62 . . . . 0.0 112.887 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.09 -52.13 67.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.278 1.031 . . . . 0.0 110.868 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.0 -5.06 58.95 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.011 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -66.55 -32.62 74.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.7 0.4 . . . . 0.0 110.331 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.59 -12.6 61.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.536 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.425 ' HE3' ' HB2' ' A' ' 97' ' ' PHE . 59.2 mtt -96.17 11.97 32.46 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.175 0.99 . . . . 0.0 111.433 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.33 73.77 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.323 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -105.49 136.18 45.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.301 0.641 . . . . 0.0 110.325 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.67 140.07 57.88 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 167.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 29.3 p -128.82 141.86 51.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.252 0.548 . . . . 0.0 110.816 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -135.28 126.85 28.85 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.765 1.226 . . . . 0.0 108.83 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.94 106.81 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.63 153.33 50.18 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.109 0.964 . . . . 0.0 109.516 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.566 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 49.0 Cg_exo -58.63 164.48 9.32 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.131 2.554 . . . . 0.0 113.195 172.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.7 t -65.69 110.7 2.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 p -80.66 25.16 0.44 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.031 0.932 . . . . 0.0 112.088 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.8 t -63.0 147.79 49.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.967 0.907 . . . . 0.0 110.337 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -69.21 -20.88 75.42 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.343 -0.389 . . . . 0.0 113.343 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.73 -8.45 56.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.018 0.527 . . . . 0.0 111.129 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.02 13.19 10.51 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.391 1.076 . . . . 0.0 109.598 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.471 ' HA ' ' OG ' ' A' ' 145' ' ' SER . 48.9 ttp180 -66.77 -31.9 72.84 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.493 0.717 . . . . 0.0 110.558 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -57.3 -32.71 66.94 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.091 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.63 -22.92 16.21 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.491 1.117 . . . . 0.0 110.674 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.579 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 84.0 p -90.43 11.64 20.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.024 0.529 . . . . 0.0 112.092 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.07 -69.79 0.18 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.112 0.965 . . . . 0.0 111.949 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -90.4 -2.97 57.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.298 0.639 . . . . 0.0 111.134 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 13.1 tpt180 -72.61 -18.36 61.6 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.744 0.818 . . . . 0.0 109.499 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -25.24 0.79 Allowed 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.58 1.152 . . . . 0.0 113.079 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.5 t -60.89 -44.95 96.41 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.089 0.955 . . . . 0.0 111.928 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.406 ' O ' HG22 ' A' ' 155' ' ' VAL . 9.5 pt-20 -72.95 -32.25 65.13 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -67.01 -40.19 87.26 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 4.7 tm-20 -71.15 -33.3 69.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.45 63.95 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.153 0.581 . . . . 0.0 111.531 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 151' ' ' GLU . 71.5 t -81.64 -57.62 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.877 0.471 . . . . 0.0 110.746 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -92.78 1.6 57.2 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -166.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -61.76 -41.46 97.71 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -77.69 -10.75 59.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.419 0.687 . . . . 0.0 111.831 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 16' ' ' ILE . 38.7 mt -78.99 -25.21 43.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.586 -168.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.39 -45.08 89.2 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 166.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 CA--C 1.556 1.193 0 C-N-CA 124.985 1.314 . . . . 0.0 111.578 174.607 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.482 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.1 mm -78.62 122.18 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.557 0.743 . . . . 0.0 109.738 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.482 ' HB2' HD22 ' A' ' 22' ' ' LEU . 56.9 mtpt -84.91 125.69 32.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.61 0.764 . . . . 0.0 109.975 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.75 135.27 35.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.281 0.633 . . . . 0.0 111.69 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.484 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -76.43 -177.01 43.13 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.986 165.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.75 144.67 37.64 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.225 -172.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.96 151.72 32.42 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.83 2.353 . . . . 0.0 112.254 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 139.33 58.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.644 0.778 . . . . 0.0 112.65 -172.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.611 HG13 HD22 ' A' ' 62' ' ' LEU . 65.9 t -104.84 88.59 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.482 HD12 HG11 ' A' ' 104' ' ' VAL . 54.1 tp -138.46 153.37 48.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.808 -160.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.07 165.23 19.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.306 1.042 . . . . 0.0 110.189 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 8.9 pt-20 -65.72 -17.66 64.78 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.99 0.916 . . . . 0.0 111.957 171.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 46.2 m-80 -120.55 91.57 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.2 m -141.07 118.8 11.68 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.059 0.944 . . . . 0.0 109.074 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.24 -37.75 19.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.685 0.794 . . . . 0.0 110.659 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 66.4 mt -125.83 124.44 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.246 0.618 . . . . 0.0 109.889 -174.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.52 115.25 29.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.447 HG21 ' ND2' ' A' ' 113' ' ' ASN . 47.8 mt -94.2 102.98 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 73' ' ' TRP . 98.2 mt -94.67 119.15 32.85 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.034 0.933 . . . . 0.0 110.233 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.62 -178.78 37.52 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -93.94 -78.55 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 3' ' ' LYS . 64.1 tp -134.3 116.34 13.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 170.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.7 Cg_exo -53.63 148.39 35.75 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.207 2.605 . . . . 0.0 113.584 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' ILE . 29.0 t -61.55 150.7 35.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.623 1.169 . . . . 0.0 111.918 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 10.4 m-20 -55.03 -43.49 73.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.877 0.871 . . . . 0.0 110.71 175.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.584 ' HB3' HD22 ' A' ' 36' ' ' ASN . 15.2 tp10 -66.55 -26.06 66.95 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.454 1.096 . . . . 0.0 111.0 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.579 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 69.4 m -73.54 -40.91 63.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 24' ' ' SER . 64.1 mt -71.32 -21.69 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.501 1.12 . . . . 0.0 111.413 -176.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 20.3 mmt85 -61.31 -33.12 73.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.035 0.534 . . . . 0.0 110.915 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.565 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 80.6 mttt -110.46 -2.47 16.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.011 0.924 . . . . 0.0 111.116 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 58.57 27.73 16.1 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.639 1.576 . . . . 0.0 112.748 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -138.27 156.35 47.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.959 0.904 . . . . 0.0 110.231 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -71.35 -5.51 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.597 0.759 . . . . 0.0 110.288 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -77.34 -16.93 58.66 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.969 1.708 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.83 -30.72 73.6 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 0.0 114.307 -175.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.584 HD22 ' HB3' ' A' ' 26' ' ' GLU . 36.8 m-80 -124.09 99.38 37.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.334 0.654 . . . . 0.0 110.437 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.08 -7.51 15.28 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.676 164.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.404 ' HA2' HH12 ' A' ' 43' ' ' ARG . . . -85.13 -15.76 66.3 Favored Glycine 0 C--N 1.357 1.741 0 O-C-N 123.525 0.516 . . . . 0.0 112.214 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -73.79 125.76 28.86 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 137' ' ' SER . 1.3 t0 -79.43 -4.88 53.19 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.926 0.891 . . . . 0.0 112.088 -158.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 113' ' ' ASN . 38.0 m-85 -48.48 -36.19 14.61 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.193 0.997 . . . . 0.0 111.663 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -73.25 -32.36 64.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.432 0.693 . . . . 0.0 112.192 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.582 ' HD2' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -88.48 -23.51 23.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.754 0.422 . . . . 0.0 111.511 177.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD23 ' HB2' ' A' ' 149' ' ' GLU . 49.4 mt -86.38 -45.67 10.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.939 0.496 . . . . 0.0 111.051 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.95 -32.48 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.54 94.49 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.476 0.485 . . . . 0.0 112.971 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -61.81 -43.59 98.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.75 0.82 . . . . 0.0 109.809 171.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 156' ' ' PHE . . . -71.61 -33.32 68.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.596 -1.183 . . . . 0.0 113.978 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -94.43 -11.37 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.991 0.517 . . . . 0.0 111.146 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 27.54 63.61 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.423 0.452 . . . . 0.0 113.314 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.14 113.0 6.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.3 99.82 0.97 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.202 0.601 . . . . 0.0 111.086 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.463 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 77.0 mt -67.66 -27.89 67.24 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.303 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.582 ' HG3' ' HD2' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -65.17 -37.85 88.69 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.443 0.697 . . . . 0.0 111.438 -173.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.5 -36.9 63.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.02 0.528 . . . . 0.0 112.081 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.9 mtt -62.83 149.15 44.97 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -171.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 153.92 40.61 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.208 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.49 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 t80 -44.34 -50.57 9.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.144 0.978 . . . . 0.0 113.501 -171.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 43.1 mt-10 -61.83 -54.17 45.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.504 0.722 . . . . 0.0 111.44 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -58.06 -37.2 73.97 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.639 0.776 . . . . 0.0 111.127 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 35.5 ttmt -62.54 -45.97 90.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.11 0.964 . . . . 0.0 110.132 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.611 HD22 HG13 ' A' ' 9' ' ' VAL . 25.8 mt -61.73 -47.28 85.97 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.134 0.896 . . . . 0.0 110.957 175.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 66.9 mttm -55.02 -38.05 67.42 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -66.79 -51.46 55.46 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.156 0.91 . . . . 0.0 110.238 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.438 HD11 ' HA ' ' A' ' 62' ' ' LEU . 57.2 mt -52.8 -56.72 13.67 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.936 0.894 . . . . 0.0 111.395 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.514 ' HE3' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.14 -30.54 71.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.315 0.646 . . . . 0.0 111.947 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.28 -36.89 85.17 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.272 0.629 . . . . 0.0 111.175 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -90.94 6.51 44.35 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.385 0.674 . . . . 0.0 110.959 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 65.57 37.44 5.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 111.359 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.24 132.37 56.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 109.46 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.3 154.02 17.24 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -121.26 132.38 54.77 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.422 ' CZ2' ' HB3' ' A' ' 95' ' ' ASN . 4.2 t90 -156.08 -169.76 3.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -143.24 165.54 27.18 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.54 0.736 . . . . 0.0 110.2 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 72.5 t -82.23 -62.29 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.468 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.66 107.7 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.326 0.584 . . . . 0.0 111.374 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.414 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.2 ttmt -64.31 -31.92 73.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.032 170.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 93' ' ' GLU . . . -152.55 126.85 9.23 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.14 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.527 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -134.3 135.45 7.99 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.8 p -86.77 105.18 16.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.171 0.588 . . . . 0.0 110.052 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -99.09 103.15 15.04 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' A' ' 84' ' ' SER . 10.7 tp10 -120.53 154.57 35.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.699 0.8 . . . . 0.0 109.379 -172.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.78 -31.18 77.59 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.477 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 45.8 t -73.14 -17.38 61.39 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.989 0.916 . . . . 0.0 111.361 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.66 ' HG3' ' HB2' ' A' ' 88' ' ' LYS . 6.2 tp-100 -126.58 99.03 5.63 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.437 0.695 . . . . 0.0 109.485 -176.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.09 77.39 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.444 1.497 . . . . 0.0 114.353 -164.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.5 m 56.04 16.8 2.34 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.482 1.513 . . . . 0.0 113.061 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.66 ' HB2' ' HG3' ' A' ' 85' ' ' GLN . 73.8 mmtt -86.26 142.35 28.62 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.4 mt -82.09 82.34 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.25 -23.57 77.2 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.312 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.527 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 7.0 t70 -84.07 157.8 21.64 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.123 0.487 . . . . 0.0 110.744 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.3 24.13 8.84 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.904 -170.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' HB3' ' HB1' ' A' ' 78' ' ' ALA . 10.8 tp10 -85.75 111.48 20.18 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.36 155.38 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.112 0.965 . . . . 0.0 109.056 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.422 ' HB3' ' CZ2' ' A' ' 73' ' ' TRP . 59.0 m-80 -76.63 149.31 36.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.169 0.988 . . . . 0.0 110.484 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.26 116.48 19.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 0.0 110.494 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.446 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.4 m-85 -103.6 4.05 35.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.652 0.781 . . . . 0.0 111.351 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.1 m -74.48 -29.95 61.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.698 0.399 . . . . 0.0 110.746 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.88 -10.79 85.27 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.014 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.6 mt -47.4 -54.15 12.02 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.133 0.973 . . . . 0.0 111.592 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.1 mtpt -61.43 -18.76 60.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -167.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.05 -39.15 17.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.282 0.633 . . . . 0.0 111.485 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -96.26 -15.49 21.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 11.1 m -126.95 91.16 47.68 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-N 118.758 0.708 . . . . 0.0 111.023 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.88 -28.78 3.79 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.387 2.058 . . . . 0.0 113.251 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 106' ' ' LYS . 11.4 mmpt? -94.73 -0.5 54.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.1 tp -60.89 104.42 0.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.518 0.675 . . . . 0.0 111.395 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -93.42 -49.36 5.96 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.841 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 42.7 tp -131.58 133.41 44.99 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.276 0.63 . . . . 0.0 110.056 -173.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.494 HG12 HD23 ' A' ' 107' ' ' LEU . 38.4 mt -105.12 115.67 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 92.4 m -96.09 113.25 24.84 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.448 0.299 . . . . 0.0 110.336 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -90.35 107.74 19.33 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.447 ' ND2' HG21 ' A' ' 18' ' ' ILE . 7.6 p30 -86.12 110.48 19.58 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.58 134.62 7.56 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.496 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.449 ' HA ' HG11 ' A' ' 133' ' ' VAL . 33.4 ttm180 -72.11 -3.25 22.04 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.231 1.012 . . . . 0.0 113.421 -175.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.54 -29.85 41.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.827 0.451 . . . . 0.0 110.307 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.373 0.669 . . . . 0.0 109.664 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.8 -16.02 58.65 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 114.925 -1.034 . . . . 0.0 115.194 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -56.34 -29.58 61.52 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.522 0.729 . . . . 0.0 111.789 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -116.51 20.29 14.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.815 0.846 . . . . 0.0 111.247 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.36 -53.85 54.3 Favored Pre-proline 0 CA--C 1.567 1.622 0 C-N-CA 123.302 0.641 . . . . 0.0 112.23 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.75 -15.49 33.37 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 121.851 1.701 . . . . 0.0 112.727 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.08 -44.87 91.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.525 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 10.0 mt -82.4 -5.38 58.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.244 -172.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -72.43 -22.5 61.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.93 -21.52 67.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.628 0.58 . . . . 0.0 113.197 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.6 mpt? -86.66 7.62 25.81 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.76 0.824 . . . . 0.0 111.026 175.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.63 20.94 70.25 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.153 0.406 . . . . 0.0 113.959 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.453 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 35.5 m-85 -110.62 145.51 37.76 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.193 0.597 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.26 143.62 40.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.3 p -130.32 151.12 51.18 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.531 0.732 . . . . 0.0 110.131 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.44 121.82 4.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 109.313 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 115' ' ' ARG . 52.2 t -85.84 130.56 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.132 0.492 . . . . 0.0 110.084 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.6 mt -101.09 152.74 37.96 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.961 1.304 . . . . 0.0 108.274 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.14 153.03 78.79 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.434 2.09 . . . . 0.0 112.575 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 m -59.52 114.46 2.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.411 1.084 . . . . 0.0 110.339 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 40' ' ' ASP . 19.4 m -86.34 49.12 1.73 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.556 0.693 . . . . 0.0 111.894 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 p -68.96 139.44 55.04 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 154.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.82 57.88 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 123.474 0.484 . . . . 0.0 113.445 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.56 86.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.108 0.563 . . . . 0.0 110.567 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.82 -41.66 67.95 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.108 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -53.93 -34.02 58.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.692 0.62 . . . . 0.0 111.76 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -69.0 -29.83 68.11 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -98.82 22.49 10.04 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.987 1.315 . . . . 0.0 110.697 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 66.6 m -157.32 34.98 0.28 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.096 0.959 . . . . 0.0 109.697 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -66.8 -35.09 79.27 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.799 1.036 . . . . 0.0 113.799 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.28 -13.86 26.05 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.586 0.355 . . . . 0.0 110.249 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.433 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.9 tpt180 -79.73 -38.7 32.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.302 0.641 . . . . 0.0 109.776 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.447 ' HB2' HD23 ' A' ' 44' ' ' LEU . 12.5 pt-20 -62.68 -18.19 61.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.479 1.112 . . . . 0.0 112.212 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.1 t -58.88 -23.05 60.49 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.42 0.688 . . . . 0.0 111.651 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 155' ' ' VAL . 9.4 pt-20 -65.6 -32.14 73.56 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 122.996 0.518 . . . . 0.0 110.654 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -65.62 -43.11 90.57 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.44 -37.72 88.38 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.695 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.13 -14.36 59.81 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.072 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 151' ' ' GLU . 48.5 t -87.13 -54.58 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.411 0.685 . . . . 0.0 110.601 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 71.9 m-85 -91.77 2.87 56.21 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -168.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -72.62 -28.18 62.6 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.271 0.487 . . . . 0.0 112.163 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -74.6 -6.87 51.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.419 HD13 HD11 ' A' ' 16' ' ' ILE . 95.4 mt -76.08 -22.6 55.41 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.98 0.512 . . . . 0.0 111.603 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.58 -15.39 62.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.871 0.468 . . . . 0.0 111.129 166.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 125.594 1.558 . . . . 0.0 110.252 175.266 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.765 0.317 . . . . 0.0 110.734 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.505 HD12 ' HB3' ' A' ' 80' ' ' SER . 46.1 mm -92.65 126.1 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.702 0.801 . . . . 0.0 109.596 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' A' ' 81' ' ' ARG . 65.6 mttm -94.81 131.88 40.2 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -91.61 130.82 37.36 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 110.305 171.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 158.96 53.62 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 162.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -82.72 143.5 47.03 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 117.779 0.789 . . . . 0.0 110.084 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 162.44 1.55 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.206 2.604 . . . . 0.0 112.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.22 125.74 26.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.37 0.605 . . . . 0.0 110.513 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.562 HG13 HD23 ' A' ' 62' ' ' LEU . 21.2 t -91.03 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.448 HD12 ' CG1' ' A' ' 104' ' ' VAL . 49.9 tp -110.27 143.94 39.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.982 -162.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -125.89 163.62 22.55 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.8 -22.17 66.55 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.194 0.521 . . . . 0.0 110.968 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.619 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 45.1 m-80 -103.43 77.64 1.53 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.5 m -133.53 104.68 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.03 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.475 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 84.3 mt-10 -89.72 -30.15 18.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.549 1.14 . . . . 0.0 109.827 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.8 mt -126.68 118.18 50.13 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 123.886 0.874 . . . . 0.0 109.023 174.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -103.72 117.05 33.47 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 HG12 ' HB2' ' A' ' 111' ' ' CYS . 44.1 mt -99.54 110.33 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.79 118.14 35.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.47 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -72.94 -168.59 12.89 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 164.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -103.99 -72.46 0.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 tp -147.31 124.62 5.79 Favored Pre-proline 0 C--O 1.243 0.763 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.58 150.31 70.18 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.935 2.423 . . . . 0.0 112.452 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.0 t -68.92 163.41 24.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.981 0.912 . . . . 0.0 110.758 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 m-20 -53.77 -48.28 69.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.417 0.687 . . . . 0.0 110.46 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.18 -39.91 80.12 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.316 1.01 . . . . 0.0 111.361 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -67.35 -45.76 75.42 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.14 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.1 mt -71.6 -19.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.298 1.039 . . . . 0.0 111.976 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 28.5 mmm180 -70.39 -46.76 63.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -90.76 -6.54 54.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.447 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 65.97 22.08 11.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.175 1.39 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -129.32 142.92 50.7 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 109.377 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -60.79 -44.24 97.08 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.027 0.918 . . . . 0.0 108.569 165.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.87 -8.62 5.22 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.389 171.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.98 -31.69 58.84 Favored Glycine 0 C--N 1.351 1.397 0 C-N-CA 123.54 0.59 . . . . 0.0 112.979 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -100.79 104.8 33.94 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.66 -10.92 29.77 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.404 2.736 . . . . 0.0 112.719 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.75 -6.84 64.11 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.06 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -79.7 116.81 20.1 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -83.24 -0.5 49.78 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.262 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -42.47 -42.66 3.35 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.454 1.901 . . . . 0.0 112.974 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -74.36 -21.71 59.55 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.697 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.54 -37.12 17.17 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.763 0.825 . . . . 0.0 111.222 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.41 -52.61 15.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.79 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.05 -39.11 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.051 0.54 . . . . 0.0 109.557 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.76 99.6 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.911 0.757 . . . . 0.0 113.982 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -69.02 -34.91 76.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.654 . . . . 0.0 110.24 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 153' ' ' GLU . . . -71.6 -38.78 70.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.045 0.938 . . . . 0.0 112.81 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.47 HD12 ' ND2' ' A' ' 68' ' ' ASN . 13.8 pt -89.72 -9.98 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.952 0.501 . . . . 0.0 111.563 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.3 29.55 66.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.211 0.32 . . . . 0.0 113.022 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -133.71 112.97 11.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -66.27 93.07 0.2 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.283 0.563 . . . . 0.0 110.298 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.17 -39.42 89.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.78 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -57.12 -46.5 82.59 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.581 1.152 . . . . 0.0 111.709 -166.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -69.59 -37.47 76.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.392 0.677 . . . . 0.0 112.195 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.13 145.74 49.95 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.497 0.719 . . . . 0.0 112.369 -172.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.18 138.82 55.91 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.29 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.525 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 57.1 t80 -43.94 -46.49 8.19 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.532 1.133 . . . . 0.0 113.529 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.13 -47.99 80.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 111.857 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -63.93 -37.99 89.45 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.251 1.021 . . . . 0.0 110.701 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 58' ' ' TYR . 19.5 ttmm -60.45 -43.15 97.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.707 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.562 HD23 HG13 ' A' ' 9' ' ' VAL . 72.7 mt -65.88 -42.53 90.18 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.015 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -61.21 -33.38 73.38 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.6 m -64.22 -45.08 89.82 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.225 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.8 mt -57.59 -47.83 81.06 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.476 0.485 . . . . 0.0 110.371 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HE2' HG12 ' A' ' 9' ' ' VAL . 26.3 mmtp -61.95 -37.68 85.62 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.204 0.602 . . . . 0.0 110.417 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -58.21 -40.83 82.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.159 0.983 . . . . 0.0 111.456 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.47 ' ND2' HD12 ' A' ' 49' ' ' ILE . 64.3 m-80 -89.88 3.5 52.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.141 0.576 . . . . 0.0 110.868 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 1.1 mpp_? 65.68 45.65 2.59 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.218 1.407 . . . . 0.0 111.592 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.8 mt -114.09 131.86 64.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 109.168 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.15 160.33 13.29 Favored Glycine 0 N--CA 1.462 0.411 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 169.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.5 mt -124.49 145.34 49.59 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -165.88 -168.9 1.38 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -128.43 170.16 13.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.077 0.551 . . . . 0.0 109.639 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 77.3 t -83.0 -45.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -95.77 112.28 24.04 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.179 0.591 . . . . 0.0 109.79 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -67.37 -24.52 65.71 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.777 0.831 . . . . 0.0 110.462 171.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.94 140.64 19.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.96 0.904 . . . . 0.0 109.854 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.525 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -150.03 134.14 4.69 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.505 ' HB3' HD12 ' A' ' 2' ' ' ILE . 47.4 p -102.7 111.73 24.18 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.57 ' HB3' ' HE2' ' A' ' 3' ' ' LYS . 43.9 ttm180 -102.29 141.75 34.62 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.472 0.709 . . . . 0.0 110.004 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.42 -161.42 1.33 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.339 1.456 . . . . 0.0 107.316 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.19 69.99 2.43 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 112.049 -0.421 . . . . 0.0 112.049 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.4 m -125.05 115.08 19.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.141 0.977 . . . . 0.0 110.609 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.09 145.68 30.97 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 79.52 -38.62 0.19 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.628 1.571 . . . . 0.0 111.826 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.5 t -86.54 115.74 24.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.05 0.54 . . . . 0.0 109.877 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -84.65 -37.8 20.61 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -130.88 103.39 7.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.32 59.01 4.89 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.525 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.4 t70 179.05 154.56 0.44 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.126 0.971 . . . . 0.0 110.26 -173.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.02 28.91 6.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.816 1.246 . . . . 0.0 112.237 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.2 100.01 6.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.716 0.689 . . . . 0.0 109.256 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.3 mt -101.86 147.76 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.346 1.059 . . . . 0.0 110.354 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.93 151.17 46.88 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.643 0.777 . . . . 0.0 110.166 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.96 103.66 10.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.444 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 54.8 m-85 -93.54 1.85 56.6 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.606 0.762 . . . . 0.0 111.032 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.3 m -74.76 -9.45 58.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.658 0.383 . . . . 0.0 111.752 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.31 -5.28 70.06 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.739 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.43 HD12 ' SD ' ' A' ' 127' ' ' MET . 17.2 mt -47.38 -58.01 4.64 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 123.898 0.879 . . . . 0.0 113.252 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -63.63 -14.52 52.54 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -164.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.21 -46.88 8.14 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.179 0.992 . . . . 0.0 111.168 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -83.23 -23.41 32.78 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 9.8 m -123.67 90.51 50.53 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 123.08 0.552 . . . . 0.0 110.629 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.06 -34.84 4.65 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.462 2.108 . . . . 0.0 111.695 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.619 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.1 mmpt? -73.41 -17.9 61.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.138 0.975 . . . . 0.0 113.471 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 33.2 tp -62.16 133.32 55.07 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 123.518 0.511 . . . . 0.0 111.445 -170.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -142.64 -28.93 0.58 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.882 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 58.1 tp -134.62 138.87 44.88 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.642 0.777 . . . . 0.0 109.715 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.564 ' HB ' HG22 ' A' ' 131' ' ' THR . 72.2 mt -113.98 143.64 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.469 ' SG ' HG13 ' A' ' 155' ' ' VAL . 72.3 m -126.64 130.31 50.2 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.492 0.717 . . . . 0.0 109.521 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.435 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 92.3 m-85 -105.04 130.18 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.191 0.596 . . . . 0.0 111.09 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.428 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 94.4 m-20 -85.29 88.81 7.53 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.141 0.576 . . . . 0.0 109.943 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 170.82 26.22 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.153 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 65.1 ttt180 -53.48 -63.65 1.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.112 0.965 . . . . 0.0 112.064 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -61.17 -12.41 12.56 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -84.65 -50.04 8.0 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.12 -9.77 72.43 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.962 -1.017 . . . . 0.0 115.108 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.1 mt-10 -64.62 -18.46 64.94 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.833 0.816 . . . . 0.0 111.762 176.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.36 25.15 12.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.199 1.0 . . . . 0.0 110.664 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.5 -52.32 73.7 Favored Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 123.628 0.771 . . . . 0.0 112.738 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' ' 125' ' ' ARG . 71.1 Cg_endo -67.17 -19.19 51.07 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.082 1.855 . . . . 0.0 112.845 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.58 -46.02 87.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.054 0.942 . . . . 0.0 110.34 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.487 ' HB2' HG23 ' A' ' 131' ' ' THR . 18.7 mt -86.65 -9.69 55.46 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.461 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 122' ' ' PRO . 95.1 mtt-85 -69.66 -26.29 64.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.123 0.569 . . . . 0.0 110.782 169.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.37 -10.56 70.32 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.964 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.43 ' SD ' HD12 ' A' ' 100' ' ' LEU . 59.9 mtt -94.99 12.11 29.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.983 0.913 . . . . 0.0 110.696 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.79 -4.39 74.82 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -91.23 144.8 25.23 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.946 0.498 . . . . 0.0 110.921 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -74.32 145.85 43.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.564 HG22 ' HB ' ' A' ' 110' ' ' ILE . 18.6 p -134.98 148.61 50.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.066 0.946 . . . . 0.0 108.901 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -142.0 127.48 18.92 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.092 0.957 . . . . 0.0 108.697 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.74 110.87 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 111' ' ' CYS . 92.9 mt -95.11 154.68 39.53 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.87 154.29 58.47 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.936 1.757 . . . . 0.0 111.586 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -66.64 113.77 5.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.8 t -79.33 36.34 0.3 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -167.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -74.67 159.6 31.87 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.286 0.634 . . . . 0.0 110.559 172.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.62 47.05 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.96 14.67 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.583 0.692 . . . . 0.0 110.737 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -74.14 -23.8 59.32 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.139 0.576 . . . . 0.0 110.923 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.586 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 37.8 ptt180 -66.88 -25.74 66.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.805 0.336 . . . . 0.0 110.625 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -63.2 -26.22 68.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.234 1.014 . . . . 0.0 110.965 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -99.13 -24.85 14.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.621 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 49.5 m -82.97 22.55 0.93 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.809 0.844 . . . . 0.0 112.59 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.95 -61.06 2.06 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.56 -30.89 67.49 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 167.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.621 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 48.0 mtp180 -83.71 -11.3 57.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.37 0.268 . . . . 0.0 111.288 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.1 -34.35 30.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.059 0.544 . . . . 0.0 111.05 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.3 m -60.25 -39.55 87.13 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.925 0.89 . . . . 0.0 112.466 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -72.31 -36.28 68.85 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -64.59 -47.51 78.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 26.7 tt0 -64.12 -37.35 87.14 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.883 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.75 -37.3 62.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.903 0.752 . . . . 0.0 111.276 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.469 HG13 ' SG ' ' A' ' 111' ' ' CYS . 20.9 t -61.88 -39.22 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.701 0.801 . . . . 0.0 111.362 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -106.36 1.21 25.57 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 122.12 -0.362 . . . . 0.0 110.44 -171.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 ttm180 -71.88 -40.11 69.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.486 0.715 . . . . 0.0 110.108 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -76.67 -4.77 44.86 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.73 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.7 -30.19 62.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.002 0.521 . . . . 0.0 109.717 172.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -94.92 -55.37 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.942 -176.107 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.5 mm -69.56 108.47 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -92.06 113.81 26.18 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -87.37 123.08 31.94 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 122.613 0.365 . . . . 0.0 111.126 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.71 166.57 54.85 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.256 168.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -94.18 145.94 30.68 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 119.284 -0.389 . . . . 0.0 111.195 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.84 159.68 32.4 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.821 2.347 . . . . 0.0 111.439 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.15 130.08 41.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.262 0.554 . . . . 0.0 111.532 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.528 HG11 HD21 ' A' ' 62' ' ' LEU . 46.5 t -95.7 60.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.42 HD13 HD11 ' A' ' 17' ' ' LEU . 42.0 tp -106.58 153.95 21.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.339 -161.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.636 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 22.7 t0 -126.07 154.83 42.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.89 1.276 . . . . 0.0 108.056 170.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.07 -11.22 60.59 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.853 0.461 . . . . 0.0 111.667 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.447 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . 23.8 m-80 -108.83 17.92 21.3 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.869 0.467 . . . . 0.0 110.79 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -72.78 117.73 14.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.194 0.598 . . . . 0.0 111.154 -174.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.07 -36.29 17.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.073 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.1 mt -126.1 112.1 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 10' ' ' LEU . 59.9 tp -103.43 118.61 37.15 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.533 HG12 ' HB2' ' A' ' 111' ' ' CYS . 41.9 mt -104.18 110.17 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 109.178 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 82.8 mt -100.27 124.77 46.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.337 1.055 . . . . 0.0 109.901 -177.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -78.84 -171.86 40.75 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 164.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.4 p -100.39 -68.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 tp -149.35 116.96 3.73 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 173.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.48 166.02 23.14 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.004 2.469 . . . . 0.0 113.423 -167.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -65.39 147.2 53.84 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.327 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.8 m-20 -57.63 -39.15 76.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.137 0.975 . . . . 0.0 111.358 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.81 -28.35 69.8 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 124.142 0.901 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.535 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 39.2 m -84.73 -38.28 19.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.584 0.753 . . . . 0.0 110.401 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.2 -29.19 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.832 0.853 . . . . 0.0 111.158 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.2 mmt180 -54.16 -38.17 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 170.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -94.25 -16.34 23.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.096 0.958 . . . . 0.0 110.514 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 56.46 24.96 9.11 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.927 1.291 . . . . 0.0 111.729 -170.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -144.16 151.49 39.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.032 0.933 . . . . 0.0 110.208 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.449 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 87.8 m-85 -70.41 -0.38 8.16 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.983 1.313 . . . . 0.0 114.52 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 2.5 p90 -96.94 -12.06 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.64 -33.07 80.72 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.845 0.715 . . . . 0.0 113.143 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -103.25 100.01 16.53 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.38 0.672 . . . . 0.0 109.525 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.25 -21.07 23.83 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.189 2.593 . . . . 0.0 111.638 171.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.57 -1.75 66.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.435 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -79.38 112.49 16.66 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -87.64 -1.36 57.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.837 0.855 . . . . 0.0 110.806 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.416 ' HE1' HG22 ' A' ' 18' ' ' ILE . 82.3 t80 -39.83 -45.08 1.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.979 1.711 . . . . 0.0 112.602 172.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.464 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 80.3 m95 -70.74 -27.78 64.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.311 -173.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -74.81 -48.4 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.414 0.286 . . . . 0.0 110.255 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.34 -47.07 83.69 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.936 0.773 . . . . 0.0 110.83 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.25 -40.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.43 0.692 . . . . 0.0 109.96 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.58 85.42 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.922 0.764 . . . . 0.0 113.636 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -73.52 -44.11 58.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.695 0.798 . . . . 0.0 110.146 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . . . -64.35 -38.99 92.99 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.541 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.9 pt -88.29 -15.25 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.34 28.43 63.88 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 116.477 -0.329 . . . . 0.0 113.828 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -143.65 96.97 2.99 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.9 105.95 0.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.011 0.924 . . . . 0.0 111.971 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.27 -23.31 40.86 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.408 0.683 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.36 -38.27 86.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.461 0.705 . . . . 0.0 111.474 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -94.13 6.13 49.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.542 0.737 . . . . 0.0 111.108 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.5 mtt -95.41 146.01 24.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.124 0.569 . . . . 0.0 110.567 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.9 158.45 35.54 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.071 170.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.566 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 32.8 t80 -47.76 -63.4 1.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.851 0.86 . . . . 0.0 113.141 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 29.8 mt-10 -59.89 -32.85 71.12 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.191 0.597 . . . . 0.0 111.095 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -54.98 12.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.925 0.89 . . . . 0.0 111.692 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HE2' ' CD2' ' A' ' 42' ' ' TRP . 8.2 ptmt -59.99 -29.75 68.67 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.473 -176.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 39.6 mt -64.95 -47.87 76.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.705 0.802 . . . . 0.0 111.476 173.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.9 mmmm -55.57 -38.16 68.99 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.234 0.54 . . . . 0.0 110.358 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.1 m -69.63 -39.53 77.09 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.355 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 62' ' ' LEU . 89.8 mt -57.4 -50.09 74.1 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.926 0.49 . . . . 0.0 110.529 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.636 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 1.8 mptm? -60.98 -37.07 81.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.72 0.637 . . . . 0.0 110.833 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -64.36 -42.09 96.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.877 0.871 . . . . 0.0 111.154 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.415 ' O ' HD12 ' A' ' 159' ' ' LEU . 59.7 m-80 -88.79 3.32 51.46 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.067 0.547 . . . . 0.0 110.903 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HD2' ' HB2' ' A' ' 13' ' ' ASN . 24.3 mmt180 67.05 35.13 4.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.356 1.062 . . . . 0.0 111.394 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -106.22 134.05 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.55 1.14 . . . . 0.0 108.797 174.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.16 151.15 18.01 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 172.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 mt -124.38 131.9 53.52 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 117.862 0.831 . . . . 0.0 109.833 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 2.8 t90 -152.74 -175.99 5.54 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -130.93 158.18 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.513 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.3 t -70.85 -44.33 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 173.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -101.79 108.28 19.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.432 0.634 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.537 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.7 ptmt -65.63 -24.71 67.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.528 167.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.94 137.52 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.919 0.888 . . . . 0.0 109.208 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.582 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -154.79 150.76 22.39 Favored Glycine 0 C--O 1.212 -1.234 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p -123.61 165.81 16.54 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 118.17 0.985 . . . . 0.0 109.544 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' A' ' 88' ' ' LYS . 73.9 ttt180 -137.8 123.67 20.07 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.759 0.423 . . . . 0.0 110.297 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' HB3' ' HG3' ' A' ' 85' ' ' GLN . 25.3 tt0 -87.41 163.37 16.79 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.303 1.041 . . . . 0.0 109.034 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.49 -35.56 89.22 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 123.246 0.341 . . . . 0.0 113.779 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.5 m -73.38 -34.13 65.39 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.974 0.51 . . . . 0.0 111.288 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' HG3' ' HB3' ' A' ' 82' ' ' GLU . 96.5 mt-30 -72.07 130.94 42.12 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.314 0.646 . . . . 0.0 110.535 -175.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' HA ' HH21 ' A' ' 81' ' ' ARG . 6.2 m-20 -87.36 -36.79 17.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.931 0.892 . . . . 0.0 109.994 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 t -69.25 140.01 54.46 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.742 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 34.9 mmtp -62.73 -25.85 68.4 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.056 0.847 . . . . 0.0 110.101 172.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.57 122.43 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.287 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.02 59.99 0.4 Allowed Glycine 0 N--CA 1.461 0.307 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.582 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 23.1 t70 -177.14 158.5 1.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.111 -1.544 . . . . 0.0 107.698 -164.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.27 20.71 11.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -167.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.537 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.7 tp10 -89.58 98.93 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 mt -110.53 150.0 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.867 0.867 . . . . 0.0 109.54 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -71.32 148.53 46.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.001 0.92 . . . . 0.0 110.632 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -79.0 96.78 5.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.822 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.513 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 31.6 m-85 -80.23 -8.45 59.46 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.23 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -72.12 -18.85 61.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.898 0.479 . . . . 0.0 110.753 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 -5.88 62.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.467 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.492 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 21.9 mt -52.57 -51.34 60.24 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.241 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.475 ' HZ1' ' HB3' ' A' ' 101' ' ' LYS . 6.8 mtpm? -58.94 -26.2 64.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.134 0.574 . . . . 0.0 112.268 -171.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.72 -35.9 65.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.5 0.72 . . . . 0.0 111.332 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -106.98 -14.56 14.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -172.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 19.2 m -125.29 86.64 56.73 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.211 0.914 . . . . 0.0 111.443 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.83 -33.13 4.01 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.714 2.276 . . . . 0.0 112.211 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.39 -7.72 58.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.107 0.563 . . . . 0.0 112.235 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 56.9 tp -58.67 104.12 0.2 Allowed 'General case' 0 C--N 1.355 0.805 0 O-C-N 123.659 0.6 . . . . 0.0 111.282 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.95 -47.2 7.13 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.5 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 49.7 tp -128.45 133.79 48.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.232 0.613 . . . . 0.0 110.967 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mt -108.46 126.39 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.533 ' HB2' HG12 ' A' ' 18' ' ' ILE . 78.9 m -109.46 115.99 30.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.513 0.725 . . . . 0.0 110.327 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.51 122.02 37.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.648 0.779 . . . . 0.0 110.549 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.533 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 84.5 m-20 -76.58 89.57 3.31 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 110.283 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.22 172.46 45.93 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.532 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 88.9 mtm180 -55.62 -50.93 68.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.467 1.107 . . . . 0.0 113.127 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 62.9 mmtt -62.32 -17.33 58.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.32 -37.76 13.82 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.65 -9.98 75.32 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.904 -1.044 . . . . 0.0 115.23 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.3 mt-10 -61.03 -26.07 67.36 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.455 0.645 . . . . 0.0 110.786 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -99.55 10.07 42.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.638 1.175 . . . . 0.0 111.405 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.472 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 35.9 tt0 -55.11 -54.06 54.57 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.698 171.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.25 -25.18 36.96 Favored 'Trans proline' 0 C--N 1.397 3.095 0 CA-C-N 121.075 1.42 . . . . 0.0 111.805 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.17 -41.74 98.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.67 0.788 . . . . 0.0 110.385 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 mt -96.34 -15.05 22.1 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.819 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -69.54 -32.07 70.65 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.456 0.646 . . . . 0.0 109.59 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.1 -5.0 64.6 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.454 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.433 ' HE3' ' HB2' ' A' ' 97' ' ' PHE . 59.5 mtt -93.98 13.03 24.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.693 0.797 . . . . 0.0 111.25 172.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.51 10.62 84.63 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.415 0.526 . . . . 0.0 114.415 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.07 145.75 27.58 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 122.869 0.468 . . . . 0.0 110.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.88 135.76 49.91 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.472 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 16.0 p -128.9 139.3 52.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.911 0.884 . . . . 0.0 109.531 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -146.36 131.12 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.15 104.37 15.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 111' ' ' CYS . 54.6 mt -82.29 147.43 56.82 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.399 172.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.645 ' HG3' ' HG3' ' A' ' 148' ' ' ARG . 42.5 Cg_endo -63.6 152.12 81.83 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 122.583 2.189 . . . . 0.0 111.727 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.0 m -60.08 123.24 16.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 m -86.16 12.4 9.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.944 0.498 . . . . 0.0 111.645 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p -60.85 149.0 37.44 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.13 0.572 . . . . 0.0 109.528 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.66 -28.72 60.35 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.328 0.393 . . . . 0.0 112.975 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.08 -35.22 79.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.909 0.884 . . . . 0.0 112.195 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -98.74 5.66 47.42 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.538 0.735 . . . . 0.0 111.43 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.409 ' HG2' ' HG ' ' A' ' 145' ' ' SER . 25.5 ttt-85 -73.93 -10.56 59.77 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.3 0.572 . . . . 0.0 110.699 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -52.29 -26.11 11.19 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.042 0.937 . . . . 0.0 112.994 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -96.47 2.82 52.87 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.599 0.76 . . . . 0.0 111.949 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.642 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 97.8 p -73.27 15.37 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -162.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.39 -74.21 0.17 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.284 0.947 . . . . 0.0 109.39 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.88 -25.21 63.59 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 112.002 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.645 ' HG3' ' HG3' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -69.42 -49.62 53.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.73 0.812 . . . . 0.0 110.158 -177.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -60.52 -36.53 78.62 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.264 0.626 . . . . 0.0 110.632 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -63.95 -40.78 97.21 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.535 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 6.9 pt-20 -70.06 -28.05 65.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.331 0.253 . . . . 0.0 110.715 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -71.63 -35.76 70.53 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.321 0.648 . . . . 0.0 109.745 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.1 -37.03 83.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.12 -17.62 64.94 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.456 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 151' ' ' GLU . 87.7 t -89.72 -61.94 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.316 0.646 . . . . 0.0 110.798 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 62.9 m-85 -86.51 2.45 47.91 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -164.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -75.55 -21.24 58.08 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -77.14 -10.86 59.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.775 0.43 . . . . 0.0 111.493 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 68' ' ' ASN . 81.2 mt -69.34 -14.78 63.11 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.639 0.775 . . . . 0.0 112.695 -170.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.64 -34.4 60.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.989 0.516 . . . . 0.0 111.003 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 124.944 1.298 . . . . 0.0 110.29 -173.235 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.473 HG22 ' HB3' ' A' ' 78' ' ' ALA . 41.0 mm -78.74 128.35 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.12 0.968 . . . . 0.0 112.443 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 2.9 mptp? -94.64 111.57 23.33 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -86.6 143.41 27.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.97 -131.31 0.04 OUTLIER Glycine 0 CA--C 1.532 1.151 0 CA-C-O 121.281 0.379 . . . . 0.0 113.434 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -136.76 145.01 49.19 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.964 -0.727 . . . . 0.0 110.234 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.04 135.81 65.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.163 1.909 . . . . 0.0 108.956 166.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 135.44 57.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.655 0.597 . . . . 0.0 110.992 -170.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.566 HG11 HD23 ' A' ' 62' ' ' LEU . 74.9 t -96.32 88.31 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.478 HD11 ' CG1' ' A' ' 104' ' ' VAL . 16.8 tp -140.0 150.41 44.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -161.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.686 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 13.6 t70 -127.17 160.17 32.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.524 1.13 . . . . 0.0 108.396 171.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -67.28 -16.86 64.52 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.972 0.509 . . . . 0.0 111.88 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -102.37 17.57 23.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.986 0.914 . . . . 0.0 110.734 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -79.22 122.84 26.8 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.938 0.495 . . . . 0.0 110.167 -176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.574 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 30.7 tt0 -97.21 -32.23 12.04 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.546 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.582 HD11 HD11 ' A' ' 159' ' ' LEU . 42.1 mt -130.25 123.91 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.416 HD13 HD12 ' A' ' 10' ' ' LEU . 58.7 tp -110.11 121.26 44.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -96.42 113.1 29.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.3 mt -99.91 111.64 23.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 109.384 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.4 177.36 21.31 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 167.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 t -90.57 -89.96 0.16 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.15 0.975 . . . . 0.0 108.789 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.77 112.31 14.93 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.93 149.11 83.01 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.172 1.915 . . . . 0.0 111.705 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.67 135.78 50.29 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.5 p-10 -61.75 -19.6 62.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -171.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -52.66 -36.57 57.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.719 1.208 . . . . 0.0 111.921 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 p -90.33 -33.97 15.88 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.294 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 81.7 mt -64.32 -37.66 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.224 1.01 . . . . 0.0 112.923 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 26.5 mmt180 -61.4 -28.59 69.36 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.204 0.526 . . . . 0.0 110.042 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -89.93 -23.28 21.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 111.131 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.08 28.02 14.27 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.994 1.317 . . . . 0.0 111.913 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.88 137.82 49.53 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.457 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.656 ' HB3' ' HZ2' ' A' ' 42' ' ' TRP . 93.5 m-85 -77.03 -2.96 36.67 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.699 167.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.695 ' HD1' ' HZ3' ' A' ' 61' ' ' LYS . 82.6 t80 -97.38 -18.68 18.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.424 1.09 . . . . 0.0 110.927 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.85 -108.44 0.03 OUTLIER Glycine 0 C--N 1.344 0.994 0 O-C-N 123.307 0.379 . . . . 0.0 112.331 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.69 93.22 46.55 Favored Pre-proline 0 N--CA 1.484 1.23 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HG2' ' HE1' ' A' ' 42' ' ' TRP . 7.7 Cg_exo -75.02 -52.43 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.916 2.411 . . . . 0.0 111.494 175.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.23 34.33 5.91 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -131.59 135.61 47.12 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.298 1.039 . . . . 0.0 111.838 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.99 0.28 28.24 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 124.946 1.299 . . . . 0.0 109.998 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -39.3 -50.3 2.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.254 2.222 . . . . 0.0 113.533 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.656 ' HZ2' ' HB3' ' A' ' 33' ' ' TYR . 72.9 m95 -69.11 -20.87 64.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.279 0.631 . . . . 0.0 112.21 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.458 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 4.6 mpt_? -86.77 -39.85 15.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.931 0.892 . . . . 0.0 110.339 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.76 -51.8 30.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.063 0.545 . . . . 0.0 111.053 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 t -73.16 -35.55 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.059 0.944 . . . . 0.0 109.61 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.74 -38.58 95.79 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.67 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -69.16 -40.6 78.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.245 0.618 . . . . 0.0 109.943 173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.77 -42.69 97.96 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.737 0.815 . . . . 0.0 112.925 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -95.15 -10.0 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.211 0.604 . . . . 0.0 112.162 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.55 59.19 Favored Glycine 0 C--N 1.353 1.496 0 O-C-N 123.266 0.354 . . . . 0.0 113.44 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.48 117.64 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.12 1.368 . . . . 0.0 108.389 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -68.47 88.73 0.34 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.597 0.713 . . . . 0.0 111.345 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.159 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -55.35 -50.94 68.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.226 1.01 . . . . 0.0 112.524 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.43 -5.78 59.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.713 0.805 . . . . 0.0 111.366 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.5 mtt -80.42 141.32 35.42 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.9 154.42 12.32 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.336 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.628 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 39.8 t80 -39.02 -50.65 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.824 0.85 . . . . 0.0 112.205 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 39.0 mt-10 -54.55 -55.72 26.34 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.154 0.909 . . . . 0.0 111.596 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.36 -39.49 74.59 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.695 ' HZ3' ' HD1' ' A' ' 34' ' ' TYR . 0.7 OUTLIER -61.18 -41.56 97.01 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.018 0.372 . . . . 0.0 110.575 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 17.0 mt -63.68 -43.94 95.2 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.887 0.742 . . . . 0.0 110.714 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 34.6 mmtp -56.76 -41.51 77.7 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.6 m -68.57 -39.55 80.97 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.042 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 61' ' ' LYS . 91.9 mt -57.35 -50.32 73.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 123.055 0.542 . . . . 0.0 109.942 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.686 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -56.79 -41.57 77.96 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 111.306 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.701 0.8 . . . . 0.0 111.278 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 56.7 m-80 -97.34 17.56 17.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.23 0.612 . . . . 0.0 110.784 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 62.72 29.39 16.78 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.452 1.101 . . . . 0.0 111.308 169.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.95 134.87 42.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.327 1.051 . . . . 0.0 108.626 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.46 157.57 15.39 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.17 131.74 53.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.569 0.748 . . . . 0.0 109.459 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -161.8 -168.07 1.85 Allowed 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.65 162.91 33.97 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.687 0.676 . . . . 0.0 111.569 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.472 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 68.9 t -88.21 -45.46 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.438 1.095 . . . . 0.0 110.222 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -100.56 109.69 21.8 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.3 ttmt -64.37 -39.96 94.9 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 124.368 1.043 . . . . 0.0 110.294 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.473 ' HB3' HG22 ' A' ' 2' ' ' ILE . . . -150.21 133.48 16.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.899 -176.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.687 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -155.15 144.22 10.8 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.8 t -116.0 168.15 10.34 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 117.452 0.626 . . . . 0.0 110.127 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -130.74 140.05 50.3 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -27.47 68.38 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.287 0.635 . . . . 0.0 112.59 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 142.25 4.15 0.97 Allowed Glycine 0 N--CA 1.474 1.218 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 t -83.31 -157.69 0.25 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 117.152 0.476 . . . . 0.0 109.845 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -56.37 150.07 15.54 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.46 0.704 . . . . 0.0 111.458 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.78 60.72 6.07 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.616 0.722 . . . . 0.0 111.731 -167.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 m -142.99 9.89 1.73 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.758 1.223 . . . . 0.0 109.33 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -78.28 124.64 28.32 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 124.088 0.955 . . . . 0.0 109.935 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 mt -104.72 89.73 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.65 58.6 0.41 Allowed Glycine 0 C--O 1.244 0.737 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.887 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.687 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 15.2 t70 -178.78 146.68 0.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 107.964 -174.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -105.18 16.82 25.11 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -167.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 15.4 tp10 -82.47 101.01 10.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.787 0.803 . . . . 0.0 109.785 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.38 145.71 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.575 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.8 156.27 34.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.867 0.467 . . . . 0.0 110.37 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.91 110.71 13.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.898 0.879 . . . . 0.0 110.367 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.472 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.7 m-85 -106.05 -9.42 17.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.281 0.632 . . . . 0.0 112.488 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.2 p -68.19 -13.49 62.27 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.62 0.368 . . . . 0.0 111.797 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -2.14 56.72 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 118.806 -0.997 . . . . 0.0 113.695 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -49.76 -37.4 29.59 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.445 0.698 . . . . 0.0 112.572 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.476 ' HA ' ' HH ' ' A' ' 129' ' ' TYR . 95.7 mttt -62.26 -31.5 72.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.52 0.328 . . . . 0.0 111.739 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.26 -50.95 8.92 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.033 0.933 . . . . 0.0 111.748 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.408 ' HG3' HG23 ' A' ' 104' ' ' VAL . 21.2 ptm -72.67 -33.54 66.6 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.302 0.641 . . . . 0.0 111.948 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.564 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -128.85 87.19 55.4 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.803 0.841 . . . . 0.0 109.64 176.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.09 -28.03 13.28 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.709 2.273 . . . . 0.0 112.501 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 0.24 56.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.316 0.646 . . . . 0.0 111.753 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 44.7 tp -57.23 110.18 0.8 Allowed 'General case' 0 C--N 1.354 0.762 0 O-C-N 123.806 0.691 . . . . 0.0 111.222 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.574 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 12.2 ptm180 -101.59 -43.47 5.88 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.67 170.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.476 ' HB3' HG12 ' A' ' 16' ' ' ILE . 59.8 tp -131.05 128.55 40.51 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.786 0.835 . . . . 0.0 110.245 -168.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.74 113.93 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.453 1.101 . . . . 0.0 108.501 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.413 ' SG ' HG13 ' A' ' 155' ' ' VAL . 73.3 m -96.48 113.73 25.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.858 0.463 . . . . 0.0 110.405 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.24 109.25 19.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.073 0.949 . . . . 0.0 110.088 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.434 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 7.2 t30 -81.85 90.4 6.41 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.95 143.25 7.32 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.768 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -54.86 -49.04 72.12 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.314 1.046 . . . . 0.0 112.141 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -49.26 -38.33 26.58 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.583 1.153 . . . . 0.0 112.744 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.77 -42.98 66.5 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.663 0.785 . . . . 0.0 110.102 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.7 -9.33 69.63 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 114.601 -1.181 . . . . 0.0 114.451 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.98 -28.99 70.47 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.138 0.469 . . . . 0.0 110.855 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.6 22.86 12.86 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.454 1.102 . . . . 0.0 110.937 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.14 -55.15 46.92 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.427 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.79 -19.18 66.61 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 122.014 1.809 . . . . 0.0 111.979 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.65 -49.04 74.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.384 1.074 . . . . 0.0 109.389 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 mt -87.59 -15.97 35.88 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.081 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -66.73 -31.71 72.53 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.24 -12.07 60.11 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.639 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.0 mtt -96.25 16.79 17.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.837 0.855 . . . . 0.0 111.338 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.94 22.51 78.75 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.04 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.476 ' HH ' ' HA ' ' A' ' 101' ' ' LYS . 33.0 m-85 -111.26 138.38 47.79 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.9 0.48 . . . . 0.0 111.225 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -62.85 142.85 58.07 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.7 p -132.46 142.07 49.08 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.988 0.515 . . . . 0.0 110.85 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -130.36 114.19 15.29 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.582 1.153 . . . . 0.0 108.325 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.0 94.44 2.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.85 140.39 88.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.013 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HG3' ' HD3' ' A' ' 148' ' ' ARG . 21.2 Cg_endo -57.97 158.08 22.46 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.424 2.083 . . . . 0.0 111.57 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.3 m -56.29 113.58 1.63 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -80.28 18.41 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.556 0.343 . . . . 0.0 111.837 -175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.0 m -57.95 149.63 22.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.108 0.963 . . . . 0.0 110.603 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.45 -24.35 65.71 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.584 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.07 70.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.384 0.673 . . . . 0.0 111.497 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -87.5 4.85 41.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.648 0.779 . . . . 0.0 111.615 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.529 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 12.7 ttm180 -62.69 -25.5 68.19 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.419 0.554 . . . . 0.0 111.984 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.53 -23.59 27.39 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.026 0.531 . . . . 0.0 111.811 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -108.04 5.94 26.55 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.105 0.962 . . . . 0.0 112.111 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 142' ' ' ARG . 41.0 t -64.23 -35.54 81.17 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -164.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -62.88 -62.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.428 0.558 . . . . 0.0 111.733 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.68 -39.91 78.22 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.428 0.691 . . . . 0.0 111.127 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.49 ' HD3' ' HG3' ' A' ' 135' ' ' PRO . 72.0 mtt-85 -74.78 -27.42 60.32 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.579 -175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.38 -35.52 79.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.985 0.514 . . . . 0.0 109.997 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.4 t -72.0 -30.08 64.87 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.984 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 4.3 pt-20 -76.66 -34.37 58.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -70.54 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.577 0.751 . . . . 0.0 109.126 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.413 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 25.0 tt0 -66.52 -37.63 85.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.658 0.783 . . . . 0.0 109.332 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.96 -13.73 62.4 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.413 HG13 ' SG ' ' A' ' 111' ' ' CYS . 85.7 t -89.48 -52.76 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.523 0.729 . . . . 0.0 110.581 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -96.09 -1.41 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -164.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 18.7 mtp180 -68.34 -38.85 81.89 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.823 0.738 . . . . 0.0 112.175 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -74.93 -9.9 58.97 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.705 0.402 . . . . 0.0 111.355 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.582 HD11 HD11 ' A' ' 16' ' ' ILE . 88.2 mt -82.51 -35.65 27.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.209 1.004 . . . . 0.0 110.221 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.04 -49.99 11.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.4 t60 . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.163 1.385 . . . . 0.0 112.384 170.554 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 80' ' ' SER . 32.8 mm -77.94 122.97 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.735 0.814 . . . . 0.0 108.968 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -95.07 118.47 31.94 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -93.57 142.72 27.03 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 110.552 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -69.97 171.59 41.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.419 167.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.79 145.78 31.19 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 122.262 -0.552 . . . . 0.0 110.561 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.45 132.52 49.06 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.312 2.008 . . . . 0.0 109.654 170.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.9 147.72 45.85 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.299 1.0 . . . . 0.0 112.755 -166.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.565 HG13 HD22 ' A' ' 62' ' ' LEU . 26.2 t -92.4 47.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.482 HD13 HD11 ' A' ' 17' ' ' LEU . 35.6 tp -89.67 147.6 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.898 -167.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.13 151.86 41.69 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.73 -16.61 64.22 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.832 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.549 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 30.3 m-80 -105.88 21.05 17.93 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -70.53 109.95 5.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.485 0.66 . . . . 0.0 110.238 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.04 -38.86 26.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.257 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.416 HD13 HD13 ' A' ' 159' ' ' LEU . 55.2 mt -124.72 120.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.691 0.796 . . . . 0.0 108.995 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.482 HD11 HD13 ' A' ' 10' ' ' LEU . 59.7 tp -103.41 117.41 34.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' A' ' 111' ' ' CYS . 50.0 mt -95.99 108.69 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 73' ' ' TRP . 88.9 mt -95.52 108.7 20.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 109.147 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.42 -174.54 7.28 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 167.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 m -87.77 -82.02 0.23 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.419 HD12 ' HD2' ' A' ' 23' ' ' PRO . 51.5 tp -148.28 124.64 5.36 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.4 Cg_exo -43.26 135.35 6.06 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.897 3.065 . . . . 0.0 114.194 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 m -72.2 169.58 15.84 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 111.107 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.92 -49.18 69.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.747 0.819 . . . . 0.0 111.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.19 -31.44 67.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.322 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.7 p -70.71 -38.89 73.69 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.7 mt -68.57 -24.85 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.138 0.975 . . . . 0.0 111.746 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.32 -44.67 87.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.017 0.436 . . . . 0.0 109.905 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -95.26 -1.54 51.31 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.019 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 64.04 24.65 13.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.692 1.197 . . . . 0.0 113.123 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.86 144.12 30.03 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.933 0.893 . . . . 0.0 109.574 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -58.27 -47.51 83.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.686 0.794 . . . . 0.0 110.334 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -60.86 -16.48 41.92 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.625 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -14.17 65.21 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 122.694 0.188 . . . . 0.0 113.438 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.03 101.5 11.15 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.697 0.799 . . . . 0.0 108.856 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.4 148.63 89.87 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.806 2.337 . . . . 0.0 111.42 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.18 -21.08 25.17 Favored Glycine 0 N--CA 1.464 0.535 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.48 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -73.15 102.13 3.51 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.845 0.831 . . . . 0.0 109.408 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -79.98 -3.97 50.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.827 1.651 . . . . 0.0 110.133 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -35.21 -53.92 0.62 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.871 2.069 . . . . 0.0 113.628 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -69.73 -28.33 65.72 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.331 0.652 . . . . 0.0 111.766 -172.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -68.21 -43.82 77.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 110.412 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.0 mt -72.31 -52.64 15.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.696 1.198 . . . . 0.0 111.225 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.97 -43.28 92.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 C-N-CA 124.048 0.939 . . . . 0.0 109.336 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.74 94.56 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.151 0.907 . . . . 0.0 113.469 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -69.41 -39.76 77.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.994 0.518 . . . . 0.0 110.318 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -69.94 -38.24 76.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.89 0.876 . . . . 0.0 112.811 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.05 -11.72 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.072 0.549 . . . . 0.0 110.938 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.94 19.15 79.06 Favored Glycine 0 C--N 1.36 1.909 0 O-C-N 123.807 0.692 . . . . 0.0 113.787 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.68 110.7 11.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 108.318 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -69.55 101.22 1.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.86 0.838 . . . . 0.0 111.553 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.48 -34.08 47.83 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.025 0.93 . . . . 0.0 111.897 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -62.7 -31.0 71.83 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -168.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -83.15 -5.86 59.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.083 0.553 . . . . 0.0 112.393 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.4 mtt -86.42 154.98 20.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.213 0.605 . . . . 0.0 109.455 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.5 152.52 45.52 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 165.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.508 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 70.0 t80 -51.08 -42.21 60.44 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.003 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.92 -45.07 93.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.946 0.898 . . . . 0.0 111.486 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -67.98 -38.09 82.29 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.637 0.775 . . . . 0.0 110.569 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -53.53 -49.48 67.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.722 0.809 . . . . 0.0 109.902 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 9' ' ' VAL . 19.2 mt -61.98 -45.41 93.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 124.655 1.222 . . . . 0.0 110.986 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -57.12 -40.61 77.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.89 0.476 . . . . 0.0 111.421 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.2 m -66.37 -36.82 83.83 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.75 -37.13 84.03 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.13 0.572 . . . . 0.0 111.085 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -57.46 -44.3 84.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -65.06 -35.39 80.99 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.413 1.085 . . . . 0.0 111.555 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -85.14 -8.59 58.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.782 0.833 . . . . 0.0 111.018 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 62.87 38.05 11.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.669 1.188 . . . . 0.0 110.462 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.78 134.17 48.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.78 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.64 142.24 17.44 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.0 128.8 54.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.439 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.1 t90 -153.26 -169.93 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.96 176.83 8.33 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.702 0.801 . . . . 0.0 109.187 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.562 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.8 t -90.87 -46.76 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.137 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -94.29 118.31 31.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.866 0.467 . . . . 0.0 110.385 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.452 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 36.9 ttmt -64.77 -41.91 95.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.322 1.049 . . . . 0.0 110.45 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.86 131.04 12.73 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.348 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.64 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.61 138.63 6.64 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.512 ' HB3' HD12 ' A' ' 2' ' ' ILE . 31.2 p -118.31 129.37 55.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.114 0.566 . . . . 0.0 111.063 -171.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -87.13 93.11 9.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -80.33 -20.0 45.26 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.223 0.609 . . . . 0.0 110.19 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.5 -152.76 5.84 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.925 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.6 m -132.46 33.67 3.79 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.233 1.013 . . . . 0.0 109.32 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -109.98 68.1 0.66 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 66.06 7.93 5.09 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 125.003 1.321 . . . . 0.0 113.111 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.5 p -82.9 83.45 7.77 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.047 0.939 . . . . 0.0 109.508 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -91.84 -40.58 11.11 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.4 mt -134.92 80.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 171.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.92 71.65 2.16 Favored Glycine 0 C--O 1.242 0.642 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.64 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.7 t70 176.48 158.31 0.29 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 108.61 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.28 23.74 8.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.861 0.864 . . . . 0.0 111.866 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 16.4 tp10 -83.06 102.56 11.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 54.9 mt -102.59 155.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.682 1.193 . . . . 0.0 109.728 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -74.26 145.19 44.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.437 1.095 . . . . 0.0 110.168 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.01 101.16 1.34 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.356 0.662 . . . . 0.0 110.377 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.562 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 22.7 m-85 -91.95 -10.27 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.065 0.546 . . . . 0.0 112.04 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.6 p -67.67 -21.73 65.33 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.134 0.174 . . . . 0.0 110.622 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.08 -3.7 75.77 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.369 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.8 mt -48.96 -46.23 43.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -64.27 -23.78 67.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.101 0.41 . . . . 0.0 111.471 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.03 -58.3 3.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.922 0.889 . . . . 0.0 111.029 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.4 ptm -71.0 -33.77 70.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.066 0.947 . . . . 0.0 112.508 -168.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.3 m -124.32 84.04 56.54 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.698 0.799 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.76 -32.38 14.49 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.889 2.393 . . . . 0.0 111.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.549 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.6 mmpt? -87.87 -0.94 57.62 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.884 0.874 . . . . 0.0 112.482 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.6 tp -59.28 107.97 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -99.27 -41.75 7.32 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.829 0.852 . . . . 0.0 109.79 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.3 tp -136.91 132.82 35.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 110.64 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.498 HG12 HD21 ' A' ' 107' ' ' LEU . 15.7 mt -104.61 123.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.509 ' HB2' HG12 ' A' ' 18' ' ' ILE . 70.9 m -101.7 114.4 28.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.977 0.511 . . . . 0.0 110.508 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.403 ' HZ ' HD12 ' A' ' 124' ' ' LEU . 95.8 m-85 -93.49 109.45 21.05 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.886 0.875 . . . . 0.0 110.225 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.531 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 22.7 t-20 -82.96 94.33 7.72 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.61 149.8 13.05 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.069 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -57.51 -43.17 84.04 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.866 1.267 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -51.41 -44.06 62.14 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.708 0.803 . . . . 0.0 112.73 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.78 85.91 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.149 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.5 -11.76 60.23 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.259 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.74 -27.89 69.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.99 0.895 . . . . 0.0 111.908 172.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -108.54 16.12 23.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.247 0.619 . . . . 0.0 111.253 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.531 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.8 tm-20 -66.4 -47.36 59.2 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.461 167.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.5 -35.29 75.78 Favored 'Trans proline' 0 C--N 1.403 3.418 0 C-N-CA 122.49 2.127 . . . . 0.0 113.18 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.54 -52.6 64.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.352 1.061 . . . . 0.0 112.014 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.403 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 15.9 mt -79.45 -6.12 56.2 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -65.6 -36.18 82.97 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.91 -17.55 71.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.214 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 62.8 mtt -86.58 9.35 18.78 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.61 0.764 . . . . 0.0 111.268 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.19 16.03 70.48 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.413 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -99.67 143.18 30.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 120.745 0.307 . . . . 0.0 110.777 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -75.84 133.2 40.67 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 161.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 36.1 p -127.62 141.1 51.72 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.999 0.92 . . . . 0.0 108.619 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -142.77 125.64 16.11 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.62 1.168 . . . . 0.0 108.17 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.31 112.82 24.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.476 HD23 HG22 ' A' ' 155' ' ' VAL . 62.8 mt -89.21 131.69 39.95 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.86 147.02 33.82 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.513 2.809 . . . . 0.0 112.772 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.6 t -54.79 116.95 3.0 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.149 0.905 . . . . 0.0 110.072 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.2 p -72.37 0.15 10.87 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.544 0.738 . . . . 0.0 112.546 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 m -60.43 143.18 53.91 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.969 0.908 . . . . 0.0 110.273 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.61 69.84 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.796 0.685 . . . . 0.0 114.368 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.54 -42.85 98.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.209 0.604 . . . . 0.0 110.436 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -81.56 -32.3 32.25 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.346 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -59.99 -23.66 63.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.42 0.45 . . . . 0.0 111.262 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -71.26 -48.9 48.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.848 0.859 . . . . 0.0 110.092 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.23 23.73 3.2 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.457 1.103 . . . . 0.0 110.382 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -169.37 70.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -91.96 -51.48 5.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.625 1.17 . . . . 0.0 108.016 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -66.0 -6.34 12.44 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.363 1.065 . . . . 0.0 112.666 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -71.43 -20.06 62.16 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.763 0.825 . . . . 0.0 110.732 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.38 -30.88 67.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.338 0.655 . . . . 0.0 111.118 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.1 t -64.52 -44.29 91.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.253 1.021 . . . . 0.0 112.445 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.2 pt-20 -75.26 -30.62 60.52 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.351 0.26 . . . . 0.0 110.485 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.59 -40.58 88.95 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 4.0 tm-20 -67.06 -39.81 86.98 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.702 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.13 64.59 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.412 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.476 HG22 HD23 ' A' ' 134' ' ' LEU . 73.1 t -84.72 -53.88 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.009 0.523 . . . . 0.0 111.001 177.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.61 2.96 52.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -168.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.41 -32.28 73.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.276 0.489 . . . . 0.0 111.137 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.405 ' CE1' HD11 ' A' ' 16' ' ' ILE . 15.4 p-80 -73.74 -12.36 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.623 0.369 . . . . 0.0 111.155 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 16' ' ' ILE . 86.7 mt -78.3 -26.06 46.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -82.7 -39.49 21.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.456 0.702 . . . . 0.0 109.121 167.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 19.9 t60 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 125.403 1.481 . . . . 0.0 110.596 -179.262 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 80' ' ' SER . 46.5 mm -67.94 111.37 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.275 0.63 . . . . 0.0 110.696 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -93.22 111.0 22.52 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -79.33 125.62 29.74 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.486 0.315 . . . . 0.0 110.739 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.23 170.74 51.92 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 124.234 0.959 . . . . 0.0 111.629 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.416 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 8.0 m-30 -89.36 141.74 29.2 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.451 -168.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.32 164.23 29.04 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.726 2.284 . . . . 0.0 111.104 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.33 128.93 37.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.358 0.663 . . . . 0.0 111.867 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.52 HG12 HD21 ' A' ' 62' ' ' LEU . 58.7 t -100.03 72.86 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.511 HD12 ' CG1' ' A' ' 104' ' ' VAL . 60.4 tp -124.86 149.56 47.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.02 -162.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.7 160.6 25.53 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 109.194 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.15 -20.19 62.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.462 1.105 . . . . 0.0 111.882 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -122.53 91.07 3.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' HG11 ' A' ' 104' ' ' VAL . 99.5 m -131.8 114.28 14.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.925 0.89 . . . . 0.0 108.769 175.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -87.75 -33.84 18.55 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.278 1.031 . . . . 0.0 110.9 -176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.481 HD13 HD11 ' A' ' 159' ' ' LEU . 60.4 mt -128.57 125.66 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.079 0.552 . . . . 0.0 109.6 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.01 123.51 49.79 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.401 HG23 ' HE1' ' A' ' 41' ' ' PHE . 20.3 mt -100.13 115.63 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 73' ' ' TRP . 97.8 mt -103.74 124.42 48.85 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.946 0.898 . . . . 0.0 110.181 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.3 -178.61 39.51 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 123.3 0.375 . . . . 0.0 112.365 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 116' ' ' LYS . 6.9 p -100.43 -71.43 0.7 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.9 119.46 2.78 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.35 167.84 8.88 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.689 2.26 . . . . 0.0 112.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.6 p -63.69 154.42 33.13 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.801 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 33.7 t70 -57.84 -37.61 74.16 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.275 0.359 . . . . 0.0 110.837 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.89 -36.0 64.71 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.187 0.995 . . . . 0.0 111.516 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.589 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 8.7 t -86.9 -39.71 15.53 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.27 -174.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HA ' ' HE1' ' A' ' 6' ' ' PHE . 70.8 mt -66.55 -38.53 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.079 0.951 . . . . 0.0 112.0 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 24.9 mmm180 -66.73 -16.59 64.35 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.543 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 93.2 mttt -106.49 -1.5 23.02 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.662 0.785 . . . . 0.0 111.566 175.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 56.16 18.24 3.15 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.436 1.494 . . . . 0.0 114.693 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -145.05 161.92 38.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.951 0.501 . . . . 0.0 110.98 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -76.6 -1.56 28.21 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.894 1.278 . . . . 0.0 112.723 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -90.54 -14.24 32.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -52.34 -40.98 54.2 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.566 1.166 . . . . 0.0 115.717 -162.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -122.11 98.01 45.05 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.979 0.512 . . . . 0.0 110.309 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.03 2.44 4.24 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.568 2.845 . . . . 0.0 113.352 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.64 -17.73 79.98 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 120.357 -0.135 . . . . 0.0 112.898 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.97 127.47 33.58 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.34 0.591 . . . . 0.0 109.983 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 6.9 m-20 -81.01 0.32 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.61 1.164 . . . . 0.0 112.304 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.401 ' HE1' HG23 ' A' ' 18' ' ' ILE . 82.0 t80 -38.94 -47.47 1.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.819 1.248 . . . . 0.0 112.649 173.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -74.85 -26.78 59.93 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.918 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -79.31 -28.23 42.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.231 0.612 . . . . 0.0 111.594 175.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 33.4 mt -85.93 -48.54 8.62 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.818 0.447 . . . . 0.0 110.432 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.08 -30.96 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.275 0.63 . . . . 0.0 109.505 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.68 -44.52 70.49 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.573 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -60.72 -37.28 81.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.476 0.71 . . . . 0.0 110.298 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 156' ' ' PHE . . . -63.58 -45.96 88.02 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.183 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.457 HD11 HD21 ' A' ' 53' ' ' LEU . 19.9 pt -91.37 -4.79 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.684 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.43 36.22 69.18 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.546 0.529 . . . . 0.0 112.838 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -149.3 105.91 3.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.675 1.59 . . . . 0.0 107.423 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -68.42 110.84 4.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.779 0.799 . . . . 0.0 109.506 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.457 HD21 HD11 ' A' ' 49' ' ' ILE . 85.1 mt -82.3 -30.72 30.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.042 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -60.32 -38.84 84.99 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.73 3.92 52.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.136 0.574 . . . . 0.0 111.337 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.553 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 66.6 mtt -85.25 150.4 24.81 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.39 45.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.751 0.657 . . . . 0.0 109.402 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.483 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 35.0 t80 -43.15 -48.99 6.48 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.362 1.065 . . . . 0.0 113.695 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 -61.31 -49.91 75.12 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 122.577 0.351 . . . . 0.0 111.322 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.25 -48.72 80.56 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.69 0.796 . . . . 0.0 112.662 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 7.6 ptmt -62.18 -36.52 82.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.489 0.316 . . . . 0.0 111.619 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.52 HD21 HG12 ' A' ' 9' ' ' VAL . 77.5 mt -68.99 -40.34 78.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.082 0.553 . . . . 0.0 111.557 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 30.3 mmmt -55.89 -44.72 78.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.386 0.674 . . . . 0.0 110.805 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -64.07 -40.06 95.44 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.285 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.98 -55.11 36.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.407 0.683 . . . . 0.0 111.688 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -22.49 64.27 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.092 0.245 . . . . 0.0 111.449 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -62.87 -33.91 76.28 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.692 0.397 . . . . 0.0 111.757 167.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -88.94 1.94 54.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.232 0.613 . . . . 0.0 110.977 172.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 64.59 46.51 3.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.683 1.193 . . . . 0.0 110.514 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.08 133.19 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.359 1.063 . . . . 0.0 108.697 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.35 17.86 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.62 132.15 56.55 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.42 0.688 . . . . 0.0 109.15 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.428 ' HB3' HD21 ' A' ' 19' ' ' LEU . 3.6 t90 -158.13 -170.2 3.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -134.32 162.74 31.34 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.477 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 48.4 t -79.09 -51.84 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 42.0 m-85 -82.2 126.66 32.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 0.0 110.58 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.576 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.3 tmtp? -68.01 -32.17 72.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.76 149.67 16.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.039 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.92 135.71 7.86 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.471 ' HB2' HD13 ' A' ' 2' ' ' ILE . 27.9 t -119.05 170.38 9.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.575 0.75 . . . . 0.0 109.537 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.452 ' NH2' ' HB3' ' A' ' 82' ' ' GLU . 3.6 tpm_? -137.83 111.44 8.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.452 ' HB3' ' NH2' ' A' ' 81' ' ' ARG . 35.7 tt0 -55.85 123.34 13.93 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.872 0.869 . . . . 0.0 111.047 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.91 82.13 0.53 Allowed Glycine 0 C--N 1.345 1.059 0 O-C-N 124.493 1.121 . . . . 0.0 112.073 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.1 t -158.76 -44.61 0.06 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -162.85 150.97 13.94 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.538 1.135 . . . . 0.0 108.685 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.92 137.58 49.37 Favored 'General case' 0 C--O 1.242 0.675 0 O-C-N 123.432 0.458 . . . . 0.0 110.224 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.444 ' H ' ' HD3' ' A' ' 81' ' ' ARG . 14.7 t -168.73 -160.22 0.28 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.132 0.973 . . . . 0.0 108.595 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -74.1 -171.07 1.05 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.4 1.08 . . . . 0.0 112.064 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.1 100.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.874 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.79 57.12 5.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.38 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -173.69 154.66 2.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.492 1.117 . . . . 0.0 108.759 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -124.25 25.92 7.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.212 1.005 . . . . 0.0 111.394 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.576 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.3 tp10 -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.468 0.707 . . . . 0.0 109.26 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 77.2 mt -127.0 140.62 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.418 1.087 . . . . 0.0 109.192 -168.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -62.39 151.54 36.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.792 0.837 . . . . 0.0 110.869 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.17 130.65 36.59 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.477 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.8 m-85 -118.94 -2.23 10.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.058 0.543 . . . . 0.0 111.091 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 86.2 p -63.99 -31.11 72.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.13 -3.97 90.58 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 118.775 -1.014 . . . . 0.0 113.878 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 mt -49.8 -49.9 46.96 Favored 'General case' 0 C--N 1.369 1.444 0 C-N-CA 123.796 0.838 . . . . 0.0 111.711 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -60.77 -16.0 35.59 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -102.92 -41.41 6.15 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.306 1.042 . . . . 0.0 112.443 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -83.09 -24.65 32.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.511 ' CG1' HD12 ' A' ' 10' ' ' LEU . 9.0 m -127.75 84.88 62.13 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.608 0.763 . . . . 0.0 110.384 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 -34.07 22.04 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.628 2.219 . . . . 0.0 111.712 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.28 -12.31 59.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.947 0.899 . . . . 0.0 112.536 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 52.7 tp -62.1 130.52 45.85 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 123.713 0.633 . . . . 0.0 110.545 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -136.68 -34.5 0.75 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.246 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.4 tp -128.48 131.23 48.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.618 0.767 . . . . 0.0 109.576 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.521 ' HB ' HG23 ' A' ' 131' ' ' THR . 61.3 mt -115.94 138.01 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.522 1.129 . . . . 0.0 108.422 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.565 ' SG ' HG12 ' A' ' 155' ' ' VAL . 83.8 m -120.57 116.95 26.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.861 0.864 . . . . 0.0 109.926 -174.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 95.7 m-85 -93.91 114.74 27.03 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -98.03 76.69 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.493 1.139 . . . . 0.0 108.851 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.19 135.61 2.71 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.265 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -52.1 -52.73 49.53 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.083 0.953 . . . . 0.0 112.382 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.592 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 28.8 mmmt -48.81 -37.44 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.039 0.936 . . . . 0.0 113.054 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.61 -34.46 77.04 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.283 0.633 . . . . 0.0 110.839 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.89 73.73 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 114.778 -1.101 . . . . 0.0 115.004 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -103.87 14.89 29.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.498 1.119 . . . . 0.0 111.097 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.7 tt0 -58.74 -49.27 94.33 Favored Pre-proline 0 CA--C 1.565 1.535 0 CA-C-O 118.049 -0.977 . . . . 0.0 112.244 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 125' ' ' ARG . 31.1 Cg_endo -57.84 -23.29 58.17 Favored 'Trans proline' 0 C--N 1.409 3.742 0 C-N-CA 122.579 2.186 . . . . 0.0 113.32 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.27 -40.02 95.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.73 0.812 . . . . 0.0 110.26 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 mt -95.22 -19.43 20.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.365 0.666 . . . . 0.0 111.248 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 122' ' ' PRO . 27.5 mtp180 -63.05 -40.16 96.87 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.052 0.541 . . . . 0.0 109.911 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.28 -19.6 66.5 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.39 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.453 ' HE1' ' HB2' ' A' ' 97' ' ' PHE . 61.3 mtt -89.8 11.75 19.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.15 73.97 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -106.8 137.82 44.13 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.371 0.585 . . . . 0.0 110.248 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.77 134.72 53.73 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 167.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.521 HG23 ' HB ' ' A' ' 110' ' ' ILE . 14.7 p -137.6 152.03 48.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 123.707 0.803 . . . . 0.0 108.968 -174.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -154.04 131.73 11.48 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.131 0.572 . . . . 0.0 109.8 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 17.2 t -90.31 93.85 4.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.52 149.53 95.55 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.203 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.11 152.66 81.54 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.619 1.546 . . . . 0.0 110.908 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.3 p -59.19 119.23 6.97 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.2 p -76.97 33.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.969 1.308 . . . . 0.0 113.994 -167.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.9 m -85.0 151.56 24.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.014 0.925 . . . . 0.0 109.204 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -20.34 58.76 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.792 0.682 . . . . 0.0 114.349 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.77 91.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.641 0.776 . . . . 0.0 111.103 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.27 -25.26 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.569 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -74.27 -25.58 59.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 123.753 0.658 . . . . 0.0 110.539 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -66.46 -27.38 67.76 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.173 0.511 . . . . 0.0 111.383 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.26 -42.41 8.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.666 0.786 . . . . 0.0 109.559 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -103.73 45.59 0.95 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.233 1.413 . . . . 0.0 110.25 -171.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -73.5 -27.47 61.4 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.333 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -86.57 -6.15 58.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.574 0.75 . . . . 0.0 111.804 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -86.14 -26.82 24.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.728 . . . . 0.0 110.399 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.79 -14.56 61.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.491 0.716 . . . . 0.0 112.171 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -34.63 77.7 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.39 0.676 . . . . 0.0 110.67 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.507 ' O ' HG22 ' A' ' 155' ' ' VAL . 4.1 pt-20 -72.16 -31.11 65.65 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 119.195 -0.431 . . . . 0.0 110.072 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -65.47 -38.01 88.51 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.58 -42.81 98.26 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.522 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.32 -9.67 58.83 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.77 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.565 HG12 ' SG ' ' A' ' 111' ' ' CYS . 75.7 t -83.87 -50.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 110.243 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 47.5 m-85 -103.2 0.82 32.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -77.36 -26.83 52.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 119.156 0.889 . . . . 0.0 112.298 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.402 ' HE1' HD11 ' A' ' 16' ' ' ILE . 15.9 p-80 -74.95 -10.85 59.87 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.444 0.698 . . . . 0.0 111.326 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.481 HD11 HD13 ' A' ' 16' ' ' ILE . 95.0 mt -73.38 -10.99 60.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.7 0.8 . . . . 0.0 111.001 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -45.96 -39.51 9.02 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.824 1.249 . . . . 0.0 111.359 164.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.689 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.986 0.422 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.509 HD12 ' HB3' ' A' ' 80' ' ' SER . 22.7 mm -77.02 125.26 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.369 0.668 . . . . 0.0 109.477 175.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.59 119.6 25.39 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 169.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -84.56 132.11 34.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.671 0.389 . . . . 0.0 111.013 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.98 -179.92 26.24 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.207 0.317 . . . . 0.0 112.585 167.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -108.87 135.0 20.16 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 122.355 -0.497 . . . . 0.0 109.726 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 157.72 33.12 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.531 2.154 . . . . 0.0 110.941 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.81 127.02 29.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.314 0.645 . . . . 0.0 112.071 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.46 HG12 HD21 ' A' ' 62' ' ' LEU . 21.6 t -91.76 88.32 2.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.558 HD12 HD13 ' A' ' 17' ' ' LEU . 34.5 tp -140.14 155.73 46.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.393 -158.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.51 159.99 27.93 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.86 -14.5 63.01 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.107 0.479 . . . . 0.0 110.945 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -111.75 84.69 2.0 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.502 ' HB ' HG13 ' A' ' 104' ' ' VAL . 98.7 m -138.92 121.43 16.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.349 0.66 . . . . 0.0 110.003 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -85.02 -41.45 15.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.551 1.54 . . . . 0.0 109.69 -173.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.453 HG12 ' HB3' ' A' ' 109' ' ' LEU . 34.2 mt -129.52 128.9 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.638 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.558 HD13 HD12 ' A' ' 10' ' ' LEU . 56.8 tp -109.89 124.91 52.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -95.67 118.26 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.0 mt -102.43 118.96 38.0 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.581 0.752 . . . . 0.0 109.557 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -75.66 -166.09 19.2 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 165.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -108.78 -73.57 0.68 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -147.68 119.98 4.65 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 161.03 46.97 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.444 2.096 . . . . 0.0 111.933 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.5 t -85.7 158.22 20.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.199 0.599 . . . . 0.0 110.399 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 5.1 p-10 -57.67 -29.97 65.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.363 0.665 . . . . 0.0 112.638 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.14 -38.17 67.88 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.381 0.673 . . . . 0.0 111.59 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.649 ' HB3' HD21 ' A' ' 36' ' ' ASN . 32.4 p -86.63 -38.01 17.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.042 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.2 mt -64.91 -38.76 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.921 0.889 . . . . 0.0 113.282 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 30.2 mmm180 -61.41 -30.78 70.77 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 0.0 110.375 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -97.29 -6.03 35.34 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.322 1.049 . . . . 0.0 112.082 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 62.1 22.39 13.08 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.813 1.245 . . . . 0.0 113.571 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.76 144.01 35.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.939 0.496 . . . . 0.0 110.453 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -55.3 -46.91 76.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.326 1.05 . . . . 0.0 110.107 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.29 -13.11 4.47 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 114.003 -1.453 . . . . 0.0 113.582 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.72 -19.91 73.65 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 114.346 0.498 . . . . 0.0 114.346 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.649 HD21 ' HB3' ' A' ' 27' ' ' SER . 4.5 p30 -110.77 135.16 20.78 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.27 -10.85 30.07 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.053 2.502 . . . . 0.0 113.018 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.14 -8.81 65.93 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.478 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.409 ' ND2' HD22 ' A' ' 36' ' ' ASN . 0.9 OUTLIER -94.29 82.02 4.06 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.685 0.755 . . . . 0.0 109.434 173.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -99.62 4.76 45.87 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.349 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -42.46 -30.06 0.32 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.094 1.357 . . . . 0.0 112.44 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.435 ' CE3' ' HD3' ' A' ' 61' ' ' LYS . 63.7 m95 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.713 1.205 . . . . 0.0 113.103 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -77.89 -32.54 51.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.818 0.447 . . . . 0.0 111.1 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 149' ' ' GLU . 43.3 mt -86.87 -47.78 8.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.798 0.839 . . . . 0.0 110.354 -170.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 -35.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.839 0.856 . . . . 0.0 109.035 172.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.34 -39.35 95.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.042 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.59 -36.32 83.4 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.947 0.899 . . . . 0.0 110.033 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . . . -63.99 -53.64 46.86 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.728 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.4 pt -84.45 -7.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.032 0.533 . . . . 0.0 111.809 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.48 73.24 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.574 0.546 . . . . 0.0 112.713 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -133.57 106.66 7.54 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -63.31 97.11 0.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 110.667 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.2 mt -75.6 -19.45 59.24 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -70.03 -27.56 64.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.804 0.842 . . . . 0.0 112.369 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -95.62 -3.15 46.8 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.73 -0.606 . . . . 0.0 110.832 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtt -88.66 159.18 17.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.005 0.522 . . . . 0.0 111.207 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.46 151.22 47.13 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.524 0.73 . . . . 0.0 109.344 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.567 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 30.3 t80 -51.91 -49.78 62.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 47.1 mt-10 -63.6 -37.04 85.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.025 0.375 . . . . 0.0 111.08 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.81 -53.32 33.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.435 ' HD3' ' CE3' ' A' ' 42' ' ' TRP . 17.3 ptpt -58.44 -32.13 68.41 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.307 0.643 . . . . 0.0 111.648 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 94.0 mt -66.83 -43.04 84.8 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.196 0.598 . . . . 0.0 111.318 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 33.8 mmtp -64.55 -31.61 72.9 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.005 0.431 . . . . 0.0 110.615 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.5 m -67.16 -39.41 86.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.145 173.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.97 -49.96 70.48 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.609 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 29.7 mmtp -57.28 -40.93 78.77 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 123.299 0.64 . . . . 0.0 110.546 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -60.82 -42.83 98.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.304 1.041 . . . . 0.0 111.11 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -87.52 5.46 39.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.773 0.829 . . . . 0.0 110.634 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 64.93 39.74 5.69 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 125.232 1.413 . . . . 0.0 110.92 171.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.03 135.96 48.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 124.917 1.287 . . . . 0.0 108.793 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.39 162.19 14.42 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 173.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.68 142.36 50.76 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -162.98 -170.74 2.43 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -131.53 166.38 21.51 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 0.0 109.379 172.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 54.2 t -78.1 -38.88 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.97 123.97 48.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.543 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -71.61 -24.0 61.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 170.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.83 140.43 14.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -152.16 155.7 26.28 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.509 ' HB3' HD12 ' A' ' 2' ' ' ILE . 40.7 p -134.88 168.38 19.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.587 0.693 . . . . 0.0 109.998 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? -139.79 145.87 38.74 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -160.31 -65.56 0.07 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.212 0.46 . . . . 0.0 112.175 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.59 -113.44 0.3 Allowed Glycine 0 CA--C 1.531 1.076 0 O-C-N 123.24 0.337 . . . . 0.0 113.383 -173.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -71.06 -21.53 62.23 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.99 0.916 . . . . 0.0 110.618 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.493 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 11.3 mm100 -84.55 101.64 12.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.232 1.013 . . . . 0.0 108.356 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.19 -41.93 4.77 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.161 0.505 . . . . 0.0 110.157 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 m -111.79 -5.91 14.36 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.807 0.843 . . . . 0.0 110.002 174.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -102.4 154.78 18.75 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.444 1.098 . . . . 0.0 108.921 -174.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp -83.15 96.4 3.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 C-N-CA 123.466 0.706 . . . . 0.0 109.311 -172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.26 65.23 3.88 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.673 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.468 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 8.2 t70 -169.86 160.29 8.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.972 0.509 . . . . 0.0 110.005 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.04 7.19 10.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.648 0.779 . . . . 0.0 112.591 -168.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.56 99.79 12.58 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.119 0.872 . . . . 0.0 109.467 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.36 152.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 109.617 -171.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -72.65 149.02 44.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.514 0.726 . . . . 0.0 110.042 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.51 114.6 16.51 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 29.0 m-85 -100.37 -5.44 27.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.592 0.757 . . . . 0.0 111.869 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.3 p -75.92 -10.92 59.82 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.71 0.29 . . . . 0.0 110.299 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.8 -5.44 62.84 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.803 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.457 HD23 ' SD ' ' A' ' 103' ' ' MET . 40.3 mt -50.42 -33.42 20.75 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.191 0.596 . . . . 0.0 112.371 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -62.58 -33.49 75.07 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.061 0.544 . . . . 0.0 112.298 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.25 -47.71 8.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.807 0.843 . . . . 0.0 112.266 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HG3' HG22 ' A' ' 104' ' ' VAL . 22.9 ptm -71.64 -32.34 67.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.546 0.739 . . . . 0.0 112.461 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' A' ' 103' ' ' MET . 0.7 OUTLIER -134.39 95.0 16.73 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.49 0.716 . . . . 0.0 110.438 177.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.8 -30.24 14.53 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.623 2.216 . . . . 0.0 111.778 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -87.3 -2.31 58.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.745 0.818 . . . . 0.0 111.758 -173.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 41.5 tp -56.09 104.34 0.13 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.798 0.839 . . . . 0.0 111.541 -175.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 18.7 ptp180 -101.87 -41.98 6.3 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.396 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.453 ' HB3' HG12 ' A' ' 16' ' ' ILE . 29.9 tp -130.73 139.57 50.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.675 0.39 . . . . 0.0 110.349 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.412 HG12 HD12 ' A' ' 107' ' ' LEU . 24.2 mt -112.75 115.99 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.489 ' SG ' HG12 ' A' ' 155' ' ' VAL . 83.6 m -98.71 118.74 36.12 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.456 0.703 . . . . 0.0 110.871 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -95.75 120.72 36.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.655 0.782 . . . . 0.0 110.227 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.482 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 95.2 m-20 -75.24 80.74 2.35 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.655 0.782 . . . . 0.0 109.815 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.93 162.94 21.23 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.474 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.5 ttp85 -64.31 -23.61 67.36 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.18 1.392 . . . . 0.0 113.056 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -74.37 -42.4 59.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.506 . . . . 0.0 110.057 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.26 75.89 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.696 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.08 -10.66 62.39 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.933 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -69.36 -20.08 63.84 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 117.402 0.601 . . . . 0.0 110.859 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -108.0 10.17 28.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.386 1.074 . . . . 0.0 111.086 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.565 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.2 tm-20 -67.58 -49.31 41.15 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.979 0.912 . . . . 0.0 111.666 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.08 -24.6 79.72 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.028 1.818 . . . . 0.0 112.685 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.92 -50.39 73.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.078 0.951 . . . . 0.0 111.287 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.31 -5.23 55.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -66.54 -31.93 72.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.038 0.535 . . . . 0.0 110.57 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.1 -17.59 70.07 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.69 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 63.7 mtt -88.07 2.17 52.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.847 0.859 . . . . 0.0 111.216 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.45 23.16 63.32 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.56 -0.291 . . . . 0.0 113.333 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -107.4 137.26 45.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 110.668 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 19.6 mm-40 -70.0 136.37 50.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.565 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 33.5 p -132.5 140.5 48.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.773 0.829 . . . . 0.0 109.504 -173.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -143.02 132.04 22.99 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.389 1.076 . . . . 0.0 109.302 -173.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.7 t -97.99 122.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 155' ' ' VAL . 96.3 mt -102.34 144.61 28.95 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 171.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.8 150.7 75.82 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.042 2.495 . . . . 0.0 112.078 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.5 t -62.14 94.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.824 0.703 . . . . 0.0 109.728 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -87.97 21.17 2.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.5 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.1 t -66.08 156.02 35.1 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.293 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 142' ' ' ARG . . . -62.75 -22.17 63.89 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 123.18 0.419 . . . . 0.0 113.787 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.36 -28.91 70.02 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 111.708 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -126.37 19.12 7.52 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.686 0.795 . . . . 0.0 111.134 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 139' ' ' GLY . 8.9 ptm85 -66.98 -27.63 67.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.011 0.525 . . . . 0.0 111.364 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -55.01 -31.07 60.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.464 1.106 . . . . 0.0 111.384 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.86 -18.26 13.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.001 0.92 . . . . 0.0 110.184 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -97.73 8.31 44.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.617 0.767 . . . . 0.0 112.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -63.23 -64.0 1.03 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.512 0.725 . . . . 0.0 109.356 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.07 -7.47 23.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.16 0.984 . . . . 0.0 112.845 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -82.08 -12.84 58.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.393 0.677 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.479 ' HB3' HD23 ' A' ' 44' ' ' LEU . 11.1 pt-20 -54.87 -25.41 28.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.523 0.729 . . . . 0.0 112.316 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -41.17 62.87 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.061 0.944 . . . . 0.0 112.209 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -72.92 -34.02 66.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -66.57 -33.4 75.58 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.987 0.915 . . . . 0.0 109.437 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.8 -42.19 98.69 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.482 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.93 87.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.897 -171.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.489 HG12 ' SG ' ' A' ' 111' ' ' CYS . 74.3 t -68.15 -30.83 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.929 -173.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 30.9 m-85 -118.15 -10.47 10.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.379 -0.825 . . . . 0.0 113.166 -173.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.0 -29.69 65.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.115 0.416 . . . . 0.0 111.107 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -81.05 -13.58 58.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.949 0.5 . . . . 0.0 111.2 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.403 HD12 HD13 ' A' ' 16' ' ' ILE . 62.7 mt -72.1 -41.06 67.71 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 122.829 0.452 . . . . 0.0 111.077 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -87.79 -53.73 4.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 CA--C 1.554 1.1 0 C-N-CA 125.313 1.445 . . . . 0.0 110.944 -179.396 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.6 mmm . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 mm -71.05 108.92 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HB3' HD13 ' A' ' 28' ' ' ILE . 50.4 mtmt -93.4 117.98 30.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.301 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -80.38 126.8 31.64 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 123.743 0.652 . . . . 0.0 110.868 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.77 156.22 53.41 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.408 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 7.3 m-85 -80.62 134.93 53.39 Favored Pre-proline 0 N--CA 1.473 0.68 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.581 -165.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.2 141.59 48.46 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.887 2.391 . . . . 0.0 111.265 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.12 128.61 37.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.571 0.748 . . . . 0.0 111.275 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.527 HG11 HD22 ' A' ' 62' ' ' LEU . 24.1 t -95.65 79.77 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 174.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.426 HD13 ' CG1' ' A' ' 104' ' ' VAL . 38.5 tp -117.18 149.86 39.69 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.517 -163.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -128.02 164.21 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.803 0.841 . . . . 0.0 109.46 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.2 -26.66 67.88 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.348 1.059 . . . . 0.0 112.462 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.497 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 61.7 m-80 -95.32 16.17 17.46 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.262 0.625 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' HG11 ' A' ' 104' ' ' VAL . 78.1 m -72.05 104.76 3.67 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.637 0.732 . . . . 0.0 110.544 -175.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG2' ' HG3' ' A' ' 108' ' ' ARG . 30.1 tt0 -88.32 -30.21 19.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.286 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.597 HD13 HD11 ' A' ' 159' ' ' LEU . 39.4 mt -127.66 120.35 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.148 0.979 . . . . 0.0 108.624 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.3 tp -106.97 116.97 32.85 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 111' ' ' CYS . 55.1 mt -91.7 108.27 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 94.9 mt -99.67 108.17 20.46 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 109.071 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.05 177.34 8.66 Favored Glycine 0 N--CA 1.47 0.932 0 O-C-N 123.002 0.189 . . . . 0.0 113.053 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB2' HD12 ' A' ' 89' ' ' ILE . 10.7 p -90.79 -72.42 0.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.492 HD21 ' HA3' ' A' ' 79' ' ' GLY . 19.0 tp -151.14 124.68 4.3 Favored Pre-proline 0 C--O 1.246 0.894 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 159.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.5 157.6 30.92 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.118 1.879 . . . . 0.0 111.67 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -62.95 150.29 42.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.605 0.762 . . . . 0.0 110.459 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 6.6 p-10 -58.88 -34.07 71.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.573 0.225 . . . . 0.0 110.452 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.1 -37.96 78.42 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.363 1.065 . . . . 0.0 111.947 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.6 p -81.23 -30.74 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.411 HD13 ' HB3' ' A' ' 3' ' ' LYS . 73.1 mt -74.66 -16.0 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 110.882 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 79.1 mtt180 -64.38 -38.3 90.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.569 0.347 . . . . 0.0 110.569 170.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -86.87 -16.22 36.7 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.624 0.77 . . . . 0.0 109.899 177.31 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.9 23.83 4.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.075 1.35 . . . . 0.0 113.206 -172.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -126.09 160.2 30.78 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.386 0.674 . . . . 0.0 109.561 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -72.43 -2.5 19.72 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.607 0.763 . . . . 0.0 110.746 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -70.13 -45.36 67.0 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.448 1.099 . . . . 0.0 108.294 174.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 31.76 -112.66 0.06 OUTLIER Glycine 0 C--N 1.374 2.678 0 O-C-N 125.086 1.491 . . . . 0.0 114.546 -172.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.65 129.59 23.99 Favored Pre-proline 0 C--O 1.246 0.886 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.06 9.3 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.968 2.446 . . . . 0.0 113.953 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.85 0.28 78.55 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 122.906 0.289 . . . . 0.0 112.566 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -84.08 130.15 34.87 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.88 3.4 29.93 Favored 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 123.852 0.861 . . . . 0.0 111.189 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -42.94 -56.42 3.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.683 0.793 . . . . 0.0 112.126 172.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.404 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 75.8 m95 -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.856 0.862 . . . . 0.0 111.897 -177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -80.99 -42.07 21.74 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.442 1.097 . . . . 0.0 111.415 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.27 -47.54 34.35 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.113 0.965 . . . . 0.0 109.2 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.91 -37.68 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.264 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.8 96.1 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.67 0.606 . . . . 0.0 113.184 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.19 -41.36 85.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.438 0.695 . . . . 0.0 109.961 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.61 87.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.358 1.063 . . . . 0.0 112.769 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 pt -89.44 -6.57 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.112 0.565 . . . . 0.0 111.645 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.86 22.99 78.61 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 113.178 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -139.87 96.47 3.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.99 109.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.881 0.872 . . . . 0.0 111.083 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.409 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 53.6 mt -75.21 -19.93 59.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.837 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -53.42 -54.53 35.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.724 0.809 . . . . 0.0 112.806 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -83.57 6.25 21.26 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.051 0.54 . . . . 0.0 112.427 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.564 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.1 mtt -88.81 139.6 30.29 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 154.64 40.04 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.501 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 36.9 t80 -48.37 -50.67 29.78 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 41.7 mt-10 -60.37 -38.85 85.18 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.609 0.364 . . . . 0.0 111.155 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -68.26 -53.46 24.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.94 0.896 . . . . 0.0 112.29 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 5.5 ptmt -59.89 -29.98 68.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.527 HD22 HG11 ' A' ' 9' ' ' VAL . 86.4 mt -65.1 -42.56 93.91 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.252 0.621 . . . . 0.0 111.231 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 43.7 mmtm -59.49 -39.71 84.64 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.673 0.389 . . . . 0.0 110.192 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.462 HG21 ' HE3' ' A' ' 56' ' ' MET . 31.3 m -66.96 -38.23 85.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.536 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.1 mt -58.22 -59.25 5.61 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 111.231 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -22.2 61.74 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.224 0.328 . . . . 0.0 111.842 -174.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -58.87 -43.68 90.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.64 0.776 . . . . 0.0 110.374 164.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -89.74 19.82 4.47 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.729 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.47 ' HB2' HD23 ' A' ' 159' ' ' LEU . 15.1 mmt180 70.28 27.15 4.16 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.289 1.036 . . . . 0.0 111.58 169.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.7 mt -109.63 123.79 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.055 0.942 . . . . 0.0 109.883 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.17 158.45 14.3 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.45 140.93 49.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.435 0.694 . . . . 0.0 109.252 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.466 ' HB3' HD21 ' A' ' 19' ' ' LEU . 8.8 t90 -165.03 -177.27 4.55 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -131.5 161.93 31.42 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.44 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 53.3 t -75.73 -48.34 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.72 128.78 41.65 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.258 0.551 . . . . 0.0 110.626 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.663 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 10.2 ptmm? -84.19 -17.56 39.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.733 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.68 134.88 11.26 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.055 0.455 . . . . 0.0 110.463 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -147.78 147.66 18.53 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.8 p -142.21 179.49 6.88 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 117.912 0.856 . . . . 0.0 111.774 -173.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.441 ' HD3' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -130.01 107.34 9.27 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 166.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -87.94 -173.2 4.17 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.26 53.77 3.51 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 117.956 0.344 . . . . 0.0 112.555 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -168.39 83.4 0.17 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 74.58 152.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.294 1.837 . . . . 0.0 112.273 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -96.48 61.39 1.96 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.11 0.964 . . . . 0.0 108.648 168.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.7 p -77.47 138.29 39.15 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.824 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -50.32 -57.92 6.81 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.178 0.991 . . . . 0.0 109.494 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 21' ' ' SER . 7.8 mt -111.09 88.12 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.483 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.92 60.47 0.63 Allowed Glycine 0 N--CA 1.465 0.58 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.555 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.2 t70 -174.72 160.05 2.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.161 0.984 . . . . 0.0 108.908 -172.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.37 18.15 13.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 111.302 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.663 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 11.8 tp10 -85.06 97.46 9.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.4 mt -106.26 150.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.653 1.181 . . . . 0.0 109.54 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -75.1 153.39 38.34 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.45 0.7 . . . . 0.0 109.847 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.42 135.55 35.65 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.44 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 45.7 m-85 -121.55 3.43 10.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.204 0.601 . . . . 0.0 111.435 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.2 p -67.77 -18.16 64.78 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.05 0.386 . . . . 0.0 111.674 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.65 -2.73 64.98 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 118.828 -0.985 . . . . 0.0 113.582 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.401 HD22 ' SD ' ' A' ' 103' ' ' MET . 40.0 mt -52.0 -36.15 48.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 117.898 0.849 . . . . 0.0 112.958 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.7 mtpt -67.7 -17.55 64.61 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -98.46 -50.57 4.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.062 0.945 . . . . 0.0 111.772 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.401 ' SD ' HD22 ' A' ' 100' ' ' LEU . 25.5 ptm -71.32 -35.14 71.12 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.218 0.607 . . . . 0.0 111.271 -173.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.1 m -126.01 84.61 60.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.708 0.803 . . . . 0.0 109.922 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.39 -29.04 5.11 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.857 2.371 . . . . 0.0 111.82 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.497 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 11.2 mmpt? -74.55 -12.69 60.53 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.241 0.616 . . . . 0.0 111.564 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -56.54 126.65 27.51 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.1 0.875 . . . . 0.0 111.179 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.533 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -134.98 -18.01 1.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.808 174.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.533 ' HB2' HH11 ' A' ' 108' ' ' ARG . 59.1 tp -143.66 131.92 21.99 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.192 0.597 . . . . 0.0 110.367 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.409 HD11 HG21 ' A' ' 131' ' ' THR . 49.4 mt -107.37 143.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.205 1.002 . . . . 0.0 108.496 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.535 ' SG ' HG13 ' A' ' 155' ' ' VAL . 74.9 m -125.54 116.23 21.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.182 0.593 . . . . 0.0 110.13 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 96.7 m-85 -93.0 111.54 23.2 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.268 0.627 . . . . 0.0 110.394 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -84.53 93.24 8.3 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.15 127.37 3.18 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -50.53 -45.06 56.55 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.382 1.473 . . . . 0.0 113.417 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -58.13 -24.0 57.15 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 112' ' ' PHE . . . -73.16 -18.33 61.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.068 0.461 . . . . 0.0 111.075 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.43 -16.9 67.95 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.28 -0.873 . . . . 0.0 114.573 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.63 -26.68 67.93 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.919 0.488 . . . . 0.0 110.018 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.78 8.26 24.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.28 1.032 . . . . 0.0 111.334 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.451 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 38.7 tt0 -60.79 -51.08 82.1 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.169 169.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.43 -17.42 57.6 Favored 'Trans proline' 0 C--N 1.401 3.321 0 C-N-CA 121.83 1.686 . . . . 0.0 113.252 -175.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.09 -41.63 99.44 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.558 1.143 . . . . 0.0 110.755 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.0 -4.98 55.99 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.171 -171.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -66.0 -31.29 72.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.036 0.534 . . . . 0.0 110.226 172.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.21 -1.46 69.41 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.084 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 56.6 mtt -103.87 11.92 35.03 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.459 1.104 . . . . 0.0 110.451 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.33 78.15 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.934 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.48 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 29.8 m-85 -110.72 141.16 44.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.263 0.625 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 13.4 mm-40 -68.43 133.68 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.451 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 41.5 p -126.3 136.91 53.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 109.172 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -141.62 130.97 23.63 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.146 0.978 . . . . 0.0 109.358 -176.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 61.0 t -101.81 130.4 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.406 0.682 . . . . 0.0 109.643 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -115.89 154.59 48.27 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.324 1.45 . . . . 0.0 108.202 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.5 170.1 14.36 Favored 'Trans proline' 0 C--N 1.367 1.539 0 C-N-CA 122.613 2.209 . . . . 0.0 112.187 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.3 m -60.86 127.44 31.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.9 m -77.63 27.68 0.17 Allowed 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.3 m -87.71 159.61 18.43 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.827 0.851 . . . . 0.0 110.369 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 142' ' ' ARG . . . -64.5 -20.78 66.1 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.411 0.925 . . . . 0.0 115.411 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.48 -43.17 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.02 0.528 . . . . 0.0 110.833 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -69.89 -39.81 76.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.516 0.326 . . . . 0.0 110.407 171.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.45 ' HB3' ' HA2' ' A' ' 139' ' ' GLY . 7.3 tmm_? -60.01 -34.11 72.9 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.218 1.007 . . . . 0.0 111.561 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.21 -23.69 37.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.386 1.074 . . . . 0.0 112.047 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -117.76 -23.13 7.69 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.026 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 53.4 m -84.41 39.69 0.74 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.758 1.223 . . . . 0.0 113.012 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 146' ' ' LYS . 71.6 mmtt -76.54 -53.89 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.582 0.353 . . . . 0.0 110.599 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -64.16 -23.14 67.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.386 0.274 . . . . 0.0 111.141 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 55.7 ttm-85 -84.5 -18.83 34.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.0 0.92 . . . . 0.0 110.475 -176.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.03 -27.53 63.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.568 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.0 t -60.36 -43.98 96.01 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.885 0.874 . . . . 0.0 111.585 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -75.9 -27.85 57.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -63.32 -44.89 93.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.73 -35.93 77.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.777 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.28 72.4 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.866 0.466 . . . . 0.0 110.369 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.535 HG13 ' SG ' ' A' ' 111' ' ' CYS . 53.1 t -68.12 -55.49 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.036 0.934 . . . . 0.0 111.083 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -94.39 -5.73 45.77 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -71.91 -38.45 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 118.255 0.48 . . . . 0.0 110.917 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.462 ' HE1' HD11 ' A' ' 16' ' ' ILE . 7.5 p-80 -76.85 -7.14 54.94 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.148 0.579 . . . . 0.0 110.751 -174.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.597 HD11 HD13 ' A' ' 16' ' ' ILE . 81.7 mt -74.17 -20.91 60.05 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.554 0.742 . . . . 0.0 111.967 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.78 -29.07 60.99 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 169.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 CA--C 1.561 1.366 0 C-N-CA 124.896 1.279 . . . . 0.0 111.753 171.05 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.492 ' SD ' ' NZ ' ' A' ' 3' ' ' LYS . 51.2 ttm . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.7 mm -76.0 124.1 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.492 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 65.7 mttm -107.53 133.72 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.258 1.023 . . . . 0.0 109.858 -174.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -101.5 135.92 42.2 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.541 0.736 . . . . 0.0 110.848 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.57 174.73 47.68 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.412 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.84 148.77 69.4 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 117.098 0.449 . . . . 0.0 111.228 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.88 163.6 9.16 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.584 2.189 . . . . 0.0 110.741 159.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.75 113.5 3.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.175 0.512 . . . . 0.0 110.585 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.492 HG12 HD22 ' A' ' 62' ' ' LEU . 13.8 t -87.08 74.71 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.54 HD22 HG13 ' A' ' 104' ' ' VAL . 28.0 tp -129.38 154.38 46.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -154.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -127.43 162.12 27.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.596 1.158 . . . . 0.0 110.073 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -66.29 -24.49 66.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.054 0.942 . . . . 0.0 112.243 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.459 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 48.7 m-80 -96.27 14.28 24.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.04 0.536 . . . . 0.0 111.056 -175.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -70.16 111.09 5.55 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.419 0.628 . . . . 0.0 110.834 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -89.88 -35.66 15.5 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.038 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 63.1 mt -121.45 114.0 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.555 0.742 . . . . 0.0 109.205 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.466 HD13 HD11 ' A' ' 10' ' ' LEU . 61.1 tp -103.47 111.9 24.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.9 mt -92.62 116.43 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.1 mt -102.99 125.78 49.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.55 0.74 . . . . 0.0 109.82 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.17 -161.52 24.22 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 163.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 p -106.45 -64.3 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.2 tp -150.67 133.47 8.46 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.1 154.81 71.62 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.524 2.149 . . . . 0.0 110.663 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -60.77 150.58 32.1 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.907 0.483 . . . . 0.0 109.733 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.418 ' HB2' ' HZ3' ' A' ' 3' ' ' LYS . 7.7 p-10 -59.06 -37.31 76.74 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.61 -30.36 68.08 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.357 0.663 . . . . 0.0 110.493 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -67.07 -45.93 75.84 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.846 0.858 . . . . 0.0 109.693 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.82 -39.34 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.582 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 29' ' ' ARG . 2.8 mmp_? -61.91 -37.85 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.914 0.486 . . . . 0.0 112.163 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.63 ' HZ3' ' HB3' ' A' ' 30' ' ' LYS . 0.9 OUTLIER -100.32 -7.86 24.03 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.023 0.529 . . . . 0.0 111.836 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 67.63 18.47 9.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.442 1.097 . . . . 0.0 113.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -113.67 127.47 56.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.772 0.829 . . . . 0.0 109.056 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.494 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 84.4 m-85 -59.77 -59.77 4.91 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -55.47 -27.13 46.4 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.619 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.36 -21.13 66.17 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 123.065 0.228 . . . . 0.0 112.863 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.44 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 4.3 t30 -86.92 108.33 18.07 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.474 1.11 . . . . 0.0 108.406 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.33 142.37 78.94 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.463 2.776 . . . . 0.0 112.412 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.23 -19.3 40.48 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.376 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.44 ' ND2' ' HB3' ' A' ' 36' ' ' ASN . 95.4 m-20 -68.87 98.98 0.99 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.515 0.674 . . . . 0.0 109.572 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -86.39 -6.89 58.82 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 126.538 1.935 . . . . 0.0 110.952 -170.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.454 ' HE1' ' HB3' ' A' ' 113' ' ' ASN . 65.1 m-85 -41.63 -43.83 2.9 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 125.221 1.408 . . . . 0.0 112.681 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.494 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 74.6 m95 -71.5 -24.13 61.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.186 0.994 . . . . 0.0 112.065 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -81.48 -36.36 29.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.873 0.869 . . . . 0.0 110.902 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.09 -45.63 17.91 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.865 0.466 . . . . 0.0 111.385 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.03 -36.65 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.49 -32.67 75.48 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.889 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.15 -42.91 79.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.452 0.701 . . . . 0.0 110.053 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 156' ' ' PHE . . . -67.75 -38.02 82.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.298 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.7 pt -96.68 -11.73 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.841 0.456 . . . . 0.0 111.137 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.66 32.42 61.64 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.438 0.461 . . . . 0.0 113.579 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -133.35 111.92 11.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -66.99 89.68 0.17 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.939 0.876 . . . . 0.0 111.579 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.37 -30.98 69.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.09 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -73.41 -10.69 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.924 -173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -98.93 -9.17 24.48 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.947 -0.471 . . . . 0.0 111.68 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.463 ' HE3' HG23 ' A' ' 64' ' ' THR . 60.0 mtt -87.44 159.28 18.74 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.228 0.611 . . . . 0.0 110.76 -172.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 159.4 31.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.526 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 17.0 t80 -52.12 -54.48 29.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.43 -36.7 83.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.644 0.378 . . . . 0.0 111.214 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -67.91 -51.77 44.0 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.852 0.861 . . . . 0.0 111.654 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 8.9 ptpp? -61.32 -34.43 75.23 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.184 0.303 . . . . 0.0 111.096 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 78.0 mt -65.18 -44.18 89.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 122.657 0.383 . . . . 0.0 111.039 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -55.79 -43.15 76.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.988 0.515 . . . . 0.0 110.624 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.463 HG23 ' HE3' ' A' ' 56' ' ' MET . 25.6 m -68.4 -41.8 79.94 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.817 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 62' ' ' LEU . 78.5 mt -56.13 -62.33 1.78 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.719 0.808 . . . . 0.0 110.591 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -23.55 64.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.772 0.67 . . . . 0.0 111.752 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -63.53 -39.14 93.64 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.987 0.515 . . . . 0.0 111.024 167.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.428 ' O ' HD12 ' A' ' 159' ' ' LEU . 60.7 m-80 -85.61 14.92 5.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.042 0.537 . . . . 0.0 110.111 173.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.4 mmt-85 69.37 25.17 5.59 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.298 1.439 . . . . 0.0 111.032 173.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.19 118.77 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.652 0.781 . . . . 0.0 109.352 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.52 161.28 15.33 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 85.7 mt -123.35 145.89 48.38 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.9 -170.29 1.72 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -130.65 163.44 27.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.583 0.753 . . . . 0.0 110.117 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.421 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 58.4 t -79.43 -54.49 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 0.0 109.89 172.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.12 128.62 35.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.576 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -78.31 -35.81 47.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.337 0.655 . . . . 0.0 110.209 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 93' ' ' GLU . . . -144.01 140.82 29.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 110.88 178.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.35 160.41 33.43 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.592 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.476 ' O ' ' HA3' ' A' ' 90' ' ' GLY . 58.8 p -133.79 124.4 26.51 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.922 0.489 . . . . 0.0 109.83 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -74.43 97.65 3.12 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -102.69 144.51 30.97 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.485 1.114 . . . . 0.0 108.71 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.92 69.58 2.88 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.9 t -156.16 167.9 28.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.929 1.292 . . . . 0.0 108.301 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.33 80.14 3.83 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -113.84 116.81 29.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.801 0.84 . . . . 0.0 109.078 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -111.45 23.33 14.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.889 0.875 . . . . 0.0 110.134 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -105.78 -64.81 1.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.619 0.768 . . . . 0.0 109.39 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.9 tp 169.68 -23.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 126.115 1.766 . . . . 0.0 109.609 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . 117.53 9.43 10.24 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.232 -175.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -171.74 177.17 3.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.829 1.251 . . . . 0.0 108.185 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.6 12.4 11.48 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.163 0.585 . . . . 0.0 111.864 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.576 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 9.1 tp10 -86.73 119.13 26.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.8 mt -124.77 138.97 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.759 1.223 . . . . 0.0 108.731 -173.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -60.76 137.38 58.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.371 0.668 . . . . 0.0 109.677 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -86.07 127.31 34.65 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.929 0.492 . . . . 0.0 109.759 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.537 ' HB2' ' HE2' ' A' ' 127' ' ' MET . 67.0 m-85 -112.82 7.77 18.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.452 0.701 . . . . 0.0 111.35 -176.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.3 m -63.52 -26.5 68.74 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.838 0.455 . . . . 0.0 111.648 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -3.04 89.36 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.706 -1.052 . . . . 0.0 115.044 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.468 HD22 ' SD ' ' A' ' 103' ' ' MET . 29.5 mt -49.02 -38.57 23.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -55.78 -39.38 71.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.429 0.558 . . . . 0.0 111.197 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -85.06 -50.52 7.37 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.236 1.015 . . . . 0.0 112.267 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.529 ' HG3' HG23 ' A' ' 104' ' ' VAL . 24.1 ptm -68.58 -35.26 77.12 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.494 0.718 . . . . 0.0 111.874 -175.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.1 m -132.74 94.55 21.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.104 0.562 . . . . 0.0 110.871 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.48 -30.99 4.7 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.55 2.167 . . . . 0.0 111.742 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.4 mmmm -88.3 -7.35 56.88 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.167 -174.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.3 tp -58.53 107.72 0.54 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.48 0.657 . . . . 0.0 111.497 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -96.52 -51.43 4.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.335 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.6 tp -126.13 132.53 51.84 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.324 0.65 . . . . 0.0 110.775 -171.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.9 mt -102.95 144.26 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.51 ' HB3' HD11 ' A' ' 134' ' ' LEU . 80.1 m -124.9 113.31 17.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.807 0.443 . . . . 0.0 110.701 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.61 111.12 22.6 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.454 ' HB3' ' HE1' ' A' ' 41' ' ' PHE . 86.7 m-20 -91.39 79.49 5.59 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.4 153.39 5.86 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.343 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -62.58 -45.27 93.67 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.17 0.588 . . . . 0.0 110.148 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -31.13 69.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.809 0.843 . . . . 0.0 112.988 172.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.53 -39.57 62.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.116 0.484 . . . . 0.0 110.016 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.68 -11.14 68.56 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.392 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.31 -38.4 65.91 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.908 0.883 . . . . 0.0 112.351 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -107.92 25.3 11.73 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.543 0.737 . . . . 0.0 111.177 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 70.6 tt0 -55.78 -53.09 66.67 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.564 165.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.44 -22.22 73.77 Favored 'Trans proline' 0 C--N 1.403 3.426 0 C-N-CA 122.313 2.009 . . . . 0.0 112.906 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.402 ' HG ' ' HE3' ' A' ' 127' ' ' MET . 59.2 tp -62.79 -47.63 82.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.213 0.605 . . . . 0.0 109.661 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.97 -20.02 29.53 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.363 -174.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 34.1 mtp85 -66.65 -42.2 87.03 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.45 -21.07 68.36 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.091 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.537 ' HE2' ' HB2' ' A' ' 97' ' ' PHE . 63.9 mtt -79.04 -19.35 51.66 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.787 0.435 . . . . 0.0 111.441 175.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.51 30.59 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.523 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 142.94 27.5 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.215 0.507 . . . . 0.0 110.824 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -65.72 135.13 54.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 170.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 54.6 p -123.57 139.51 53.93 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.257 0.623 . . . . 0.0 110.161 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.442 ' HB2' HD12 ' A' ' 109' ' ' LEU . 53.1 tptt -134.12 116.75 15.79 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 107.89 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.6 110.63 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 111' ' ' CYS . 93.6 mt -95.71 150.92 38.06 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.226 1.411 . . . . 0.0 109.124 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.422 ' HB2' HD22 ' A' ' 141' ' ' ASN . 94.1 Cg_endo -74.45 130.74 14.19 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.557 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.0 p -54.46 107.91 0.33 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.728 0.811 . . . . 0.0 110.974 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.5 m -79.59 50.28 1.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.214 1.006 . . . . 0.0 112.05 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -73.29 160.45 31.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 109.804 163.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.74 59.73 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 114.758 0.663 . . . . 0.0 114.758 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.0 -37.83 78.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.795 0.438 . . . . 0.0 111.405 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.422 HD22 ' HB2' ' A' ' 135' ' ' PRO . 49.2 t30 -70.65 -20.06 62.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.481 0.712 . . . . 0.0 111.646 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.419 ' O ' ' HD3' ' A' ' 142' ' ' ARG . 12.5 tpp180 -57.22 -29.04 63.42 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.082 0.553 . . . . 0.0 110.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -53.27 -36.53 61.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.41 1.084 . . . . 0.0 111.084 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -107.33 -22.88 12.42 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.674 1.189 . . . . 0.0 111.697 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.509 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 8.2 t -87.47 13.29 10.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -165.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -72.79 -61.12 1.92 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.415 0.286 . . . . 0.0 110.478 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -24.24 64.13 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.123 0.569 . . . . 0.0 112.052 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 0.7 OUTLIER -74.99 -22.24 58.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.713 0.805 . . . . 0.0 111.225 -174.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.61 -23.19 49.64 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 t -63.84 -41.32 97.84 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.798 0.839 . . . . 0.0 111.166 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.4 pt-20 -70.78 -35.64 72.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -65.76 -41.85 91.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.099 0.559 . . . . 0.0 109.995 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -66.86 -34.55 78.04 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.985 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.05 -9.73 59.27 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.982 0.913 . . . . 0.0 111.887 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 151' ' ' GLU . 37.9 t -90.29 -43.3 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.801 0.84 . . . . 0.0 111.171 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 80.0 m-85 -102.81 4.83 38.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -168.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -86.62 -14.4 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.198 0.908 . . . . 0.0 112.384 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -84.29 -4.9 59.15 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 118.205 0.457 . . . . 0.0 111.669 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 68' ' ' ASN . 71.5 mt -61.27 -10.01 6.15 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.98 0.912 . . . . 0.0 113.113 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -51.36 -41.21 60.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.865 0.866 . . . . 0.0 111.538 164.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 C--O 1.255 1.378 0 C-N-CA 123.991 0.917 . . . . 0.0 109.015 173.622 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.477 0.909 0 CA-C-O 120.846 0.355 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 78' ' ' ALA . 47.3 mm -82.34 123.39 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.773 0.829 . . . . 0.0 110.387 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.7 125.8 45.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.324 1.05 . . . . 0.0 108.255 171.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -97.14 141.27 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.039 0.447 . . . . 0.0 111.835 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.4 171.14 51.77 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.977 163.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -107.95 125.48 31.99 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.514 1.157 . . . . 0.0 110.211 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.48 155.16 0.47 Allowed 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 124.178 3.252 . . . . 0.0 113.881 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.46 122.46 14.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.876 0.87 . . . . 0.0 113.042 -167.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.529 HG12 HD21 ' A' ' 62' ' ' LEU . 25.3 t -94.34 81.84 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.481 HD22 ' HE1' ' A' ' 103' ' ' MET . 28.7 tp -123.35 153.35 40.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -159.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.543 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 9.8 t70 -124.88 157.46 35.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.411 170.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.66 -18.62 65.01 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.097 0.559 . . . . 0.0 112.125 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.525 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 52.0 m-80 -97.04 13.64 28.35 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.914 0.886 . . . . 0.0 111.628 -176.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.0 m -77.39 116.22 17.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.922 0.489 . . . . 0.0 111.432 -171.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -99.4 -26.2 14.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.459 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.481 HD12 HD22 ' A' ' 159' ' ' LEU . 42.8 mt -121.45 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -104.16 111.09 23.55 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 111' ' ' CYS . 47.3 mt -93.62 113.23 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.8 mt -103.72 110.99 23.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.885 0.874 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.36 175.44 25.26 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.018 -0.433 . . . . 0.0 112.018 169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -87.14 -77.57 0.33 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -140.99 123.35 9.52 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -55.14 156.74 15.47 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.745 2.297 . . . . 0.0 112.445 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.452 ' O ' HG13 ' A' ' 28' ' ' ILE . 42.2 t -60.38 145.26 48.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.102 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.46 -39.85 70.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.239 0.616 . . . . 0.0 110.782 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.83 -23.71 62.4 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.355 1.062 . . . . 0.0 111.437 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.9 m -77.68 -37.4 49.81 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 24' ' ' SER . 43.6 mt -74.31 -19.25 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.599 0.76 . . . . 0.0 110.992 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.72 -33.26 75.54 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 120.953 0.406 . . . . 0.0 110.357 172.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.88 -8.43 30.88 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.203 1.001 . . . . 0.0 111.183 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 60.14 30.28 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 111.366 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -146.51 132.91 19.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.925 0.89 . . . . 0.0 110.148 -168.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -64.4 -44.96 89.64 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.384 0.612 . . . . 0.0 109.753 173.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.01 -4.42 7.13 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.227 172.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.96 -37.2 53.08 Favored Glycine 0 C--N 1.361 1.958 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -103.23 102.09 26.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.0 0.92 . . . . 0.0 108.873 165.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.17 -10.44 28.93 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.969 2.446 . . . . 0.0 112.61 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.58 -9.66 86.08 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -71.51 117.89 13.64 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.27 -4.17 37.51 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.647 0.779 . . . . 0.0 112.139 -167.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -43.94 -44.84 7.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.104 1.762 . . . . 0.0 112.847 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.431 ' HZ3' HD11 ' A' ' 65' ' ' LEU . 54.4 m95 -72.25 -22.35 61.24 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.443 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -86.91 -32.81 19.98 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 124.169 0.988 . . . . 0.0 111.697 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.9 mt -75.9 -53.95 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.391 0.676 . . . . 0.0 110.016 -174.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.38 -36.05 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.402 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.1 -36.98 91.3 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.024 0.828 . . . . 0.0 112.678 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -67.68 -41.88 83.0 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.596 0.759 . . . . 0.0 109.93 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.19 86.19 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.652 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 pt -96.52 -11.72 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.097 0.559 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.97 -59.26 2.8 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -50.24 111.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.367 1.067 . . . . 0.0 112.966 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -70.64 116.87 11.46 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.53 -30.75 57.26 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.428 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -60.24 -52.38 65.55 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -164.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.89 -22.17 63.25 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.361 0.413 . . . . 0.0 111.708 -170.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.1 mtt -60.25 152.02 25.9 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.313 0.645 . . . . 0.0 110.823 174.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.38 152.77 44.38 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.542 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 52.4 t80 -46.22 -52.27 12.75 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 0.0 112.589 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.88 -34.81 78.17 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.92 0.488 . . . . 0.0 111.704 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -73.38 -47.33 42.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.842 0.457 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -32.27 72.9 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.853 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 42.1 mt -63.24 -49.07 75.61 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.437 0.461 . . . . 0.0 110.377 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -55.54 -38.89 69.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 123.803 0.689 . . . . 0.0 111.313 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -63.78 -46.34 85.66 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.862 0.726 . . . . 0.0 109.625 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.431 HD11 ' HZ3' ' A' ' 42' ' ' TRP . 95.4 mt -59.79 -43.28 94.51 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.738 0.815 . . . . 0.0 110.889 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.543 ' HD2' ' HB2' ' A' ' 11' ' ' ASP . 28.6 mmtp -61.32 -38.09 85.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.865 0.466 . . . . 0.0 110.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -74.86 -23.11 58.37 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.228 1.011 . . . . 0.0 110.966 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' HD11 ' A' ' 159' ' ' LEU . 18.5 m120 -88.74 0.04 56.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.612 0.765 . . . . 0.0 110.256 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 65.34 32.92 9.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.777 1.231 . . . . 0.0 110.67 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.76 136.64 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 0.0 109.405 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.72 154.32 16.68 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.3 mt -120.13 129.26 54.07 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.483 0.642 . . . . 0.0 109.81 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -155.97 -168.88 2.9 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -133.25 170.38 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.206 1.003 . . . . 0.0 109.306 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.54 -61.2 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.414 ' HE1' ' HH ' ' A' ' 120' ' ' TYR . 70.9 m-85 -74.18 102.07 4.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -65.08 -28.89 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.663 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 93' ' ' GLU . . . -149.15 141.79 24.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.957 172.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.44 134.39 6.05 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.328 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.524 ' HB2' HD13 ' A' ' 2' ' ' ILE . 39.8 t -112.62 169.91 8.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.756 0.822 . . . . 0.0 109.275 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -134.39 119.68 18.9 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.55 -27.72 25.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.393 0.677 . . . . 0.0 111.929 -172.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.78 -161.48 11.12 Favored Glycine 0 C--N 1.342 0.861 0 O-C-N 123.27 0.356 . . . . 0.0 112.697 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.4 m -80.98 -34.62 32.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.558 0.743 . . . . 0.0 110.48 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -42.74 35.74 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.14 71.5 10.88 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.349 0.66 . . . . 0.0 109.387 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.4 m -111.63 6.13 19.76 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.67 0.788 . . . . 0.0 111.509 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -86.89 -159.21 0.48 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.935 0.894 . . . . 0.0 108.76 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.4 HG23 ' CD1' ' A' ' 76' ' ' PHE . 3.4 mp -82.05 83.24 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 171.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.15 61.68 4.11 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.116 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.575 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 11.8 t70 -176.04 153.44 1.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.445 1.098 . . . . 0.0 108.218 -172.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -125.27 26.37 6.9 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 78' ' ' ALA . 8.3 tp10 -80.3 102.82 9.76 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.5 149.9 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.047 0.939 . . . . 0.0 108.699 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.44 ' OD1' ' HD2' ' A' ' 77' ' ' LYS . 88.8 m-20 -66.7 141.03 57.91 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.794 0.684 . . . . 0.0 110.117 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.79 116.63 26.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.521 ' HB2' ' HE1' ' A' ' 127' ' ' MET . 76.2 m-85 -101.45 18.48 20.03 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.167 0.587 . . . . 0.0 112.087 -171.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.4 p -69.61 -18.34 63.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.37 -3.34 63.19 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.361 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.95 -38.5 36.85 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.982 0.891 . . . . 0.0 113.139 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.75 -24.27 67.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.842 0.457 . . . . 0.0 111.571 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -93.56 -50.28 5.49 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.691 0.797 . . . . 0.0 111.835 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.537 ' HG3' HG23 ' A' ' 104' ' ' VAL . 24.1 ptm -70.86 -38.74 73.16 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.575 0.75 . . . . 0.0 111.942 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -122.57 89.1 49.7 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 123.375 0.67 . . . . 0.0 110.262 178.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.24 -29.5 17.14 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.826 2.351 . . . . 0.0 111.997 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.8 mmpt? -82.7 -8.65 59.58 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.832 0.853 . . . . 0.0 112.708 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.0 tp -57.54 127.95 34.61 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.604 0.565 . . . . 0.0 111.698 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -134.76 -37.48 0.82 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.639 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 26.0 tp -129.57 125.34 35.99 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.054 0.542 . . . . 0.0 110.057 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.499 ' HB ' HG23 ' A' ' 131' ' ' THR . 57.0 mt -107.2 110.82 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.517 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.9 m -96.69 115.23 27.07 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 122.612 0.365 . . . . 0.0 110.606 -175.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.11 123.03 33.0 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.403 0.681 . . . . 0.0 109.726 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -90.99 99.27 12.34 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.05 138.88 8.13 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.447 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -52.71 -42.1 64.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.753 1.221 . . . . 0.0 112.19 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 116' ' ' LYS . 5.1 mtpm? -59.8 -30.65 69.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.59 -38.97 64.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.286 0.565 . . . . 0.0 109.943 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.77 -9.45 62.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.707 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.12 -26.29 67.57 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.562 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.414 ' HH ' ' HE1' ' A' ' 76' ' ' PHE . 73.5 m-85 -102.55 14.03 33.0 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.034 1.334 . . . . 0.0 111.373 -176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -58.5 -53.19 68.7 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.242 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.65 -18.09 53.36 Favored 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 121.742 1.628 . . . . 0.0 113.15 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 tp -66.93 -46.35 75.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.501 0.72 . . . . 0.0 109.705 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.92 -18.98 31.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.168 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -69.2 -33.0 72.66 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.124 0.569 . . . . 0.0 109.966 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.68 -22.92 64.63 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.741 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.521 ' HE1' ' HB2' ' A' ' 97' ' ' PHE . 49.3 mtt -90.21 10.7 23.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.056 0.942 . . . . 0.0 111.401 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.3 25.56 75.22 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.899 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -109.56 132.65 53.94 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.282 0.633 . . . . 0.0 110.82 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -70.2 142.5 52.41 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.499 HG23 ' HB ' ' A' ' 110' ' ' ILE . 32.2 p -133.65 150.67 51.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.524 1.13 . . . . 0.0 110.159 -173.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -142.12 119.22 11.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.704 1.201 . . . . 0.0 108.866 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.9 t -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.642 0.735 . . . . 0.0 109.765 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.86 154.39 94.29 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.711 1.204 . . . . 0.0 110.287 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.96 165.51 27.87 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.277 1.985 . . . . 0.0 112.191 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.1 t -67.35 143.74 56.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.0 t -74.02 5.92 3.85 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.125 0.97 . . . . 0.0 113.513 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -64.26 140.35 58.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.139 0.576 . . . . 0.0 110.371 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.95 -28.98 73.56 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.212 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.04 98.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.555 0.742 . . . . 0.0 110.29 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -65.93 -22.9 66.52 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.003 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.486 HH12 ' HB3' ' A' ' 149' ' ' GLU . 18.7 mmm180 -81.99 -16.74 49.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.644 0.778 . . . . 0.0 111.504 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -67.0 -36.58 82.47 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -91.54 -34.14 14.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.659 0.783 . . . . 0.0 110.397 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.1 m -101.43 29.76 4.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.509 1.123 . . . . 0.0 112.038 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.31 -62.02 2.07 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.3 -4.93 32.62 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.252 1.021 . . . . 0.0 112.464 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 64.6 mtm-85 -88.91 -8.14 54.77 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.631 0.773 . . . . 0.0 111.84 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.486 ' HB3' HH12 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -59.64 -23.99 63.5 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.589 0.632 . . . . 0.0 110.665 172.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -61.19 -32.24 72.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.851 1.26 . . . . 0.0 111.481 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.5 pt-20 -74.34 -27.03 60.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -70.82 -37.91 73.23 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.93 -36.71 84.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.618 0.767 . . . . 0.0 110.168 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.6 -12.55 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.342 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 151' ' ' GLU . 41.6 t -95.1 -44.93 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.435 1.094 . . . . 0.0 111.157 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -99.37 3.12 45.83 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -69.75 -34.6 74.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.437 ' HE1' HD13 ' A' ' 16' ' ' ILE . 11.5 p-80 -82.1 -9.73 59.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.481 HD22 HD12 ' A' ' 16' ' ' ILE . 99.3 mt -51.21 -61.79 2.02 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 124.164 0.915 . . . . 0.0 111.979 -168.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.85 -60.8 2.24 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 172.502 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.424 ' HA ' ' HB2' ' A' ' 80' ' ' SER . 34.2 mm -65.46 101.02 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.1 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HB2' HD22 ' A' ' 22' ' ' LEU . 33.5 mtmm -95.51 118.79 32.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.744 -1.116 . . . . 0.0 107.989 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -87.82 134.19 33.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.203 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.18 171.8 48.16 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.953 170.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -98.26 143.85 27.02 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 117.353 0.576 . . . . 0.0 110.031 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.78 150.11 79.2 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.219 1.946 . . . . 0.0 110.449 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.96 143.32 56.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 112.325 -174.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.495 HG13 ' HE2' ' A' ' 66' ' ' LYS . 11.8 t -101.21 61.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 168.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.48 HD13 ' CG1' ' A' ' 104' ' ' VAL . 42.3 tp -98.18 146.36 25.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.162 -165.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.517 ' HB2' ' HZ3' ' A' ' 66' ' ' LYS . 2.3 t70 -124.06 159.73 29.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.85 -19.32 63.45 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.773 0.429 . . . . 0.0 111.696 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -95.49 6.99 47.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.642 0.377 . . . . 0.0 111.792 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 m -66.84 114.58 5.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.227 0.611 . . . . 0.0 111.223 -171.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 40.6 tt0 -94.23 -35.44 12.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.384 1.474 . . . . 0.0 110.223 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.9 mt -121.42 118.47 56.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 10' ' ' LEU . 63.7 tp -105.01 116.5 32.05 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.517 HG23 ' HE1' ' A' ' 41' ' ' PHE . 52.6 mt -92.84 107.63 19.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' A' ' 73' ' ' TRP . 96.0 mt -99.24 108.45 21.02 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.065 0.946 . . . . 0.0 109.152 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.83 179.66 12.78 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 123.281 0.363 . . . . 0.0 112.26 170.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 m -86.89 -69.04 0.7 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.506 HD21 ' HA3' ' A' ' 79' ' ' GLY . 27.6 tp -146.21 131.81 9.31 Favored Pre-proline 0 C--O 1.246 0.917 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 163.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HD2' HD11 ' A' ' 22' ' ' LEU . 18.4 Cg_endo -56.96 159.28 15.03 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.087 1.858 . . . . 0.0 112.075 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 m -60.37 136.94 58.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.893 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.66 -29.09 58.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.682 0.393 . . . . 0.0 110.927 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.46 -63.1 1.27 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.934 1.293 . . . . 0.0 110.549 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.466 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 51.0 p -57.24 -28.2 62.73 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.626 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.8 mt -73.28 -28.02 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -59.9 -29.13 68.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.888 0.475 . . . . 0.0 111.095 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 67.0 mttm -111.69 -0.55 15.98 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.115 0.966 . . . . 0.0 111.318 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 51.09 34.16 10.48 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.416 1.486 . . . . 0.0 113.832 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 27' ' ' SER . 13.3 pt20 -138.67 151.64 47.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.706 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -70.27 -2.51 13.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.836 0.854 . . . . 0.0 111.433 174.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -103.11 -4.85 23.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.428 1.091 . . . . 0.0 109.843 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -72.91 -25.43 73.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.996 0.358 . . . . 0.0 113.996 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -106.83 103.27 46.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.254 0.622 . . . . 0.0 109.662 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.03 -19.71 29.76 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.724 2.283 . . . . 0.0 111.791 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.36 31.07 5.61 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.655 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -115.5 116.33 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.776 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 37.0 m-20 -85.11 3.51 38.61 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.658 0.783 . . . . 0.0 112.299 -175.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.517 ' HE1' HG23 ' A' ' 18' ' ' ILE . 86.0 t80 -40.95 -51.08 3.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.282 1.033 . . . . 0.0 112.899 172.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.411 ' HE3' ' HB3' ' A' ' 53' ' ' LEU . 86.1 m95 -71.66 -23.21 61.63 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.236 -175.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.776 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 2.9 mpt_? -79.12 -42.63 25.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.957 0.903 . . . . 0.0 110.219 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.14 -49.78 16.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.957 0.903 . . . . 0.0 110.649 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.1 -31.54 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.329 0.652 . . . . 0.0 109.655 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.03 -40.54 88.58 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.485 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -62.72 -39.68 94.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.833 0.853 . . . . 0.0 109.753 172.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . . . -72.62 -30.06 64.01 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.892 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.5 pt -102.75 -4.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.58 38.59 86.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.314 0.384 . . . . 0.0 113.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -137.15 136.26 38.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.111 1.364 . . . . 0.0 108.265 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 56' ' ' MET . 14.8 p-10 -74.38 87.07 2.02 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.307 0.575 . . . . 0.0 109.866 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.411 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 92.0 mt -68.14 -51.85 41.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -46.87 -39.34 11.91 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.528 1.531 . . . . 0.0 113.258 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.45 -33.15 48.62 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.434 1.093 . . . . 0.0 111.343 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.523 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.0 mtt -66.01 151.58 46.51 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 123.103 0.561 . . . . 0.0 111.842 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.15 157.39 37.69 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.491 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.498 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 21.2 t80 -43.63 -56.43 3.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.968 1.307 . . . . 0.0 113.862 -171.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.07 -31.49 72.74 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.923 0.489 . . . . 0.0 111.668 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -72.53 -52.15 16.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 0.0 111.439 -175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 6.4 ptmt -61.54 -32.6 72.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.528 0.731 . . . . 0.0 112.491 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 89.8 mt -64.84 -42.99 94.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.438 0.695 . . . . 0.0 111.504 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.25 -40.75 95.2 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.936 0.495 . . . . 0.0 110.853 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.404 ' HA ' ' CD2' ' A' ' 67' ' ' HIS . 17.8 m -60.8 -41.23 95.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.105 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 90.4 mt -61.35 -46.93 88.16 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.828 0.705 . . . . 0.0 110.782 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.517 ' HZ3' ' HB2' ' A' ' 11' ' ' ASP . 23.0 mttm -65.77 -28.0 68.7 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.016 0.926 . . . . 0.0 112.617 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.404 ' CD2' ' HA ' ' A' ' 64' ' ' THR . 12.2 m-70 -57.54 -43.28 84.26 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.319 0.581 . . . . 0.0 111.061 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -90.69 11.41 22.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.417 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER 66.66 39.28 3.7 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.09 1.356 . . . . 0.0 111.26 174.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 69.1 mt -109.72 131.56 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.01 152.83 17.15 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 171.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.5 mt -116.98 137.58 52.12 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.494 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.6 t90 -165.6 -169.1 1.47 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -140.59 171.92 13.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.741 0.816 . . . . 0.0 110.852 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.547 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 78.9 t -88.15 -56.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 123.841 0.857 . . . . 0.0 109.616 176.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.67 104.37 16.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.113 0.565 . . . . 0.0 110.22 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.72 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.6 ptmt -71.34 -14.74 62.29 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.758 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 93' ' ' GLU . . . -149.89 123.91 9.39 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.506 ' HA3' HD21 ' A' ' 22' ' ' LEU . . . -128.7 125.8 5.09 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 2' ' ' ILE . 30.3 t -149.2 168.48 23.13 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 110.315 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 85' ' ' GLN . 30.0 ptt180 -141.55 162.83 34.54 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.66 149.62 23.93 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.375 0.422 . . . . 0.0 110.937 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.71 -91.71 1.58 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.299 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 t -157.13 51.32 0.47 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.265 1.026 . . . . 0.0 108.552 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 81' ' ' ARG . 9.1 tp-100 -89.43 130.68 35.74 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.966 -175.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.08 -39.22 50.49 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.757 0.823 . . . . 0.0 109.948 176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.0 t -67.76 111.09 4.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.844 0.715 . . . . 0.0 109.398 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -65.64 -38.78 90.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.984 0.913 . . . . 0.0 110.029 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mt -97.6 85.79 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.93 -59.05 1.82 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.89 142.51 1.32 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.097 1.359 . . . . 0.0 114.124 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -111.01 24.27 13.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.167 -161.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.72 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.5 tp10 -80.83 102.76 10.22 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.6 153.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.126 0.971 . . . . 0.0 110.622 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -80.56 151.9 28.89 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.37 1.068 . . . . 0.0 110.161 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.94 119.87 24.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.547 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.5 m-85 -104.28 -19.48 14.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.655 0.782 . . . . 0.0 111.582 -175.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 p -62.89 -19.89 64.61 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.29 -19.24 53.45 Favored Glycine 0 C--N 1.356 1.648 0 CA-C-O 119.773 -0.46 . . . . 0.0 112.484 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -38.89 -45.98 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.996 1.318 . . . . 0.0 113.727 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -65.87 -20.79 66.36 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -163.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -74.25 -45.21 49.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.515 0.726 . . . . 0.0 110.85 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -90.77 -18.16 25.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 13.6 m -130.12 90.06 43.32 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 121.348 0.594 . . . . 0.0 110.566 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.92 -36.59 2.53 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.116 1.878 . . . . 0.0 111.17 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 13.4 mmmm -81.1 -9.15 59.86 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 123.895 0.878 . . . . 0.0 112.551 -171.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 38.2 tp -58.36 104.28 0.2 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.848 0.718 . . . . 0.0 110.791 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 106' ' ' LYS . 23.6 mtp180 -98.33 -42.89 7.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.604 0.762 . . . . 0.0 110.019 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 37.9 tp -128.93 139.77 51.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.133 0.573 . . . . 0.0 110.531 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.45 127.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.3 m -106.98 115.56 30.4 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.291 0.636 . . . . 0.0 109.717 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 95.6 m-85 -89.16 114.61 25.92 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.451 0.7 . . . . 0.0 109.819 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.53 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 11.8 t-20 -83.11 89.54 6.95 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.87 144.56 8.82 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.335 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.45 -37.66 81.68 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.052 0.941 . . . . 0.0 112.358 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -60.06 -31.63 70.17 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.17 -43.56 56.86 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.323 0.582 . . . . 0.0 109.512 170.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -9.73 52.79 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.281 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.9 -35.64 66.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.326 0.65 . . . . 0.0 111.113 171.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.07 23.79 12.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.72 1.208 . . . . 0.0 110.945 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.52 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -65.29 -55.96 22.58 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.386 0.675 . . . . 0.0 111.29 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.6 -16.35 34.01 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.714 1.61 . . . . 0.0 112.035 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.53 -43.76 88.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.971 0.909 . . . . 0.0 109.977 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.551 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 8.1 mt -82.27 -9.88 59.32 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.813 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 75.5 mtt180 -67.56 -22.07 65.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.312 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.28 69.29 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.823 0.702 . . . . 0.0 113.481 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.551 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -84.18 7.09 20.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.462 0.705 . . . . 0.0 111.094 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.1 28.33 68.57 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 116.876 -0.147 . . . . 0.0 112.738 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 21.0 m-85 -108.43 145.46 34.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.602 0.761 . . . . 0.0 110.866 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -79.72 139.12 37.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.52 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 51.4 p -134.85 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.914 0.486 . . . . 0.0 110.57 -174.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -140.32 130.59 25.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 -174.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.13 113.02 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 111' ' ' CYS . 85.5 mt -96.49 150.8 37.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 166.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.35 167.42 23.96 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.118 1.879 . . . . 0.0 111.277 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.9 t -62.52 115.03 3.9 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.3 p -75.21 5.9 4.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.286 0.634 . . . . 0.0 112.359 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.9 p -62.23 152.58 33.01 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.854 0.862 . . . . 0.0 110.919 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.29 65.72 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.737 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.07 -23.64 51.94 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.814 0.846 . . . . 0.0 111.705 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -110.23 4.51 21.01 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.97 0.908 . . . . 0.0 110.314 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -59.95 -34.67 73.58 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.325 0.65 . . . . 0.0 111.152 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.85 -37.4 63.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 111.595 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.26 -25.51 15.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.699 0.8 . . . . 0.0 111.009 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -80.45 22.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.545 ' HZ3' ' HB2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -61.98 -67.84 0.38 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.021 0.928 . . . . 0.0 110.952 177.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.48 -10.74 27.51 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.084 0.954 . . . . 0.0 113.142 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.421 ' O ' ' HD1' ' A' ' 152' ' ' TRP . 35.1 mmt180 -86.34 -18.75 31.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.301 0.64 . . . . 0.0 110.489 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -54.39 -36.52 64.01 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.244 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -62.19 -46.35 89.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.418 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.35 -30.67 63.48 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 119.462 -0.304 . . . . 0.0 110.471 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.421 ' HD1' ' O ' ' A' ' 148' ' ' ARG . 44.3 m95 -66.29 -43.3 86.74 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -59.13 -42.72 91.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.083 0.864 . . . . 0.0 109.512 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.33 77.45 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 124.242 0.963 . . . . 0.0 111.522 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.411 HG23 HD21 ' A' ' 134' ' ' LEU . 36.6 t -62.5 -34.6 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.959 0.903 . . . . 0.0 111.936 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 83.6 m-85 -110.24 2.42 19.24 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -65.7 -40.91 92.78 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.368 1.067 . . . . 0.0 110.793 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.414 ' CE1' HD11 ' A' ' 16' ' ' ILE . 19.5 p-80 -69.84 -6.79 34.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 112.424 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.4 -18.11 60.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.907 0.483 . . . . 0.0 111.051 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -89.43 -3.39 58.43 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 122.434 0.294 . . . . 0.0 110.237 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 . . . . . 0 N--CA 1.484 1.262 0 C-N-CA 126.123 1.769 . . . . 0.0 111.048 177.657 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.3 mm -64.97 120.2 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.683 0.793 . . . . 0.0 111.218 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' HG3' ' HD2' ' A' ' 81' ' ' ARG . 74.3 mmtt -110.11 116.28 31.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.398 1.079 . . . . 0.0 108.701 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -83.26 135.38 34.77 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 122.704 0.402 . . . . 0.0 110.233 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.4 150.17 44.8 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.817 0.698 . . . . 0.0 112.952 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -79.17 132.42 63.22 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 147.83 22.1 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.287 2.658 . . . . 0.0 112.275 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.95 133.19 50.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.039 0.536 . . . . 0.0 111.597 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG13 HD21 ' A' ' 62' ' ' LEU . 94.6 t -95.59 88.07 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.524 HD12 HD11 ' A' ' 17' ' ' LEU . 18.0 tp -136.58 149.54 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -163.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -128.99 163.79 24.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.407 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.16 -12.44 61.19 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.943 0.897 . . . . 0.0 112.567 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.3 12.44 37.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.217 0.607 . . . . 0.0 111.42 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -75.79 118.75 18.93 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 108' ' ' ARG . 56.7 mt-10 -93.49 -33.75 13.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.366 1.067 . . . . 0.0 111.366 -177.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mt -126.72 120.22 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.524 HD11 HD12 ' A' ' 10' ' ' LEU . 63.0 tp -104.57 121.77 44.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 111' ' ' CYS . 48.6 mt -99.55 109.65 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.659 0.784 . . . . 0.0 109.378 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.59 118.49 31.44 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -74.38 0.32 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.895 0.747 . . . . 0.0 113.121 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' A' ' 117' ' ' ALA . 10.8 p 151.25 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -165.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.7 136.23 14.27 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 164.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 129.75 36.47 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.078 1.852 . . . . 0.0 111.917 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.7 p -69.04 140.21 54.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -49.84 -42.77 48.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.214 1.005 . . . . 0.0 112.848 -174.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 11.8 tp10 -63.38 -29.53 70.82 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -74.39 -33.26 62.99 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.5 mt -74.47 -14.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.064 0.946 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.502 ' HG2' ' HA ' ' A' ' 26' ' ' GLU . 2.5 mmp_? -66.18 -35.28 80.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.62 -3.28 26.91 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.759 0.824 . . . . 0.0 111.484 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.48 18.98 9.91 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.008 1.323 . . . . 0.0 114.034 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -146.18 161.14 40.89 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -71.61 -12.95 61.61 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.524 1.129 . . . . 0.0 110.91 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.514 ' HD1' ' HZ2' ' A' ' 61' ' ' LYS . 85.0 t80 -87.2 -9.16 55.89 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.831 1.252 . . . . 0.0 109.731 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.3 -44.3 20.53 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 124.499 1.124 . . . . 0.0 115.589 -170.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -125.95 115.53 24.23 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -63.06 99.26 0.22 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.484 2.123 . . . . 0.0 108.196 154.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.7 -38.1 0.57 Allowed Glycine 0 C--O 1.241 0.541 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.575 -164.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -72.77 105.5 4.36 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 167.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.85 6.92 14.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.951 0.9 . . . . 0.0 111.938 -168.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -44.11 -43.09 6.71 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.857 0.863 . . . . 0.0 111.975 166.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -75.16 -21.96 58.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 112.158 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.71 -53.53 8.4 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.758 0.823 . . . . 0.0 110.471 170.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -69.84 -47.94 60.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.861 0.864 . . . . 0.0 111.535 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.45 -31.93 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.083 0.553 . . . . 0.0 109.876 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.39 -38.26 93.43 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.323 0.389 . . . . 0.0 112.689 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -72.22 -36.71 69.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.305 1.042 . . . . 0.0 110.198 174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 156' ' ' PHE . . . -63.54 -42.28 98.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.573 0.749 . . . . 0.0 112.52 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -94.08 -15.17 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.642 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 35.31 61.12 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -136.14 127.69 28.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -70.0 89.76 0.62 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.014 0.911 . . . . 0.0 110.98 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -74.68 -0.44 18.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.76 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -84.6 -39.22 18.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.646 0.379 . . . . 0.0 111.18 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -99.12 0.37 43.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.693 0.797 . . . . 0.0 112.089 -166.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -90.78 141.77 28.46 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.033 0.533 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.51 147.23 53.59 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.715 0.634 . . . . 0.0 109.373 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.474 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 56.0 t80 -45.28 -51.62 10.67 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.539 1.135 . . . . 0.0 113.776 -169.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.78 -46.15 90.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.826 0.851 . . . . 0.0 111.63 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -66.04 -38.89 89.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.652 0.781 . . . . 0.0 110.572 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.514 ' HZ2' ' HD1' ' A' ' 34' ' ' TYR . 30.9 ttmt -59.94 -40.42 88.9 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.523 1.129 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.582 HD21 HG13 ' A' ' 9' ' ' VAL . 27.0 mt -61.13 -49.03 78.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.355 174.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.16 -29.2 70.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.757 0.823 . . . . 0.0 111.516 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.481 ' HA ' ' HD2' ' A' ' 67' ' ' HIS . 85.1 m -62.19 -50.02 73.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 0.0 109.985 170.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.78 -40.34 79.61 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.046 0.841 . . . . 0.0 109.961 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.492 ' HE3' HG12 ' A' ' 9' ' ' VAL . 2.3 mptm? -59.39 -39.04 82.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.71 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.481 ' HD2' ' HA ' ' A' ' 64' ' ' THR . 79.8 m-70 -55.44 -41.18 72.48 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 122.72 0.408 . . . . 0.0 111.367 173.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -90.12 2.18 55.58 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.983 0.913 . . . . 0.0 111.05 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.32 36.76 8.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.847 1.259 . . . . 0.0 110.868 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -104.05 132.93 49.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.795 1.238 . . . . 0.0 108.66 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.05 159.88 13.77 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 172.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 87.6 mt -122.53 143.87 49.45 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.839 0.856 . . . . 0.0 108.872 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -163.71 -168.59 1.68 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 171.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -125.84 179.88 4.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.276 0.63 . . . . 0.0 110.34 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 92.4 t -90.66 -44.49 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 109.884 175.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -99.26 133.19 43.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.874 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 88.4 tttt -78.56 -25.11 45.29 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.671 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.24 136.43 11.9 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.297 0.639 . . . . 0.0 110.025 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.648 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -145.73 130.17 3.68 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.4 t -88.39 106.21 18.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.367 1.083 . . . . 0.0 109.535 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.465 ' HD2' ' HG3' ' A' ' 3' ' ' LYS . 95.2 mtt-85 -85.68 108.83 18.21 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -78.79 152.59 31.31 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.847 0.717 . . . . 0.0 110.816 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.59 -19.55 73.05 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 120.404 -0.109 . . . . 0.0 113.252 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.7 m -84.3 -173.47 4.74 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.257 1.023 . . . . 0.0 111.759 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.1 -16.97 64.66 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.902 0.881 . . . . 0.0 111.756 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.4 52.08 2.27 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.369 1.08 . . . . 0.0 110.209 170.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.9 p -83.14 29.63 0.48 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.264 -1.334 . . . . 0.0 111.7 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.03 -163.35 1.0 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.989 0.915 . . . . 0.0 109.723 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.508 HD13 ' HD2' ' A' ' 116' ' ' LYS . 37.1 mt -84.18 79.88 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.16 62.63 4.31 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.247 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.648 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.4 t70 -175.25 156.57 2.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -120.73 21.44 11.48 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 0.0 111.062 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.9 tp10 -85.39 109.14 18.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.49 137.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.077 0.951 . . . . 0.0 109.741 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -59.72 142.11 53.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 111.177 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.23 91.78 0.74 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.52 0.728 . . . . 0.0 111.295 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.52 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 21.6 m-85 -80.18 -13.14 59.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.244 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.1 p -57.03 -31.64 65.35 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.736 0.815 . . . . 0.0 111.154 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.94 -4.24 69.51 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.134 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -51.67 -39.5 58.33 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.181 0.991 . . . . 0.0 112.749 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.543 ' HA ' ' HH ' ' A' ' 129' ' ' TYR . 46.4 mtpt -56.8 -34.77 68.01 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.419 0.688 . . . . 0.0 111.894 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.79 -46.71 8.39 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.822 0.849 . . . . 0.0 112.031 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptm -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.482 0.713 . . . . 0.0 111.804 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.7 m -121.22 85.92 42.38 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 123.527 0.731 . . . . 0.0 109.189 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.77 -32.54 7.33 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.56 2.173 . . . . 0.0 112.3 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.606 ' HA ' ' HZ2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -86.15 1.9 48.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 -177.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 42.6 tp -58.14 115.13 2.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.698 0.799 . . . . 0.0 112.223 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.424 ' HD3' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -107.6 -40.06 5.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.651 168.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.06 131.95 37.61 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.118 0.567 . . . . 0.0 110.496 -171.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.436 ' HB ' HG21 ' A' ' 131' ' ' THR . 54.3 mt -102.54 145.08 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.595 ' HB2' HG12 ' A' ' 18' ' ' ILE . 76.9 m -124.56 116.22 22.1 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.346 0.521 . . . . 0.0 110.425 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.417 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 97.9 m-85 -96.72 128.07 43.31 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.646 1.178 . . . . 0.0 110.377 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -97.25 78.86 2.76 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.448 0.642 . . . . 0.0 110.412 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.1 152.48 5.76 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.052 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -65.76 -40.25 91.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.241 0.616 . . . . 0.0 110.604 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.508 ' HD2' HD13 ' A' ' 89' ' ' ILE . 4.7 tmtm? -60.07 -37.12 78.95 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.163 175.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -67.82 -41.75 82.59 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.98 172.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.7 -9.85 59.78 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 114.815 -1.084 . . . . 0.0 114.232 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.61 -33.12 74.9 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.069 0.548 . . . . 0.0 110.566 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -98.87 13.59 31.95 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.968 . . . . 0.0 111.359 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.515 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -67.34 -54.64 18.11 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.57 0.748 . . . . 0.0 111.629 177.274 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.94 -15.61 43.94 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.713 1.609 . . . . 0.0 113.143 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.43 -48.64 76.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.453 0.701 . . . . 0.0 110.886 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.513 ' HB2' HG22 ' A' ' 131' ' ' THR . 17.2 mt -82.12 -9.41 59.54 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.386 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -68.03 -28.59 67.53 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.812 0.445 . . . . 0.0 110.332 165.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.51 -19.35 64.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.53 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.4 mtt -94.07 12.15 27.39 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.098 0.959 . . . . 0.0 111.369 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.98 18.23 79.0 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.727 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.543 ' HH ' ' HA ' ' A' ' 101' ' ' LYS . 23.7 m-85 -110.88 131.52 54.98 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.919 0.488 . . . . 0.0 110.706 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.61 140.97 51.76 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.515 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 16.3 p -132.8 151.78 51.93 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.952 0.901 . . . . 0.0 109.848 -172.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -134.94 123.58 23.6 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.044 0.538 . . . . 0.0 110.266 -175.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.6 t -83.11 98.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' A' ' 111' ' ' CYS . 69.8 mt -90.88 156.88 44.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.456 ' HD3' ' CZ ' ' A' ' 148' ' ' ARG . 84.2 Cg_endo -71.02 165.03 33.71 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.985 1.79 . . . . 0.0 110.616 177.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 40.6 t -63.93 117.39 6.93 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 170.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.9 p -77.74 19.03 0.41 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.346 0.658 . . . . 0.0 112.578 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.7 p -77.26 153.1 34.29 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.895 0.878 . . . . 0.0 108.905 170.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -9.89 51.2 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.635 0.614 . . . . 0.0 114.635 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.06 -6.85 56.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 111.795 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -123.05 -2.64 8.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.696 0.798 . . . . 0.0 110.59 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -75.6 -10.01 59.08 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 120.996 0.427 . . . . 0.0 111.727 -169.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.38 -26.85 13.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.674 1.189 . . . . 0.0 113.463 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -103.29 -5.37 23.12 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 0.0 110.911 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.622 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 66.3 m -88.14 0.36 56.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.654 0.781 . . . . 0.0 111.968 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.26 -70.96 0.09 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.63 0.772 . . . . 0.0 109.906 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.9 -12.05 59.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.112 0.565 . . . . 0.0 111.535 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 74.4 ttt180 -87.51 -11.71 48.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.395 0.678 . . . . 0.0 110.58 -172.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.49 -23.76 64.77 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.009 0.524 . . . . 0.0 111.298 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.8 t -66.96 -36.33 81.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.031 0.932 . . . . 0.0 109.85 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -67.42 -44.69 78.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.554 0.742 . . . . 0.0 110.223 175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -60.06 -44.35 94.79 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.115 0.884 . . . . 0.0 109.184 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -60.6 -42.25 96.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.489 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.59 -37.95 70.95 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.4 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 52.4 t -59.06 -34.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.115 0.966 . . . . 0.0 111.286 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 57.1 m-85 -107.98 -8.75 15.81 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -75.16 -48.59 22.91 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.1 0.409 . . . . 0.0 110.317 172.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -62.27 -14.56 40.08 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.03 -13.05 22.19 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.706 1.202 . . . . 0.0 112.329 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.23 -7.31 35.48 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.018 0.927 . . . . 0.0 112.304 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.9 t60 . . . . . 0 C--N 1.362 1.132 0 C-N-CA 125.972 1.709 . . . . 0.0 109.375 -175.165 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.773 -0.084 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' A' ' 80' ' ' SER . 44.1 mm -65.07 118.73 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.837 0.855 . . . . 0.0 111.515 -170.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -104.53 116.56 32.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.467 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.1 mmt85 -84.73 133.39 34.37 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.498 0.719 . . . . 0.0 110.027 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.32 -179.79 34.84 Favored Glycine 0 C--O 1.247 0.96 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.739 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.439 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 20.4 m-30 -93.91 139.12 22.56 Favored Pre-proline 0 N--CA 1.47 0.548 0 O-C-N 122.504 -0.41 . . . . 0.0 110.495 -177.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.97 162.34 26.18 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.482 2.122 . . . . 0.0 110.752 163.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.74 133.59 47.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.33 0.652 . . . . 0.0 112.606 -172.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.589 HG12 HD21 ' A' ' 62' ' ' LEU . 84.2 t -93.24 80.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 167.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.459 HD13 ' CG1' ' A' ' 104' ' ' VAL . 37.3 tp -128.24 149.41 50.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.23 -161.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.674 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 34.4 t70 -111.5 153.2 26.53 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -53.66 -48.61 69.27 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.283 0.633 . . . . 0.0 112.305 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -105.8 59.83 0.66 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.779 0.799 . . . . 0.0 111.817 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.49 ' HG1' ' HB3' ' A' ' 11' ' ' ASP . 27.6 m -85.9 135.2 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.37 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.94 -39.57 11.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.836 0.855 . . . . 0.0 111.809 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.408 HD11 ' CE1' ' A' ' 158' ' ' HIS . 44.3 mt -122.31 123.99 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.437 HD12 HD11 ' A' ' 10' ' ' LEU . 51.2 tp -109.37 117.18 33.37 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.489 HG12 ' HB2' ' A' ' 111' ' ' CYS . 43.9 mt -98.56 113.35 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 73' ' ' TRP . 88.2 mt -106.08 122.52 46.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.846 0.858 . . . . 0.0 110.176 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 -154.71 10.84 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 164.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.6 p -119.16 -66.88 1.03 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.067 0.933 . . . . 0.0 108.825 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.8 tp -146.72 119.33 4.92 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.63 158.24 56.85 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.116 1.877 . . . . 0.0 111.053 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -67.94 146.46 53.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.16 0.584 . . . . 0.0 109.436 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.529 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 36.5 t70 -61.81 -27.04 68.48 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.14 0.275 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.91 -31.48 62.91 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.555 0.742 . . . . 0.0 111.249 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 m -86.6 -41.27 14.4 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.744 0.818 . . . . 0.0 110.489 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 72.3 mt -63.73 -32.09 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 124.107 0.963 . . . . 0.0 112.974 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -62.7 -27.43 69.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.495 0.318 . . . . 0.0 111.283 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -91.02 -26.37 19.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.714 0.806 . . . . 0.0 110.596 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 61.51 34.5 17.94 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 125.25 1.42 . . . . 0.0 110.728 -165.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -135.7 133.25 37.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 109.672 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -60.59 -54.83 40.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.751 0.82 . . . . 0.0 110.547 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.429 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 83.7 t80 -65.41 -15.16 62.31 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.618 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.48 -30.33 49.61 Favored Glycine 0 C--N 1.359 1.859 0 O-C-N 123.249 0.343 . . . . 0.0 112.854 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -99.47 106.98 42.87 Favored Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.14 179.61 6.05 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.303 2.002 . . . . 0.0 110.644 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.18 -11.53 65.03 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -170.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 41' ' ' PHE . 28.8 t-20 -80.77 122.78 27.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.893 1.277 . . . . 0.0 109.5 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.06 -3.9 50.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.543 0.737 . . . . 0.0 111.986 -170.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.41 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 87.6 t80 -48.07 -45.24 32.24 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.306 1.042 . . . . 0.0 112.451 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -60.97 -37.03 81.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.482 0.713 . . . . 0.0 111.374 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.62 -41.64 71.96 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.616 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.03 -55.04 25.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.725 0.81 . . . . 0.0 111.057 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 49' ' ' ILE . 63.2 t -66.48 -44.73 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.68 -177.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -34.44 88.61 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.179 0.924 . . . . 0.0 113.975 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -68.33 -43.22 78.02 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.544 0.738 . . . . 0.0 110.313 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 153' ' ' GLU . . . -70.52 -41.35 72.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.005 0.922 . . . . 0.0 112.474 -174.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.464 HD11 ' ND2' ' A' ' 68' ' ' ASN . 17.1 pt -85.12 -14.88 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.23 0.612 . . . . 0.0 110.141 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.14 78.42 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.661 0.601 . . . . 0.0 113.933 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' HG3' HD22 ' A' ' 68' ' ' ASN . 11.6 mm-40 -115.65 142.81 46.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.012 0.925 . . . . 0.0 109.282 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.82 88.83 6.3 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.25 -47.47 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.88 -48.58 81.1 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.747 1.279 . . . . 0.0 112.248 -165.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.37 -32.44 64.5 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.7 137.0 57.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.507 0.323 . . . . 0.0 110.733 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.92 31.51 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.397 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.548 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 42.9 t80 -44.1 -43.75 7.12 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.82 -49.1 78.97 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.816 0.846 . . . . 0.0 111.101 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.1 -34.75 76.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.862 1.265 . . . . 0.0 111.473 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.33 -45.5 94.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.764 1.226 . . . . 0.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.589 HD21 HG12 ' A' ' 9' ' ' VAL . 80.7 mt -63.14 -42.78 99.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 110.816 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -63.08 -31.21 72.3 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.707 0.403 . . . . 0.0 111.339 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -74.4 -28.05 60.91 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.954 0.502 . . . . 0.0 110.948 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.27 -48.36 80.25 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.674 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -57.11 -39.28 74.78 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.617 0.767 . . . . 0.0 111.019 176.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -57.68 -40.58 79.74 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.295 1.038 . . . . 0.0 112.15 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.486 HD22 ' HG3' ' A' ' 51' ' ' GLU . 52.8 m-80 -92.15 4.76 52.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.644 0.378 . . . . 0.0 111.671 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 63.39 40.6 8.32 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.18 1.392 . . . . 0.0 111.15 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.86 138.69 29.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 125.066 1.346 . . . . 0.0 109.065 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.08 154.77 16.41 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 170.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -126.33 134.19 51.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.692 0.797 . . . . 0.0 108.866 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.415 ' HB3' HD22 ' A' ' 19' ' ' LEU . 4.8 t90 -160.71 -170.27 2.69 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -134.75 162.88 31.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.345 1.058 . . . . 0.0 109.236 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 56.0 t -73.39 -48.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 52.6 m-85 -87.45 133.75 33.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.525 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.7 tmmm? -75.17 -32.64 61.33 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.467 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -159.82 152.93 21.89 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.695 0.798 . . . . 0.0 110.817 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.504 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -146.54 128.44 3.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.458 ' HB3' HD13 ' A' ' 2' ' ' ILE . 43.5 p -89.46 119.81 30.23 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -173.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.423 ' HA ' ' NE2' ' A' ' 85' ' ' GLN . 43.4 mtm180 -90.92 102.22 14.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.017 0.527 . . . . 0.0 110.116 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -57.4 -42.42 82.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.078 0.951 . . . . 0.0 110.432 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.81 -71.91 0.18 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.444 176.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.1 m -116.36 88.02 2.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.801 0.84 . . . . 0.0 109.356 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.423 ' NE2' ' HA ' ' A' ' 81' ' ' ARG . 25.2 mt-30 -115.04 -5.22 12.48 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.674 0.79 . . . . 0.0 111.375 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 71.99 -64.92 0.37 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 125.736 1.614 . . . . 0.0 112.756 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.4 t -82.41 7.47 14.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.797 0.839 . . . . 0.0 112.157 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt 78.36 -43.98 0.37 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 125.828 1.651 . . . . 0.0 113.09 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.9 mt -73.66 139.78 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.924 0.89 . . . . 0.0 110.111 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.03 55.32 0.4 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.504 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 18.7 t70 174.77 158.57 0.17 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.577 1.151 . . . . 0.0 108.813 -167.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.86 25.56 10.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.953 0.901 . . . . 0.0 111.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.525 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 6.1 tp10 -79.82 102.81 9.31 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 87.5 mt -114.81 146.81 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.744 1.218 . . . . 0.0 109.735 -173.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -68.26 141.82 55.78 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.833 0.853 . . . . 0.0 108.981 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.17 114.56 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.403 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 62.3 m-85 -100.78 6.37 43.83 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.86 0.464 . . . . 0.0 112.124 -175.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.1 t -63.73 -26.05 68.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 0.0 111.615 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.83 -1.88 84.7 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 118.898 -0.946 . . . . 0.0 114.302 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.453 HD23 ' SD ' ' A' ' 103' ' ' MET . 35.9 mt -50.03 -34.84 22.65 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 117.87 0.835 . . . . 0.0 113.071 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -65.42 -22.43 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -99.33 -45.97 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.515 ' HG3' HG22 ' A' ' 104' ' ' VAL . 17.4 ptm -69.81 -35.85 75.17 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.874 0.87 . . . . 0.0 111.314 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 2.0 m -132.87 88.11 38.49 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.336 0.654 . . . . 0.0 109.698 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.455 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 94.9 Cg_endo -72.59 -25.3 17.76 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.013 2.475 . . . . 0.0 111.771 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.2 mmmt -91.72 -6.65 51.61 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.553 1.141 . . . . 0.0 111.537 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.548 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -58.82 109.62 0.85 Allowed 'General case' 0 C--N 1.356 0.861 0 O-C-N 123.771 0.669 . . . . 0.0 110.253 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -108.38 -40.14 5.23 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.659 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 130' ' ' GLU . 47.7 tp -125.45 130.12 51.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -174.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.6 mt -110.2 116.59 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.909 0.884 . . . . 0.0 108.793 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.492 ' HB3' HD11 ' A' ' 134' ' ' LEU . 68.1 m -97.9 117.33 31.99 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 123.417 0.687 . . . . 0.0 109.699 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 91.2 m-85 -93.34 123.05 36.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.206 0.602 . . . . 0.0 110.57 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -79.95 79.62 6.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.166 0.586 . . . . 0.0 109.564 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.64 175.3 19.98 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.379 -0.828 . . . . 0.0 115.02 169.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 73.5 ttt180 -57.31 -61.04 2.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.709 1.204 . . . . 0.0 111.52 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.24 -27.66 36.22 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.86 0.864 . . . . 0.0 113.316 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.16 -50.74 15.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.443 0.697 . . . . 0.0 109.914 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.17 -10.53 84.26 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.63 -1.168 . . . . 0.0 114.789 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 96.1 mt-10 -66.24 -22.58 66.33 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.667 0.734 . . . . 0.0 110.265 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -103.53 19.63 19.41 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.347 1.059 . . . . 0.0 110.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.513 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 37.2 tt0 -60.68 -51.54 78.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 118.146 -0.931 . . . . 0.0 112.0 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -54.99 -27.56 55.11 Favored 'Trans proline' 0 C--N 1.406 3.563 0 C-N-CA 122.76 2.307 . . . . 0.0 113.571 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -62.2 -42.84 99.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.299 1.04 . . . . 0.0 110.444 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.5 -15.04 25.94 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.633 -172.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.6 mtp85 -66.85 -34.3 77.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.863 0.465 . . . . 0.0 109.975 171.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.44 -13.02 70.5 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.758 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.5 mtt -93.36 12.25 25.43 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.154 0.982 . . . . 0.0 111.292 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.0 27.83 69.68 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.387 0.429 . . . . 0.0 114.028 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.86 137.96 45.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.715 0.406 . . . . 0.0 111.306 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 28.1 mt-10 -65.1 129.83 41.12 Favored 'General case' 0 C--N 1.345 0.406 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 165.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.513 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.9 p -130.66 144.45 51.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.88 0.472 . . . . 0.0 110.16 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -139.64 125.56 19.69 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.095 0.958 . . . . 0.0 109.835 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 46.3 t -87.13 104.62 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 111' ' ' CYS . 74.3 mt -90.14 154.08 46.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.4 145.14 70.33 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 111.164 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.5 t -59.91 107.39 0.61 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.71 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.5 p -57.97 85.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 O-C-N 124.447 1.092 . . . . 0.0 111.04 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.7 t -129.81 161.0 31.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.616 1.566 . . . . 0.0 108.395 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -42.92 95.84 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.414 0.446 . . . . 0.0 112.865 167.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.0 82.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.41 0.684 . . . . 0.0 111.23 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -65.02 -44.4 89.3 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.979 172.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -67.9 -23.54 65.11 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.417 1.073 . . . . 0.0 110.309 -172.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -56.94 -28.34 62.01 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.819 1.247 . . . . 0.0 111.684 171.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -118.17 -20.04 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.301 1.04 . . . . 0.0 111.496 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.2 t -98.28 31.71 2.7 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.834 0.853 . . . . 0.0 110.973 -173.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -65.35 0.68 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.77 -6.94 59.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.642 0.777 . . . . 0.0 111.965 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -85.85 -14.22 45.62 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.318 0.647 . . . . 0.0 110.042 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -51.76 -23.52 4.72 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.862 0.865 . . . . 0.0 112.57 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -63.63 -29.6 70.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.619 0.768 . . . . 0.0 111.376 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 155' ' ' VAL . 8.3 pt-20 -73.22 -35.2 66.27 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -68.03 -35.9 79.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 2.1 tm-20 -70.8 -33.12 70.4 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.751 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.72 -11.95 60.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.858 0.863 . . . . 0.0 112.307 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 151' ' ' GLU . 53.2 t -89.61 -49.17 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.002 0.521 . . . . 0.0 110.29 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 68.4 m-85 -99.36 2.17 45.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -71.19 -35.03 71.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.651 0.66 . . . . 0.0 111.469 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.408 ' CE1' HD11 ' A' ' 16' ' ' ILE . 31.7 p-80 -69.44 -11.77 61.1 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.803 0.441 . . . . 0.0 111.441 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.39 -35.71 71.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.38 -45.81 24.78 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.601 0.761 . . . . 0.0 109.273 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 . . . . . 0 CA--C 1.563 1.468 0 C-N-CA 126.077 1.751 . . . . 0.0 112.518 -176.506 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 120.763 0.316 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm -79.1 129.43 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.102 0.961 . . . . 0.0 110.085 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HB2' HD22 ' A' ' 22' ' ' LEU . 3.4 mptp? -100.1 117.55 34.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -93.38 130.94 38.98 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.974 0.51 . . . . 0.0 111.766 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.87 165.05 45.63 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.942 0.776 . . . . 0.0 112.502 172.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.45 149.23 38.54 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.295 0.638 . . . . 0.0 111.544 -165.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -56.74 137.29 80.64 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.519 2.146 . . . . 0.0 110.311 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 142.99 56.6 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.87 0.731 . . . . 0.0 112.419 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.45 HG13 HD22 ' A' ' 62' ' ' LEU . 59.9 t -91.06 86.61 2.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.25 139.76 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.839 -162.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.89 162.26 23.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.426 1.091 . . . . 0.0 108.353 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.65 -24.39 67.59 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.761 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -104.14 36.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.128 0.571 . . . . 0.0 111.075 -175.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 m -89.53 106.63 18.58 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.268 0.556 . . . . 0.0 110.334 -176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.63 -29.98 17.44 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.95 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.44 HD13 HD13 ' A' ' 159' ' ' LEU . 43.2 mt -123.95 121.49 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 tp -107.98 115.12 29.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.41 HG12 ' HB2' ' A' ' 111' ' ' CYS . 39.9 mt -97.31 119.91 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.328 0.651 . . . . 0.0 109.268 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.414 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 60.7 mt -111.0 115.87 30.22 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.669 0.788 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -70.99 178.32 33.57 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 167.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 p -86.24 -80.28 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 3' ' ' LYS . 45.9 tp -131.68 122.39 18.67 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 171.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.12 149.42 44.13 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.901 2.4 . . . . 0.0 113.25 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.504 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.9 m -60.78 152.2 27.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.693 1.197 . . . . 0.0 111.12 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 54.2 m-20 -58.98 -40.56 85.18 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.185 0.594 . . . . 0.0 111.35 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.04 -25.54 67.88 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.838 1.255 . . . . 0.0 110.506 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.2 m -83.36 -38.59 21.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.718 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 24' ' ' SER . 48.6 mm -61.34 -41.03 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.346 1.058 . . . . 0.0 110.795 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.5 mmm180 -58.68 -30.95 67.77 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.717 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -106.73 -7.51 17.23 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.896 0.878 . . . . 0.0 112.33 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 58.74 30.95 20.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.814 1.246 . . . . 0.0 113.421 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -145.9 141.67 28.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.97 0.908 . . . . 0.0 109.554 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -59.69 -42.73 93.62 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.688 0.795 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -62.14 -12.63 20.72 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.404 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.45 -21.94 55.29 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.277 0.465 . . . . 0.0 113.615 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -115.77 96.69 47.26 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.65 131.87 4.05 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.38 2.72 . . . . 0.0 110.032 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.14 -13.38 5.48 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -171.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -75.17 126.44 31.03 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 171.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -82.18 1.88 34.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.326 0.512 . . . . 0.0 111.025 -169.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -46.52 -44.21 17.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.161 0.984 . . . . 0.0 112.179 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -71.55 -26.42 62.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.813 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -76.58 -40.12 50.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.233 1.013 . . . . 0.0 111.495 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 149' ' ' GLU . 80.3 mt -79.56 -46.71 16.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.59 0.756 . . . . 0.0 110.9 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 49' ' ' ILE . 98.7 t -72.64 -32.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.75 -40.97 93.95 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.804 0.69 . . . . 0.0 112.325 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -67.22 -36.07 80.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.421 0.689 . . . . 0.0 110.113 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 156' ' ' PHE . . . -70.95 -32.33 69.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 45' ' ' VAL . 18.5 pt -103.09 -10.93 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.241 0.617 . . . . 0.0 111.732 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.7 40.99 44.33 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.37 0.419 . . . . 0.0 113.76 177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HB3' ' HE1' ' A' ' 56' ' ' MET . 20.2 mm-40 -134.02 142.63 47.69 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.668 1.187 . . . . 0.0 108.794 -178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -86.48 87.8 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.522 0.677 . . . . 0.0 109.976 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.8 -31.94 67.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.831 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -62.13 -39.19 91.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.639 0.776 . . . . 0.0 112.399 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.38 -36.76 66.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.856 0.462 . . . . 0.0 110.638 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.447 ' HE1' ' HB3' ' A' ' 51' ' ' GLU . 65.3 mtt -57.67 130.39 46.17 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.19 -173.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.63 151.79 19.96 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.479 166.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.475 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 69.1 t80 -48.11 -49.58 31.47 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.501 0.72 . . . . 0.0 112.524 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.24 -40.65 94.32 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.767 0.827 . . . . 0.0 112.249 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.47 -39.49 92.04 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.573 0.702 . . . . 0.0 110.567 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -62.2 -40.59 96.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.011 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 28.8 mt -57.91 -52.33 65.94 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.012 0.82 . . . . 0.0 109.398 174.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -52.52 -46.62 66.78 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.18 0.992 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.42 HG22 ' HE1' ' A' ' 56' ' ' MET . 89.7 m -63.19 -54.74 32.75 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.058 0.943 . . . . 0.0 112.304 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.24 -50.37 70.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.498 0.719 . . . . 0.0 110.739 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -66.0 -32.24 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 112.105 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -60.34 -42.39 95.59 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.546 0.738 . . . . 0.0 110.628 168.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.43 ' O ' HD11 ' A' ' 159' ' ' LEU . 92.0 m-20 -81.32 8.08 9.99 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.984 0.914 . . . . 0.0 110.83 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 68.51 31.57 4.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 0.0 111.161 176.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.7 mt -111.09 136.85 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.489 1.115 . . . . 0.0 109.349 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.55 160.63 19.14 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 74.5 mt -123.6 144.18 49.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.462 0.705 . . . . 0.0 109.187 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.414 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.5 t90 -167.07 -169.27 1.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -137.68 -177.89 5.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.424 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 97.1 t -98.67 -55.48 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.522 0.729 . . . . 0.0 110.289 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -80.46 107.82 13.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.986 0.514 . . . . 0.0 111.552 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -64.53 -36.4 84.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.194 0.998 . . . . 0.0 110.519 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.44 122.95 10.41 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.713 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.89 116.26 1.94 Allowed Glycine 0 C--N 1.33 0.236 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.5 p -88.08 154.28 20.6 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.196 0.598 . . . . 0.0 110.878 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -138.97 96.01 3.05 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -80.89 137.72 36.16 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.756 169.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.73 -24.26 71.16 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 123.315 0.384 . . . . 0.0 112.868 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -85.17 -1.83 57.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.918 0.887 . . . . 0.0 112.026 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -114.31 132.97 55.99 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.097 0.959 . . . . 0.0 109.523 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.55 2.83 27.35 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.799 0.84 . . . . 0.0 111.665 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.6 m -83.91 130.96 34.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.911 0.484 . . . . 0.0 110.066 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -76.49 -44.98 32.97 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.8 0.84 . . . . 0.0 108.999 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.5 mt -115.77 88.63 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.417 -1.265 . . . . 0.0 107.94 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.44 -75.9 1.13 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -38.96 137.79 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.214 1.406 . . . . 0.0 114.208 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.24 28.08 7.65 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.491 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -75.64 106.09 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.2 mm -97.4 155.27 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.22 0.608 . . . . 0.0 110.013 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -78.7 158.33 28.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.868 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.6 121.69 24.97 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.424 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 58.9 m-85 -117.71 -0.01 11.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.2 p -74.96 -19.59 60.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.13 79.1 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.575 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 69.2 mt -52.93 -29.43 28.63 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 123.444 0.698 . . . . 0.0 112.855 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.492 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 36.8 mtpt -65.09 -27.6 68.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -85.59 -55.28 4.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.196 0.998 . . . . 0.0 111.405 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 ptm -74.52 -33.82 62.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.21 0.604 . . . . 0.0 112.594 -169.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.1 m -127.08 90.77 48.46 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.221 0.608 . . . . 0.0 110.933 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.93 -32.54 2.55 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.512 2.141 . . . . 0.0 112.325 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.761 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 8.1 mmpt? -76.51 -9.49 58.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 112.241 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.2 tp -59.97 112.46 1.88 Allowed 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.687 0.617 . . . . 0.0 111.218 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -101.71 -45.38 5.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.413 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 132' ' ' LYS . 40.8 tp -134.39 133.49 40.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.2 mt -105.53 115.76 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.161 0.984 . . . . 0.0 108.487 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.475 ' HB3' HD12 ' A' ' 134' ' ' LEU . 80.0 m -98.97 116.15 30.55 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.022 0.529 . . . . 0.0 110.466 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.22 127.98 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.702 0.801 . . . . 0.0 110.195 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.494 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 14.4 m120 -90.2 102.28 15.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.59 155.05 29.89 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.586 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 78.6 ttt180 -55.84 -48.05 76.17 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.4 1.08 . . . . 0.0 112.359 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.25 -29.61 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.45 27.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 173.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.82 -9.55 62.8 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.874 -1.057 . . . . 0.0 114.597 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 115' ' ' ARG . 15.2 mm-40 -62.13 -19.97 63.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.56 0.744 . . . . 0.0 111.703 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -110.13 22.11 15.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 110.674 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.8 tt0 -59.02 -55.84 42.34 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.367 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.29 -17.71 23.98 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.458 1.438 . . . . 0.0 111.801 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.5 -48.1 78.97 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 109.83 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.502 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 6.7 mt -84.17 -16.64 42.75 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.533 -176.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 7.9 ttt180 -73.54 -17.81 61.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 176.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.88 -16.66 78.19 Favored Glycine 0 C--N 1.355 1.637 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.021 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.502 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -83.38 4.55 26.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.633 0.773 . . . . 0.0 111.197 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.97 14.56 72.07 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.542 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 36.2 m-85 -110.95 130.43 55.59 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.305 0.642 . . . . 0.0 111.222 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.42 139.1 58.74 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 15.2 p -128.13 147.01 50.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.553 0.741 . . . . 0.0 109.967 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.499 ' HB2' HD13 ' A' ' 109' ' ' LEU . 51.9 tptt -140.38 124.72 17.76 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 109.164 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.0 t -90.39 118.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.6 mt -102.9 147.79 34.62 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.19 167.45 16.31 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.328 2.019 . . . . 0.0 112.87 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.7 m -65.46 126.55 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.48 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.6 m -77.12 12.75 1.31 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.028 0.931 . . . . 0.0 112.94 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 m -72.93 145.8 46.54 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.862 0.865 . . . . 0.0 109.975 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.57 -26.9 71.2 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-O 121.298 0.388 . . . . 0.0 112.185 173.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.97 -10.87 54.04 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.501 1.121 . . . . 0.0 112.667 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -119.17 -15.85 9.15 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.764 0.826 . . . . 0.0 109.216 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.695 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 39.6 ttp85 -83.54 -17.74 40.8 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.629 0.772 . . . . 0.0 110.705 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.7 mtp-105 -61.14 -27.12 68.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.701 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -106.46 -28.92 10.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.233 1.013 . . . . 0.0 110.12 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.695 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 23.1 t -81.49 37.73 0.47 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.176 0.991 . . . . 0.0 111.501 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 54.0 mtmt -69.82 -54.11 15.11 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.744 0.818 . . . . 0.0 110.626 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.39 -15.04 57.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 5.0 mpt_? -88.44 -13.73 39.69 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.107 0.563 . . . . 0.0 111.459 -174.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.514 ' HB2' HD23 ' A' ' 44' ' ' LEU . 12.9 pt-20 -80.42 -22.66 40.97 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 120.654 0.264 . . . . 0.0 110.605 172.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -66.5 -28.49 68.61 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.426 0.69 . . . . 0.0 111.309 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.8 pt-20 -71.27 -21.37 62.1 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 122.848 0.459 . . . . 0.0 110.819 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -67.52 -42.09 83.33 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.724 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.63 -36.45 78.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.7 63.65 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.782 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.437 HG12 ' SG ' ' A' ' 111' ' ' CYS . 45.8 t -89.54 -45.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.583 0.753 . . . . 0.0 111.195 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 72.0 m-85 -96.46 -20.36 18.47 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -166.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -76.18 -6.13 49.9 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.85 1.205 . . . . 0.0 113.156 -171.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -73.54 -5.83 42.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.986 -0.447 . . . . 0.0 110.632 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.44 HD13 HD13 ' A' ' 16' ' ' ILE . 39.1 mt -87.57 -17.41 32.03 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.44 1.096 . . . . 0.0 108.787 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.59 -44.29 10.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.625 1.17 . . . . 0.0 109.904 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 70.4 m80 . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 125.46 1.504 . . . . 0.0 110.771 -175.769 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.521 ' HB3' ' HB2' ' A' ' 81' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mm -74.14 125.27 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.066 0.546 . . . . 0.0 110.279 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -107.97 114.18 27.9 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 168.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.49 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.3 mmt85 -78.69 129.73 35.03 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.821 0.701 . . . . 0.0 109.995 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.62 151.03 52.23 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -80.6 145.32 58.37 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.787 0.294 . . . . 0.0 111.269 -167.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.5 149.17 68.18 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.322 2.015 . . . . 0.0 110.248 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 131.93 50.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.247 0.619 . . . . 0.0 112.58 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.665 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 57.7 t -89.92 86.15 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.49 HD23 HG13 ' A' ' 104' ' ' VAL . 19.9 tp -144.41 153.67 42.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -160.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -128.27 168.32 15.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.433 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.47 -13.65 61.1 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.446 0.698 . . . . 0.0 112.277 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.86 38.09 2.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.616 . . . . 0.0 111.464 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.591 ' HB ' HG11 ' A' ' 104' ' ' VAL . 94.9 m -101.61 130.96 48.05 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.458 0.303 . . . . 0.0 110.899 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -98.2 -39.7 8.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.258 1.023 . . . . 0.0 111.21 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.609 HD13 HD12 ' A' ' 159' ' ' LEU . 51.9 mt -120.21 119.81 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 tp -106.94 118.21 36.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -94.43 109.94 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -98.0 109.3 22.08 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.8 -168.92 3.4 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 169.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 p -103.76 -76.12 0.6 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.518 HD22 HG22 ' A' ' 89' ' ' ILE . 31.1 tp -155.34 121.78 2.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 22' ' ' LEU . 9.8 Cg_exo -72.23 151.59 54.93 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.949 2.433 . . . . 0.0 112.707 -174.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 28' ' ' ILE . 18.3 m -67.31 157.77 33.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.088 0.955 . . . . 0.0 111.092 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.17 -24.57 67.95 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.14 -45.33 95.08 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.549 0.74 . . . . 0.0 110.437 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 m -68.53 -41.13 80.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.307 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 24' ' ' SER . 19.2 mm -57.35 -34.96 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 124.265 0.978 . . . . 0.0 111.647 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -58.11 -38.0 75.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.116 0.566 . . . . 0.0 112.258 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -94.77 -17.01 22.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.252 0.621 . . . . 0.0 111.168 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 64.19 30.34 13.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.514 1.125 . . . . 0.0 111.264 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -145.68 143.64 29.91 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.784 0.834 . . . . 0.0 109.851 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.32 -41.68 97.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.181 0.992 . . . . 0.0 110.113 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.25 -24.16 62.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.733 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.5 -14.4 41.97 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.368 0.418 . . . . 0.0 113.725 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.25 104.59 30.7 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.851 0.86 . . . . 0.0 109.468 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.42 97.79 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.27 2.646 . . . . 0.0 109.539 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.08 -30.14 0.72 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -170.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -67.45 103.65 1.36 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.049 0.94 . . . . 0.0 108.467 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -84.83 -0.94 55.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.418 0.687 . . . . 0.0 112.01 -166.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -42.78 -46.1 5.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.22 1.408 . . . . 0.0 113.135 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -79.4 -18.66 51.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.87 0.868 . . . . 0.0 111.254 -170.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -72.72 -47.71 44.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.114 0.565 . . . . 0.0 110.12 167.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.7 -46.63 71.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.962 0.905 . . . . 0.0 111.413 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.9 t -73.68 -41.46 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.66 0.784 . . . . 0.0 109.685 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.92 91.2 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.793 0.683 . . . . 0.0 112.453 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -66.77 -45.1 79.57 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.288 1.035 . . . . 0.0 109.83 174.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 153' ' ' GLU . . . -67.03 -36.64 82.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.815 0.846 . . . . 0.0 112.816 -173.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.2 pt -93.78 -11.26 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.164 0.585 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.61 78.8 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.25 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.33 117.4 18.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.48 96.56 2.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.359 0.664 . . . . 0.0 110.432 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.34 -22.16 61.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.285 1.034 . . . . 0.0 113.035 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -19.87 59.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -168.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -85.18 -36.18 21.2 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.425 0.557 . . . . 0.0 110.325 169.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.1 mtt -63.18 120.55 11.73 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.553 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 160.07 2.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.087 0.555 . . . . 0.0 110.884 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.589 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 47.5 t80 -42.23 -53.59 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.708 0.803 . . . . 0.0 112.85 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 37.2 mt-10 -60.05 -35.78 75.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.635 0.774 . . . . 0.0 112.295 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.02 -48.88 13.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.944 0.897 . . . . 0.0 112.092 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -59.6 -34.96 73.4 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.837 0.455 . . . . 0.0 112.203 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 15.3 mt -64.94 -41.35 95.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.54 0.336 . . . . 0.0 110.492 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 47.7 mmtm -56.83 -37.37 71.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.273 0.629 . . . . 0.0 110.835 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -64.35 -44.16 92.32 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 123.754 0.658 . . . . 0.0 110.741 177.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.65 -57.33 13.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.56 0.744 . . . . 0.0 111.538 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -21.77 60.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -60.07 -40.29 89.01 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 110.442 165.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -86.59 7.57 25.8 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.99 0.916 . . . . 0.0 110.676 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 68.69 29.89 5.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.495 1.518 . . . . 0.0 110.864 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.5 mt -102.29 133.95 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.518 1.127 . . . . 0.0 108.838 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.81 158.15 18.33 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.665 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 66.6 mt -126.39 143.3 51.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.681 0.792 . . . . 0.0 108.995 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.65 -171.54 2.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.13 169.71 10.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 52.8 t -83.93 -34.97 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.268 0.627 . . . . 0.0 109.534 169.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 55.2 m-85 -101.92 141.65 34.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.846 0.458 . . . . 0.0 111.153 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.639 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 6.7 tmtm? -81.1 -41.87 21.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.953 0.901 . . . . 0.0 108.898 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.49 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -156.47 150.82 25.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.937 0.895 . . . . 0.0 109.768 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -160.23 139.7 6.28 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 t -97.54 167.1 11.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.527 0.679 . . . . 0.0 111.935 -168.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.521 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 22.4 mmm180 -115.46 94.19 4.6 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 167.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 179.0 149.81 0.26 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.88 -5.55 83.54 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.655 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 37.9 t -178.42 137.11 0.16 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 126.349 1.859 . . . . 0.0 106.659 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -64.77 -36.88 85.75 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -105.02 22.6 15.02 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.878 0.871 . . . . 0.0 111.371 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.655 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 57.3 p -62.13 99.55 0.14 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 122.809 0.444 . . . . 0.0 110.075 177.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -54.19 -51.4 64.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.574 0.75 . . . . 0.0 110.09 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.518 HG22 HD22 ' A' ' 22' ' ' LEU . 16.0 mt -136.28 78.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.9 57.5 4.29 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.605 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.669 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 10.2 t70 174.17 159.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -119.38 23.82 11.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.612 0.765 . . . . 0.0 112.058 -173.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.639 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 14.9 tp10 -80.4 101.85 9.26 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 54.8 mt -105.97 149.12 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.669 1.188 . . . . 0.0 110.033 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -69.51 147.18 51.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.922 0.889 . . . . 0.0 110.008 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.62 131.8 34.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.418 ' HB2' ' HE3' ' A' ' 127' ' ' MET . 50.3 m-85 -110.0 9.72 24.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.529 0.731 . . . . 0.0 111.779 -175.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 t -69.21 -20.62 63.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.682 0.393 . . . . 0.0 110.843 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -4.52 63.87 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 118.941 -0.921 . . . . 0.0 113.714 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.402 HD23 ' SD ' ' A' ' 103' ' ' MET . 31.1 mt -50.04 -37.3 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -63.73 -31.28 72.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.591 0.356 . . . . 0.0 111.165 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -82.01 -53.12 6.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.817 0.847 . . . . 0.0 111.42 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.472 ' HG3' HG22 ' A' ' 104' ' ' VAL . 23.4 ptm -67.24 -34.95 78.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.534 0.733 . . . . 0.0 111.527 -173.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.591 HG11 ' HB ' ' A' ' 14' ' ' THR . 1.6 m -129.25 84.98 60.77 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.003 0.921 . . . . 0.0 108.857 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.4 -23.74 20.11 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.736 2.29 . . . . 0.0 112.79 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 7.45 38.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.42 0.688 . . . . 0.0 111.827 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 40.2 tp -61.4 125.44 23.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.833 0.349 . . . . 0.0 111.397 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -132.09 -30.58 1.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.13 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.7 tp -130.98 129.61 42.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.047 0.539 . . . . 0.0 110.039 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.56 122.16 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.3 1.04 . . . . 0.0 108.245 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.464 ' HB2' HG12 ' A' ' 18' ' ' ILE . 77.4 m -100.41 114.26 27.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.827 0.451 . . . . 0.0 109.881 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -89.88 115.5 27.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.983 0.913 . . . . 0.0 109.902 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.58 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 23.3 t30 -89.11 99.98 12.85 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.92 0.888 . . . . 0.0 109.124 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.89 156.43 20.8 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.811 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.54 -50.39 72.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.717 1.207 . . . . 0.0 111.681 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -55.06 -31.47 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.0 -43.91 51.14 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.037 0.535 . . . . 0.0 109.757 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.43 -11.43 64.85 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.007 -0.997 . . . . 0.0 114.149 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -60.43 -34.32 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.038 0.535 . . . . 0.0 110.955 170.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -107.16 18.26 21.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.12 0.968 . . . . 0.0 110.743 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.566 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.9 tm-20 -70.4 -48.79 17.71 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.631 0.772 . . . . 0.0 111.197 170.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.23 -28.77 72.88 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 122.322 2.014 . . . . 0.0 113.192 172.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.7 -48.95 79.47 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.645 0.778 . . . . 0.0 111.12 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 14.0 mt -85.61 -5.23 59.3 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -171.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -65.21 -34.44 78.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.75 -14.36 67.45 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.156 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.418 ' HE3' ' HB2' ' A' ' 97' ' ' PHE . 54.9 mtt -90.59 8.0 36.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.806 0.842 . . . . 0.0 111.4 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.48 0.75 89.58 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.33 0.492 . . . . 0.0 114.33 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -92.22 137.4 32.4 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 117.105 0.453 . . . . 0.0 110.331 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.43 131.31 45.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.566 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 49.5 p -120.69 136.83 54.74 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.303 0.641 . . . . 0.0 109.403 -176.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -134.51 115.79 14.34 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.304 1.042 . . . . 0.0 109.173 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.7 94.79 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.445 HD11 ' HB3' ' A' ' 111' ' ' CYS . 73.6 mt -77.11 139.07 64.81 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 169.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.01 159.46 29.62 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.522 2.148 . . . . 0.0 112.505 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t -65.39 104.15 0.92 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.427 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.8 p -73.29 77.21 1.33 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.162 0.982 . . . . 0.0 109.037 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.8 p -129.1 159.77 34.94 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.98 29.7 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.04 -45.42 8.32 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.206 0.602 . . . . 0.0 112.143 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.82 -9.88 52.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.626 0.37 . . . . 0.0 111.896 -169.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -65.15 -33.18 75.41 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 0.0 110.369 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.13 -30.88 70.99 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.836 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.37 23.3 6.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.182 . . . . 0.0 110.596 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.5 t -139.42 24.4 2.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.294 1.038 . . . . 0.0 108.818 -170.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 49.2 tptt -66.8 -55.93 12.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 -175.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.53 -25.55 52.19 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.244 0.618 . . . . 0.0 112.355 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.564 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -88.54 -17.52 30.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.597 0.759 . . . . 0.0 111.146 -168.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 10.9 pt-20 -65.8 -19.91 66.06 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.21 0.459 . . . . 0.0 110.424 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.6 t -67.98 -44.86 75.69 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.075 0.95 . . . . 0.0 111.172 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.8 pt-20 -73.77 -29.42 62.19 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -62.68 -48.54 78.84 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.447 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 1.2 tm-20 -60.89 -38.01 84.19 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.782 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.88 -19.89 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.088 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 151' ' ' GLU . 43.7 t -68.77 -47.14 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.443 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 33.7 m-85 -91.82 2.74 56.31 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -174.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -60.78 -55.51 32.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.475 0.71 . . . . 0.0 112.128 177.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -70.3 -9.73 56.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.609 HD12 HD13 ' A' ' 16' ' ' ILE . 93.8 mt -73.53 -31.18 63.54 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.995 0.518 . . . . 0.0 109.896 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.4 -52.21 3.57 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 . . . . . 0 CA--C 1.554 1.134 0 C-N-CA 125.456 1.502 . . . . 0.0 111.167 177.28 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.495 HD11 ' HB3' ' A' ' 80' ' ' SER . 38.0 mm -87.29 135.38 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.493 0.717 . . . . 0.0 110.082 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.447 ' HZ2' ' HB3' ' A' ' 25' ' ' ASP . 55.2 mttm -91.31 112.41 24.31 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.06 138.03 35.21 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.019 0.527 . . . . 0.0 111.367 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.18 152.44 49.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.536 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -84.53 138.56 38.41 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.029 0.531 . . . . 0.0 110.267 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.61 154.94 11.05 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 123.046 2.497 . . . . 0.0 112.22 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.83 129.75 40.92 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.573 HG11 HD21 ' A' ' 62' ' ' LEU . 97.4 t -91.12 76.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 17' ' ' LEU . 26.9 tp -135.6 153.64 51.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -158.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.559 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 9.2 t70 -126.5 167.46 15.58 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.595 0.758 . . . . 0.0 109.09 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.26 -12.77 61.63 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.799 0.84 . . . . 0.0 111.085 170.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -119.45 73.72 0.96 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.513 ' HB ' HG13 ' A' ' 104' ' ' VAL . 99.9 m -125.15 122.63 37.66 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.508 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.471 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.0 tt0 -93.34 -39.27 11.04 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.966 1.306 . . . . 0.0 110.283 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 52.5 mt -120.11 113.67 41.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.522 HD11 HD12 ' A' ' 10' ' ' LEU . 52.3 tp -103.84 116.18 31.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.491 ' HB ' HD23 ' A' ' 72' ' ' LEU . 46.2 mt -94.38 114.1 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.288 0.635 . . . . 0.0 109.372 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -104.25 113.7 27.43 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.552 0.741 . . . . 0.0 110.424 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -67.54 174.09 28.55 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.9 m -86.91 -79.8 0.26 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 tp -136.46 122.34 13.53 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.422 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.7 Cg_exo -58.04 135.3 67.75 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.073 1.849 . . . . 0.0 111.371 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.411 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.3 t -60.89 146.12 47.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.765 0.665 . . . . 0.0 109.58 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 4.9 p-10 -58.08 -34.3 69.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.431 0.292 . . . . 0.0 111.339 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.06 -43.01 69.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.272 1.029 . . . . 0.0 111.722 172.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.546 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 26.3 t -68.99 -39.19 79.5 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.011 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 24' ' ' SER . 40.3 mt -76.97 -15.62 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.27 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 13.7 mmt180 -60.63 -36.27 78.25 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.353 0.597 . . . . 0.0 109.599 176.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.76 -0.14 40.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.204 1.002 . . . . 0.0 111.288 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 61.93 21.87 12.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.35 1.06 . . . . 0.0 112.737 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.54 HE21 ' HB3' ' A' ' 34' ' ' TYR . 18.4 pt20 -146.52 158.69 43.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.491 0.316 . . . . 0.0 111.689 -173.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.565 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 83.5 m-85 -68.6 -0.88 5.68 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.745 1.218 . . . . 0.0 112.564 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.54 ' HB3' HE21 ' A' ' 32' ' ' GLN . 63.3 t80 -105.41 1.77 28.08 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.689 1.196 . . . . 0.0 110.024 -176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -38.22 -42.42 1.24 Allowed Glycine 0 C--N 1.361 1.961 0 C-N-CA 124.917 1.246 . . . . 0.0 116.083 -174.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -126.78 146.38 56.97 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.5 2.133 . . . . 0.0 112.762 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.9 -6.36 85.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.02 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -67.58 104.78 1.68 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.58 6.39 41.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.267 0.627 . . . . 0.0 111.131 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -42.77 -43.24 3.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.898 0.879 . . . . 0.0 111.045 164.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.565 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 57.3 m95 -82.71 -28.13 30.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.868 0.867 . . . . 0.0 111.966 -177.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -68.79 -45.81 70.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.812 0.845 . . . . 0.0 111.071 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 mt -87.03 -39.03 16.01 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.133 0.573 . . . . 0.0 111.96 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.3 t -71.39 -36.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 -39.72 95.61 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.891 0.745 . . . . 0.0 112.471 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -67.96 -39.29 83.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.15 0.58 . . . . 0.0 110.496 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.93 72.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.022 0.929 . . . . 0.0 113.07 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 pt -94.74 -11.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.929 0.492 . . . . 0.0 111.151 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.78 72.83 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 0.0 113.574 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -142.98 104.26 4.29 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.09 99.91 0.19 Allowed 'General case' 0 C--N 1.352 0.703 0 CA-C-O 121.453 0.644 . . . . 0.0 110.993 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 73.2 mt -67.06 -34.49 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -66.17 -21.21 66.32 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.227 1.011 . . . . 0.0 112.539 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -95.39 -31.55 13.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.87 0.468 . . . . 0.0 111.229 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.4 mtt -58.1 141.09 51.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.236 0.614 . . . . 0.0 111.176 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.41 137.69 57.1 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.141 -0.933 . . . . 0.0 109.395 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.48 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 38.4 t80 -45.66 -38.82 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -167.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 40.3 mt-10 -58.79 -59.93 4.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.534 0.734 . . . . 0.0 110.923 175.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -60.11 -34.15 73.1 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.971 0.908 . . . . 0.0 111.729 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.437 ' HG3' ' HB3' ' A' ' 53' ' ' LEU . 2.3 ttmp? -60.17 -47.5 85.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.875 1.27 . . . . 0.0 110.006 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.573 HD21 HG11 ' A' ' 9' ' ' VAL . 46.0 mt -67.5 -40.35 85.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.001 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 57.7 mtpt -60.2 -31.34 70.06 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.574 0.35 . . . . 0.0 111.736 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -67.88 -34.52 76.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.072 0.549 . . . . 0.0 110.58 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.55 -57.31 11.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.559 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -58.73 -36.78 74.87 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.137 0.575 . . . . 0.0 111.264 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -53.51 -46.58 70.13 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 111.9 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -87.06 8.41 23.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.0 0.92 . . . . 0.0 111.852 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.471 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 60.53 37.3 19.67 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.595 1.158 . . . . 0.0 110.353 -178.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.81 140.41 21.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.383 1.073 . . . . 0.0 109.225 174.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 9' ' ' VAL . . . -123.35 162.88 17.07 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 170.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.491 HD23 ' HB ' ' A' ' 18' ' ' ILE . 98.0 mt -128.76 138.95 52.38 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -164.69 -168.74 1.55 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -131.29 160.98 33.35 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.61 0.641 . . . . 0.0 111.553 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.498 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.6 t -94.04 -48.28 13.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 124.204 1.002 . . . . 0.0 110.809 175.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -93.78 113.35 25.38 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.438 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 87.9 tttt -64.28 -37.29 86.95 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.252 0.97 . . . . 0.0 110.513 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.86 134.97 17.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.849 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -143.66 136.26 6.81 Favored Glycine 0 C--O 1.218 -0.892 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.495 ' HB3' HD11 ' A' ' 2' ' ' ILE . 23.9 p -114.43 162.94 16.01 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.958 0.879 . . . . 0.0 110.594 -177.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -141.17 135.25 30.63 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -160.76 -163.04 1.0 Allowed 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.575 0.547 . . . . 0.0 109.824 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.53 69.39 1.75 Allowed Glycine 0 C--N 1.341 0.847 0 O-C-N 123.216 0.322 . . . . 0.0 112.676 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 t -127.04 176.34 7.42 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.719 1.208 . . . . 0.0 109.267 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' A' ' 86' ' ' ASP . 49.8 tp60 -72.79 169.8 15.98 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 85' ' ' GLN . 18.3 m-20 -47.49 89.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.839 1.256 . . . . 0.0 113.471 -171.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.9 m -153.14 105.94 2.95 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.752 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -87.44 -32.97 19.22 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mt -101.32 66.91 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 165.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.36 65.05 4.07 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.802 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.58 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.0 t70 -177.87 153.85 0.87 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.075 0.95 . . . . 0.0 108.577 -169.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -121.62 22.07 10.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.574 0.75 . . . . 0.0 111.746 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.0 tp10 -80.28 101.32 8.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.0 mt -94.61 153.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.18 0.992 . . . . 0.0 110.162 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.97 156.33 19.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.947 0.899 . . . . 0.0 109.429 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.01 122.12 34.22 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.515 0.726 . . . . 0.0 110.312 -174.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.498 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 48.2 m-85 -109.0 6.85 25.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.52 0.728 . . . . 0.0 112.007 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -70.45 -17.14 62.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.63 0.372 . . . . 0.0 111.048 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.94 -5.19 77.69 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.657 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -47.89 -49.06 31.02 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.561 0.745 . . . . 0.0 112.666 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -62.0 -27.8 69.12 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -82.91 -54.36 5.14 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.444 0.698 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -75.45 -27.72 59.02 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 4.1 m -132.54 92.61 27.04 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.285 0.634 . . . . 0.0 110.851 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 71.5 Cg_endo -74.19 -36.89 2.95 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.907 2.405 . . . . 0.0 111.781 172.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.3 mmmt -79.83 -5.93 56.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.095 0.958 . . . . 0.0 111.392 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.3 tp -57.84 128.91 39.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.842 0.857 . . . . 0.0 111.316 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.521 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -137.7 -22.61 1.09 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.328 171.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.521 ' HB2' HH11 ' A' ' 108' ' ' ARG . 23.6 tp -129.64 126.57 38.72 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.883 0.473 . . . . 0.0 110.577 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.535 ' HB ' HG21 ' A' ' 131' ' ' THR . 33.7 mt -113.78 110.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.454 ' HB3' HD13 ' A' ' 134' ' ' LEU . 76.8 m -96.12 114.21 25.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 110.509 -175.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.47 116.19 28.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.023 0.929 . . . . 0.0 110.742 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.527 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 83.1 m-20 -82.92 102.39 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.75 138.32 9.48 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -58.83 -32.1 69.08 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.144 0.578 . . . . 0.0 111.513 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -53.31 -42.89 67.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.892 0.877 . . . . 0.0 112.303 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.29 -38.72 71.8 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.426 0.631 . . . . 0.0 110.314 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.57 -9.53 55.7 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.561 -1.2 . . . . 0.0 114.44 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -24.64 66.91 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 117.374 0.587 . . . . 0.0 110.547 172.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.4 21.5 16.59 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.198 0.999 . . . . 0.0 111.215 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 1.3 tm-20 -66.24 -52.16 39.79 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.17 0.988 . . . . 0.0 112.405 176.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.46 -14.61 30.89 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.608 1.539 . . . . 0.0 112.357 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -66.1 -44.98 82.82 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.905 0.882 . . . . 0.0 109.668 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 -20.49 29.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 50.5 ttt180 -72.24 -29.13 63.63 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.06 -22.28 75.87 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 58.4 mtt -76.66 -9.9 59.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.195 0.598 . . . . 0.0 111.719 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.89 14.75 16.4 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 120.175 -0.236 . . . . 0.0 113.412 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.2 m-85 -109.12 145.72 35.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 0.0 109.734 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 mm-40 -70.55 137.11 49.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 163.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.535 HG21 ' HB ' ' A' ' 110' ' ' ILE . 25.8 p -128.43 138.4 52.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -129.33 117.99 21.54 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.785 1.234 . . . . 0.0 108.849 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.41 103.33 9.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 111' ' ' CYS . 48.0 mt -88.53 131.92 40.53 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 148' ' ' ARG . 45.8 Cg_exo -59.57 136.3 70.24 Favored 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.687 2.258 . . . . 0.0 111.133 176.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.6 t -50.24 118.99 3.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.261 0.975 . . . . 0.0 111.013 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 p -83.65 30.17 0.5 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.901 0.881 . . . . 0.0 111.529 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 p -61.05 149.52 36.73 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.715 0.806 . . . . 0.0 110.576 165.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -53.14 -42.97 62.89 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.729 0.643 . . . . 0.0 114.4 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.01 93.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.329 0.652 . . . . 0.0 111.782 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -78.27 -28.51 47.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.168 0.587 . . . . 0.0 110.065 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.98 -36.62 77.55 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.322 0.649 . . . . 0.0 110.952 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -57.02 -20.78 26.19 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.118 0.967 . . . . 0.0 112.565 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -112.5 -33.69 6.08 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.243 0.617 . . . . 0.0 110.847 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.7 m -69.5 83.12 0.41 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -95.8 -57.18 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.396 1.079 . . . . 0.0 110.586 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.05 -32.41 69.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.182 0.593 . . . . 0.0 110.399 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.532 ' HB3' ' HG2' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -86.95 -31.81 20.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.908 -172.599 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.75 -28.85 67.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.006 0.821 . . . . 0.0 109.01 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -65.87 -42.91 89.74 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.1 pt-20 -71.9 -26.96 62.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -67.52 -43.21 81.38 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.69 -39.12 84.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.401 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.497 -175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 151' ' ' GLU . 54.8 t -80.73 -62.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.003 0.521 . . . . 0.0 110.407 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.08 2.45 43.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -165.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -25.62 62.84 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -78.21 -8.15 57.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.558 0.343 . . . . 0.0 111.814 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.81 -38.8 76.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.815 0.446 . . . . 0.0 111.312 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.25 -41.68 40.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 C--O 1.243 0.733 0 C-N-CA 125.566 1.547 . . . . 0.0 106.89 175.552 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.34 139.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -88.34 110.14 20.54 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.2 mmt-85 -84.25 136.42 33.94 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.182 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -68.22 162.46 49.32 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 123.634 0.584 . . . . 0.0 112.052 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -101.47 146.14 31.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.05 137.09 17.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.741 2.294 . . . . 0.0 111.866 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.4 138.79 58.27 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.94 0.896 . . . . 0.0 111.625 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.63 81.29 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD12 ' CG1' ' A' ' 104' ' ' VAL . 40.8 tp -128.0 145.36 51.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.358 -163.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -123.41 159.67 28.46 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.603 1.161 . . . . 0.0 107.909 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.13 -26.73 64.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.987 0.515 . . . . 0.0 111.202 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -111.46 89.53 3.08 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -135.48 107.64 7.21 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.303 0.641 . . . . 0.0 109.61 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.493 ' HG2' ' HB3' ' A' ' 69' ' ' ARG . 59.7 mm-40 -80.47 -35.74 34.39 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.396 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 24.3 mt -129.09 124.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 123.461 0.704 . . . . 0.0 109.857 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.79 117.4 34.02 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mt -94.15 112.83 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.52 119.66 39.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.727 0.811 . . . . 0.0 109.981 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.24 177.11 46.39 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 164.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 116' ' ' LYS . 47.4 t -90.16 -75.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 tp -129.59 125.2 22.26 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 175.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 50.6 Cg_exo -59.28 125.0 16.78 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.033 1.822 . . . . 0.0 110.509 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -78.76 173.07 12.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.8 -37.28 78.69 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.046 0.539 . . . . 0.0 111.578 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.57 -42.95 89.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.871 0.868 . . . . 0.0 111.475 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.5 m -65.4 -41.9 93.15 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.024 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.02 -26.78 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.852 1.261 . . . . 0.0 112.304 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -63.37 -39.56 94.86 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.892 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -5.18 22.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.149 0.58 . . . . 0.0 111.186 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 62.5 31.22 17.13 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.688 1.195 . . . . 0.0 111.253 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -127.68 139.34 52.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.908 1.283 . . . . 0.0 108.887 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -57.56 -40.48 78.99 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.378 0.609 . . . . 0.0 109.535 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -47.71 -44.76 27.98 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.422 169.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.39 -107.29 0.1 Allowed Glycine 0 C--N 1.362 2.012 0 O-C-N 124.043 0.839 . . . . 0.0 113.301 -170.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -122.72 146.6 48.44 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.294 1.037 . . . . 0.0 109.794 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -40.54 119.04 0.67 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.821 3.68 . . . . 0.0 114.216 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.29 -33.12 0.09 OUTLIER Glycine 0 N--CA 1.472 1.071 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.431 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -93.46 126.9 38.85 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.52 0.728 . . . . 0.0 109.245 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -81.64 1.49 33.81 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.399 1.08 . . . . 0.0 111.017 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -37.51 -49.48 1.06 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.918 1.687 . . . . 0.0 113.073 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -73.37 -24.21 60.3 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.402 -173.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 ttm-85 -88.29 -27.17 21.88 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 111.117 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.35 -51.36 9.52 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 110.569 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.96 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.27 -36.79 85.55 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.069 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -64.23 -40.97 97.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.631 . . . . 0.0 109.498 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.409 ' CB ' ' HB2' ' A' ' 156' ' ' PHE . . . -62.81 -50.32 71.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.585 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.3 pt -88.19 -4.98 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.49 0.316 . . . . 0.0 111.212 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.3 28.99 64.93 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.147 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -146.15 92.28 2.17 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.01 101.16 0.14 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.243 0.617 . . . . 0.0 109.868 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.415 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 54.3 mt -68.73 -17.43 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.401 1.081 . . . . 0.0 112.229 -167.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.02 -41.93 93.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.543 0.737 . . . . 0.0 112.044 -169.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.38 -32.64 71.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.58 0.752 . . . . 0.0 112.459 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -60.37 148.85 35.73 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.307 0.643 . . . . 0.0 112.55 -175.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 153.72 32.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 167.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.51 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 33.5 t80 -54.45 -45.61 73.12 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -164.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -63.8 -45.2 90.75 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.044 0.538 . . . . 0.0 111.271 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -34.59 78.74 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.06 0.944 . . . . 0.0 110.333 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 29.7 ttmt -65.46 -41.44 93.37 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.814 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 29.2 mt -58.06 -48.46 80.04 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.07 0.856 . . . . 0.0 109.625 173.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -55.92 -45.23 78.78 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.237 0.96 . . . . 0.0 111.693 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -67.41 -45.64 75.57 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 123.543 0.527 . . . . 0.0 110.691 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.7 mt -55.84 -56.56 19.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.752 0.821 . . . . 0.0 110.527 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -67.95 -30.65 70.0 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.296 1.039 . . . . 0.0 111.58 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -63.45 -35.94 82.1 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.815 0.846 . . . . 0.0 110.884 170.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -84.82 5.13 29.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.388 0.675 . . . . 0.0 111.254 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.493 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 2.0 mpt_? 65.36 34.47 8.19 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-O 122.25 1.024 . . . . 0.0 110.197 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.06 135.65 49.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 108.731 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.61 169.04 13.66 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.0 mt -126.73 147.42 49.97 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.759 0.824 . . . . 0.0 109.127 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -166.18 -169.02 1.34 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.33 164.34 30.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.312 0.645 . . . . 0.0 110.565 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.408 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.7 t -86.14 -42.38 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.037 0.935 . . . . 0.0 111.074 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -100.22 115.78 30.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.095 0.558 . . . . 0.0 110.625 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.405 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 1.6 tmtp? -66.47 -34.75 78.64 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.492 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -144.82 135.26 24.35 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.684 -0.635 . . . . 0.0 110.614 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.524 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -157.26 148.72 18.78 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.547 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 p -116.41 173.51 6.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.303 1.041 . . . . 0.0 109.119 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.66 109.93 11.38 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -89.67 -61.8 1.61 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.238 -167.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 138.65 -60.04 0.59 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.7 m -88.18 38.16 0.84 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.876 0.87 . . . . 0.0 111.368 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -126.35 153.67 44.58 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.477 1.111 . . . . 0.0 108.488 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.38 -67.18 0.47 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.7 t -81.81 135.98 35.42 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -39.74 91.92 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.04 0.536 . . . . 0.0 111.204 -176.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt -63.44 89.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.933 0.893 . . . . 0.0 110.743 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.38 58.09 4.18 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.519 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.524 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.9 t0 -171.19 144.05 2.0 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -110.43 17.67 20.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.887 0.875 . . . . 0.0 111.59 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 45.8 tt0 -85.01 103.01 13.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.488 0.661 . . . . 0.0 109.376 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.55 154.01 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.809 1.244 . . . . 0.0 109.451 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -79.58 157.2 27.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.686 0.794 . . . . 0.0 109.748 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.22 139.78 30.14 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.408 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 80.8 m-85 -130.48 11.58 5.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.713 0.805 . . . . 0.0 110.951 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 99.2 p -77.62 -12.1 59.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.969 -0.457 . . . . 0.0 110.469 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.03 -4.87 68.55 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.532 -0.593 . . . . 0.0 112.307 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 mt -51.23 -49.47 61.02 Favored 'General case' 0 C--N 1.37 1.494 0 C-N-CA 123.729 0.812 . . . . 0.0 111.362 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.541 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 44.6 mtpt -64.92 -16.18 62.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -171.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.94 -40.13 9.04 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 111.611 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -85.44 -26.61 26.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 2.2 m -129.02 89.5 48.46 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 122.868 0.467 . . . . 0.0 110.04 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.64 -28.7 20.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.296 1.997 . . . . 0.0 110.969 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -84.61 -11.95 54.97 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 112.864 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 32.3 tp -57.69 101.85 0.08 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.033 0.833 . . . . 0.0 110.665 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -93.21 -43.97 8.57 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.588 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.7 tp -134.19 135.66 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.555 0.742 . . . . 0.0 109.894 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.4 mt -105.08 136.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 86.3 m -117.75 115.39 24.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.14 0.427 . . . . 0.0 110.251 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -93.56 123.06 36.62 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -101.81 111.35 23.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.18 134.99 8.62 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -53.17 -47.17 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.304 1.042 . . . . 0.0 112.18 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -60.22 -20.83 60.53 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.805 0.842 . . . . 0.0 112.641 -178.13 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.56 -46.36 17.47 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.372 0.606 . . . . 0.0 109.476 170.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.26 -9.76 68.33 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.95 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -68.35 -17.52 64.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.009 0.524 . . . . 0.0 110.636 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.79 21.47 17.45 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.183 0.993 . . . . 0.0 110.988 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.44 -51.48 59.96 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.15 -0.928 . . . . 0.0 112.357 171.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.28 -24.44 67.7 Favored 'Trans proline' 0 C--N 1.405 3.551 0 C-N-CA 122.084 1.856 . . . . 0.0 112.698 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.81 -57.21 8.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.914 0.886 . . . . 0.0 110.181 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.474 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 12.2 mt -79.18 -21.03 46.96 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 6.9 ptm180 -75.22 -11.65 60.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 120.703 0.287 . . . . 0.0 110.715 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.59 -15.14 81.44 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.405 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -81.94 10.71 5.98 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 174.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.24 19.74 79.76 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 122.749 0.214 . . . . 0.0 112.716 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 18.3 m-85 -108.79 139.59 43.39 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.304 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -73.48 142.42 46.8 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -129.99 148.15 51.82 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -139.37 123.54 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.215 1.006 . . . . 0.0 108.864 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.04 122.81 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.505 HD22 HG23 ' A' ' 155' ' ' VAL . 90.4 mt -113.02 150.15 42.44 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.58 177.37 4.08 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.772 2.314 . . . . 0.0 111.561 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 m -66.02 130.29 42.74 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -83.89 14.91 3.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.834 0.854 . . . . 0.0 112.044 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -69.88 156.26 39.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.147 0.979 . . . . 0.0 111.78 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.17 -18.61 69.38 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.693 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.22 83.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.362 0.665 . . . . 0.0 111.056 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -76.56 -2.59 33.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.7 0.8 . . . . 0.0 112.477 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 20.1 ttm-85 -56.13 -33.68 65.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.039 0.935 . . . . 0.0 113.317 -172.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -33.38 72.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.643 0.589 . . . . 0.0 110.606 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.01 5.94 20.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.774 0.829 . . . . 0.0 111.994 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 13.7 t -91.07 14.8 13.05 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.151 0.58 . . . . 0.0 112.195 -175.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.98 -58.06 5.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.425 ' HB2' ' NH1' ' A' ' 148' ' ' ARG . 17.4 m120 -59.21 -15.06 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.425 ' NH1' ' HB2' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -74.96 -23.65 58.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.974 0.51 . . . . 0.0 110.101 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.36 -55.63 32.27 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.26 0.624 . . . . 0.0 110.695 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -73.93 -32.34 63.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 111.161 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.41 ' O ' HG21 ' A' ' 155' ' ' VAL . 19.3 tt0 -67.37 -56.75 8.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.165 0.586 . . . . 0.0 110.224 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -69.58 -25.91 64.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.52 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 32.4 tt0 -59.35 -49.61 77.14 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 123.821 0.7 . . . . 0.0 109.442 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.53 77.69 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.553 -171.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.505 HG23 HD22 ' A' ' 134' ' ' LEU . 92.6 t -61.91 -32.64 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 124.173 0.989 . . . . 0.0 112.673 -174.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.409 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 44.0 m-85 -115.55 -11.99 11.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 112.909 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.52 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 14.4 ptm180 -74.1 -26.56 60.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.555 0.616 . . . . 0.0 111.591 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -73.84 -8.8 57.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.571 0.348 . . . . 0.0 111.906 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.26 -12.21 61.43 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.338 0.655 . . . . 0.0 112.732 -176.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -90.37 -1.99 57.94 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.036 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 . . . . . 0 CA--C 1.555 1.148 0 C-N-CA 125.561 1.544 . . . . 0.0 110.435 -175.01 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 25' ' ' ASP . 11.1 mptt -87.61 117.51 26.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -100.12 134.04 43.62 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.366 0.667 . . . . 0.0 110.558 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.512 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.2 -174.03 17.55 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.384 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -117.03 144.23 33.16 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 122.948 0.499 . . . . 0.0 110.281 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.42 145.42 16.13 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.024 2.483 . . . . 0.0 112.003 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.11 128.85 38.46 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.825 0.703 . . . . 0.0 111.124 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 62' ' ' LEU . 48.7 t -93.75 78.88 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.472 HD11 ' CG1' ' A' ' 104' ' ' VAL . 41.9 tp -128.71 154.07 46.69 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 112.164 -161.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.51 154.92 37.21 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.13 -10.68 32.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.15 0.58 . . . . 0.0 112.222 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -120.08 97.38 5.57 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.46 ' HB ' HG12 ' A' ' 104' ' ' VAL . 52.6 m -144.04 112.93 6.71 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.387 0.675 . . . . 0.0 110.205 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.56 -36.21 29.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.053 . . . . 0.0 110.75 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.16 116.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.241 0.616 . . . . 0.0 109.484 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -104.95 115.51 30.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.0 mt -98.38 109.32 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.736 0.814 . . . . 0.0 109.046 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.432 HD23 ' HB3' ' A' ' 73' ' ' TRP . 80.8 mt -98.08 108.93 21.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 109.026 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.72 -177.9 11.99 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 166.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 p -89.61 -82.17 0.27 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -136.12 114.92 10.88 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.5 Cg_exo -52.89 136.77 60.62 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.958 2.438 . . . . 0.0 112.846 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 m -61.22 145.64 50.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.105 0.878 . . . . 0.0 109.634 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 7.8 p-10 -61.89 -31.26 71.53 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.158 0.436 . . . . 0.0 110.73 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.75 -36.24 76.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.87 0.868 . . . . 0.0 110.793 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.1 m -66.5 -47.08 74.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.45 -26.57 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.763 1.225 . . . . 0.0 112.832 -171.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 18.7 mmt85 -69.4 -36.36 76.68 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 110.089 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.64 -16.12 35.33 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.281 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 65.38 21.59 11.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.695 1.598 . . . . 0.0 111.597 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.89 135.9 40.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.842 1.257 . . . . 0.0 108.873 -173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -57.98 -40.49 80.79 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 122.936 0.495 . . . . 0.0 110.817 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.98 -13.33 45.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.512 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.89 16.41 Favored Glycine 0 C--N 1.362 1.984 0 C-N-CA 124.02 0.819 . . . . 0.0 113.523 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -109.78 112.29 58.39 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 165.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.07 0.56 3.1 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.794 2.996 . . . . 0.0 114.273 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.29 -14.2 80.89 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -72.82 97.64 2.28 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 168.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -80.07 -1.65 40.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.971 0.909 . . . . 0.0 110.885 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -36.03 -41.91 0.26 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.916 2.087 . . . . 0.0 113.443 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.36 -28.9 64.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.57 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -84.11 -37.84 21.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.106 0.562 . . . . 0.0 111.117 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.68 -48.24 80.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 0.0 110.224 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -74.02 -37.26 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.416 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.08 -41.11 99.88 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.071 0.388 . . . . 0.0 114.071 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -71.41 -30.63 66.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.745 0.418 . . . . 0.0 110.363 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -75.82 -36.91 59.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.807 0.843 . . . . 0.0 112.465 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 pt -91.11 -10.46 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.396 0.678 . . . . 0.0 111.143 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.18 19.81 79.75 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.588 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -135.7 112.64 10.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -71.53 96.44 1.53 Allowed 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.588 0.709 . . . . 0.0 111.696 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.68 -35.87 81.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.013 0.925 . . . . 0.0 110.917 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -53.29 -50.44 64.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.627 1.171 . . . . 0.0 112.626 -170.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -81.96 -6.31 59.02 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.275 0.63 . . . . 0.0 112.097 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtt -86.11 139.62 30.95 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 151.35 33.56 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.081 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.517 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 53.6 t80 -50.0 -42.94 50.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -167.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 42.5 mt-10 -60.31 -46.2 90.73 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.305 0.378 . . . . 0.0 110.758 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -68.53 -45.13 73.02 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -59.71 -32.99 71.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.14 0.427 . . . . 0.0 110.885 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.565 HD22 HG11 ' A' ' 9' ' ' VAL . 47.2 mt -66.77 -43.15 84.8 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.81 172.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 74.7 mmtt -57.06 -41.17 78.27 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.216 0.606 . . . . 0.0 110.233 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -65.27 -39.25 92.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.498 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.05 -46.25 85.22 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.851 0.461 . . . . 0.0 110.228 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 28.6 mmtp -59.88 -39.77 86.43 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.104 0.561 . . . . 0.0 109.882 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.05 -45.65 90.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.992 1.317 . . . . 0.0 111.335 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -86.25 7.78 23.86 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.328 0.251 . . . . 0.0 111.035 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 67.85 38.5 2.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.479 1.111 . . . . 0.0 110.988 171.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.63 132.92 57.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.15 1.38 . . . . 0.0 109.504 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.5 151.6 18.03 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 46.5 mt -119.84 141.06 49.87 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.341 0.656 . . . . 0.0 109.29 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.432 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.9 t90 -165.09 -168.96 1.53 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -133.54 177.91 7.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.956 0.902 . . . . 0.0 109.888 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.7 t -95.64 -56.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.675 0.79 . . . . 0.0 109.647 172.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 57.3 m-85 -84.21 107.98 16.84 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.095 0.558 . . . . 0.0 110.607 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.501 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 3.7 tmtm? -66.82 -31.14 71.57 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.813 0.845 . . . . 0.0 109.044 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -152.86 130.87 11.81 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.061 0.544 . . . . 0.0 109.742 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 91' ' ' ASP . . . -151.03 144.21 11.49 Favored Glycine 0 C--O 1.238 0.4 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.825 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.059 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.37 -70.1 1.3 Allowed Glycine 0 C--N 1.344 0.989 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.759 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.528 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 1.1 m-20 -38.88 133.41 1.12 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.873 1.269 . . . . 0.0 113.349 173.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -114.62 25.87 10.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.438 -165.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 8.4 tp10 -78.88 111.96 15.57 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.72 144.07 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.88 0.872 . . . . 0.0 109.134 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -68.95 149.61 48.65 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.233 1.013 . . . . 0.0 110.796 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -78.27 130.94 36.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.516 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 35.3 m-85 -120.67 3.88 10.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.252 0.621 . . . . 0.0 111.395 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.0 t -74.63 -14.69 60.79 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.007 0.523 . . . . 0.0 109.817 173.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.88 -4.04 61.87 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.148 -0.807 . . . . 0.0 113.094 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 mt -52.8 -32.88 46.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 117.732 0.766 . . . . 0.0 112.879 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -68.59 -27.19 65.82 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.779 0.323 . . . . 0.0 111.444 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -83.31 -53.0 6.07 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.696 0.799 . . . . 0.0 111.466 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.534 ' HG3' HG22 ' A' ' 104' ' ' VAL . 25.4 ptm -73.32 -29.41 62.66 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.305 0.642 . . . . 0.0 111.341 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -139.24 86.96 14.12 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.449 0.7 . . . . 0.0 111.209 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.69 -25.97 8.78 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.469 2.113 . . . . 0.0 112.554 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -77.8 -10.13 59.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.4 0.68 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 36.2 tp -54.39 131.09 41.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.81 0.694 . . . . 0.0 110.673 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.41 ' HD2' ' NE2' ' A' ' 158' ' ' HIS . 18.0 ptp180 -128.56 -37.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.004 0.921 . . . . 0.0 108.707 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 tp -132.29 125.34 30.75 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.255 0.622 . . . . 0.0 110.432 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.508 HG12 HD21 ' A' ' 107' ' ' LEU . 32.9 mt -101.69 109.53 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.531 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.5 m -95.12 112.98 24.62 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.165 0.507 . . . . 0.0 109.928 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.1 114.49 25.75 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.189 0.996 . . . . 0.0 109.396 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -90.51 107.16 18.98 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.34 28.45 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.327 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -56.07 -50.7 70.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 112.851 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 76' ' ' PHE . 26.3 mmmt -50.26 -37.22 34.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.41 -46.03 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.018 0.527 . . . . 0.0 110.103 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.73 -14.59 70.25 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 114.736 -1.12 . . . . 0.0 114.705 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.64 -28.38 69.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.974 0.51 . . . . 0.0 110.837 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.19 19.99 12.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.271 1.028 . . . . 0.0 111.227 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 41.2 tt0 -61.6 -54.71 49.36 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.627 170.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.23 -20.59 55.78 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 122.262 1.975 . . . . 0.0 113.438 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.56 -50.31 70.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.932 0.893 . . . . 0.0 110.163 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.49 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 9.8 mt -89.46 -6.67 56.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 29.3 mtp180 -69.62 -20.04 63.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.966 0.507 . . . . 0.0 109.944 168.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.35 -16.74 80.15 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.402 -0.666 . . . . 0.0 113.42 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.2 mpt? -85.73 9.97 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.702 0.751 . . . . 0.0 112.183 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.96 17.28 71.45 Favored Glycine 0 C--N 1.352 1.441 0 C-N-CA 122.869 0.271 . . . . 0.0 113.633 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -111.07 134.34 52.74 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.548 0.739 . . . . 0.0 109.611 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.99 143.28 56.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.446 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.4 p -127.85 139.59 52.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.706 0.802 . . . . 0.0 110.16 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -132.14 118.7 19.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.668 1.187 . . . . 0.0 108.928 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.96 95.11 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.9 mt -75.42 150.99 85.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 73.0 Cg_endo -72.5 163.88 37.25 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.084 1.856 . . . . 0.0 110.359 171.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -63.4 133.09 53.43 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.7 p -79.31 -3.97 48.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.264 0.626 . . . . 0.0 112.026 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -66.68 159.52 27.55 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 111.059 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 142' ' ' ARG . . . -58.43 -28.93 62.77 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.501 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.9 76.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.837 0.855 . . . . 0.0 112.002 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 135' ' ' PRO . 49.1 t30 -89.94 -33.76 16.29 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.063 0.545 . . . . 0.0 110.982 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.539 HH21 ' HA ' ' A' ' 146' ' ' LYS . 6.5 tpm_? -51.61 -44.42 62.88 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.089 1.356 . . . . 0.0 112.458 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -60.87 -12.88 12.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.745 1.218 . . . . 0.0 113.317 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -121.06 -40.63 2.59 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.155 0.982 . . . . 0.0 110.823 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 65.4 m -93.3 85.64 5.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.697 0.799 . . . . 0.0 110.407 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.539 ' HA ' HH21 ' A' ' 142' ' ' ARG . 34.0 mmtp -93.99 -50.64 5.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.51 0.724 . . . . 0.0 111.475 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -86.05 -4.15 59.1 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.932 0.493 . . . . 0.0 111.506 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.3 tpt180 -78.31 -24.62 46.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.675 0.39 . . . . 0.0 110.097 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 11.3 pt-20 -62.12 -13.46 27.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 m -65.68 -30.5 71.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.37 0.668 . . . . 0.0 112.194 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 155' ' ' VAL . 14.7 pt-20 -72.61 -29.6 63.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.795 0.438 . . . . 0.0 109.925 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -67.35 -37.65 83.56 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 31.5 tt0 -67.55 -37.69 83.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.978 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.48 72.63 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.793 0.683 . . . . 0.0 111.168 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 151' ' ' GLU . 80.2 t -71.87 -60.39 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.567 0.747 . . . . 0.0 111.03 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.432 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 50.1 m-85 -88.09 -7.56 56.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.77 -28.57 66.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.1 0.409 . . . . 0.0 110.86 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.41 ' NE2' ' HD2' ' A' ' 108' ' ' ARG . 0.6 OUTLIER -67.88 -21.66 65.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.596 0.758 . . . . 0.0 111.219 -175.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.4 mt -64.85 -14.28 58.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.428 1.091 . . . . 0.0 113.277 -170.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -98.48 -62.52 1.23 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 166.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 124.565 1.146 . . . . 0.0 108.179 178.132 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 80' ' ' SER . 40.5 mm . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -97.21 111.95 23.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -95.15 133.8 38.58 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.579 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.67 -166.66 9.71 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.948 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -117.97 147.77 41.99 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.384 0.674 . . . . 0.0 109.318 -172.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.06 162.16 27.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.196 1.931 . . . . 0.0 110.668 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.55 120.43 10.54 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.24 0.616 . . . . 0.0 111.486 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 62' ' ' LEU . 41.0 t -94.56 84.6 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.545 HD11 HG12 ' A' ' 104' ' ' VAL . 48.8 tp -129.47 154.56 46.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.246 -159.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -123.62 159.31 29.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.936 0.894 . . . . 0.0 108.623 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HG3' HD22 ' A' ' 13' ' ' ASN . 11.4 pt-20 -59.57 -28.12 66.85 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.433 HD22 ' HG3' ' A' ' 12' ' ' GLU . 43.7 m-80 -111.18 86.84 2.4 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -131.1 112.11 12.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.692 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.1 tt0 -91.56 -31.97 15.71 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.748 1.219 . . . . 0.0 110.091 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 69.1 mt -125.58 122.16 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.796 0.838 . . . . 0.0 109.465 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.2 tp -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -95.41 106.35 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.411 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 75.7 mt -95.79 108.5 20.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 108.85 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.84 178.32 9.13 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 166.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 15.5 t -89.81 -75.59 0.45 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 tp -130.58 124.01 20.69 Favored Pre-proline 0 C--O 1.244 0.8 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.76 155.18 11.06 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -59.32 124.12 18.96 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -61.88 -22.37 65.49 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.121 0.568 . . . . 0.0 112.157 -171.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.29 -51.48 56.97 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.646 0.591 . . . . 0.0 110.111 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 t -55.04 -30.74 60.22 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.728 0.811 . . . . 0.0 111.872 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.8 mt -77.56 -26.75 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.893 0.877 . . . . 0.0 110.873 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -61.84 -27.63 68.92 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.256 0.623 . . . . 0.0 111.45 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -102.71 -3.48 26.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.474 0.71 . . . . 0.0 110.396 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 50.34 28.0 3.01 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.837 1.255 . . . . 0.0 113.168 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 34' ' ' TYR . 7.6 tt0 -149.09 141.78 24.5 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.001 0.521 . . . . 0.0 110.708 -170.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.456 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 66.1 m-85 -67.62 -6.03 18.43 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 123.94 0.896 . . . . 0.0 112.437 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 90.9 t80 -82.07 -24.85 35.02 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 109.357 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.3 -31.39 79.08 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.877 0.736 . . . . 0.0 114.84 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -123.24 111.98 30.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.995 0.398 . . . . 0.0 110.462 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -88.35 -0.94 6.86 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.445 2.764 . . . . 0.0 112.566 170.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.57 -6.39 89.35 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 41' ' ' PHE . 11.7 m120 -76.19 126.21 30.57 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.52 4.94 50.25 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 124.246 1.018 . . . . 0.0 110.027 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.562 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 86.6 m-85 -50.1 -36.56 30.07 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 109.674 163.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -73.56 -26.75 60.98 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.616 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -79.28 -44.84 20.89 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.727 0.811 . . . . 0.0 111.736 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.95 -38.64 57.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 0.0 111.473 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.25 -30.31 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.49 -53.29 36.51 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.559 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 149' ' ' GLU . 14.4 p-80 -65.84 -30.3 70.9 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.006 0.431 . . . . 0.0 110.356 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -68.88 -34.44 75.43 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.093 0.957 . . . . 0.0 112.145 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 64' ' ' THR . 11.4 pt -96.33 -10.39 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.987 0.915 . . . . 0.0 110.405 176.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.62 39.15 22.36 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 115.039 0.776 . . . . 0.0 115.039 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.92 127.68 1.31 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.425 1.09 . . . . 0.0 108.769 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -72.0 102.78 3.04 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.043 0.937 . . . . 0.0 112.556 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.3 mt -61.03 -25.55 66.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.478 1.111 . . . . 0.0 111.809 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -68.78 -31.24 70.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.657 0.783 . . . . 0.0 111.238 -172.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.36 -11.04 53.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.973 0.909 . . . . 0.0 110.962 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 56.8 mtt -85.08 137.66 32.9 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 152.4 38.4 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.327 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 34.4 t80 -40.28 -51.12 2.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.259 1.424 . . . . 0.0 113.331 -171.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.53 -52.17 62.32 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.1 0.96 . . . . 0.0 111.311 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.92 -42.71 90.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.591 0.756 . . . . 0.0 110.797 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -56.5 -53.34 58.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.829 1.252 . . . . 0.0 110.911 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.602 HD22 HG11 ' A' ' 9' ' ' VAL . 84.5 mt -65.48 -41.69 93.05 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.814 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -71.89 -28.14 63.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.698 0.399 . . . . 0.0 111.769 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.428 HG22 HD12 ' A' ' 49' ' ' ILE . 41.3 m -60.9 -42.32 97.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.109 0.48 . . . . 0.0 109.755 169.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.4 -50.29 66.05 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.013 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 30.8 mmtp -57.01 -44.78 83.13 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.454 0.702 . . . . 0.0 109.932 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -53.75 -41.29 66.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.243 1.417 . . . . 0.0 112.226 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -84.1 0.88 46.65 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.92 0.888 . . . . 0.0 111.746 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 66.9 42.73 2.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.852 1.261 . . . . 0.0 110.387 -178.243 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.38 136.92 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.806 1.242 . . . . 0.0 109.191 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.25 163.17 14.06 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 170.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -124.39 144.4 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.929 0.892 . . . . 0.0 109.162 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.411 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.1 t90 -165.29 -169.14 1.54 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -134.8 170.33 16.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 61.4 t -97.05 -35.39 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.478 0.711 . . . . 0.0 110.549 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -111.43 105.2 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.52 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 50.7 tptt -64.97 -26.98 68.53 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.362 1.065 . . . . 0.0 111.748 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.28 138.53 25.15 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.7 114.39 0.86 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.403 ' HB3' HD13 ' A' ' 2' ' ' ILE . 87.3 p . . . . . 0 C--O 1.239 0.543 0 CA-C-N 117.562 0.681 . . . . 0.0 109.925 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 mt . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.06 54.99 0.8 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 16.7 t70 -176.45 150.44 0.88 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -172.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.92 17.85 14.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.309 0.644 . . . . 0.0 112.623 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 77' ' ' LYS . 24.6 tt0 -77.76 105.67 9.08 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 mm -89.71 147.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.113 0.965 . . . . 0.0 109.392 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -74.6 143.92 44.17 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 168.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -82.88 127.4 33.46 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.447 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 64.2 m-85 -114.92 10.97 16.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.369 0.667 . . . . 0.0 110.998 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.1 t -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.696 0.398 . . . . 0.0 110.818 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.26 -4.76 86.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.738 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 104' ' ' VAL . 16.6 mt -49.41 -53.11 24.36 Favored 'General case' 0 C--N 1.368 1.392 0 C-N-CA 123.676 0.79 . . . . 0.0 111.212 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -59.35 -18.7 40.63 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.467 0.707 . . . . 0.0 112.58 -168.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.38 -42.74 13.41 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.501 1.121 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -94.97 -16.02 23.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 10' ' ' LEU . 17.1 m -122.35 88.12 48.8 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.168 0.587 . . . . 0.0 110.48 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.1 -39.12 3.3 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.184 1.923 . . . . 0.0 112.101 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -86.2 -6.12 59.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.765 0.826 . . . . 0.0 113.117 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.1 tp -61.85 117.45 5.91 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.611 0.569 . . . . 0.0 111.073 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -111.47 -40.53 4.35 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.941 0.896 . . . . 0.0 109.52 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 56.2 tp -129.35 133.08 47.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.925 0.89 . . . . 0.0 110.875 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.4 mt -112.7 146.31 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 134' ' ' LEU . 81.7 m -125.69 113.51 17.44 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.598 0.759 . . . . 0.0 110.317 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.64 107.93 19.59 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.595 1.158 . . . . 0.0 109.086 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -98.79 88.24 3.98 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.65 139.1 3.96 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.625 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.0 -50.84 65.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 111.695 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.48 -38.43 69.1 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.461 1.104 . . . . 0.0 112.008 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 21' ' ' SER . . . -65.57 -36.19 83.04 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.996 0.518 . . . . 0.0 110.823 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.85 -16.37 59.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 115.099 -0.955 . . . . 0.0 114.556 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.59 -29.73 70.75 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.11 0.481 . . . . 0.0 110.947 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -111.31 25.33 11.83 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.722 0.809 . . . . 0.0 111.084 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.52 -44.22 24.48 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.066 0.946 . . . . 0.0 112.543 170.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.426 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 71.9 Cg_endo -70.72 -13.77 32.53 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 121.8 1.667 . . . . 0.0 112.828 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 tp -58.91 -41.03 86.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.562 1.145 . . . . 0.0 110.191 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -96.98 -10.55 26.01 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.489 -174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 122' ' ' PRO . 19.6 mtm180 -63.93 -34.91 79.03 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.078 0.466 . . . . 0.0 110.244 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.93 -12.26 70.95 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.446 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.3 mtt -94.94 9.67 38.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 0.0 111.708 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.01 17.87 77.7 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 113.878 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -110.0 133.59 53.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.437 0.695 . . . . 0.0 110.071 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.68 143.74 55.82 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.0 p -132.93 149.73 52.22 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.707 0.803 . . . . 0.0 110.351 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -145.5 129.23 17.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.353 1.061 . . . . 0.0 109.369 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.64 97.07 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 111' ' ' CYS . 39.6 mt -77.62 144.34 69.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.951 176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.461 ' HD2' ' HE1' ' A' ' 152' ' ' TRP . 44.7 Cg_exo -59.3 154.82 44.14 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.521 2.814 . . . . 0.0 113.269 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.5 m -68.91 108.88 3.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 m -84.69 21.03 1.61 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.422 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.1 t -59.73 154.14 18.76 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.454 0.702 . . . . 0.0 110.522 171.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.19 69.69 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.149 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.48 -15.37 61.32 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.962 0.905 . . . . 0.0 111.452 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 144' ' ' PHE . 9.5 t30 -132.51 8.55 4.25 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.324 0.65 . . . . 0.0 111.204 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -65.77 -36.22 82.92 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.899 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -66.03 -25.88 67.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.725 1.21 . . . . 0.0 111.47 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.488 ' HD2' ' HA ' ' A' ' 141' ' ' ASN . 56.2 m-85 -92.56 -35.89 13.33 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.595 0.758 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 t -86.85 30.08 0.77 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.36 1.064 . . . . 0.0 111.425 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -67.71 -70.57 0.25 Allowed 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.79 -4.69 17.03 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 17.0 mmt180 -73.2 -22.92 60.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.167 0.587 . . . . 0.0 110.41 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 47' ' ' HIS . 12.7 pt-20 -55.54 -24.59 33.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.824 0.85 . . . . 0.0 112.592 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.7 t -67.53 -46.97 71.27 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 111.724 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 10.9 pt-20 -66.47 -31.97 73.05 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.461 ' HE1' ' HD2' ' A' ' 135' ' ' PRO . 35.8 m95 -68.66 -46.73 68.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 27.2 tt0 -62.47 -37.87 87.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.762 -173.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.29 82.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.153 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 151' ' ' GLU . 55.4 t -66.41 -35.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.901 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.565 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 45.9 m-85 -104.62 -1.73 26.03 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.489 -0.757 . . . . 0.0 112.648 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -81.17 -36.82 29.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.928 0.491 . . . . 0.0 110.768 170.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.409 ' HE1' HD11 ' A' ' 16' ' ' ILE . 4.3 p-80 -67.23 -17.74 64.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.034 0.209 . . . . 0.0 110.648 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.46 -30.75 71.78 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.523 0.729 . . . . 0.0 110.38 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.68 -44.92 95.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.563 0.745 . . . . 0.0 110.228 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.56 1.338 0 C-N-CA 124.415 1.086 . . . . 0.0 109.997 -179.652 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.53 HD13 ' HB3' ' A' ' 80' ' ' SER . 39.2 mm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -124.39 123.72 40.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.648 1.179 . . . . 0.0 108.88 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -89.64 139.35 30.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 122.755 0.422 . . . . 0.0 110.893 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -72.73 166.39 54.26 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.663 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -95.21 139.94 22.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.952 0.501 . . . . 0.0 111.174 -172.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.86 134.26 54.13 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.719 2.279 . . . . 0.0 110.251 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.73 143.35 54.54 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.005 0.816 . . . . 0.0 112.257 -169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 62' ' ' LEU . 34.5 t -97.92 61.35 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.502 HD11 ' CG1' ' A' ' 104' ' ' VAL . 64.4 tp -104.13 145.75 29.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.837 -171.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.659 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 5.2 t70 -116.38 158.42 23.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.86 -21.87 66.65 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.406 0.622 . . . . 0.0 111.084 170.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -110.46 84.12 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.755 1.622 . . . . 0.0 107.754 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -135.56 123.73 23.02 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.515 0.726 . . . . 0.0 110.282 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 38.9 tt0 -106.36 -29.69 9.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.734 1.214 . . . . 0.0 110.677 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.658 HD12 HD11 ' A' ' 159' ' ' LEU . 37.9 mt -131.82 125.18 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.963 0.905 . . . . 0.0 109.628 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.0 tp -110.86 124.82 52.81 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.348 1.059 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' CYS . 47.1 mt -102.45 111.27 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.211 0.604 . . . . 0.0 109.66 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 73' ' ' TRP . 97.4 mt -99.07 127.94 45.1 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.2 -175.13 49.77 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 162.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -94.64 -71.78 0.65 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -134.82 124.59 16.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 71.0 Cg_exo -52.09 137.26 54.02 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.593 2.195 . . . . 0.0 112.442 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 28' ' ' ILE . 30.1 m -61.01 146.17 48.07 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.775 0.672 . . . . 0.0 110.537 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.6 t70 -58.07 -41.72 84.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.799 0.44 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -47.63 -40.54 19.89 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.973 1.309 . . . . 0.0 111.72 171.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -78.34 -39.67 38.81 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.137 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 24' ' ' SER . 74.8 mt -68.12 -25.62 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 124.365 1.066 . . . . 0.0 111.691 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 23.7 mmt180 -65.29 -28.01 69.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.475 0.31 . . . . 0.0 111.349 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -114.62 0.25 13.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.962 0.505 . . . . 0.0 111.393 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 62.69 24.96 14.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.901 1.28 . . . . 0.0 112.878 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -129.63 134.37 47.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.286 1.034 . . . . 0.0 108.806 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -56.51 -46.1 80.71 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.418 0.687 . . . . 0.0 110.513 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -64.15 -0.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.229 1.412 . . . . 0.0 112.889 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.24 -26.45 9.37 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.743 0.687 . . . . 0.0 113.609 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -102.74 108.85 59.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 163.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -26.75 41.21 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.68 2.253 . . . . 0.0 112.019 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.33 -6.53 40.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.791 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.455 HD22 ' HE1' ' A' ' 42' ' ' TRP . 30.3 p-10 -65.86 129.21 38.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.61 -6.73 59.52 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.396 0.679 . . . . 0.0 111.723 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -37.91 -41.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.555 1.542 . . . . 0.0 113.541 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.455 ' HE1' HD22 ' A' ' 39' ' ' ASN . 74.3 m95 -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.603 0.761 . . . . 0.0 112.216 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.3 mtp-105 -75.63 -40.9 55.53 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.403 0.281 . . . . 0.0 110.797 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.77 -55.22 15.96 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.62 -34.32 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.496 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.77 88.42 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.346 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.77 -37.91 89.19 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.769 0.828 . . . . 0.0 109.754 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HA ' ' HG2' ' A' ' 153' ' ' GLU . . . -65.02 -47.78 76.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.296 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.8 pt -89.48 -14.79 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.536 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.99 39.45 20.04 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.034 0.374 . . . . 0.0 114.034 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -133.0 146.27 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.317 1.047 . . . . 0.0 109.361 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -85.15 91.46 8.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.43 -1.29 49.69 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.228 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.15 -48.99 11.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.32 -30.22 60.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.485 1.114 . . . . 0.0 112.307 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.3 mtt -61.23 156.43 18.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.973 0.509 . . . . 0.0 111.001 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.66 162.45 20.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.574 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 31.3 t80 -49.42 -55.37 13.32 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.929 0.892 . . . . 0.0 112.765 -173.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.59 -40.31 82.86 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.7 0.8 . . . . 0.0 111.526 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -66.56 -53.62 32.67 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.971 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 15.9 ptpt -64.86 -30.34 71.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.676 0.61 . . . . 0.0 112.074 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 80.8 mt -61.48 -49.56 76.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.124 0.57 . . . . 0.0 110.612 171.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -64.59 -28.59 69.73 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.447 0.467 . . . . 0.0 111.356 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -68.93 -39.23 79.72 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.371 0.668 . . . . 0.0 110.671 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 72.0 mt -65.15 -49.58 69.3 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 122.913 0.485 . . . . 0.0 110.479 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 4.5 mtpp -68.65 -27.4 65.96 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.945 0.898 . . . . 0.0 112.671 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -58.37 -40.9 83.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.623 0.769 . . . . 0.0 110.349 165.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 87.0 m-20 -93.6 19.28 8.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.397 1.079 . . . . 0.0 110.078 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 64.99 32.89 10.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.124 0.97 . . . . 0.0 111.693 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 72.3 mt -108.59 126.08 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.86 0.864 . . . . 0.0 109.514 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.8 156.04 16.22 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.4 mt -120.98 133.25 55.26 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.469 ' HB3' HD23 ' A' ' 19' ' ' LEU . 6.9 t90 -162.62 -169.16 2.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -145.64 165.25 29.25 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.287 1.035 . . . . 0.0 110.34 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.49 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.9 t -80.77 -47.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.644 0.778 . . . . 0.0 110.805 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -98.14 110.86 23.37 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.355 0.662 . . . . 0.0 111.711 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.09 -24.64 65.06 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.027 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.12 135.0 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.492 0.717 . . . . 0.0 109.609 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.29 146.46 15.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB3' HD13 ' A' ' 2' ' ' ILE . 79.1 p . . . . . 0 N--CA 1.477 0.887 0 CA-C-N 117.87 0.835 . . . . 0.0 110.344 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 51.2 mt . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.78 54.81 4.98 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.42 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.704 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.2 t70 -170.42 148.98 3.25 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.51 17.38 12.1 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.474 0.71 . . . . 0.0 112.434 -166.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -89.71 118.13 29.09 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.312 0.577 . . . . 0.0 109.49 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.1 mt -122.55 146.73 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 109.248 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -64.38 147.33 52.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.921 0.888 . . . . 0.0 110.173 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -81.52 117.48 21.96 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.49 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 59.9 m-85 -105.65 0.65 26.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.509 0.724 . . . . 0.0 111.107 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.9 p -75.4 -16.81 60.33 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.98 -5.82 70.27 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.385 -0.675 . . . . 0.0 112.396 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' O ' HG22 ' A' ' 104' ' ' VAL . 15.3 mt -48.16 -55.08 11.25 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 123.857 0.863 . . . . 0.0 111.107 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -60.29 -26.99 66.92 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.334 0.653 . . . . 0.0 111.77 -167.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -76.16 -41.12 50.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.084 0.954 . . . . 0.0 111.881 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -91.4 -23.15 20.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.502 ' CG1' HD11 ' A' ' 10' ' ' LEU . 15.0 m -122.08 107.95 34.81 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.363 0.529 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.98 -36.49 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.32 2.013 . . . . 0.0 111.961 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -86.35 -10.06 55.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -170.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.35 116.49 5.56 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 121.147 0.499 . . . . 0.0 110.756 -171.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.435 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 5.9 ptm180 -111.06 -43.63 3.72 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.338 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.466 ' HB3' HG12 ' A' ' 16' ' ' ILE . 47.5 tp -126.11 127.58 46.0 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 122.933 0.493 . . . . 0.0 110.009 -167.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.8 mt -110.99 114.15 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.6 m -96.55 115.8 28.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.952 0.901 . . . . 0.0 110.993 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.05 116.26 28.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.655 1.182 . . . . 0.0 109.04 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -93.75 119.35 32.62 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.43 143.05 11.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.103 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 57.2 ttp180 -50.98 -48.75 61.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.45 1.1 . . . . 0.0 112.068 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -49.21 -36.01 18.8 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.73 1.212 . . . . 0.0 112.761 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.88 -42.7 23.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.174 0.59 . . . . 0.0 109.9 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.58 -10.13 47.82 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.54 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 76.4 mt-10 -68.24 -34.59 76.5 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.041 0.536 . . . . 0.0 110.701 172.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -100.71 19.49 16.97 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.931 0.893 . . . . 0.0 110.885 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.1 tm-20 -63.07 -49.34 81.55 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.344 1.058 . . . . 0.0 112.933 170.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.85 -16.27 49.48 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.73 1.62 . . . . 0.0 112.887 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.09 -52.13 67.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.278 1.031 . . . . 0.0 110.868 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.0 -5.06 58.95 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.011 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -66.55 -32.62 74.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.7 0.4 . . . . 0.0 110.331 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.59 -12.6 61.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.536 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.2 mtt -96.17 11.97 32.46 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.175 0.99 . . . . 0.0 111.433 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.33 73.77 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.323 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -105.49 136.18 45.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.301 0.641 . . . . 0.0 110.325 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.67 140.07 57.88 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 167.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.519 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 29.3 p -128.82 141.86 51.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.252 0.548 . . . . 0.0 110.816 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -135.28 126.85 28.85 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.765 1.226 . . . . 0.0 108.83 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.94 106.81 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 111' ' ' CYS . 90.5 mt -88.63 153.33 50.18 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.109 0.964 . . . . 0.0 109.516 170.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.598 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 49.0 Cg_exo -58.63 164.48 9.32 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.131 2.554 . . . . 0.0 113.195 172.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.7 t -65.69 110.7 2.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 p -80.66 25.16 0.44 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.031 0.932 . . . . 0.0 112.088 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.8 t -63.0 147.79 49.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.967 0.907 . . . . 0.0 110.337 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 142' ' ' ARG . . . -69.21 -20.88 75.42 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.343 -0.389 . . . . 0.0 113.343 174.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.73 -8.45 56.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.018 0.527 . . . . 0.0 111.129 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.02 13.19 10.51 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.391 1.076 . . . . 0.0 109.598 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.473 ' HA ' ' OG ' ' A' ' 145' ' ' SER . 48.9 ttp180 -66.77 -31.9 72.84 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.493 0.717 . . . . 0.0 110.558 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -57.3 -32.71 66.94 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.091 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.63 -22.92 16.21 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.491 1.117 . . . . 0.0 110.674 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 84.0 p -90.43 11.64 20.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.024 0.529 . . . . 0.0 112.092 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.07 -69.79 0.18 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.112 0.965 . . . . 0.0 111.949 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -90.4 -2.97 57.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.298 0.639 . . . . 0.0 111.134 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.603 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 13.1 tpt180 -72.61 -18.36 61.6 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.744 0.818 . . . . 0.0 109.499 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -25.24 0.79 Allowed 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.58 1.152 . . . . 0.0 113.079 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.5 t -60.89 -44.95 96.41 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.089 0.955 . . . . 0.0 111.928 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 155' ' ' VAL . 9.5 pt-20 -72.95 -32.25 65.13 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -67.01 -40.19 87.26 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 4.7 tm-20 -71.15 -33.3 69.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.45 63.95 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.153 0.581 . . . . 0.0 111.531 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 151' ' ' GLU . 71.5 t -81.64 -57.62 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.877 0.471 . . . . 0.0 110.746 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.402 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 39.4 m-85 -92.78 1.6 57.2 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -166.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -61.76 -41.46 97.71 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -77.69 -10.75 59.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.419 0.687 . . . . 0.0 111.831 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 16' ' ' ILE . 38.7 mt -78.99 -25.21 43.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.586 -168.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.39 -45.08 89.2 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 166.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 CA--C 1.556 1.193 0 C-N-CA 124.985 1.314 . . . . 0.0 111.578 174.607 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.1 mm . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HB2' HD21 ' A' ' 22' ' ' LEU . 56.9 mtpt -84.91 125.69 32.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.61 0.764 . . . . 0.0 109.975 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.75 135.27 35.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.281 0.633 . . . . 0.0 111.69 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -76.43 -177.01 43.13 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.986 165.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.75 144.67 37.64 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.225 -172.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.96 151.72 32.42 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.83 2.353 . . . . 0.0 112.254 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 139.33 58.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.644 0.778 . . . . 0.0 112.65 -172.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.672 HG11 HD22 ' A' ' 62' ' ' LEU . 65.9 t -104.84 88.59 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.512 HD11 HG12 ' A' ' 104' ' ' VAL . 54.1 tp -138.46 153.37 48.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.808 -160.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.07 165.23 19.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.306 1.042 . . . . 0.0 110.189 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.72 -17.66 64.78 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.99 0.916 . . . . 0.0 111.957 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -120.55 91.57 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.2 m -141.07 118.8 11.68 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.059 0.944 . . . . 0.0 109.074 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.24 -37.75 19.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.685 0.794 . . . . 0.0 110.659 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.438 HD12 HD11 ' A' ' 159' ' ' LEU . 66.4 mt -125.83 124.44 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.246 0.618 . . . . 0.0 109.889 -174.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.52 115.25 29.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' CYS . 47.8 mt -94.2 102.98 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 73' ' ' TRP . 98.2 mt -94.67 119.15 32.85 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.034 0.933 . . . . 0.0 110.233 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.62 -178.78 37.52 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -93.94 -78.55 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 3' ' ' LYS . 64.1 tp -134.3 116.34 13.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 170.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.478 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.7 Cg_exo -53.63 148.39 35.75 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.207 2.605 . . . . 0.0 113.584 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' ILE . 29.0 t -61.55 150.7 35.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.623 1.169 . . . . 0.0 111.918 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 10.4 m-20 -55.03 -43.49 73.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.877 0.871 . . . . 0.0 110.71 175.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -66.55 -26.06 66.95 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.454 1.096 . . . . 0.0 111.0 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.576 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 69.4 m -73.54 -40.91 63.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 24' ' ' SER . 64.1 mt -71.32 -21.69 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.501 1.12 . . . . 0.0 111.413 -176.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 20.3 mmt85 -61.31 -33.12 73.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.035 0.534 . . . . 0.0 110.915 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 80.6 mttt -110.46 -2.47 16.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.011 0.924 . . . . 0.0 111.116 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 58.57 27.73 16.1 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.639 1.576 . . . . 0.0 112.748 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -138.27 156.35 47.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.959 0.904 . . . . 0.0 110.231 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -71.35 -5.51 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.597 0.759 . . . . 0.0 110.288 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -77.34 -16.93 58.66 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.969 1.708 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.83 -30.72 73.6 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 0.0 114.307 -175.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -124.09 99.38 37.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.334 0.654 . . . . 0.0 110.437 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.08 -7.51 15.28 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.676 164.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' HH12 ' A' ' 43' ' ' ARG . . . -85.13 -15.76 66.3 Favored Glycine 0 C--N 1.357 1.741 0 O-C-N 123.525 0.516 . . . . 0.0 112.214 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -73.79 125.76 28.86 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 137' ' ' SER . 1.3 t0 -79.43 -4.88 53.19 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.926 0.891 . . . . 0.0 112.088 -158.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 113' ' ' ASN . 38.0 m-85 -48.48 -36.19 14.61 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.193 0.997 . . . . 0.0 111.663 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -73.25 -32.36 64.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.432 0.693 . . . . 0.0 112.192 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.592 ' HD2' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -88.48 -23.51 23.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.754 0.422 . . . . 0.0 111.511 177.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 149' ' ' GLU . 49.4 mt -86.38 -45.67 10.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.939 0.496 . . . . 0.0 111.051 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.95 -32.48 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.54 94.49 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.476 0.485 . . . . 0.0 112.971 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -61.81 -43.59 98.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.75 0.82 . . . . 0.0 109.809 171.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -71.61 -33.32 68.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.596 -1.183 . . . . 0.0 113.978 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -94.43 -11.37 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.991 0.517 . . . . 0.0 111.146 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 27.54 63.61 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.423 0.452 . . . . 0.0 113.314 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.14 113.0 6.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.3 99.82 0.97 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.202 0.601 . . . . 0.0 111.086 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.465 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 77.0 mt -67.66 -27.89 67.24 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.303 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.592 ' HG3' ' HD2' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -65.17 -37.85 88.69 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.443 0.697 . . . . 0.0 111.438 -173.566 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.5 -36.9 63.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.02 0.528 . . . . 0.0 112.081 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.9 mtt -62.83 149.15 44.97 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -171.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 153.92 40.61 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.208 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.505 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 t80 -44.34 -50.57 9.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.144 0.978 . . . . 0.0 113.501 -171.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 43.1 mt-10 -61.83 -54.17 45.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.504 0.722 . . . . 0.0 111.44 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -58.06 -37.2 73.97 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.639 0.776 . . . . 0.0 111.127 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 35.5 ttmt -62.54 -45.97 90.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.11 0.964 . . . . 0.0 110.132 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.672 HD22 HG11 ' A' ' 9' ' ' VAL . 25.8 mt -61.73 -47.28 85.97 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.134 0.896 . . . . 0.0 110.957 175.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 66.9 mttm -55.02 -38.05 67.42 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -66.79 -51.46 55.46 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.156 0.91 . . . . 0.0 110.238 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 62' ' ' LEU . 57.2 mt -52.8 -56.72 13.67 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.936 0.894 . . . . 0.0 111.395 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.14 -30.54 71.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.315 0.646 . . . . 0.0 111.947 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.28 -36.89 85.17 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.272 0.629 . . . . 0.0 111.175 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -90.94 6.51 44.35 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.385 0.674 . . . . 0.0 110.959 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 65.57 37.44 5.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 111.359 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.24 132.37 56.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 109.46 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.3 154.02 17.24 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -121.26 132.38 54.77 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.439 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.2 t90 -156.08 -169.76 3.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -143.24 165.54 27.18 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.54 0.736 . . . . 0.0 110.2 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.45 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 72.5 t -82.23 -62.29 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.468 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.66 107.7 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.326 0.584 . . . . 0.0 111.374 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.2 ttmt -64.31 -31.92 73.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.032 170.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -152.55 126.85 9.23 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.14 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -134.3 135.45 7.99 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 123.171 0.588 . . . . 0.0 110.052 -176.933 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.25 -23.57 77.2 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.312 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 7.0 t70 -84.07 157.8 21.64 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.123 0.487 . . . . 0.0 110.744 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.3 24.13 8.84 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.904 -170.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 10.8 tp10 -85.75 111.48 20.18 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.36 155.38 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.112 0.965 . . . . 0.0 109.056 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 73' ' ' TRP . 59.0 m-80 -76.63 149.31 36.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.169 0.988 . . . . 0.0 110.484 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.26 116.48 19.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 0.0 110.494 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.45 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.4 m-85 -103.6 4.05 35.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.652 0.781 . . . . 0.0 111.351 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.1 m -74.48 -29.95 61.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.698 0.399 . . . . 0.0 110.746 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.88 -10.79 85.27 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.014 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.405 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.6 mt -47.4 -54.15 12.02 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.133 0.973 . . . . 0.0 111.592 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.442 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.1 mtpt -61.43 -18.76 60.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -167.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.05 -39.15 17.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.282 0.633 . . . . 0.0 111.485 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -96.26 -15.49 21.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 11.1 m -126.95 91.16 47.68 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-N 118.758 0.708 . . . . 0.0 111.023 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.88 -28.78 3.79 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.387 2.058 . . . . 0.0 113.251 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 11.4 mmpt? -94.73 -0.5 54.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.1 tp -60.89 104.42 0.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.518 0.675 . . . . 0.0 111.395 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -93.42 -49.36 5.96 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.841 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 42.7 tp -131.58 133.41 44.99 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.276 0.63 . . . . 0.0 110.056 -173.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.5 HG12 HD21 ' A' ' 107' ' ' LEU . 38.4 mt -105.12 115.67 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 92.4 m -96.09 113.25 24.84 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.448 0.299 . . . . 0.0 110.336 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 133' ' ' VAL . 84.2 m-85 -90.35 107.74 19.33 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 41' ' ' PHE . 4.6 p-10 -86.12 110.48 19.58 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.58 134.62 7.56 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.496 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HA ' HG11 ' A' ' 133' ' ' VAL . 33.4 ttm180 -72.11 -3.25 22.04 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.231 1.012 . . . . 0.0 113.421 -175.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.54 -29.85 41.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.827 0.451 . . . . 0.0 110.307 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.373 0.669 . . . . 0.0 109.664 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.8 -16.02 58.65 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 114.925 -1.034 . . . . 0.0 115.194 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -56.34 -29.58 61.52 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.522 0.729 . . . . 0.0 111.789 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -116.51 20.29 14.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.815 0.846 . . . . 0.0 111.247 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.36 -53.85 54.3 Favored Pre-proline 0 CA--C 1.567 1.622 0 C-N-CA 123.302 0.641 . . . . 0.0 112.23 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.75 -15.49 33.37 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 121.851 1.701 . . . . 0.0 112.727 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.08 -44.87 91.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.534 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 10.0 mt -82.4 -5.38 58.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.244 -172.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -72.43 -22.5 61.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.93 -21.52 67.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.628 0.58 . . . . 0.0 113.197 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.6 mpt? -86.66 7.62 25.81 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.76 0.824 . . . . 0.0 111.026 175.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.63 20.94 70.25 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.153 0.406 . . . . 0.0 113.959 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.442 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 35.5 m-85 -110.62 145.51 37.76 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.193 0.597 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.26 143.62 40.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.3 p -130.32 151.12 51.18 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.531 0.732 . . . . 0.0 110.131 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.44 121.82 4.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 109.313 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 112' ' ' PHE . 52.2 t -85.84 130.56 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.132 0.492 . . . . 0.0 110.084 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.6 mt -101.09 152.74 37.96 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.961 1.304 . . . . 0.0 108.274 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.14 153.03 78.79 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.434 2.09 . . . . 0.0 112.575 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 m -59.52 114.46 2.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.411 1.084 . . . . 0.0 110.339 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' A' ' 40' ' ' ASP . 19.4 m -86.34 49.12 1.73 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.556 0.693 . . . . 0.0 111.894 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 p -68.96 139.44 55.04 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 154.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.82 57.88 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 123.474 0.484 . . . . 0.0 113.445 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.56 86.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.108 0.563 . . . . 0.0 110.567 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.82 -41.66 67.95 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.108 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -53.93 -34.02 58.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.692 0.62 . . . . 0.0 111.76 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -69.0 -29.83 68.11 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -98.82 22.49 10.04 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.987 1.315 . . . . 0.0 110.697 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 66.6 m -157.32 34.98 0.28 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.096 0.959 . . . . 0.0 109.697 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -66.8 -35.09 79.27 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.799 1.036 . . . . 0.0 113.799 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.28 -13.86 26.05 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.586 0.355 . . . . 0.0 110.249 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.9 tpt180 -79.73 -38.7 32.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.302 0.641 . . . . 0.0 109.776 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.478 ' HB2' HD22 ' A' ' 44' ' ' LEU . 12.5 pt-20 -62.68 -18.19 61.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.479 1.112 . . . . 0.0 112.212 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.1 t -58.88 -23.05 60.49 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.42 0.688 . . . . 0.0 111.651 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 155' ' ' VAL . 9.4 pt-20 -65.6 -32.14 73.56 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 122.996 0.518 . . . . 0.0 110.654 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -65.62 -43.11 90.57 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.44 -37.72 88.38 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.695 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.13 -14.36 59.81 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.072 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 151' ' ' GLU . 48.5 t -87.13 -54.58 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.411 0.685 . . . . 0.0 110.601 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.548 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 71.9 m-85 -91.77 2.87 56.21 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -168.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -72.62 -28.18 62.6 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.271 0.487 . . . . 0.0 112.163 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -74.6 -6.87 51.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.438 HD11 HD12 ' A' ' 16' ' ' ILE . 95.4 mt -76.08 -22.6 55.41 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.98 0.512 . . . . 0.0 111.603 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.58 -15.39 62.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.871 0.468 . . . . 0.0 111.129 166.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 125.594 1.558 . . . . 0.0 110.252 175.266 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 80' ' ' SER . 46.1 mm . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -94.81 131.88 40.2 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -91.61 130.82 37.36 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 110.305 171.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 158.96 53.62 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 162.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -82.72 143.5 47.03 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 117.779 0.789 . . . . 0.0 110.084 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 162.44 1.55 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.206 2.604 . . . . 0.0 112.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -66.22 125.74 26.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.37 0.605 . . . . 0.0 110.513 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.646 HG11 HD22 ' A' ' 62' ' ' LEU . 21.2 t -91.03 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.556 HD11 ' CG1' ' A' ' 104' ' ' VAL . 49.9 tp -110.27 143.94 39.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.982 -162.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -125.89 163.62 22.55 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.8 -22.17 66.55 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.194 0.521 . . . . 0.0 110.968 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.617 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 22.3 m120 -103.43 77.64 1.53 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.5 m -133.53 104.68 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.03 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.544 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 84.3 mt-10 -89.72 -30.15 18.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.549 1.14 . . . . 0.0 109.827 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.8 mt -126.68 118.18 50.13 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 123.886 0.874 . . . . 0.0 109.023 174.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -103.72 117.05 33.47 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.465 HG12 ' HB2' ' A' ' 111' ' ' CYS . 44.1 mt -99.54 110.33 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.79 118.14 35.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.47 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -72.94 -168.59 12.89 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 164.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -103.99 -72.46 0.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 tp -147.31 124.62 5.79 Favored Pre-proline 0 C--O 1.243 0.763 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.58 150.31 70.18 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.935 2.423 . . . . 0.0 112.452 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.0 t -68.92 163.41 24.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.981 0.912 . . . . 0.0 110.758 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 m-20 -53.77 -48.28 69.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.417 0.687 . . . . 0.0 110.46 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.18 -39.91 80.12 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.316 1.01 . . . . 0.0 111.361 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -67.35 -45.76 75.42 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.14 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.1 mt -71.6 -19.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.298 1.039 . . . . 0.0 111.976 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 28.5 mmm180 -70.39 -46.76 63.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -90.76 -6.54 54.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.447 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 65.97 22.08 11.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.175 1.39 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -129.32 142.92 50.7 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 109.377 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -60.79 -44.24 97.08 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.027 0.918 . . . . 0.0 108.569 165.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.87 -8.62 5.22 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.389 171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.98 -31.69 58.84 Favored Glycine 0 C--N 1.351 1.397 0 C-N-CA 123.54 0.59 . . . . 0.0 112.979 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -100.79 104.8 33.94 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.66 -10.92 29.77 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.404 2.736 . . . . 0.0 112.719 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.75 -6.84 64.11 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.06 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -79.7 116.81 20.1 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -83.24 -0.5 49.78 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.262 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -42.47 -42.66 3.35 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.454 1.901 . . . . 0.0 112.974 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -74.36 -21.71 59.55 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.697 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.54 -37.12 17.17 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.763 0.825 . . . . 0.0 111.222 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.41 -52.61 15.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.79 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.05 -39.11 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.051 0.54 . . . . 0.0 109.557 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.76 99.6 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.911 0.757 . . . . 0.0 113.982 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -69.02 -34.91 76.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.654 . . . . 0.0 110.24 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -71.6 -38.78 70.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.045 0.938 . . . . 0.0 112.81 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.8 pt -89.72 -9.98 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.952 0.501 . . . . 0.0 111.563 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.3 29.55 66.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.211 0.32 . . . . 0.0 113.022 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -133.71 112.97 11.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -66.27 93.07 0.2 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.283 0.563 . . . . 0.0 110.298 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.17 -39.42 89.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.78 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -57.12 -46.5 82.59 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.581 1.152 . . . . 0.0 111.709 -166.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -69.59 -37.47 76.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.392 0.677 . . . . 0.0 112.195 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.13 145.74 49.95 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.497 0.719 . . . . 0.0 112.369 -172.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.18 138.82 55.91 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.29 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.534 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 57.1 t80 -43.94 -46.49 8.19 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.532 1.133 . . . . 0.0 113.529 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.13 -47.99 80.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 111.857 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -63.93 -37.99 89.45 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.251 1.021 . . . . 0.0 110.701 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 58' ' ' TYR . 19.5 ttmm -60.45 -43.15 97.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.707 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.646 HD22 HG11 ' A' ' 9' ' ' VAL . 72.7 mt -65.88 -42.53 90.18 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.015 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -61.21 -33.38 73.38 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.6 m -64.22 -45.08 89.82 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.225 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.8 mt -57.59 -47.83 81.06 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.476 0.485 . . . . 0.0 110.371 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HE2' HG12 ' A' ' 9' ' ' VAL . 26.3 mmtp -61.95 -37.68 85.62 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.204 0.602 . . . . 0.0 110.417 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -58.21 -40.83 82.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.159 0.983 . . . . 0.0 111.456 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -89.88 3.5 52.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.141 0.576 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.544 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 1.1 mpp_? 65.68 45.65 2.59 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.218 1.407 . . . . 0.0 111.592 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.8 mt -114.09 131.86 64.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 109.168 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.15 160.33 13.29 Favored Glycine 0 N--CA 1.462 0.411 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 169.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.5 mt -124.49 145.34 49.59 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -165.88 -168.9 1.38 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -128.43 170.16 13.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.077 0.551 . . . . 0.0 109.639 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 77.3 t -83.0 -45.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -95.77 112.28 24.04 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.179 0.591 . . . . 0.0 109.79 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -67.37 -24.52 65.71 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.777 0.831 . . . . 0.0 110.462 171.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.94 140.64 19.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.96 0.904 . . . . 0.0 109.854 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -150.03 134.14 4.69 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.524 ' HB3' HD13 ' A' ' 2' ' ' ILE . 47.4 p . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.241 0.642 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.32 59.01 4.89 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.529 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.4 t70 179.05 154.56 0.44 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.126 0.971 . . . . 0.0 110.26 -173.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.02 28.91 6.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.816 1.246 . . . . 0.0 112.237 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.2 100.01 6.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.716 0.689 . . . . 0.0 109.256 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.3 mt -101.86 147.76 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.346 1.059 . . . . 0.0 110.354 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.93 151.17 46.88 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.643 0.777 . . . . 0.0 110.166 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.96 103.66 10.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 54.8 m-85 -93.54 1.85 56.6 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.606 0.762 . . . . 0.0 111.032 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.3 m -74.76 -9.45 58.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.658 0.383 . . . . 0.0 111.752 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.31 -5.28 70.06 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.739 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.441 HD12 ' SD ' ' A' ' 127' ' ' MET . 17.2 mt -47.38 -58.01 4.64 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 123.898 0.879 . . . . 0.0 113.252 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -63.63 -14.52 52.54 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -164.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.21 -46.88 8.14 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.179 0.992 . . . . 0.0 111.168 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -83.23 -23.41 32.78 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 9.8 m -123.67 90.51 50.53 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 123.08 0.552 . . . . 0.0 110.629 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.06 -34.84 4.65 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.462 2.108 . . . . 0.0 111.695 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.617 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.1 mmpt? -73.41 -17.9 61.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.138 0.975 . . . . 0.0 113.471 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 33.2 tp -62.16 133.32 55.07 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 123.518 0.511 . . . . 0.0 111.445 -170.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -142.64 -28.93 0.58 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.882 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 58.1 tp -134.62 138.87 44.88 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.642 0.777 . . . . 0.0 109.715 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 131' ' ' THR . 72.2 mt -113.98 143.64 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.469 ' HB3' HD12 ' A' ' 134' ' ' LEU . 72.3 m -126.64 130.31 50.2 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.492 0.717 . . . . 0.0 109.521 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.441 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 92.3 m-85 -105.04 130.18 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.191 0.596 . . . . 0.0 111.09 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.438 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 94.4 m-20 -85.29 88.81 7.53 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.141 0.576 . . . . 0.0 109.943 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 170.82 26.22 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.153 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 65.1 ttt180 -53.48 -63.65 1.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.112 0.965 . . . . 0.0 112.064 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -61.17 -12.41 12.56 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -84.65 -50.04 8.0 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.12 -9.77 72.43 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.962 -1.017 . . . . 0.0 115.108 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.1 mt-10 -64.62 -18.46 64.94 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.833 0.816 . . . . 0.0 111.762 176.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.36 25.15 12.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.199 1.0 . . . . 0.0 110.664 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.5 -52.32 73.7 Favored Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 123.628 0.771 . . . . 0.0 112.738 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.17 -19.19 51.07 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.082 1.855 . . . . 0.0 112.845 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.58 -46.02 87.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.054 0.942 . . . . 0.0 110.34 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.492 ' HB2' HG21 ' A' ' 131' ' ' THR . 18.7 mt -86.65 -9.69 55.46 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.461 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.66 -26.29 64.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.123 0.569 . . . . 0.0 110.782 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.37 -10.56 70.32 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.964 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.441 ' SD ' HD12 ' A' ' 100' ' ' LEU . 59.9 mtt -94.99 12.11 29.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.983 0.913 . . . . 0.0 110.696 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.79 -4.39 74.82 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -91.23 144.8 25.23 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.946 0.498 . . . . 0.0 110.921 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -74.32 145.85 43.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' HB ' ' A' ' 110' ' ' ILE . 18.6 p -134.98 148.61 50.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.066 0.946 . . . . 0.0 108.901 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -142.0 127.48 18.92 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.092 0.957 . . . . 0.0 108.697 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.74 110.87 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 111' ' ' CYS . 92.9 mt -95.11 154.68 39.53 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.87 154.29 58.47 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.936 1.757 . . . . 0.0 111.586 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -66.64 113.77 5.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.8 t -79.33 36.34 0.3 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -167.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -74.67 159.6 31.87 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.286 0.634 . . . . 0.0 110.559 172.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.62 47.05 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.96 14.67 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.583 0.692 . . . . 0.0 110.737 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -74.14 -23.8 59.32 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.139 0.576 . . . . 0.0 110.923 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.575 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 37.8 ptt180 -66.88 -25.74 66.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.805 0.336 . . . . 0.0 110.625 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -63.2 -26.22 68.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.234 1.014 . . . . 0.0 110.965 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -99.13 -24.85 14.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.632 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 49.5 m -82.97 22.55 0.93 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.809 0.844 . . . . 0.0 112.59 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.95 -61.06 2.06 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.56 -30.89 67.49 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 167.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.632 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 48.0 mtp180 -83.71 -11.3 57.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.37 0.268 . . . . 0.0 111.288 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.1 -34.35 30.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.059 0.544 . . . . 0.0 111.05 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.3 m -60.25 -39.55 87.13 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.925 0.89 . . . . 0.0 112.466 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -72.31 -36.28 68.85 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -64.59 -47.51 78.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 26.7 tt0 -64.12 -37.35 87.14 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.883 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.75 -37.3 62.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.903 0.752 . . . . 0.0 111.276 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.46 HG11 ' SG ' ' A' ' 111' ' ' CYS . 20.9 t -61.88 -39.22 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.701 0.801 . . . . 0.0 111.362 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -106.36 1.21 25.57 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 122.12 -0.362 . . . . 0.0 110.44 -171.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 ttm180 -71.88 -40.11 69.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.486 0.715 . . . . 0.0 110.108 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -76.67 -4.77 44.86 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.73 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.7 -30.19 62.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.002 0.521 . . . . 0.0 109.717 172.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -94.92 -55.37 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.942 -176.107 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -92.06 113.81 26.18 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -87.37 123.08 31.94 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 122.613 0.365 . . . . 0.0 111.126 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.71 166.57 54.85 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.256 168.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -94.18 145.94 30.68 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 119.284 -0.389 . . . . 0.0 111.195 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.84 159.68 32.4 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.821 2.347 . . . . 0.0 111.439 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -67.15 130.08 41.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.262 0.554 . . . . 0.0 111.532 -174.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.597 HG11 HD22 ' A' ' 62' ' ' LEU . 46.5 t -95.7 60.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.454 HD11 ' CG1' ' A' ' 104' ' ' VAL . 42.0 tp -106.58 153.95 21.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.339 -161.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.649 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 22.7 t0 -126.07 154.83 42.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.89 1.276 . . . . 0.0 108.056 170.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.07 -11.22 60.59 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.853 0.461 . . . . 0.0 111.667 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.471 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . 23.8 m-80 -108.83 17.92 21.3 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.869 0.467 . . . . 0.0 110.79 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -72.78 117.73 14.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.194 0.598 . . . . 0.0 111.154 -174.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.07 -36.29 17.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.073 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.1 mt -126.1 112.1 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.428 HD13 HD13 ' A' ' 10' ' ' LEU . 59.9 tp -103.43 118.61 37.15 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.54 HG12 ' HB2' ' A' ' 111' ' ' CYS . 41.9 mt -104.18 110.17 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 109.178 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 82.8 mt -100.27 124.77 46.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.337 1.055 . . . . 0.0 109.901 -177.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -78.84 -171.86 40.75 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 164.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.4 p -100.39 -68.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.417 HD12 ' HD2' ' A' ' 23' ' ' PRO . 39.0 tp -149.35 116.96 3.73 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 173.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD2' HD12 ' A' ' 22' ' ' LEU . 58.9 Cg_endo -66.48 166.02 23.14 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.004 2.469 . . . . 0.0 113.423 -167.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -65.39 147.2 53.84 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.327 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.8 m-20 -57.63 -39.15 76.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.137 0.975 . . . . 0.0 111.358 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.81 -28.35 69.8 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 124.142 0.901 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.533 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 39.2 m -84.73 -38.28 19.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.584 0.753 . . . . 0.0 110.401 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.2 -29.19 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.832 0.853 . . . . 0.0 111.158 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.2 mmt180 -54.16 -38.17 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 170.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -94.25 -16.34 23.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.096 0.958 . . . . 0.0 110.514 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 56.46 24.96 9.11 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.927 1.291 . . . . 0.0 111.729 -170.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -144.16 151.49 39.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.032 0.933 . . . . 0.0 110.208 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.452 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 87.8 m-85 -70.41 -0.38 8.16 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.983 1.313 . . . . 0.0 114.52 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.415 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 2.5 p90 -96.94 -12.06 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.64 -33.07 80.72 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.845 0.715 . . . . 0.0 113.143 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -103.25 100.01 16.53 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.38 0.672 . . . . 0.0 109.525 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.25 -21.07 23.83 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.189 2.593 . . . . 0.0 111.638 171.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.57 -1.75 66.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.435 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -79.38 112.49 16.66 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -87.64 -1.36 57.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.837 0.855 . . . . 0.0 110.806 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.425 ' HE1' HG21 ' A' ' 18' ' ' ILE . 82.3 t80 -39.83 -45.08 1.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.979 1.711 . . . . 0.0 112.602 172.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.472 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 80.3 m95 -70.74 -27.78 64.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.311 -173.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -74.81 -48.4 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.414 0.286 . . . . 0.0 110.255 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.34 -47.07 83.69 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.936 0.773 . . . . 0.0 110.83 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.25 -40.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.43 0.692 . . . . 0.0 109.96 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.58 85.42 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.922 0.764 . . . . 0.0 113.636 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -73.52 -44.11 58.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.695 0.798 . . . . 0.0 110.146 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -64.35 -38.99 92.99 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.541 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.9 pt -88.29 -15.25 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.34 28.43 63.88 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 116.477 -0.329 . . . . 0.0 113.828 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -143.65 96.97 2.99 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.9 105.95 0.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.011 0.924 . . . . 0.0 111.971 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.27 -23.31 40.86 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.408 0.683 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.36 -38.27 86.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.461 0.705 . . . . 0.0 111.474 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -94.13 6.13 49.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.542 0.737 . . . . 0.0 111.108 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.5 mtt -95.41 146.01 24.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.124 0.569 . . . . 0.0 110.567 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.9 158.45 35.54 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.071 170.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.578 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 32.8 t80 -47.76 -63.4 1.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.851 0.86 . . . . 0.0 113.141 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 29.8 mt-10 -59.89 -32.85 71.12 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.191 0.597 . . . . 0.0 111.095 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -54.98 12.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.925 0.89 . . . . 0.0 111.692 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HE2' ' CD2' ' A' ' 42' ' ' TRP . 8.2 ptmt -59.99 -29.75 68.67 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.473 -176.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.597 HD22 HG11 ' A' ' 9' ' ' VAL . 39.6 mt -64.95 -47.87 76.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.705 0.802 . . . . 0.0 111.476 173.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.9 mmmm -55.57 -38.16 68.99 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.234 0.54 . . . . 0.0 110.358 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.1 m -69.63 -39.53 77.09 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.355 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 62' ' ' LEU . 89.8 mt -57.4 -50.09 74.1 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.926 0.49 . . . . 0.0 110.529 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.649 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 1.8 mptm? -60.98 -37.07 81.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.72 0.637 . . . . 0.0 110.833 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -64.36 -42.09 96.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.877 0.871 . . . . 0.0 111.154 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.429 ' O ' HD13 ' A' ' 159' ' ' LEU . 59.7 m-80 -88.79 3.32 51.46 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.067 0.547 . . . . 0.0 110.903 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.471 ' HD2' ' HB2' ' A' ' 13' ' ' ASN . 24.3 mmt180 67.05 35.13 4.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.356 1.062 . . . . 0.0 111.394 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -106.22 134.05 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.55 1.14 . . . . 0.0 108.797 174.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.16 151.15 18.01 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 172.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 mt -124.38 131.9 53.52 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 117.862 0.831 . . . . 0.0 109.833 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 2.8 t90 -152.74 -175.99 5.54 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -130.93 158.18 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.539 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.3 t -70.85 -44.33 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 173.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -101.79 108.28 19.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.432 0.634 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.7 ptmt -65.63 -24.71 67.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.528 167.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.94 137.52 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.919 0.888 . . . . 0.0 109.208 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -154.79 150.76 22.39 Favored Glycine 0 C--O 1.212 -1.234 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.479 0.977 0 CA-C-N 118.17 0.985 . . . . 0.0 109.544 -179.598 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.02 59.99 0.4 Allowed Glycine 0 N--CA 1.461 0.307 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.603 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 23.1 t70 -177.14 158.5 1.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.111 -1.544 . . . . 0.0 107.698 -164.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.27 20.71 11.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -167.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.7 tp10 -89.58 98.93 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 mt -110.53 150.0 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.867 0.867 . . . . 0.0 109.54 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -71.32 148.53 46.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.001 0.92 . . . . 0.0 110.632 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -79.0 96.78 5.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.822 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.539 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 31.6 m-85 -80.23 -8.45 59.46 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.23 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -72.12 -18.85 61.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.898 0.479 . . . . 0.0 110.753 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 -5.88 62.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.467 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 21.9 mt -52.57 -51.34 60.24 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.241 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -58.94 -26.2 64.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.134 0.574 . . . . 0.0 112.268 -171.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.72 -35.9 65.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.5 0.72 . . . . 0.0 111.332 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -106.98 -14.56 14.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -172.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 19.2 m -125.29 86.64 56.73 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.211 0.914 . . . . 0.0 111.443 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.83 -33.13 4.01 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.714 2.276 . . . . 0.0 112.211 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.39 -7.72 58.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.107 0.563 . . . . 0.0 112.235 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 56.9 tp -58.67 104.12 0.2 Allowed 'General case' 0 C--N 1.355 0.805 0 O-C-N 123.659 0.6 . . . . 0.0 111.282 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.95 -47.2 7.13 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.5 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 49.7 tp -128.45 133.79 48.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.232 0.613 . . . . 0.0 110.967 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mt -108.46 126.39 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.54 ' HB2' HG12 ' A' ' 18' ' ' ILE . 78.9 m -109.46 115.99 30.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.513 0.725 . . . . 0.0 110.327 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.51 122.02 37.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.648 0.779 . . . . 0.0 110.549 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.544 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 84.5 m-20 -76.58 89.57 3.31 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 110.283 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.22 172.46 45.93 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.532 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 88.9 mtm180 -55.62 -50.93 68.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.467 1.107 . . . . 0.0 113.127 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 62.9 mmtt -62.32 -17.33 58.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.32 -37.76 13.82 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.65 -9.98 75.32 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.904 -1.044 . . . . 0.0 115.23 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.3 mt-10 -61.03 -26.07 67.36 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.455 0.645 . . . . 0.0 110.786 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -99.55 10.07 42.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.638 1.175 . . . . 0.0 111.405 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 35.9 tt0 -55.11 -54.06 54.57 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.698 171.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.25 -25.18 36.96 Favored 'Trans proline' 0 C--N 1.397 3.095 0 CA-C-N 121.075 1.42 . . . . 0.0 111.805 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.17 -41.74 98.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.67 0.788 . . . . 0.0 110.385 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 mt -96.34 -15.05 22.1 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.819 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -69.54 -32.07 70.65 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.456 0.646 . . . . 0.0 109.59 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.1 -5.0 64.6 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.454 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.5 mtt -93.98 13.03 24.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.693 0.797 . . . . 0.0 111.25 172.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.51 10.62 84.63 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.415 0.526 . . . . 0.0 114.415 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.07 145.75 27.58 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 122.869 0.468 . . . . 0.0 110.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.88 135.76 49.91 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.446 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 16.0 p -128.9 139.3 52.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.911 0.884 . . . . 0.0 109.531 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -146.36 131.12 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.15 104.37 15.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 111' ' ' CYS . 54.6 mt -82.29 147.43 56.82 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.399 172.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.662 ' HG3' ' HG3' ' A' ' 148' ' ' ARG . 42.5 Cg_endo -63.6 152.12 81.83 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 122.583 2.189 . . . . 0.0 111.727 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.0 m -60.08 123.24 16.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 m -86.16 12.4 9.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.944 0.498 . . . . 0.0 111.645 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p -60.85 149.0 37.44 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.13 0.572 . . . . 0.0 109.528 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.66 -28.72 60.35 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.328 0.393 . . . . 0.0 112.975 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.08 -35.22 79.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.909 0.884 . . . . 0.0 112.195 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -98.74 5.66 47.42 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.538 0.735 . . . . 0.0 111.43 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -73.93 -10.56 59.77 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.3 0.572 . . . . 0.0 110.699 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -52.29 -26.11 11.19 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.042 0.937 . . . . 0.0 112.994 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -96.47 2.82 52.87 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.599 0.76 . . . . 0.0 111.949 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.701 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 97.8 p -73.27 15.37 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -162.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.39 -74.21 0.17 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.284 0.947 . . . . 0.0 109.39 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.88 -25.21 63.59 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 112.002 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.701 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -69.42 -49.62 53.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.73 0.812 . . . . 0.0 110.158 -177.128 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -60.52 -36.53 78.62 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.264 0.626 . . . . 0.0 110.632 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -63.95 -40.78 97.21 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.535 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 6.9 pt-20 -70.06 -28.05 65.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.331 0.253 . . . . 0.0 110.715 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -71.63 -35.76 70.53 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.321 0.648 . . . . 0.0 109.745 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.1 -37.03 83.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.12 -17.62 64.94 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.456 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 151' ' ' GLU . 87.7 t -89.72 -61.94 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.316 0.646 . . . . 0.0 110.798 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.485 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 62.9 m-85 -86.51 2.45 47.91 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -164.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -75.55 -21.24 58.08 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.415 ' HE1' HD11 ' A' ' 16' ' ' ILE . 7.8 p-80 -77.14 -10.86 59.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.775 0.43 . . . . 0.0 111.493 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 68' ' ' ASN . 81.2 mt -69.34 -14.78 63.11 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.639 0.775 . . . . 0.0 112.695 -170.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.64 -34.4 60.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.989 0.516 . . . . 0.0 111.003 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 124.944 1.298 . . . . 0.0 110.29 -173.235 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.471 HG23 ' HB1' ' A' ' 78' ' ' ALA . 41.0 mm . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 2.9 mptp? -94.64 111.57 23.33 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -86.6 143.41 27.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.97 -131.31 0.04 OUTLIER Glycine 0 CA--C 1.532 1.151 0 CA-C-O 121.281 0.379 . . . . 0.0 113.434 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -136.76 145.01 49.19 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.964 -0.727 . . . . 0.0 110.234 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.04 135.81 65.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.163 1.909 . . . . 0.0 108.956 166.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 135.44 57.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.655 0.597 . . . . 0.0 110.992 -170.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.647 HG11 HD22 ' A' ' 62' ' ' LEU . 74.9 t -96.32 88.31 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.508 HD11 ' CG1' ' A' ' 104' ' ' VAL . 16.8 tp -140.0 150.41 44.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -161.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.701 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 13.6 t70 -127.17 160.17 32.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.524 1.13 . . . . 0.0 108.396 171.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -67.28 -16.86 64.52 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.972 0.509 . . . . 0.0 111.88 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -102.37 17.57 23.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.986 0.914 . . . . 0.0 110.734 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.417 ' HB ' HG12 ' A' ' 104' ' ' VAL . 85.5 m -79.22 122.84 26.8 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.938 0.495 . . . . 0.0 110.167 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 30.7 tt0 -97.21 -32.23 12.04 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.546 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.597 HD12 HD11 ' A' ' 159' ' ' LEU . 42.1 mt -130.25 123.91 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.11 121.26 44.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -96.42 113.1 29.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.3 mt -99.91 111.64 23.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 109.384 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.4 177.36 21.31 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 167.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 t -90.57 -89.96 0.16 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.15 0.975 . . . . 0.0 108.789 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.77 112.31 14.93 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.93 149.11 83.01 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.172 1.915 . . . . 0.0 111.705 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.67 135.78 50.29 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.5 p-10 -61.75 -19.6 62.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -171.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -52.66 -36.57 57.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.719 1.208 . . . . 0.0 111.921 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 p -90.33 -33.97 15.88 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.294 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 81.7 mt -64.32 -37.66 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.224 1.01 . . . . 0.0 112.923 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 26.5 mmt180 -61.4 -28.59 69.36 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.204 0.526 . . . . 0.0 110.042 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -89.93 -23.28 21.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 111.131 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.08 28.02 14.27 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.994 1.317 . . . . 0.0 111.913 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.88 137.82 49.53 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.457 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.661 ' HB3' ' HZ2' ' A' ' 42' ' ' TRP . 93.5 m-85 -77.03 -2.96 36.67 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.699 167.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -97.38 -18.68 18.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.424 1.09 . . . . 0.0 110.927 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.85 -108.44 0.03 OUTLIER Glycine 0 C--N 1.344 0.994 0 O-C-N 123.307 0.379 . . . . 0.0 112.331 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -124.69 93.22 46.55 Favored Pre-proline 0 N--CA 1.484 1.23 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HG2' ' HE1' ' A' ' 42' ' ' TRP . 7.7 Cg_exo -75.02 -52.43 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.916 2.411 . . . . 0.0 111.494 175.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.23 34.33 5.91 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -131.59 135.61 47.12 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.298 1.039 . . . . 0.0 111.838 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.99 0.28 28.24 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 124.946 1.299 . . . . 0.0 109.998 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -39.3 -50.3 2.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.254 2.222 . . . . 0.0 113.533 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.661 ' HZ2' ' HB3' ' A' ' 33' ' ' TYR . 72.9 m95 -69.11 -20.87 64.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.279 0.631 . . . . 0.0 112.21 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 4.6 mpt_? -86.77 -39.85 15.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.931 0.892 . . . . 0.0 110.339 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.76 -51.8 30.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.063 0.545 . . . . 0.0 111.053 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 t -73.16 -35.55 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.059 0.944 . . . . 0.0 109.61 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.74 -38.58 95.79 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.67 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -69.16 -40.6 78.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.245 0.618 . . . . 0.0 109.943 173.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -60.77 -42.69 97.96 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.737 0.815 . . . . 0.0 112.925 -175.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -95.15 -10.0 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.211 0.604 . . . . 0.0 112.162 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.55 59.19 Favored Glycine 0 C--N 1.353 1.496 0 O-C-N 123.266 0.354 . . . . 0.0 113.44 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.48 117.64 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.12 1.368 . . . . 0.0 108.389 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -68.47 88.73 0.34 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.597 0.713 . . . . 0.0 111.345 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.159 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -55.35 -50.94 68.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.226 1.01 . . . . 0.0 112.524 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.43 -5.78 59.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.713 0.805 . . . . 0.0 111.366 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.5 mtt -80.42 141.32 35.42 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.9 154.42 12.32 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.336 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.64 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 39.8 t80 -39.02 -50.65 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.824 0.85 . . . . 0.0 112.205 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 39.0 mt-10 -54.55 -55.72 26.34 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.154 0.909 . . . . 0.0 111.596 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.36 -39.49 74.59 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -61.18 -41.56 97.01 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.018 0.372 . . . . 0.0 110.575 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.647 HD22 HG11 ' A' ' 9' ' ' VAL . 17.0 mt -63.68 -43.94 95.2 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.887 0.742 . . . . 0.0 110.714 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 34.6 mmtp -56.76 -41.51 77.7 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.6 m -68.57 -39.55 80.97 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.042 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 61' ' ' LYS . 91.9 mt -57.35 -50.32 73.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 123.055 0.542 . . . . 0.0 109.942 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.701 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -56.79 -41.57 77.96 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 111.306 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.701 0.8 . . . . 0.0 111.278 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 56.7 m-80 -97.34 17.56 17.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.23 0.612 . . . . 0.0 110.784 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER 62.72 29.39 16.78 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.452 1.101 . . . . 0.0 111.308 169.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.95 134.87 42.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.327 1.051 . . . . 0.0 108.626 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.46 157.57 15.39 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.17 131.74 53.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.569 0.748 . . . . 0.0 109.459 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -161.8 -168.07 1.85 Allowed 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.65 162.91 33.97 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.687 0.676 . . . . 0.0 111.569 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 68.9 t -88.21 -45.46 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.438 1.095 . . . . 0.0 110.222 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -100.56 109.69 21.8 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.527 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.3 ttmt -64.37 -39.96 94.9 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 124.368 1.043 . . . . 0.0 110.294 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 2' ' ' ILE . . . -150.21 133.48 16.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.899 -176.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.72 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -155.15 144.22 10.8 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.48 1.06 0 CA-C-N 117.452 0.626 . . . . 0.0 110.127 -175.893 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 mt . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.65 58.6 0.41 Allowed Glycine 0 C--O 1.244 0.737 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.887 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 15.2 t70 -178.78 146.68 0.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 107.964 -174.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -105.18 16.82 25.11 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -167.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 15.4 tp10 -82.47 101.01 10.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.787 0.803 . . . . 0.0 109.785 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.38 145.71 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.575 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.8 156.27 34.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.867 0.467 . . . . 0.0 110.37 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.91 110.71 13.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.898 0.879 . . . . 0.0 110.367 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.7 m-85 -106.05 -9.42 17.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.281 0.632 . . . . 0.0 112.488 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.2 p -68.19 -13.49 62.27 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.62 0.368 . . . . 0.0 111.797 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -2.14 56.72 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 118.806 -0.997 . . . . 0.0 113.695 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -49.76 -37.4 29.59 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.445 0.698 . . . . 0.0 112.572 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.26 -31.5 72.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.52 0.328 . . . . 0.0 111.739 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.26 -50.95 8.92 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.033 0.933 . . . . 0.0 111.748 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.418 ' HG3' HG22 ' A' ' 104' ' ' VAL . 21.2 ptm -72.67 -33.54 66.6 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.302 0.641 . . . . 0.0 111.948 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -128.85 87.19 55.4 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.803 0.841 . . . . 0.0 109.64 176.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.09 -28.03 13.28 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.709 2.273 . . . . 0.0 112.501 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 0.24 56.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.316 0.646 . . . . 0.0 111.753 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 44.7 tp -57.23 110.18 0.8 Allowed 'General case' 0 C--N 1.354 0.762 0 O-C-N 123.806 0.691 . . . . 0.0 111.222 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.595 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 12.2 ptm180 -101.59 -43.47 5.88 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.67 170.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.468 ' HB3' HG12 ' A' ' 16' ' ' ILE . 59.8 tp -131.05 128.55 40.51 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.786 0.835 . . . . 0.0 110.245 -168.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.74 113.93 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.453 1.101 . . . . 0.0 108.501 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.424 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.3 m -96.48 113.73 25.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.858 0.463 . . . . 0.0 110.405 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.24 109.25 19.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.073 0.949 . . . . 0.0 110.088 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.445 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 7.2 t30 -81.85 90.4 6.41 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.95 143.25 7.32 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.768 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -54.86 -49.04 72.12 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.314 1.046 . . . . 0.0 112.141 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -49.26 -38.33 26.58 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.583 1.153 . . . . 0.0 112.744 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.77 -42.98 66.5 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.663 0.785 . . . . 0.0 110.102 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.7 -9.33 69.63 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 114.601 -1.181 . . . . 0.0 114.451 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.98 -28.99 70.47 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.138 0.469 . . . . 0.0 110.855 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.6 22.86 12.86 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.454 1.102 . . . . 0.0 110.937 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.14 -55.15 46.92 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.427 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.79 -19.18 66.61 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 122.014 1.809 . . . . 0.0 111.979 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.65 -49.04 74.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.384 1.074 . . . . 0.0 109.389 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 mt -87.59 -15.97 35.88 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.081 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -66.73 -31.71 72.53 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.24 -12.07 60.11 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.639 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.0 mtt -96.25 16.79 17.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.837 0.855 . . . . 0.0 111.338 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.94 22.51 78.75 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.04 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -111.26 138.38 47.79 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.9 0.48 . . . . 0.0 111.225 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -62.85 142.85 58.07 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.7 p -132.46 142.07 49.08 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.988 0.515 . . . . 0.0 110.85 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -130.36 114.19 15.29 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.582 1.153 . . . . 0.0 108.325 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.0 94.44 2.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.85 140.39 88.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.013 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.505 ' HG3' ' HD3' ' A' ' 148' ' ' ARG . 21.2 Cg_endo -57.97 158.08 22.46 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.424 2.083 . . . . 0.0 111.57 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.3 m -56.29 113.58 1.63 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -80.28 18.41 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.556 0.343 . . . . 0.0 111.837 -175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.0 m -57.95 149.63 22.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.108 0.963 . . . . 0.0 110.603 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.45 -24.35 65.71 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.584 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.07 70.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.384 0.673 . . . . 0.0 111.497 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -87.5 4.85 41.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.648 0.779 . . . . 0.0 111.615 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 12.7 ttm180 -62.69 -25.5 68.19 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.419 0.554 . . . . 0.0 111.984 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.53 -23.59 27.39 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.026 0.531 . . . . 0.0 111.811 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -108.04 5.94 26.55 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.105 0.962 . . . . 0.0 112.111 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.556 ' HB2' ' HA ' ' A' ' 142' ' ' ARG . 41.0 t -64.23 -35.54 81.17 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -164.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -62.88 -62.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.428 0.558 . . . . 0.0 111.733 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.68 -39.91 78.22 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.428 0.691 . . . . 0.0 111.127 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.505 ' HD3' ' HG3' ' A' ' 135' ' ' PRO . 72.0 mtt-85 -74.78 -27.42 60.32 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.579 -175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.38 -35.52 79.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.985 0.514 . . . . 0.0 109.997 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.4 t -72.0 -30.08 64.87 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.984 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 4.3 pt-20 -76.66 -34.37 58.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -70.54 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.577 0.751 . . . . 0.0 109.126 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.421 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 25.0 tt0 -66.52 -37.63 85.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.658 0.783 . . . . 0.0 109.332 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.96 -13.73 62.4 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.42 HG11 ' SG ' ' A' ' 111' ' ' CYS . 85.7 t -89.48 -52.76 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.523 0.729 . . . . 0.0 110.581 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.445 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 51.5 m-85 -96.09 -1.41 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -164.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.421 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 18.7 mtp180 -68.34 -38.85 81.89 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.823 0.738 . . . . 0.0 112.175 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -74.93 -9.9 58.97 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.705 0.402 . . . . 0.0 111.355 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.597 HD11 HD12 ' A' ' 16' ' ' ILE . 88.2 mt -82.51 -35.65 27.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.209 1.004 . . . . 0.0 110.221 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.04 -49.99 11.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.4 t60 . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.163 1.385 . . . . 0.0 112.384 170.554 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 80' ' ' SER . 32.8 mm . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -95.07 118.47 31.94 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -93.57 142.72 27.03 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 110.552 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.446 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -69.97 171.59 41.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.419 167.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.79 145.78 31.19 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 122.262 -0.552 . . . . 0.0 110.561 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.45 132.52 49.06 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.312 2.008 . . . . 0.0 109.654 170.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.9 147.72 45.85 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.299 1.0 . . . . 0.0 112.755 -166.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.628 HG11 HD22 ' A' ' 62' ' ' LEU . 26.2 t -92.4 47.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.457 HD11 ' CG1' ' A' ' 104' ' ' VAL . 35.6 tp -89.67 147.6 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.898 -167.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.13 151.86 41.69 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.73 -16.61 64.22 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.832 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.557 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 30.3 m-80 -105.88 21.05 17.93 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -70.53 109.95 5.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.485 0.66 . . . . 0.0 110.238 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.04 -38.86 26.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.257 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.428 HD12 HD11 ' A' ' 159' ' ' LEU . 55.2 mt -124.72 120.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.691 0.796 . . . . 0.0 108.995 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.451 HD13 HD13 ' A' ' 10' ' ' LEU . 59.7 tp -103.41 117.41 34.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 111' ' ' CYS . 50.0 mt -95.99 108.69 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 73' ' ' TRP . 88.9 mt -95.52 108.7 20.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 109.147 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.42 -174.54 7.28 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 167.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 m -87.77 -82.02 0.23 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 ' HD2' ' A' ' 23' ' ' PRO . 51.5 tp -148.28 124.64 5.36 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.4 Cg_exo -43.26 135.35 6.06 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.897 3.065 . . . . 0.0 114.194 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 m -72.2 169.58 15.84 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 111.107 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.92 -49.18 69.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.747 0.819 . . . . 0.0 111.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.19 -31.44 67.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.322 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.7 p -70.71 -38.89 73.69 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.7 mt -68.57 -24.85 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.138 0.975 . . . . 0.0 111.746 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.32 -44.67 87.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.017 0.436 . . . . 0.0 109.905 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -95.26 -1.54 51.31 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.019 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 64.04 24.65 13.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.692 1.197 . . . . 0.0 113.123 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.86 144.12 30.03 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.933 0.893 . . . . 0.0 109.574 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -58.27 -47.51 83.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.686 0.794 . . . . 0.0 110.334 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.412 ' HE1' HE22 ' A' ' 54' ' ' GLN . 30.3 t80 -60.86 -16.48 41.92 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.625 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -14.17 65.21 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 122.694 0.188 . . . . 0.0 113.438 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.03 101.5 11.15 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.697 0.799 . . . . 0.0 108.856 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.4 148.63 89.87 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.806 2.337 . . . . 0.0 111.42 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.18 -21.08 25.17 Favored Glycine 0 N--CA 1.464 0.535 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.48 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -73.15 102.13 3.51 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.845 0.831 . . . . 0.0 109.408 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -79.98 -3.97 50.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.827 1.651 . . . . 0.0 110.133 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -35.21 -53.92 0.62 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.871 2.069 . . . . 0.0 113.628 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -69.73 -28.33 65.72 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.331 0.652 . . . . 0.0 111.766 -172.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -68.21 -43.82 77.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 110.412 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.0 mt -72.31 -52.64 15.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.696 1.198 . . . . 0.0 111.225 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.97 -43.28 92.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 C-N-CA 124.048 0.939 . . . . 0.0 109.336 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.74 94.56 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.151 0.907 . . . . 0.0 113.469 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -69.41 -39.76 77.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.994 0.518 . . . . 0.0 110.318 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -69.94 -38.24 76.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.89 0.876 . . . . 0.0 112.811 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.05 -11.72 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.072 0.549 . . . . 0.0 110.938 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.94 19.15 79.06 Favored Glycine 0 C--N 1.36 1.909 0 O-C-N 123.807 0.692 . . . . 0.0 113.787 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.68 110.7 11.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 108.318 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -69.55 101.22 1.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.86 0.838 . . . . 0.0 111.553 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.48 -34.08 47.83 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.025 0.93 . . . . 0.0 111.897 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.412 HE22 ' HE1' ' A' ' 34' ' ' TYR . 60.5 tp60 -62.7 -31.0 71.83 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -168.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -83.15 -5.86 59.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.083 0.553 . . . . 0.0 112.393 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.4 mtt -86.42 154.98 20.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.213 0.605 . . . . 0.0 109.455 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.5 152.52 45.52 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 165.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.528 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 70.0 t80 -51.08 -42.21 60.44 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.003 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.92 -45.07 93.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.946 0.898 . . . . 0.0 111.486 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -67.98 -38.09 82.29 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.637 0.775 . . . . 0.0 110.569 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -53.53 -49.48 67.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.722 0.809 . . . . 0.0 109.902 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD22 HG11 ' A' ' 9' ' ' VAL . 19.2 mt -61.98 -45.41 93.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 124.655 1.222 . . . . 0.0 110.986 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -57.12 -40.61 77.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.89 0.476 . . . . 0.0 111.421 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.2 m -66.37 -36.82 83.83 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.75 -37.13 84.03 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.13 0.572 . . . . 0.0 111.085 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -57.46 -44.3 84.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -65.06 -35.39 80.99 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.413 1.085 . . . . 0.0 111.555 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -85.14 -8.59 58.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.782 0.833 . . . . 0.0 111.018 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 62.87 38.05 11.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.669 1.188 . . . . 0.0 110.462 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.78 134.17 48.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.78 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.64 142.24 17.44 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.0 128.8 54.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.448 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.1 t90 -153.26 -169.93 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.96 176.83 8.33 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.702 0.801 . . . . 0.0 109.187 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.583 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.8 t -90.87 -46.76 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.137 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -94.29 118.31 31.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.866 0.467 . . . . 0.0 110.385 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 36.9 ttmt -64.77 -41.91 95.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.322 1.049 . . . . 0.0 110.45 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.86 131.04 12.73 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.348 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.667 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.61 138.63 6.64 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.533 ' HB3' HD13 ' A' ' 2' ' ' ILE . 31.2 p . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 123.114 0.566 . . . . 0.0 111.063 -171.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.4 mt . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.92 71.65 2.16 Favored Glycine 0 C--O 1.242 0.642 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.667 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.7 t70 176.48 158.31 0.29 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 108.61 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.28 23.74 8.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.861 0.864 . . . . 0.0 111.866 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 16.4 tp10 -83.06 102.56 11.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 54.9 mt -102.59 155.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.682 1.193 . . . . 0.0 109.728 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -74.26 145.19 44.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.437 1.095 . . . . 0.0 110.168 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.01 101.16 1.34 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.356 0.662 . . . . 0.0 110.377 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.583 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 22.7 m-85 -91.95 -10.27 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.065 0.546 . . . . 0.0 112.04 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.6 p -67.67 -21.73 65.33 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.134 0.174 . . . . 0.0 110.622 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.08 -3.7 75.77 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.369 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.8 mt -48.96 -46.23 43.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -64.27 -23.78 67.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.101 0.41 . . . . 0.0 111.471 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.03 -58.3 3.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.922 0.889 . . . . 0.0 111.029 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.4 ptm -71.0 -33.77 70.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.066 0.947 . . . . 0.0 112.508 -168.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.3 m -124.32 84.04 56.54 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.698 0.799 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.76 -32.38 14.49 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.889 2.393 . . . . 0.0 111.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.557 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.6 mmpt? -87.87 -0.94 57.62 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.884 0.874 . . . . 0.0 112.482 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.6 tp -59.28 107.97 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -99.27 -41.75 7.32 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.829 0.852 . . . . 0.0 109.79 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.3 tp -136.91 132.82 35.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 110.64 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.518 HG12 HD21 ' A' ' 107' ' ' LEU . 15.7 mt -104.61 123.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.525 ' HB2' HG12 ' A' ' 18' ' ' ILE . 70.9 m -101.7 114.4 28.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.977 0.511 . . . . 0.0 110.508 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HZ ' HD12 ' A' ' 124' ' ' LEU . 95.8 m-85 -93.49 109.45 21.05 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.886 0.875 . . . . 0.0 110.225 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 5.4 t30 -82.96 94.33 7.72 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.61 149.8 13.05 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.069 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -57.51 -43.17 84.04 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.866 1.267 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -51.41 -44.06 62.14 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.708 0.803 . . . . 0.0 112.73 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.78 85.91 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.149 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.5 -11.76 60.23 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.259 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.74 -27.89 69.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.99 0.895 . . . . 0.0 111.908 172.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -108.54 16.12 23.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.247 0.619 . . . . 0.0 111.253 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.509 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.8 tm-20 -66.4 -47.36 59.2 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.461 167.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.5 -35.29 75.78 Favored 'Trans proline' 0 C--N 1.403 3.418 0 C-N-CA 122.49 2.127 . . . . 0.0 113.18 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.54 -52.6 64.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.352 1.061 . . . . 0.0 112.014 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.459 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 15.9 mt -79.45 -6.12 56.2 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -65.6 -36.18 82.97 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.91 -17.55 71.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.214 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 62.8 mtt -86.58 9.35 18.78 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.61 0.764 . . . . 0.0 111.268 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.19 16.03 70.48 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.413 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -99.67 143.18 30.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 120.745 0.307 . . . . 0.0 110.777 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -75.84 133.2 40.67 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 161.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 36.1 p -127.62 141.1 51.72 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.999 0.92 . . . . 0.0 108.619 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -142.77 125.64 16.11 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.62 1.168 . . . . 0.0 108.17 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.31 112.82 24.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 155' ' ' VAL . 62.8 mt -89.21 131.69 39.95 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.86 147.02 33.82 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.513 2.809 . . . . 0.0 112.772 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.6 t -54.79 116.95 3.0 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.149 0.905 . . . . 0.0 110.072 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.2 p -72.37 0.15 10.87 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.544 0.738 . . . . 0.0 112.546 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 m -60.43 143.18 53.91 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.969 0.908 . . . . 0.0 110.273 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.61 69.84 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.796 0.685 . . . . 0.0 114.368 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.54 -42.85 98.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.209 0.604 . . . . 0.0 110.436 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -81.56 -32.3 32.25 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.346 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -59.99 -23.66 63.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.42 0.45 . . . . 0.0 111.262 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -71.26 -48.9 48.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.848 0.859 . . . . 0.0 110.092 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.23 23.73 3.2 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.457 1.103 . . . . 0.0 110.382 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -169.37 70.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -91.96 -51.48 5.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.625 1.17 . . . . 0.0 108.016 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -66.0 -6.34 12.44 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.363 1.065 . . . . 0.0 112.666 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -71.43 -20.06 62.16 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.763 0.825 . . . . 0.0 110.732 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.38 -30.88 67.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.338 0.655 . . . . 0.0 111.118 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.1 t -64.52 -44.29 91.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.253 1.021 . . . . 0.0 112.445 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.2 pt-20 -75.26 -30.62 60.52 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.351 0.26 . . . . 0.0 110.485 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.59 -40.58 88.95 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 4.0 tm-20 -67.06 -39.81 86.98 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.702 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.13 64.59 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.412 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 151' ' ' GLU . 73.1 t -84.72 -53.88 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.009 0.523 . . . . 0.0 111.001 177.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.408 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 40.0 m-85 -96.61 2.96 52.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -168.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.41 -32.28 73.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.276 0.489 . . . . 0.0 111.137 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 16' ' ' ILE . 15.4 p-80 -73.74 -12.36 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.623 0.369 . . . . 0.0 111.155 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 16' ' ' ILE . 86.7 mt -78.3 -26.06 46.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -82.7 -39.49 21.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.456 0.702 . . . . 0.0 109.121 167.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 19.9 t60 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 125.403 1.481 . . . . 0.0 110.596 -179.262 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 80' ' ' SER . 46.5 mm . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 120.764 0.316 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -93.22 111.0 22.52 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -79.33 125.62 29.74 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.486 0.315 . . . . 0.0 110.739 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.23 170.74 51.92 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 124.234 0.959 . . . . 0.0 111.629 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.427 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 8.0 m-30 -89.36 141.74 29.2 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.451 -168.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.32 164.23 29.04 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.726 2.284 . . . . 0.0 111.104 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.33 128.93 37.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.358 0.663 . . . . 0.0 111.867 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.535 HG11 HD22 ' A' ' 62' ' ' LEU . 58.7 t -100.03 72.86 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.572 HD11 ' CG1' ' A' ' 104' ' ' VAL . 60.4 tp -124.86 149.56 47.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.02 -162.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.7 160.6 25.53 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 109.194 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.15 -20.19 62.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.462 1.105 . . . . 0.0 111.882 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -122.53 91.07 3.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.496 ' HB ' HG12 ' A' ' 104' ' ' VAL . 99.5 m -131.8 114.28 14.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.925 0.89 . . . . 0.0 108.769 175.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 12.9 tt0 -87.75 -33.84 18.55 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.278 1.031 . . . . 0.0 110.9 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 159' ' ' LEU . 60.4 mt -128.57 125.66 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.079 0.552 . . . . 0.0 109.6 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.01 123.51 49.79 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 mt -100.13 115.63 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' A' ' 73' ' ' TRP . 97.8 mt -103.74 124.42 48.85 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.946 0.898 . . . . 0.0 110.181 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.3 -178.61 39.51 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 123.3 0.375 . . . . 0.0 112.365 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 116' ' ' LYS . 6.9 p -100.43 -71.43 0.7 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.9 119.46 2.78 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.35 167.84 8.88 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.689 2.26 . . . . 0.0 112.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.6 p -63.69 154.42 33.13 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.801 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 33.7 t70 -57.84 -37.61 74.16 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.275 0.359 . . . . 0.0 110.837 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.89 -36.0 64.71 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.187 0.995 . . . . 0.0 111.516 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.603 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 8.7 t -86.9 -39.71 15.53 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.27 -174.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.427 ' HA ' ' HE1' ' A' ' 6' ' ' PHE . 70.8 mt -66.55 -38.53 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.079 0.951 . . . . 0.0 112.0 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 24.9 mmm180 -66.73 -16.59 64.35 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.579 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 93.2 mttt -106.49 -1.5 23.02 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.662 0.785 . . . . 0.0 111.566 175.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 56.16 18.24 3.15 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.436 1.494 . . . . 0.0 114.693 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -145.05 161.92 38.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.951 0.501 . . . . 0.0 110.98 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -76.6 -1.56 28.21 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.894 1.278 . . . . 0.0 112.723 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -90.54 -14.24 32.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -52.34 -40.98 54.2 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.566 1.166 . . . . 0.0 115.717 -162.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -122.11 98.01 45.05 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.979 0.512 . . . . 0.0 110.309 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.03 2.44 4.24 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.568 2.845 . . . . 0.0 113.352 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.64 -17.73 79.98 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 120.357 -0.135 . . . . 0.0 112.898 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -82.97 127.47 33.58 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.34 0.591 . . . . 0.0 109.983 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.444 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 6.9 m-20 -81.01 0.32 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.61 1.164 . . . . 0.0 112.304 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -38.94 -47.47 1.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.819 1.248 . . . . 0.0 112.649 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -74.85 -26.78 59.93 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.918 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -79.31 -28.23 42.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.231 0.612 . . . . 0.0 111.594 175.166 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 33.4 mt -85.93 -48.54 8.62 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.818 0.447 . . . . 0.0 110.432 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.08 -30.96 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.275 0.63 . . . . 0.0 109.505 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.68 -44.52 70.49 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.573 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -60.72 -37.28 81.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.476 0.71 . . . . 0.0 110.298 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.58 -45.96 88.02 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.183 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.47 HD11 HD21 ' A' ' 53' ' ' LEU . 19.9 pt -91.37 -4.79 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.684 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.43 36.22 69.18 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.546 0.529 . . . . 0.0 112.838 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -149.3 105.91 3.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.675 1.59 . . . . 0.0 107.423 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -68.42 110.84 4.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.779 0.799 . . . . 0.0 109.506 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.47 HD21 HD11 ' A' ' 49' ' ' ILE . 85.1 mt -82.3 -30.72 30.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.042 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -60.32 -38.84 84.99 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.73 3.92 52.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.136 0.574 . . . . 0.0 111.337 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.552 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 66.6 mtt -85.25 150.4 24.81 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.39 45.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.751 0.657 . . . . 0.0 109.402 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.482 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 35.0 t80 -43.15 -48.99 6.48 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.362 1.065 . . . . 0.0 113.695 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 -61.31 -49.91 75.12 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 122.577 0.351 . . . . 0.0 111.322 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.25 -48.72 80.56 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.69 0.796 . . . . 0.0 112.662 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 7.6 ptmt -62.18 -36.52 82.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.489 0.316 . . . . 0.0 111.619 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.535 HD22 HG11 ' A' ' 9' ' ' VAL . 77.5 mt -68.99 -40.34 78.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.082 0.553 . . . . 0.0 111.557 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 30.3 mmmt -55.89 -44.72 78.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.386 0.674 . . . . 0.0 110.805 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -64.07 -40.06 95.44 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.285 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.98 -55.11 36.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.407 0.683 . . . . 0.0 111.688 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -22.49 64.27 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.092 0.245 . . . . 0.0 111.449 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -62.87 -33.91 76.28 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.692 0.397 . . . . 0.0 111.757 167.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -88.94 1.94 54.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.232 0.613 . . . . 0.0 110.977 172.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 8.0 mpt_? 64.59 46.51 3.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.683 1.193 . . . . 0.0 110.514 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.08 133.19 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.359 1.063 . . . . 0.0 108.697 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.35 17.86 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.62 132.15 56.55 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.42 0.688 . . . . 0.0 109.15 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.447 ' HB3' HD23 ' A' ' 19' ' ' LEU . 3.6 t90 -158.13 -170.2 3.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -134.32 162.74 31.34 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 48.4 t -79.09 -51.84 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 42.0 m-85 -82.2 126.66 32.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 0.0 110.58 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.591 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.3 tmtp? -68.01 -32.17 72.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.76 149.67 16.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.039 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.92 135.71 7.86 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.479 ' HB2' HD13 ' A' ' 2' ' ' ILE . 27.9 t . . . . . 0 N--CA 1.468 0.439 0 C-N-CA 123.575 0.75 . . . . 0.0 109.537 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.7 mt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.79 57.12 5.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.38 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -173.69 154.66 2.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.492 1.117 . . . . 0.0 108.759 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -124.25 25.92 7.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.212 1.005 . . . . 0.0 111.394 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.3 tp10 -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.468 0.707 . . . . 0.0 109.26 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 77.2 mt -127.0 140.62 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.418 1.087 . . . . 0.0 109.192 -168.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -62.39 151.54 36.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.792 0.837 . . . . 0.0 110.869 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.17 130.65 36.59 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.8 m-85 -118.94 -2.23 10.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.058 0.543 . . . . 0.0 111.091 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 86.2 p -63.99 -31.11 72.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.13 -3.97 90.58 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 118.775 -1.014 . . . . 0.0 113.878 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 mt -49.8 -49.9 46.96 Favored 'General case' 0 C--N 1.369 1.444 0 C-N-CA 123.796 0.838 . . . . 0.0 111.711 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -60.77 -16.0 35.59 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -102.92 -41.41 6.15 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.306 1.042 . . . . 0.0 112.443 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -83.09 -24.65 32.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.572 ' CG1' HD11 ' A' ' 10' ' ' LEU . 9.0 m -127.75 84.88 62.13 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.608 0.763 . . . . 0.0 110.384 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 -34.07 22.04 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.628 2.219 . . . . 0.0 111.712 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.28 -12.31 59.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.947 0.899 . . . . 0.0 112.536 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 52.7 tp -62.1 130.52 45.85 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 123.713 0.633 . . . . 0.0 110.545 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -136.68 -34.5 0.75 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.246 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.4 tp -128.48 131.23 48.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.618 0.767 . . . . 0.0 109.576 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.552 ' HB ' HG22 ' A' ' 131' ' ' THR . 61.3 mt -115.94 138.01 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.522 1.129 . . . . 0.0 108.422 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.579 ' SG ' HG11 ' A' ' 155' ' ' VAL . 83.8 m -120.57 116.95 26.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.861 0.864 . . . . 0.0 109.926 -174.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 95.7 m-85 -93.91 114.74 27.03 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -98.03 76.69 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.493 1.139 . . . . 0.0 108.851 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.19 135.61 2.71 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.265 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -52.1 -52.73 49.53 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.083 0.953 . . . . 0.0 112.382 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 28.8 mmmt -48.81 -37.44 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.039 0.936 . . . . 0.0 113.054 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.61 -34.46 77.04 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.283 0.633 . . . . 0.0 110.839 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.89 73.73 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 114.778 -1.101 . . . . 0.0 115.004 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -103.87 14.89 29.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.498 1.119 . . . . 0.0 111.097 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.405 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.7 tt0 -58.74 -49.27 94.33 Favored Pre-proline 0 CA--C 1.565 1.535 0 CA-C-O 118.049 -0.977 . . . . 0.0 112.244 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -57.84 -23.29 58.17 Favored 'Trans proline' 0 C--N 1.409 3.742 0 C-N-CA 122.579 2.186 . . . . 0.0 113.32 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.27 -40.02 95.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.73 0.812 . . . . 0.0 110.26 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 mt -95.22 -19.43 20.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.365 0.666 . . . . 0.0 111.248 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -63.05 -40.16 96.87 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.052 0.541 . . . . 0.0 109.911 169.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.28 -19.6 66.5 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.39 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.8 11.75 19.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.15 73.97 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -106.8 137.82 44.13 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.371 0.585 . . . . 0.0 110.248 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.77 134.72 53.73 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 167.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.552 HG22 ' HB ' ' A' ' 110' ' ' ILE . 14.7 p -137.6 152.03 48.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 123.707 0.803 . . . . 0.0 108.968 -174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -154.04 131.73 11.48 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.131 0.572 . . . . 0.0 109.8 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 17.2 t -90.31 93.85 4.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.52 149.53 95.55 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.203 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.11 152.66 81.54 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.619 1.546 . . . . 0.0 110.908 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.3 p -59.19 119.23 6.97 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.2 p -76.97 33.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.969 1.308 . . . . 0.0 113.994 -167.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.9 m -85.0 151.56 24.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.014 0.925 . . . . 0.0 109.204 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -20.34 58.76 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.792 0.682 . . . . 0.0 114.349 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.77 91.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.641 0.776 . . . . 0.0 111.103 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.27 -25.26 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.569 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -74.27 -25.58 59.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 123.753 0.658 . . . . 0.0 110.539 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -66.46 -27.38 67.76 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.173 0.511 . . . . 0.0 111.383 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.26 -42.41 8.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.666 0.786 . . . . 0.0 109.559 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -103.73 45.59 0.95 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.233 1.413 . . . . 0.0 110.25 -171.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -73.5 -27.47 61.4 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.333 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -86.57 -6.15 58.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.574 0.75 . . . . 0.0 111.804 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -86.14 -26.82 24.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.728 . . . . 0.0 110.399 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.79 -14.56 61.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.491 0.716 . . . . 0.0 112.171 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -34.63 77.7 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.39 0.676 . . . . 0.0 110.67 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 155' ' ' VAL . 4.1 pt-20 -72.16 -31.11 65.65 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 119.195 -0.431 . . . . 0.0 110.072 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -65.47 -38.01 88.51 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.58 -42.81 98.26 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.522 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.32 -9.67 58.83 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.77 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.579 HG11 ' SG ' ' A' ' 111' ' ' CYS . 75.7 t -83.87 -50.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 110.243 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.548 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 47.5 m-85 -103.2 0.82 32.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -77.36 -26.83 52.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 119.156 0.889 . . . . 0.0 112.298 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -74.95 -10.85 59.87 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.444 0.698 . . . . 0.0 111.326 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.512 HD11 HD12 ' A' ' 16' ' ' ILE . 95.0 mt -73.38 -10.99 60.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.7 0.8 . . . . 0.0 111.001 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -45.96 -39.51 9.02 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.824 1.249 . . . . 0.0 111.359 164.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.689 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 80' ' ' SER . 22.7 mm . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.59 119.6 25.39 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 169.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -84.56 132.11 34.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.671 0.389 . . . . 0.0 111.013 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.98 -179.92 26.24 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.207 0.317 . . . . 0.0 112.585 167.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -108.87 135.0 20.16 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 122.355 -0.497 . . . . 0.0 109.726 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 157.72 33.12 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.531 2.154 . . . . 0.0 110.941 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.81 127.02 29.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.314 0.645 . . . . 0.0 112.071 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 62' ' ' LEU . 21.6 t -91.76 88.32 2.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.534 HD21 HG13 ' A' ' 104' ' ' VAL . 34.5 tp -140.14 155.73 46.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.393 -158.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.51 159.99 27.93 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.86 -14.5 63.01 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.107 0.479 . . . . 0.0 110.945 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -111.75 84.69 2.0 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.537 ' HB ' HG12 ' A' ' 104' ' ' VAL . 98.7 m -138.92 121.43 16.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.349 0.66 . . . . 0.0 110.003 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 3.4 tp10 -85.02 -41.45 15.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.551 1.54 . . . . 0.0 109.69 -173.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.447 HG12 ' HB3' ' A' ' 109' ' ' LEU . 34.2 mt -129.52 128.9 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.638 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.53 HD13 HD13 ' A' ' 10' ' ' LEU . 56.8 tp -109.89 124.91 52.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -95.67 118.26 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.404 HD23 ' HB3' ' A' ' 73' ' ' TRP . 75.0 mt -102.43 118.96 38.0 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.581 0.752 . . . . 0.0 109.557 174.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -75.66 -166.09 19.2 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 165.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -108.78 -73.57 0.68 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -147.68 119.98 4.65 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 161.03 46.97 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.444 2.096 . . . . 0.0 111.933 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.5 t -85.7 158.22 20.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.199 0.599 . . . . 0.0 110.399 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 5.1 p-10 -57.67 -29.97 65.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.363 0.665 . . . . 0.0 112.638 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.14 -38.17 67.88 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.381 0.673 . . . . 0.0 111.59 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 p -86.63 -38.01 17.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.042 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.2 mt -64.91 -38.76 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.921 0.889 . . . . 0.0 113.282 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 30.2 mmm180 -61.41 -30.78 70.77 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 0.0 110.375 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -97.29 -6.03 35.34 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.322 1.049 . . . . 0.0 112.082 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 62.1 22.39 13.08 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.813 1.245 . . . . 0.0 113.571 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.76 144.01 35.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.939 0.496 . . . . 0.0 110.453 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 96.9 m-85 -55.3 -46.91 76.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.326 1.05 . . . . 0.0 110.107 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.29 -13.11 4.47 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 114.003 -1.453 . . . . 0.0 113.582 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.72 -19.91 73.65 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 114.346 0.498 . . . . 0.0 114.346 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -110.77 135.16 20.78 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.27 -10.85 30.07 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.053 2.502 . . . . 0.0 113.018 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.14 -8.81 65.93 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.478 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 33' ' ' TYR . 4.0 m-20 -94.29 82.02 4.06 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.685 0.755 . . . . 0.0 109.434 173.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -99.62 4.76 45.87 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.349 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -42.46 -30.06 0.32 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.094 1.357 . . . . 0.0 112.44 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.447 ' CE3' ' HD3' ' A' ' 61' ' ' LYS . 63.7 m95 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.713 1.205 . . . . 0.0 113.103 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -77.89 -32.54 51.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.818 0.447 . . . . 0.0 111.1 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' A' ' 149' ' ' GLU . 43.3 mt -86.87 -47.78 8.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.798 0.839 . . . . 0.0 110.354 -170.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 -35.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.839 0.856 . . . . 0.0 109.035 172.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.34 -39.35 95.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.042 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.59 -36.32 83.4 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.947 0.899 . . . . 0.0 110.033 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.99 -53.64 46.86 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.728 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.4 pt -84.45 -7.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.032 0.533 . . . . 0.0 111.809 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.48 73.24 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.574 0.546 . . . . 0.0 112.713 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -133.57 106.66 7.54 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -63.31 97.11 0.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 110.667 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.2 mt -75.6 -19.45 59.24 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -70.03 -27.56 64.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.804 0.842 . . . . 0.0 112.369 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -95.62 -3.15 46.8 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.73 -0.606 . . . . 0.0 110.832 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtt -88.66 159.18 17.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.005 0.522 . . . . 0.0 111.207 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.46 151.22 47.13 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.524 0.73 . . . . 0.0 109.344 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.568 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 30.3 t80 -51.91 -49.78 62.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 47.1 mt-10 -63.6 -37.04 85.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.025 0.375 . . . . 0.0 111.08 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.81 -53.32 33.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HD3' ' CE3' ' A' ' 42' ' ' TRP . 17.3 ptpt -58.44 -32.13 68.41 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.307 0.643 . . . . 0.0 111.648 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 94.0 mt -66.83 -43.04 84.8 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.196 0.598 . . . . 0.0 111.318 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 33.8 mmtp -64.55 -31.61 72.9 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.005 0.431 . . . . 0.0 110.615 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.5 m -67.16 -39.41 86.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.145 173.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.97 -49.96 70.48 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.609 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 29.7 mmtp -57.28 -40.93 78.77 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 123.299 0.64 . . . . 0.0 110.546 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -60.82 -42.83 98.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.304 1.041 . . . . 0.0 111.11 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -87.52 5.46 39.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.773 0.829 . . . . 0.0 110.634 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 25.8 mmt180 64.93 39.74 5.69 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 125.232 1.413 . . . . 0.0 110.92 171.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.03 135.96 48.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 124.917 1.287 . . . . 0.0 108.793 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.39 162.19 14.42 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 173.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.68 142.36 50.76 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.404 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.5 t90 -162.98 -170.74 2.43 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -131.53 166.38 21.51 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 0.0 109.379 172.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 54.2 t -78.1 -38.88 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.97 123.97 48.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.543 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -71.61 -24.0 61.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 170.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.83 140.43 14.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -152.16 155.7 26.28 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB3' HD13 ' A' ' 2' ' ' ILE . 40.7 p . . . . . 0 N--CA 1.474 0.763 0 CA-C-N 117.587 0.693 . . . . 0.0 109.998 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.26 65.23 3.88 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.673 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.474 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 8.2 t70 -169.86 160.29 8.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.972 0.509 . . . . 0.0 110.005 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.04 7.19 10.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.648 0.779 . . . . 0.0 112.591 -168.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.56 99.79 12.58 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.119 0.872 . . . . 0.0 109.467 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.36 152.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 109.617 -171.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -72.65 149.02 44.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.514 0.726 . . . . 0.0 110.042 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.51 114.6 16.51 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.496 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 29.0 m-85 -100.37 -5.44 27.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.592 0.757 . . . . 0.0 111.869 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.3 p -75.92 -10.92 59.82 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.71 0.29 . . . . 0.0 110.299 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.8 -5.44 62.84 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.803 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' SD ' ' A' ' 103' ' ' MET . 40.3 mt -50.42 -33.42 20.75 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.191 0.596 . . . . 0.0 112.371 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -62.58 -33.49 75.07 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.061 0.544 . . . . 0.0 112.298 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.25 -47.71 8.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.807 0.843 . . . . 0.0 112.266 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.525 ' HG3' HG22 ' A' ' 104' ' ' VAL . 22.9 ptm -71.64 -32.34 67.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.546 0.739 . . . . 0.0 112.461 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' A' ' 14' ' ' THR . 0.7 OUTLIER -134.39 95.0 16.73 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.49 0.716 . . . . 0.0 110.438 177.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.8 -30.24 14.53 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.623 2.216 . . . . 0.0 111.778 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -87.3 -2.31 58.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.745 0.818 . . . . 0.0 111.758 -173.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 41.5 tp -56.09 104.34 0.13 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.798 0.839 . . . . 0.0 111.541 -175.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 18.7 ptp180 -101.87 -41.98 6.3 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.396 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.447 ' HB3' HG12 ' A' ' 16' ' ' ILE . 29.9 tp -130.73 139.57 50.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.675 0.39 . . . . 0.0 110.349 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.438 HG12 HD11 ' A' ' 107' ' ' LEU . 24.2 mt -112.75 115.99 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.486 ' SG ' HG11 ' A' ' 155' ' ' VAL . 83.6 m -98.71 118.74 36.12 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.456 0.703 . . . . 0.0 110.871 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -95.75 120.72 36.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.655 0.782 . . . . 0.0 110.227 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 95.2 m-20 -75.24 80.74 2.35 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.655 0.782 . . . . 0.0 109.815 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.93 162.94 21.23 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.474 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.5 ttp85 -64.31 -23.61 67.36 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.18 1.392 . . . . 0.0 113.056 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -74.37 -42.4 59.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.506 . . . . 0.0 110.057 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.26 75.89 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.696 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.08 -10.66 62.39 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.933 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -69.36 -20.08 63.84 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 117.402 0.601 . . . . 0.0 110.859 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -108.0 10.17 28.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.386 1.074 . . . . 0.0 111.086 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.2 tm-20 -67.58 -49.31 41.15 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.979 0.912 . . . . 0.0 111.666 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.08 -24.6 79.72 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.028 1.818 . . . . 0.0 112.685 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.92 -50.39 73.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.078 0.951 . . . . 0.0 111.287 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.31 -5.23 55.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -66.54 -31.93 72.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.038 0.535 . . . . 0.0 110.57 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.1 -17.59 70.07 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.69 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 63.7 mtt -88.07 2.17 52.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.847 0.859 . . . . 0.0 111.216 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.45 23.16 63.32 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.56 -0.291 . . . . 0.0 113.333 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -107.4 137.26 45.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 110.668 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 19.6 mm-40 -70.0 136.37 50.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.54 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 33.5 p -132.5 140.5 48.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.773 0.829 . . . . 0.0 109.504 -173.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 109' ' ' LEU . 53.7 tptt -143.02 132.04 22.99 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.389 1.076 . . . . 0.0 109.302 -173.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.7 t -97.99 122.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 155' ' ' VAL . 96.3 mt -102.34 144.61 28.95 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 171.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.8 150.7 75.82 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.042 2.495 . . . . 0.0 112.078 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.5 t -62.14 94.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.824 0.703 . . . . 0.0 109.728 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -87.97 21.17 2.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.5 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.1 t -66.08 156.02 35.1 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.293 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 142' ' ' ARG . . . -62.75 -22.17 63.89 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 123.18 0.419 . . . . 0.0 113.787 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.36 -28.91 70.02 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 111.708 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -126.37 19.12 7.52 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.686 0.795 . . . . 0.0 111.134 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 139' ' ' GLY . 8.9 ptm85 -66.98 -27.63 67.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.011 0.525 . . . . 0.0 111.364 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -55.01 -31.07 60.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.464 1.106 . . . . 0.0 111.384 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.86 -18.26 13.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.001 0.92 . . . . 0.0 110.184 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -97.73 8.31 44.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.617 0.767 . . . . 0.0 112.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -63.23 -64.0 1.03 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.512 0.725 . . . . 0.0 109.356 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.07 -7.47 23.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.16 0.984 . . . . 0.0 112.845 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -82.08 -12.84 58.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.393 0.677 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 44' ' ' LEU . 11.1 pt-20 -54.87 -25.41 28.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.523 0.729 . . . . 0.0 112.316 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -41.17 62.87 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.061 0.944 . . . . 0.0 112.209 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -72.92 -34.02 66.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -66.57 -33.4 75.58 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.987 0.915 . . . . 0.0 109.437 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.8 -42.19 98.69 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.482 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.93 87.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.897 -171.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.486 HG11 ' SG ' ' A' ' 111' ' ' CYS . 74.3 t -68.15 -30.83 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.929 -173.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.532 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 30.9 m-85 -118.15 -10.47 10.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.379 -0.825 . . . . 0.0 113.166 -173.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.0 -29.69 65.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.115 0.416 . . . . 0.0 111.107 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -81.05 -13.58 58.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.949 0.5 . . . . 0.0 111.2 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.42 HD11 HD12 ' A' ' 16' ' ' ILE . 62.7 mt -72.1 -41.06 67.71 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 122.829 0.452 . . . . 0.0 111.077 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -87.79 -53.73 4.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 CA--C 1.554 1.1 0 C-N-CA 125.313 1.445 . . . . 0.0 110.944 -179.396 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 mm . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HB3' HD13 ' A' ' 28' ' ' ILE . 50.4 mtmt -93.4 117.98 30.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.301 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -80.38 126.8 31.64 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 123.743 0.652 . . . . 0.0 110.868 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.77 156.22 53.41 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.409 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 7.3 m-85 -80.62 134.93 53.39 Favored Pre-proline 0 N--CA 1.473 0.68 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.581 -165.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.2 141.59 48.46 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.887 2.391 . . . . 0.0 111.265 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.12 128.61 37.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.571 0.748 . . . . 0.0 111.275 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 62' ' ' LEU . 24.1 t -95.65 79.77 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 174.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.484 HD11 ' CG1' ' A' ' 104' ' ' VAL . 38.5 tp -117.18 149.86 39.69 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.517 -163.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 37.9 t70 -128.02 164.21 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.803 0.841 . . . . 0.0 109.46 169.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.2 -26.66 67.88 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.348 1.059 . . . . 0.0 112.462 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.504 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 61.7 m-80 -95.32 16.17 17.46 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.262 0.625 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.468 ' HB ' HG12 ' A' ' 104' ' ' VAL . 78.1 m -72.05 104.76 3.67 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.637 0.732 . . . . 0.0 110.544 -175.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 108' ' ' ARG . 30.1 tt0 -88.32 -30.21 19.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.286 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 159' ' ' LEU . 39.4 mt -127.66 120.35 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.148 0.979 . . . . 0.0 108.624 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.3 tp -106.97 116.97 32.85 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 111' ' ' CYS . 55.1 mt -91.7 108.27 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 94.9 mt -99.67 108.17 20.46 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 109.071 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.05 177.34 8.66 Favored Glycine 0 N--CA 1.47 0.932 0 O-C-N 123.002 0.189 . . . . 0.0 113.053 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 89' ' ' ILE . 10.7 p -90.79 -72.42 0.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.476 HD22 ' HA3' ' A' ' 79' ' ' GLY . 19.0 tp -151.14 124.68 4.3 Favored Pre-proline 0 C--O 1.246 0.894 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 159.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.5 157.6 30.92 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.118 1.879 . . . . 0.0 111.67 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -62.95 150.29 42.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.605 0.762 . . . . 0.0 110.459 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 6.6 p-10 -58.88 -34.07 71.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.573 0.225 . . . . 0.0 110.452 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.1 -37.96 78.42 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.363 1.065 . . . . 0.0 111.947 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.6 p -81.23 -30.74 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 3' ' ' LYS . 73.1 mt -74.66 -16.0 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 110.882 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 79.1 mtt180 -64.38 -38.3 90.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.569 0.347 . . . . 0.0 110.569 170.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -86.87 -16.22 36.7 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.624 0.77 . . . . 0.0 109.899 177.31 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 53.9 23.83 4.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.075 1.35 . . . . 0.0 113.206 -172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -126.09 160.2 30.78 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.386 0.674 . . . . 0.0 109.561 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -72.43 -2.5 19.72 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.607 0.763 . . . . 0.0 110.746 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -70.13 -45.36 67.0 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.448 1.099 . . . . 0.0 108.294 174.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 31.76 -112.66 0.06 OUTLIER Glycine 0 C--N 1.374 2.678 0 O-C-N 125.086 1.491 . . . . 0.0 114.546 -172.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.65 129.59 23.99 Favored Pre-proline 0 C--O 1.246 0.886 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.06 9.3 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.968 2.446 . . . . 0.0 113.953 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.85 0.28 78.55 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 122.906 0.289 . . . . 0.0 112.566 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -84.08 130.15 34.87 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.88 3.4 29.93 Favored 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 123.852 0.861 . . . . 0.0 111.189 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -42.94 -56.42 3.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.683 0.793 . . . . 0.0 112.126 172.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 75.8 m95 -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.856 0.862 . . . . 0.0 111.897 -177.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -80.99 -42.07 21.74 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.442 1.097 . . . . 0.0 111.415 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.27 -47.54 34.35 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.113 0.965 . . . . 0.0 109.2 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.91 -37.68 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.264 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.8 96.1 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.67 0.606 . . . . 0.0 113.184 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.19 -41.36 85.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.438 0.695 . . . . 0.0 109.961 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -66.92 -40.61 87.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.358 1.063 . . . . 0.0 112.769 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 pt -89.44 -6.57 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.112 0.565 . . . . 0.0 111.645 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.86 22.99 78.61 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 113.178 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -139.87 96.47 3.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.99 109.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.881 0.872 . . . . 0.0 111.083 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.4 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 53.6 mt -75.21 -19.93 59.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.837 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -53.42 -54.53 35.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.724 0.809 . . . . 0.0 112.806 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -83.57 6.25 21.26 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.051 0.54 . . . . 0.0 112.427 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.573 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.1 mtt -88.81 139.6 30.29 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 154.64 40.04 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.499 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 36.9 t80 -48.37 -50.67 29.78 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 41.7 mt-10 -60.37 -38.85 85.18 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.609 0.364 . . . . 0.0 111.155 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -68.26 -53.46 24.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.94 0.896 . . . . 0.0 112.29 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 5.5 ptmt -59.89 -29.98 68.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 9' ' ' VAL . 86.4 mt -65.1 -42.56 93.91 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.252 0.621 . . . . 0.0 111.231 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 43.7 mmtm -59.49 -39.71 84.64 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.673 0.389 . . . . 0.0 110.192 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.3 m -66.96 -38.23 85.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.536 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 61' ' ' LYS . 79.1 mt -58.22 -59.25 5.61 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 111.231 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.413 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -71.61 -22.2 61.74 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.224 0.328 . . . . 0.0 111.842 -174.136 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -58.87 -43.68 90.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.64 0.776 . . . . 0.0 110.374 164.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -89.74 19.82 4.47 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.729 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.486 ' HB2' HD22 ' A' ' 159' ' ' LEU . 15.1 mmt180 70.28 27.15 4.16 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.289 1.036 . . . . 0.0 111.58 169.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.7 mt -109.63 123.79 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.055 0.942 . . . . 0.0 109.883 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.17 158.45 14.3 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.45 140.93 49.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.435 0.694 . . . . 0.0 109.252 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.475 ' HB3' HD23 ' A' ' 19' ' ' LEU . 8.8 t90 -165.03 -177.27 4.55 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -131.5 161.93 31.42 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 53.3 t -75.73 -48.34 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.72 128.78 41.65 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.258 0.551 . . . . 0.0 110.626 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.682 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 10.2 ptmm? -84.19 -17.56 39.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.733 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.68 134.88 11.26 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.055 0.455 . . . . 0.0 110.463 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -147.78 147.66 18.53 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.485 1.275 0 CA-C-N 117.912 0.856 . . . . 0.0 111.774 -173.223 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 21' ' ' SER . 7.8 mt . . . . . 0 C--O 1.24 0.572 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.92 60.47 0.63 Allowed Glycine 0 N--CA 1.465 0.58 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.568 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.2 t70 -174.72 160.05 2.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.161 0.984 . . . . 0.0 108.908 -172.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.37 18.15 13.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 111.302 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.682 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 11.8 tp10 -85.06 97.46 9.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.4 mt -106.26 150.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.653 1.181 . . . . 0.0 109.54 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -75.1 153.39 38.34 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.45 0.7 . . . . 0.0 109.847 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.42 135.55 35.65 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.445 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 45.7 m-85 -121.55 3.43 10.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.204 0.601 . . . . 0.0 111.435 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.2 p -67.77 -18.16 64.78 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.05 0.386 . . . . 0.0 111.674 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.65 -2.73 64.98 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 118.828 -0.985 . . . . 0.0 113.582 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 103' ' ' MET . 40.0 mt -52.0 -36.15 48.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 117.898 0.849 . . . . 0.0 112.958 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.477 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.7 mtpt -67.7 -17.55 64.61 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -98.46 -50.57 4.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.062 0.945 . . . . 0.0 111.772 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 100' ' ' LEU . 25.5 ptm -71.32 -35.14 71.12 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.218 0.607 . . . . 0.0 111.271 -173.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.1 m -126.01 84.61 60.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.708 0.803 . . . . 0.0 109.922 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.39 -29.04 5.11 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.857 2.371 . . . . 0.0 111.82 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 11.2 mmpt? -74.55 -12.69 60.53 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.241 0.616 . . . . 0.0 111.564 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -56.54 126.65 27.51 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.1 0.875 . . . . 0.0 111.179 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.556 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -134.98 -18.01 1.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.808 174.658 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.556 ' HB2' HH11 ' A' ' 108' ' ' ARG . 59.1 tp -143.66 131.92 21.99 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.192 0.597 . . . . 0.0 110.367 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 131' ' ' THR . 49.4 mt -107.37 143.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.205 1.002 . . . . 0.0 108.496 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.534 ' SG ' HG11 ' A' ' 155' ' ' VAL . 74.9 m -125.54 116.23 21.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.182 0.593 . . . . 0.0 110.13 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 96.7 m-85 -93.0 111.54 23.2 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.268 0.627 . . . . 0.0 110.394 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -84.53 93.24 8.3 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.15 127.37 3.18 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -50.53 -45.06 56.55 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.382 1.473 . . . . 0.0 113.417 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -58.13 -24.0 57.15 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . . . -73.16 -18.33 61.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.068 0.461 . . . . 0.0 111.075 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.43 -16.9 67.95 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.28 -0.873 . . . . 0.0 114.573 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.63 -26.68 67.93 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.919 0.488 . . . . 0.0 110.018 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.78 8.26 24.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.28 1.032 . . . . 0.0 111.334 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 38.7 tt0 -60.79 -51.08 82.1 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.169 169.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 16.2 Cg_exo -65.43 -17.42 57.6 Favored 'Trans proline' 0 C--N 1.401 3.321 0 C-N-CA 121.83 1.686 . . . . 0.0 113.252 -175.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.09 -41.63 99.44 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.558 1.143 . . . . 0.0 110.755 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.0 -4.98 55.99 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.171 -171.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.424 ' HG3' ' HA ' ' A' ' 122' ' ' PRO . 66.6 mtm180 -66.0 -31.29 72.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.036 0.534 . . . . 0.0 110.226 172.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.21 -1.46 69.41 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.084 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 56.6 mtt -103.87 11.92 35.03 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.459 1.104 . . . . 0.0 110.451 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.33 78.15 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.934 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.477 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 29.8 m-85 -110.72 141.16 44.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.263 0.625 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 13.4 mm-40 -68.43 133.68 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.422 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 41.5 p -126.3 136.91 53.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 109.172 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -141.62 130.97 23.63 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.146 0.978 . . . . 0.0 109.358 -176.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 61.0 t -101.81 130.4 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.406 0.682 . . . . 0.0 109.643 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -115.89 154.59 48.27 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.324 1.45 . . . . 0.0 108.202 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.5 170.1 14.36 Favored 'Trans proline' 0 C--N 1.367 1.539 0 C-N-CA 122.613 2.209 . . . . 0.0 112.187 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.3 m -60.86 127.44 31.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.9 m -77.63 27.68 0.17 Allowed 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.3 m -87.71 159.61 18.43 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.827 0.851 . . . . 0.0 110.369 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 142' ' ' ARG . . . -64.5 -20.78 66.1 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.411 0.925 . . . . 0.0 115.411 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.48 -43.17 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.02 0.528 . . . . 0.0 110.833 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -69.89 -39.81 76.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.516 0.326 . . . . 0.0 110.407 171.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.454 ' HB3' ' HA2' ' A' ' 139' ' ' GLY . 7.3 tmm_? -60.01 -34.11 72.9 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.218 1.007 . . . . 0.0 111.561 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.21 -23.69 37.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.386 1.074 . . . . 0.0 112.047 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -117.76 -23.13 7.69 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.026 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 53.4 m -84.41 39.69 0.74 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.758 1.223 . . . . 0.0 113.012 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 146' ' ' LYS . 71.6 mmtt -76.54 -53.89 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.582 0.353 . . . . 0.0 110.599 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -64.16 -23.14 67.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.386 0.274 . . . . 0.0 111.141 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 55.7 ttm-85 -84.5 -18.83 34.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.0 0.92 . . . . 0.0 110.475 -176.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.03 -27.53 63.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.568 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.0 t -60.36 -43.98 96.01 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.885 0.874 . . . . 0.0 111.585 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -75.9 -27.85 57.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -63.32 -44.89 93.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.73 -35.93 77.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.777 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.28 72.4 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.866 0.466 . . . . 0.0 110.369 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.534 HG11 ' SG ' ' A' ' 111' ' ' CYS . 53.1 t -68.12 -55.49 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.036 0.934 . . . . 0.0 111.083 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.402 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 56.0 m-85 -94.39 -5.73 45.77 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -71.91 -38.45 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 118.255 0.48 . . . . 0.0 110.917 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.46 ' HE1' HD11 ' A' ' 16' ' ' ILE . 7.5 p-80 -76.85 -7.14 54.94 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.148 0.579 . . . . 0.0 110.751 -174.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 16' ' ' ILE . 81.7 mt -74.17 -20.91 60.05 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.554 0.742 . . . . 0.0 111.967 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.78 -29.07 60.99 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 169.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 CA--C 1.561 1.366 0 C-N-CA 124.896 1.279 . . . . 0.0 111.753 171.05 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.7 mm . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -107.53 133.72 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.258 1.023 . . . . 0.0 109.858 -174.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -101.5 135.92 42.2 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.541 0.736 . . . . 0.0 110.848 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.57 174.73 47.68 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.412 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.84 148.77 69.4 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 117.098 0.449 . . . . 0.0 111.228 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.88 163.6 9.16 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.584 2.189 . . . . 0.0 110.741 159.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.75 113.5 3.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.175 0.512 . . . . 0.0 110.585 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.515 HG11 HD22 ' A' ' 62' ' ' LEU . 13.8 t -87.08 74.71 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD21 HG13 ' A' ' 104' ' ' VAL . 28.0 tp -129.38 154.38 46.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -154.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -127.43 162.12 27.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.596 1.158 . . . . 0.0 110.073 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -66.29 -24.49 66.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.054 0.942 . . . . 0.0 112.243 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.452 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 48.7 m-80 -96.27 14.28 24.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.04 0.536 . . . . 0.0 111.056 -175.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -70.16 111.09 5.55 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.419 0.628 . . . . 0.0 110.834 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 24.8 tt0 -89.88 -35.66 15.5 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.038 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 63.1 mt -121.45 114.0 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.555 0.742 . . . . 0.0 109.205 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.453 HD13 HD13 ' A' ' 10' ' ' LEU . 61.1 tp -103.47 111.9 24.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.438 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.9 mt -92.62 116.43 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.1 mt -102.99 125.78 49.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.55 0.74 . . . . 0.0 109.82 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.17 -161.52 24.22 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 163.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 p -106.45 -64.3 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.2 tp -150.67 133.47 8.46 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.1 154.81 71.62 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.524 2.149 . . . . 0.0 110.663 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 27' ' ' SER . 24.7 t -60.77 150.58 32.1 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.907 0.483 . . . . 0.0 109.733 177.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 7.7 p-10 -59.06 -37.31 76.74 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.61 -30.36 68.08 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.357 0.663 . . . . 0.0 110.493 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 24' ' ' SER . 31.4 t -67.07 -45.93 75.84 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.846 0.858 . . . . 0.0 109.693 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.82 -39.34 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.582 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 2.8 mmp_? -61.91 -37.85 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.914 0.486 . . . . 0.0 112.163 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.32 -7.86 24.03 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.023 0.529 . . . . 0.0 111.836 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 67.63 18.47 9.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.442 1.097 . . . . 0.0 113.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -113.67 127.47 56.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.772 0.829 . . . . 0.0 109.056 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.504 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 84.4 m-85 -59.77 -59.77 4.91 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -55.47 -27.13 46.4 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.619 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.36 -21.13 66.17 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 123.065 0.228 . . . . 0.0 112.863 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 4.3 t30 -86.92 108.33 18.07 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.474 1.11 . . . . 0.0 108.406 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.33 142.37 78.94 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.463 2.776 . . . . 0.0 112.412 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.23 -19.3 40.48 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.376 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 36' ' ' ASN . 95.4 m-20 -68.87 98.98 0.99 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.515 0.674 . . . . 0.0 109.572 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -86.39 -6.89 58.82 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 126.538 1.935 . . . . 0.0 110.952 -170.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.457 ' HE1' ' HB3' ' A' ' 113' ' ' ASN . 65.1 m-85 -41.63 -43.83 2.9 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 125.221 1.408 . . . . 0.0 112.681 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.504 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 74.6 m95 -71.5 -24.13 61.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.186 0.994 . . . . 0.0 112.065 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -81.48 -36.36 29.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.873 0.869 . . . . 0.0 110.902 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.09 -45.63 17.91 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.865 0.466 . . . . 0.0 111.385 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 49' ' ' ILE . 59.2 t -69.03 -36.65 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.49 -32.67 75.48 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.889 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.15 -42.91 79.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.452 0.701 . . . . 0.0 110.053 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -67.75 -38.02 82.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.298 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 45' ' ' VAL . 23.7 pt -96.68 -11.73 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.841 0.456 . . . . 0.0 111.137 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.66 32.42 61.64 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.438 0.461 . . . . 0.0 113.579 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -133.35 111.92 11.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -66.99 89.68 0.17 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.939 0.876 . . . . 0.0 111.579 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.37 -30.98 69.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.09 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -73.41 -10.69 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.924 -173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -98.93 -9.17 24.48 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.947 -0.471 . . . . 0.0 111.68 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.479 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 60.0 mtt -87.44 159.28 18.74 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.228 0.611 . . . . 0.0 110.76 -172.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 159.4 31.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.535 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 17.0 t80 -52.12 -54.48 29.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.43 -36.7 83.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.644 0.378 . . . . 0.0 111.214 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -67.91 -51.77 44.0 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.852 0.861 . . . . 0.0 111.654 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 8.9 ptpp? -61.32 -34.43 75.23 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.184 0.303 . . . . 0.0 111.096 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 78.0 mt -65.18 -44.18 89.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 122.657 0.383 . . . . 0.0 111.039 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -55.79 -43.15 76.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.988 0.515 . . . . 0.0 110.624 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.6 m -68.4 -41.8 79.94 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.817 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 62' ' ' LEU . 78.5 mt -56.13 -62.33 1.78 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.719 0.808 . . . . 0.0 110.591 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -23.55 64.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.772 0.67 . . . . 0.0 111.752 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -63.53 -39.14 93.64 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.987 0.515 . . . . 0.0 111.024 167.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.455 ' O ' HD13 ' A' ' 159' ' ' LEU . 60.7 m-80 -85.61 14.92 5.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.042 0.537 . . . . 0.0 110.111 173.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 14.4 mmt-85 69.37 25.17 5.59 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.298 1.439 . . . . 0.0 111.032 173.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.19 118.77 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.652 0.781 . . . . 0.0 109.352 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.52 161.28 15.33 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.35 145.89 48.38 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.9 -170.29 1.72 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -130.65 163.44 27.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.583 0.753 . . . . 0.0 110.117 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 58.4 t -79.43 -54.49 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 0.0 109.89 172.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.12 128.62 35.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -78.31 -35.81 47.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.337 0.655 . . . . 0.0 110.209 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -144.01 140.82 29.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 110.88 178.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.35 160.41 33.43 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.592 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.484 ' O ' ' HA3' ' A' ' 90' ' ' GLY . 58.8 p . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 122.922 0.489 . . . . 0.0 109.83 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.9 tp . . . . . 0 CA--C 1.555 1.151 0 CA-C-O 121.211 0.529 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . 117.53 9.43 10.24 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.232 -175.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -171.74 177.17 3.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.829 1.251 . . . . 0.0 108.185 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.6 12.4 11.48 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.163 0.585 . . . . 0.0 111.864 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 9.1 tp10 -86.73 119.13 26.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.8 mt -124.77 138.97 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.759 1.223 . . . . 0.0 108.731 -173.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -60.76 137.38 58.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.371 0.668 . . . . 0.0 109.677 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -86.07 127.31 34.65 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.929 0.492 . . . . 0.0 109.759 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.416 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 67.0 m-85 -112.82 7.77 18.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.452 0.701 . . . . 0.0 111.35 -176.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.3 m -63.52 -26.5 68.74 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.838 0.455 . . . . 0.0 111.648 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -3.04 89.36 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.706 -1.052 . . . . 0.0 115.044 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.476 HD23 ' SD ' ' A' ' 103' ' ' MET . 29.5 mt -49.02 -38.57 23.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 101' ' ' LYS . 10.0 mmpt? -55.78 -39.38 71.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.429 0.558 . . . . 0.0 111.197 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -85.06 -50.52 7.37 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.236 1.015 . . . . 0.0 112.267 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.549 ' HG3' HG22 ' A' ' 104' ' ' VAL . 24.1 ptm -68.58 -35.26 77.12 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.494 0.718 . . . . 0.0 111.874 -175.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 10' ' ' LEU . 1.1 m -132.74 94.55 21.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.104 0.562 . . . . 0.0 110.871 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.48 -30.99 4.7 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.55 2.167 . . . . 0.0 111.742 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.4 mmmm -88.3 -7.35 56.88 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.167 -174.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.3 tp -58.53 107.72 0.54 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.48 0.657 . . . . 0.0 111.497 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -96.52 -51.43 4.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.335 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.6 tp -126.13 132.53 51.84 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.324 0.65 . . . . 0.0 110.775 -171.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.9 mt -102.95 144.26 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 134' ' ' LEU . 80.1 m -124.9 113.31 17.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.807 0.443 . . . . 0.0 110.701 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.61 111.12 22.6 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.457 ' HB3' ' HE1' ' A' ' 41' ' ' PHE . 86.7 m-20 -91.39 79.49 5.59 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.4 153.39 5.86 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.343 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -62.58 -45.27 93.67 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.17 0.588 . . . . 0.0 110.148 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -31.13 69.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.809 0.843 . . . . 0.0 112.988 172.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.53 -39.57 62.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.116 0.484 . . . . 0.0 110.016 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.68 -11.14 68.56 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.392 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.31 -38.4 65.91 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.908 0.883 . . . . 0.0 112.351 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -107.92 25.3 11.73 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.543 0.737 . . . . 0.0 111.177 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 70.6 tt0 -55.78 -53.09 66.67 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.564 165.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.44 -22.22 73.77 Favored 'Trans proline' 0 C--N 1.403 3.426 0 C-N-CA 122.313 2.009 . . . . 0.0 112.906 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.79 -47.63 82.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.213 0.605 . . . . 0.0 109.661 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.97 -20.02 29.53 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.363 -174.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 34.1 mtp85 -66.65 -42.2 87.03 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.45 -21.07 68.36 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.091 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 63.9 mtt -79.04 -19.35 51.66 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.787 0.435 . . . . 0.0 111.441 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.51 30.59 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.523 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 142.94 27.5 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.215 0.507 . . . . 0.0 110.824 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -65.72 135.13 54.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 170.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 54.6 p -123.57 139.51 53.93 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.257 0.623 . . . . 0.0 110.161 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HB2' HD11 ' A' ' 109' ' ' LEU . 53.1 tptt -134.12 116.75 15.79 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 107.89 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.6 110.63 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 111' ' ' CYS . 93.6 mt -95.71 150.92 38.06 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.226 1.411 . . . . 0.0 109.124 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.45 130.74 14.19 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.557 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.0 p -54.46 107.91 0.33 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.728 0.811 . . . . 0.0 110.974 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.5 m -79.59 50.28 1.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.214 1.006 . . . . 0.0 112.05 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -73.29 160.45 31.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 109.804 163.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.74 59.73 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 114.758 0.663 . . . . 0.0 114.758 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.0 -37.83 78.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.795 0.438 . . . . 0.0 111.405 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -70.65 -20.06 62.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.481 0.712 . . . . 0.0 111.646 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 142' ' ' ARG . 12.5 tpp180 -57.22 -29.04 63.42 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.082 0.553 . . . . 0.0 110.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -53.27 -36.53 61.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.41 1.084 . . . . 0.0 111.084 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -107.33 -22.88 12.42 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.674 1.189 . . . . 0.0 111.697 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 8.2 t -87.47 13.29 10.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -165.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -72.79 -61.12 1.92 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.415 0.286 . . . . 0.0 110.478 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -24.24 64.13 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.123 0.569 . . . . 0.0 112.052 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 0.7 OUTLIER -74.99 -22.24 58.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.713 0.805 . . . . 0.0 111.225 -174.369 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.61 -23.19 49.64 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 t -63.84 -41.32 97.84 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.798 0.839 . . . . 0.0 111.166 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.4 pt-20 -70.78 -35.64 72.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -65.76 -41.85 91.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.099 0.559 . . . . 0.0 109.995 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -66.86 -34.55 78.04 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.985 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.05 -9.73 59.27 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.982 0.913 . . . . 0.0 111.887 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 151' ' ' GLU . 37.9 t -90.29 -43.3 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.801 0.84 . . . . 0.0 111.171 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.561 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 80.0 m-85 -102.81 4.83 38.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -168.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -86.62 -14.4 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.198 0.908 . . . . 0.0 112.384 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -84.29 -4.9 59.15 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 118.205 0.457 . . . . 0.0 111.669 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 68' ' ' ASN . 71.5 mt -61.27 -10.01 6.15 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.98 0.912 . . . . 0.0 113.113 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -51.36 -41.21 60.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.865 0.866 . . . . 0.0 111.538 164.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 C--O 1.255 1.378 0 C-N-CA 123.991 0.917 . . . . 0.0 109.015 173.622 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 78' ' ' ALA . 47.3 mm . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 120.816 0.341 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.7 125.8 45.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.324 1.05 . . . . 0.0 108.255 171.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -97.14 141.27 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.039 0.447 . . . . 0.0 111.835 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.4 171.14 51.77 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.977 163.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -107.95 125.48 31.99 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.514 1.157 . . . . 0.0 110.211 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.48 155.16 0.47 Allowed 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 124.178 3.252 . . . . 0.0 113.881 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.46 122.46 14.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.876 0.87 . . . . 0.0 113.042 -167.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.595 HG11 HD22 ' A' ' 62' ' ' LEU . 25.3 t -94.34 81.84 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.528 HD11 ' CG1' ' A' ' 104' ' ' VAL . 28.7 tp -123.35 153.35 40.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -159.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 9.8 t70 -124.88 157.46 35.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.411 170.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.66 -18.62 65.01 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.097 0.559 . . . . 0.0 112.125 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 52.0 m-80 -97.04 13.64 28.35 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.914 0.886 . . . . 0.0 111.628 -176.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.428 ' HB ' HG12 ' A' ' 104' ' ' VAL . 83.0 m -77.39 116.22 17.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.922 0.489 . . . . 0.0 111.432 -171.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -99.4 -26.2 14.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.459 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.479 HD12 HD21 ' A' ' 159' ' ' LEU . 42.8 mt -121.45 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -104.16 111.09 23.55 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 111' ' ' CYS . 47.3 mt -93.62 113.23 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.8 mt -103.72 110.99 23.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.885 0.874 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.36 175.44 25.26 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.018 -0.433 . . . . 0.0 112.018 169.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -87.14 -77.57 0.33 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -140.99 123.35 9.52 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -55.14 156.74 15.47 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.745 2.297 . . . . 0.0 112.445 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 28' ' ' ILE . 42.2 t -60.38 145.26 48.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.102 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.46 -39.85 70.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.239 0.616 . . . . 0.0 110.782 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.83 -23.71 62.4 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.355 1.062 . . . . 0.0 111.437 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.9 m -77.68 -37.4 49.81 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 24' ' ' SER . 43.6 mt -74.31 -19.25 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.599 0.76 . . . . 0.0 110.992 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.72 -33.26 75.54 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 120.953 0.406 . . . . 0.0 110.357 172.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.88 -8.43 30.88 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.203 1.001 . . . . 0.0 111.183 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 60.14 30.28 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 111.366 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -146.51 132.91 19.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.925 0.89 . . . . 0.0 110.148 -168.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -64.4 -44.96 89.64 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.384 0.612 . . . . 0.0 109.753 173.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.01 -4.42 7.13 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.227 172.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.96 -37.2 53.08 Favored Glycine 0 C--N 1.361 1.958 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -103.23 102.09 26.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.0 0.92 . . . . 0.0 108.873 165.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.17 -10.44 28.93 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.969 2.446 . . . . 0.0 112.61 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.58 -9.66 86.08 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -71.51 117.89 13.64 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 5.2 m-20 -75.27 -4.17 37.51 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.647 0.779 . . . . 0.0 112.139 -167.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -43.94 -44.84 7.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.104 1.762 . . . . 0.0 112.847 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.44 ' HZ3' HD11 ' A' ' 65' ' ' LEU . 54.4 m95 -72.25 -22.35 61.24 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.443 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -86.91 -32.81 19.98 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 124.169 0.988 . . . . 0.0 111.697 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 96.9 mt -75.9 -53.95 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.391 0.676 . . . . 0.0 110.016 -174.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.38 -36.05 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.402 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.1 -36.98 91.3 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.024 0.828 . . . . 0.0 112.678 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -67.68 -41.88 83.0 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.596 0.759 . . . . 0.0 109.93 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.01 -37.19 86.19 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.652 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 pt -96.52 -11.72 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.097 0.559 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.97 -59.26 2.8 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -50.24 111.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.367 1.067 . . . . 0.0 112.966 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -70.64 116.87 11.46 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.53 -30.75 57.26 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.428 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -60.24 -52.38 65.55 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -164.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.89 -22.17 63.25 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.361 0.413 . . . . 0.0 111.708 -170.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.1 mtt -60.25 152.02 25.9 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.313 0.645 . . . . 0.0 110.823 174.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.38 152.77 44.38 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 52.4 t80 -46.22 -52.27 12.75 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 0.0 112.589 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.88 -34.81 78.17 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.92 0.488 . . . . 0.0 111.704 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -73.38 -47.33 42.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.842 0.457 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -32.27 72.9 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.853 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.595 HD22 HG11 ' A' ' 9' ' ' VAL . 42.1 mt -63.24 -49.07 75.61 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.437 0.461 . . . . 0.0 110.377 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -55.54 -38.89 69.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 123.803 0.689 . . . . 0.0 111.313 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -63.78 -46.34 85.66 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.862 0.726 . . . . 0.0 109.625 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD11 ' HZ3' ' A' ' 42' ' ' TRP . 95.4 mt -59.79 -43.28 94.51 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.738 0.815 . . . . 0.0 110.889 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.564 ' HD2' ' HB2' ' A' ' 11' ' ' ASP . 28.6 mmtp -61.32 -38.09 85.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.865 0.466 . . . . 0.0 110.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -74.86 -23.11 58.37 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.228 1.011 . . . . 0.0 110.966 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.427 ' O ' HD13 ' A' ' 159' ' ' LEU . 18.5 m120 -88.74 0.04 56.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.612 0.765 . . . . 0.0 110.256 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 65.34 32.92 9.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.777 1.231 . . . . 0.0 110.67 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.76 136.64 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 0.0 109.405 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.72 154.32 16.68 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.3 mt -120.13 129.26 54.07 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.483 0.642 . . . . 0.0 109.81 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -155.97 -168.88 2.9 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -133.25 170.38 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.206 1.003 . . . . 0.0 109.306 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.54 -61.2 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.401 ' CD1' HG21 ' A' ' 89' ' ' ILE . 70.9 m-85 -74.18 102.07 4.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -65.08 -28.89 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.663 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -149.15 141.79 24.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.957 172.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.585 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.44 134.39 6.05 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.328 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB2' HD13 ' A' ' 2' ' ' ILE . 39.8 t . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 123.756 0.822 . . . . 0.0 109.275 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' A' ' 76' ' ' PHE . 3.4 mp . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.15 61.68 4.11 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.116 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.585 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 11.8 t70 -176.04 153.44 1.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.445 1.098 . . . . 0.0 108.218 -172.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -125.27 26.37 6.9 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 8.3 tp10 -80.3 102.82 9.76 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.5 149.9 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.047 0.939 . . . . 0.0 108.699 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.453 ' OD1' ' HD2' ' A' ' 77' ' ' LYS . 88.8 m-20 -66.7 141.03 57.91 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.794 0.684 . . . . 0.0 110.117 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.79 116.63 26.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -101.45 18.48 20.03 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.167 0.587 . . . . 0.0 112.087 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.4 p -69.61 -18.34 63.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.37 -3.34 63.19 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.361 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.95 -38.5 36.85 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.982 0.891 . . . . 0.0 113.139 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.75 -24.27 67.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.842 0.457 . . . . 0.0 111.571 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -93.56 -50.28 5.49 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.691 0.797 . . . . 0.0 111.835 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.557 ' HG3' HG22 ' A' ' 104' ' ' VAL . 24.1 ptm -70.86 -38.74 73.16 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.575 0.75 . . . . 0.0 111.942 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -122.57 89.1 49.7 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 123.375 0.67 . . . . 0.0 110.262 178.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.24 -29.5 17.14 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.826 2.351 . . . . 0.0 111.997 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.8 mmpt? -82.7 -8.65 59.58 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.832 0.853 . . . . 0.0 112.708 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.575 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.0 tp -57.54 127.95 34.61 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.604 0.565 . . . . 0.0 111.698 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -134.76 -37.48 0.82 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.639 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 26.0 tp -129.57 125.34 35.99 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.054 0.542 . . . . 0.0 110.057 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.518 ' HB ' HG22 ' A' ' 131' ' ' THR . 57.0 mt -107.2 110.82 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.524 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.9 m -96.69 115.23 27.07 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 122.612 0.365 . . . . 0.0 110.606 -175.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.11 123.03 33.0 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.403 0.681 . . . . 0.0 109.726 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -90.99 99.27 12.34 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.05 138.88 8.13 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.447 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -52.71 -42.1 64.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.753 1.221 . . . . 0.0 112.19 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HB3' ' NZ ' ' A' ' 116' ' ' LYS . 5.1 mtpm? -59.8 -30.65 69.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.59 -38.97 64.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.286 0.565 . . . . 0.0 109.943 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.77 -9.45 62.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.707 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.12 -26.29 67.57 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.562 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -102.55 14.03 33.0 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.034 1.334 . . . . 0.0 111.373 -176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.4 ' HG3' ' OG1' ' A' ' 131' ' ' THR . 41.3 tt0 -58.5 -53.19 68.7 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.242 172.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.65 -18.09 53.36 Favored 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 121.742 1.628 . . . . 0.0 113.15 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 tp -66.93 -46.35 75.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.501 0.72 . . . . 0.0 109.705 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.92 -18.98 31.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.168 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -69.2 -33.0 72.66 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.124 0.569 . . . . 0.0 109.966 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.68 -22.92 64.63 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.741 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 49.3 mtt -90.21 10.7 23.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.056 0.942 . . . . 0.0 111.401 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.3 25.56 75.22 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.899 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -109.56 132.65 53.94 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.282 0.633 . . . . 0.0 110.82 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -70.2 142.5 52.41 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.518 HG22 ' HB ' ' A' ' 110' ' ' ILE . 32.2 p -133.65 150.67 51.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.524 1.13 . . . . 0.0 110.159 -173.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -142.12 119.22 11.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.704 1.201 . . . . 0.0 108.866 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.9 t -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.642 0.735 . . . . 0.0 109.765 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.86 154.39 94.29 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.711 1.204 . . . . 0.0 110.287 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.96 165.51 27.87 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.277 1.985 . . . . 0.0 112.191 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.1 t -67.35 143.74 56.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.0 t -74.02 5.92 3.85 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.125 0.97 . . . . 0.0 113.513 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -64.26 140.35 58.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.139 0.576 . . . . 0.0 110.371 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.95 -28.98 73.56 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.212 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.04 98.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.555 0.742 . . . . 0.0 110.29 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -65.93 -22.9 66.52 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.003 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.519 HH12 ' HB3' ' A' ' 149' ' ' GLU . 18.7 mmm180 -81.99 -16.74 49.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.644 0.778 . . . . 0.0 111.504 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -67.0 -36.58 82.47 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -91.54 -34.14 14.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.659 0.783 . . . . 0.0 110.397 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.1 m -101.43 29.76 4.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.509 1.123 . . . . 0.0 112.038 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.31 -62.02 2.07 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.3 -4.93 32.62 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.252 1.021 . . . . 0.0 112.464 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 64.6 mtm-85 -88.91 -8.14 54.77 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.631 0.773 . . . . 0.0 111.84 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.519 ' HB3' HH12 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -59.64 -23.99 63.5 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.589 0.632 . . . . 0.0 110.665 172.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -61.19 -32.24 72.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.851 1.26 . . . . 0.0 111.481 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 155' ' ' VAL . 7.5 pt-20 -74.34 -27.03 60.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -70.82 -37.91 73.23 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.93 -36.71 84.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.618 0.767 . . . . 0.0 110.168 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.6 -12.55 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.342 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 151' ' ' GLU . 41.6 t -95.1 -44.93 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.435 1.094 . . . . 0.0 111.157 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.44 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 56.3 m-85 -99.37 3.12 45.83 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -69.75 -34.6 74.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.459 ' HE1' HD11 ' A' ' 16' ' ' ILE . 11.5 p-80 -82.1 -9.73 59.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 16' ' ' ILE . 99.3 mt -51.21 -61.79 2.02 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 124.164 0.915 . . . . 0.0 111.979 -168.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.85 -60.8 2.24 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 172.502 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 80' ' ' SER . 34.2 mm . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.259 0.552 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 22' ' ' LEU . 33.5 mtmm -95.51 118.79 32.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.744 -1.116 . . . . 0.0 107.989 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -87.82 134.19 33.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.203 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.18 171.8 48.16 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.953 170.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -98.26 143.85 27.02 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 117.353 0.576 . . . . 0.0 110.031 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.78 150.11 79.2 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.219 1.946 . . . . 0.0 110.449 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -61.96 143.32 56.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 112.325 -174.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.519 HG12 ' HE2' ' A' ' 66' ' ' LYS . 11.8 t -101.21 61.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 168.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.518 HD11 ' CG1' ' A' ' 104' ' ' VAL . 42.3 tp -98.18 146.36 25.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.162 -165.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.06 159.73 29.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.85 -19.32 63.45 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.773 0.429 . . . . 0.0 111.696 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -95.49 6.99 47.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.642 0.377 . . . . 0.0 111.792 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 m -66.84 114.58 5.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.227 0.611 . . . . 0.0 111.223 -171.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 40.6 tt0 -94.23 -35.44 12.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.384 1.474 . . . . 0.0 110.223 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.9 mt -121.42 118.47 56.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.431 HD13 HD13 ' A' ' 10' ' ' LEU . 63.7 tp -105.01 116.5 32.05 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.524 HG21 ' HE1' ' A' ' 41' ' ' PHE . 52.6 mt -92.84 107.63 19.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 73' ' ' TRP . 96.0 mt -99.24 108.45 21.02 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.065 0.946 . . . . 0.0 109.152 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.83 179.66 12.78 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 123.281 0.363 . . . . 0.0 112.26 170.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 m -86.89 -69.04 0.7 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.486 HD22 ' HA3' ' A' ' 79' ' ' GLY . 27.6 tp -146.21 131.81 9.31 Favored Pre-proline 0 C--O 1.246 0.917 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 163.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 22' ' ' LEU . 18.4 Cg_endo -56.96 159.28 15.03 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.087 1.858 . . . . 0.0 112.075 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 m -60.37 136.94 58.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.893 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.66 -29.09 58.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.682 0.393 . . . . 0.0 110.927 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.46 -63.1 1.27 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.934 1.293 . . . . 0.0 110.549 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' GLN . 51.0 p -57.24 -28.2 62.73 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.626 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.8 mt -73.28 -28.02 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -59.9 -29.13 68.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.888 0.475 . . . . 0.0 111.095 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 67.0 mttm -111.69 -0.55 15.98 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.115 0.966 . . . . 0.0 111.318 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 51.09 34.16 10.48 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.416 1.486 . . . . 0.0 113.832 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 27' ' ' SER . 13.3 pt20 -138.67 151.64 47.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.706 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -70.27 -2.51 13.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.836 0.854 . . . . 0.0 111.433 174.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -103.11 -4.85 23.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.428 1.091 . . . . 0.0 109.843 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -72.91 -25.43 73.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.996 0.358 . . . . 0.0 113.996 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.83 103.27 46.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.254 0.622 . . . . 0.0 109.662 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.03 -19.71 29.76 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.724 2.283 . . . . 0.0 111.791 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.36 31.07 5.61 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.655 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -115.5 116.33 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.783 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 37.0 m-20 -85.11 3.51 38.61 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.658 0.783 . . . . 0.0 112.299 -175.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.524 ' HE1' HG21 ' A' ' 18' ' ' ILE . 86.0 t80 -40.95 -51.08 3.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.282 1.033 . . . . 0.0 112.899 172.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.419 ' HE3' ' HB3' ' A' ' 53' ' ' LEU . 86.1 m95 -71.66 -23.21 61.63 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.236 -175.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.783 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 2.9 mpt_? -79.12 -42.63 25.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.957 0.903 . . . . 0.0 110.219 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.14 -49.78 16.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.957 0.903 . . . . 0.0 110.649 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.1 -31.54 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.329 0.652 . . . . 0.0 109.655 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.03 -40.54 88.58 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.485 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -62.72 -39.68 94.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.833 0.853 . . . . 0.0 109.753 172.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.63 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -72.62 -30.06 64.01 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.892 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.5 pt -102.75 -4.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.58 38.59 86.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.314 0.384 . . . . 0.0 113.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -137.15 136.26 38.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.111 1.364 . . . . 0.0 108.265 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 56' ' ' MET . 14.8 p-10 -74.38 87.07 2.02 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.307 0.575 . . . . 0.0 109.866 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 92.0 mt -68.14 -51.85 41.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -46.87 -39.34 11.91 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.528 1.531 . . . . 0.0 113.258 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.45 -33.15 48.62 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.434 1.093 . . . . 0.0 111.343 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.53 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.0 mtt -66.01 151.58 46.51 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 123.103 0.561 . . . . 0.0 111.842 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.15 157.39 37.69 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.491 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.502 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 21.2 t80 -43.63 -56.43 3.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.968 1.307 . . . . 0.0 113.862 -171.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.07 -31.49 72.74 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.923 0.489 . . . . 0.0 111.668 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -72.53 -52.15 16.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 0.0 111.439 -175.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 6.4 ptmt -61.54 -32.6 72.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.528 0.731 . . . . 0.0 112.491 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 89.8 mt -64.84 -42.99 94.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.438 0.695 . . . . 0.0 111.504 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.25 -40.75 95.2 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.936 0.495 . . . . 0.0 110.853 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 m -60.8 -41.23 95.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.105 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 90.4 mt -61.35 -46.93 88.16 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.828 0.705 . . . . 0.0 110.782 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.519 ' HE2' HG12 ' A' ' 9' ' ' VAL . 23.0 mttm -65.77 -28.0 68.7 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.016 0.926 . . . . 0.0 112.617 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -57.54 -43.28 84.26 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.319 0.581 . . . . 0.0 111.061 168.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -90.69 11.41 22.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.417 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.508 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER 66.66 39.28 3.7 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.09 1.356 . . . . 0.0 111.26 174.251 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 69.1 mt -109.72 131.56 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.01 152.83 17.15 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 171.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.5 mt -116.98 137.58 52.12 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.509 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.6 t90 -165.6 -169.1 1.47 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -140.59 171.92 13.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.741 0.816 . . . . 0.0 110.852 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.571 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 78.9 t -88.15 -56.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 123.841 0.857 . . . . 0.0 109.616 176.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.67 104.37 16.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.113 0.565 . . . . 0.0 110.22 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.736 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.6 ptmt -71.34 -14.74 62.29 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.758 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -149.89 123.91 9.39 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.486 ' HA3' HD22 ' A' ' 22' ' ' LEU . . . -128.7 125.8 5.09 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 2' ' ' ILE . 30.3 t . . . . . 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 110.315 -174.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.93 -59.05 1.82 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.89 142.51 1.32 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.097 1.359 . . . . 0.0 114.124 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -111.01 24.27 13.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.167 -161.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.736 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.5 tp10 -80.83 102.76 10.22 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.6 153.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.126 0.971 . . . . 0.0 110.622 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -80.56 151.9 28.89 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.37 1.068 . . . . 0.0 110.161 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.94 119.87 24.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.571 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.5 m-85 -104.28 -19.48 14.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.655 0.782 . . . . 0.0 111.582 -175.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 p -62.89 -19.89 64.61 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.29 -19.24 53.45 Favored Glycine 0 C--N 1.356 1.648 0 CA-C-O 119.773 -0.46 . . . . 0.0 112.484 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -38.89 -45.98 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.996 1.318 . . . . 0.0 113.727 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -65.87 -20.79 66.36 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -163.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -74.25 -45.21 49.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.515 0.726 . . . . 0.0 110.85 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -90.77 -18.16 25.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 13.6 m -130.12 90.06 43.32 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 121.348 0.594 . . . . 0.0 110.566 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.92 -36.59 2.53 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.116 1.878 . . . . 0.0 111.17 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 13.4 mmmm -81.1 -9.15 59.86 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 123.895 0.878 . . . . 0.0 112.551 -171.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 38.2 tp -58.36 104.28 0.2 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.848 0.718 . . . . 0.0 110.791 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 106' ' ' LYS . 23.6 mtp180 -98.33 -42.89 7.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.604 0.762 . . . . 0.0 110.019 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 37.9 tp -128.93 139.77 51.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.133 0.573 . . . . 0.0 110.531 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.45 127.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.3 m -106.98 115.56 30.4 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.291 0.636 . . . . 0.0 109.717 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 95.6 m-85 -89.16 114.61 25.92 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.451 0.7 . . . . 0.0 109.819 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.554 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 3.3 t30 -83.11 89.54 6.95 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.87 144.56 8.82 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.335 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.45 -37.66 81.68 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.052 0.941 . . . . 0.0 112.358 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -60.06 -31.63 70.17 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.17 -43.56 56.86 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.323 0.582 . . . . 0.0 109.512 170.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -9.73 52.79 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.281 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.9 -35.64 66.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.326 0.65 . . . . 0.0 111.113 171.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.07 23.79 12.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.72 1.208 . . . . 0.0 110.945 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.485 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -65.29 -55.96 22.58 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.386 0.675 . . . . 0.0 111.29 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.6 -16.35 34.01 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.714 1.61 . . . . 0.0 112.035 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.53 -43.76 88.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.971 0.909 . . . . 0.0 109.977 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.554 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 8.1 mt -82.27 -9.88 59.32 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.813 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 75.5 mtt180 -67.56 -22.07 65.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.312 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.28 69.29 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.823 0.702 . . . . 0.0 113.481 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.554 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -84.18 7.09 20.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.462 0.705 . . . . 0.0 111.094 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.1 28.33 68.57 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 116.876 -0.147 . . . . 0.0 112.738 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 21.0 m-85 -108.43 145.46 34.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.602 0.761 . . . . 0.0 110.866 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -79.72 139.12 37.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 51.4 p -134.85 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.914 0.486 . . . . 0.0 110.57 -174.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -140.32 130.59 25.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 -174.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.13 113.02 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 111' ' ' CYS . 85.5 mt -96.49 150.8 37.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 166.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.35 167.42 23.96 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.118 1.879 . . . . 0.0 111.277 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.9 t -62.52 115.03 3.9 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.3 p -75.21 5.9 4.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.286 0.634 . . . . 0.0 112.359 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.9 p -62.23 152.58 33.01 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.854 0.862 . . . . 0.0 110.919 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.29 65.72 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.737 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.07 -23.64 51.94 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.814 0.846 . . . . 0.0 111.705 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -110.23 4.51 21.01 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.97 0.908 . . . . 0.0 110.314 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -59.95 -34.67 73.58 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.325 0.65 . . . . 0.0 111.152 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.85 -37.4 63.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 111.595 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.26 -25.51 15.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.699 0.8 . . . . 0.0 111.009 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -80.45 22.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -67.84 0.38 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.021 0.928 . . . . 0.0 110.952 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.48 -10.74 27.51 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.084 0.954 . . . . 0.0 113.142 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.427 ' O ' ' HD1' ' A' ' 152' ' ' TRP . 35.1 mmt180 -86.34 -18.75 31.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.301 0.64 . . . . 0.0 110.489 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -54.39 -36.52 64.01 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.244 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -62.19 -46.35 89.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.418 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.35 -30.67 63.48 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 119.462 -0.304 . . . . 0.0 110.471 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.427 ' HD1' ' O ' ' A' ' 148' ' ' ARG . 44.3 m95 -66.29 -43.3 86.74 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -59.13 -42.72 91.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.083 0.864 . . . . 0.0 109.512 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.33 77.45 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 124.242 0.963 . . . . 0.0 111.522 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.6 t -62.5 -34.6 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.959 0.903 . . . . 0.0 111.936 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.63 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 83.6 m-85 -110.24 2.42 19.24 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -65.7 -40.91 92.78 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.368 1.067 . . . . 0.0 110.793 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.466 ' HE1' HD11 ' A' ' 16' ' ' ILE . 19.5 p-80 -69.84 -6.79 34.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 112.424 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.413 HD11 HD12 ' A' ' 16' ' ' ILE . 96.6 mt -75.4 -18.11 60.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.907 0.483 . . . . 0.0 111.051 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -89.43 -3.39 58.43 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 122.434 0.294 . . . . 0.0 110.237 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 . . . . . 0 N--CA 1.484 1.262 0 C-N-CA 126.123 1.769 . . . . 0.0 111.048 177.657 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 80' ' ' SER . 42.3 mm . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 121.062 0.458 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -110.11 116.28 31.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.398 1.079 . . . . 0.0 108.701 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -83.26 135.38 34.77 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 122.704 0.402 . . . . 0.0 110.233 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.4 150.17 44.8 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.817 0.698 . . . . 0.0 112.952 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -79.17 132.42 63.22 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 147.83 22.1 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.287 2.658 . . . . 0.0 112.275 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.95 133.19 50.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.039 0.536 . . . . 0.0 111.597 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.635 HG11 HD22 ' A' ' 62' ' ' LEU . 94.6 t -95.59 88.07 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.498 HD11 ' CG1' ' A' ' 104' ' ' VAL . 18.0 tp -136.58 149.54 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -163.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 13.9 t70 -128.99 163.79 24.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.407 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.16 -12.44 61.19 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.943 0.897 . . . . 0.0 112.567 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.3 12.44 37.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.217 0.607 . . . . 0.0 111.42 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -75.79 118.75 18.93 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 108' ' ' ARG . 56.7 mt-10 -93.49 -33.75 13.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.366 1.067 . . . . 0.0 111.366 -177.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mt -126.72 120.22 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 10' ' ' LEU . 63.0 tp -104.57 121.77 44.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 111' ' ' CYS . 48.6 mt -99.55 109.65 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.659 0.784 . . . . 0.0 109.378 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 76.1 mt -93.59 118.49 31.44 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -74.38 0.32 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.895 0.747 . . . . 0.0 113.121 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 117' ' ' ALA . 10.8 p 151.25 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -165.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.7 136.23 14.27 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 164.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 129.75 36.47 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.078 1.852 . . . . 0.0 111.917 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.7 p -69.04 140.21 54.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -49.84 -42.77 48.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.214 1.005 . . . . 0.0 112.848 -174.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 11.8 tp10 -63.38 -29.53 70.82 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -74.39 -33.26 62.99 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.5 mt -74.47 -14.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.064 0.946 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' A' ' 26' ' ' GLU . 2.5 mmp_? -66.18 -35.28 80.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.62 -3.28 26.91 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.759 0.824 . . . . 0.0 111.484 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.48 18.98 9.91 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.008 1.323 . . . . 0.0 114.034 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -146.18 161.14 40.89 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -71.61 -12.95 61.61 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.524 1.129 . . . . 0.0 110.91 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.476 ' HD1' ' HZ1' ' A' ' 61' ' ' LYS . 85.0 t80 -87.2 -9.16 55.89 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.831 1.252 . . . . 0.0 109.731 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.3 -44.3 20.53 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 124.499 1.124 . . . . 0.0 115.589 -170.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -125.95 115.53 24.23 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -63.06 99.26 0.22 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.484 2.123 . . . . 0.0 108.196 154.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.7 -38.1 0.57 Allowed Glycine 0 C--O 1.241 0.541 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.575 -164.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -72.77 105.5 4.36 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 167.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.85 6.92 14.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.951 0.9 . . . . 0.0 111.938 -168.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -44.11 -43.09 6.71 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.857 0.863 . . . . 0.0 111.975 166.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -75.16 -21.96 58.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 112.158 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.71 -53.53 8.4 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.758 0.823 . . . . 0.0 110.471 170.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -69.84 -47.94 60.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.861 0.864 . . . . 0.0 111.535 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.45 -31.93 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.083 0.553 . . . . 0.0 109.876 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.39 -38.26 93.43 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.323 0.389 . . . . 0.0 112.689 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -72.22 -36.71 69.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.305 1.042 . . . . 0.0 110.198 174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.54 -42.28 98.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.573 0.749 . . . . 0.0 112.52 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -94.08 -15.17 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.642 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 35.31 61.12 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -136.14 127.69 28.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -70.0 89.76 0.62 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.014 0.911 . . . . 0.0 110.98 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -74.68 -0.44 18.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.76 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -84.6 -39.22 18.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.646 0.379 . . . . 0.0 111.18 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -99.12 0.37 43.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.693 0.797 . . . . 0.0 112.089 -166.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -90.78 141.77 28.46 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.033 0.533 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.51 147.23 53.59 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.715 0.634 . . . . 0.0 109.373 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.488 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 56.0 t80 -45.28 -51.62 10.67 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.539 1.135 . . . . 0.0 113.776 -169.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.78 -46.15 90.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.826 0.851 . . . . 0.0 111.63 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -66.04 -38.89 89.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.652 0.781 . . . . 0.0 110.572 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.476 ' HZ1' ' HD1' ' A' ' 34' ' ' TYR . 30.9 ttmt -59.94 -40.42 88.9 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.523 1.129 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.635 HD22 HG11 ' A' ' 9' ' ' VAL . 27.0 mt -61.13 -49.03 78.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.355 174.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.16 -29.2 70.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.757 0.823 . . . . 0.0 111.516 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -62.19 -50.02 73.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 0.0 109.985 170.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.78 -40.34 79.61 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.046 0.841 . . . . 0.0 109.961 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HE3' HG12 ' A' ' 9' ' ' VAL . 2.3 mptm? -59.39 -39.04 82.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.71 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -55.44 -41.18 72.48 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 122.72 0.408 . . . . 0.0 111.367 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -90.12 2.18 55.58 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.983 0.913 . . . . 0.0 111.05 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER 64.32 36.76 8.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.847 1.259 . . . . 0.0 110.868 177.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -104.05 132.93 49.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.795 1.238 . . . . 0.0 108.66 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.05 159.88 13.77 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 172.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 87.6 mt -122.53 143.87 49.45 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.839 0.856 . . . . 0.0 108.872 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -163.71 -168.59 1.68 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 171.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -125.84 179.88 4.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.276 0.63 . . . . 0.0 110.34 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.498 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 92.4 t -90.66 -44.49 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 109.884 175.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -99.26 133.19 43.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.874 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.592 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 88.4 tttt -78.56 -25.11 45.29 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.671 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.24 136.43 11.9 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.297 0.639 . . . . 0.0 110.025 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.672 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -145.73 130.17 3.68 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.406 ' HB2' HD13 ' A' ' 2' ' ' ILE . 34.4 t . . . . . 0 N--CA 1.467 0.421 0 CA-C-N 118.367 1.083 . . . . 0.0 109.535 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.498 HD12 ' HD2' ' A' ' 116' ' ' LYS . 37.1 mt . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.16 62.63 4.31 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.247 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.672 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.4 t70 -175.25 156.57 2.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -120.73 21.44 11.48 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 0.0 111.062 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.9 tp10 -85.39 109.14 18.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.49 137.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.077 0.951 . . . . 0.0 109.741 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -59.72 142.11 53.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 111.177 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.23 91.78 0.74 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.52 0.728 . . . . 0.0 111.295 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.525 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 21.6 m-85 -80.18 -13.14 59.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.244 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.1 p -57.03 -31.64 65.35 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.736 0.815 . . . . 0.0 111.154 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.94 -4.24 69.51 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.134 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -51.67 -39.5 58.33 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.181 0.991 . . . . 0.0 112.749 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -56.8 -34.77 68.01 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.419 0.688 . . . . 0.0 111.894 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.79 -46.71 8.39 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.822 0.849 . . . . 0.0 112.031 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptm -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.482 0.713 . . . . 0.0 111.804 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.7 m -121.22 85.92 42.38 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 123.527 0.731 . . . . 0.0 109.189 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.77 -32.54 7.33 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.56 2.173 . . . . 0.0 112.3 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.15 1.9 48.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 42.6 tp -58.14 115.13 2.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.698 0.799 . . . . 0.0 112.223 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.457 ' HD3' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -107.6 -40.06 5.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.651 168.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.06 131.95 37.61 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.118 0.567 . . . . 0.0 110.496 -171.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.457 ' HB ' HG22 ' A' ' 131' ' ' THR . 54.3 mt -102.54 145.08 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.601 ' HB2' HG12 ' A' ' 18' ' ' ILE . 76.9 m -124.56 116.22 22.1 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.346 0.521 . . . . 0.0 110.425 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.455 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 97.9 m-85 -96.72 128.07 43.31 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.646 1.178 . . . . 0.0 110.377 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -97.25 78.86 2.76 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.448 0.642 . . . . 0.0 110.412 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.1 152.48 5.76 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.052 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -65.76 -40.25 91.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.241 0.616 . . . . 0.0 110.604 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.498 ' HD2' HD12 ' A' ' 89' ' ' ILE . 4.7 tmtm? -60.07 -37.12 78.95 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.163 175.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -67.82 -41.75 82.59 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.98 172.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.7 -9.85 59.78 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 114.815 -1.084 . . . . 0.0 114.232 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.61 -33.12 74.9 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.069 0.548 . . . . 0.0 110.566 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -98.87 13.59 31.95 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.968 . . . . 0.0 111.359 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.471 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -67.34 -54.64 18.11 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.57 0.748 . . . . 0.0 111.629 177.274 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.94 -15.61 43.94 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.713 1.609 . . . . 0.0 113.143 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.43 -48.64 76.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.453 0.701 . . . . 0.0 110.886 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.518 ' HB2' HG21 ' A' ' 131' ' ' THR . 17.2 mt -82.12 -9.41 59.54 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.386 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -68.03 -28.59 67.53 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.812 0.445 . . . . 0.0 110.332 165.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.51 -19.35 64.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.53 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.4 mtt -94.07 12.15 27.39 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.098 0.959 . . . . 0.0 111.369 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.98 18.23 79.0 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.727 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.88 131.52 54.98 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.919 0.488 . . . . 0.0 110.706 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.61 140.97 51.76 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.518 HG21 ' HB2' ' A' ' 124' ' ' LEU . 16.3 p -132.8 151.78 51.93 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.952 0.901 . . . . 0.0 109.848 -172.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -134.94 123.58 23.6 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.044 0.538 . . . . 0.0 110.266 -175.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.6 t -83.11 98.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 111' ' ' CYS . 69.8 mt -90.88 156.88 44.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 148' ' ' ARG . 84.2 Cg_endo -71.02 165.03 33.71 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.985 1.79 . . . . 0.0 110.616 177.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 40.6 t -63.93 117.39 6.93 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 170.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.9 p -77.74 19.03 0.41 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.346 0.658 . . . . 0.0 112.578 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.7 p -77.26 153.1 34.29 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.895 0.878 . . . . 0.0 108.905 170.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -9.89 51.2 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.635 0.614 . . . . 0.0 114.635 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.06 -6.85 56.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 111.795 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 135' ' ' PRO . 26.2 t-20 -123.05 -2.64 8.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.696 0.798 . . . . 0.0 110.59 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -75.6 -10.01 59.08 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 120.996 0.427 . . . . 0.0 111.727 -169.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.38 -26.85 13.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.674 1.189 . . . . 0.0 113.463 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -103.29 -5.37 23.12 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 0.0 110.911 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.641 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 66.3 m -88.14 0.36 56.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.654 0.781 . . . . 0.0 111.968 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.26 -70.96 0.09 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.63 0.772 . . . . 0.0 109.906 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.9 -12.05 59.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.112 0.565 . . . . 0.0 111.535 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.641 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 74.4 ttt180 -87.51 -11.71 48.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.395 0.678 . . . . 0.0 110.58 -172.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.49 -23.76 64.77 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.009 0.524 . . . . 0.0 111.298 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.8 t -66.96 -36.33 81.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.031 0.932 . . . . 0.0 109.85 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 155' ' ' VAL . 5.7 tt0 -67.42 -44.69 78.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.554 0.742 . . . . 0.0 110.223 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -60.06 -44.35 94.79 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.115 0.884 . . . . 0.0 109.184 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -60.6 -42.25 96.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.489 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.59 -37.95 70.95 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.4 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 151' ' ' GLU . 52.4 t -59.06 -34.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.115 0.966 . . . . 0.0 111.286 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.525 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 57.1 m-85 -107.98 -8.75 15.81 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -75.16 -48.59 22.91 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.1 0.409 . . . . 0.0 110.317 172.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -62.27 -14.56 40.08 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.03 -13.05 22.19 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.706 1.202 . . . . 0.0 112.329 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.23 -7.31 35.48 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.018 0.927 . . . . 0.0 112.304 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.9 t60 . . . . . 0 C--N 1.362 1.132 0 C-N-CA 125.972 1.709 . . . . 0.0 109.375 -175.165 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 80' ' ' SER . 44.1 mm . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -104.53 116.56 32.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.51 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.1 mmt85 -84.73 133.39 34.37 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.498 0.719 . . . . 0.0 110.027 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.32 -179.79 34.84 Favored Glycine 0 C--O 1.247 0.96 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.739 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.448 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 20.4 m-30 -93.91 139.12 22.56 Favored Pre-proline 0 N--CA 1.47 0.548 0 O-C-N 122.504 -0.41 . . . . 0.0 110.495 -177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.97 162.34 26.18 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.482 2.122 . . . . 0.0 110.752 163.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.457 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -69.74 133.59 47.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.33 0.652 . . . . 0.0 112.606 -172.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.675 HG11 HD22 ' A' ' 62' ' ' LEU . 84.2 t -93.24 80.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 167.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.475 HD11 ' CG1' ' A' ' 104' ' ' VAL . 37.3 tp -128.24 149.41 50.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.23 -161.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.697 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 34.4 t70 -111.5 153.2 26.53 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -53.66 -48.61 69.27 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.283 0.633 . . . . 0.0 112.305 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -105.8 59.83 0.66 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.779 0.799 . . . . 0.0 111.817 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.479 ' HB ' HG12 ' A' ' 104' ' ' VAL . 27.6 m -85.9 135.2 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.37 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.94 -39.57 11.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.836 0.855 . . . . 0.0 111.809 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.419 HD11 ' CE1' ' A' ' 158' ' ' HIS . 44.3 mt -122.31 123.99 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.455 HD13 HD13 ' A' ' 10' ' ' LEU . 51.2 tp -109.37 117.18 33.37 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 111' ' ' CYS . 43.9 mt -98.56 113.35 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 73' ' ' TRP . 88.2 mt -106.08 122.52 46.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.846 0.858 . . . . 0.0 110.176 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 -154.71 10.84 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 164.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.6 p -119.16 -66.88 1.03 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.067 0.933 . . . . 0.0 108.825 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.8 tp -146.72 119.33 4.92 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.63 158.24 56.85 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.116 1.877 . . . . 0.0 111.053 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -67.94 146.46 53.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.16 0.584 . . . . 0.0 109.436 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 36.5 t70 -61.81 -27.04 68.48 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.14 0.275 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.91 -31.48 62.91 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.555 0.742 . . . . 0.0 111.249 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 m -86.6 -41.27 14.4 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.744 0.818 . . . . 0.0 110.489 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 72.3 mt -63.73 -32.09 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 124.107 0.963 . . . . 0.0 112.974 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -62.7 -27.43 69.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.495 0.318 . . . . 0.0 111.283 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -91.02 -26.37 19.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.714 0.806 . . . . 0.0 110.596 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 61.51 34.5 17.94 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 125.25 1.42 . . . . 0.0 110.728 -165.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -135.7 133.25 37.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 109.672 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -60.59 -54.83 40.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.751 0.82 . . . . 0.0 110.547 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 83.7 t80 -65.41 -15.16 62.31 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.618 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.48 -30.33 49.61 Favored Glycine 0 C--N 1.359 1.859 0 O-C-N 123.249 0.343 . . . . 0.0 112.854 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -99.47 106.98 42.87 Favored Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.14 179.61 6.05 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.303 2.002 . . . . 0.0 110.644 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.18 -11.53 65.03 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -170.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' A' ' 41' ' ' PHE . 28.8 t-20 -80.77 122.78 27.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.893 1.277 . . . . 0.0 109.5 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.06 -3.9 50.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.543 0.737 . . . . 0.0 111.986 -170.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 87.6 t80 -48.07 -45.24 32.24 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.306 1.042 . . . . 0.0 112.451 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -60.97 -37.03 81.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.482 0.713 . . . . 0.0 111.374 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.62 -41.64 71.96 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.616 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.03 -55.04 25.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.725 0.81 . . . . 0.0 111.057 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 49' ' ' ILE . 63.2 t -66.48 -44.73 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.68 -177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -34.44 88.61 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.179 0.924 . . . . 0.0 113.975 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -68.33 -43.22 78.02 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.544 0.738 . . . . 0.0 110.313 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -70.52 -41.35 72.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.005 0.922 . . . . 0.0 112.474 -174.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 45' ' ' VAL . 17.1 pt -85.12 -14.88 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.23 0.612 . . . . 0.0 110.141 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.14 78.42 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.661 0.601 . . . . 0.0 113.933 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -115.65 142.81 46.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.012 0.925 . . . . 0.0 109.282 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.82 88.83 6.3 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.25 -47.47 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.88 -48.58 81.1 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.747 1.279 . . . . 0.0 112.248 -165.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.37 -32.44 64.5 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.7 137.0 57.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.507 0.323 . . . . 0.0 110.733 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.92 31.51 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.397 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.558 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 42.9 t80 -44.1 -43.75 7.12 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.82 -49.1 78.97 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.816 0.846 . . . . 0.0 111.101 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.1 -34.75 76.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.862 1.265 . . . . 0.0 111.473 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.33 -45.5 94.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.764 1.226 . . . . 0.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.675 HD22 HG11 ' A' ' 9' ' ' VAL . 80.7 mt -63.14 -42.78 99.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 110.816 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -63.08 -31.21 72.3 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.707 0.403 . . . . 0.0 111.339 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -74.4 -28.05 60.91 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.954 0.502 . . . . 0.0 110.948 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.27 -48.36 80.25 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.697 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -57.11 -39.28 74.78 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.617 0.767 . . . . 0.0 111.019 176.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -57.68 -40.58 79.74 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.295 1.038 . . . . 0.0 112.15 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -92.15 4.76 52.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.644 0.378 . . . . 0.0 111.671 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 63.39 40.6 8.32 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.18 1.392 . . . . 0.0 111.15 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.86 138.69 29.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 125.066 1.346 . . . . 0.0 109.065 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.08 154.77 16.41 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 170.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -126.33 134.19 51.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.692 0.797 . . . . 0.0 108.866 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.431 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.8 t90 -160.71 -170.27 2.69 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -134.75 162.88 31.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.345 1.058 . . . . 0.0 109.236 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.39 -48.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 52.6 m-85 -87.45 133.75 33.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.537 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.7 tmmm? -75.17 -32.64 61.33 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.51 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -159.82 152.93 21.89 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.695 0.798 . . . . 0.0 110.817 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -146.54 128.44 3.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' ' 2' ' ' ILE . 43.5 p . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -173.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.03 55.32 0.4 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 18.7 t70 174.77 158.57 0.17 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.577 1.151 . . . . 0.0 108.813 -167.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.86 25.56 10.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.953 0.901 . . . . 0.0 111.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 6.1 tp10 -79.82 102.81 9.31 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 87.5 mt -114.81 146.81 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.744 1.218 . . . . 0.0 109.735 -173.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -68.26 141.82 55.78 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.833 0.853 . . . . 0.0 108.981 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.17 114.56 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.78 6.37 43.83 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.86 0.464 . . . . 0.0 112.124 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.1 t -63.73 -26.05 68.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 0.0 111.615 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.83 -1.88 84.7 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 118.898 -0.946 . . . . 0.0 114.302 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' SD ' ' A' ' 103' ' ' MET . 35.9 mt -50.03 -34.84 22.65 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 117.87 0.835 . . . . 0.0 113.071 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -65.42 -22.43 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -99.33 -45.97 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.525 ' HG3' HG22 ' A' ' 104' ' ' VAL . 17.4 ptm -69.81 -35.85 75.17 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.874 0.87 . . . . 0.0 111.314 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 2.0 m -132.87 88.11 38.49 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.336 0.654 . . . . 0.0 109.698 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 94.9 Cg_endo -72.59 -25.3 17.76 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.013 2.475 . . . . 0.0 111.771 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.2 mmmt -91.72 -6.65 51.61 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.553 1.141 . . . . 0.0 111.537 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -58.82 109.62 0.85 Allowed 'General case' 0 C--N 1.356 0.861 0 O-C-N 123.771 0.669 . . . . 0.0 110.253 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -108.38 -40.14 5.23 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.659 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 130' ' ' GLU . 47.7 tp -125.45 130.12 51.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -174.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.6 mt -110.2 116.59 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.909 0.884 . . . . 0.0 108.793 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.506 ' HB3' HD12 ' A' ' 134' ' ' LEU . 68.1 m -97.9 117.33 31.99 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 123.417 0.687 . . . . 0.0 109.699 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 91.2 m-85 -93.34 123.05 36.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.206 0.602 . . . . 0.0 110.57 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -79.95 79.62 6.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.166 0.586 . . . . 0.0 109.564 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.64 175.3 19.98 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.379 -0.828 . . . . 0.0 115.02 169.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 73.5 ttt180 -57.31 -61.04 2.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.709 1.204 . . . . 0.0 111.52 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.24 -27.66 36.22 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.86 0.864 . . . . 0.0 113.316 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.16 -50.74 15.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.443 0.697 . . . . 0.0 109.914 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.17 -10.53 84.26 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.63 -1.168 . . . . 0.0 114.789 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 96.1 mt-10 -66.24 -22.58 66.33 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.667 0.734 . . . . 0.0 110.265 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -103.53 19.63 19.41 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.347 1.059 . . . . 0.0 110.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 37.2 tt0 -60.68 -51.54 78.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 118.146 -0.931 . . . . 0.0 112.0 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 121' ' ' GLU . 18.2 Cg_endo -54.99 -27.56 55.11 Favored 'Trans proline' 0 C--N 1.406 3.563 0 C-N-CA 122.76 2.307 . . . . 0.0 113.571 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -62.2 -42.84 99.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.299 1.04 . . . . 0.0 110.444 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.415 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 20.0 mt -93.5 -15.04 25.94 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.633 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 37.6 mtp85 -66.85 -34.3 77.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.863 0.465 . . . . 0.0 109.975 171.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.44 -13.02 70.5 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.758 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.5 mtt -93.36 12.25 25.43 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.154 0.982 . . . . 0.0 111.292 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.0 27.83 69.68 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.387 0.429 . . . . 0.0 114.028 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.86 137.96 45.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.715 0.406 . . . . 0.0 111.306 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 28.1 mt-10 -65.1 129.83 41.12 Favored 'General case' 0 C--N 1.345 0.406 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 165.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.488 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.9 p -130.66 144.45 51.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.88 0.472 . . . . 0.0 110.16 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -139.64 125.56 19.69 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.095 0.958 . . . . 0.0 109.835 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 46.3 t -87.13 104.62 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 111' ' ' CYS . 74.3 mt -90.14 154.08 46.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.4 145.14 70.33 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 111.164 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.5 t -59.91 107.39 0.61 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.71 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.5 p -57.97 85.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 O-C-N 124.447 1.092 . . . . 0.0 111.04 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.7 t -129.81 161.0 31.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.616 1.566 . . . . 0.0 108.395 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -42.92 95.84 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.414 0.446 . . . . 0.0 112.865 167.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.0 82.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.41 0.684 . . . . 0.0 111.23 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -65.02 -44.4 89.3 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.979 172.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -67.9 -23.54 65.11 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.417 1.073 . . . . 0.0 110.309 -172.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -56.94 -28.34 62.01 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.819 1.247 . . . . 0.0 111.684 171.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -118.17 -20.04 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.301 1.04 . . . . 0.0 111.496 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.427 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 22.2 t -98.28 31.71 2.7 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.834 0.853 . . . . 0.0 110.973 -173.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -65.35 0.68 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.77 -6.94 59.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.642 0.777 . . . . 0.0 111.965 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.427 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 13.8 tpt180 -85.85 -14.22 45.62 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.318 0.647 . . . . 0.0 110.042 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -51.76 -23.52 4.72 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.862 0.865 . . . . 0.0 112.57 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -63.63 -29.6 70.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.619 0.768 . . . . 0.0 111.376 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 155' ' ' VAL . 8.3 pt-20 -73.22 -35.2 66.27 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -68.03 -35.9 79.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 2.1 tm-20 -70.8 -33.12 70.4 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.751 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.72 -11.95 60.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.858 0.863 . . . . 0.0 112.307 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 151' ' ' GLU . 53.2 t -89.61 -49.17 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.002 0.521 . . . . 0.0 110.29 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -99.36 2.17 45.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -71.19 -35.03 71.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.651 0.66 . . . . 0.0 111.469 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.419 ' CE1' HD11 ' A' ' 16' ' ' ILE . 31.7 p-80 -69.44 -11.77 61.1 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.803 0.441 . . . . 0.0 111.441 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.39 -35.71 71.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.38 -45.81 24.78 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.601 0.761 . . . . 0.0 109.273 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 . . . . . 0 CA--C 1.563 1.468 0 C-N-CA 126.077 1.751 . . . . 0.0 112.518 -176.506 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.5 ' HB2' HD21 ' A' ' 22' ' ' LEU . 3.4 mptp? -100.1 117.55 34.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -93.38 130.94 38.98 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.974 0.51 . . . . 0.0 111.766 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.87 165.05 45.63 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.942 0.776 . . . . 0.0 112.502 172.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.45 149.23 38.54 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.295 0.638 . . . . 0.0 111.544 -165.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -56.74 137.29 80.64 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.519 2.146 . . . . 0.0 110.311 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 142.99 56.6 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.87 0.731 . . . . 0.0 112.419 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 62' ' ' LEU . 59.9 t -91.06 86.61 2.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.25 139.76 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.839 -162.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.89 162.26 23.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.426 1.091 . . . . 0.0 108.353 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.65 -24.39 67.59 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.758 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 29.4 p30 -104.14 36.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.128 0.571 . . . . 0.0 111.075 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 m -89.53 106.63 18.58 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.268 0.556 . . . . 0.0 110.334 -176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.63 -29.98 17.44 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.95 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 159' ' ' LEU . 43.2 mt -123.95 121.49 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 tp -107.98 115.12 29.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 111' ' ' CYS . 39.9 mt -97.31 119.91 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.328 0.651 . . . . 0.0 109.268 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 60.7 mt -111.0 115.87 30.22 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.669 0.788 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -70.99 178.32 33.57 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 167.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 p -86.24 -80.28 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 3' ' ' LYS . 45.9 tp -131.68 122.39 18.67 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 171.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.12 149.42 44.13 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.901 2.4 . . . . 0.0 113.25 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.517 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.9 m -60.78 152.2 27.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.693 1.197 . . . . 0.0 111.12 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 54.2 m-20 -58.98 -40.56 85.18 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.185 0.594 . . . . 0.0 111.35 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.04 -25.54 67.88 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.838 1.255 . . . . 0.0 110.506 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.2 m -83.36 -38.59 21.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.718 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 24' ' ' SER . 48.6 mm -61.34 -41.03 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.346 1.058 . . . . 0.0 110.795 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.5 mmm180 -58.68 -30.95 67.77 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.717 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -106.73 -7.51 17.23 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.896 0.878 . . . . 0.0 112.33 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 58.74 30.95 20.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.814 1.246 . . . . 0.0 113.421 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -145.9 141.67 28.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.97 0.908 . . . . 0.0 109.554 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -59.69 -42.73 93.62 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.688 0.795 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -62.14 -12.63 20.72 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.404 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.45 -21.94 55.29 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.277 0.465 . . . . 0.0 113.615 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -115.77 96.69 47.26 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.65 131.87 4.05 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.38 2.72 . . . . 0.0 110.032 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.14 -13.38 5.48 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -171.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -75.17 126.44 31.03 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 171.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.4 m-20 -82.18 1.88 34.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.326 0.512 . . . . 0.0 111.025 -169.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -46.52 -44.21 17.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.161 0.984 . . . . 0.0 112.179 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -71.55 -26.42 62.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.813 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -76.58 -40.12 50.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.233 1.013 . . . . 0.0 111.495 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 149' ' ' GLU . 80.3 mt -79.56 -46.71 16.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.59 0.756 . . . . 0.0 110.9 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 49' ' ' ILE . 98.7 t -72.64 -32.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.75 -40.97 93.95 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.804 0.69 . . . . 0.0 112.325 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -67.22 -36.07 80.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.421 0.689 . . . . 0.0 110.113 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -70.95 -32.33 69.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 45' ' ' VAL . 18.5 pt -103.09 -10.93 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.241 0.617 . . . . 0.0 111.732 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.7 40.99 44.33 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.37 0.419 . . . . 0.0 113.76 177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -134.02 142.63 47.69 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.668 1.187 . . . . 0.0 108.794 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -86.48 87.8 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.522 0.677 . . . . 0.0 109.976 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.8 -31.94 67.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.831 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -62.13 -39.19 91.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.639 0.776 . . . . 0.0 112.399 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.38 -36.76 66.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.856 0.462 . . . . 0.0 110.638 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.3 mtt -57.67 130.39 46.17 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.19 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.63 151.79 19.96 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.479 166.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.494 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 69.1 t80 -48.11 -49.58 31.47 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.501 0.72 . . . . 0.0 112.524 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.24 -40.65 94.32 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.767 0.827 . . . . 0.0 112.249 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.47 -39.49 92.04 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.573 0.702 . . . . 0.0 110.567 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -62.2 -40.59 96.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.011 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 28.8 mt -57.91 -52.33 65.94 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.012 0.82 . . . . 0.0 109.398 174.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -52.52 -46.62 66.78 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.18 0.992 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.7 m -63.19 -54.74 32.75 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.058 0.943 . . . . 0.0 112.304 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.24 -50.37 70.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.498 0.719 . . . . 0.0 110.739 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -66.0 -32.24 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 112.105 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -60.34 -42.39 95.59 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.546 0.738 . . . . 0.0 110.628 168.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.443 ' O ' HD13 ' A' ' 159' ' ' LEU . 18.6 m120 -81.32 8.08 9.99 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.984 0.914 . . . . 0.0 110.83 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HB2' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER 68.51 31.57 4.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 0.0 111.161 176.001 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.7 mt -111.09 136.85 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.489 1.115 . . . . 0.0 109.349 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.55 160.63 19.14 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 74.5 mt -123.6 144.18 49.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.462 0.705 . . . . 0.0 109.187 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.427 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.5 t90 -167.07 -169.27 1.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -137.68 -177.89 5.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.43 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 97.1 t -98.67 -55.48 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.522 0.729 . . . . 0.0 110.289 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -80.46 107.82 13.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.986 0.514 . . . . 0.0 111.552 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -64.53 -36.4 84.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.194 0.998 . . . . 0.0 110.519 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.44 122.95 10.41 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.713 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.89 116.26 1.94 Allowed Glycine 0 C--N 1.33 0.236 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.236 0.375 0 C-N-CA 123.196 0.598 . . . . 0.0 110.878 -170.664 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.405 HG23 HD22 ' A' ' 22' ' ' LEU . 29.5 mt . . . . . 0 CA--C 1.549 0.908 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.44 -75.9 1.13 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -38.96 137.79 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.214 1.406 . . . . 0.0 114.208 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.24 28.08 7.65 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.491 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -75.64 106.09 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.2 mm -97.4 155.27 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.22 0.608 . . . . 0.0 110.013 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -78.7 158.33 28.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.868 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.6 121.69 24.97 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.43 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 58.9 m-85 -117.71 -0.01 11.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.2 p -74.96 -19.59 60.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.13 79.1 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.575 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 103' ' ' MET . 69.2 mt -52.93 -29.43 28.63 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 123.444 0.698 . . . . 0.0 112.855 176.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.493 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 36.8 mtpt -65.09 -27.6 68.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -85.59 -55.28 4.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.196 0.998 . . . . 0.0 111.405 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.413 ' HG2' ' HA ' ' A' ' 100' ' ' LEU . 24.7 ptm -74.52 -33.82 62.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.21 0.604 . . . . 0.0 112.594 -169.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.1 m -127.08 90.77 48.46 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.221 0.608 . . . . 0.0 110.933 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.93 -32.54 2.55 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.512 2.141 . . . . 0.0 112.325 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.758 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 8.1 mmpt? -76.51 -9.49 58.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 112.241 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.2 tp -59.97 112.46 1.88 Allowed 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.687 0.617 . . . . 0.0 111.218 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -101.71 -45.38 5.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.413 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 132' ' ' LYS . 40.8 tp -134.39 133.49 40.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.2 mt -105.53 115.76 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.161 0.984 . . . . 0.0 108.487 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 134' ' ' LEU . 80.0 m -98.97 116.15 30.55 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.022 0.529 . . . . 0.0 110.466 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.22 127.98 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.702 0.801 . . . . 0.0 110.195 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.498 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 82.3 m-20 -90.2 102.28 15.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.59 155.05 29.89 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.586 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 78.6 ttt180 -55.84 -48.05 76.17 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.4 1.08 . . . . 0.0 112.359 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.25 -29.61 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.45 27.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 173.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.82 -9.55 62.8 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.874 -1.057 . . . . 0.0 114.597 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 115' ' ' ARG . 15.2 mm-40 -62.13 -19.97 63.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.56 0.744 . . . . 0.0 111.703 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.4 ' CD2' HG11 ' A' ' 75' ' ' VAL . 59.4 m-85 -110.13 22.11 15.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 110.674 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.442 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.8 tt0 -59.02 -55.84 42.34 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.367 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.29 -17.71 23.98 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.458 1.438 . . . . 0.0 111.801 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.5 -48.1 78.97 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 109.83 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.503 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 6.7 mt -84.17 -16.64 42.75 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.533 -176.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 7.9 ttt180 -73.54 -17.81 61.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 176.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.88 -16.66 78.19 Favored Glycine 0 C--N 1.355 1.637 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.021 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.503 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -83.38 4.55 26.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.633 0.773 . . . . 0.0 111.197 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.97 14.56 72.07 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.542 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 36.2 m-85 -110.95 130.43 55.59 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.305 0.642 . . . . 0.0 111.222 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.42 139.1 58.74 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 15.2 p -128.13 147.01 50.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.553 0.741 . . . . 0.0 109.967 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 109' ' ' LEU . 51.9 tptt -140.38 124.72 17.76 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 109.164 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.0 t -90.39 118.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.6 mt -102.9 147.79 34.62 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.19 167.45 16.31 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.328 2.019 . . . . 0.0 112.87 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.7 m -65.46 126.55 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.48 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.6 m -77.12 12.75 1.31 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.028 0.931 . . . . 0.0 112.94 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 m -72.93 145.8 46.54 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.862 0.865 . . . . 0.0 109.975 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.57 -26.9 71.2 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-O 121.298 0.388 . . . . 0.0 112.185 173.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.97 -10.87 54.04 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.501 1.121 . . . . 0.0 112.667 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -119.17 -15.85 9.15 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.764 0.826 . . . . 0.0 109.216 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.71 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 39.6 ttp85 -83.54 -17.74 40.8 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.629 0.772 . . . . 0.0 110.705 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.7 mtp-105 -61.14 -27.12 68.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.701 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -106.46 -28.92 10.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.233 1.013 . . . . 0.0 110.12 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.71 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 23.1 t -81.49 37.73 0.47 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.176 0.991 . . . . 0.0 111.501 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 54.0 mtmt -69.82 -54.11 15.11 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.744 0.818 . . . . 0.0 110.626 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.39 -15.04 57.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 5.0 mpt_? -88.44 -13.73 39.69 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.107 0.563 . . . . 0.0 111.459 -174.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.552 ' HB2' HD22 ' A' ' 44' ' ' LEU . 12.9 pt-20 -80.42 -22.66 40.97 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 120.654 0.264 . . . . 0.0 110.605 172.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -66.5 -28.49 68.61 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.426 0.69 . . . . 0.0 111.309 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.8 pt-20 -71.27 -21.37 62.1 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 122.848 0.459 . . . . 0.0 110.819 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -67.52 -42.09 83.33 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.724 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.63 -36.45 78.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.7 63.65 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.782 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.435 HG11 ' SG ' ' A' ' 111' ' ' CYS . 45.8 t -89.54 -45.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.583 0.753 . . . . 0.0 111.195 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.59 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 72.0 m-85 -96.46 -20.36 18.47 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -166.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -76.18 -6.13 49.9 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.85 1.205 . . . . 0.0 113.156 -171.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -73.54 -5.83 42.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.986 -0.447 . . . . 0.0 110.632 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.469 HD11 HD12 ' A' ' 16' ' ' ILE . 39.1 mt -87.57 -17.41 32.03 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.44 1.096 . . . . 0.0 108.787 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.59 -44.29 10.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.625 1.17 . . . . 0.0 109.904 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 125.46 1.504 . . . . 0.0 110.771 -175.769 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.789 0.328 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -107.97 114.18 27.9 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 168.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.3 mmt85 -78.69 129.73 35.03 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.821 0.701 . . . . 0.0 109.995 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.62 151.03 52.23 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -80.6 145.32 58.37 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.787 0.294 . . . . 0.0 111.269 -167.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.5 149.17 68.18 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.322 2.015 . . . . 0.0 110.248 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 131.93 50.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.247 0.619 . . . . 0.0 112.58 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 57.7 t -89.92 86.15 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.506 HD21 HG13 ' A' ' 104' ' ' VAL . 19.9 tp -144.41 153.67 42.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -160.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -128.27 168.32 15.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.433 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.47 -13.65 61.1 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.446 0.698 . . . . 0.0 112.277 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -105.86 38.09 2.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.616 . . . . 0.0 111.464 -176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.63 ' HB ' HG12 ' A' ' 104' ' ' VAL . 94.9 m -101.61 130.96 48.05 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.458 0.303 . . . . 0.0 110.899 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -98.2 -39.7 8.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.258 1.023 . . . . 0.0 111.21 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 159' ' ' LEU . 51.9 mt -120.21 119.81 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 tp -106.94 118.21 36.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.478 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -94.43 109.94 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -98.0 109.3 22.08 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.8 -168.92 3.4 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 169.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 p -103.76 -76.12 0.6 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.54 HD22 HG23 ' A' ' 89' ' ' ILE . 31.1 tp -155.34 121.78 2.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 22' ' ' LEU . 9.8 Cg_exo -72.23 151.59 54.93 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.949 2.433 . . . . 0.0 112.707 -174.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 28' ' ' ILE . 18.3 m -67.31 157.77 33.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.088 0.955 . . . . 0.0 111.092 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.17 -24.57 67.95 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.14 -45.33 95.08 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.549 0.74 . . . . 0.0 110.437 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 m -68.53 -41.13 80.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.307 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 24' ' ' SER . 19.2 mm -57.35 -34.96 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 124.265 0.978 . . . . 0.0 111.647 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -58.11 -38.0 75.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.116 0.566 . . . . 0.0 112.258 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -94.77 -17.01 22.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.252 0.621 . . . . 0.0 111.168 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 64.19 30.34 13.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.514 1.125 . . . . 0.0 111.264 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -145.68 143.64 29.91 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.784 0.834 . . . . 0.0 109.851 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.32 -41.68 97.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.181 0.992 . . . . 0.0 110.113 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.25 -24.16 62.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.733 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.5 -14.4 41.97 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.368 0.418 . . . . 0.0 113.725 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -100.25 104.59 30.7 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.851 0.86 . . . . 0.0 109.468 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.42 97.79 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.27 2.646 . . . . 0.0 109.539 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.08 -30.14 0.72 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -170.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -67.45 103.65 1.36 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.049 0.94 . . . . 0.0 108.467 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -84.83 -0.94 55.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.418 0.687 . . . . 0.0 112.01 -166.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -42.78 -46.1 5.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.22 1.408 . . . . 0.0 113.135 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -79.4 -18.66 51.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.87 0.868 . . . . 0.0 111.254 -170.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 4.6 mmp_? -72.72 -47.71 44.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.114 0.565 . . . . 0.0 110.12 167.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.7 -46.63 71.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.962 0.905 . . . . 0.0 111.413 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.9 t -73.68 -41.46 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.66 0.784 . . . . 0.0 109.685 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.92 91.2 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.793 0.683 . . . . 0.0 112.453 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -66.77 -45.1 79.57 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.288 1.035 . . . . 0.0 109.83 174.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -67.03 -36.64 82.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.815 0.846 . . . . 0.0 112.816 -173.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.2 pt -93.78 -11.26 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.164 0.585 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.61 78.8 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.25 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.33 117.4 18.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.48 96.56 2.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.359 0.664 . . . . 0.0 110.432 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.34 -22.16 61.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.285 1.034 . . . . 0.0 113.035 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -19.87 59.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -168.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -85.18 -36.18 21.2 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.425 0.557 . . . . 0.0 110.325 169.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.1 mtt -63.18 120.55 11.73 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.553 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 160.07 2.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.087 0.555 . . . . 0.0 110.884 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.605 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 47.5 t80 -42.23 -53.59 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.708 0.803 . . . . 0.0 112.85 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 37.2 mt-10 -60.05 -35.78 75.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.635 0.774 . . . . 0.0 112.295 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.02 -48.88 13.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.944 0.897 . . . . 0.0 112.092 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -59.6 -34.96 73.4 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.837 0.455 . . . . 0.0 112.203 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 15.3 mt -64.94 -41.35 95.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.54 0.336 . . . . 0.0 110.492 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 47.7 mmtm -56.83 -37.37 71.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.273 0.629 . . . . 0.0 110.835 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -64.35 -44.16 92.32 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 123.754 0.658 . . . . 0.0 110.741 177.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.65 -57.33 13.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.56 0.744 . . . . 0.0 111.538 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -21.77 60.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -60.07 -40.29 89.01 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 110.442 165.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -86.59 7.57 25.8 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.99 0.916 . . . . 0.0 110.676 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 68.69 29.89 5.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.495 1.518 . . . . 0.0 110.864 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.5 mt -102.29 133.95 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.518 1.127 . . . . 0.0 108.838 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.81 158.15 18.33 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.663 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 66.6 mt -126.39 143.3 51.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.681 0.792 . . . . 0.0 108.995 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.65 -171.54 2.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.13 169.71 10.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.412 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 52.8 t -83.93 -34.97 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.268 0.627 . . . . 0.0 109.534 169.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 55.2 m-85 -101.92 141.65 34.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.846 0.458 . . . . 0.0 111.153 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.662 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 6.7 tmtm? -81.1 -41.87 21.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.953 0.901 . . . . 0.0 108.898 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.512 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -156.47 150.82 25.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.937 0.895 . . . . 0.0 109.768 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -160.23 139.7 6.28 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 121.527 0.679 . . . . 0.0 111.935 -168.483 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.54 HG23 HD22 ' A' ' 22' ' ' LEU . 16.0 mt . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.9 57.5 4.29 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.605 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.694 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 10.2 t70 174.17 159.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -119.38 23.82 11.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.612 0.765 . . . . 0.0 112.058 -173.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 14.9 tp10 -80.4 101.85 9.26 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 54.8 mt -105.97 149.12 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.669 1.188 . . . . 0.0 110.033 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -69.51 147.18 51.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.922 0.889 . . . . 0.0 110.008 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.62 131.8 34.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.412 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 50.3 m-85 -110.0 9.72 24.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.529 0.731 . . . . 0.0 111.779 -175.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 t -69.21 -20.62 63.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.682 0.393 . . . . 0.0 110.843 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -4.52 63.87 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 118.941 -0.921 . . . . 0.0 113.714 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.424 HD23 ' SD ' ' A' ' 103' ' ' MET . 31.1 mt -50.04 -37.3 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -63.73 -31.28 72.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.591 0.356 . . . . 0.0 111.165 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -82.01 -53.12 6.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.817 0.847 . . . . 0.0 111.42 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.485 ' HG3' HG22 ' A' ' 104' ' ' VAL . 23.4 ptm -67.24 -34.95 78.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.534 0.733 . . . . 0.0 111.527 -173.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.63 HG12 ' HB ' ' A' ' 14' ' ' THR . 1.6 m -129.25 84.98 60.77 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.003 0.921 . . . . 0.0 108.857 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.4 -23.74 20.11 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.736 2.29 . . . . 0.0 112.79 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 7.45 38.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.42 0.688 . . . . 0.0 111.827 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 40.2 tp -61.4 125.44 23.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.833 0.349 . . . . 0.0 111.397 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -132.09 -30.58 1.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.13 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.7 tp -130.98 129.61 42.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.047 0.539 . . . . 0.0 110.039 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.56 122.16 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.3 1.04 . . . . 0.0 108.245 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.478 ' HB2' HG12 ' A' ' 18' ' ' ILE . 77.4 m -100.41 114.26 27.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.827 0.451 . . . . 0.0 109.881 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.412 ' HZ ' HD12 ' A' ' 124' ' ' LEU . 96.2 m-85 -89.88 115.5 27.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.983 0.913 . . . . 0.0 109.902 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.595 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 23.3 t30 -89.11 99.98 12.85 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.92 0.888 . . . . 0.0 109.124 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.89 156.43 20.8 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.811 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.54 -50.39 72.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.717 1.207 . . . . 0.0 111.681 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -55.06 -31.47 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.0 -43.91 51.14 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.037 0.535 . . . . 0.0 109.757 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.43 -11.43 64.85 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.007 -0.997 . . . . 0.0 114.149 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -60.43 -34.32 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.038 0.535 . . . . 0.0 110.955 170.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -107.16 18.26 21.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.12 0.968 . . . . 0.0 110.743 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.555 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.9 tm-20 -70.4 -48.79 17.71 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.631 0.772 . . . . 0.0 111.197 170.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.23 -28.77 72.88 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 122.322 2.014 . . . . 0.0 113.192 172.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.7 -48.95 79.47 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.645 0.778 . . . . 0.0 111.12 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.412 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 14.0 mt -85.61 -5.23 59.3 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -171.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -65.21 -34.44 78.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.75 -14.36 67.45 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.156 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 54.9 mtt -90.59 8.0 36.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.806 0.842 . . . . 0.0 111.4 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.48 0.75 89.58 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.33 0.492 . . . . 0.0 114.33 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -92.22 137.4 32.4 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 117.105 0.453 . . . . 0.0 110.331 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.43 131.31 45.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 49.5 p -120.69 136.83 54.74 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.303 0.641 . . . . 0.0 109.403 -176.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -134.51 115.79 14.34 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.304 1.042 . . . . 0.0 109.173 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.7 94.79 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 111' ' ' CYS . 73.6 mt -77.11 139.07 64.81 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 169.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.01 159.46 29.62 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.522 2.148 . . . . 0.0 112.505 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t -65.39 104.15 0.92 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.427 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.8 p -73.29 77.21 1.33 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.162 0.982 . . . . 0.0 109.037 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.8 p -129.1 159.77 34.94 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.98 29.7 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.04 -45.42 8.32 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.206 0.602 . . . . 0.0 112.143 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.82 -9.88 52.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.626 0.37 . . . . 0.0 111.896 -169.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -65.15 -33.18 75.41 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 0.0 110.369 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.13 -30.88 70.99 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.836 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.37 23.3 6.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.182 . . . . 0.0 110.596 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.5 t -139.42 24.4 2.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.294 1.038 . . . . 0.0 108.818 -170.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 49.2 tptt -66.8 -55.93 12.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 -175.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.53 -25.55 52.19 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.244 0.618 . . . . 0.0 112.355 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.576 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -88.54 -17.52 30.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.597 0.759 . . . . 0.0 111.146 -168.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 10.9 pt-20 -65.8 -19.91 66.06 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.21 0.459 . . . . 0.0 110.424 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.6 t -67.98 -44.86 75.69 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.075 0.95 . . . . 0.0 111.172 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.8 pt-20 -73.77 -29.42 62.19 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -62.68 -48.54 78.84 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 1.2 tm-20 -60.89 -38.01 84.19 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.782 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.88 -19.89 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.088 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 151' ' ' GLU . 43.7 t -68.77 -47.14 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.512 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 33.7 m-85 -91.82 2.74 56.31 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -174.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -60.78 -55.51 32.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.475 0.71 . . . . 0.0 112.128 177.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -70.3 -9.73 56.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 16' ' ' ILE . 93.8 mt -73.53 -31.18 63.54 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.995 0.518 . . . . 0.0 109.896 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.4 -52.21 3.57 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 . . . . . 0 CA--C 1.554 1.134 0 C-N-CA 125.456 1.502 . . . . 0.0 111.167 177.28 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 80' ' ' SER . 38.0 mm . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -91.31 112.41 24.31 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.06 138.03 35.21 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.019 0.527 . . . . 0.0 111.367 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.18 152.44 49.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.536 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -84.53 138.56 38.41 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.029 0.531 . . . . 0.0 110.267 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.61 154.94 11.05 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 123.046 2.497 . . . . 0.0 112.22 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -64.83 129.75 40.92 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -167.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG11 HD22 ' A' ' 62' ' ' LEU . 97.4 t -91.12 76.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.518 HD13 HD13 ' A' ' 17' ' ' LEU . 26.9 tp -135.6 153.64 51.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -158.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.585 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 9.2 t70 -126.5 167.46 15.58 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.595 0.758 . . . . 0.0 109.09 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.26 -12.77 61.63 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.799 0.84 . . . . 0.0 111.085 170.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -119.45 73.72 0.96 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.565 ' HB ' HG12 ' A' ' 104' ' ' VAL . 99.9 m -125.15 122.63 37.66 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.508 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.0 tt0 -93.34 -39.27 11.04 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.966 1.306 . . . . 0.0 110.283 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 109' ' ' LEU . 52.5 mt -120.11 113.67 41.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 HD13 ' A' ' 10' ' ' LEU . 52.3 tp -103.84 116.18 31.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.504 ' HB ' HD23 ' A' ' 72' ' ' LEU . 46.2 mt -94.38 114.1 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.288 0.635 . . . . 0.0 109.372 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -104.25 113.7 27.43 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.552 0.741 . . . . 0.0 110.424 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -67.54 174.09 28.55 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.9 m -86.91 -79.8 0.26 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 tp -136.46 122.34 13.53 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.437 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.7 Cg_exo -58.04 135.3 67.75 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.073 1.849 . . . . 0.0 111.371 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.3 t -60.89 146.12 47.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.765 0.665 . . . . 0.0 109.58 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 4.9 p-10 -58.08 -34.3 69.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.431 0.292 . . . . 0.0 111.339 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.06 -43.01 69.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.272 1.029 . . . . 0.0 111.722 172.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.554 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 26.3 t -68.99 -39.19 79.5 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.011 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 24' ' ' SER . 40.3 mt -76.97 -15.62 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.27 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 13.7 mmt180 -60.63 -36.27 78.25 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.353 0.597 . . . . 0.0 109.599 176.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.76 -0.14 40.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.204 1.002 . . . . 0.0 111.288 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 61.93 21.87 12.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.35 1.06 . . . . 0.0 112.737 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 58' ' ' TYR . 10.6 pt20 -146.52 158.69 43.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.491 0.316 . . . . 0.0 111.689 -173.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.584 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 83.5 m-85 -68.6 -0.88 5.68 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.745 1.218 . . . . 0.0 112.564 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -105.41 1.77 28.08 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.689 1.196 . . . . 0.0 110.024 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -38.22 -42.42 1.24 Allowed Glycine 0 C--N 1.361 1.961 0 C-N-CA 124.917 1.246 . . . . 0.0 116.083 -174.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -126.78 146.38 56.97 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.5 2.133 . . . . 0.0 112.762 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.9 -6.36 85.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.02 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -67.58 104.78 1.68 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.58 6.39 41.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.267 0.627 . . . . 0.0 111.131 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -42.77 -43.24 3.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.898 0.879 . . . . 0.0 111.045 164.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.584 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 57.3 m95 -82.71 -28.13 30.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.868 0.867 . . . . 0.0 111.966 -177.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -68.79 -45.81 70.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.812 0.845 . . . . 0.0 111.071 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 mt -87.03 -39.03 16.01 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.133 0.573 . . . . 0.0 111.96 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.3 t -71.39 -36.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 -39.72 95.61 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.891 0.745 . . . . 0.0 112.471 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -67.96 -39.29 83.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.15 0.58 . . . . 0.0 110.496 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -68.89 -32.93 72.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.022 0.929 . . . . 0.0 113.07 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 pt -94.74 -11.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.929 0.492 . . . . 0.0 111.151 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.78 72.83 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 0.0 113.574 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -142.98 104.26 4.29 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.09 99.91 0.19 Allowed 'General case' 0 C--N 1.352 0.703 0 CA-C-O 121.453 0.644 . . . . 0.0 110.993 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 73.2 mt -67.06 -34.49 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -66.17 -21.21 66.32 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.227 1.011 . . . . 0.0 112.539 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -95.39 -31.55 13.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.87 0.468 . . . . 0.0 111.229 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.4 mtt -58.1 141.09 51.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.236 0.614 . . . . 0.0 111.176 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.41 137.69 57.1 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.141 -0.933 . . . . 0.0 109.395 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.491 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 38.4 t80 -45.66 -38.82 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -167.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 40.3 mt-10 -58.79 -59.93 4.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.534 0.734 . . . . 0.0 110.923 175.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -60.11 -34.15 73.1 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.971 0.908 . . . . 0.0 111.729 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 53' ' ' LEU . 2.3 ttmp? -60.17 -47.5 85.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.875 1.27 . . . . 0.0 110.006 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.629 HD22 HG11 ' A' ' 9' ' ' VAL . 46.0 mt -67.5 -40.35 85.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.001 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 57.7 mtpt -60.2 -31.34 70.06 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.574 0.35 . . . . 0.0 111.736 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -67.88 -34.52 76.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.072 0.549 . . . . 0.0 110.58 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.55 -57.31 11.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.585 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -58.73 -36.78 74.87 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.137 0.575 . . . . 0.0 111.264 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -53.51 -46.58 70.13 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 111.9 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.06 8.41 23.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.0 0.92 . . . . 0.0 111.852 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 60.53 37.3 19.67 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.595 1.158 . . . . 0.0 110.353 -178.403 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.81 140.41 21.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.383 1.073 . . . . 0.0 109.225 174.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.35 162.88 17.07 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 170.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.504 HD23 ' HB ' ' A' ' 18' ' ' ILE . 98.0 mt -128.76 138.95 52.38 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -164.69 -168.74 1.55 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -131.29 160.98 33.35 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.61 0.641 . . . . 0.0 111.553 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.504 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.6 t -94.04 -48.28 13.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 124.204 1.002 . . . . 0.0 110.809 175.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -93.78 113.35 25.38 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 87.9 tttt -64.28 -37.29 86.95 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.252 0.97 . . . . 0.0 110.513 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.86 134.97 17.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.849 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -143.66 136.26 6.81 Favored Glycine 0 C--O 1.218 -0.892 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.513 ' HB3' HD13 ' A' ' 2' ' ' ILE . 23.9 p . . . . . 0 N--CA 1.473 0.69 0 CA-C-N 117.958 0.879 . . . . 0.0 110.594 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.36 65.05 4.07 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.802 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.593 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.0 t70 -177.87 153.85 0.87 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.075 0.95 . . . . 0.0 108.577 -169.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -121.62 22.07 10.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.574 0.75 . . . . 0.0 111.746 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.0 tp10 -80.28 101.32 8.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.0 mt -94.61 153.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.18 0.992 . . . . 0.0 110.162 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.97 156.33 19.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.947 0.899 . . . . 0.0 109.429 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.01 122.12 34.22 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.515 0.726 . . . . 0.0 110.312 -174.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.504 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 48.2 m-85 -109.0 6.85 25.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.52 0.728 . . . . 0.0 112.007 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -70.45 -17.14 62.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.63 0.372 . . . . 0.0 111.048 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.94 -5.19 77.69 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.657 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -47.89 -49.06 31.02 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.561 0.745 . . . . 0.0 112.666 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -62.0 -27.8 69.12 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -82.91 -54.36 5.14 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.444 0.698 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -75.45 -27.72 59.02 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' A' ' 14' ' ' THR . 4.1 m -132.54 92.61 27.04 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.285 0.634 . . . . 0.0 110.851 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 71.5 Cg_endo -74.19 -36.89 2.95 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.907 2.405 . . . . 0.0 111.781 172.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.3 mmmt -79.83 -5.93 56.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.095 0.958 . . . . 0.0 111.392 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.3 tp -57.84 128.91 39.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.842 0.857 . . . . 0.0 111.316 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.528 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -137.7 -22.61 1.09 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.328 171.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB2' HH11 ' A' ' 108' ' ' ARG . 23.6 tp -129.64 126.57 38.72 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.883 0.473 . . . . 0.0 110.577 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.551 ' HB ' HG22 ' A' ' 131' ' ' THR . 33.7 mt -113.78 110.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.458 ' HB3' HD12 ' A' ' 134' ' ' LEU . 76.8 m -96.12 114.21 25.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 110.509 -175.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.47 116.19 28.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.023 0.929 . . . . 0.0 110.742 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.538 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 83.1 m-20 -82.92 102.39 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.75 138.32 9.48 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -58.83 -32.1 69.08 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.144 0.578 . . . . 0.0 111.513 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -53.31 -42.89 67.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.892 0.877 . . . . 0.0 112.303 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.29 -38.72 71.8 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.426 0.631 . . . . 0.0 110.314 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.57 -9.53 55.7 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.561 -1.2 . . . . 0.0 114.44 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -24.64 66.91 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 117.374 0.587 . . . . 0.0 110.547 172.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.4 21.5 16.59 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.198 0.999 . . . . 0.0 111.215 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -66.24 -52.16 39.79 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.17 0.988 . . . . 0.0 112.405 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.46 -14.61 30.89 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.608 1.539 . . . . 0.0 112.357 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -66.1 -44.98 82.82 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.905 0.882 . . . . 0.0 109.668 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 -20.49 29.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 50.5 ttt180 -72.24 -29.13 63.63 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.06 -22.28 75.87 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 58.4 mtt -76.66 -9.9 59.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.195 0.598 . . . . 0.0 111.719 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.89 14.75 16.4 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 120.175 -0.236 . . . . 0.0 113.412 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.2 m-85 -109.12 145.72 35.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 0.0 109.734 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 mm-40 -70.55 137.11 49.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 163.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.551 HG22 ' HB ' ' A' ' 110' ' ' ILE . 25.8 p -128.43 138.4 52.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -129.33 117.99 21.54 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.785 1.234 . . . . 0.0 108.849 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.41 103.33 9.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 111' ' ' CYS . 48.0 mt -88.53 131.92 40.53 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 148' ' ' ARG . 45.8 Cg_exo -59.57 136.3 70.24 Favored 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.687 2.258 . . . . 0.0 111.133 176.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.6 t -50.24 118.99 3.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.261 0.975 . . . . 0.0 111.013 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 p -83.65 30.17 0.5 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.901 0.881 . . . . 0.0 111.529 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 p -61.05 149.52 36.73 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.715 0.806 . . . . 0.0 110.576 165.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -53.14 -42.97 62.89 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.729 0.643 . . . . 0.0 114.4 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.01 93.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.329 0.652 . . . . 0.0 111.782 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -78.27 -28.51 47.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.168 0.587 . . . . 0.0 110.065 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.98 -36.62 77.55 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.322 0.649 . . . . 0.0 110.952 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -57.02 -20.78 26.19 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.118 0.967 . . . . 0.0 112.565 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -112.5 -33.69 6.08 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.243 0.617 . . . . 0.0 110.847 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.7 m -69.5 83.12 0.41 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -95.8 -57.18 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.396 1.079 . . . . 0.0 110.586 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.05 -32.41 69.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.182 0.593 . . . . 0.0 110.399 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.514 ' HB3' ' HG2' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -86.95 -31.81 20.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.908 -172.599 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.75 -28.85 67.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.006 0.821 . . . . 0.0 109.01 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -65.87 -42.91 89.74 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.1 pt-20 -71.9 -26.96 62.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -67.52 -43.21 81.38 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.69 -39.12 84.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.401 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.497 -175.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 151' ' ' GLU . 54.8 t -80.73 -62.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.003 0.521 . . . . 0.0 110.407 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 54.6 m-85 -85.08 2.45 43.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -165.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -25.62 62.84 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -78.21 -8.15 57.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.558 0.343 . . . . 0.0 111.814 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.81 -38.8 76.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.815 0.446 . . . . 0.0 111.312 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.25 -41.68 40.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 C--O 1.243 0.733 0 C-N-CA 125.566 1.547 . . . . 0.0 106.89 175.552 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.2 mm . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -88.34 110.14 20.54 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.2 mmt-85 -84.25 136.42 33.94 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.182 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.538 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -68.22 162.46 49.32 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 123.634 0.584 . . . . 0.0 112.052 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -101.47 146.14 31.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.05 137.09 17.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.741 2.294 . . . . 0.0 111.866 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.4 138.79 58.27 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.94 0.896 . . . . 0.0 111.625 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.63 81.29 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.537 HD11 ' CG1' ' A' ' 104' ' ' VAL . 40.8 tp -128.0 145.36 51.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.358 -163.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -123.41 159.67 28.46 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.603 1.161 . . . . 0.0 107.909 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.13 -26.73 64.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.987 0.515 . . . . 0.0 111.202 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -111.46 89.53 3.08 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -135.48 107.64 7.21 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.303 0.641 . . . . 0.0 109.61 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 69' ' ' ARG . 59.7 mm-40 -80.47 -35.74 34.39 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.396 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 24.3 mt -129.09 124.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 123.461 0.704 . . . . 0.0 109.857 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.79 117.4 34.02 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mt -94.15 112.83 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.52 119.66 39.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.727 0.811 . . . . 0.0 109.981 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.24 177.11 46.39 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 164.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.508 ' OG ' ' HB3' ' A' ' 116' ' ' LYS . 47.4 t -90.16 -75.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 tp -129.59 125.2 22.26 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 175.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.538 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 50.6 Cg_exo -59.28 125.0 16.78 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.033 1.822 . . . . 0.0 110.509 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -78.76 173.07 12.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.8 -37.28 78.69 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.046 0.539 . . . . 0.0 111.578 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.57 -42.95 89.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.871 0.868 . . . . 0.0 111.475 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.5 m -65.4 -41.9 93.15 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.024 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.02 -26.78 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.852 1.261 . . . . 0.0 112.304 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -63.37 -39.56 94.86 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.892 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -5.18 22.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.149 0.58 . . . . 0.0 111.186 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 62.5 31.22 17.13 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.688 1.195 . . . . 0.0 111.253 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -127.68 139.34 52.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.908 1.283 . . . . 0.0 108.887 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -57.56 -40.48 78.99 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.378 0.609 . . . . 0.0 109.535 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HA ' ' HE1' ' A' ' 42' ' ' TRP . 24.6 t80 -47.71 -44.76 27.98 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.422 169.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.39 -107.29 0.1 Allowed Glycine 0 C--N 1.362 2.012 0 O-C-N 124.043 0.839 . . . . 0.0 113.301 -170.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -122.72 146.6 48.44 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.294 1.037 . . . . 0.0 109.794 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -40.54 119.04 0.67 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.821 3.68 . . . . 0.0 114.216 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.29 -33.12 0.09 OUTLIER Glycine 0 N--CA 1.472 1.071 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.431 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -93.46 126.9 38.85 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.52 0.728 . . . . 0.0 109.245 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -81.64 1.49 33.81 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.399 1.08 . . . . 0.0 111.017 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -37.51 -49.48 1.06 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.918 1.687 . . . . 0.0 113.073 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.418 ' HE1' ' HA ' ' A' ' 34' ' ' TYR . 74.7 m95 -73.37 -24.21 60.3 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.402 -173.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 ttm-85 -88.29 -27.17 21.88 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 111.117 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.35 -51.36 9.52 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 110.569 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.96 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.27 -36.79 85.55 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.069 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -64.23 -40.97 97.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.631 . . . . 0.0 109.498 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 156' ' ' PHE . . . -62.81 -50.32 71.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.585 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.3 pt -88.19 -4.98 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.49 0.316 . . . . 0.0 111.212 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.3 28.99 64.93 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.147 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -146.15 92.28 2.17 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.01 101.16 0.14 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.243 0.617 . . . . 0.0 109.868 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.402 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 54.3 mt -68.73 -17.43 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.401 1.081 . . . . 0.0 112.229 -167.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.02 -41.93 93.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.543 0.737 . . . . 0.0 112.044 -169.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.38 -32.64 71.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.58 0.752 . . . . 0.0 112.459 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -60.37 148.85 35.73 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.307 0.643 . . . . 0.0 112.55 -175.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 153.72 32.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 167.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.521 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 33.5 t80 -54.45 -45.61 73.12 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -164.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -63.8 -45.2 90.75 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.044 0.538 . . . . 0.0 111.271 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -34.59 78.74 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.06 0.944 . . . . 0.0 110.333 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 29.7 ttmt -65.46 -41.44 93.37 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.814 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 29.2 mt -58.06 -48.46 80.04 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.07 0.856 . . . . 0.0 109.625 173.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -55.92 -45.23 78.78 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.237 0.96 . . . . 0.0 111.693 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -67.41 -45.64 75.57 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 123.543 0.527 . . . . 0.0 110.691 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.7 mt -55.84 -56.56 19.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.752 0.821 . . . . 0.0 110.527 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -67.95 -30.65 70.0 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.296 1.039 . . . . 0.0 111.58 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -63.45 -35.94 82.1 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.815 0.846 . . . . 0.0 110.884 170.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -84.82 5.13 29.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.388 0.675 . . . . 0.0 111.254 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 2.0 mpt_? 65.36 34.47 8.19 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-O 122.25 1.024 . . . . 0.0 110.197 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.06 135.65 49.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 108.731 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.61 169.04 13.66 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.0 mt -126.73 147.42 49.97 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.759 0.824 . . . . 0.0 109.127 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -166.18 -169.02 1.34 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.33 164.34 30.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.312 0.645 . . . . 0.0 110.565 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.414 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.7 t -86.14 -42.38 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.037 0.935 . . . . 0.0 111.074 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -100.22 115.78 30.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.095 0.558 . . . . 0.0 110.625 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 1.6 tmtp? -66.47 -34.75 78.64 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -144.82 135.26 24.35 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.684 -0.635 . . . . 0.0 110.614 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -157.26 148.72 18.78 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.547 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.476 0.84 0 C-N-CA 124.303 1.041 . . . . 0.0 109.119 177.444 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.376 0.608 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.38 58.09 4.18 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.519 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.542 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.9 t0 -171.19 144.05 2.0 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -110.43 17.67 20.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.887 0.875 . . . . 0.0 111.59 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 45.8 tt0 -85.01 103.01 13.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.488 0.661 . . . . 0.0 109.376 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.55 154.01 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.809 1.244 . . . . 0.0 109.451 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -79.58 157.2 27.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.686 0.794 . . . . 0.0 109.748 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.22 139.78 30.14 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.414 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 80.8 m-85 -130.48 11.58 5.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.713 0.805 . . . . 0.0 110.951 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 99.2 p -77.62 -12.1 59.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.969 -0.457 . . . . 0.0 110.469 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.03 -4.87 68.55 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.532 -0.593 . . . . 0.0 112.307 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 mt -51.23 -49.47 61.02 Favored 'General case' 0 C--N 1.37 1.494 0 C-N-CA 123.729 0.812 . . . . 0.0 111.362 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.549 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 44.6 mtpt -64.92 -16.18 62.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -171.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.94 -40.13 9.04 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 111.611 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -85.44 -26.61 26.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.537 ' CG1' HD11 ' A' ' 10' ' ' LEU . 2.2 m -129.02 89.5 48.46 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 122.868 0.467 . . . . 0.0 110.04 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.64 -28.7 20.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.296 1.997 . . . . 0.0 110.969 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -84.61 -11.95 54.97 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 112.864 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 32.3 tp -57.69 101.85 0.08 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.033 0.833 . . . . 0.0 110.665 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -93.21 -43.97 8.57 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.588 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.7 tp -134.19 135.66 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.555 0.742 . . . . 0.0 109.894 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.4 mt -105.08 136.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 86.3 m -117.75 115.39 24.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.14 0.427 . . . . 0.0 110.251 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -93.56 123.06 36.62 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -101.81 111.35 23.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.18 134.99 8.62 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -53.17 -47.17 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.304 1.042 . . . . 0.0 112.18 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.508 ' HB3' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -60.22 -20.83 60.53 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.805 0.842 . . . . 0.0 112.641 -178.13 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.56 -46.36 17.47 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.372 0.606 . . . . 0.0 109.476 170.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.26 -9.76 68.33 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.95 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -68.35 -17.52 64.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.009 0.524 . . . . 0.0 110.636 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.79 21.47 17.45 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.183 0.993 . . . . 0.0 110.988 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.44 -51.48 59.96 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.15 -0.928 . . . . 0.0 112.357 171.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.28 -24.44 67.7 Favored 'Trans proline' 0 C--N 1.405 3.551 0 C-N-CA 122.084 1.856 . . . . 0.0 112.698 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.81 -57.21 8.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.914 0.886 . . . . 0.0 110.181 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.48 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 12.2 mt -79.18 -21.03 46.96 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 6.9 ptm180 -75.22 -11.65 60.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 120.703 0.287 . . . . 0.0 110.715 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.59 -15.14 81.44 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.405 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.48 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -81.94 10.71 5.98 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 174.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.24 19.74 79.76 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 122.749 0.214 . . . . 0.0 112.716 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.549 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 18.3 m-85 -108.79 139.59 43.39 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.304 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -73.48 142.42 46.8 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -129.99 148.15 51.82 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.401 ' HB2' HD11 ' A' ' 109' ' ' LEU . 54.3 tptt -139.37 123.54 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.215 1.006 . . . . 0.0 108.864 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.04 122.81 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.52 HD21 HG21 ' A' ' 155' ' ' VAL . 90.4 mt -113.02 150.15 42.44 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.58 177.37 4.08 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.772 2.314 . . . . 0.0 111.561 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 m -66.02 130.29 42.74 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -83.89 14.91 3.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.834 0.854 . . . . 0.0 112.044 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -69.88 156.26 39.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.147 0.979 . . . . 0.0 111.78 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.17 -18.61 69.38 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.693 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.22 83.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.362 0.665 . . . . 0.0 111.056 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -76.56 -2.59 33.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.7 0.8 . . . . 0.0 112.477 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.446 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 20.1 ttm-85 -56.13 -33.68 65.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.039 0.935 . . . . 0.0 113.317 -172.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -33.38 72.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.643 0.589 . . . . 0.0 110.606 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.01 5.94 20.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.774 0.829 . . . . 0.0 111.994 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 13.7 t -91.07 14.8 13.05 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.151 0.58 . . . . 0.0 112.195 -175.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.98 -58.06 5.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.44 ' HB2' ' NH1' ' A' ' 148' ' ' ARG . 17.4 m120 -59.21 -15.06 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.44 ' NH1' ' HB2' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -74.96 -23.65 58.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.974 0.51 . . . . 0.0 110.101 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.36 -55.63 32.27 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.26 0.624 . . . . 0.0 110.695 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -73.93 -32.34 63.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 111.161 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 155' ' ' VAL . 19.3 tt0 -67.37 -56.75 8.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.165 0.586 . . . . 0.0 110.224 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -69.58 -25.91 64.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.523 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 32.4 tt0 -59.35 -49.61 77.14 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 123.821 0.7 . . . . 0.0 109.442 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.53 77.69 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.553 -171.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.52 HG21 HD21 ' A' ' 134' ' ' LEU . 92.6 t -61.91 -32.64 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 124.173 0.989 . . . . 0.0 112.673 -174.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.417 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 44.0 m-85 -115.55 -11.99 11.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 112.909 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.523 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 14.4 ptm180 -74.1 -26.56 60.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.555 0.616 . . . . 0.0 111.591 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -73.84 -8.8 57.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.571 0.348 . . . . 0.0 111.906 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.412 HD11 HD12 ' A' ' 16' ' ' ILE . 80.8 mt -70.26 -12.21 61.43 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.338 0.655 . . . . 0.0 112.732 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -90.37 -1.99 57.94 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.036 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 . . . . . 0 CA--C 1.555 1.148 0 C-N-CA 125.561 1.544 . . . . 0.0 110.435 -175.01 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptp . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.812 0.339 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.89 139.75 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 25' ' ' ASP . 11.1 mptt -87.61 117.51 26.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -100.12 134.04 43.62 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.366 0.667 . . . . 0.0 110.558 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.512 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.2 -174.03 17.55 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.384 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -117.03 144.23 33.16 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 122.948 0.499 . . . . 0.0 110.281 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.42 145.42 16.13 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.024 2.483 . . . . 0.0 112.003 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.11 128.85 38.46 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.825 0.703 . . . . 0.0 111.124 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 62' ' ' LEU . 48.7 t -93.75 78.88 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.472 HD11 ' CG1' ' A' ' 104' ' ' VAL . 41.9 tp -128.71 154.07 46.69 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 112.164 -161.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.51 154.92 37.21 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.13 -10.68 32.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.15 0.58 . . . . 0.0 112.222 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -120.08 97.38 5.57 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.46 ' HB ' HG12 ' A' ' 104' ' ' VAL . 52.6 m -144.04 112.93 6.71 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.387 0.675 . . . . 0.0 110.205 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.56 -36.21 29.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.053 . . . . 0.0 110.75 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.16 116.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.241 0.616 . . . . 0.0 109.484 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -104.95 115.51 30.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.0 mt -98.38 109.32 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.736 0.814 . . . . 0.0 109.046 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.432 HD23 ' HB3' ' A' ' 73' ' ' TRP . 80.8 mt -98.08 108.93 21.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 109.026 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.72 -177.9 11.99 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 166.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 p -89.61 -82.17 0.27 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -136.12 114.92 10.88 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.5 Cg_exo -52.89 136.77 60.62 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.958 2.438 . . . . 0.0 112.846 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 m -61.22 145.64 50.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.105 0.878 . . . . 0.0 109.634 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 7.8 p-10 -61.89 -31.26 71.53 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.158 0.436 . . . . 0.0 110.73 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.75 -36.24 76.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.87 0.868 . . . . 0.0 110.793 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.1 m -66.5 -47.08 74.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.45 -26.57 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.763 1.225 . . . . 0.0 112.832 -171.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 18.7 mmt85 -69.4 -36.36 76.68 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 110.089 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.64 -16.12 35.33 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.281 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 65.38 21.59 11.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.695 1.598 . . . . 0.0 111.597 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.89 135.9 40.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.842 1.257 . . . . 0.0 108.873 -173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -57.98 -40.49 80.79 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 122.936 0.495 . . . . 0.0 110.817 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.98 -13.33 45.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.512 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.89 16.41 Favored Glycine 0 C--N 1.362 1.984 0 C-N-CA 124.02 0.819 . . . . 0.0 113.523 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -109.78 112.29 58.39 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 165.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.07 0.56 3.1 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.794 2.996 . . . . 0.0 114.273 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.29 -14.2 80.89 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -72.82 97.64 2.28 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 168.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -80.07 -1.65 40.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.971 0.909 . . . . 0.0 110.885 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -36.03 -41.91 0.26 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.916 2.087 . . . . 0.0 113.443 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.36 -28.9 64.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.57 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -84.11 -37.84 21.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.106 0.562 . . . . 0.0 111.117 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.68 -48.24 80.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 0.0 110.224 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -74.02 -37.26 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.416 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.08 -41.11 99.88 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.071 0.388 . . . . 0.0 114.071 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -71.41 -30.63 66.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.745 0.418 . . . . 0.0 110.363 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -75.82 -36.91 59.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.807 0.843 . . . . 0.0 112.465 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 pt -91.11 -10.46 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.396 0.678 . . . . 0.0 111.143 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.18 19.81 79.75 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.588 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -135.7 112.64 10.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -71.53 96.44 1.53 Allowed 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.588 0.709 . . . . 0.0 111.696 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.68 -35.87 81.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.013 0.925 . . . . 0.0 110.917 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -53.29 -50.44 64.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.627 1.171 . . . . 0.0 112.626 -170.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -81.96 -6.31 59.02 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.275 0.63 . . . . 0.0 112.097 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtt -86.11 139.62 30.95 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 151.35 33.56 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.081 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.517 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 53.6 t80 -50.0 -42.94 50.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -167.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 42.5 mt-10 -60.31 -46.2 90.73 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.305 0.378 . . . . 0.0 110.758 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -68.53 -45.13 73.02 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -59.71 -32.99 71.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.14 0.427 . . . . 0.0 110.885 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.565 HD22 HG11 ' A' ' 9' ' ' VAL . 47.2 mt -66.77 -43.15 84.8 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.81 172.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 74.7 mmtt -57.06 -41.17 78.27 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.216 0.606 . . . . 0.0 110.233 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -65.27 -39.25 92.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.498 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.05 -46.25 85.22 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.851 0.461 . . . . 0.0 110.228 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 28.6 mmtp -59.88 -39.77 86.43 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.104 0.561 . . . . 0.0 109.882 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.05 -45.65 90.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.992 1.317 . . . . 0.0 111.335 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -86.25 7.78 23.86 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.328 0.251 . . . . 0.0 111.035 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 67.85 38.5 2.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.479 1.111 . . . . 0.0 110.988 171.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.63 132.92 57.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.15 1.38 . . . . 0.0 109.504 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.5 151.6 18.03 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 46.5 mt -119.84 141.06 49.87 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.341 0.656 . . . . 0.0 109.29 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.432 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.9 t90 -165.09 -168.96 1.53 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -133.54 177.91 7.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.956 0.902 . . . . 0.0 109.888 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.7 t -95.64 -56.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.675 0.79 . . . . 0.0 109.647 172.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 57.3 m-85 -84.21 107.98 16.84 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.095 0.558 . . . . 0.0 110.607 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 3.7 tmtm? -66.82 -31.14 71.57 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.813 0.845 . . . . 0.0 109.044 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -152.86 130.87 11.81 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.061 0.544 . . . . 0.0 109.742 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 91' ' ' ASP . . . -151.03 144.21 11.49 Favored Glycine 0 C--O 1.238 0.4 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.825 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -90.04 105.37 17.76 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -119.06 92.72 3.87 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 170.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -133.24 168.37 18.67 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.859 -0.525 . . . . 0.0 109.964 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.61 92.88 0.36 Allowed Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.572 -175.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 p -143.9 -171.02 3.46 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.012 0.925 . . . . 0.0 109.904 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -68.04 -62.41 1.41 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.388 0.675 . . . . 0.0 109.973 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.467 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 4.1 m-20 -72.87 -46.44 52.83 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.702 -175.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.2 m 56.07 36.36 27.26 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.582 1.153 . . . . 0.0 111.161 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 86' ' ' ASP . 31.9 mmmt -92.29 153.2 19.38 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.007 0.923 . . . . 0.0 110.097 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -70.04 97.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.37 -70.1 1.3 Allowed Glycine 0 C--N 1.344 0.989 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.759 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.528 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 1.1 m-20 -38.88 133.41 1.12 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.873 1.269 . . . . 0.0 113.349 173.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -114.62 25.87 10.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.438 -165.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 8.4 tp10 -78.88 111.96 15.57 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.72 144.07 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.88 0.872 . . . . 0.0 109.134 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -68.95 149.61 48.65 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.233 1.013 . . . . 0.0 110.796 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -78.27 130.94 36.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.516 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 35.3 m-85 -120.67 3.88 10.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.252 0.621 . . . . 0.0 111.395 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.0 t -74.63 -14.69 60.79 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.007 0.523 . . . . 0.0 109.817 173.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.88 -4.04 61.87 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.148 -0.807 . . . . 0.0 113.094 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 mt -52.8 -32.88 46.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 117.732 0.766 . . . . 0.0 112.879 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -68.59 -27.19 65.82 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.779 0.323 . . . . 0.0 111.444 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -83.31 -53.0 6.07 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.696 0.799 . . . . 0.0 111.466 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.534 ' HG3' HG22 ' A' ' 104' ' ' VAL . 25.4 ptm -73.32 -29.41 62.66 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.305 0.642 . . . . 0.0 111.341 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -139.24 86.96 14.12 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.449 0.7 . . . . 0.0 111.209 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.69 -25.97 8.78 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.469 2.113 . . . . 0.0 112.554 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -77.8 -10.13 59.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.4 0.68 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 36.2 tp -54.39 131.09 41.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.81 0.694 . . . . 0.0 110.673 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.41 ' HD2' ' NE2' ' A' ' 158' ' ' HIS . 18.0 ptp180 -128.56 -37.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.004 0.921 . . . . 0.0 108.707 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 tp -132.29 125.34 30.75 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.255 0.622 . . . . 0.0 110.432 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.508 HG12 HD21 ' A' ' 107' ' ' LEU . 32.9 mt -101.69 109.53 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.531 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.5 m -95.12 112.98 24.62 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.165 0.507 . . . . 0.0 109.928 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.1 114.49 25.75 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.189 0.996 . . . . 0.0 109.396 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -90.51 107.16 18.98 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.34 28.45 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.327 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -56.07 -50.7 70.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 112.851 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 76' ' ' PHE . 26.3 mmmt -50.26 -37.22 34.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.41 -46.03 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.018 0.527 . . . . 0.0 110.103 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.73 -14.59 70.25 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 114.736 -1.12 . . . . 0.0 114.705 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.64 -28.38 69.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.974 0.51 . . . . 0.0 110.837 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.19 19.99 12.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.271 1.028 . . . . 0.0 111.227 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 41.2 tt0 -61.6 -54.71 49.36 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.627 170.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.23 -20.59 55.78 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 122.262 1.975 . . . . 0.0 113.438 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.56 -50.31 70.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.932 0.893 . . . . 0.0 110.163 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.49 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 9.8 mt -89.46 -6.67 56.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 29.3 mtp180 -69.62 -20.04 63.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.966 0.507 . . . . 0.0 109.944 168.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.35 -16.74 80.15 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.402 -0.666 . . . . 0.0 113.42 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.2 mpt? -85.73 9.97 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.702 0.751 . . . . 0.0 112.183 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.96 17.28 71.45 Favored Glycine 0 C--N 1.352 1.441 0 C-N-CA 122.869 0.271 . . . . 0.0 113.633 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -111.07 134.34 52.74 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.548 0.739 . . . . 0.0 109.611 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.99 143.28 56.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.446 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.4 p -127.85 139.59 52.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.706 0.802 . . . . 0.0 110.16 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -132.14 118.7 19.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.668 1.187 . . . . 0.0 108.928 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.96 95.11 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.9 mt -75.42 150.99 85.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 73.0 Cg_endo -72.5 163.88 37.25 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.084 1.856 . . . . 0.0 110.359 171.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -63.4 133.09 53.43 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.7 p -79.31 -3.97 48.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.264 0.626 . . . . 0.0 112.026 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -66.68 159.52 27.55 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 111.059 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 142' ' ' ARG . . . -58.43 -28.93 62.77 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.501 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.9 76.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.837 0.855 . . . . 0.0 112.002 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 135' ' ' PRO . 49.1 t30 -89.94 -33.76 16.29 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.063 0.545 . . . . 0.0 110.982 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.539 HH21 ' HA ' ' A' ' 146' ' ' LYS . 6.5 tpm_? -51.61 -44.42 62.88 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.089 1.356 . . . . 0.0 112.458 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -60.87 -12.88 12.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.745 1.218 . . . . 0.0 113.317 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -121.06 -40.63 2.59 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.155 0.982 . . . . 0.0 110.823 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 65.4 m -93.3 85.64 5.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.697 0.799 . . . . 0.0 110.407 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.539 ' HA ' HH21 ' A' ' 142' ' ' ARG . 34.0 mmtp -93.99 -50.64 5.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.51 0.724 . . . . 0.0 111.475 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -86.05 -4.15 59.1 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.932 0.493 . . . . 0.0 111.506 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.3 tpt180 -78.31 -24.62 46.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.675 0.39 . . . . 0.0 110.097 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 11.3 pt-20 -62.12 -13.46 27.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 m -65.68 -30.5 71.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.37 0.668 . . . . 0.0 112.194 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 155' ' ' VAL . 14.7 pt-20 -72.61 -29.6 63.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.795 0.438 . . . . 0.0 109.925 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -67.35 -37.65 83.56 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 31.5 tt0 -67.55 -37.69 83.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.978 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.48 72.63 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.793 0.683 . . . . 0.0 111.168 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 151' ' ' GLU . 80.2 t -71.87 -60.39 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.567 0.747 . . . . 0.0 111.03 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.432 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 50.1 m-85 -88.09 -7.56 56.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.77 -28.57 66.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.1 0.409 . . . . 0.0 110.86 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.41 ' NE2' ' HD2' ' A' ' 108' ' ' ARG . 0.6 OUTLIER -67.88 -21.66 65.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.596 0.758 . . . . 0.0 111.219 -175.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.4 mt -64.85 -14.28 58.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.428 1.091 . . . . 0.0 113.277 -170.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -98.48 -62.52 1.23 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 166.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 124.565 1.146 . . . . 0.0 108.179 178.132 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 80' ' ' SER . 40.5 mm -72.91 108.03 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.179 0.592 . . . . 0.0 109.967 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -97.21 111.95 23.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -95.15 133.8 38.58 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.579 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.67 -166.66 9.71 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.948 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -117.97 147.77 41.99 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.384 0.674 . . . . 0.0 109.318 -172.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.06 162.16 27.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.196 1.931 . . . . 0.0 110.668 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.55 120.43 10.54 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.24 0.616 . . . . 0.0 111.486 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 62' ' ' LEU . 41.0 t -94.56 84.6 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.545 HD11 HG12 ' A' ' 104' ' ' VAL . 48.8 tp -129.47 154.56 46.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.246 -159.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -123.62 159.31 29.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.936 0.894 . . . . 0.0 108.623 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HG3' HD22 ' A' ' 13' ' ' ASN . 11.4 pt-20 -59.57 -28.12 66.85 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.433 HD22 ' HG3' ' A' ' 12' ' ' GLU . 43.7 m-80 -111.18 86.84 2.4 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -131.1 112.11 12.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.692 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.1 tt0 -91.56 -31.97 15.71 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.748 1.219 . . . . 0.0 110.091 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 69.1 mt -125.58 122.16 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.796 0.838 . . . . 0.0 109.465 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.2 tp -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -95.41 106.35 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.411 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 75.7 mt -95.79 108.5 20.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 108.85 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.84 178.32 9.13 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 166.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 15.5 t -89.81 -75.59 0.45 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 tp -130.58 124.01 20.69 Favored Pre-proline 0 C--O 1.244 0.8 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.76 155.18 11.06 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -59.32 124.12 18.96 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -61.88 -22.37 65.49 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.121 0.568 . . . . 0.0 112.157 -171.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.29 -51.48 56.97 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.646 0.591 . . . . 0.0 110.111 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 t -55.04 -30.74 60.22 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.728 0.811 . . . . 0.0 111.872 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.8 mt -77.56 -26.75 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.893 0.877 . . . . 0.0 110.873 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -61.84 -27.63 68.92 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.256 0.623 . . . . 0.0 111.45 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -102.71 -3.48 26.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.474 0.71 . . . . 0.0 110.396 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 50.34 28.0 3.01 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.837 1.255 . . . . 0.0 113.168 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 34' ' ' TYR . 7.6 tt0 -149.09 141.78 24.5 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.001 0.521 . . . . 0.0 110.708 -170.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.456 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 66.1 m-85 -67.62 -6.03 18.43 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 123.94 0.896 . . . . 0.0 112.437 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 90.9 t80 -82.07 -24.85 35.02 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 109.357 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.3 -31.39 79.08 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.877 0.736 . . . . 0.0 114.84 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -123.24 111.98 30.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.995 0.398 . . . . 0.0 110.462 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -88.35 -0.94 6.86 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.445 2.764 . . . . 0.0 112.566 170.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.57 -6.39 89.35 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 41' ' ' PHE . 11.7 m120 -76.19 126.21 30.57 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.52 4.94 50.25 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 124.246 1.018 . . . . 0.0 110.027 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.562 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 86.6 m-85 -50.1 -36.56 30.07 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 109.674 163.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -73.56 -26.75 60.98 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.616 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -79.28 -44.84 20.89 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.727 0.811 . . . . 0.0 111.736 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.95 -38.64 57.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 0.0 111.473 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.25 -30.31 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.49 -53.29 36.51 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.559 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 149' ' ' GLU . 14.4 p-80 -65.84 -30.3 70.9 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.006 0.431 . . . . 0.0 110.356 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -68.88 -34.44 75.43 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.093 0.957 . . . . 0.0 112.145 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 64' ' ' THR . 11.4 pt -96.33 -10.39 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.987 0.915 . . . . 0.0 110.405 176.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.62 39.15 22.36 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 115.039 0.776 . . . . 0.0 115.039 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.92 127.68 1.31 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.425 1.09 . . . . 0.0 108.769 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -72.0 102.78 3.04 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.043 0.937 . . . . 0.0 112.556 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.3 mt -61.03 -25.55 66.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.478 1.111 . . . . 0.0 111.809 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -68.78 -31.24 70.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.657 0.783 . . . . 0.0 111.238 -172.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.36 -11.04 53.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.973 0.909 . . . . 0.0 110.962 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 56.8 mtt -85.08 137.66 32.9 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 152.4 38.4 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.327 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 34.4 t80 -40.28 -51.12 2.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.259 1.424 . . . . 0.0 113.331 -171.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.53 -52.17 62.32 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.1 0.96 . . . . 0.0 111.311 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.92 -42.71 90.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.591 0.756 . . . . 0.0 110.797 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -56.5 -53.34 58.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.829 1.252 . . . . 0.0 110.911 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.602 HD22 HG11 ' A' ' 9' ' ' VAL . 84.5 mt -65.48 -41.69 93.05 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.814 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -71.89 -28.14 63.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.698 0.399 . . . . 0.0 111.769 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.428 HG22 HD12 ' A' ' 49' ' ' ILE . 41.3 m -60.9 -42.32 97.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.109 0.48 . . . . 0.0 109.755 169.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.4 -50.29 66.05 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.013 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 30.8 mmtp -57.01 -44.78 83.13 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.454 0.702 . . . . 0.0 109.932 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -53.75 -41.29 66.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.243 1.417 . . . . 0.0 112.226 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -84.1 0.88 46.65 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.92 0.888 . . . . 0.0 111.746 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 66.9 42.73 2.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.852 1.261 . . . . 0.0 110.387 -178.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.38 136.92 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.806 1.242 . . . . 0.0 109.191 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.25 163.17 14.06 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 170.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -124.39 144.4 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.929 0.892 . . . . 0.0 109.162 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.411 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.1 t90 -165.29 -169.14 1.54 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -134.8 170.33 16.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 61.4 t -97.05 -35.39 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.478 0.711 . . . . 0.0 110.549 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -111.43 105.2 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.52 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 50.7 tptt -64.97 -26.98 68.53 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.362 1.065 . . . . 0.0 111.748 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.28 138.53 25.15 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.7 114.39 0.86 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.403 ' HB3' HD13 ' A' ' 2' ' ' ILE . 87.3 p -93.97 123.95 37.67 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.562 0.681 . . . . 0.0 109.925 -171.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -85.69 96.47 9.71 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -17.34 20.42 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.511 1.124 . . . . 0.0 111.649 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.51 -15.62 1.26 Allowed Glycine 0 C--N 1.353 1.477 0 CA-C-O 119.738 -0.479 . . . . 0.0 114.131 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.7 t -69.28 133.91 48.48 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.177 0.591 . . . . 0.0 111.251 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -88.55 138.61 31.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.125 0.97 . . . . 0.0 110.203 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 73.24 -24.82 0.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 126.441 1.896 . . . . 0.0 113.154 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 m -74.42 96.23 2.85 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -77.58 -42.29 35.71 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.542 0.737 . . . . 0.0 109.788 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 mt -104.54 97.86 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.444 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.06 54.99 0.8 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 16.7 t70 -176.45 150.44 0.88 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -172.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.92 17.85 14.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.309 0.644 . . . . 0.0 112.623 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 77' ' ' LYS . 24.6 tt0 -77.76 105.67 9.08 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 mm -89.71 147.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.113 0.965 . . . . 0.0 109.392 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -74.6 143.92 44.17 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 168.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -82.88 127.4 33.46 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.447 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 64.2 m-85 -114.92 10.97 16.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.369 0.667 . . . . 0.0 110.998 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.1 t -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.696 0.398 . . . . 0.0 110.818 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.26 -4.76 86.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.738 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 104' ' ' VAL . 16.6 mt -49.41 -53.11 24.36 Favored 'General case' 0 C--N 1.368 1.392 0 C-N-CA 123.676 0.79 . . . . 0.0 111.212 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -59.35 -18.7 40.63 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.467 0.707 . . . . 0.0 112.58 -168.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.38 -42.74 13.41 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.501 1.121 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -94.97 -16.02 23.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 10' ' ' LEU . 17.1 m -122.35 88.12 48.8 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.168 0.587 . . . . 0.0 110.48 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.1 -39.12 3.3 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.184 1.923 . . . . 0.0 112.101 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -86.2 -6.12 59.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.765 0.826 . . . . 0.0 113.117 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.1 tp -61.85 117.45 5.91 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.611 0.569 . . . . 0.0 111.073 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -111.47 -40.53 4.35 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.941 0.896 . . . . 0.0 109.52 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 56.2 tp -129.35 133.08 47.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.925 0.89 . . . . 0.0 110.875 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.4 mt -112.7 146.31 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 134' ' ' LEU . 81.7 m -125.69 113.51 17.44 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.598 0.759 . . . . 0.0 110.317 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.64 107.93 19.59 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.595 1.158 . . . . 0.0 109.086 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -98.79 88.24 3.98 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.65 139.1 3.96 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.625 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.0 -50.84 65.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 111.695 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.48 -38.43 69.1 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.461 1.104 . . . . 0.0 112.008 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 21' ' ' SER . . . -65.57 -36.19 83.04 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.996 0.518 . . . . 0.0 110.823 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.85 -16.37 59.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 115.099 -0.955 . . . . 0.0 114.556 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.59 -29.73 70.75 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.11 0.481 . . . . 0.0 110.947 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -111.31 25.33 11.83 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.722 0.809 . . . . 0.0 111.084 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.52 -44.22 24.48 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.066 0.946 . . . . 0.0 112.543 170.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.426 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 71.9 Cg_endo -70.72 -13.77 32.53 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 121.8 1.667 . . . . 0.0 112.828 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 tp -58.91 -41.03 86.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.562 1.145 . . . . 0.0 110.191 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -96.98 -10.55 26.01 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.489 -174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 122' ' ' PRO . 19.6 mtm180 -63.93 -34.91 79.03 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.078 0.466 . . . . 0.0 110.244 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.93 -12.26 70.95 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.446 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.3 mtt -94.94 9.67 38.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 0.0 111.708 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.01 17.87 77.7 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 113.878 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -110.0 133.59 53.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.437 0.695 . . . . 0.0 110.071 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.68 143.74 55.82 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.0 p -132.93 149.73 52.22 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.707 0.803 . . . . 0.0 110.351 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -145.5 129.23 17.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.353 1.061 . . . . 0.0 109.369 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.64 97.07 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 111' ' ' CYS . 39.6 mt -77.62 144.34 69.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.951 176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.461 ' HD2' ' HE1' ' A' ' 152' ' ' TRP . 44.7 Cg_exo -59.3 154.82 44.14 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.521 2.814 . . . . 0.0 113.269 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.5 m -68.91 108.88 3.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 m -84.69 21.03 1.61 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.422 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.1 t -59.73 154.14 18.76 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.454 0.702 . . . . 0.0 110.522 171.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.19 69.69 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.149 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.48 -15.37 61.32 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.962 0.905 . . . . 0.0 111.452 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 144' ' ' PHE . 9.5 t30 -132.51 8.55 4.25 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.324 0.65 . . . . 0.0 111.204 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -65.77 -36.22 82.92 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.899 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -66.03 -25.88 67.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.725 1.21 . . . . 0.0 111.47 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.488 ' HD2' ' HA ' ' A' ' 141' ' ' ASN . 56.2 m-85 -92.56 -35.89 13.33 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.595 0.758 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 t -86.85 30.08 0.77 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.36 1.064 . . . . 0.0 111.425 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -67.71 -70.57 0.25 Allowed 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.79 -4.69 17.03 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 17.0 mmt180 -73.2 -22.92 60.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.167 0.587 . . . . 0.0 110.41 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 47' ' ' HIS . 12.7 pt-20 -55.54 -24.59 33.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.824 0.85 . . . . 0.0 112.592 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.7 t -67.53 -46.97 71.27 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 111.724 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 10.9 pt-20 -66.47 -31.97 73.05 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.461 ' HE1' ' HD2' ' A' ' 135' ' ' PRO . 35.8 m95 -68.66 -46.73 68.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 27.2 tt0 -62.47 -37.87 87.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.762 -173.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.29 82.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.153 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 151' ' ' GLU . 55.4 t -66.41 -35.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.901 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.565 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 45.9 m-85 -104.62 -1.73 26.03 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.489 -0.757 . . . . 0.0 112.648 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -81.17 -36.82 29.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.928 0.491 . . . . 0.0 110.768 170.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.409 ' HE1' HD11 ' A' ' 16' ' ' ILE . 4.3 p-80 -67.23 -17.74 64.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.034 0.209 . . . . 0.0 110.648 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.46 -30.75 71.78 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.523 0.729 . . . . 0.0 110.38 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.68 -44.92 95.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.563 0.745 . . . . 0.0 110.228 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.56 1.338 0 C-N-CA 124.415 1.086 . . . . 0.0 109.997 -179.652 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 111.05 0.019 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.53 HD13 ' HB3' ' A' ' 80' ' ' SER . 39.2 mm -75.26 135.3 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.849 0.459 . . . . 0.0 110.063 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -124.39 123.72 40.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.648 1.179 . . . . 0.0 108.88 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -89.64 139.35 30.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 122.755 0.422 . . . . 0.0 110.893 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -72.73 166.39 54.26 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.663 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -95.21 139.94 22.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.952 0.501 . . . . 0.0 111.174 -172.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.86 134.26 54.13 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.719 2.279 . . . . 0.0 110.251 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.73 143.35 54.54 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.005 0.816 . . . . 0.0 112.257 -169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 62' ' ' LEU . 34.5 t -97.92 61.35 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.502 HD11 ' CG1' ' A' ' 104' ' ' VAL . 64.4 tp -104.13 145.75 29.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.837 -171.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.659 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 5.2 t70 -116.38 158.42 23.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -63.86 -21.87 66.65 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.406 0.622 . . . . 0.0 111.084 170.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -110.46 84.12 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.755 1.622 . . . . 0.0 107.754 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -135.56 123.73 23.02 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.515 0.726 . . . . 0.0 110.282 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 38.9 tt0 -106.36 -29.69 9.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.734 1.214 . . . . 0.0 110.677 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.658 HD12 HD11 ' A' ' 159' ' ' LEU . 37.9 mt -131.82 125.18 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.963 0.905 . . . . 0.0 109.628 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.0 tp -110.86 124.82 52.81 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.348 1.059 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' CYS . 47.1 mt -102.45 111.27 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.211 0.604 . . . . 0.0 109.66 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 73' ' ' TRP . 97.4 mt -99.07 127.94 45.1 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.2 -175.13 49.77 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 162.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -94.64 -71.78 0.65 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -134.82 124.59 16.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 71.0 Cg_exo -52.09 137.26 54.02 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.593 2.195 . . . . 0.0 112.442 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 28' ' ' ILE . 30.1 m -61.01 146.17 48.07 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.775 0.672 . . . . 0.0 110.537 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.6 t70 -58.07 -41.72 84.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.799 0.44 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -47.63 -40.54 19.89 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.973 1.309 . . . . 0.0 111.72 171.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -78.34 -39.67 38.81 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.137 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 24' ' ' SER . 74.8 mt -68.12 -25.62 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 124.365 1.066 . . . . 0.0 111.691 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 23.7 mmt180 -65.29 -28.01 69.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.475 0.31 . . . . 0.0 111.349 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -114.62 0.25 13.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.962 0.505 . . . . 0.0 111.393 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 62.69 24.96 14.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.901 1.28 . . . . 0.0 112.878 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -129.63 134.37 47.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.286 1.034 . . . . 0.0 108.806 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -56.51 -46.1 80.71 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.418 0.687 . . . . 0.0 110.513 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -64.15 -0.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.229 1.412 . . . . 0.0 112.889 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.24 -26.45 9.37 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.743 0.687 . . . . 0.0 113.609 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -102.74 108.85 59.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 163.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -26.75 41.21 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.68 2.253 . . . . 0.0 112.019 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.33 -6.53 40.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.791 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.455 HD22 ' HE1' ' A' ' 42' ' ' TRP . 30.3 p-10 -65.86 129.21 38.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.61 -6.73 59.52 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.396 0.679 . . . . 0.0 111.723 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -37.91 -41.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.555 1.542 . . . . 0.0 113.541 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.455 ' HE1' HD22 ' A' ' 39' ' ' ASN . 74.3 m95 -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.603 0.761 . . . . 0.0 112.216 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.3 mtp-105 -75.63 -40.9 55.53 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.403 0.281 . . . . 0.0 110.797 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.77 -55.22 15.96 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.62 -34.32 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.496 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.77 88.42 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.346 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.77 -37.91 89.19 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.769 0.828 . . . . 0.0 109.754 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HA ' ' HG2' ' A' ' 153' ' ' GLU . . . -65.02 -47.78 76.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.296 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.8 pt -89.48 -14.79 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.536 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.99 39.45 20.04 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.034 0.374 . . . . 0.0 114.034 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -133.0 146.27 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.317 1.047 . . . . 0.0 109.361 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -85.15 91.46 8.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.43 -1.29 49.69 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.228 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.15 -48.99 11.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.32 -30.22 60.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.485 1.114 . . . . 0.0 112.307 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.3 mtt -61.23 156.43 18.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.973 0.509 . . . . 0.0 111.001 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.66 162.45 20.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.574 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 31.3 t80 -49.42 -55.37 13.32 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.929 0.892 . . . . 0.0 112.765 -173.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.59 -40.31 82.86 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.7 0.8 . . . . 0.0 111.526 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -66.56 -53.62 32.67 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.971 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 15.9 ptpt -64.86 -30.34 71.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.676 0.61 . . . . 0.0 112.074 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 80.8 mt -61.48 -49.56 76.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.124 0.57 . . . . 0.0 110.612 171.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -64.59 -28.59 69.73 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.447 0.467 . . . . 0.0 111.356 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -68.93 -39.23 79.72 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.371 0.668 . . . . 0.0 110.671 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 72.0 mt -65.15 -49.58 69.3 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 122.913 0.485 . . . . 0.0 110.479 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 4.5 mtpp -68.65 -27.4 65.96 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.945 0.898 . . . . 0.0 112.671 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -58.37 -40.9 83.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.623 0.769 . . . . 0.0 110.349 165.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 87.0 m-20 -93.6 19.28 8.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.397 1.079 . . . . 0.0 110.078 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 64.99 32.89 10.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.124 0.97 . . . . 0.0 111.693 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 72.3 mt -108.59 126.08 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.86 0.864 . . . . 0.0 109.514 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.8 156.04 16.22 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.4 mt -120.98 133.25 55.26 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.469 ' HB3' HD23 ' A' ' 19' ' ' LEU . 6.9 t90 -162.62 -169.16 2.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -145.64 165.25 29.25 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.287 1.035 . . . . 0.0 110.34 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.49 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.9 t -80.77 -47.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.644 0.778 . . . . 0.0 110.805 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -98.14 110.86 23.37 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.355 0.662 . . . . 0.0 111.711 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.09 -24.64 65.06 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.027 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.12 135.0 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.492 0.717 . . . . 0.0 109.609 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.29 146.46 15.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB3' HD13 ' A' ' 2' ' ' ILE . 79.1 p -115.06 168.9 9.52 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 117.87 0.835 . . . . 0.0 110.344 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -137.15 97.11 3.41 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -134.51 -72.92 0.48 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.44 0.462 . . . . 0.0 110.998 -171.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.31 91.35 0.13 Allowed Glycine 0 C--N 1.345 1.042 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.7 p -153.72 168.41 26.35 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.811 0.845 . . . . 0.0 109.97 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -121.6 156.16 33.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.706 1.203 . . . . 0.0 109.796 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 66.57 -72.44 0.08 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.282 1.433 . . . . 0.0 110.914 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 t -98.48 118.42 35.13 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 167.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -81.39 -5.63 58.08 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.005 0.922 . . . . 0.0 111.584 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 51.2 mt -72.81 90.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.78 54.81 4.98 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.42 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.704 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.2 t70 -170.42 148.98 3.25 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.51 17.38 12.1 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.474 0.71 . . . . 0.0 112.434 -166.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -89.71 118.13 29.09 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.312 0.577 . . . . 0.0 109.49 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.1 mt -122.55 146.73 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 109.248 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -64.38 147.33 52.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.921 0.888 . . . . 0.0 110.173 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -81.52 117.48 21.96 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.49 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 59.9 m-85 -105.65 0.65 26.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.509 0.724 . . . . 0.0 111.107 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.9 p -75.4 -16.81 60.33 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.98 -5.82 70.27 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.385 -0.675 . . . . 0.0 112.396 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' O ' HG22 ' A' ' 104' ' ' VAL . 15.3 mt -48.16 -55.08 11.25 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 123.857 0.863 . . . . 0.0 111.107 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -60.29 -26.99 66.92 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.334 0.653 . . . . 0.0 111.77 -167.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -76.16 -41.12 50.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.084 0.954 . . . . 0.0 111.881 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -91.4 -23.15 20.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.502 ' CG1' HD11 ' A' ' 10' ' ' LEU . 15.0 m -122.08 107.95 34.81 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.363 0.529 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.98 -36.49 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.32 2.013 . . . . 0.0 111.961 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -86.35 -10.06 55.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -170.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.35 116.49 5.56 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 121.147 0.499 . . . . 0.0 110.756 -171.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.435 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 5.9 ptm180 -111.06 -43.63 3.72 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.338 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.466 ' HB3' HG12 ' A' ' 16' ' ' ILE . 47.5 tp -126.11 127.58 46.0 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 122.933 0.493 . . . . 0.0 110.009 -167.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.8 mt -110.99 114.15 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.6 m -96.55 115.8 28.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.952 0.901 . . . . 0.0 110.993 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.05 116.26 28.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.655 1.182 . . . . 0.0 109.04 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -93.75 119.35 32.62 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.43 143.05 11.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.103 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 57.2 ttp180 -50.98 -48.75 61.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.45 1.1 . . . . 0.0 112.068 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -49.21 -36.01 18.8 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.73 1.212 . . . . 0.0 112.761 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.88 -42.7 23.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.174 0.59 . . . . 0.0 109.9 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.58 -10.13 47.82 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.54 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 76.4 mt-10 -68.24 -34.59 76.5 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.041 0.536 . . . . 0.0 110.701 172.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -100.71 19.49 16.97 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.931 0.893 . . . . 0.0 110.885 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.1 tm-20 -63.07 -49.34 81.55 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.344 1.058 . . . . 0.0 112.933 170.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.85 -16.27 49.48 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.73 1.62 . . . . 0.0 112.887 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.09 -52.13 67.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.278 1.031 . . . . 0.0 110.868 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.0 -5.06 58.95 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.011 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -66.55 -32.62 74.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.7 0.4 . . . . 0.0 110.331 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.59 -12.6 61.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.536 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.2 mtt -96.17 11.97 32.46 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.175 0.99 . . . . 0.0 111.433 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.33 73.77 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.323 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -105.49 136.18 45.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.301 0.641 . . . . 0.0 110.325 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.67 140.07 57.88 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 167.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.519 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 29.3 p -128.82 141.86 51.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.252 0.548 . . . . 0.0 110.816 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -135.28 126.85 28.85 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.765 1.226 . . . . 0.0 108.83 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.94 106.81 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 111' ' ' CYS . 90.5 mt -88.63 153.33 50.18 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.109 0.964 . . . . 0.0 109.516 170.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.598 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 49.0 Cg_exo -58.63 164.48 9.32 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.131 2.554 . . . . 0.0 113.195 172.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.7 t -65.69 110.7 2.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 p -80.66 25.16 0.44 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.031 0.932 . . . . 0.0 112.088 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.8 t -63.0 147.79 49.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.967 0.907 . . . . 0.0 110.337 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 142' ' ' ARG . . . -69.21 -20.88 75.42 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.343 -0.389 . . . . 0.0 113.343 174.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.73 -8.45 56.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.018 0.527 . . . . 0.0 111.129 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.02 13.19 10.51 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.391 1.076 . . . . 0.0 109.598 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.473 ' HA ' ' OG ' ' A' ' 145' ' ' SER . 48.9 ttp180 -66.77 -31.9 72.84 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.493 0.717 . . . . 0.0 110.558 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -57.3 -32.71 66.94 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.091 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.63 -22.92 16.21 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.491 1.117 . . . . 0.0 110.674 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 84.0 p -90.43 11.64 20.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.024 0.529 . . . . 0.0 112.092 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.07 -69.79 0.18 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.112 0.965 . . . . 0.0 111.949 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -90.4 -2.97 57.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.298 0.639 . . . . 0.0 111.134 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.603 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 13.1 tpt180 -72.61 -18.36 61.6 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.744 0.818 . . . . 0.0 109.499 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -25.24 0.79 Allowed 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.58 1.152 . . . . 0.0 113.079 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.5 t -60.89 -44.95 96.41 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.089 0.955 . . . . 0.0 111.928 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 155' ' ' VAL . 9.5 pt-20 -72.95 -32.25 65.13 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -67.01 -40.19 87.26 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 4.7 tm-20 -71.15 -33.3 69.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.45 63.95 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.153 0.581 . . . . 0.0 111.531 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 151' ' ' GLU . 71.5 t -81.64 -57.62 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.877 0.471 . . . . 0.0 110.746 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.402 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 39.4 m-85 -92.78 1.6 57.2 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -166.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -61.76 -41.46 97.71 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -77.69 -10.75 59.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.419 0.687 . . . . 0.0 111.831 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 16' ' ' ILE . 38.7 mt -78.99 -25.21 43.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.586 -168.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.39 -45.08 89.2 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 166.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 CA--C 1.556 1.193 0 C-N-CA 124.985 1.314 . . . . 0.0 111.578 174.607 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.1 mm -78.62 122.18 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.557 0.743 . . . . 0.0 109.738 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HB2' HD21 ' A' ' 22' ' ' LEU . 56.9 mtpt -84.91 125.69 32.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.61 0.764 . . . . 0.0 109.975 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.75 135.27 35.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.281 0.633 . . . . 0.0 111.69 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -76.43 -177.01 43.13 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.986 165.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.75 144.67 37.64 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.225 -172.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.96 151.72 32.42 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.83 2.353 . . . . 0.0 112.254 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 139.33 58.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.644 0.778 . . . . 0.0 112.65 -172.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.672 HG11 HD22 ' A' ' 62' ' ' LEU . 65.9 t -104.84 88.59 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.512 HD11 HG12 ' A' ' 104' ' ' VAL . 54.1 tp -138.46 153.37 48.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.808 -160.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.07 165.23 19.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.306 1.042 . . . . 0.0 110.189 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.72 -17.66 64.78 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.99 0.916 . . . . 0.0 111.957 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -120.55 91.57 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.2 m -141.07 118.8 11.68 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.059 0.944 . . . . 0.0 109.074 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.24 -37.75 19.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.685 0.794 . . . . 0.0 110.659 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.438 HD12 HD11 ' A' ' 159' ' ' LEU . 66.4 mt -125.83 124.44 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.246 0.618 . . . . 0.0 109.889 -174.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.52 115.25 29.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' CYS . 47.8 mt -94.2 102.98 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 73' ' ' TRP . 98.2 mt -94.67 119.15 32.85 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.034 0.933 . . . . 0.0 110.233 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.62 -178.78 37.52 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -93.94 -78.55 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 3' ' ' LYS . 64.1 tp -134.3 116.34 13.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 170.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.478 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.7 Cg_exo -53.63 148.39 35.75 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.207 2.605 . . . . 0.0 113.584 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' ILE . 29.0 t -61.55 150.7 35.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.623 1.169 . . . . 0.0 111.918 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 10.4 m-20 -55.03 -43.49 73.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.877 0.871 . . . . 0.0 110.71 175.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -66.55 -26.06 66.95 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.454 1.096 . . . . 0.0 111.0 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.576 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 69.4 m -73.54 -40.91 63.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 24' ' ' SER . 64.1 mt -71.32 -21.69 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.501 1.12 . . . . 0.0 111.413 -176.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 20.3 mmt85 -61.31 -33.12 73.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.035 0.534 . . . . 0.0 110.915 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 80.6 mttt -110.46 -2.47 16.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.011 0.924 . . . . 0.0 111.116 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 58.57 27.73 16.1 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.639 1.576 . . . . 0.0 112.748 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -138.27 156.35 47.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.959 0.904 . . . . 0.0 110.231 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -71.35 -5.51 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.597 0.759 . . . . 0.0 110.288 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -77.34 -16.93 58.66 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.969 1.708 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.83 -30.72 73.6 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 0.0 114.307 -175.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -124.09 99.38 37.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.334 0.654 . . . . 0.0 110.437 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.08 -7.51 15.28 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.676 164.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' HH12 ' A' ' 43' ' ' ARG . . . -85.13 -15.76 66.3 Favored Glycine 0 C--N 1.357 1.741 0 O-C-N 123.525 0.516 . . . . 0.0 112.214 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -73.79 125.76 28.86 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 137' ' ' SER . 1.3 t0 -79.43 -4.88 53.19 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.926 0.891 . . . . 0.0 112.088 -158.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 113' ' ' ASN . 38.0 m-85 -48.48 -36.19 14.61 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.193 0.997 . . . . 0.0 111.663 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -73.25 -32.36 64.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.432 0.693 . . . . 0.0 112.192 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.592 ' HD2' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -88.48 -23.51 23.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.754 0.422 . . . . 0.0 111.511 177.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 149' ' ' GLU . 49.4 mt -86.38 -45.67 10.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.939 0.496 . . . . 0.0 111.051 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.95 -32.48 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.54 94.49 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.476 0.485 . . . . 0.0 112.971 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -61.81 -43.59 98.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.75 0.82 . . . . 0.0 109.809 171.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -71.61 -33.32 68.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.596 -1.183 . . . . 0.0 113.978 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -94.43 -11.37 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.991 0.517 . . . . 0.0 111.146 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 27.54 63.61 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.423 0.452 . . . . 0.0 113.314 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.14 113.0 6.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.3 99.82 0.97 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.202 0.601 . . . . 0.0 111.086 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.465 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 77.0 mt -67.66 -27.89 67.24 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.303 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.592 ' HG3' ' HD2' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -65.17 -37.85 88.69 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.443 0.697 . . . . 0.0 111.438 -173.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.5 -36.9 63.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.02 0.528 . . . . 0.0 112.081 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.9 mtt -62.83 149.15 44.97 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -171.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 153.92 40.61 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.208 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.505 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 t80 -44.34 -50.57 9.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.144 0.978 . . . . 0.0 113.501 -171.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 43.1 mt-10 -61.83 -54.17 45.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.504 0.722 . . . . 0.0 111.44 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -58.06 -37.2 73.97 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.639 0.776 . . . . 0.0 111.127 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 35.5 ttmt -62.54 -45.97 90.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.11 0.964 . . . . 0.0 110.132 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.672 HD22 HG11 ' A' ' 9' ' ' VAL . 25.8 mt -61.73 -47.28 85.97 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.134 0.896 . . . . 0.0 110.957 175.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 66.9 mttm -55.02 -38.05 67.42 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -66.79 -51.46 55.46 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.156 0.91 . . . . 0.0 110.238 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 62' ' ' LEU . 57.2 mt -52.8 -56.72 13.67 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.936 0.894 . . . . 0.0 111.395 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.14 -30.54 71.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.315 0.646 . . . . 0.0 111.947 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.28 -36.89 85.17 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.272 0.629 . . . . 0.0 111.175 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -90.94 6.51 44.35 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.385 0.674 . . . . 0.0 110.959 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 65.57 37.44 5.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 111.359 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.24 132.37 56.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 109.46 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.3 154.02 17.24 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -121.26 132.38 54.77 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.439 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.2 t90 -156.08 -169.76 3.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -143.24 165.54 27.18 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.54 0.736 . . . . 0.0 110.2 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.45 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 72.5 t -82.23 -62.29 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.468 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.66 107.7 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.326 0.584 . . . . 0.0 111.374 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.2 ttmt -64.31 -31.92 73.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.032 170.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -152.55 126.85 9.23 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.14 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -134.3 135.45 7.99 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.8 p -86.77 105.18 16.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.171 0.588 . . . . 0.0 110.052 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -99.09 103.15 15.04 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' A' ' 84' ' ' SER . 10.7 tp10 -120.53 154.57 35.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.699 0.8 . . . . 0.0 109.379 -172.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.78 -31.18 77.59 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.52 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 45.8 t -73.14 -17.38 61.39 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.989 0.916 . . . . 0.0 111.361 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.672 ' HG3' ' HB2' ' A' ' 88' ' ' LYS . 6.2 tp-100 -126.58 99.03 5.63 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.437 0.695 . . . . 0.0 109.485 -176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.09 77.39 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.444 1.497 . . . . 0.0 114.353 -164.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.5 m 56.04 16.8 2.34 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.482 1.513 . . . . 0.0 113.061 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.672 ' HB2' ' HG3' ' A' ' 85' ' ' GLN . 73.8 mmtt -86.26 142.35 28.62 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.4 mt -82.09 82.34 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.25 -23.57 77.2 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.312 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 7.0 t70 -84.07 157.8 21.64 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.123 0.487 . . . . 0.0 110.744 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.3 24.13 8.84 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.904 -170.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 10.8 tp10 -85.75 111.48 20.18 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.36 155.38 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.112 0.965 . . . . 0.0 109.056 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 73' ' ' TRP . 59.0 m-80 -76.63 149.31 36.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.169 0.988 . . . . 0.0 110.484 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.26 116.48 19.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 0.0 110.494 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.45 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.4 m-85 -103.6 4.05 35.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.652 0.781 . . . . 0.0 111.351 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.1 m -74.48 -29.95 61.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.698 0.399 . . . . 0.0 110.746 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.88 -10.79 85.27 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.014 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.405 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.6 mt -47.4 -54.15 12.02 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.133 0.973 . . . . 0.0 111.592 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.442 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.1 mtpt -61.43 -18.76 60.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -167.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.05 -39.15 17.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.282 0.633 . . . . 0.0 111.485 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -96.26 -15.49 21.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 11.1 m -126.95 91.16 47.68 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-N 118.758 0.708 . . . . 0.0 111.023 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.88 -28.78 3.79 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.387 2.058 . . . . 0.0 113.251 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 11.4 mmpt? -94.73 -0.5 54.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.1 tp -60.89 104.42 0.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.518 0.675 . . . . 0.0 111.395 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -93.42 -49.36 5.96 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.841 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 42.7 tp -131.58 133.41 44.99 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.276 0.63 . . . . 0.0 110.056 -173.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.5 HG12 HD21 ' A' ' 107' ' ' LEU . 38.4 mt -105.12 115.67 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 92.4 m -96.09 113.25 24.84 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.448 0.299 . . . . 0.0 110.336 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 133' ' ' VAL . 84.2 m-85 -90.35 107.74 19.33 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 41' ' ' PHE . 4.6 p-10 -86.12 110.48 19.58 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.58 134.62 7.56 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.496 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HA ' HG11 ' A' ' 133' ' ' VAL . 33.4 ttm180 -72.11 -3.25 22.04 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.231 1.012 . . . . 0.0 113.421 -175.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.54 -29.85 41.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.827 0.451 . . . . 0.0 110.307 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.373 0.669 . . . . 0.0 109.664 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.8 -16.02 58.65 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 114.925 -1.034 . . . . 0.0 115.194 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -56.34 -29.58 61.52 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.522 0.729 . . . . 0.0 111.789 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -116.51 20.29 14.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.815 0.846 . . . . 0.0 111.247 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.36 -53.85 54.3 Favored Pre-proline 0 CA--C 1.567 1.622 0 C-N-CA 123.302 0.641 . . . . 0.0 112.23 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.75 -15.49 33.37 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 121.851 1.701 . . . . 0.0 112.727 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.08 -44.87 91.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.534 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 10.0 mt -82.4 -5.38 58.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.244 -172.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -72.43 -22.5 61.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.93 -21.52 67.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.628 0.58 . . . . 0.0 113.197 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.6 mpt? -86.66 7.62 25.81 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.76 0.824 . . . . 0.0 111.026 175.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.63 20.94 70.25 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.153 0.406 . . . . 0.0 113.959 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.442 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 35.5 m-85 -110.62 145.51 37.76 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.193 0.597 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.26 143.62 40.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.3 p -130.32 151.12 51.18 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.531 0.732 . . . . 0.0 110.131 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.44 121.82 4.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 109.313 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 112' ' ' PHE . 52.2 t -85.84 130.56 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.132 0.492 . . . . 0.0 110.084 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.6 mt -101.09 152.74 37.96 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.961 1.304 . . . . 0.0 108.274 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.14 153.03 78.79 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.434 2.09 . . . . 0.0 112.575 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 m -59.52 114.46 2.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.411 1.084 . . . . 0.0 110.339 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' A' ' 40' ' ' ASP . 19.4 m -86.34 49.12 1.73 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.556 0.693 . . . . 0.0 111.894 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 p -68.96 139.44 55.04 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 154.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.82 57.88 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 123.474 0.484 . . . . 0.0 113.445 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.56 86.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.108 0.563 . . . . 0.0 110.567 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.82 -41.66 67.95 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.108 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -53.93 -34.02 58.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.692 0.62 . . . . 0.0 111.76 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -69.0 -29.83 68.11 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -98.82 22.49 10.04 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.987 1.315 . . . . 0.0 110.697 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 66.6 m -157.32 34.98 0.28 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.096 0.959 . . . . 0.0 109.697 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -66.8 -35.09 79.27 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.799 1.036 . . . . 0.0 113.799 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.28 -13.86 26.05 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.586 0.355 . . . . 0.0 110.249 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.9 tpt180 -79.73 -38.7 32.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.302 0.641 . . . . 0.0 109.776 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.478 ' HB2' HD22 ' A' ' 44' ' ' LEU . 12.5 pt-20 -62.68 -18.19 61.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.479 1.112 . . . . 0.0 112.212 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.1 t -58.88 -23.05 60.49 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.42 0.688 . . . . 0.0 111.651 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 155' ' ' VAL . 9.4 pt-20 -65.6 -32.14 73.56 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 122.996 0.518 . . . . 0.0 110.654 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -65.62 -43.11 90.57 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.44 -37.72 88.38 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.695 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.13 -14.36 59.81 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.072 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 151' ' ' GLU . 48.5 t -87.13 -54.58 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.411 0.685 . . . . 0.0 110.601 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.548 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 71.9 m-85 -91.77 2.87 56.21 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -168.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -72.62 -28.18 62.6 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.271 0.487 . . . . 0.0 112.163 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -74.6 -6.87 51.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.438 HD11 HD12 ' A' ' 16' ' ' ILE . 95.4 mt -76.08 -22.6 55.41 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.98 0.512 . . . . 0.0 111.603 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.58 -15.39 62.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.871 0.468 . . . . 0.0 111.129 166.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 125.594 1.558 . . . . 0.0 110.252 175.266 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.765 0.317 . . . . 0.0 110.734 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 80' ' ' SER . 46.1 mm -92.65 126.1 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.702 0.801 . . . . 0.0 109.596 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.589 ' HE2' ' HB3' ' A' ' 81' ' ' ARG . 65.6 mttm -94.81 131.88 40.2 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -91.61 130.82 37.36 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 110.305 171.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 158.96 53.62 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 162.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -82.72 143.5 47.03 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 117.779 0.789 . . . . 0.0 110.084 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 162.44 1.55 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.206 2.604 . . . . 0.0 112.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -66.22 125.74 26.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.37 0.605 . . . . 0.0 110.513 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.646 HG11 HD22 ' A' ' 62' ' ' LEU . 21.2 t -91.03 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.556 HD11 ' CG1' ' A' ' 104' ' ' VAL . 49.9 tp -110.27 143.94 39.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.982 -162.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -125.89 163.62 22.55 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.8 -22.17 66.55 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.194 0.521 . . . . 0.0 110.968 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.617 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 22.3 m120 -103.43 77.64 1.53 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.5 m -133.53 104.68 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.03 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.544 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 84.3 mt-10 -89.72 -30.15 18.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.549 1.14 . . . . 0.0 109.827 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.8 mt -126.68 118.18 50.13 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 123.886 0.874 . . . . 0.0 109.023 174.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -103.72 117.05 33.47 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.465 HG12 ' HB2' ' A' ' 111' ' ' CYS . 44.1 mt -99.54 110.33 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.79 118.14 35.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.47 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -72.94 -168.59 12.89 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 164.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -103.99 -72.46 0.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 tp -147.31 124.62 5.79 Favored Pre-proline 0 C--O 1.243 0.763 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.58 150.31 70.18 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.935 2.423 . . . . 0.0 112.452 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.0 t -68.92 163.41 24.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.981 0.912 . . . . 0.0 110.758 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 m-20 -53.77 -48.28 69.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.417 0.687 . . . . 0.0 110.46 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.18 -39.91 80.12 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.316 1.01 . . . . 0.0 111.361 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -67.35 -45.76 75.42 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.14 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.1 mt -71.6 -19.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.298 1.039 . . . . 0.0 111.976 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 28.5 mmm180 -70.39 -46.76 63.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -90.76 -6.54 54.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.447 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 65.97 22.08 11.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.175 1.39 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -129.32 142.92 50.7 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 109.377 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -60.79 -44.24 97.08 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.027 0.918 . . . . 0.0 108.569 165.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.87 -8.62 5.22 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.389 171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.98 -31.69 58.84 Favored Glycine 0 C--N 1.351 1.397 0 C-N-CA 123.54 0.59 . . . . 0.0 112.979 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -100.79 104.8 33.94 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.66 -10.92 29.77 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.404 2.736 . . . . 0.0 112.719 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.75 -6.84 64.11 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.06 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -79.7 116.81 20.1 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -83.24 -0.5 49.78 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.262 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -42.47 -42.66 3.35 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.454 1.901 . . . . 0.0 112.974 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -74.36 -21.71 59.55 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.697 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.54 -37.12 17.17 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.763 0.825 . . . . 0.0 111.222 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.41 -52.61 15.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.79 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.05 -39.11 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.051 0.54 . . . . 0.0 109.557 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.76 99.6 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.911 0.757 . . . . 0.0 113.982 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -69.02 -34.91 76.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.654 . . . . 0.0 110.24 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -71.6 -38.78 70.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.045 0.938 . . . . 0.0 112.81 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.8 pt -89.72 -9.98 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.952 0.501 . . . . 0.0 111.563 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.3 29.55 66.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.211 0.32 . . . . 0.0 113.022 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -133.71 112.97 11.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -66.27 93.07 0.2 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.283 0.563 . . . . 0.0 110.298 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.17 -39.42 89.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.78 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -57.12 -46.5 82.59 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.581 1.152 . . . . 0.0 111.709 -166.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -69.59 -37.47 76.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.392 0.677 . . . . 0.0 112.195 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.13 145.74 49.95 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.497 0.719 . . . . 0.0 112.369 -172.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.18 138.82 55.91 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.29 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.534 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 57.1 t80 -43.94 -46.49 8.19 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.532 1.133 . . . . 0.0 113.529 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.13 -47.99 80.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 111.857 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -63.93 -37.99 89.45 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.251 1.021 . . . . 0.0 110.701 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 58' ' ' TYR . 19.5 ttmm -60.45 -43.15 97.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.707 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.646 HD22 HG11 ' A' ' 9' ' ' VAL . 72.7 mt -65.88 -42.53 90.18 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.015 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -61.21 -33.38 73.38 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.6 m -64.22 -45.08 89.82 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.225 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.8 mt -57.59 -47.83 81.06 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.476 0.485 . . . . 0.0 110.371 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HE2' HG12 ' A' ' 9' ' ' VAL . 26.3 mmtp -61.95 -37.68 85.62 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.204 0.602 . . . . 0.0 110.417 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -58.21 -40.83 82.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.159 0.983 . . . . 0.0 111.456 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -89.88 3.5 52.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.141 0.576 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.544 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 1.1 mpp_? 65.68 45.65 2.59 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.218 1.407 . . . . 0.0 111.592 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.8 mt -114.09 131.86 64.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 109.168 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.15 160.33 13.29 Favored Glycine 0 N--CA 1.462 0.411 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 169.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.5 mt -124.49 145.34 49.59 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -165.88 -168.9 1.38 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -128.43 170.16 13.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.077 0.551 . . . . 0.0 109.639 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 77.3 t -83.0 -45.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -95.77 112.28 24.04 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.179 0.591 . . . . 0.0 109.79 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -67.37 -24.52 65.71 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.777 0.831 . . . . 0.0 110.462 171.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.94 140.64 19.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.96 0.904 . . . . 0.0 109.854 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -150.03 134.14 4.69 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.524 ' HB3' HD13 ' A' ' 2' ' ' ILE . 47.4 p -102.7 111.73 24.18 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.589 ' HB3' ' HE2' ' A' ' 3' ' ' LYS . 43.9 ttm180 -102.29 141.75 34.62 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.472 0.709 . . . . 0.0 110.004 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.42 -161.42 1.33 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.339 1.456 . . . . 0.0 107.316 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.19 69.99 2.43 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 112.049 -0.421 . . . . 0.0 112.049 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.4 m -125.05 115.08 19.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.141 0.977 . . . . 0.0 110.609 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.09 145.68 30.97 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 79.52 -38.62 0.19 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.628 1.571 . . . . 0.0 111.826 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.5 t -86.54 115.74 24.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.05 0.54 . . . . 0.0 109.877 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -84.65 -37.8 20.61 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -130.88 103.39 7.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.32 59.01 4.89 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.529 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.4 t70 179.05 154.56 0.44 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.126 0.971 . . . . 0.0 110.26 -173.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.02 28.91 6.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.816 1.246 . . . . 0.0 112.237 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.2 100.01 6.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.716 0.689 . . . . 0.0 109.256 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.3 mt -101.86 147.76 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.346 1.059 . . . . 0.0 110.354 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.93 151.17 46.88 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.643 0.777 . . . . 0.0 110.166 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.96 103.66 10.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 54.8 m-85 -93.54 1.85 56.6 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.606 0.762 . . . . 0.0 111.032 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.3 m -74.76 -9.45 58.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.658 0.383 . . . . 0.0 111.752 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.31 -5.28 70.06 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.739 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.441 HD12 ' SD ' ' A' ' 127' ' ' MET . 17.2 mt -47.38 -58.01 4.64 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 123.898 0.879 . . . . 0.0 113.252 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -63.63 -14.52 52.54 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -164.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.21 -46.88 8.14 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.179 0.992 . . . . 0.0 111.168 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -83.23 -23.41 32.78 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 9.8 m -123.67 90.51 50.53 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 123.08 0.552 . . . . 0.0 110.629 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.06 -34.84 4.65 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.462 2.108 . . . . 0.0 111.695 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.617 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.1 mmpt? -73.41 -17.9 61.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.138 0.975 . . . . 0.0 113.471 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 33.2 tp -62.16 133.32 55.07 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 123.518 0.511 . . . . 0.0 111.445 -170.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -142.64 -28.93 0.58 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.882 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 58.1 tp -134.62 138.87 44.88 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.642 0.777 . . . . 0.0 109.715 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 131' ' ' THR . 72.2 mt -113.98 143.64 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.469 ' HB3' HD12 ' A' ' 134' ' ' LEU . 72.3 m -126.64 130.31 50.2 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.492 0.717 . . . . 0.0 109.521 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.441 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 92.3 m-85 -105.04 130.18 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.191 0.596 . . . . 0.0 111.09 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.438 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 94.4 m-20 -85.29 88.81 7.53 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.141 0.576 . . . . 0.0 109.943 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 170.82 26.22 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.153 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 65.1 ttt180 -53.48 -63.65 1.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.112 0.965 . . . . 0.0 112.064 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -61.17 -12.41 12.56 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -84.65 -50.04 8.0 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.12 -9.77 72.43 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.962 -1.017 . . . . 0.0 115.108 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.1 mt-10 -64.62 -18.46 64.94 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.833 0.816 . . . . 0.0 111.762 176.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.36 25.15 12.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.199 1.0 . . . . 0.0 110.664 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.5 -52.32 73.7 Favored Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 123.628 0.771 . . . . 0.0 112.738 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.17 -19.19 51.07 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.082 1.855 . . . . 0.0 112.845 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.58 -46.02 87.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.054 0.942 . . . . 0.0 110.34 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.492 ' HB2' HG21 ' A' ' 131' ' ' THR . 18.7 mt -86.65 -9.69 55.46 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.461 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.66 -26.29 64.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.123 0.569 . . . . 0.0 110.782 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.37 -10.56 70.32 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.964 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.441 ' SD ' HD12 ' A' ' 100' ' ' LEU . 59.9 mtt -94.99 12.11 29.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.983 0.913 . . . . 0.0 110.696 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.79 -4.39 74.82 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -91.23 144.8 25.23 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.946 0.498 . . . . 0.0 110.921 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -74.32 145.85 43.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' HB ' ' A' ' 110' ' ' ILE . 18.6 p -134.98 148.61 50.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.066 0.946 . . . . 0.0 108.901 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -142.0 127.48 18.92 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.092 0.957 . . . . 0.0 108.697 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.74 110.87 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 111' ' ' CYS . 92.9 mt -95.11 154.68 39.53 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.87 154.29 58.47 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.936 1.757 . . . . 0.0 111.586 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -66.64 113.77 5.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.8 t -79.33 36.34 0.3 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -167.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -74.67 159.6 31.87 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.286 0.634 . . . . 0.0 110.559 172.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.62 47.05 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.96 14.67 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.583 0.692 . . . . 0.0 110.737 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -74.14 -23.8 59.32 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.139 0.576 . . . . 0.0 110.923 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.575 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 37.8 ptt180 -66.88 -25.74 66.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.805 0.336 . . . . 0.0 110.625 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -63.2 -26.22 68.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.234 1.014 . . . . 0.0 110.965 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -99.13 -24.85 14.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.632 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 49.5 m -82.97 22.55 0.93 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.809 0.844 . . . . 0.0 112.59 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.95 -61.06 2.06 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.56 -30.89 67.49 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 167.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.632 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 48.0 mtp180 -83.71 -11.3 57.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.37 0.268 . . . . 0.0 111.288 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.1 -34.35 30.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.059 0.544 . . . . 0.0 111.05 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.3 m -60.25 -39.55 87.13 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.925 0.89 . . . . 0.0 112.466 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -72.31 -36.28 68.85 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -64.59 -47.51 78.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 26.7 tt0 -64.12 -37.35 87.14 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.883 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.75 -37.3 62.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.903 0.752 . . . . 0.0 111.276 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.46 HG11 ' SG ' ' A' ' 111' ' ' CYS . 20.9 t -61.88 -39.22 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.701 0.801 . . . . 0.0 111.362 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -106.36 1.21 25.57 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 122.12 -0.362 . . . . 0.0 110.44 -171.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 ttm180 -71.88 -40.11 69.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.486 0.715 . . . . 0.0 110.108 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -76.67 -4.77 44.86 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.73 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.7 -30.19 62.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.002 0.521 . . . . 0.0 109.717 172.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -94.92 -55.37 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.942 -176.107 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.5 mm -69.56 108.47 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -92.06 113.81 26.18 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -87.37 123.08 31.94 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 122.613 0.365 . . . . 0.0 111.126 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.71 166.57 54.85 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.256 168.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -94.18 145.94 30.68 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 119.284 -0.389 . . . . 0.0 111.195 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.84 159.68 32.4 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.821 2.347 . . . . 0.0 111.439 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -67.15 130.08 41.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.262 0.554 . . . . 0.0 111.532 -174.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.597 HG11 HD22 ' A' ' 62' ' ' LEU . 46.5 t -95.7 60.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.454 HD11 ' CG1' ' A' ' 104' ' ' VAL . 42.0 tp -106.58 153.95 21.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.339 -161.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.649 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 22.7 t0 -126.07 154.83 42.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.89 1.276 . . . . 0.0 108.056 170.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.07 -11.22 60.59 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.853 0.461 . . . . 0.0 111.667 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.471 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . 23.8 m-80 -108.83 17.92 21.3 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.869 0.467 . . . . 0.0 110.79 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -72.78 117.73 14.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.194 0.598 . . . . 0.0 111.154 -174.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.07 -36.29 17.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.073 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.1 mt -126.1 112.1 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.428 HD13 HD13 ' A' ' 10' ' ' LEU . 59.9 tp -103.43 118.61 37.15 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.54 HG12 ' HB2' ' A' ' 111' ' ' CYS . 41.9 mt -104.18 110.17 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 109.178 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 82.8 mt -100.27 124.77 46.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.337 1.055 . . . . 0.0 109.901 -177.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -78.84 -171.86 40.75 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 164.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.4 p -100.39 -68.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.417 HD12 ' HD2' ' A' ' 23' ' ' PRO . 39.0 tp -149.35 116.96 3.73 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 173.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD2' HD12 ' A' ' 22' ' ' LEU . 58.9 Cg_endo -66.48 166.02 23.14 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.004 2.469 . . . . 0.0 113.423 -167.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -65.39 147.2 53.84 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.327 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.8 m-20 -57.63 -39.15 76.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.137 0.975 . . . . 0.0 111.358 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.81 -28.35 69.8 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 124.142 0.901 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.533 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 39.2 m -84.73 -38.28 19.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.584 0.753 . . . . 0.0 110.401 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.2 -29.19 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.832 0.853 . . . . 0.0 111.158 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.2 mmt180 -54.16 -38.17 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 170.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -94.25 -16.34 23.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.096 0.958 . . . . 0.0 110.514 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 56.46 24.96 9.11 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.927 1.291 . . . . 0.0 111.729 -170.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -144.16 151.49 39.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.032 0.933 . . . . 0.0 110.208 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.452 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 87.8 m-85 -70.41 -0.38 8.16 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.983 1.313 . . . . 0.0 114.52 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.415 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 2.5 p90 -96.94 -12.06 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.64 -33.07 80.72 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.845 0.715 . . . . 0.0 113.143 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -103.25 100.01 16.53 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.38 0.672 . . . . 0.0 109.525 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.25 -21.07 23.83 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.189 2.593 . . . . 0.0 111.638 171.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.57 -1.75 66.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.435 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -79.38 112.49 16.66 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -87.64 -1.36 57.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.837 0.855 . . . . 0.0 110.806 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.425 ' HE1' HG21 ' A' ' 18' ' ' ILE . 82.3 t80 -39.83 -45.08 1.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.979 1.711 . . . . 0.0 112.602 172.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.472 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 80.3 m95 -70.74 -27.78 64.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.311 -173.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -74.81 -48.4 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.414 0.286 . . . . 0.0 110.255 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.34 -47.07 83.69 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.936 0.773 . . . . 0.0 110.83 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.25 -40.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.43 0.692 . . . . 0.0 109.96 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.58 85.42 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.922 0.764 . . . . 0.0 113.636 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -73.52 -44.11 58.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.695 0.798 . . . . 0.0 110.146 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -64.35 -38.99 92.99 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.541 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.9 pt -88.29 -15.25 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.34 28.43 63.88 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 116.477 -0.329 . . . . 0.0 113.828 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -143.65 96.97 2.99 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.9 105.95 0.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.011 0.924 . . . . 0.0 111.971 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.27 -23.31 40.86 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.408 0.683 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.36 -38.27 86.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.461 0.705 . . . . 0.0 111.474 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -94.13 6.13 49.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.542 0.737 . . . . 0.0 111.108 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.5 mtt -95.41 146.01 24.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.124 0.569 . . . . 0.0 110.567 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.9 158.45 35.54 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.071 170.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.578 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 32.8 t80 -47.76 -63.4 1.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.851 0.86 . . . . 0.0 113.141 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 29.8 mt-10 -59.89 -32.85 71.12 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.191 0.597 . . . . 0.0 111.095 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -54.98 12.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.925 0.89 . . . . 0.0 111.692 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HE2' ' CD2' ' A' ' 42' ' ' TRP . 8.2 ptmt -59.99 -29.75 68.67 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.473 -176.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.597 HD22 HG11 ' A' ' 9' ' ' VAL . 39.6 mt -64.95 -47.87 76.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.705 0.802 . . . . 0.0 111.476 173.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.9 mmmm -55.57 -38.16 68.99 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.234 0.54 . . . . 0.0 110.358 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.1 m -69.63 -39.53 77.09 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.355 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 62' ' ' LEU . 89.8 mt -57.4 -50.09 74.1 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.926 0.49 . . . . 0.0 110.529 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.649 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 1.8 mptm? -60.98 -37.07 81.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.72 0.637 . . . . 0.0 110.833 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -64.36 -42.09 96.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.877 0.871 . . . . 0.0 111.154 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.429 ' O ' HD13 ' A' ' 159' ' ' LEU . 59.7 m-80 -88.79 3.32 51.46 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.067 0.547 . . . . 0.0 110.903 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.471 ' HD2' ' HB2' ' A' ' 13' ' ' ASN . 24.3 mmt180 67.05 35.13 4.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.356 1.062 . . . . 0.0 111.394 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -106.22 134.05 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.55 1.14 . . . . 0.0 108.797 174.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.16 151.15 18.01 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 172.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 mt -124.38 131.9 53.52 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 117.862 0.831 . . . . 0.0 109.833 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 2.8 t90 -152.74 -175.99 5.54 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -130.93 158.18 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.539 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.3 t -70.85 -44.33 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 173.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -101.79 108.28 19.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.432 0.634 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.7 ptmt -65.63 -24.71 67.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.528 167.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.94 137.52 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.919 0.888 . . . . 0.0 109.208 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -154.79 150.76 22.39 Favored Glycine 0 C--O 1.212 -1.234 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p -123.61 165.81 16.54 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 118.17 0.985 . . . . 0.0 109.544 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.486 ' HD2' ' HA ' ' A' ' 88' ' ' LYS . 73.9 ttt180 -137.8 123.67 20.07 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.759 0.423 . . . . 0.0 110.297 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' HB3' ' HG3' ' A' ' 85' ' ' GLN . 25.3 tt0 -87.41 163.37 16.79 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.303 1.041 . . . . 0.0 109.034 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.49 -35.56 89.22 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 123.246 0.341 . . . . 0.0 113.779 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.5 m -73.38 -34.13 65.39 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.974 0.51 . . . . 0.0 111.288 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.426 ' HG3' ' HB3' ' A' ' 82' ' ' GLU . 96.5 mt-30 -72.07 130.94 42.12 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.314 0.646 . . . . 0.0 110.535 -175.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' HA ' HH21 ' A' ' 81' ' ' ARG . 6.2 m-20 -87.36 -36.79 17.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.931 0.892 . . . . 0.0 109.994 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 t -69.25 140.01 54.46 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.742 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 34.9 mmtp -62.73 -25.85 68.4 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.056 0.847 . . . . 0.0 110.101 172.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.57 122.43 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.287 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.02 59.99 0.4 Allowed Glycine 0 N--CA 1.461 0.307 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.603 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 23.1 t70 -177.14 158.5 1.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.111 -1.544 . . . . 0.0 107.698 -164.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.27 20.71 11.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -167.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.7 tp10 -89.58 98.93 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 mt -110.53 150.0 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.867 0.867 . . . . 0.0 109.54 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -71.32 148.53 46.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.001 0.92 . . . . 0.0 110.632 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -79.0 96.78 5.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.822 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.539 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 31.6 m-85 -80.23 -8.45 59.46 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.23 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -72.12 -18.85 61.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.898 0.479 . . . . 0.0 110.753 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 -5.88 62.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.467 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 21.9 mt -52.57 -51.34 60.24 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.241 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -58.94 -26.2 64.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.134 0.574 . . . . 0.0 112.268 -171.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.72 -35.9 65.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.5 0.72 . . . . 0.0 111.332 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -106.98 -14.56 14.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -172.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 19.2 m -125.29 86.64 56.73 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.211 0.914 . . . . 0.0 111.443 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.83 -33.13 4.01 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.714 2.276 . . . . 0.0 112.211 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.39 -7.72 58.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.107 0.563 . . . . 0.0 112.235 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 56.9 tp -58.67 104.12 0.2 Allowed 'General case' 0 C--N 1.355 0.805 0 O-C-N 123.659 0.6 . . . . 0.0 111.282 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.95 -47.2 7.13 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.5 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 49.7 tp -128.45 133.79 48.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.232 0.613 . . . . 0.0 110.967 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mt -108.46 126.39 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.54 ' HB2' HG12 ' A' ' 18' ' ' ILE . 78.9 m -109.46 115.99 30.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.513 0.725 . . . . 0.0 110.327 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.51 122.02 37.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.648 0.779 . . . . 0.0 110.549 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.544 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 84.5 m-20 -76.58 89.57 3.31 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 110.283 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.22 172.46 45.93 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.532 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 88.9 mtm180 -55.62 -50.93 68.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.467 1.107 . . . . 0.0 113.127 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 62.9 mmtt -62.32 -17.33 58.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.32 -37.76 13.82 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.65 -9.98 75.32 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.904 -1.044 . . . . 0.0 115.23 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.3 mt-10 -61.03 -26.07 67.36 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.455 0.645 . . . . 0.0 110.786 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -99.55 10.07 42.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.638 1.175 . . . . 0.0 111.405 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 35.9 tt0 -55.11 -54.06 54.57 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.698 171.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.25 -25.18 36.96 Favored 'Trans proline' 0 C--N 1.397 3.095 0 CA-C-N 121.075 1.42 . . . . 0.0 111.805 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.17 -41.74 98.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.67 0.788 . . . . 0.0 110.385 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 mt -96.34 -15.05 22.1 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.819 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -69.54 -32.07 70.65 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.456 0.646 . . . . 0.0 109.59 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.1 -5.0 64.6 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.454 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.5 mtt -93.98 13.03 24.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.693 0.797 . . . . 0.0 111.25 172.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.51 10.62 84.63 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.415 0.526 . . . . 0.0 114.415 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.07 145.75 27.58 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 122.869 0.468 . . . . 0.0 110.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.88 135.76 49.91 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.446 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 16.0 p -128.9 139.3 52.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.911 0.884 . . . . 0.0 109.531 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -146.36 131.12 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.15 104.37 15.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 111' ' ' CYS . 54.6 mt -82.29 147.43 56.82 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.399 172.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.662 ' HG3' ' HG3' ' A' ' 148' ' ' ARG . 42.5 Cg_endo -63.6 152.12 81.83 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 122.583 2.189 . . . . 0.0 111.727 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.0 m -60.08 123.24 16.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 m -86.16 12.4 9.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.944 0.498 . . . . 0.0 111.645 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p -60.85 149.0 37.44 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.13 0.572 . . . . 0.0 109.528 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.66 -28.72 60.35 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.328 0.393 . . . . 0.0 112.975 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.08 -35.22 79.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.909 0.884 . . . . 0.0 112.195 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -98.74 5.66 47.42 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.538 0.735 . . . . 0.0 111.43 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -73.93 -10.56 59.77 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.3 0.572 . . . . 0.0 110.699 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -52.29 -26.11 11.19 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.042 0.937 . . . . 0.0 112.994 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -96.47 2.82 52.87 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.599 0.76 . . . . 0.0 111.949 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.701 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 97.8 p -73.27 15.37 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -162.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.39 -74.21 0.17 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.284 0.947 . . . . 0.0 109.39 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.88 -25.21 63.59 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 112.002 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.701 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -69.42 -49.62 53.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.73 0.812 . . . . 0.0 110.158 -177.128 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -60.52 -36.53 78.62 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.264 0.626 . . . . 0.0 110.632 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -63.95 -40.78 97.21 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.535 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 6.9 pt-20 -70.06 -28.05 65.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.331 0.253 . . . . 0.0 110.715 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -71.63 -35.76 70.53 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.321 0.648 . . . . 0.0 109.745 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.1 -37.03 83.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.12 -17.62 64.94 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.456 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 151' ' ' GLU . 87.7 t -89.72 -61.94 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.316 0.646 . . . . 0.0 110.798 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.485 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 62.9 m-85 -86.51 2.45 47.91 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -164.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -75.55 -21.24 58.08 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.415 ' HE1' HD11 ' A' ' 16' ' ' ILE . 7.8 p-80 -77.14 -10.86 59.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.775 0.43 . . . . 0.0 111.493 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 68' ' ' ASN . 81.2 mt -69.34 -14.78 63.11 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.639 0.775 . . . . 0.0 112.695 -170.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.64 -34.4 60.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.989 0.516 . . . . 0.0 111.003 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 124.944 1.298 . . . . 0.0 110.29 -173.235 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.471 HG23 ' HB1' ' A' ' 78' ' ' ALA . 41.0 mm -78.74 128.35 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.12 0.968 . . . . 0.0 112.443 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 2.9 mptp? -94.64 111.57 23.33 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -86.6 143.41 27.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.97 -131.31 0.04 OUTLIER Glycine 0 CA--C 1.532 1.151 0 CA-C-O 121.281 0.379 . . . . 0.0 113.434 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -136.76 145.01 49.19 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.964 -0.727 . . . . 0.0 110.234 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.04 135.81 65.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.163 1.909 . . . . 0.0 108.956 166.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 135.44 57.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.655 0.597 . . . . 0.0 110.992 -170.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.647 HG11 HD22 ' A' ' 62' ' ' LEU . 74.9 t -96.32 88.31 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.508 HD11 ' CG1' ' A' ' 104' ' ' VAL . 16.8 tp -140.0 150.41 44.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -161.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.701 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 13.6 t70 -127.17 160.17 32.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.524 1.13 . . . . 0.0 108.396 171.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -67.28 -16.86 64.52 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.972 0.509 . . . . 0.0 111.88 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -102.37 17.57 23.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.986 0.914 . . . . 0.0 110.734 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.417 ' HB ' HG12 ' A' ' 104' ' ' VAL . 85.5 m -79.22 122.84 26.8 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.938 0.495 . . . . 0.0 110.167 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 30.7 tt0 -97.21 -32.23 12.04 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.546 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.597 HD12 HD11 ' A' ' 159' ' ' LEU . 42.1 mt -130.25 123.91 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.11 121.26 44.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -96.42 113.1 29.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.3 mt -99.91 111.64 23.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 109.384 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.4 177.36 21.31 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 167.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 t -90.57 -89.96 0.16 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.15 0.975 . . . . 0.0 108.789 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.77 112.31 14.93 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.93 149.11 83.01 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.172 1.915 . . . . 0.0 111.705 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.67 135.78 50.29 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.5 p-10 -61.75 -19.6 62.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -171.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -52.66 -36.57 57.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.719 1.208 . . . . 0.0 111.921 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 p -90.33 -33.97 15.88 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.294 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 81.7 mt -64.32 -37.66 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.224 1.01 . . . . 0.0 112.923 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 26.5 mmt180 -61.4 -28.59 69.36 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.204 0.526 . . . . 0.0 110.042 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -89.93 -23.28 21.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 111.131 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.08 28.02 14.27 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.994 1.317 . . . . 0.0 111.913 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.88 137.82 49.53 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.457 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.661 ' HB3' ' HZ2' ' A' ' 42' ' ' TRP . 93.5 m-85 -77.03 -2.96 36.67 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.699 167.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -97.38 -18.68 18.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.424 1.09 . . . . 0.0 110.927 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.85 -108.44 0.03 OUTLIER Glycine 0 C--N 1.344 0.994 0 O-C-N 123.307 0.379 . . . . 0.0 112.331 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -124.69 93.22 46.55 Favored Pre-proline 0 N--CA 1.484 1.23 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HG2' ' HE1' ' A' ' 42' ' ' TRP . 7.7 Cg_exo -75.02 -52.43 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.916 2.411 . . . . 0.0 111.494 175.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.23 34.33 5.91 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -131.59 135.61 47.12 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.298 1.039 . . . . 0.0 111.838 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.99 0.28 28.24 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 124.946 1.299 . . . . 0.0 109.998 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -39.3 -50.3 2.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.254 2.222 . . . . 0.0 113.533 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.661 ' HZ2' ' HB3' ' A' ' 33' ' ' TYR . 72.9 m95 -69.11 -20.87 64.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.279 0.631 . . . . 0.0 112.21 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 4.6 mpt_? -86.77 -39.85 15.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.931 0.892 . . . . 0.0 110.339 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.76 -51.8 30.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.063 0.545 . . . . 0.0 111.053 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 t -73.16 -35.55 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.059 0.944 . . . . 0.0 109.61 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.74 -38.58 95.79 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.67 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -69.16 -40.6 78.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.245 0.618 . . . . 0.0 109.943 173.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -60.77 -42.69 97.96 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.737 0.815 . . . . 0.0 112.925 -175.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -95.15 -10.0 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.211 0.604 . . . . 0.0 112.162 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.55 59.19 Favored Glycine 0 C--N 1.353 1.496 0 O-C-N 123.266 0.354 . . . . 0.0 113.44 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.48 117.64 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.12 1.368 . . . . 0.0 108.389 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -68.47 88.73 0.34 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.597 0.713 . . . . 0.0 111.345 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.159 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -55.35 -50.94 68.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.226 1.01 . . . . 0.0 112.524 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.43 -5.78 59.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.713 0.805 . . . . 0.0 111.366 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.5 mtt -80.42 141.32 35.42 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.9 154.42 12.32 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.336 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.64 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 39.8 t80 -39.02 -50.65 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.824 0.85 . . . . 0.0 112.205 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 39.0 mt-10 -54.55 -55.72 26.34 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.154 0.909 . . . . 0.0 111.596 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.36 -39.49 74.59 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -61.18 -41.56 97.01 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.018 0.372 . . . . 0.0 110.575 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.647 HD22 HG11 ' A' ' 9' ' ' VAL . 17.0 mt -63.68 -43.94 95.2 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.887 0.742 . . . . 0.0 110.714 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 34.6 mmtp -56.76 -41.51 77.7 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.6 m -68.57 -39.55 80.97 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.042 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 61' ' ' LYS . 91.9 mt -57.35 -50.32 73.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 123.055 0.542 . . . . 0.0 109.942 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.701 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -56.79 -41.57 77.96 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 111.306 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.701 0.8 . . . . 0.0 111.278 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 56.7 m-80 -97.34 17.56 17.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.23 0.612 . . . . 0.0 110.784 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER 62.72 29.39 16.78 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.452 1.101 . . . . 0.0 111.308 169.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.95 134.87 42.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.327 1.051 . . . . 0.0 108.626 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.46 157.57 15.39 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.17 131.74 53.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.569 0.748 . . . . 0.0 109.459 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -161.8 -168.07 1.85 Allowed 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.65 162.91 33.97 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.687 0.676 . . . . 0.0 111.569 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 68.9 t -88.21 -45.46 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.438 1.095 . . . . 0.0 110.222 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -100.56 109.69 21.8 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.527 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.3 ttmt -64.37 -39.96 94.9 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 124.368 1.043 . . . . 0.0 110.294 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 2' ' ' ILE . . . -150.21 133.48 16.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.899 -176.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.72 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -155.15 144.22 10.8 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.8 t -116.0 168.15 10.34 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 117.452 0.626 . . . . 0.0 110.127 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -130.74 140.05 50.3 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -27.47 68.38 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.287 0.635 . . . . 0.0 112.59 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 142.25 4.15 0.97 Allowed Glycine 0 N--CA 1.474 1.218 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 t -83.31 -157.69 0.25 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 117.152 0.476 . . . . 0.0 109.845 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -56.37 150.07 15.54 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.46 0.704 . . . . 0.0 111.458 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.78 60.72 6.07 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.616 0.722 . . . . 0.0 111.731 -167.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 m -142.99 9.89 1.73 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.758 1.223 . . . . 0.0 109.33 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -78.28 124.64 28.32 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 124.088 0.955 . . . . 0.0 109.935 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 mt -104.72 89.73 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.65 58.6 0.41 Allowed Glycine 0 C--O 1.244 0.737 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.887 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 15.2 t70 -178.78 146.68 0.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 107.964 -174.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -105.18 16.82 25.11 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -167.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 15.4 tp10 -82.47 101.01 10.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.787 0.803 . . . . 0.0 109.785 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.38 145.71 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.575 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.8 156.27 34.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.867 0.467 . . . . 0.0 110.37 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.91 110.71 13.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.898 0.879 . . . . 0.0 110.367 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.7 m-85 -106.05 -9.42 17.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.281 0.632 . . . . 0.0 112.488 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.2 p -68.19 -13.49 62.27 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.62 0.368 . . . . 0.0 111.797 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -2.14 56.72 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 118.806 -0.997 . . . . 0.0 113.695 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -49.76 -37.4 29.59 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.445 0.698 . . . . 0.0 112.572 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.26 -31.5 72.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.52 0.328 . . . . 0.0 111.739 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.26 -50.95 8.92 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.033 0.933 . . . . 0.0 111.748 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.418 ' HG3' HG22 ' A' ' 104' ' ' VAL . 21.2 ptm -72.67 -33.54 66.6 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.302 0.641 . . . . 0.0 111.948 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -128.85 87.19 55.4 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.803 0.841 . . . . 0.0 109.64 176.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.09 -28.03 13.28 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.709 2.273 . . . . 0.0 112.501 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 0.24 56.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.316 0.646 . . . . 0.0 111.753 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 44.7 tp -57.23 110.18 0.8 Allowed 'General case' 0 C--N 1.354 0.762 0 O-C-N 123.806 0.691 . . . . 0.0 111.222 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.595 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 12.2 ptm180 -101.59 -43.47 5.88 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.67 170.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.468 ' HB3' HG12 ' A' ' 16' ' ' ILE . 59.8 tp -131.05 128.55 40.51 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.786 0.835 . . . . 0.0 110.245 -168.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.74 113.93 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.453 1.101 . . . . 0.0 108.501 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.424 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.3 m -96.48 113.73 25.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.858 0.463 . . . . 0.0 110.405 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.24 109.25 19.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.073 0.949 . . . . 0.0 110.088 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.445 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 7.2 t30 -81.85 90.4 6.41 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.95 143.25 7.32 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.768 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -54.86 -49.04 72.12 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.314 1.046 . . . . 0.0 112.141 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -49.26 -38.33 26.58 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.583 1.153 . . . . 0.0 112.744 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.77 -42.98 66.5 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.663 0.785 . . . . 0.0 110.102 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.7 -9.33 69.63 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 114.601 -1.181 . . . . 0.0 114.451 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.98 -28.99 70.47 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.138 0.469 . . . . 0.0 110.855 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.6 22.86 12.86 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.454 1.102 . . . . 0.0 110.937 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.14 -55.15 46.92 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.427 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.79 -19.18 66.61 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 122.014 1.809 . . . . 0.0 111.979 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.65 -49.04 74.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.384 1.074 . . . . 0.0 109.389 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 mt -87.59 -15.97 35.88 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.081 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -66.73 -31.71 72.53 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.24 -12.07 60.11 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.639 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.0 mtt -96.25 16.79 17.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.837 0.855 . . . . 0.0 111.338 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.94 22.51 78.75 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.04 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -111.26 138.38 47.79 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.9 0.48 . . . . 0.0 111.225 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -62.85 142.85 58.07 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.7 p -132.46 142.07 49.08 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.988 0.515 . . . . 0.0 110.85 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -130.36 114.19 15.29 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.582 1.153 . . . . 0.0 108.325 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.0 94.44 2.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.85 140.39 88.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.013 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.505 ' HG3' ' HD3' ' A' ' 148' ' ' ARG . 21.2 Cg_endo -57.97 158.08 22.46 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.424 2.083 . . . . 0.0 111.57 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.3 m -56.29 113.58 1.63 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -80.28 18.41 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.556 0.343 . . . . 0.0 111.837 -175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.0 m -57.95 149.63 22.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.108 0.963 . . . . 0.0 110.603 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.45 -24.35 65.71 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.584 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.07 70.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.384 0.673 . . . . 0.0 111.497 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -87.5 4.85 41.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.648 0.779 . . . . 0.0 111.615 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 12.7 ttm180 -62.69 -25.5 68.19 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.419 0.554 . . . . 0.0 111.984 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.53 -23.59 27.39 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.026 0.531 . . . . 0.0 111.811 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -108.04 5.94 26.55 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.105 0.962 . . . . 0.0 112.111 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.556 ' HB2' ' HA ' ' A' ' 142' ' ' ARG . 41.0 t -64.23 -35.54 81.17 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -164.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -62.88 -62.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.428 0.558 . . . . 0.0 111.733 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.68 -39.91 78.22 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.428 0.691 . . . . 0.0 111.127 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.505 ' HD3' ' HG3' ' A' ' 135' ' ' PRO . 72.0 mtt-85 -74.78 -27.42 60.32 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.579 -175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.38 -35.52 79.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.985 0.514 . . . . 0.0 109.997 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.4 t -72.0 -30.08 64.87 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.984 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 4.3 pt-20 -76.66 -34.37 58.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -70.54 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.577 0.751 . . . . 0.0 109.126 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.421 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 25.0 tt0 -66.52 -37.63 85.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.658 0.783 . . . . 0.0 109.332 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.96 -13.73 62.4 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.42 HG11 ' SG ' ' A' ' 111' ' ' CYS . 85.7 t -89.48 -52.76 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.523 0.729 . . . . 0.0 110.581 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.445 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 51.5 m-85 -96.09 -1.41 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -164.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.421 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 18.7 mtp180 -68.34 -38.85 81.89 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.823 0.738 . . . . 0.0 112.175 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -74.93 -9.9 58.97 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.705 0.402 . . . . 0.0 111.355 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.597 HD11 HD12 ' A' ' 16' ' ' ILE . 88.2 mt -82.51 -35.65 27.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.209 1.004 . . . . 0.0 110.221 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.04 -49.99 11.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.4 t60 . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.163 1.385 . . . . 0.0 112.384 170.554 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 80' ' ' SER . 32.8 mm -77.94 122.97 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.735 0.814 . . . . 0.0 108.968 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -95.07 118.47 31.94 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -93.57 142.72 27.03 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 110.552 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.446 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -69.97 171.59 41.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.419 167.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.79 145.78 31.19 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 122.262 -0.552 . . . . 0.0 110.561 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.45 132.52 49.06 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.312 2.008 . . . . 0.0 109.654 170.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.9 147.72 45.85 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.299 1.0 . . . . 0.0 112.755 -166.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.628 HG11 HD22 ' A' ' 62' ' ' LEU . 26.2 t -92.4 47.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.457 HD11 ' CG1' ' A' ' 104' ' ' VAL . 35.6 tp -89.67 147.6 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.898 -167.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.13 151.86 41.69 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.73 -16.61 64.22 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.832 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.557 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 30.3 m-80 -105.88 21.05 17.93 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -70.53 109.95 5.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.485 0.66 . . . . 0.0 110.238 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.04 -38.86 26.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.257 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.428 HD12 HD11 ' A' ' 159' ' ' LEU . 55.2 mt -124.72 120.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.691 0.796 . . . . 0.0 108.995 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD13 HD13 ' A' ' 10' ' ' LEU . 59.7 tp -103.41 117.41 34.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 111' ' ' CYS . 50.0 mt -95.99 108.69 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 73' ' ' TRP . 88.9 mt -95.52 108.7 20.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 109.147 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.42 -174.54 7.28 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 167.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 m -87.77 -82.02 0.23 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 ' HD2' ' A' ' 23' ' ' PRO . 51.5 tp -148.28 124.64 5.36 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.4 Cg_exo -43.26 135.35 6.06 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.897 3.065 . . . . 0.0 114.194 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 m -72.2 169.58 15.84 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 111.107 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.92 -49.18 69.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.747 0.819 . . . . 0.0 111.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.19 -31.44 67.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.322 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.7 p -70.71 -38.89 73.69 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.7 mt -68.57 -24.85 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.138 0.975 . . . . 0.0 111.746 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.32 -44.67 87.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.017 0.436 . . . . 0.0 109.905 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -95.26 -1.54 51.31 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.019 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 64.04 24.65 13.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.692 1.197 . . . . 0.0 113.123 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.86 144.12 30.03 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.933 0.893 . . . . 0.0 109.574 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -58.27 -47.51 83.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.686 0.794 . . . . 0.0 110.334 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.412 ' HE1' HE22 ' A' ' 54' ' ' GLN . 30.3 t80 -60.86 -16.48 41.92 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.625 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -14.17 65.21 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 122.694 0.188 . . . . 0.0 113.438 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.03 101.5 11.15 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.697 0.799 . . . . 0.0 108.856 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.4 148.63 89.87 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.806 2.337 . . . . 0.0 111.42 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.18 -21.08 25.17 Favored Glycine 0 N--CA 1.464 0.535 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.48 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -73.15 102.13 3.51 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.845 0.831 . . . . 0.0 109.408 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -79.98 -3.97 50.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.827 1.651 . . . . 0.0 110.133 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -35.21 -53.92 0.62 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.871 2.069 . . . . 0.0 113.628 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -69.73 -28.33 65.72 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.331 0.652 . . . . 0.0 111.766 -172.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -68.21 -43.82 77.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 110.412 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.0 mt -72.31 -52.64 15.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.696 1.198 . . . . 0.0 111.225 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.97 -43.28 92.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 C-N-CA 124.048 0.939 . . . . 0.0 109.336 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.74 94.56 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.151 0.907 . . . . 0.0 113.469 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -69.41 -39.76 77.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.994 0.518 . . . . 0.0 110.318 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -69.94 -38.24 76.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.89 0.876 . . . . 0.0 112.811 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.05 -11.72 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.072 0.549 . . . . 0.0 110.938 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.94 19.15 79.06 Favored Glycine 0 C--N 1.36 1.909 0 O-C-N 123.807 0.692 . . . . 0.0 113.787 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.68 110.7 11.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 108.318 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -69.55 101.22 1.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.86 0.838 . . . . 0.0 111.553 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.48 -34.08 47.83 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.025 0.93 . . . . 0.0 111.897 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.412 HE22 ' HE1' ' A' ' 34' ' ' TYR . 60.5 tp60 -62.7 -31.0 71.83 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -168.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -83.15 -5.86 59.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.083 0.553 . . . . 0.0 112.393 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.4 mtt -86.42 154.98 20.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.213 0.605 . . . . 0.0 109.455 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.5 152.52 45.52 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 165.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.528 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 70.0 t80 -51.08 -42.21 60.44 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.003 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.92 -45.07 93.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.946 0.898 . . . . 0.0 111.486 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -67.98 -38.09 82.29 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.637 0.775 . . . . 0.0 110.569 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -53.53 -49.48 67.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.722 0.809 . . . . 0.0 109.902 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD22 HG11 ' A' ' 9' ' ' VAL . 19.2 mt -61.98 -45.41 93.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 124.655 1.222 . . . . 0.0 110.986 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -57.12 -40.61 77.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.89 0.476 . . . . 0.0 111.421 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.2 m -66.37 -36.82 83.83 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.75 -37.13 84.03 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.13 0.572 . . . . 0.0 111.085 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -57.46 -44.3 84.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -65.06 -35.39 80.99 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.413 1.085 . . . . 0.0 111.555 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -85.14 -8.59 58.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.782 0.833 . . . . 0.0 111.018 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 62.87 38.05 11.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.669 1.188 . . . . 0.0 110.462 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.78 134.17 48.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.78 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.64 142.24 17.44 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.0 128.8 54.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.448 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.1 t90 -153.26 -169.93 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.96 176.83 8.33 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.702 0.801 . . . . 0.0 109.187 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.583 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.8 t -90.87 -46.76 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.137 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -94.29 118.31 31.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.866 0.467 . . . . 0.0 110.385 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 36.9 ttmt -64.77 -41.91 95.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.322 1.049 . . . . 0.0 110.45 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.86 131.04 12.73 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.348 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.667 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.61 138.63 6.64 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.533 ' HB3' HD13 ' A' ' 2' ' ' ILE . 31.2 p -118.31 129.37 55.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.114 0.566 . . . . 0.0 111.063 -171.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -87.13 93.11 9.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -80.33 -20.0 45.26 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.223 0.609 . . . . 0.0 110.19 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.5 -152.76 5.84 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.925 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.6 m -132.46 33.67 3.79 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.233 1.013 . . . . 0.0 109.32 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -109.98 68.1 0.66 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 66.06 7.93 5.09 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 125.003 1.321 . . . . 0.0 113.111 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.5 p -82.9 83.45 7.77 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.047 0.939 . . . . 0.0 109.508 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -91.84 -40.58 11.11 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.4 mt -134.92 80.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 171.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.92 71.65 2.16 Favored Glycine 0 C--O 1.242 0.642 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.667 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.7 t70 176.48 158.31 0.29 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 108.61 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.28 23.74 8.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.861 0.864 . . . . 0.0 111.866 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 16.4 tp10 -83.06 102.56 11.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 54.9 mt -102.59 155.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.682 1.193 . . . . 0.0 109.728 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -74.26 145.19 44.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.437 1.095 . . . . 0.0 110.168 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.01 101.16 1.34 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.356 0.662 . . . . 0.0 110.377 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.583 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 22.7 m-85 -91.95 -10.27 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.065 0.546 . . . . 0.0 112.04 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.6 p -67.67 -21.73 65.33 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.134 0.174 . . . . 0.0 110.622 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.08 -3.7 75.77 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.369 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.8 mt -48.96 -46.23 43.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -64.27 -23.78 67.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.101 0.41 . . . . 0.0 111.471 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.03 -58.3 3.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.922 0.889 . . . . 0.0 111.029 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.4 ptm -71.0 -33.77 70.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.066 0.947 . . . . 0.0 112.508 -168.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.3 m -124.32 84.04 56.54 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.698 0.799 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.76 -32.38 14.49 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.889 2.393 . . . . 0.0 111.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.557 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.6 mmpt? -87.87 -0.94 57.62 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.884 0.874 . . . . 0.0 112.482 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.6 tp -59.28 107.97 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -99.27 -41.75 7.32 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.829 0.852 . . . . 0.0 109.79 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.3 tp -136.91 132.82 35.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 110.64 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.518 HG12 HD21 ' A' ' 107' ' ' LEU . 15.7 mt -104.61 123.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.525 ' HB2' HG12 ' A' ' 18' ' ' ILE . 70.9 m -101.7 114.4 28.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.977 0.511 . . . . 0.0 110.508 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HZ ' HD12 ' A' ' 124' ' ' LEU . 95.8 m-85 -93.49 109.45 21.05 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.886 0.875 . . . . 0.0 110.225 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 5.4 t30 -82.96 94.33 7.72 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.61 149.8 13.05 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.069 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -57.51 -43.17 84.04 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.866 1.267 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -51.41 -44.06 62.14 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.708 0.803 . . . . 0.0 112.73 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.78 85.91 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.149 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.5 -11.76 60.23 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.259 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.74 -27.89 69.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.99 0.895 . . . . 0.0 111.908 172.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -108.54 16.12 23.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.247 0.619 . . . . 0.0 111.253 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.509 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.8 tm-20 -66.4 -47.36 59.2 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.461 167.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.5 -35.29 75.78 Favored 'Trans proline' 0 C--N 1.403 3.418 0 C-N-CA 122.49 2.127 . . . . 0.0 113.18 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.54 -52.6 64.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.352 1.061 . . . . 0.0 112.014 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.459 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 15.9 mt -79.45 -6.12 56.2 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -65.6 -36.18 82.97 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.91 -17.55 71.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.214 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 62.8 mtt -86.58 9.35 18.78 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.61 0.764 . . . . 0.0 111.268 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.19 16.03 70.48 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.413 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -99.67 143.18 30.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 120.745 0.307 . . . . 0.0 110.777 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -75.84 133.2 40.67 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 161.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 36.1 p -127.62 141.1 51.72 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.999 0.92 . . . . 0.0 108.619 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -142.77 125.64 16.11 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.62 1.168 . . . . 0.0 108.17 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.31 112.82 24.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 155' ' ' VAL . 62.8 mt -89.21 131.69 39.95 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.86 147.02 33.82 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.513 2.809 . . . . 0.0 112.772 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.6 t -54.79 116.95 3.0 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.149 0.905 . . . . 0.0 110.072 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.2 p -72.37 0.15 10.87 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.544 0.738 . . . . 0.0 112.546 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 m -60.43 143.18 53.91 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.969 0.908 . . . . 0.0 110.273 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.61 69.84 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.796 0.685 . . . . 0.0 114.368 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.54 -42.85 98.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.209 0.604 . . . . 0.0 110.436 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -81.56 -32.3 32.25 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.346 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -59.99 -23.66 63.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.42 0.45 . . . . 0.0 111.262 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -71.26 -48.9 48.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.848 0.859 . . . . 0.0 110.092 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.23 23.73 3.2 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.457 1.103 . . . . 0.0 110.382 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -169.37 70.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -91.96 -51.48 5.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.625 1.17 . . . . 0.0 108.016 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -66.0 -6.34 12.44 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.363 1.065 . . . . 0.0 112.666 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -71.43 -20.06 62.16 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.763 0.825 . . . . 0.0 110.732 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.38 -30.88 67.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.338 0.655 . . . . 0.0 111.118 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.1 t -64.52 -44.29 91.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.253 1.021 . . . . 0.0 112.445 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.2 pt-20 -75.26 -30.62 60.52 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.351 0.26 . . . . 0.0 110.485 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.59 -40.58 88.95 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 4.0 tm-20 -67.06 -39.81 86.98 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.702 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.13 64.59 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.412 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 151' ' ' GLU . 73.1 t -84.72 -53.88 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.009 0.523 . . . . 0.0 111.001 177.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.408 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 40.0 m-85 -96.61 2.96 52.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -168.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.41 -32.28 73.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.276 0.489 . . . . 0.0 111.137 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 16' ' ' ILE . 15.4 p-80 -73.74 -12.36 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.623 0.369 . . . . 0.0 111.155 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 16' ' ' ILE . 86.7 mt -78.3 -26.06 46.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -82.7 -39.49 21.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.456 0.702 . . . . 0.0 109.121 167.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 19.9 t60 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 125.403 1.481 . . . . 0.0 110.596 -179.262 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 80' ' ' SER . 46.5 mm -67.94 111.37 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.275 0.63 . . . . 0.0 110.696 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -93.22 111.0 22.52 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -79.33 125.62 29.74 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.486 0.315 . . . . 0.0 110.739 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.23 170.74 51.92 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 124.234 0.959 . . . . 0.0 111.629 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 8.0 m-30 -89.36 141.74 29.2 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.451 -168.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.32 164.23 29.04 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.726 2.284 . . . . 0.0 111.104 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.33 128.93 37.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.358 0.663 . . . . 0.0 111.867 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG11 HD22 ' A' ' 62' ' ' LEU . 58.7 t -100.03 72.86 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.572 HD11 ' CG1' ' A' ' 104' ' ' VAL . 60.4 tp -124.86 149.56 47.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.02 -162.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.7 160.6 25.53 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 109.194 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.15 -20.19 62.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.462 1.105 . . . . 0.0 111.882 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -122.53 91.07 3.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.496 ' HB ' HG12 ' A' ' 104' ' ' VAL . 99.5 m -131.8 114.28 14.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.925 0.89 . . . . 0.0 108.769 175.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 12.9 tt0 -87.75 -33.84 18.55 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.278 1.031 . . . . 0.0 110.9 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 159' ' ' LEU . 60.4 mt -128.57 125.66 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.079 0.552 . . . . 0.0 109.6 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.01 123.51 49.79 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 mt -100.13 115.63 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' A' ' 73' ' ' TRP . 97.8 mt -103.74 124.42 48.85 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.946 0.898 . . . . 0.0 110.181 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.3 -178.61 39.51 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 123.3 0.375 . . . . 0.0 112.365 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 116' ' ' LYS . 6.9 p -100.43 -71.43 0.7 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.9 119.46 2.78 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.35 167.84 8.88 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.689 2.26 . . . . 0.0 112.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.6 p -63.69 154.42 33.13 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.801 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 33.7 t70 -57.84 -37.61 74.16 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.275 0.359 . . . . 0.0 110.837 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.89 -36.0 64.71 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.187 0.995 . . . . 0.0 111.516 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.603 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 8.7 t -86.9 -39.71 15.53 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.27 -174.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.427 ' HA ' ' HE1' ' A' ' 6' ' ' PHE . 70.8 mt -66.55 -38.53 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.079 0.951 . . . . 0.0 112.0 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 24.9 mmm180 -66.73 -16.59 64.35 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.579 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 93.2 mttt -106.49 -1.5 23.02 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.662 0.785 . . . . 0.0 111.566 175.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 56.16 18.24 3.15 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.436 1.494 . . . . 0.0 114.693 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -145.05 161.92 38.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.951 0.501 . . . . 0.0 110.98 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -76.6 -1.56 28.21 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.894 1.278 . . . . 0.0 112.723 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -90.54 -14.24 32.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -52.34 -40.98 54.2 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.566 1.166 . . . . 0.0 115.717 -162.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -122.11 98.01 45.05 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.979 0.512 . . . . 0.0 110.309 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.03 2.44 4.24 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.568 2.845 . . . . 0.0 113.352 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.64 -17.73 79.98 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 120.357 -0.135 . . . . 0.0 112.898 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -82.97 127.47 33.58 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.34 0.591 . . . . 0.0 109.983 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 6.9 m-20 -81.01 0.32 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.61 1.164 . . . . 0.0 112.304 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -38.94 -47.47 1.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.819 1.248 . . . . 0.0 112.649 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -74.85 -26.78 59.93 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.918 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -79.31 -28.23 42.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.231 0.612 . . . . 0.0 111.594 175.166 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 33.4 mt -85.93 -48.54 8.62 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.818 0.447 . . . . 0.0 110.432 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.08 -30.96 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.275 0.63 . . . . 0.0 109.505 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.68 -44.52 70.49 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.573 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -60.72 -37.28 81.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.476 0.71 . . . . 0.0 110.298 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.58 -45.96 88.02 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.183 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.47 HD11 HD21 ' A' ' 53' ' ' LEU . 19.9 pt -91.37 -4.79 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.684 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.43 36.22 69.18 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.546 0.529 . . . . 0.0 112.838 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -149.3 105.91 3.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.675 1.59 . . . . 0.0 107.423 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -68.42 110.84 4.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.779 0.799 . . . . 0.0 109.506 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.47 HD21 HD11 ' A' ' 49' ' ' ILE . 85.1 mt -82.3 -30.72 30.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.042 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -60.32 -38.84 84.99 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.73 3.92 52.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.136 0.574 . . . . 0.0 111.337 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.552 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 66.6 mtt -85.25 150.4 24.81 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.39 45.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.751 0.657 . . . . 0.0 109.402 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.482 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 35.0 t80 -43.15 -48.99 6.48 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.362 1.065 . . . . 0.0 113.695 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 -61.31 -49.91 75.12 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 122.577 0.351 . . . . 0.0 111.322 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.25 -48.72 80.56 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.69 0.796 . . . . 0.0 112.662 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 7.6 ptmt -62.18 -36.52 82.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.489 0.316 . . . . 0.0 111.619 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.535 HD22 HG11 ' A' ' 9' ' ' VAL . 77.5 mt -68.99 -40.34 78.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.082 0.553 . . . . 0.0 111.557 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 30.3 mmmt -55.89 -44.72 78.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.386 0.674 . . . . 0.0 110.805 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -64.07 -40.06 95.44 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.285 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.98 -55.11 36.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.407 0.683 . . . . 0.0 111.688 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -22.49 64.27 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.092 0.245 . . . . 0.0 111.449 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -62.87 -33.91 76.28 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.692 0.397 . . . . 0.0 111.757 167.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -88.94 1.94 54.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.232 0.613 . . . . 0.0 110.977 172.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 8.0 mpt_? 64.59 46.51 3.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.683 1.193 . . . . 0.0 110.514 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.08 133.19 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.359 1.063 . . . . 0.0 108.697 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.35 17.86 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.62 132.15 56.55 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.42 0.688 . . . . 0.0 109.15 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.447 ' HB3' HD23 ' A' ' 19' ' ' LEU . 3.6 t90 -158.13 -170.2 3.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -134.32 162.74 31.34 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 48.4 t -79.09 -51.84 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 42.0 m-85 -82.2 126.66 32.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 0.0 110.58 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.591 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.3 tmtp? -68.01 -32.17 72.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.76 149.67 16.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.039 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.92 135.71 7.86 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.479 ' HB2' HD13 ' A' ' 2' ' ' ILE . 27.9 t -119.05 170.38 9.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.575 0.75 . . . . 0.0 109.537 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 87' ' ' SER . 3.6 tpm_? -137.83 111.44 8.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.453 ' HB3' ' NH2' ' A' ' 81' ' ' ARG . 35.7 tt0 -55.85 123.34 13.93 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.872 0.869 . . . . 0.0 111.047 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.91 82.13 0.53 Allowed Glycine 0 C--N 1.345 1.059 0 O-C-N 124.493 1.121 . . . . 0.0 112.073 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.1 t -158.76 -44.61 0.06 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -162.85 150.97 13.94 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.538 1.135 . . . . 0.0 108.685 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.92 137.58 49.37 Favored 'General case' 0 C--O 1.242 0.675 0 O-C-N 123.432 0.458 . . . . 0.0 110.224 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.498 ' H ' ' HD3' ' A' ' 81' ' ' ARG . 14.7 t -168.73 -160.22 0.28 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.132 0.973 . . . . 0.0 108.595 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -74.1 -171.07 1.05 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.4 1.08 . . . . 0.0 112.064 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.1 100.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.874 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.79 57.12 5.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.38 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -173.69 154.66 2.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.492 1.117 . . . . 0.0 108.759 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -124.25 25.92 7.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.212 1.005 . . . . 0.0 111.394 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.3 tp10 -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.468 0.707 . . . . 0.0 109.26 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 77.2 mt -127.0 140.62 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.418 1.087 . . . . 0.0 109.192 -168.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -62.39 151.54 36.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.792 0.837 . . . . 0.0 110.869 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.17 130.65 36.59 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.8 m-85 -118.94 -2.23 10.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.058 0.543 . . . . 0.0 111.091 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 86.2 p -63.99 -31.11 72.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.13 -3.97 90.58 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 118.775 -1.014 . . . . 0.0 113.878 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 mt -49.8 -49.9 46.96 Favored 'General case' 0 C--N 1.369 1.444 0 C-N-CA 123.796 0.838 . . . . 0.0 111.711 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -60.77 -16.0 35.59 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -102.92 -41.41 6.15 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.306 1.042 . . . . 0.0 112.443 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -83.09 -24.65 32.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.572 ' CG1' HD11 ' A' ' 10' ' ' LEU . 9.0 m -127.75 84.88 62.13 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.608 0.763 . . . . 0.0 110.384 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 -34.07 22.04 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.628 2.219 . . . . 0.0 111.712 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.28 -12.31 59.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.947 0.899 . . . . 0.0 112.536 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 52.7 tp -62.1 130.52 45.85 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 123.713 0.633 . . . . 0.0 110.545 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -136.68 -34.5 0.75 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.246 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.4 tp -128.48 131.23 48.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.618 0.767 . . . . 0.0 109.576 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.552 ' HB ' HG22 ' A' ' 131' ' ' THR . 61.3 mt -115.94 138.01 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.522 1.129 . . . . 0.0 108.422 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.579 ' SG ' HG11 ' A' ' 155' ' ' VAL . 83.8 m -120.57 116.95 26.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.861 0.864 . . . . 0.0 109.926 -174.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 95.7 m-85 -93.91 114.74 27.03 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -98.03 76.69 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.493 1.139 . . . . 0.0 108.851 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.19 135.61 2.71 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.265 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -52.1 -52.73 49.53 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.083 0.953 . . . . 0.0 112.382 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 28.8 mmmt -48.81 -37.44 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.039 0.936 . . . . 0.0 113.054 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.61 -34.46 77.04 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.283 0.633 . . . . 0.0 110.839 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.89 73.73 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 114.778 -1.101 . . . . 0.0 115.004 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -103.87 14.89 29.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.498 1.119 . . . . 0.0 111.097 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.405 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.7 tt0 -58.74 -49.27 94.33 Favored Pre-proline 0 CA--C 1.565 1.535 0 CA-C-O 118.049 -0.977 . . . . 0.0 112.244 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -57.84 -23.29 58.17 Favored 'Trans proline' 0 C--N 1.409 3.742 0 C-N-CA 122.579 2.186 . . . . 0.0 113.32 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.27 -40.02 95.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.73 0.812 . . . . 0.0 110.26 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 mt -95.22 -19.43 20.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.365 0.666 . . . . 0.0 111.248 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -63.05 -40.16 96.87 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.052 0.541 . . . . 0.0 109.911 169.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.28 -19.6 66.5 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.39 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.8 11.75 19.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.15 73.97 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -106.8 137.82 44.13 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.371 0.585 . . . . 0.0 110.248 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.77 134.72 53.73 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 167.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.552 HG22 ' HB ' ' A' ' 110' ' ' ILE . 14.7 p -137.6 152.03 48.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 123.707 0.803 . . . . 0.0 108.968 -174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -154.04 131.73 11.48 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.131 0.572 . . . . 0.0 109.8 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 17.2 t -90.31 93.85 4.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.52 149.53 95.55 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.203 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.11 152.66 81.54 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.619 1.546 . . . . 0.0 110.908 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.3 p -59.19 119.23 6.97 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.2 p -76.97 33.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.969 1.308 . . . . 0.0 113.994 -167.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.9 m -85.0 151.56 24.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.014 0.925 . . . . 0.0 109.204 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -20.34 58.76 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.792 0.682 . . . . 0.0 114.349 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.77 91.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.641 0.776 . . . . 0.0 111.103 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.27 -25.26 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.569 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -74.27 -25.58 59.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 123.753 0.658 . . . . 0.0 110.539 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -66.46 -27.38 67.76 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.173 0.511 . . . . 0.0 111.383 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.26 -42.41 8.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.666 0.786 . . . . 0.0 109.559 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -103.73 45.59 0.95 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.233 1.413 . . . . 0.0 110.25 -171.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -73.5 -27.47 61.4 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.333 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -86.57 -6.15 58.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.574 0.75 . . . . 0.0 111.804 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -86.14 -26.82 24.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.728 . . . . 0.0 110.399 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.79 -14.56 61.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.491 0.716 . . . . 0.0 112.171 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -34.63 77.7 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.39 0.676 . . . . 0.0 110.67 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 155' ' ' VAL . 4.1 pt-20 -72.16 -31.11 65.65 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 119.195 -0.431 . . . . 0.0 110.072 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -65.47 -38.01 88.51 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.58 -42.81 98.26 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.522 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.32 -9.67 58.83 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.77 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.579 HG11 ' SG ' ' A' ' 111' ' ' CYS . 75.7 t -83.87 -50.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 110.243 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.548 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 47.5 m-85 -103.2 0.82 32.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -77.36 -26.83 52.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 119.156 0.889 . . . . 0.0 112.298 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -74.95 -10.85 59.87 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.444 0.698 . . . . 0.0 111.326 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.512 HD11 HD12 ' A' ' 16' ' ' ILE . 95.0 mt -73.38 -10.99 60.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.7 0.8 . . . . 0.0 111.001 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -45.96 -39.51 9.02 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.824 1.249 . . . . 0.0 111.359 164.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.689 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.986 0.422 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 80' ' ' SER . 22.7 mm -77.02 125.26 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.369 0.668 . . . . 0.0 109.477 175.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.59 119.6 25.39 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 169.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -84.56 132.11 34.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.671 0.389 . . . . 0.0 111.013 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.98 -179.92 26.24 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.207 0.317 . . . . 0.0 112.585 167.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -108.87 135.0 20.16 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 122.355 -0.497 . . . . 0.0 109.726 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 157.72 33.12 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.531 2.154 . . . . 0.0 110.941 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.81 127.02 29.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.314 0.645 . . . . 0.0 112.071 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 62' ' ' LEU . 21.6 t -91.76 88.32 2.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.534 HD21 HG13 ' A' ' 104' ' ' VAL . 34.5 tp -140.14 155.73 46.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.393 -158.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.51 159.99 27.93 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.86 -14.5 63.01 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.107 0.479 . . . . 0.0 110.945 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -111.75 84.69 2.0 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.537 ' HB ' HG12 ' A' ' 104' ' ' VAL . 98.7 m -138.92 121.43 16.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.349 0.66 . . . . 0.0 110.003 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 3.4 tp10 -85.02 -41.45 15.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.551 1.54 . . . . 0.0 109.69 -173.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.447 HG12 ' HB3' ' A' ' 109' ' ' LEU . 34.2 mt -129.52 128.9 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.638 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD13 HD13 ' A' ' 10' ' ' LEU . 56.8 tp -109.89 124.91 52.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -95.67 118.26 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD23 ' HB3' ' A' ' 73' ' ' TRP . 75.0 mt -102.43 118.96 38.0 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.581 0.752 . . . . 0.0 109.557 174.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -75.66 -166.09 19.2 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 165.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -108.78 -73.57 0.68 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -147.68 119.98 4.65 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 161.03 46.97 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.444 2.096 . . . . 0.0 111.933 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.5 t -85.7 158.22 20.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.199 0.599 . . . . 0.0 110.399 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 5.1 p-10 -57.67 -29.97 65.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.363 0.665 . . . . 0.0 112.638 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.14 -38.17 67.88 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.381 0.673 . . . . 0.0 111.59 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 p -86.63 -38.01 17.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.042 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.2 mt -64.91 -38.76 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.921 0.889 . . . . 0.0 113.282 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 30.2 mmm180 -61.41 -30.78 70.77 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 0.0 110.375 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -97.29 -6.03 35.34 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.322 1.049 . . . . 0.0 112.082 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 62.1 22.39 13.08 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.813 1.245 . . . . 0.0 113.571 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.76 144.01 35.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.939 0.496 . . . . 0.0 110.453 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 96.9 m-85 -55.3 -46.91 76.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.326 1.05 . . . . 0.0 110.107 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.29 -13.11 4.47 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 114.003 -1.453 . . . . 0.0 113.582 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.72 -19.91 73.65 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 114.346 0.498 . . . . 0.0 114.346 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -110.77 135.16 20.78 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.27 -10.85 30.07 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.053 2.502 . . . . 0.0 113.018 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.14 -8.81 65.93 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.478 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 33' ' ' TYR . 4.0 m-20 -94.29 82.02 4.06 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.685 0.755 . . . . 0.0 109.434 173.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -99.62 4.76 45.87 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.349 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -42.46 -30.06 0.32 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.094 1.357 . . . . 0.0 112.44 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.447 ' CE3' ' HD3' ' A' ' 61' ' ' LYS . 63.7 m95 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.713 1.205 . . . . 0.0 113.103 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -77.89 -32.54 51.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.818 0.447 . . . . 0.0 111.1 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' A' ' 149' ' ' GLU . 43.3 mt -86.87 -47.78 8.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.798 0.839 . . . . 0.0 110.354 -170.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 -35.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.839 0.856 . . . . 0.0 109.035 172.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.34 -39.35 95.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.042 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.59 -36.32 83.4 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.947 0.899 . . . . 0.0 110.033 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.99 -53.64 46.86 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.728 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.4 pt -84.45 -7.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.032 0.533 . . . . 0.0 111.809 -175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.48 73.24 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.574 0.546 . . . . 0.0 112.713 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -133.57 106.66 7.54 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -63.31 97.11 0.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 110.667 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.2 mt -75.6 -19.45 59.24 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -70.03 -27.56 64.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.804 0.842 . . . . 0.0 112.369 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -95.62 -3.15 46.8 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.73 -0.606 . . . . 0.0 110.832 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtt -88.66 159.18 17.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.005 0.522 . . . . 0.0 111.207 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.46 151.22 47.13 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.524 0.73 . . . . 0.0 109.344 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.568 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 30.3 t80 -51.91 -49.78 62.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 47.1 mt-10 -63.6 -37.04 85.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.025 0.375 . . . . 0.0 111.08 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.81 -53.32 33.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HD3' ' CE3' ' A' ' 42' ' ' TRP . 17.3 ptpt -58.44 -32.13 68.41 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.307 0.643 . . . . 0.0 111.648 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 94.0 mt -66.83 -43.04 84.8 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.196 0.598 . . . . 0.0 111.318 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 33.8 mmtp -64.55 -31.61 72.9 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.005 0.431 . . . . 0.0 110.615 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.5 m -67.16 -39.41 86.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.145 173.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.97 -49.96 70.48 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.609 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 29.7 mmtp -57.28 -40.93 78.77 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 123.299 0.64 . . . . 0.0 110.546 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -60.82 -42.83 98.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.304 1.041 . . . . 0.0 111.11 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -87.52 5.46 39.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.773 0.829 . . . . 0.0 110.634 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 25.8 mmt180 64.93 39.74 5.69 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 125.232 1.413 . . . . 0.0 110.92 171.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.03 135.96 48.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 124.917 1.287 . . . . 0.0 108.793 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.39 162.19 14.42 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 173.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.68 142.36 50.76 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.404 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.5 t90 -162.98 -170.74 2.43 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -131.53 166.38 21.51 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 0.0 109.379 172.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 54.2 t -78.1 -38.88 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.97 123.97 48.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.543 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -71.61 -24.0 61.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 170.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.83 140.43 14.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -152.16 155.7 26.28 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB3' HD13 ' A' ' 2' ' ' ILE . 40.7 p -134.88 168.38 19.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.587 0.693 . . . . 0.0 109.998 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? -139.79 145.87 38.74 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -160.31 -65.56 0.07 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.212 0.46 . . . . 0.0 112.175 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.59 -113.44 0.3 Allowed Glycine 0 CA--C 1.531 1.076 0 O-C-N 123.24 0.337 . . . . 0.0 113.383 -173.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -71.06 -21.53 62.23 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.99 0.916 . . . . 0.0 110.618 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.497 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 11.3 mm100 -84.55 101.64 12.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.232 1.013 . . . . 0.0 108.356 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.19 -41.93 4.77 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.161 0.505 . . . . 0.0 110.157 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 m -111.79 -5.91 14.36 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.807 0.843 . . . . 0.0 110.002 174.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -102.4 154.78 18.75 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.444 1.098 . . . . 0.0 108.921 -174.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp -83.15 96.4 3.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 C-N-CA 123.466 0.706 . . . . 0.0 109.311 -172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.26 65.23 3.88 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.673 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.474 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 8.2 t70 -169.86 160.29 8.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.972 0.509 . . . . 0.0 110.005 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.04 7.19 10.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.648 0.779 . . . . 0.0 112.591 -168.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.56 99.79 12.58 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.119 0.872 . . . . 0.0 109.467 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.36 152.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 109.617 -171.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -72.65 149.02 44.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.514 0.726 . . . . 0.0 110.042 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.51 114.6 16.51 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.496 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 29.0 m-85 -100.37 -5.44 27.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.592 0.757 . . . . 0.0 111.869 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.3 p -75.92 -10.92 59.82 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.71 0.29 . . . . 0.0 110.299 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.8 -5.44 62.84 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.803 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' SD ' ' A' ' 103' ' ' MET . 40.3 mt -50.42 -33.42 20.75 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.191 0.596 . . . . 0.0 112.371 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -62.58 -33.49 75.07 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.061 0.544 . . . . 0.0 112.298 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.25 -47.71 8.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.807 0.843 . . . . 0.0 112.266 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.525 ' HG3' HG22 ' A' ' 104' ' ' VAL . 22.9 ptm -71.64 -32.34 67.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.546 0.739 . . . . 0.0 112.461 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' A' ' 14' ' ' THR . 0.7 OUTLIER -134.39 95.0 16.73 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.49 0.716 . . . . 0.0 110.438 177.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.8 -30.24 14.53 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.623 2.216 . . . . 0.0 111.778 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -87.3 -2.31 58.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.745 0.818 . . . . 0.0 111.758 -173.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 41.5 tp -56.09 104.34 0.13 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.798 0.839 . . . . 0.0 111.541 -175.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 18.7 ptp180 -101.87 -41.98 6.3 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.396 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.447 ' HB3' HG12 ' A' ' 16' ' ' ILE . 29.9 tp -130.73 139.57 50.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.675 0.39 . . . . 0.0 110.349 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.438 HG12 HD11 ' A' ' 107' ' ' LEU . 24.2 mt -112.75 115.99 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.486 ' SG ' HG11 ' A' ' 155' ' ' VAL . 83.6 m -98.71 118.74 36.12 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.456 0.703 . . . . 0.0 110.871 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -95.75 120.72 36.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.655 0.782 . . . . 0.0 110.227 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 95.2 m-20 -75.24 80.74 2.35 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.655 0.782 . . . . 0.0 109.815 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.93 162.94 21.23 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.474 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.5 ttp85 -64.31 -23.61 67.36 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.18 1.392 . . . . 0.0 113.056 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -74.37 -42.4 59.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.506 . . . . 0.0 110.057 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.26 75.89 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.696 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.08 -10.66 62.39 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.933 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -69.36 -20.08 63.84 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 117.402 0.601 . . . . 0.0 110.859 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -108.0 10.17 28.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.386 1.074 . . . . 0.0 111.086 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.2 tm-20 -67.58 -49.31 41.15 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.979 0.912 . . . . 0.0 111.666 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.08 -24.6 79.72 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.028 1.818 . . . . 0.0 112.685 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.92 -50.39 73.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.078 0.951 . . . . 0.0 111.287 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.31 -5.23 55.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -66.54 -31.93 72.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.038 0.535 . . . . 0.0 110.57 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.1 -17.59 70.07 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.69 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 63.7 mtt -88.07 2.17 52.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.847 0.859 . . . . 0.0 111.216 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.45 23.16 63.32 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.56 -0.291 . . . . 0.0 113.333 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -107.4 137.26 45.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 110.668 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 19.6 mm-40 -70.0 136.37 50.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.54 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 33.5 p -132.5 140.5 48.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.773 0.829 . . . . 0.0 109.504 -173.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 109' ' ' LEU . 53.7 tptt -143.02 132.04 22.99 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.389 1.076 . . . . 0.0 109.302 -173.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.7 t -97.99 122.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 155' ' ' VAL . 96.3 mt -102.34 144.61 28.95 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 171.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.8 150.7 75.82 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.042 2.495 . . . . 0.0 112.078 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.5 t -62.14 94.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.824 0.703 . . . . 0.0 109.728 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -87.97 21.17 2.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.5 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.1 t -66.08 156.02 35.1 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.293 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 142' ' ' ARG . . . -62.75 -22.17 63.89 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 123.18 0.419 . . . . 0.0 113.787 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.36 -28.91 70.02 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 111.708 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -126.37 19.12 7.52 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.686 0.795 . . . . 0.0 111.134 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 139' ' ' GLY . 8.9 ptm85 -66.98 -27.63 67.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.011 0.525 . . . . 0.0 111.364 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -55.01 -31.07 60.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.464 1.106 . . . . 0.0 111.384 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.86 -18.26 13.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.001 0.92 . . . . 0.0 110.184 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -97.73 8.31 44.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.617 0.767 . . . . 0.0 112.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -63.23 -64.0 1.03 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.512 0.725 . . . . 0.0 109.356 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.07 -7.47 23.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.16 0.984 . . . . 0.0 112.845 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -82.08 -12.84 58.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.393 0.677 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 44' ' ' LEU . 11.1 pt-20 -54.87 -25.41 28.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.523 0.729 . . . . 0.0 112.316 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -41.17 62.87 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.061 0.944 . . . . 0.0 112.209 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -72.92 -34.02 66.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -66.57 -33.4 75.58 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.987 0.915 . . . . 0.0 109.437 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.8 -42.19 98.69 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.482 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.93 87.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.897 -171.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.486 HG11 ' SG ' ' A' ' 111' ' ' CYS . 74.3 t -68.15 -30.83 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.929 -173.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.532 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 30.9 m-85 -118.15 -10.47 10.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.379 -0.825 . . . . 0.0 113.166 -173.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.0 -29.69 65.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.115 0.416 . . . . 0.0 111.107 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -81.05 -13.58 58.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.949 0.5 . . . . 0.0 111.2 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.42 HD11 HD12 ' A' ' 16' ' ' ILE . 62.7 mt -72.1 -41.06 67.71 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 122.829 0.452 . . . . 0.0 111.077 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -87.79 -53.73 4.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 CA--C 1.554 1.1 0 C-N-CA 125.313 1.445 . . . . 0.0 110.944 -179.396 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.6 mmm . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 mm -71.05 108.92 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HB3' HD13 ' A' ' 28' ' ' ILE . 50.4 mtmt -93.4 117.98 30.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.301 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -80.38 126.8 31.64 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 123.743 0.652 . . . . 0.0 110.868 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.77 156.22 53.41 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.409 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 7.3 m-85 -80.62 134.93 53.39 Favored Pre-proline 0 N--CA 1.473 0.68 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.581 -165.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.2 141.59 48.46 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.887 2.391 . . . . 0.0 111.265 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.12 128.61 37.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.571 0.748 . . . . 0.0 111.275 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 62' ' ' LEU . 24.1 t -95.65 79.77 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 174.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.484 HD11 ' CG1' ' A' ' 104' ' ' VAL . 38.5 tp -117.18 149.86 39.69 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.517 -163.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 37.9 t70 -128.02 164.21 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.803 0.841 . . . . 0.0 109.46 169.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.2 -26.66 67.88 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.348 1.059 . . . . 0.0 112.462 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.504 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 61.7 m-80 -95.32 16.17 17.46 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.262 0.625 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.468 ' HB ' HG12 ' A' ' 104' ' ' VAL . 78.1 m -72.05 104.76 3.67 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.637 0.732 . . . . 0.0 110.544 -175.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 108' ' ' ARG . 30.1 tt0 -88.32 -30.21 19.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.286 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 159' ' ' LEU . 39.4 mt -127.66 120.35 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.148 0.979 . . . . 0.0 108.624 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.3 tp -106.97 116.97 32.85 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 111' ' ' CYS . 55.1 mt -91.7 108.27 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 94.9 mt -99.67 108.17 20.46 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 109.071 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.05 177.34 8.66 Favored Glycine 0 N--CA 1.47 0.932 0 O-C-N 123.002 0.189 . . . . 0.0 113.053 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 89' ' ' ILE . 10.7 p -90.79 -72.42 0.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.476 HD22 ' HA3' ' A' ' 79' ' ' GLY . 19.0 tp -151.14 124.68 4.3 Favored Pre-proline 0 C--O 1.246 0.894 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 159.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.5 157.6 30.92 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.118 1.879 . . . . 0.0 111.67 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -62.95 150.29 42.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.605 0.762 . . . . 0.0 110.459 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 6.6 p-10 -58.88 -34.07 71.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.573 0.225 . . . . 0.0 110.452 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.1 -37.96 78.42 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.363 1.065 . . . . 0.0 111.947 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.6 p -81.23 -30.74 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 3' ' ' LYS . 73.1 mt -74.66 -16.0 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 110.882 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 79.1 mtt180 -64.38 -38.3 90.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.569 0.347 . . . . 0.0 110.569 170.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -86.87 -16.22 36.7 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.624 0.77 . . . . 0.0 109.899 177.31 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 53.9 23.83 4.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.075 1.35 . . . . 0.0 113.206 -172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -126.09 160.2 30.78 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.386 0.674 . . . . 0.0 109.561 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -72.43 -2.5 19.72 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.607 0.763 . . . . 0.0 110.746 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -70.13 -45.36 67.0 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.448 1.099 . . . . 0.0 108.294 174.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 31.76 -112.66 0.06 OUTLIER Glycine 0 C--N 1.374 2.678 0 O-C-N 125.086 1.491 . . . . 0.0 114.546 -172.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.65 129.59 23.99 Favored Pre-proline 0 C--O 1.246 0.886 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.06 9.3 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.968 2.446 . . . . 0.0 113.953 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.85 0.28 78.55 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 122.906 0.289 . . . . 0.0 112.566 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -84.08 130.15 34.87 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.88 3.4 29.93 Favored 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 123.852 0.861 . . . . 0.0 111.189 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -42.94 -56.42 3.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.683 0.793 . . . . 0.0 112.126 172.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 75.8 m95 -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.856 0.862 . . . . 0.0 111.897 -177.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -80.99 -42.07 21.74 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.442 1.097 . . . . 0.0 111.415 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.27 -47.54 34.35 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.113 0.965 . . . . 0.0 109.2 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.91 -37.68 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.264 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.8 96.1 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.67 0.606 . . . . 0.0 113.184 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.19 -41.36 85.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.438 0.695 . . . . 0.0 109.961 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -66.92 -40.61 87.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.358 1.063 . . . . 0.0 112.769 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 pt -89.44 -6.57 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.112 0.565 . . . . 0.0 111.645 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.86 22.99 78.61 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 113.178 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -139.87 96.47 3.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.99 109.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.881 0.872 . . . . 0.0 111.083 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.4 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 53.6 mt -75.21 -19.93 59.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.837 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -53.42 -54.53 35.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.724 0.809 . . . . 0.0 112.806 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -83.57 6.25 21.26 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.051 0.54 . . . . 0.0 112.427 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.573 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.1 mtt -88.81 139.6 30.29 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 154.64 40.04 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.499 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 36.9 t80 -48.37 -50.67 29.78 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 41.7 mt-10 -60.37 -38.85 85.18 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.609 0.364 . . . . 0.0 111.155 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -68.26 -53.46 24.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.94 0.896 . . . . 0.0 112.29 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 5.5 ptmt -59.89 -29.98 68.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 9' ' ' VAL . 86.4 mt -65.1 -42.56 93.91 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.252 0.621 . . . . 0.0 111.231 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 43.7 mmtm -59.49 -39.71 84.64 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.673 0.389 . . . . 0.0 110.192 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.3 m -66.96 -38.23 85.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.536 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 61' ' ' LYS . 79.1 mt -58.22 -59.25 5.61 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 111.231 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.413 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -71.61 -22.2 61.74 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.224 0.328 . . . . 0.0 111.842 -174.136 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -58.87 -43.68 90.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.64 0.776 . . . . 0.0 110.374 164.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -89.74 19.82 4.47 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.729 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.486 ' HB2' HD22 ' A' ' 159' ' ' LEU . 15.1 mmt180 70.28 27.15 4.16 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.289 1.036 . . . . 0.0 111.58 169.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.7 mt -109.63 123.79 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.055 0.942 . . . . 0.0 109.883 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.17 158.45 14.3 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.45 140.93 49.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.435 0.694 . . . . 0.0 109.252 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.475 ' HB3' HD23 ' A' ' 19' ' ' LEU . 8.8 t90 -165.03 -177.27 4.55 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -131.5 161.93 31.42 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 53.3 t -75.73 -48.34 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.72 128.78 41.65 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.258 0.551 . . . . 0.0 110.626 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.682 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 10.2 ptmm? -84.19 -17.56 39.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.733 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.68 134.88 11.26 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.055 0.455 . . . . 0.0 110.463 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -147.78 147.66 18.53 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.8 p -142.21 179.49 6.88 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 117.912 0.856 . . . . 0.0 111.774 -173.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -130.01 107.34 9.27 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 166.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -87.94 -173.2 4.17 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.26 53.77 3.51 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 117.956 0.344 . . . . 0.0 112.555 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -168.39 83.4 0.17 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 74.58 152.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.294 1.837 . . . . 0.0 112.273 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -96.48 61.39 1.96 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.11 0.964 . . . . 0.0 108.648 168.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.7 p -77.47 138.29 39.15 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.824 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -50.32 -57.92 6.81 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.178 0.991 . . . . 0.0 109.494 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 21' ' ' SER . 7.8 mt -111.09 88.12 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.483 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.92 60.47 0.63 Allowed Glycine 0 N--CA 1.465 0.58 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.568 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.2 t70 -174.72 160.05 2.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.161 0.984 . . . . 0.0 108.908 -172.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.37 18.15 13.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 111.302 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.682 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 11.8 tp10 -85.06 97.46 9.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.4 mt -106.26 150.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.653 1.181 . . . . 0.0 109.54 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -75.1 153.39 38.34 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.45 0.7 . . . . 0.0 109.847 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.42 135.55 35.65 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.445 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 45.7 m-85 -121.55 3.43 10.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.204 0.601 . . . . 0.0 111.435 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.2 p -67.77 -18.16 64.78 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.05 0.386 . . . . 0.0 111.674 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.65 -2.73 64.98 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 118.828 -0.985 . . . . 0.0 113.582 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 103' ' ' MET . 40.0 mt -52.0 -36.15 48.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 117.898 0.849 . . . . 0.0 112.958 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.477 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.7 mtpt -67.7 -17.55 64.61 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -98.46 -50.57 4.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.062 0.945 . . . . 0.0 111.772 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 100' ' ' LEU . 25.5 ptm -71.32 -35.14 71.12 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.218 0.607 . . . . 0.0 111.271 -173.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.1 m -126.01 84.61 60.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.708 0.803 . . . . 0.0 109.922 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.39 -29.04 5.11 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.857 2.371 . . . . 0.0 111.82 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 11.2 mmpt? -74.55 -12.69 60.53 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.241 0.616 . . . . 0.0 111.564 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -56.54 126.65 27.51 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.1 0.875 . . . . 0.0 111.179 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.556 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -134.98 -18.01 1.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.808 174.658 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.556 ' HB2' HH11 ' A' ' 108' ' ' ARG . 59.1 tp -143.66 131.92 21.99 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.192 0.597 . . . . 0.0 110.367 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 131' ' ' THR . 49.4 mt -107.37 143.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.205 1.002 . . . . 0.0 108.496 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.534 ' SG ' HG11 ' A' ' 155' ' ' VAL . 74.9 m -125.54 116.23 21.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.182 0.593 . . . . 0.0 110.13 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 96.7 m-85 -93.0 111.54 23.2 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.268 0.627 . . . . 0.0 110.394 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -84.53 93.24 8.3 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.15 127.37 3.18 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -50.53 -45.06 56.55 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.382 1.473 . . . . 0.0 113.417 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -58.13 -24.0 57.15 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . . . -73.16 -18.33 61.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.068 0.461 . . . . 0.0 111.075 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.43 -16.9 67.95 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.28 -0.873 . . . . 0.0 114.573 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.63 -26.68 67.93 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.919 0.488 . . . . 0.0 110.018 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.78 8.26 24.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.28 1.032 . . . . 0.0 111.334 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 38.7 tt0 -60.79 -51.08 82.1 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.169 169.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 16.2 Cg_exo -65.43 -17.42 57.6 Favored 'Trans proline' 0 C--N 1.401 3.321 0 C-N-CA 121.83 1.686 . . . . 0.0 113.252 -175.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.09 -41.63 99.44 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.558 1.143 . . . . 0.0 110.755 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.0 -4.98 55.99 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.171 -171.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.424 ' HG3' ' HA ' ' A' ' 122' ' ' PRO . 66.6 mtm180 -66.0 -31.29 72.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.036 0.534 . . . . 0.0 110.226 172.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.21 -1.46 69.41 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.084 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 56.6 mtt -103.87 11.92 35.03 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.459 1.104 . . . . 0.0 110.451 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.33 78.15 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.934 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.477 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 29.8 m-85 -110.72 141.16 44.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.263 0.625 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 13.4 mm-40 -68.43 133.68 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.422 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 41.5 p -126.3 136.91 53.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 109.172 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -141.62 130.97 23.63 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.146 0.978 . . . . 0.0 109.358 -176.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 61.0 t -101.81 130.4 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.406 0.682 . . . . 0.0 109.643 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -115.89 154.59 48.27 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.324 1.45 . . . . 0.0 108.202 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.5 170.1 14.36 Favored 'Trans proline' 0 C--N 1.367 1.539 0 C-N-CA 122.613 2.209 . . . . 0.0 112.187 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.3 m -60.86 127.44 31.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.9 m -77.63 27.68 0.17 Allowed 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.3 m -87.71 159.61 18.43 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.827 0.851 . . . . 0.0 110.369 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 142' ' ' ARG . . . -64.5 -20.78 66.1 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.411 0.925 . . . . 0.0 115.411 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.48 -43.17 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.02 0.528 . . . . 0.0 110.833 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -69.89 -39.81 76.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.516 0.326 . . . . 0.0 110.407 171.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.454 ' HB3' ' HA2' ' A' ' 139' ' ' GLY . 7.3 tmm_? -60.01 -34.11 72.9 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.218 1.007 . . . . 0.0 111.561 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.21 -23.69 37.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.386 1.074 . . . . 0.0 112.047 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -117.76 -23.13 7.69 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.026 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 53.4 m -84.41 39.69 0.74 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.758 1.223 . . . . 0.0 113.012 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 146' ' ' LYS . 71.6 mmtt -76.54 -53.89 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.582 0.353 . . . . 0.0 110.599 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -64.16 -23.14 67.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.386 0.274 . . . . 0.0 111.141 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 55.7 ttm-85 -84.5 -18.83 34.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.0 0.92 . . . . 0.0 110.475 -176.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.03 -27.53 63.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.568 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.0 t -60.36 -43.98 96.01 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.885 0.874 . . . . 0.0 111.585 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -75.9 -27.85 57.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -63.32 -44.89 93.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.73 -35.93 77.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.777 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.28 72.4 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.866 0.466 . . . . 0.0 110.369 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.534 HG11 ' SG ' ' A' ' 111' ' ' CYS . 53.1 t -68.12 -55.49 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.036 0.934 . . . . 0.0 111.083 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.402 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 56.0 m-85 -94.39 -5.73 45.77 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -71.91 -38.45 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 118.255 0.48 . . . . 0.0 110.917 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.46 ' HE1' HD11 ' A' ' 16' ' ' ILE . 7.5 p-80 -76.85 -7.14 54.94 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.148 0.579 . . . . 0.0 110.751 -174.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 16' ' ' ILE . 81.7 mt -74.17 -20.91 60.05 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.554 0.742 . . . . 0.0 111.967 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.78 -29.07 60.99 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 169.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 CA--C 1.561 1.366 0 C-N-CA 124.896 1.279 . . . . 0.0 111.753 171.05 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' SD ' ' NZ ' ' A' ' 3' ' ' LYS . 51.2 ttm . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.7 mm -76.0 124.1 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 65.7 mttm -107.53 133.72 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.258 1.023 . . . . 0.0 109.858 -174.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -101.5 135.92 42.2 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.541 0.736 . . . . 0.0 110.848 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.57 174.73 47.68 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.412 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.84 148.77 69.4 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 117.098 0.449 . . . . 0.0 111.228 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.88 163.6 9.16 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.584 2.189 . . . . 0.0 110.741 159.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.75 113.5 3.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.175 0.512 . . . . 0.0 110.585 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.515 HG11 HD22 ' A' ' 62' ' ' LEU . 13.8 t -87.08 74.71 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD21 HG13 ' A' ' 104' ' ' VAL . 28.0 tp -129.38 154.38 46.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -154.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -127.43 162.12 27.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.596 1.158 . . . . 0.0 110.073 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -66.29 -24.49 66.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.054 0.942 . . . . 0.0 112.243 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.452 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 48.7 m-80 -96.27 14.28 24.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.04 0.536 . . . . 0.0 111.056 -175.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -70.16 111.09 5.55 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.419 0.628 . . . . 0.0 110.834 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 24.8 tt0 -89.88 -35.66 15.5 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.038 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 63.1 mt -121.45 114.0 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.555 0.742 . . . . 0.0 109.205 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.453 HD13 HD13 ' A' ' 10' ' ' LEU . 61.1 tp -103.47 111.9 24.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.438 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.9 mt -92.62 116.43 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.1 mt -102.99 125.78 49.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.55 0.74 . . . . 0.0 109.82 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.17 -161.52 24.22 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 163.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 p -106.45 -64.3 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.2 tp -150.67 133.47 8.46 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.1 154.81 71.62 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.524 2.149 . . . . 0.0 110.663 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 27' ' ' SER . 24.7 t -60.77 150.58 32.1 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.907 0.483 . . . . 0.0 109.733 177.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 7.7 p-10 -59.06 -37.31 76.74 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.61 -30.36 68.08 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.357 0.663 . . . . 0.0 110.493 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 24' ' ' SER . 31.4 t -67.07 -45.93 75.84 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.846 0.858 . . . . 0.0 109.693 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.82 -39.34 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.582 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 2.8 mmp_? -61.91 -37.85 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.914 0.486 . . . . 0.0 112.163 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.32 -7.86 24.03 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.023 0.529 . . . . 0.0 111.836 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 67.63 18.47 9.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.442 1.097 . . . . 0.0 113.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -113.67 127.47 56.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.772 0.829 . . . . 0.0 109.056 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.504 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 84.4 m-85 -59.77 -59.77 4.91 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -55.47 -27.13 46.4 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.619 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.36 -21.13 66.17 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 123.065 0.228 . . . . 0.0 112.863 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 4.3 t30 -86.92 108.33 18.07 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.474 1.11 . . . . 0.0 108.406 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.33 142.37 78.94 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.463 2.776 . . . . 0.0 112.412 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.23 -19.3 40.48 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.376 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 36' ' ' ASN . 95.4 m-20 -68.87 98.98 0.99 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.515 0.674 . . . . 0.0 109.572 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -86.39 -6.89 58.82 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 126.538 1.935 . . . . 0.0 110.952 -170.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.457 ' HE1' ' HB3' ' A' ' 113' ' ' ASN . 65.1 m-85 -41.63 -43.83 2.9 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 125.221 1.408 . . . . 0.0 112.681 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.504 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 74.6 m95 -71.5 -24.13 61.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.186 0.994 . . . . 0.0 112.065 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -81.48 -36.36 29.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.873 0.869 . . . . 0.0 110.902 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.09 -45.63 17.91 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.865 0.466 . . . . 0.0 111.385 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 49' ' ' ILE . 59.2 t -69.03 -36.65 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.49 -32.67 75.48 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.889 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.15 -42.91 79.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.452 0.701 . . . . 0.0 110.053 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -67.75 -38.02 82.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.298 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 45' ' ' VAL . 23.7 pt -96.68 -11.73 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.841 0.456 . . . . 0.0 111.137 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.66 32.42 61.64 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.438 0.461 . . . . 0.0 113.579 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -133.35 111.92 11.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -66.99 89.68 0.17 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.939 0.876 . . . . 0.0 111.579 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.37 -30.98 69.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.09 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -73.41 -10.69 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.924 -173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -98.93 -9.17 24.48 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.947 -0.471 . . . . 0.0 111.68 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.479 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 60.0 mtt -87.44 159.28 18.74 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.228 0.611 . . . . 0.0 110.76 -172.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 159.4 31.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.535 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 17.0 t80 -52.12 -54.48 29.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.43 -36.7 83.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.644 0.378 . . . . 0.0 111.214 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -67.91 -51.77 44.0 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.852 0.861 . . . . 0.0 111.654 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 8.9 ptpp? -61.32 -34.43 75.23 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.184 0.303 . . . . 0.0 111.096 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 78.0 mt -65.18 -44.18 89.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 122.657 0.383 . . . . 0.0 111.039 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -55.79 -43.15 76.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.988 0.515 . . . . 0.0 110.624 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.6 m -68.4 -41.8 79.94 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.817 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 62' ' ' LEU . 78.5 mt -56.13 -62.33 1.78 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.719 0.808 . . . . 0.0 110.591 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -23.55 64.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.772 0.67 . . . . 0.0 111.752 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -63.53 -39.14 93.64 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.987 0.515 . . . . 0.0 111.024 167.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.455 ' O ' HD13 ' A' ' 159' ' ' LEU . 60.7 m-80 -85.61 14.92 5.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.042 0.537 . . . . 0.0 110.111 173.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 14.4 mmt-85 69.37 25.17 5.59 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.298 1.439 . . . . 0.0 111.032 173.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.19 118.77 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.652 0.781 . . . . 0.0 109.352 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.52 161.28 15.33 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.35 145.89 48.38 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.9 -170.29 1.72 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -130.65 163.44 27.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.583 0.753 . . . . 0.0 110.117 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 58.4 t -79.43 -54.49 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 0.0 109.89 172.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.12 128.62 35.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -78.31 -35.81 47.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.337 0.655 . . . . 0.0 110.209 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -144.01 140.82 29.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 110.88 178.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.35 160.41 33.43 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.592 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.484 ' O ' ' HA3' ' A' ' 90' ' ' GLY . 58.8 p -133.79 124.4 26.51 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.922 0.489 . . . . 0.0 109.83 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -74.43 97.65 3.12 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -102.69 144.51 30.97 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.485 1.114 . . . . 0.0 108.71 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.92 69.58 2.88 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.9 t -156.16 167.9 28.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.929 1.292 . . . . 0.0 108.301 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.33 80.14 3.83 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -113.84 116.81 29.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.801 0.84 . . . . 0.0 109.078 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -111.45 23.33 14.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.889 0.875 . . . . 0.0 110.134 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -105.78 -64.81 1.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.619 0.768 . . . . 0.0 109.39 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.9 tp 169.68 -23.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 126.115 1.766 . . . . 0.0 109.609 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . 117.53 9.43 10.24 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.232 -175.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -171.74 177.17 3.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.829 1.251 . . . . 0.0 108.185 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.6 12.4 11.48 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.163 0.585 . . . . 0.0 111.864 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 9.1 tp10 -86.73 119.13 26.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.8 mt -124.77 138.97 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.759 1.223 . . . . 0.0 108.731 -173.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -60.76 137.38 58.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.371 0.668 . . . . 0.0 109.677 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -86.07 127.31 34.65 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.929 0.492 . . . . 0.0 109.759 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.416 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 67.0 m-85 -112.82 7.77 18.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.452 0.701 . . . . 0.0 111.35 -176.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.3 m -63.52 -26.5 68.74 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.838 0.455 . . . . 0.0 111.648 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -3.04 89.36 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.706 -1.052 . . . . 0.0 115.044 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.476 HD23 ' SD ' ' A' ' 103' ' ' MET . 29.5 mt -49.02 -38.57 23.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 101' ' ' LYS . 10.0 mmpt? -55.78 -39.38 71.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.429 0.558 . . . . 0.0 111.197 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -85.06 -50.52 7.37 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.236 1.015 . . . . 0.0 112.267 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.549 ' HG3' HG22 ' A' ' 104' ' ' VAL . 24.1 ptm -68.58 -35.26 77.12 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.494 0.718 . . . . 0.0 111.874 -175.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 10' ' ' LEU . 1.1 m -132.74 94.55 21.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.104 0.562 . . . . 0.0 110.871 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.48 -30.99 4.7 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.55 2.167 . . . . 0.0 111.742 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.4 mmmm -88.3 -7.35 56.88 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.167 -174.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.3 tp -58.53 107.72 0.54 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.48 0.657 . . . . 0.0 111.497 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -96.52 -51.43 4.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.335 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.6 tp -126.13 132.53 51.84 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.324 0.65 . . . . 0.0 110.775 -171.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.9 mt -102.95 144.26 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 134' ' ' LEU . 80.1 m -124.9 113.31 17.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.807 0.443 . . . . 0.0 110.701 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.61 111.12 22.6 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.457 ' HB3' ' HE1' ' A' ' 41' ' ' PHE . 86.7 m-20 -91.39 79.49 5.59 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.4 153.39 5.86 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.343 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -62.58 -45.27 93.67 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.17 0.588 . . . . 0.0 110.148 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -31.13 69.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.809 0.843 . . . . 0.0 112.988 172.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.53 -39.57 62.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.116 0.484 . . . . 0.0 110.016 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.68 -11.14 68.56 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.392 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.31 -38.4 65.91 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.908 0.883 . . . . 0.0 112.351 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -107.92 25.3 11.73 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.543 0.737 . . . . 0.0 111.177 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 70.6 tt0 -55.78 -53.09 66.67 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.564 165.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.44 -22.22 73.77 Favored 'Trans proline' 0 C--N 1.403 3.426 0 C-N-CA 122.313 2.009 . . . . 0.0 112.906 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.79 -47.63 82.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.213 0.605 . . . . 0.0 109.661 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.97 -20.02 29.53 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.363 -174.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 34.1 mtp85 -66.65 -42.2 87.03 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.45 -21.07 68.36 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.091 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 63.9 mtt -79.04 -19.35 51.66 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.787 0.435 . . . . 0.0 111.441 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.51 30.59 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.523 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 142.94 27.5 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.215 0.507 . . . . 0.0 110.824 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -65.72 135.13 54.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 170.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 54.6 p -123.57 139.51 53.93 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.257 0.623 . . . . 0.0 110.161 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HB2' HD11 ' A' ' 109' ' ' LEU . 53.1 tptt -134.12 116.75 15.79 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 107.89 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.6 110.63 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 111' ' ' CYS . 93.6 mt -95.71 150.92 38.06 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.226 1.411 . . . . 0.0 109.124 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.45 130.74 14.19 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.557 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.0 p -54.46 107.91 0.33 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.728 0.811 . . . . 0.0 110.974 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.5 m -79.59 50.28 1.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.214 1.006 . . . . 0.0 112.05 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -73.29 160.45 31.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 109.804 163.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.74 59.73 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 114.758 0.663 . . . . 0.0 114.758 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.0 -37.83 78.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.795 0.438 . . . . 0.0 111.405 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -70.65 -20.06 62.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.481 0.712 . . . . 0.0 111.646 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 142' ' ' ARG . 12.5 tpp180 -57.22 -29.04 63.42 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.082 0.553 . . . . 0.0 110.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -53.27 -36.53 61.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.41 1.084 . . . . 0.0 111.084 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -107.33 -22.88 12.42 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.674 1.189 . . . . 0.0 111.697 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 8.2 t -87.47 13.29 10.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -165.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -72.79 -61.12 1.92 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.415 0.286 . . . . 0.0 110.478 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -24.24 64.13 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.123 0.569 . . . . 0.0 112.052 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 0.7 OUTLIER -74.99 -22.24 58.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.713 0.805 . . . . 0.0 111.225 -174.369 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.61 -23.19 49.64 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 t -63.84 -41.32 97.84 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.798 0.839 . . . . 0.0 111.166 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.4 pt-20 -70.78 -35.64 72.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -65.76 -41.85 91.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.099 0.559 . . . . 0.0 109.995 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -66.86 -34.55 78.04 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.985 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.05 -9.73 59.27 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.982 0.913 . . . . 0.0 111.887 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 151' ' ' GLU . 37.9 t -90.29 -43.3 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.801 0.84 . . . . 0.0 111.171 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.561 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 80.0 m-85 -102.81 4.83 38.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -168.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -86.62 -14.4 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.198 0.908 . . . . 0.0 112.384 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -84.29 -4.9 59.15 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 118.205 0.457 . . . . 0.0 111.669 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 68' ' ' ASN . 71.5 mt -61.27 -10.01 6.15 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.98 0.912 . . . . 0.0 113.113 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -51.36 -41.21 60.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.865 0.866 . . . . 0.0 111.538 164.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 C--O 1.255 1.378 0 C-N-CA 123.991 0.917 . . . . 0.0 109.015 173.622 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.477 0.909 0 CA-C-O 120.846 0.355 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 78' ' ' ALA . 47.3 mm -82.34 123.39 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.773 0.829 . . . . 0.0 110.387 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.7 125.8 45.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.324 1.05 . . . . 0.0 108.255 171.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -97.14 141.27 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.039 0.447 . . . . 0.0 111.835 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.4 171.14 51.77 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.977 163.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -107.95 125.48 31.99 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.514 1.157 . . . . 0.0 110.211 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.48 155.16 0.47 Allowed 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 124.178 3.252 . . . . 0.0 113.881 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.46 122.46 14.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.876 0.87 . . . . 0.0 113.042 -167.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.595 HG11 HD22 ' A' ' 62' ' ' LEU . 25.3 t -94.34 81.84 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.528 HD11 ' CG1' ' A' ' 104' ' ' VAL . 28.7 tp -123.35 153.35 40.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -159.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 9.8 t70 -124.88 157.46 35.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.411 170.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.66 -18.62 65.01 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.097 0.559 . . . . 0.0 112.125 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 52.0 m-80 -97.04 13.64 28.35 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.914 0.886 . . . . 0.0 111.628 -176.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.428 ' HB ' HG12 ' A' ' 104' ' ' VAL . 83.0 m -77.39 116.22 17.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.922 0.489 . . . . 0.0 111.432 -171.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -99.4 -26.2 14.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.459 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.479 HD12 HD21 ' A' ' 159' ' ' LEU . 42.8 mt -121.45 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -104.16 111.09 23.55 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 111' ' ' CYS . 47.3 mt -93.62 113.23 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.8 mt -103.72 110.99 23.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.885 0.874 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.36 175.44 25.26 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.018 -0.433 . . . . 0.0 112.018 169.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -87.14 -77.57 0.33 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -140.99 123.35 9.52 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -55.14 156.74 15.47 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.745 2.297 . . . . 0.0 112.445 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 28' ' ' ILE . 42.2 t -60.38 145.26 48.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.102 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.46 -39.85 70.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.239 0.616 . . . . 0.0 110.782 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.83 -23.71 62.4 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.355 1.062 . . . . 0.0 111.437 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.9 m -77.68 -37.4 49.81 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 24' ' ' SER . 43.6 mt -74.31 -19.25 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.599 0.76 . . . . 0.0 110.992 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.72 -33.26 75.54 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 120.953 0.406 . . . . 0.0 110.357 172.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.88 -8.43 30.88 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.203 1.001 . . . . 0.0 111.183 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 60.14 30.28 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 111.366 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -146.51 132.91 19.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.925 0.89 . . . . 0.0 110.148 -168.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -64.4 -44.96 89.64 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.384 0.612 . . . . 0.0 109.753 173.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.01 -4.42 7.13 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.227 172.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.96 -37.2 53.08 Favored Glycine 0 C--N 1.361 1.958 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -103.23 102.09 26.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.0 0.92 . . . . 0.0 108.873 165.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.17 -10.44 28.93 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.969 2.446 . . . . 0.0 112.61 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.58 -9.66 86.08 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -71.51 117.89 13.64 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 5.2 m-20 -75.27 -4.17 37.51 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.647 0.779 . . . . 0.0 112.139 -167.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -43.94 -44.84 7.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.104 1.762 . . . . 0.0 112.847 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.44 ' HZ3' HD11 ' A' ' 65' ' ' LEU . 54.4 m95 -72.25 -22.35 61.24 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.443 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -86.91 -32.81 19.98 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 124.169 0.988 . . . . 0.0 111.697 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 96.9 mt -75.9 -53.95 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.391 0.676 . . . . 0.0 110.016 -174.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.38 -36.05 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.402 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.1 -36.98 91.3 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.024 0.828 . . . . 0.0 112.678 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -67.68 -41.88 83.0 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.596 0.759 . . . . 0.0 109.93 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.01 -37.19 86.19 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.652 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 pt -96.52 -11.72 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.097 0.559 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.97 -59.26 2.8 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -50.24 111.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.367 1.067 . . . . 0.0 112.966 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -70.64 116.87 11.46 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.53 -30.75 57.26 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.428 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -60.24 -52.38 65.55 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -164.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.89 -22.17 63.25 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.361 0.413 . . . . 0.0 111.708 -170.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.1 mtt -60.25 152.02 25.9 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.313 0.645 . . . . 0.0 110.823 174.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.38 152.77 44.38 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 52.4 t80 -46.22 -52.27 12.75 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 0.0 112.589 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.88 -34.81 78.17 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.92 0.488 . . . . 0.0 111.704 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -73.38 -47.33 42.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.842 0.457 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -32.27 72.9 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.853 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.595 HD22 HG11 ' A' ' 9' ' ' VAL . 42.1 mt -63.24 -49.07 75.61 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.437 0.461 . . . . 0.0 110.377 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -55.54 -38.89 69.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 123.803 0.689 . . . . 0.0 111.313 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -63.78 -46.34 85.66 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.862 0.726 . . . . 0.0 109.625 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD11 ' HZ3' ' A' ' 42' ' ' TRP . 95.4 mt -59.79 -43.28 94.51 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.738 0.815 . . . . 0.0 110.889 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.564 ' HD2' ' HB2' ' A' ' 11' ' ' ASP . 28.6 mmtp -61.32 -38.09 85.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.865 0.466 . . . . 0.0 110.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -74.86 -23.11 58.37 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.228 1.011 . . . . 0.0 110.966 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.427 ' O ' HD13 ' A' ' 159' ' ' LEU . 18.5 m120 -88.74 0.04 56.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.612 0.765 . . . . 0.0 110.256 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 65.34 32.92 9.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.777 1.231 . . . . 0.0 110.67 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.76 136.64 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 0.0 109.405 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.72 154.32 16.68 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.3 mt -120.13 129.26 54.07 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.483 0.642 . . . . 0.0 109.81 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -155.97 -168.88 2.9 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -133.25 170.38 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.206 1.003 . . . . 0.0 109.306 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.54 -61.2 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.401 ' CD1' HG21 ' A' ' 89' ' ' ILE . 70.9 m-85 -74.18 102.07 4.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -65.08 -28.89 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.663 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -149.15 141.79 24.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.957 172.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.585 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.44 134.39 6.05 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.328 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB2' HD13 ' A' ' 2' ' ' ILE . 39.8 t -112.62 169.91 8.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.756 0.822 . . . . 0.0 109.275 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -134.39 119.68 18.9 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.55 -27.72 25.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.393 0.677 . . . . 0.0 111.929 -172.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.78 -161.48 11.12 Favored Glycine 0 C--N 1.342 0.861 0 O-C-N 123.27 0.356 . . . . 0.0 112.697 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.4 m -80.98 -34.62 32.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.558 0.743 . . . . 0.0 110.48 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -42.74 35.74 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.14 71.5 10.88 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.349 0.66 . . . . 0.0 109.387 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.4 m -111.63 6.13 19.76 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.67 0.788 . . . . 0.0 111.509 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -86.89 -159.21 0.48 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.935 0.894 . . . . 0.0 108.76 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' A' ' 76' ' ' PHE . 3.4 mp -82.05 83.24 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 171.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.15 61.68 4.11 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.116 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.585 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 11.8 t70 -176.04 153.44 1.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.445 1.098 . . . . 0.0 108.218 -172.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -125.27 26.37 6.9 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 8.3 tp10 -80.3 102.82 9.76 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.5 149.9 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.047 0.939 . . . . 0.0 108.699 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.453 ' OD1' ' HD2' ' A' ' 77' ' ' LYS . 88.8 m-20 -66.7 141.03 57.91 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.794 0.684 . . . . 0.0 110.117 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.79 116.63 26.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -101.45 18.48 20.03 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.167 0.587 . . . . 0.0 112.087 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.4 p -69.61 -18.34 63.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.37 -3.34 63.19 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.361 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.95 -38.5 36.85 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.982 0.891 . . . . 0.0 113.139 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.75 -24.27 67.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.842 0.457 . . . . 0.0 111.571 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -93.56 -50.28 5.49 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.691 0.797 . . . . 0.0 111.835 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.557 ' HG3' HG22 ' A' ' 104' ' ' VAL . 24.1 ptm -70.86 -38.74 73.16 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.575 0.75 . . . . 0.0 111.942 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -122.57 89.1 49.7 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 123.375 0.67 . . . . 0.0 110.262 178.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.24 -29.5 17.14 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.826 2.351 . . . . 0.0 111.997 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.8 mmpt? -82.7 -8.65 59.58 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.832 0.853 . . . . 0.0 112.708 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.575 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.0 tp -57.54 127.95 34.61 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.604 0.565 . . . . 0.0 111.698 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -134.76 -37.48 0.82 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.639 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 26.0 tp -129.57 125.34 35.99 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.054 0.542 . . . . 0.0 110.057 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.518 ' HB ' HG22 ' A' ' 131' ' ' THR . 57.0 mt -107.2 110.82 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.524 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.9 m -96.69 115.23 27.07 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 122.612 0.365 . . . . 0.0 110.606 -175.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.11 123.03 33.0 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.403 0.681 . . . . 0.0 109.726 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -90.99 99.27 12.34 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.05 138.88 8.13 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.447 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -52.71 -42.1 64.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.753 1.221 . . . . 0.0 112.19 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HB3' ' NZ ' ' A' ' 116' ' ' LYS . 5.1 mtpm? -59.8 -30.65 69.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.59 -38.97 64.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.286 0.565 . . . . 0.0 109.943 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.77 -9.45 62.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.707 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.12 -26.29 67.57 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.562 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -102.55 14.03 33.0 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.034 1.334 . . . . 0.0 111.373 -176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.4 ' HG3' ' OG1' ' A' ' 131' ' ' THR . 41.3 tt0 -58.5 -53.19 68.7 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.242 172.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.65 -18.09 53.36 Favored 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 121.742 1.628 . . . . 0.0 113.15 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 tp -66.93 -46.35 75.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.501 0.72 . . . . 0.0 109.705 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.92 -18.98 31.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.168 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -69.2 -33.0 72.66 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.124 0.569 . . . . 0.0 109.966 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.68 -22.92 64.63 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.741 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 49.3 mtt -90.21 10.7 23.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.056 0.942 . . . . 0.0 111.401 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.3 25.56 75.22 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.899 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -109.56 132.65 53.94 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.282 0.633 . . . . 0.0 110.82 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -70.2 142.5 52.41 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.518 HG22 ' HB ' ' A' ' 110' ' ' ILE . 32.2 p -133.65 150.67 51.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.524 1.13 . . . . 0.0 110.159 -173.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -142.12 119.22 11.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.704 1.201 . . . . 0.0 108.866 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.9 t -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.642 0.735 . . . . 0.0 109.765 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.86 154.39 94.29 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.711 1.204 . . . . 0.0 110.287 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.96 165.51 27.87 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.277 1.985 . . . . 0.0 112.191 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.1 t -67.35 143.74 56.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.0 t -74.02 5.92 3.85 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.125 0.97 . . . . 0.0 113.513 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -64.26 140.35 58.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.139 0.576 . . . . 0.0 110.371 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.95 -28.98 73.56 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.212 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.04 98.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.555 0.742 . . . . 0.0 110.29 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -65.93 -22.9 66.52 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.003 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.519 HH12 ' HB3' ' A' ' 149' ' ' GLU . 18.7 mmm180 -81.99 -16.74 49.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.644 0.778 . . . . 0.0 111.504 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -67.0 -36.58 82.47 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -91.54 -34.14 14.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.659 0.783 . . . . 0.0 110.397 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.1 m -101.43 29.76 4.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.509 1.123 . . . . 0.0 112.038 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.31 -62.02 2.07 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.3 -4.93 32.62 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.252 1.021 . . . . 0.0 112.464 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 64.6 mtm-85 -88.91 -8.14 54.77 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.631 0.773 . . . . 0.0 111.84 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.519 ' HB3' HH12 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -59.64 -23.99 63.5 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.589 0.632 . . . . 0.0 110.665 172.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -61.19 -32.24 72.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.851 1.26 . . . . 0.0 111.481 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 155' ' ' VAL . 7.5 pt-20 -74.34 -27.03 60.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -70.82 -37.91 73.23 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.93 -36.71 84.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.618 0.767 . . . . 0.0 110.168 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.6 -12.55 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.342 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 151' ' ' GLU . 41.6 t -95.1 -44.93 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.435 1.094 . . . . 0.0 111.157 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.44 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 56.3 m-85 -99.37 3.12 45.83 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -69.75 -34.6 74.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.459 ' HE1' HD11 ' A' ' 16' ' ' ILE . 11.5 p-80 -82.1 -9.73 59.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 16' ' ' ILE . 99.3 mt -51.21 -61.79 2.02 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 124.164 0.915 . . . . 0.0 111.979 -168.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.85 -60.8 2.24 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 172.502 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 80' ' ' SER . 34.2 mm -65.46 101.02 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.1 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 22' ' ' LEU . 33.5 mtmm -95.51 118.79 32.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.744 -1.116 . . . . 0.0 107.989 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -87.82 134.19 33.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.203 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.18 171.8 48.16 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.953 170.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -98.26 143.85 27.02 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 117.353 0.576 . . . . 0.0 110.031 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.78 150.11 79.2 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.219 1.946 . . . . 0.0 110.449 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -61.96 143.32 56.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 112.325 -174.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.519 HG12 ' HE2' ' A' ' 66' ' ' LYS . 11.8 t -101.21 61.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 168.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.518 HD11 ' CG1' ' A' ' 104' ' ' VAL . 42.3 tp -98.18 146.36 25.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.162 -165.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.06 159.73 29.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.85 -19.32 63.45 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.773 0.429 . . . . 0.0 111.696 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -95.49 6.99 47.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.642 0.377 . . . . 0.0 111.792 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 m -66.84 114.58 5.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.227 0.611 . . . . 0.0 111.223 -171.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 40.6 tt0 -94.23 -35.44 12.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.384 1.474 . . . . 0.0 110.223 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.9 mt -121.42 118.47 56.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.431 HD13 HD13 ' A' ' 10' ' ' LEU . 63.7 tp -105.01 116.5 32.05 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.524 HG21 ' HE1' ' A' ' 41' ' ' PHE . 52.6 mt -92.84 107.63 19.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 73' ' ' TRP . 96.0 mt -99.24 108.45 21.02 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.065 0.946 . . . . 0.0 109.152 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.83 179.66 12.78 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 123.281 0.363 . . . . 0.0 112.26 170.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 m -86.89 -69.04 0.7 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.486 HD22 ' HA3' ' A' ' 79' ' ' GLY . 27.6 tp -146.21 131.81 9.31 Favored Pre-proline 0 C--O 1.246 0.917 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 163.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 22' ' ' LEU . 18.4 Cg_endo -56.96 159.28 15.03 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.087 1.858 . . . . 0.0 112.075 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 m -60.37 136.94 58.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.893 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.66 -29.09 58.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.682 0.393 . . . . 0.0 110.927 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.46 -63.1 1.27 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.934 1.293 . . . . 0.0 110.549 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' GLN . 51.0 p -57.24 -28.2 62.73 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.626 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.8 mt -73.28 -28.02 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -59.9 -29.13 68.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.888 0.475 . . . . 0.0 111.095 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 67.0 mttm -111.69 -0.55 15.98 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.115 0.966 . . . . 0.0 111.318 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 51.09 34.16 10.48 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.416 1.486 . . . . 0.0 113.832 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 27' ' ' SER . 13.3 pt20 -138.67 151.64 47.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.706 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -70.27 -2.51 13.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.836 0.854 . . . . 0.0 111.433 174.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -103.11 -4.85 23.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.428 1.091 . . . . 0.0 109.843 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -72.91 -25.43 73.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.996 0.358 . . . . 0.0 113.996 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.83 103.27 46.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.254 0.622 . . . . 0.0 109.662 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.03 -19.71 29.76 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.724 2.283 . . . . 0.0 111.791 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.36 31.07 5.61 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.655 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -115.5 116.33 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.783 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 37.0 m-20 -85.11 3.51 38.61 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.658 0.783 . . . . 0.0 112.299 -175.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.524 ' HE1' HG21 ' A' ' 18' ' ' ILE . 86.0 t80 -40.95 -51.08 3.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.282 1.033 . . . . 0.0 112.899 172.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.419 ' HE3' ' HB3' ' A' ' 53' ' ' LEU . 86.1 m95 -71.66 -23.21 61.63 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.236 -175.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.783 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 2.9 mpt_? -79.12 -42.63 25.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.957 0.903 . . . . 0.0 110.219 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.14 -49.78 16.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.957 0.903 . . . . 0.0 110.649 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.1 -31.54 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.329 0.652 . . . . 0.0 109.655 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.03 -40.54 88.58 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.485 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -62.72 -39.68 94.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.833 0.853 . . . . 0.0 109.753 172.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.63 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -72.62 -30.06 64.01 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.892 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.5 pt -102.75 -4.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.58 38.59 86.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.314 0.384 . . . . 0.0 113.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -137.15 136.26 38.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.111 1.364 . . . . 0.0 108.265 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 56' ' ' MET . 14.8 p-10 -74.38 87.07 2.02 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.307 0.575 . . . . 0.0 109.866 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 92.0 mt -68.14 -51.85 41.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -46.87 -39.34 11.91 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.528 1.531 . . . . 0.0 113.258 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.45 -33.15 48.62 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.434 1.093 . . . . 0.0 111.343 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.53 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.0 mtt -66.01 151.58 46.51 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 123.103 0.561 . . . . 0.0 111.842 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.15 157.39 37.69 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.491 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.502 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 21.2 t80 -43.63 -56.43 3.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.968 1.307 . . . . 0.0 113.862 -171.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.07 -31.49 72.74 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.923 0.489 . . . . 0.0 111.668 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -72.53 -52.15 16.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 0.0 111.439 -175.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 6.4 ptmt -61.54 -32.6 72.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.528 0.731 . . . . 0.0 112.491 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 89.8 mt -64.84 -42.99 94.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.438 0.695 . . . . 0.0 111.504 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.25 -40.75 95.2 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.936 0.495 . . . . 0.0 110.853 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.8 m -60.8 -41.23 95.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.105 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 90.4 mt -61.35 -46.93 88.16 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.828 0.705 . . . . 0.0 110.782 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.519 ' HE2' HG12 ' A' ' 9' ' ' VAL . 23.0 mttm -65.77 -28.0 68.7 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.016 0.926 . . . . 0.0 112.617 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -57.54 -43.28 84.26 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.319 0.581 . . . . 0.0 111.061 168.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -90.69 11.41 22.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.417 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.508 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER 66.66 39.28 3.7 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.09 1.356 . . . . 0.0 111.26 174.251 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 69.1 mt -109.72 131.56 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.01 152.83 17.15 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 171.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.5 mt -116.98 137.58 52.12 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.509 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.6 t90 -165.6 -169.1 1.47 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -140.59 171.92 13.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.741 0.816 . . . . 0.0 110.852 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.571 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 78.9 t -88.15 -56.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 123.841 0.857 . . . . 0.0 109.616 176.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.67 104.37 16.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.113 0.565 . . . . 0.0 110.22 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.736 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.6 ptmt -71.34 -14.74 62.29 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.758 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -149.89 123.91 9.39 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.486 ' HA3' HD22 ' A' ' 22' ' ' LEU . . . -128.7 125.8 5.09 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 2' ' ' ILE . 30.3 t -149.2 168.48 23.13 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 110.315 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 85' ' ' GLN . 30.0 ptt180 -141.55 162.83 34.54 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.66 149.62 23.93 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.375 0.422 . . . . 0.0 110.937 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.71 -91.71 1.58 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.299 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 t -157.13 51.32 0.47 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.265 1.026 . . . . 0.0 108.552 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 81' ' ' ARG . 9.1 tp-100 -89.43 130.68 35.74 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.966 -175.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.08 -39.22 50.49 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.757 0.823 . . . . 0.0 109.948 176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.0 t -67.76 111.09 4.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.844 0.715 . . . . 0.0 109.398 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -65.64 -38.78 90.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.984 0.913 . . . . 0.0 110.029 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mt -97.6 85.79 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.93 -59.05 1.82 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.89 142.51 1.32 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.097 1.359 . . . . 0.0 114.124 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -111.01 24.27 13.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.167 -161.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.736 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.5 tp10 -80.83 102.76 10.22 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.6 153.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.126 0.971 . . . . 0.0 110.622 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -80.56 151.9 28.89 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.37 1.068 . . . . 0.0 110.161 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.94 119.87 24.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.571 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.5 m-85 -104.28 -19.48 14.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.655 0.782 . . . . 0.0 111.582 -175.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 p -62.89 -19.89 64.61 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.29 -19.24 53.45 Favored Glycine 0 C--N 1.356 1.648 0 CA-C-O 119.773 -0.46 . . . . 0.0 112.484 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -38.89 -45.98 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.996 1.318 . . . . 0.0 113.727 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -65.87 -20.79 66.36 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -163.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -74.25 -45.21 49.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.515 0.726 . . . . 0.0 110.85 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -90.77 -18.16 25.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 13.6 m -130.12 90.06 43.32 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 121.348 0.594 . . . . 0.0 110.566 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.92 -36.59 2.53 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.116 1.878 . . . . 0.0 111.17 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 13.4 mmmm -81.1 -9.15 59.86 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 123.895 0.878 . . . . 0.0 112.551 -171.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 38.2 tp -58.36 104.28 0.2 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.848 0.718 . . . . 0.0 110.791 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 106' ' ' LYS . 23.6 mtp180 -98.33 -42.89 7.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.604 0.762 . . . . 0.0 110.019 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 37.9 tp -128.93 139.77 51.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.133 0.573 . . . . 0.0 110.531 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.45 127.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.3 m -106.98 115.56 30.4 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.291 0.636 . . . . 0.0 109.717 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 95.6 m-85 -89.16 114.61 25.92 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.451 0.7 . . . . 0.0 109.819 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.554 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 3.3 t30 -83.11 89.54 6.95 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.87 144.56 8.82 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.335 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.45 -37.66 81.68 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.052 0.941 . . . . 0.0 112.358 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -60.06 -31.63 70.17 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.17 -43.56 56.86 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.323 0.582 . . . . 0.0 109.512 170.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -9.73 52.79 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.281 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.9 -35.64 66.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.326 0.65 . . . . 0.0 111.113 171.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.07 23.79 12.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.72 1.208 . . . . 0.0 110.945 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.485 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -65.29 -55.96 22.58 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.386 0.675 . . . . 0.0 111.29 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.6 -16.35 34.01 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.714 1.61 . . . . 0.0 112.035 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.53 -43.76 88.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.971 0.909 . . . . 0.0 109.977 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.554 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 8.1 mt -82.27 -9.88 59.32 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.813 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 75.5 mtt180 -67.56 -22.07 65.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.312 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.28 69.29 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.823 0.702 . . . . 0.0 113.481 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.554 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -84.18 7.09 20.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.462 0.705 . . . . 0.0 111.094 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.1 28.33 68.57 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 116.876 -0.147 . . . . 0.0 112.738 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 21.0 m-85 -108.43 145.46 34.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.602 0.761 . . . . 0.0 110.866 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -79.72 139.12 37.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 51.4 p -134.85 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.914 0.486 . . . . 0.0 110.57 -174.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -140.32 130.59 25.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 -174.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.13 113.02 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 111' ' ' CYS . 85.5 mt -96.49 150.8 37.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 166.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.35 167.42 23.96 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.118 1.879 . . . . 0.0 111.277 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.9 t -62.52 115.03 3.9 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.3 p -75.21 5.9 4.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.286 0.634 . . . . 0.0 112.359 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.9 p -62.23 152.58 33.01 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.854 0.862 . . . . 0.0 110.919 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.29 65.72 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.737 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.07 -23.64 51.94 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.814 0.846 . . . . 0.0 111.705 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -110.23 4.51 21.01 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.97 0.908 . . . . 0.0 110.314 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -59.95 -34.67 73.58 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.325 0.65 . . . . 0.0 111.152 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.85 -37.4 63.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 111.595 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.26 -25.51 15.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.699 0.8 . . . . 0.0 111.009 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -80.45 22.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -67.84 0.38 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.021 0.928 . . . . 0.0 110.952 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.48 -10.74 27.51 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.084 0.954 . . . . 0.0 113.142 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.427 ' O ' ' HD1' ' A' ' 152' ' ' TRP . 35.1 mmt180 -86.34 -18.75 31.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.301 0.64 . . . . 0.0 110.489 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -54.39 -36.52 64.01 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.244 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -62.19 -46.35 89.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.418 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.35 -30.67 63.48 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 119.462 -0.304 . . . . 0.0 110.471 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.427 ' HD1' ' O ' ' A' ' 148' ' ' ARG . 44.3 m95 -66.29 -43.3 86.74 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -59.13 -42.72 91.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.083 0.864 . . . . 0.0 109.512 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.33 77.45 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 124.242 0.963 . . . . 0.0 111.522 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.6 t -62.5 -34.6 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.959 0.903 . . . . 0.0 111.936 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.63 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 83.6 m-85 -110.24 2.42 19.24 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -65.7 -40.91 92.78 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.368 1.067 . . . . 0.0 110.793 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.466 ' HE1' HD11 ' A' ' 16' ' ' ILE . 19.5 p-80 -69.84 -6.79 34.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 112.424 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.413 HD11 HD12 ' A' ' 16' ' ' ILE . 96.6 mt -75.4 -18.11 60.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.907 0.483 . . . . 0.0 111.051 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -89.43 -3.39 58.43 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 122.434 0.294 . . . . 0.0 110.237 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 . . . . . 0 N--CA 1.484 1.262 0 C-N-CA 126.123 1.769 . . . . 0.0 111.048 177.657 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 80' ' ' SER . 42.3 mm -64.97 120.2 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.683 0.793 . . . . 0.0 111.218 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HG3' ' HD2' ' A' ' 81' ' ' ARG . 74.3 mmtt -110.11 116.28 31.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.398 1.079 . . . . 0.0 108.701 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -83.26 135.38 34.77 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 122.704 0.402 . . . . 0.0 110.233 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.4 150.17 44.8 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.817 0.698 . . . . 0.0 112.952 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -79.17 132.42 63.22 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 147.83 22.1 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.287 2.658 . . . . 0.0 112.275 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.95 133.19 50.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.039 0.536 . . . . 0.0 111.597 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.635 HG11 HD22 ' A' ' 62' ' ' LEU . 94.6 t -95.59 88.07 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.498 HD11 ' CG1' ' A' ' 104' ' ' VAL . 18.0 tp -136.58 149.54 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -163.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 13.9 t70 -128.99 163.79 24.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.407 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.16 -12.44 61.19 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.943 0.897 . . . . 0.0 112.567 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.3 12.44 37.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.217 0.607 . . . . 0.0 111.42 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -75.79 118.75 18.93 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 108' ' ' ARG . 56.7 mt-10 -93.49 -33.75 13.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.366 1.067 . . . . 0.0 111.366 -177.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mt -126.72 120.22 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 10' ' ' LEU . 63.0 tp -104.57 121.77 44.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 111' ' ' CYS . 48.6 mt -99.55 109.65 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.659 0.784 . . . . 0.0 109.378 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 76.1 mt -93.59 118.49 31.44 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -74.38 0.32 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.895 0.747 . . . . 0.0 113.121 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 117' ' ' ALA . 10.8 p 151.25 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -165.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.7 136.23 14.27 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 164.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 129.75 36.47 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.078 1.852 . . . . 0.0 111.917 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.7 p -69.04 140.21 54.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -49.84 -42.77 48.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.214 1.005 . . . . 0.0 112.848 -174.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 11.8 tp10 -63.38 -29.53 70.82 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -74.39 -33.26 62.99 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.5 mt -74.47 -14.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.064 0.946 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' A' ' 26' ' ' GLU . 2.5 mmp_? -66.18 -35.28 80.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.62 -3.28 26.91 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.759 0.824 . . . . 0.0 111.484 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.48 18.98 9.91 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.008 1.323 . . . . 0.0 114.034 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -146.18 161.14 40.89 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -71.61 -12.95 61.61 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.524 1.129 . . . . 0.0 110.91 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.476 ' HD1' ' HZ1' ' A' ' 61' ' ' LYS . 85.0 t80 -87.2 -9.16 55.89 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.831 1.252 . . . . 0.0 109.731 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.3 -44.3 20.53 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 124.499 1.124 . . . . 0.0 115.589 -170.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -125.95 115.53 24.23 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -63.06 99.26 0.22 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.484 2.123 . . . . 0.0 108.196 154.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.7 -38.1 0.57 Allowed Glycine 0 C--O 1.241 0.541 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.575 -164.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -72.77 105.5 4.36 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 167.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.85 6.92 14.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.951 0.9 . . . . 0.0 111.938 -168.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -44.11 -43.09 6.71 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.857 0.863 . . . . 0.0 111.975 166.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -75.16 -21.96 58.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 112.158 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.71 -53.53 8.4 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.758 0.823 . . . . 0.0 110.471 170.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -69.84 -47.94 60.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.861 0.864 . . . . 0.0 111.535 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.45 -31.93 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.083 0.553 . . . . 0.0 109.876 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.39 -38.26 93.43 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.323 0.389 . . . . 0.0 112.689 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -72.22 -36.71 69.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.305 1.042 . . . . 0.0 110.198 174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.54 -42.28 98.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.573 0.749 . . . . 0.0 112.52 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -94.08 -15.17 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.642 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 35.31 61.12 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -136.14 127.69 28.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -70.0 89.76 0.62 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.014 0.911 . . . . 0.0 110.98 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -74.68 -0.44 18.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.76 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -84.6 -39.22 18.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.646 0.379 . . . . 0.0 111.18 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -99.12 0.37 43.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.693 0.797 . . . . 0.0 112.089 -166.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -90.78 141.77 28.46 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.033 0.533 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.51 147.23 53.59 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.715 0.634 . . . . 0.0 109.373 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.488 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 56.0 t80 -45.28 -51.62 10.67 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.539 1.135 . . . . 0.0 113.776 -169.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.78 -46.15 90.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.826 0.851 . . . . 0.0 111.63 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -66.04 -38.89 89.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.652 0.781 . . . . 0.0 110.572 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.476 ' HZ1' ' HD1' ' A' ' 34' ' ' TYR . 30.9 ttmt -59.94 -40.42 88.9 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.523 1.129 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.635 HD22 HG11 ' A' ' 9' ' ' VAL . 27.0 mt -61.13 -49.03 78.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.355 174.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.16 -29.2 70.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.757 0.823 . . . . 0.0 111.516 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -62.19 -50.02 73.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 0.0 109.985 170.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.78 -40.34 79.61 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.046 0.841 . . . . 0.0 109.961 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HE3' HG12 ' A' ' 9' ' ' VAL . 2.3 mptm? -59.39 -39.04 82.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.71 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -55.44 -41.18 72.48 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 122.72 0.408 . . . . 0.0 111.367 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -90.12 2.18 55.58 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.983 0.913 . . . . 0.0 111.05 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER 64.32 36.76 8.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.847 1.259 . . . . 0.0 110.868 177.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -104.05 132.93 49.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.795 1.238 . . . . 0.0 108.66 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.05 159.88 13.77 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 172.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 87.6 mt -122.53 143.87 49.45 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.839 0.856 . . . . 0.0 108.872 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -163.71 -168.59 1.68 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 171.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -125.84 179.88 4.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.276 0.63 . . . . 0.0 110.34 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.498 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 92.4 t -90.66 -44.49 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 109.884 175.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -99.26 133.19 43.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.874 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.592 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 88.4 tttt -78.56 -25.11 45.29 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.671 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.24 136.43 11.9 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.297 0.639 . . . . 0.0 110.025 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.672 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -145.73 130.17 3.68 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.406 ' HB2' HD13 ' A' ' 2' ' ' ILE . 34.4 t -88.39 106.21 18.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.367 1.083 . . . . 0.0 109.535 -174.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.462 ' HD2' ' HG3' ' A' ' 3' ' ' LYS . 95.2 mtt-85 -85.68 108.83 18.21 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 84' ' ' SER . 10.7 tp10 -78.79 152.59 31.31 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.847 0.717 . . . . 0.0 110.816 -172.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.59 -19.55 73.05 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 120.404 -0.109 . . . . 0.0 113.252 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.409 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 17.7 m -84.3 -173.47 4.74 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.257 1.023 . . . . 0.0 111.759 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.1 -16.97 64.66 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.902 0.881 . . . . 0.0 111.756 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.4 52.08 2.27 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.369 1.08 . . . . 0.0 110.209 170.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.9 p -83.14 29.63 0.48 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.264 -1.334 . . . . 0.0 111.7 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.03 -163.35 1.0 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.989 0.915 . . . . 0.0 109.723 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.498 HD12 ' HD2' ' A' ' 116' ' ' LYS . 37.1 mt -84.18 79.88 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.16 62.63 4.31 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.247 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.672 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.4 t70 -175.25 156.57 2.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -120.73 21.44 11.48 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 0.0 111.062 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.9 tp10 -85.39 109.14 18.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.49 137.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.077 0.951 . . . . 0.0 109.741 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -59.72 142.11 53.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 111.177 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.23 91.78 0.74 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.52 0.728 . . . . 0.0 111.295 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.525 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 21.6 m-85 -80.18 -13.14 59.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.244 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.1 p -57.03 -31.64 65.35 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.736 0.815 . . . . 0.0 111.154 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.94 -4.24 69.51 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.134 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -51.67 -39.5 58.33 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.181 0.991 . . . . 0.0 112.749 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -56.8 -34.77 68.01 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.419 0.688 . . . . 0.0 111.894 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.79 -46.71 8.39 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.822 0.849 . . . . 0.0 112.031 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptm -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.482 0.713 . . . . 0.0 111.804 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.7 m -121.22 85.92 42.38 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 123.527 0.731 . . . . 0.0 109.189 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.77 -32.54 7.33 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.56 2.173 . . . . 0.0 112.3 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.15 1.9 48.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 42.6 tp -58.14 115.13 2.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.698 0.799 . . . . 0.0 112.223 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.457 ' HD3' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -107.6 -40.06 5.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.651 168.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.06 131.95 37.61 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.118 0.567 . . . . 0.0 110.496 -171.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.457 ' HB ' HG22 ' A' ' 131' ' ' THR . 54.3 mt -102.54 145.08 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.601 ' HB2' HG12 ' A' ' 18' ' ' ILE . 76.9 m -124.56 116.22 22.1 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.346 0.521 . . . . 0.0 110.425 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.455 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 97.9 m-85 -96.72 128.07 43.31 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.646 1.178 . . . . 0.0 110.377 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -97.25 78.86 2.76 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.448 0.642 . . . . 0.0 110.412 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.1 152.48 5.76 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.052 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -65.76 -40.25 91.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.241 0.616 . . . . 0.0 110.604 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.498 ' HD2' HD12 ' A' ' 89' ' ' ILE . 4.7 tmtm? -60.07 -37.12 78.95 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.163 175.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -67.82 -41.75 82.59 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.98 172.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.7 -9.85 59.78 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 114.815 -1.084 . . . . 0.0 114.232 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.61 -33.12 74.9 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.069 0.548 . . . . 0.0 110.566 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -98.87 13.59 31.95 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.968 . . . . 0.0 111.359 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.471 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -67.34 -54.64 18.11 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.57 0.748 . . . . 0.0 111.629 177.274 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.94 -15.61 43.94 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.713 1.609 . . . . 0.0 113.143 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.43 -48.64 76.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.453 0.701 . . . . 0.0 110.886 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.518 ' HB2' HG21 ' A' ' 131' ' ' THR . 17.2 mt -82.12 -9.41 59.54 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.386 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -68.03 -28.59 67.53 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.812 0.445 . . . . 0.0 110.332 165.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.51 -19.35 64.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.53 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.4 mtt -94.07 12.15 27.39 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.098 0.959 . . . . 0.0 111.369 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.98 18.23 79.0 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.727 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.88 131.52 54.98 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.919 0.488 . . . . 0.0 110.706 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.61 140.97 51.76 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.518 HG21 ' HB2' ' A' ' 124' ' ' LEU . 16.3 p -132.8 151.78 51.93 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.952 0.901 . . . . 0.0 109.848 -172.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -134.94 123.58 23.6 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.044 0.538 . . . . 0.0 110.266 -175.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.6 t -83.11 98.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 111' ' ' CYS . 69.8 mt -90.88 156.88 44.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 148' ' ' ARG . 84.2 Cg_endo -71.02 165.03 33.71 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.985 1.79 . . . . 0.0 110.616 177.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 40.6 t -63.93 117.39 6.93 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 170.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.9 p -77.74 19.03 0.41 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.346 0.658 . . . . 0.0 112.578 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.7 p -77.26 153.1 34.29 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.895 0.878 . . . . 0.0 108.905 170.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -9.89 51.2 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.635 0.614 . . . . 0.0 114.635 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.06 -6.85 56.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 111.795 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 135' ' ' PRO . 26.2 t-20 -123.05 -2.64 8.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.696 0.798 . . . . 0.0 110.59 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -75.6 -10.01 59.08 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 120.996 0.427 . . . . 0.0 111.727 -169.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.38 -26.85 13.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.674 1.189 . . . . 0.0 113.463 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -103.29 -5.37 23.12 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 0.0 110.911 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.641 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 66.3 m -88.14 0.36 56.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.654 0.781 . . . . 0.0 111.968 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.26 -70.96 0.09 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.63 0.772 . . . . 0.0 109.906 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.9 -12.05 59.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.112 0.565 . . . . 0.0 111.535 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.641 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 74.4 ttt180 -87.51 -11.71 48.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.395 0.678 . . . . 0.0 110.58 -172.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.49 -23.76 64.77 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.009 0.524 . . . . 0.0 111.298 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.8 t -66.96 -36.33 81.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.031 0.932 . . . . 0.0 109.85 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 155' ' ' VAL . 5.7 tt0 -67.42 -44.69 78.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.554 0.742 . . . . 0.0 110.223 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -60.06 -44.35 94.79 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.115 0.884 . . . . 0.0 109.184 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -60.6 -42.25 96.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.489 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.59 -37.95 70.95 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.4 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 151' ' ' GLU . 52.4 t -59.06 -34.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.115 0.966 . . . . 0.0 111.286 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.525 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 57.1 m-85 -107.98 -8.75 15.81 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -75.16 -48.59 22.91 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.1 0.409 . . . . 0.0 110.317 172.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -62.27 -14.56 40.08 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.03 -13.05 22.19 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.706 1.202 . . . . 0.0 112.329 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.23 -7.31 35.48 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.018 0.927 . . . . 0.0 112.304 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.9 t60 . . . . . 0 C--N 1.362 1.132 0 C-N-CA 125.972 1.709 . . . . 0.0 109.375 -175.165 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.773 -0.084 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 80' ' ' SER . 44.1 mm -65.07 118.73 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.837 0.855 . . . . 0.0 111.515 -170.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -104.53 116.56 32.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.51 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.1 mmt85 -84.73 133.39 34.37 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.498 0.719 . . . . 0.0 110.027 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.32 -179.79 34.84 Favored Glycine 0 C--O 1.247 0.96 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.739 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.448 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 20.4 m-30 -93.91 139.12 22.56 Favored Pre-proline 0 N--CA 1.47 0.548 0 O-C-N 122.504 -0.41 . . . . 0.0 110.495 -177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.97 162.34 26.18 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.482 2.122 . . . . 0.0 110.752 163.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.457 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -69.74 133.59 47.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.33 0.652 . . . . 0.0 112.606 -172.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.675 HG11 HD22 ' A' ' 62' ' ' LEU . 84.2 t -93.24 80.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 167.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.475 HD11 ' CG1' ' A' ' 104' ' ' VAL . 37.3 tp -128.24 149.41 50.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.23 -161.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.697 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 34.4 t70 -111.5 153.2 26.53 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -53.66 -48.61 69.27 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.283 0.633 . . . . 0.0 112.305 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -105.8 59.83 0.66 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.779 0.799 . . . . 0.0 111.817 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.479 ' HB ' HG12 ' A' ' 104' ' ' VAL . 27.6 m -85.9 135.2 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.37 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.94 -39.57 11.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.836 0.855 . . . . 0.0 111.809 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.419 HD11 ' CE1' ' A' ' 158' ' ' HIS . 44.3 mt -122.31 123.99 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.455 HD13 HD13 ' A' ' 10' ' ' LEU . 51.2 tp -109.37 117.18 33.37 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 111' ' ' CYS . 43.9 mt -98.56 113.35 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 73' ' ' TRP . 88.2 mt -106.08 122.52 46.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.846 0.858 . . . . 0.0 110.176 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 -154.71 10.84 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 164.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.6 p -119.16 -66.88 1.03 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.067 0.933 . . . . 0.0 108.825 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.8 tp -146.72 119.33 4.92 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.63 158.24 56.85 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.116 1.877 . . . . 0.0 111.053 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -67.94 146.46 53.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.16 0.584 . . . . 0.0 109.436 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 36.5 t70 -61.81 -27.04 68.48 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.14 0.275 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.91 -31.48 62.91 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.555 0.742 . . . . 0.0 111.249 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 m -86.6 -41.27 14.4 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.744 0.818 . . . . 0.0 110.489 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 72.3 mt -63.73 -32.09 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 124.107 0.963 . . . . 0.0 112.974 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -62.7 -27.43 69.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.495 0.318 . . . . 0.0 111.283 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -91.02 -26.37 19.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.714 0.806 . . . . 0.0 110.596 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 61.51 34.5 17.94 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 125.25 1.42 . . . . 0.0 110.728 -165.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -135.7 133.25 37.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 109.672 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -60.59 -54.83 40.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.751 0.82 . . . . 0.0 110.547 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 83.7 t80 -65.41 -15.16 62.31 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.618 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.48 -30.33 49.61 Favored Glycine 0 C--N 1.359 1.859 0 O-C-N 123.249 0.343 . . . . 0.0 112.854 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -99.47 106.98 42.87 Favored Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.14 179.61 6.05 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.303 2.002 . . . . 0.0 110.644 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.18 -11.53 65.03 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -170.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' A' ' 41' ' ' PHE . 28.8 t-20 -80.77 122.78 27.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.893 1.277 . . . . 0.0 109.5 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.06 -3.9 50.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.543 0.737 . . . . 0.0 111.986 -170.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 87.6 t80 -48.07 -45.24 32.24 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.306 1.042 . . . . 0.0 112.451 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -60.97 -37.03 81.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.482 0.713 . . . . 0.0 111.374 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.62 -41.64 71.96 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.616 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.03 -55.04 25.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.725 0.81 . . . . 0.0 111.057 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 49' ' ' ILE . 63.2 t -66.48 -44.73 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.68 -177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -34.44 88.61 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.179 0.924 . . . . 0.0 113.975 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -68.33 -43.22 78.02 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.544 0.738 . . . . 0.0 110.313 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -70.52 -41.35 72.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.005 0.922 . . . . 0.0 112.474 -174.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 45' ' ' VAL . 17.1 pt -85.12 -14.88 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.23 0.612 . . . . 0.0 110.141 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.14 78.42 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.661 0.601 . . . . 0.0 113.933 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -115.65 142.81 46.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.012 0.925 . . . . 0.0 109.282 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.82 88.83 6.3 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.25 -47.47 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.88 -48.58 81.1 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.747 1.279 . . . . 0.0 112.248 -165.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.37 -32.44 64.5 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.7 137.0 57.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.507 0.323 . . . . 0.0 110.733 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.92 31.51 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.397 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.558 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 42.9 t80 -44.1 -43.75 7.12 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.82 -49.1 78.97 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.816 0.846 . . . . 0.0 111.101 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.1 -34.75 76.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.862 1.265 . . . . 0.0 111.473 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.33 -45.5 94.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.764 1.226 . . . . 0.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.675 HD22 HG11 ' A' ' 9' ' ' VAL . 80.7 mt -63.14 -42.78 99.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 110.816 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -63.08 -31.21 72.3 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.707 0.403 . . . . 0.0 111.339 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -74.4 -28.05 60.91 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.954 0.502 . . . . 0.0 110.948 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.27 -48.36 80.25 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.697 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -57.11 -39.28 74.78 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.617 0.767 . . . . 0.0 111.019 176.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -57.68 -40.58 79.74 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.295 1.038 . . . . 0.0 112.15 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -92.15 4.76 52.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.644 0.378 . . . . 0.0 111.671 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 63.39 40.6 8.32 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.18 1.392 . . . . 0.0 111.15 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.86 138.69 29.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 125.066 1.346 . . . . 0.0 109.065 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.08 154.77 16.41 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 170.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -126.33 134.19 51.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.692 0.797 . . . . 0.0 108.866 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.431 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.8 t90 -160.71 -170.27 2.69 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -134.75 162.88 31.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.345 1.058 . . . . 0.0 109.236 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.39 -48.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 52.6 m-85 -87.45 133.75 33.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.537 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.7 tmmm? -75.17 -32.64 61.33 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.51 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -159.82 152.93 21.89 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.695 0.798 . . . . 0.0 110.817 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -146.54 128.44 3.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' ' 2' ' ' ILE . 43.5 p -89.46 119.81 30.23 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -173.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.421 ' HA ' ' NE2' ' A' ' 85' ' ' GLN . 43.4 mtm180 -90.92 102.22 14.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.017 0.527 . . . . 0.0 110.116 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -57.4 -42.42 82.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.078 0.951 . . . . 0.0 110.432 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.81 -71.91 0.18 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.444 176.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.1 m -116.36 88.02 2.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.801 0.84 . . . . 0.0 109.356 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 81' ' ' ARG . 25.2 mt-30 -115.04 -5.22 12.48 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.674 0.79 . . . . 0.0 111.375 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 71.99 -64.92 0.37 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 125.736 1.614 . . . . 0.0 112.756 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.4 t -82.41 7.47 14.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.797 0.839 . . . . 0.0 112.157 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt 78.36 -43.98 0.37 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 125.828 1.651 . . . . 0.0 113.09 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.9 mt -73.66 139.78 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.924 0.89 . . . . 0.0 110.111 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.03 55.32 0.4 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 18.7 t70 174.77 158.57 0.17 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.577 1.151 . . . . 0.0 108.813 -167.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.86 25.56 10.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.953 0.901 . . . . 0.0 111.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 6.1 tp10 -79.82 102.81 9.31 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 87.5 mt -114.81 146.81 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.744 1.218 . . . . 0.0 109.735 -173.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -68.26 141.82 55.78 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.833 0.853 . . . . 0.0 108.981 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.17 114.56 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.78 6.37 43.83 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.86 0.464 . . . . 0.0 112.124 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.1 t -63.73 -26.05 68.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 0.0 111.615 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.83 -1.88 84.7 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 118.898 -0.946 . . . . 0.0 114.302 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' SD ' ' A' ' 103' ' ' MET . 35.9 mt -50.03 -34.84 22.65 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 117.87 0.835 . . . . 0.0 113.071 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -65.42 -22.43 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -99.33 -45.97 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.525 ' HG3' HG22 ' A' ' 104' ' ' VAL . 17.4 ptm -69.81 -35.85 75.17 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.874 0.87 . . . . 0.0 111.314 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 2.0 m -132.87 88.11 38.49 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.336 0.654 . . . . 0.0 109.698 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 94.9 Cg_endo -72.59 -25.3 17.76 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.013 2.475 . . . . 0.0 111.771 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.2 mmmt -91.72 -6.65 51.61 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.553 1.141 . . . . 0.0 111.537 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -58.82 109.62 0.85 Allowed 'General case' 0 C--N 1.356 0.861 0 O-C-N 123.771 0.669 . . . . 0.0 110.253 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -108.38 -40.14 5.23 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.659 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 130' ' ' GLU . 47.7 tp -125.45 130.12 51.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -174.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.6 mt -110.2 116.59 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.909 0.884 . . . . 0.0 108.793 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.506 ' HB3' HD12 ' A' ' 134' ' ' LEU . 68.1 m -97.9 117.33 31.99 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 123.417 0.687 . . . . 0.0 109.699 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 91.2 m-85 -93.34 123.05 36.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.206 0.602 . . . . 0.0 110.57 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -79.95 79.62 6.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.166 0.586 . . . . 0.0 109.564 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.64 175.3 19.98 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.379 -0.828 . . . . 0.0 115.02 169.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 73.5 ttt180 -57.31 -61.04 2.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.709 1.204 . . . . 0.0 111.52 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.24 -27.66 36.22 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.86 0.864 . . . . 0.0 113.316 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.16 -50.74 15.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.443 0.697 . . . . 0.0 109.914 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.17 -10.53 84.26 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.63 -1.168 . . . . 0.0 114.789 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 96.1 mt-10 -66.24 -22.58 66.33 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.667 0.734 . . . . 0.0 110.265 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -103.53 19.63 19.41 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.347 1.059 . . . . 0.0 110.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 37.2 tt0 -60.68 -51.54 78.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 118.146 -0.931 . . . . 0.0 112.0 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 121' ' ' GLU . 18.2 Cg_endo -54.99 -27.56 55.11 Favored 'Trans proline' 0 C--N 1.406 3.563 0 C-N-CA 122.76 2.307 . . . . 0.0 113.571 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -62.2 -42.84 99.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.299 1.04 . . . . 0.0 110.444 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.415 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 20.0 mt -93.5 -15.04 25.94 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.633 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 37.6 mtp85 -66.85 -34.3 77.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.863 0.465 . . . . 0.0 109.975 171.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.44 -13.02 70.5 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.758 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.5 mtt -93.36 12.25 25.43 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.154 0.982 . . . . 0.0 111.292 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.0 27.83 69.68 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.387 0.429 . . . . 0.0 114.028 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.86 137.96 45.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.715 0.406 . . . . 0.0 111.306 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 28.1 mt-10 -65.1 129.83 41.12 Favored 'General case' 0 C--N 1.345 0.406 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 165.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.488 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.9 p -130.66 144.45 51.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.88 0.472 . . . . 0.0 110.16 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -139.64 125.56 19.69 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.095 0.958 . . . . 0.0 109.835 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 46.3 t -87.13 104.62 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 111' ' ' CYS . 74.3 mt -90.14 154.08 46.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.4 145.14 70.33 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 111.164 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.5 t -59.91 107.39 0.61 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.71 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.5 p -57.97 85.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 O-C-N 124.447 1.092 . . . . 0.0 111.04 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.7 t -129.81 161.0 31.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.616 1.566 . . . . 0.0 108.395 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -42.92 95.84 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.414 0.446 . . . . 0.0 112.865 167.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.0 82.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.41 0.684 . . . . 0.0 111.23 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -65.02 -44.4 89.3 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.979 172.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -67.9 -23.54 65.11 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.417 1.073 . . . . 0.0 110.309 -172.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -56.94 -28.34 62.01 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.819 1.247 . . . . 0.0 111.684 171.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -118.17 -20.04 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.301 1.04 . . . . 0.0 111.496 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.427 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 22.2 t -98.28 31.71 2.7 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.834 0.853 . . . . 0.0 110.973 -173.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -65.35 0.68 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.77 -6.94 59.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.642 0.777 . . . . 0.0 111.965 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.427 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 13.8 tpt180 -85.85 -14.22 45.62 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.318 0.647 . . . . 0.0 110.042 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -51.76 -23.52 4.72 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.862 0.865 . . . . 0.0 112.57 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -63.63 -29.6 70.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.619 0.768 . . . . 0.0 111.376 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 155' ' ' VAL . 8.3 pt-20 -73.22 -35.2 66.27 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -68.03 -35.9 79.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 2.1 tm-20 -70.8 -33.12 70.4 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.751 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.72 -11.95 60.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.858 0.863 . . . . 0.0 112.307 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 151' ' ' GLU . 53.2 t -89.61 -49.17 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.002 0.521 . . . . 0.0 110.29 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -99.36 2.17 45.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -71.19 -35.03 71.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.651 0.66 . . . . 0.0 111.469 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.419 ' CE1' HD11 ' A' ' 16' ' ' ILE . 31.7 p-80 -69.44 -11.77 61.1 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.803 0.441 . . . . 0.0 111.441 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.39 -35.71 71.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.38 -45.81 24.78 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.601 0.761 . . . . 0.0 109.273 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 . . . . . 0 CA--C 1.563 1.468 0 C-N-CA 126.077 1.751 . . . . 0.0 112.518 -176.506 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 120.763 0.316 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm -79.1 129.43 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.102 0.961 . . . . 0.0 110.085 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' HB2' HD21 ' A' ' 22' ' ' LEU . 3.4 mptp? -100.1 117.55 34.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -93.38 130.94 38.98 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.974 0.51 . . . . 0.0 111.766 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.87 165.05 45.63 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.942 0.776 . . . . 0.0 112.502 172.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.45 149.23 38.54 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.295 0.638 . . . . 0.0 111.544 -165.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -56.74 137.29 80.64 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.519 2.146 . . . . 0.0 110.311 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 142.99 56.6 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.87 0.731 . . . . 0.0 112.419 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 62' ' ' LEU . 59.9 t -91.06 86.61 2.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.25 139.76 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.839 -162.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.89 162.26 23.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.426 1.091 . . . . 0.0 108.353 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.65 -24.39 67.59 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.758 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 29.4 p30 -104.14 36.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.128 0.571 . . . . 0.0 111.075 -175.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 m -89.53 106.63 18.58 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.268 0.556 . . . . 0.0 110.334 -176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.63 -29.98 17.44 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.95 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 159' ' ' LEU . 43.2 mt -123.95 121.49 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 tp -107.98 115.12 29.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 111' ' ' CYS . 39.9 mt -97.31 119.91 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.328 0.651 . . . . 0.0 109.268 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 60.7 mt -111.0 115.87 30.22 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.669 0.788 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -70.99 178.32 33.57 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 167.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 p -86.24 -80.28 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 3' ' ' LYS . 45.9 tp -131.68 122.39 18.67 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 171.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.12 149.42 44.13 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.901 2.4 . . . . 0.0 113.25 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.517 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.9 m -60.78 152.2 27.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.693 1.197 . . . . 0.0 111.12 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 54.2 m-20 -58.98 -40.56 85.18 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.185 0.594 . . . . 0.0 111.35 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.04 -25.54 67.88 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.838 1.255 . . . . 0.0 110.506 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.2 m -83.36 -38.59 21.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.718 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 24' ' ' SER . 48.6 mm -61.34 -41.03 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.346 1.058 . . . . 0.0 110.795 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.5 mmm180 -58.68 -30.95 67.77 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.717 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -106.73 -7.51 17.23 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.896 0.878 . . . . 0.0 112.33 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 58.74 30.95 20.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.814 1.246 . . . . 0.0 113.421 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -145.9 141.67 28.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.97 0.908 . . . . 0.0 109.554 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -59.69 -42.73 93.62 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.688 0.795 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -62.14 -12.63 20.72 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.404 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.45 -21.94 55.29 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.277 0.465 . . . . 0.0 113.615 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -115.77 96.69 47.26 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.65 131.87 4.05 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.38 2.72 . . . . 0.0 110.032 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.14 -13.38 5.48 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -171.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -75.17 126.44 31.03 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 171.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.4 m-20 -82.18 1.88 34.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.326 0.512 . . . . 0.0 111.025 -169.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -46.52 -44.21 17.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.161 0.984 . . . . 0.0 112.179 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -71.55 -26.42 62.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.813 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -76.58 -40.12 50.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.233 1.013 . . . . 0.0 111.495 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 149' ' ' GLU . 80.3 mt -79.56 -46.71 16.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.59 0.756 . . . . 0.0 110.9 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 49' ' ' ILE . 98.7 t -72.64 -32.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.75 -40.97 93.95 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.804 0.69 . . . . 0.0 112.325 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -67.22 -36.07 80.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.421 0.689 . . . . 0.0 110.113 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -70.95 -32.33 69.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 45' ' ' VAL . 18.5 pt -103.09 -10.93 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.241 0.617 . . . . 0.0 111.732 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.7 40.99 44.33 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.37 0.419 . . . . 0.0 113.76 177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -134.02 142.63 47.69 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.668 1.187 . . . . 0.0 108.794 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -86.48 87.8 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.522 0.677 . . . . 0.0 109.976 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.8 -31.94 67.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.831 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -62.13 -39.19 91.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.639 0.776 . . . . 0.0 112.399 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.38 -36.76 66.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.856 0.462 . . . . 0.0 110.638 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.3 mtt -57.67 130.39 46.17 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.19 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.63 151.79 19.96 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.479 166.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.494 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 69.1 t80 -48.11 -49.58 31.47 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.501 0.72 . . . . 0.0 112.524 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.24 -40.65 94.32 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.767 0.827 . . . . 0.0 112.249 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.47 -39.49 92.04 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.573 0.702 . . . . 0.0 110.567 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -62.2 -40.59 96.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.011 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 28.8 mt -57.91 -52.33 65.94 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.012 0.82 . . . . 0.0 109.398 174.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -52.52 -46.62 66.78 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.18 0.992 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.7 m -63.19 -54.74 32.75 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.058 0.943 . . . . 0.0 112.304 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.24 -50.37 70.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.498 0.719 . . . . 0.0 110.739 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -66.0 -32.24 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 112.105 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -60.34 -42.39 95.59 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.546 0.738 . . . . 0.0 110.628 168.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.443 ' O ' HD13 ' A' ' 159' ' ' LEU . 18.6 m120 -81.32 8.08 9.99 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.984 0.914 . . . . 0.0 110.83 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HB2' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER 68.51 31.57 4.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 0.0 111.161 176.001 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.7 mt -111.09 136.85 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.489 1.115 . . . . 0.0 109.349 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.55 160.63 19.14 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 74.5 mt -123.6 144.18 49.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.462 0.705 . . . . 0.0 109.187 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.427 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.5 t90 -167.07 -169.27 1.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -137.68 -177.89 5.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.43 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 97.1 t -98.67 -55.48 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.522 0.729 . . . . 0.0 110.289 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -80.46 107.82 13.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.986 0.514 . . . . 0.0 111.552 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -64.53 -36.4 84.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.194 0.998 . . . . 0.0 110.519 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.44 122.95 10.41 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.713 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.89 116.26 1.94 Allowed Glycine 0 C--N 1.33 0.236 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.5 p -88.08 154.28 20.6 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.196 0.598 . . . . 0.0 110.878 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -138.97 96.01 3.05 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 84' ' ' SER . 12.1 tp10 -80.89 137.72 36.16 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.756 169.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.73 -24.26 71.16 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 123.315 0.384 . . . . 0.0 112.868 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.444 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 17.2 m -85.17 -1.83 57.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.918 0.887 . . . . 0.0 112.026 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -114.31 132.97 55.99 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.097 0.959 . . . . 0.0 109.523 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.55 2.83 27.35 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.799 0.84 . . . . 0.0 111.665 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.6 m -83.91 130.96 34.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.911 0.484 . . . . 0.0 110.066 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -76.49 -44.98 32.97 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.8 0.84 . . . . 0.0 108.999 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.405 HG23 HD22 ' A' ' 22' ' ' LEU . 29.5 mt -115.77 88.63 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.417 -1.265 . . . . 0.0 107.94 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.44 -75.9 1.13 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -38.96 137.79 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.214 1.406 . . . . 0.0 114.208 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.24 28.08 7.65 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.491 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -75.64 106.09 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.2 mm -97.4 155.27 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.22 0.608 . . . . 0.0 110.013 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -78.7 158.33 28.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.868 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.6 121.69 24.97 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.43 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 58.9 m-85 -117.71 -0.01 11.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.2 p -74.96 -19.59 60.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.13 79.1 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.575 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 103' ' ' MET . 69.2 mt -52.93 -29.43 28.63 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 123.444 0.698 . . . . 0.0 112.855 176.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.493 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 36.8 mtpt -65.09 -27.6 68.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -85.59 -55.28 4.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.196 0.998 . . . . 0.0 111.405 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.413 ' HG2' ' HA ' ' A' ' 100' ' ' LEU . 24.7 ptm -74.52 -33.82 62.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.21 0.604 . . . . 0.0 112.594 -169.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.1 m -127.08 90.77 48.46 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.221 0.608 . . . . 0.0 110.933 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.93 -32.54 2.55 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.512 2.141 . . . . 0.0 112.325 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.758 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 8.1 mmpt? -76.51 -9.49 58.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 112.241 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.2 tp -59.97 112.46 1.88 Allowed 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.687 0.617 . . . . 0.0 111.218 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -101.71 -45.38 5.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.413 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 132' ' ' LYS . 40.8 tp -134.39 133.49 40.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.2 mt -105.53 115.76 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.161 0.984 . . . . 0.0 108.487 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 134' ' ' LEU . 80.0 m -98.97 116.15 30.55 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.022 0.529 . . . . 0.0 110.466 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.22 127.98 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.702 0.801 . . . . 0.0 110.195 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.498 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 82.3 m-20 -90.2 102.28 15.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.59 155.05 29.89 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.586 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 78.6 ttt180 -55.84 -48.05 76.17 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.4 1.08 . . . . 0.0 112.359 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.25 -29.61 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.45 27.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 173.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.82 -9.55 62.8 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.874 -1.057 . . . . 0.0 114.597 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 115' ' ' ARG . 15.2 mm-40 -62.13 -19.97 63.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.56 0.744 . . . . 0.0 111.703 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.4 ' CD2' HG11 ' A' ' 75' ' ' VAL . 59.4 m-85 -110.13 22.11 15.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 110.674 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.442 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.8 tt0 -59.02 -55.84 42.34 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.367 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.29 -17.71 23.98 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.458 1.438 . . . . 0.0 111.801 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.5 -48.1 78.97 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 109.83 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.503 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 6.7 mt -84.17 -16.64 42.75 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.533 -176.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 7.9 ttt180 -73.54 -17.81 61.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 176.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.88 -16.66 78.19 Favored Glycine 0 C--N 1.355 1.637 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.021 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.503 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -83.38 4.55 26.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.633 0.773 . . . . 0.0 111.197 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.97 14.56 72.07 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.542 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 36.2 m-85 -110.95 130.43 55.59 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.305 0.642 . . . . 0.0 111.222 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.42 139.1 58.74 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 15.2 p -128.13 147.01 50.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.553 0.741 . . . . 0.0 109.967 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 109' ' ' LEU . 51.9 tptt -140.38 124.72 17.76 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 109.164 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.0 t -90.39 118.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.6 mt -102.9 147.79 34.62 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.19 167.45 16.31 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.328 2.019 . . . . 0.0 112.87 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.7 m -65.46 126.55 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.48 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.6 m -77.12 12.75 1.31 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.028 0.931 . . . . 0.0 112.94 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 m -72.93 145.8 46.54 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.862 0.865 . . . . 0.0 109.975 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.57 -26.9 71.2 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-O 121.298 0.388 . . . . 0.0 112.185 173.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.97 -10.87 54.04 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.501 1.121 . . . . 0.0 112.667 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -119.17 -15.85 9.15 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.764 0.826 . . . . 0.0 109.216 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.71 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 39.6 ttp85 -83.54 -17.74 40.8 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.629 0.772 . . . . 0.0 110.705 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.7 mtp-105 -61.14 -27.12 68.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.701 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -106.46 -28.92 10.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.233 1.013 . . . . 0.0 110.12 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.71 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 23.1 t -81.49 37.73 0.47 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.176 0.991 . . . . 0.0 111.501 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 54.0 mtmt -69.82 -54.11 15.11 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.744 0.818 . . . . 0.0 110.626 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.39 -15.04 57.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 5.0 mpt_? -88.44 -13.73 39.69 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.107 0.563 . . . . 0.0 111.459 -174.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.552 ' HB2' HD22 ' A' ' 44' ' ' LEU . 12.9 pt-20 -80.42 -22.66 40.97 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 120.654 0.264 . . . . 0.0 110.605 172.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -66.5 -28.49 68.61 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.426 0.69 . . . . 0.0 111.309 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.8 pt-20 -71.27 -21.37 62.1 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 122.848 0.459 . . . . 0.0 110.819 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -67.52 -42.09 83.33 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.724 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.63 -36.45 78.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.7 63.65 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.782 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.435 HG11 ' SG ' ' A' ' 111' ' ' CYS . 45.8 t -89.54 -45.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.583 0.753 . . . . 0.0 111.195 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.59 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 72.0 m-85 -96.46 -20.36 18.47 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -166.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -76.18 -6.13 49.9 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.85 1.205 . . . . 0.0 113.156 -171.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -73.54 -5.83 42.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.986 -0.447 . . . . 0.0 110.632 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.469 HD11 HD12 ' A' ' 16' ' ' ILE . 39.1 mt -87.57 -17.41 32.03 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.44 1.096 . . . . 0.0 108.787 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.59 -44.29 10.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.625 1.17 . . . . 0.0 109.904 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 125.46 1.504 . . . . 0.0 110.771 -175.769 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.524 ' HB3' ' HB2' ' A' ' 81' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mm -74.14 125.27 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.066 0.546 . . . . 0.0 110.279 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -107.97 114.18 27.9 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 168.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.3 mmt85 -78.69 129.73 35.03 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.821 0.701 . . . . 0.0 109.995 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.62 151.03 52.23 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -80.6 145.32 58.37 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.787 0.294 . . . . 0.0 111.269 -167.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.5 149.17 68.18 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.322 2.015 . . . . 0.0 110.248 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 131.93 50.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.247 0.619 . . . . 0.0 112.58 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 57.7 t -89.92 86.15 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.506 HD21 HG13 ' A' ' 104' ' ' VAL . 19.9 tp -144.41 153.67 42.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -160.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -128.27 168.32 15.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.433 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.47 -13.65 61.1 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.446 0.698 . . . . 0.0 112.277 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -105.86 38.09 2.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.616 . . . . 0.0 111.464 -176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.63 ' HB ' HG12 ' A' ' 104' ' ' VAL . 94.9 m -101.61 130.96 48.05 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.458 0.303 . . . . 0.0 110.899 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -98.2 -39.7 8.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.258 1.023 . . . . 0.0 111.21 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 159' ' ' LEU . 51.9 mt -120.21 119.81 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 tp -106.94 118.21 36.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.478 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -94.43 109.94 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -98.0 109.3 22.08 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.8 -168.92 3.4 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 169.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 p -103.76 -76.12 0.6 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.54 HD22 HG23 ' A' ' 89' ' ' ILE . 31.1 tp -155.34 121.78 2.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 22' ' ' LEU . 9.8 Cg_exo -72.23 151.59 54.93 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.949 2.433 . . . . 0.0 112.707 -174.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 28' ' ' ILE . 18.3 m -67.31 157.77 33.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.088 0.955 . . . . 0.0 111.092 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.17 -24.57 67.95 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.14 -45.33 95.08 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.549 0.74 . . . . 0.0 110.437 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 m -68.53 -41.13 80.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.307 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 24' ' ' SER . 19.2 mm -57.35 -34.96 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 124.265 0.978 . . . . 0.0 111.647 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -58.11 -38.0 75.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.116 0.566 . . . . 0.0 112.258 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -94.77 -17.01 22.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.252 0.621 . . . . 0.0 111.168 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 64.19 30.34 13.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.514 1.125 . . . . 0.0 111.264 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -145.68 143.64 29.91 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.784 0.834 . . . . 0.0 109.851 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.32 -41.68 97.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.181 0.992 . . . . 0.0 110.113 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.25 -24.16 62.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.733 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.5 -14.4 41.97 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.368 0.418 . . . . 0.0 113.725 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -100.25 104.59 30.7 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.851 0.86 . . . . 0.0 109.468 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.42 97.79 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.27 2.646 . . . . 0.0 109.539 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.08 -30.14 0.72 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -170.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -67.45 103.65 1.36 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.049 0.94 . . . . 0.0 108.467 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -84.83 -0.94 55.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.418 0.687 . . . . 0.0 112.01 -166.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -42.78 -46.1 5.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.22 1.408 . . . . 0.0 113.135 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -79.4 -18.66 51.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.87 0.868 . . . . 0.0 111.254 -170.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 4.6 mmp_? -72.72 -47.71 44.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.114 0.565 . . . . 0.0 110.12 167.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.7 -46.63 71.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.962 0.905 . . . . 0.0 111.413 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.9 t -73.68 -41.46 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.66 0.784 . . . . 0.0 109.685 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.92 91.2 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.793 0.683 . . . . 0.0 112.453 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -66.77 -45.1 79.57 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.288 1.035 . . . . 0.0 109.83 174.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -67.03 -36.64 82.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.815 0.846 . . . . 0.0 112.816 -173.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.2 pt -93.78 -11.26 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.164 0.585 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.61 78.8 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.25 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.33 117.4 18.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.48 96.56 2.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.359 0.664 . . . . 0.0 110.432 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.34 -22.16 61.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.285 1.034 . . . . 0.0 113.035 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -19.87 59.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -168.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -85.18 -36.18 21.2 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.425 0.557 . . . . 0.0 110.325 169.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.1 mtt -63.18 120.55 11.73 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.553 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 160.07 2.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.087 0.555 . . . . 0.0 110.884 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.605 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 47.5 t80 -42.23 -53.59 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.708 0.803 . . . . 0.0 112.85 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 37.2 mt-10 -60.05 -35.78 75.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.635 0.774 . . . . 0.0 112.295 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.02 -48.88 13.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.944 0.897 . . . . 0.0 112.092 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -59.6 -34.96 73.4 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.837 0.455 . . . . 0.0 112.203 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 15.3 mt -64.94 -41.35 95.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.54 0.336 . . . . 0.0 110.492 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 47.7 mmtm -56.83 -37.37 71.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.273 0.629 . . . . 0.0 110.835 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -64.35 -44.16 92.32 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 123.754 0.658 . . . . 0.0 110.741 177.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.65 -57.33 13.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.56 0.744 . . . . 0.0 111.538 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -21.77 60.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -60.07 -40.29 89.01 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 110.442 165.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -86.59 7.57 25.8 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.99 0.916 . . . . 0.0 110.676 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 68.69 29.89 5.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.495 1.518 . . . . 0.0 110.864 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.5 mt -102.29 133.95 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.518 1.127 . . . . 0.0 108.838 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.81 158.15 18.33 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.663 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 66.6 mt -126.39 143.3 51.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.681 0.792 . . . . 0.0 108.995 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.65 -171.54 2.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.13 169.71 10.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.412 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 52.8 t -83.93 -34.97 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.268 0.627 . . . . 0.0 109.534 169.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 55.2 m-85 -101.92 141.65 34.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.846 0.458 . . . . 0.0 111.153 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.662 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 6.7 tmtm? -81.1 -41.87 21.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.953 0.901 . . . . 0.0 108.898 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.512 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -156.47 150.82 25.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.937 0.895 . . . . 0.0 109.768 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -160.23 139.7 6.28 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 t -97.54 167.1 11.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.527 0.679 . . . . 0.0 111.935 -168.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.524 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 22.4 mmm180 -115.46 94.19 4.6 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 167.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 179.0 149.81 0.26 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.88 -5.55 83.54 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 37.9 t -178.42 137.11 0.16 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 126.349 1.859 . . . . 0.0 106.659 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -64.77 -36.88 85.75 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -105.02 22.6 15.02 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.878 0.871 . . . . 0.0 111.371 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 57.3 p -62.13 99.55 0.14 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 122.809 0.444 . . . . 0.0 110.075 177.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -54.19 -51.4 64.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.574 0.75 . . . . 0.0 110.09 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.54 HG23 HD22 ' A' ' 22' ' ' LEU . 16.0 mt -136.28 78.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.9 57.5 4.29 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.605 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.694 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 10.2 t70 174.17 159.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -119.38 23.82 11.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.612 0.765 . . . . 0.0 112.058 -173.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 14.9 tp10 -80.4 101.85 9.26 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 54.8 mt -105.97 149.12 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.669 1.188 . . . . 0.0 110.033 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -69.51 147.18 51.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.922 0.889 . . . . 0.0 110.008 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.62 131.8 34.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.412 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 50.3 m-85 -110.0 9.72 24.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.529 0.731 . . . . 0.0 111.779 -175.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 t -69.21 -20.62 63.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.682 0.393 . . . . 0.0 110.843 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -4.52 63.87 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 118.941 -0.921 . . . . 0.0 113.714 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.424 HD23 ' SD ' ' A' ' 103' ' ' MET . 31.1 mt -50.04 -37.3 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -63.73 -31.28 72.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.591 0.356 . . . . 0.0 111.165 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -82.01 -53.12 6.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.817 0.847 . . . . 0.0 111.42 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.485 ' HG3' HG22 ' A' ' 104' ' ' VAL . 23.4 ptm -67.24 -34.95 78.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.534 0.733 . . . . 0.0 111.527 -173.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.63 HG12 ' HB ' ' A' ' 14' ' ' THR . 1.6 m -129.25 84.98 60.77 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.003 0.921 . . . . 0.0 108.857 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.4 -23.74 20.11 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.736 2.29 . . . . 0.0 112.79 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 7.45 38.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.42 0.688 . . . . 0.0 111.827 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 40.2 tp -61.4 125.44 23.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.833 0.349 . . . . 0.0 111.397 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -132.09 -30.58 1.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.13 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.7 tp -130.98 129.61 42.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.047 0.539 . . . . 0.0 110.039 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.56 122.16 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.3 1.04 . . . . 0.0 108.245 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.478 ' HB2' HG12 ' A' ' 18' ' ' ILE . 77.4 m -100.41 114.26 27.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.827 0.451 . . . . 0.0 109.881 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.412 ' HZ ' HD12 ' A' ' 124' ' ' LEU . 96.2 m-85 -89.88 115.5 27.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.983 0.913 . . . . 0.0 109.902 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.595 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 23.3 t30 -89.11 99.98 12.85 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.92 0.888 . . . . 0.0 109.124 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.89 156.43 20.8 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.811 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.54 -50.39 72.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.717 1.207 . . . . 0.0 111.681 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -55.06 -31.47 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.0 -43.91 51.14 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.037 0.535 . . . . 0.0 109.757 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.43 -11.43 64.85 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.007 -0.997 . . . . 0.0 114.149 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -60.43 -34.32 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.038 0.535 . . . . 0.0 110.955 170.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -107.16 18.26 21.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.12 0.968 . . . . 0.0 110.743 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.555 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.9 tm-20 -70.4 -48.79 17.71 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.631 0.772 . . . . 0.0 111.197 170.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.23 -28.77 72.88 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 122.322 2.014 . . . . 0.0 113.192 172.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.7 -48.95 79.47 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.645 0.778 . . . . 0.0 111.12 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.412 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 14.0 mt -85.61 -5.23 59.3 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -171.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -65.21 -34.44 78.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.75 -14.36 67.45 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.156 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 54.9 mtt -90.59 8.0 36.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.806 0.842 . . . . 0.0 111.4 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.48 0.75 89.58 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.33 0.492 . . . . 0.0 114.33 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -92.22 137.4 32.4 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 117.105 0.453 . . . . 0.0 110.331 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.43 131.31 45.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 49.5 p -120.69 136.83 54.74 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.303 0.641 . . . . 0.0 109.403 -176.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -134.51 115.79 14.34 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.304 1.042 . . . . 0.0 109.173 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.7 94.79 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 111' ' ' CYS . 73.6 mt -77.11 139.07 64.81 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 169.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.01 159.46 29.62 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.522 2.148 . . . . 0.0 112.505 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t -65.39 104.15 0.92 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.427 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.8 p -73.29 77.21 1.33 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.162 0.982 . . . . 0.0 109.037 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.8 p -129.1 159.77 34.94 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.98 29.7 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.04 -45.42 8.32 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.206 0.602 . . . . 0.0 112.143 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.82 -9.88 52.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.626 0.37 . . . . 0.0 111.896 -169.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -65.15 -33.18 75.41 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 0.0 110.369 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.13 -30.88 70.99 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.836 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.37 23.3 6.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.182 . . . . 0.0 110.596 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.5 t -139.42 24.4 2.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.294 1.038 . . . . 0.0 108.818 -170.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 49.2 tptt -66.8 -55.93 12.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 -175.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.53 -25.55 52.19 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.244 0.618 . . . . 0.0 112.355 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.576 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -88.54 -17.52 30.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.597 0.759 . . . . 0.0 111.146 -168.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 10.9 pt-20 -65.8 -19.91 66.06 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.21 0.459 . . . . 0.0 110.424 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.6 t -67.98 -44.86 75.69 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.075 0.95 . . . . 0.0 111.172 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.8 pt-20 -73.77 -29.42 62.19 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -62.68 -48.54 78.84 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 1.2 tm-20 -60.89 -38.01 84.19 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.782 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.88 -19.89 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.088 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 151' ' ' GLU . 43.7 t -68.77 -47.14 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.512 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 33.7 m-85 -91.82 2.74 56.31 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -174.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -60.78 -55.51 32.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.475 0.71 . . . . 0.0 112.128 177.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -70.3 -9.73 56.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 16' ' ' ILE . 93.8 mt -73.53 -31.18 63.54 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.995 0.518 . . . . 0.0 109.896 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.4 -52.21 3.57 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 . . . . . 0 CA--C 1.554 1.134 0 C-N-CA 125.456 1.502 . . . . 0.0 111.167 177.28 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 80' ' ' SER . 38.0 mm -87.29 135.38 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.493 0.717 . . . . 0.0 110.082 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -91.31 112.41 24.31 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.06 138.03 35.21 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.019 0.527 . . . . 0.0 111.367 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.18 152.44 49.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.536 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -84.53 138.56 38.41 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.029 0.531 . . . . 0.0 110.267 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.61 154.94 11.05 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 123.046 2.497 . . . . 0.0 112.22 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -64.83 129.75 40.92 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -167.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG11 HD22 ' A' ' 62' ' ' LEU . 97.4 t -91.12 76.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.518 HD13 HD13 ' A' ' 17' ' ' LEU . 26.9 tp -135.6 153.64 51.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -158.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.585 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 9.2 t70 -126.5 167.46 15.58 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.595 0.758 . . . . 0.0 109.09 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.26 -12.77 61.63 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.799 0.84 . . . . 0.0 111.085 170.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -119.45 73.72 0.96 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.565 ' HB ' HG12 ' A' ' 104' ' ' VAL . 99.9 m -125.15 122.63 37.66 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.508 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.0 tt0 -93.34 -39.27 11.04 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.966 1.306 . . . . 0.0 110.283 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 109' ' ' LEU . 52.5 mt -120.11 113.67 41.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 HD13 ' A' ' 10' ' ' LEU . 52.3 tp -103.84 116.18 31.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.504 ' HB ' HD23 ' A' ' 72' ' ' LEU . 46.2 mt -94.38 114.1 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.288 0.635 . . . . 0.0 109.372 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -104.25 113.7 27.43 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.552 0.741 . . . . 0.0 110.424 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -67.54 174.09 28.55 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.9 m -86.91 -79.8 0.26 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 tp -136.46 122.34 13.53 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.437 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.7 Cg_exo -58.04 135.3 67.75 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.073 1.849 . . . . 0.0 111.371 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.3 t -60.89 146.12 47.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.765 0.665 . . . . 0.0 109.58 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 4.9 p-10 -58.08 -34.3 69.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.431 0.292 . . . . 0.0 111.339 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.06 -43.01 69.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.272 1.029 . . . . 0.0 111.722 172.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.554 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 26.3 t -68.99 -39.19 79.5 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.011 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 24' ' ' SER . 40.3 mt -76.97 -15.62 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.27 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 13.7 mmt180 -60.63 -36.27 78.25 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.353 0.597 . . . . 0.0 109.599 176.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.76 -0.14 40.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.204 1.002 . . . . 0.0 111.288 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 61.93 21.87 12.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.35 1.06 . . . . 0.0 112.737 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 58' ' ' TYR . 10.6 pt20 -146.52 158.69 43.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.491 0.316 . . . . 0.0 111.689 -173.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.584 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 83.5 m-85 -68.6 -0.88 5.68 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.745 1.218 . . . . 0.0 112.564 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -105.41 1.77 28.08 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.689 1.196 . . . . 0.0 110.024 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -38.22 -42.42 1.24 Allowed Glycine 0 C--N 1.361 1.961 0 C-N-CA 124.917 1.246 . . . . 0.0 116.083 -174.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -126.78 146.38 56.97 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.5 2.133 . . . . 0.0 112.762 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.9 -6.36 85.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.02 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -67.58 104.78 1.68 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.58 6.39 41.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.267 0.627 . . . . 0.0 111.131 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -42.77 -43.24 3.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.898 0.879 . . . . 0.0 111.045 164.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.584 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 57.3 m95 -82.71 -28.13 30.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.868 0.867 . . . . 0.0 111.966 -177.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -68.79 -45.81 70.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.812 0.845 . . . . 0.0 111.071 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 mt -87.03 -39.03 16.01 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.133 0.573 . . . . 0.0 111.96 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.3 t -71.39 -36.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 -39.72 95.61 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.891 0.745 . . . . 0.0 112.471 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -67.96 -39.29 83.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.15 0.58 . . . . 0.0 110.496 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -68.89 -32.93 72.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.022 0.929 . . . . 0.0 113.07 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 pt -94.74 -11.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.929 0.492 . . . . 0.0 111.151 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.78 72.83 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 0.0 113.574 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -142.98 104.26 4.29 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.09 99.91 0.19 Allowed 'General case' 0 C--N 1.352 0.703 0 CA-C-O 121.453 0.644 . . . . 0.0 110.993 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 73.2 mt -67.06 -34.49 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -66.17 -21.21 66.32 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.227 1.011 . . . . 0.0 112.539 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -95.39 -31.55 13.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.87 0.468 . . . . 0.0 111.229 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.4 mtt -58.1 141.09 51.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.236 0.614 . . . . 0.0 111.176 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.41 137.69 57.1 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.141 -0.933 . . . . 0.0 109.395 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.491 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 38.4 t80 -45.66 -38.82 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -167.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 40.3 mt-10 -58.79 -59.93 4.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.534 0.734 . . . . 0.0 110.923 175.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -60.11 -34.15 73.1 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.971 0.908 . . . . 0.0 111.729 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 53' ' ' LEU . 2.3 ttmp? -60.17 -47.5 85.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.875 1.27 . . . . 0.0 110.006 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.629 HD22 HG11 ' A' ' 9' ' ' VAL . 46.0 mt -67.5 -40.35 85.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.001 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 57.7 mtpt -60.2 -31.34 70.06 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.574 0.35 . . . . 0.0 111.736 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -67.88 -34.52 76.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.072 0.549 . . . . 0.0 110.58 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.55 -57.31 11.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.585 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -58.73 -36.78 74.87 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.137 0.575 . . . . 0.0 111.264 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -53.51 -46.58 70.13 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 111.9 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.06 8.41 23.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.0 0.92 . . . . 0.0 111.852 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 60.53 37.3 19.67 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.595 1.158 . . . . 0.0 110.353 -178.403 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.81 140.41 21.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.383 1.073 . . . . 0.0 109.225 174.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.35 162.88 17.07 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 170.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.504 HD23 ' HB ' ' A' ' 18' ' ' ILE . 98.0 mt -128.76 138.95 52.38 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -164.69 -168.74 1.55 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -131.29 160.98 33.35 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.61 0.641 . . . . 0.0 111.553 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.504 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.6 t -94.04 -48.28 13.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 124.204 1.002 . . . . 0.0 110.809 175.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -93.78 113.35 25.38 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 87.9 tttt -64.28 -37.29 86.95 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.252 0.97 . . . . 0.0 110.513 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.86 134.97 17.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.849 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -143.66 136.26 6.81 Favored Glycine 0 C--O 1.218 -0.892 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.513 ' HB3' HD13 ' A' ' 2' ' ' ILE . 23.9 p -114.43 162.94 16.01 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.958 0.879 . . . . 0.0 110.594 -177.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -141.17 135.25 30.63 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -160.76 -163.04 1.0 Allowed 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.575 0.547 . . . . 0.0 109.824 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.53 69.39 1.75 Allowed Glycine 0 C--N 1.341 0.847 0 O-C-N 123.216 0.322 . . . . 0.0 112.676 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 t -127.04 176.34 7.42 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.719 1.208 . . . . 0.0 109.267 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' A' ' 86' ' ' ASP . 49.8 tp60 -72.79 169.8 15.98 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' H ' ' HG3' ' A' ' 85' ' ' GLN . 18.3 m-20 -47.49 89.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.839 1.256 . . . . 0.0 113.471 -171.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.9 m -153.14 105.94 2.95 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.752 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -87.44 -32.97 19.22 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mt -101.32 66.91 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 165.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.36 65.05 4.07 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.802 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.593 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.0 t70 -177.87 153.85 0.87 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.075 0.95 . . . . 0.0 108.577 -169.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -121.62 22.07 10.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.574 0.75 . . . . 0.0 111.746 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.0 tp10 -80.28 101.32 8.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.0 mt -94.61 153.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.18 0.992 . . . . 0.0 110.162 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.97 156.33 19.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.947 0.899 . . . . 0.0 109.429 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.01 122.12 34.22 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.515 0.726 . . . . 0.0 110.312 -174.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.504 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 48.2 m-85 -109.0 6.85 25.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.52 0.728 . . . . 0.0 112.007 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -70.45 -17.14 62.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.63 0.372 . . . . 0.0 111.048 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.94 -5.19 77.69 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.657 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -47.89 -49.06 31.02 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.561 0.745 . . . . 0.0 112.666 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -62.0 -27.8 69.12 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -82.91 -54.36 5.14 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.444 0.698 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -75.45 -27.72 59.02 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' A' ' 14' ' ' THR . 4.1 m -132.54 92.61 27.04 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.285 0.634 . . . . 0.0 110.851 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 71.5 Cg_endo -74.19 -36.89 2.95 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.907 2.405 . . . . 0.0 111.781 172.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.3 mmmt -79.83 -5.93 56.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.095 0.958 . . . . 0.0 111.392 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.3 tp -57.84 128.91 39.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.842 0.857 . . . . 0.0 111.316 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.528 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -137.7 -22.61 1.09 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.328 171.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB2' HH11 ' A' ' 108' ' ' ARG . 23.6 tp -129.64 126.57 38.72 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.883 0.473 . . . . 0.0 110.577 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.551 ' HB ' HG22 ' A' ' 131' ' ' THR . 33.7 mt -113.78 110.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.458 ' HB3' HD12 ' A' ' 134' ' ' LEU . 76.8 m -96.12 114.21 25.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 110.509 -175.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.47 116.19 28.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.023 0.929 . . . . 0.0 110.742 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.538 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 83.1 m-20 -82.92 102.39 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.75 138.32 9.48 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -58.83 -32.1 69.08 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.144 0.578 . . . . 0.0 111.513 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -53.31 -42.89 67.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.892 0.877 . . . . 0.0 112.303 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.29 -38.72 71.8 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.426 0.631 . . . . 0.0 110.314 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.57 -9.53 55.7 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.561 -1.2 . . . . 0.0 114.44 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -24.64 66.91 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 117.374 0.587 . . . . 0.0 110.547 172.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.4 21.5 16.59 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.198 0.999 . . . . 0.0 111.215 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -66.24 -52.16 39.79 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.17 0.988 . . . . 0.0 112.405 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.46 -14.61 30.89 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.608 1.539 . . . . 0.0 112.357 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -66.1 -44.98 82.82 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.905 0.882 . . . . 0.0 109.668 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 -20.49 29.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 50.5 ttt180 -72.24 -29.13 63.63 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.06 -22.28 75.87 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 58.4 mtt -76.66 -9.9 59.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.195 0.598 . . . . 0.0 111.719 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.89 14.75 16.4 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 120.175 -0.236 . . . . 0.0 113.412 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.2 m-85 -109.12 145.72 35.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 0.0 109.734 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 mm-40 -70.55 137.11 49.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 163.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.551 HG22 ' HB ' ' A' ' 110' ' ' ILE . 25.8 p -128.43 138.4 52.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -129.33 117.99 21.54 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.785 1.234 . . . . 0.0 108.849 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.41 103.33 9.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 111' ' ' CYS . 48.0 mt -88.53 131.92 40.53 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 148' ' ' ARG . 45.8 Cg_exo -59.57 136.3 70.24 Favored 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.687 2.258 . . . . 0.0 111.133 176.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.6 t -50.24 118.99 3.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.261 0.975 . . . . 0.0 111.013 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 p -83.65 30.17 0.5 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.901 0.881 . . . . 0.0 111.529 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 p -61.05 149.52 36.73 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.715 0.806 . . . . 0.0 110.576 165.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -53.14 -42.97 62.89 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.729 0.643 . . . . 0.0 114.4 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.01 93.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.329 0.652 . . . . 0.0 111.782 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -78.27 -28.51 47.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.168 0.587 . . . . 0.0 110.065 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.98 -36.62 77.55 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.322 0.649 . . . . 0.0 110.952 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -57.02 -20.78 26.19 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.118 0.967 . . . . 0.0 112.565 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -112.5 -33.69 6.08 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.243 0.617 . . . . 0.0 110.847 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.7 m -69.5 83.12 0.41 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -95.8 -57.18 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.396 1.079 . . . . 0.0 110.586 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.05 -32.41 69.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.182 0.593 . . . . 0.0 110.399 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.514 ' HB3' ' HG2' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -86.95 -31.81 20.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.908 -172.599 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.75 -28.85 67.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.006 0.821 . . . . 0.0 109.01 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -65.87 -42.91 89.74 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.1 pt-20 -71.9 -26.96 62.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -67.52 -43.21 81.38 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.69 -39.12 84.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.401 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.497 -175.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 151' ' ' GLU . 54.8 t -80.73 -62.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.003 0.521 . . . . 0.0 110.407 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 54.6 m-85 -85.08 2.45 43.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -165.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -25.62 62.84 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -78.21 -8.15 57.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.558 0.343 . . . . 0.0 111.814 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.81 -38.8 76.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.815 0.446 . . . . 0.0 111.312 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.25 -41.68 40.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 C--O 1.243 0.733 0 C-N-CA 125.566 1.547 . . . . 0.0 106.89 175.552 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.34 139.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -88.34 110.14 20.54 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.2 mmt-85 -84.25 136.42 33.94 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.182 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.538 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -68.22 162.46 49.32 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 123.634 0.584 . . . . 0.0 112.052 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -101.47 146.14 31.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.05 137.09 17.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.741 2.294 . . . . 0.0 111.866 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.4 138.79 58.27 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.94 0.896 . . . . 0.0 111.625 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.63 81.29 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.537 HD11 ' CG1' ' A' ' 104' ' ' VAL . 40.8 tp -128.0 145.36 51.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.358 -163.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -123.41 159.67 28.46 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.603 1.161 . . . . 0.0 107.909 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.13 -26.73 64.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.987 0.515 . . . . 0.0 111.202 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -111.46 89.53 3.08 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -135.48 107.64 7.21 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.303 0.641 . . . . 0.0 109.61 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 69' ' ' ARG . 59.7 mm-40 -80.47 -35.74 34.39 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.396 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 24.3 mt -129.09 124.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 123.461 0.704 . . . . 0.0 109.857 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.79 117.4 34.02 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mt -94.15 112.83 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.52 119.66 39.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.727 0.811 . . . . 0.0 109.981 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.24 177.11 46.39 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 164.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.508 ' OG ' ' HB3' ' A' ' 116' ' ' LYS . 47.4 t -90.16 -75.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 tp -129.59 125.2 22.26 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 175.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.538 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 50.6 Cg_exo -59.28 125.0 16.78 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.033 1.822 . . . . 0.0 110.509 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -78.76 173.07 12.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.8 -37.28 78.69 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.046 0.539 . . . . 0.0 111.578 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.57 -42.95 89.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.871 0.868 . . . . 0.0 111.475 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.5 m -65.4 -41.9 93.15 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.024 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.02 -26.78 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.852 1.261 . . . . 0.0 112.304 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -63.37 -39.56 94.86 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.892 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -5.18 22.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.149 0.58 . . . . 0.0 111.186 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 62.5 31.22 17.13 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.688 1.195 . . . . 0.0 111.253 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -127.68 139.34 52.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.908 1.283 . . . . 0.0 108.887 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -57.56 -40.48 78.99 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.378 0.609 . . . . 0.0 109.535 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HA ' ' HE1' ' A' ' 42' ' ' TRP . 24.6 t80 -47.71 -44.76 27.98 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.422 169.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.39 -107.29 0.1 Allowed Glycine 0 C--N 1.362 2.012 0 O-C-N 124.043 0.839 . . . . 0.0 113.301 -170.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -122.72 146.6 48.44 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.294 1.037 . . . . 0.0 109.794 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -40.54 119.04 0.67 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.821 3.68 . . . . 0.0 114.216 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.29 -33.12 0.09 OUTLIER Glycine 0 N--CA 1.472 1.071 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.431 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -93.46 126.9 38.85 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.52 0.728 . . . . 0.0 109.245 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -81.64 1.49 33.81 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.399 1.08 . . . . 0.0 111.017 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -37.51 -49.48 1.06 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.918 1.687 . . . . 0.0 113.073 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.418 ' HE1' ' HA ' ' A' ' 34' ' ' TYR . 74.7 m95 -73.37 -24.21 60.3 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.402 -173.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 ttm-85 -88.29 -27.17 21.88 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 111.117 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.35 -51.36 9.52 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 110.569 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.96 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.27 -36.79 85.55 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.069 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -64.23 -40.97 97.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.631 . . . . 0.0 109.498 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 156' ' ' PHE . . . -62.81 -50.32 71.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.585 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.3 pt -88.19 -4.98 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.49 0.316 . . . . 0.0 111.212 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.3 28.99 64.93 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.147 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -146.15 92.28 2.17 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.01 101.16 0.14 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.243 0.617 . . . . 0.0 109.868 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.402 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 54.3 mt -68.73 -17.43 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.401 1.081 . . . . 0.0 112.229 -167.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.02 -41.93 93.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.543 0.737 . . . . 0.0 112.044 -169.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.38 -32.64 71.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.58 0.752 . . . . 0.0 112.459 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -60.37 148.85 35.73 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.307 0.643 . . . . 0.0 112.55 -175.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 153.72 32.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 167.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.521 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 33.5 t80 -54.45 -45.61 73.12 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -164.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -63.8 -45.2 90.75 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.044 0.538 . . . . 0.0 111.271 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -34.59 78.74 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.06 0.944 . . . . 0.0 110.333 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 29.7 ttmt -65.46 -41.44 93.37 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.814 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 29.2 mt -58.06 -48.46 80.04 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.07 0.856 . . . . 0.0 109.625 173.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -55.92 -45.23 78.78 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.237 0.96 . . . . 0.0 111.693 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -67.41 -45.64 75.57 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 123.543 0.527 . . . . 0.0 110.691 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.7 mt -55.84 -56.56 19.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.752 0.821 . . . . 0.0 110.527 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -67.95 -30.65 70.0 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.296 1.039 . . . . 0.0 111.58 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -63.45 -35.94 82.1 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.815 0.846 . . . . 0.0 110.884 170.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -84.82 5.13 29.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.388 0.675 . . . . 0.0 111.254 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 2.0 mpt_? 65.36 34.47 8.19 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-O 122.25 1.024 . . . . 0.0 110.197 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.06 135.65 49.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 108.731 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.61 169.04 13.66 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.0 mt -126.73 147.42 49.97 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.759 0.824 . . . . 0.0 109.127 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -166.18 -169.02 1.34 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.33 164.34 30.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.312 0.645 . . . . 0.0 110.565 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.414 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.7 t -86.14 -42.38 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.037 0.935 . . . . 0.0 111.074 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -100.22 115.78 30.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.095 0.558 . . . . 0.0 110.625 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 1.6 tmtp? -66.47 -34.75 78.64 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -144.82 135.26 24.35 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.684 -0.635 . . . . 0.0 110.614 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -157.26 148.72 18.78 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.547 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 p -116.41 173.51 6.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.303 1.041 . . . . 0.0 109.119 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.66 109.93 11.38 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -89.67 -61.8 1.61 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.238 -167.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 138.65 -60.04 0.59 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.7 m -88.18 38.16 0.84 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.876 0.87 . . . . 0.0 111.368 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -126.35 153.67 44.58 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.477 1.111 . . . . 0.0 108.488 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.38 -67.18 0.47 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.7 t -81.81 135.98 35.42 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -39.74 91.92 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.04 0.536 . . . . 0.0 111.204 -176.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt -63.44 89.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.933 0.893 . . . . 0.0 110.743 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.38 58.09 4.18 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.519 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.542 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.9 t0 -171.19 144.05 2.0 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -110.43 17.67 20.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.887 0.875 . . . . 0.0 111.59 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 45.8 tt0 -85.01 103.01 13.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.488 0.661 . . . . 0.0 109.376 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.55 154.01 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.809 1.244 . . . . 0.0 109.451 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -79.58 157.2 27.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.686 0.794 . . . . 0.0 109.748 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.22 139.78 30.14 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.414 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 80.8 m-85 -130.48 11.58 5.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.713 0.805 . . . . 0.0 110.951 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 99.2 p -77.62 -12.1 59.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.969 -0.457 . . . . 0.0 110.469 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.03 -4.87 68.55 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.532 -0.593 . . . . 0.0 112.307 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 mt -51.23 -49.47 61.02 Favored 'General case' 0 C--N 1.37 1.494 0 C-N-CA 123.729 0.812 . . . . 0.0 111.362 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.549 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 44.6 mtpt -64.92 -16.18 62.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -171.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.94 -40.13 9.04 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 111.611 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -85.44 -26.61 26.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.537 ' CG1' HD11 ' A' ' 10' ' ' LEU . 2.2 m -129.02 89.5 48.46 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 122.868 0.467 . . . . 0.0 110.04 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.64 -28.7 20.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.296 1.997 . . . . 0.0 110.969 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -84.61 -11.95 54.97 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 112.864 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 32.3 tp -57.69 101.85 0.08 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.033 0.833 . . . . 0.0 110.665 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -93.21 -43.97 8.57 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.588 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.7 tp -134.19 135.66 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.555 0.742 . . . . 0.0 109.894 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.4 mt -105.08 136.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 86.3 m -117.75 115.39 24.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.14 0.427 . . . . 0.0 110.251 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -93.56 123.06 36.62 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -101.81 111.35 23.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.18 134.99 8.62 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -53.17 -47.17 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.304 1.042 . . . . 0.0 112.18 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.508 ' HB3' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -60.22 -20.83 60.53 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.805 0.842 . . . . 0.0 112.641 -178.13 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.56 -46.36 17.47 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.372 0.606 . . . . 0.0 109.476 170.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.26 -9.76 68.33 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.95 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -68.35 -17.52 64.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.009 0.524 . . . . 0.0 110.636 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.79 21.47 17.45 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.183 0.993 . . . . 0.0 110.988 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.44 -51.48 59.96 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.15 -0.928 . . . . 0.0 112.357 171.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.28 -24.44 67.7 Favored 'Trans proline' 0 C--N 1.405 3.551 0 C-N-CA 122.084 1.856 . . . . 0.0 112.698 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.81 -57.21 8.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.914 0.886 . . . . 0.0 110.181 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.48 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 12.2 mt -79.18 -21.03 46.96 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 6.9 ptm180 -75.22 -11.65 60.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 120.703 0.287 . . . . 0.0 110.715 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.59 -15.14 81.44 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.405 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.48 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -81.94 10.71 5.98 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 174.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.24 19.74 79.76 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 122.749 0.214 . . . . 0.0 112.716 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.549 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 18.3 m-85 -108.79 139.59 43.39 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.304 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -73.48 142.42 46.8 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -129.99 148.15 51.82 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.401 ' HB2' HD11 ' A' ' 109' ' ' LEU . 54.3 tptt -139.37 123.54 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.215 1.006 . . . . 0.0 108.864 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.04 122.81 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.52 HD21 HG21 ' A' ' 155' ' ' VAL . 90.4 mt -113.02 150.15 42.44 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.58 177.37 4.08 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.772 2.314 . . . . 0.0 111.561 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 m -66.02 130.29 42.74 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -83.89 14.91 3.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.834 0.854 . . . . 0.0 112.044 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -69.88 156.26 39.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.147 0.979 . . . . 0.0 111.78 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.17 -18.61 69.38 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.693 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.22 83.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.362 0.665 . . . . 0.0 111.056 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -76.56 -2.59 33.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.7 0.8 . . . . 0.0 112.477 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.446 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 20.1 ttm-85 -56.13 -33.68 65.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.039 0.935 . . . . 0.0 113.317 -172.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -33.38 72.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.643 0.589 . . . . 0.0 110.606 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.01 5.94 20.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.774 0.829 . . . . 0.0 111.994 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 13.7 t -91.07 14.8 13.05 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.151 0.58 . . . . 0.0 112.195 -175.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.98 -58.06 5.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.44 ' HB2' ' NH1' ' A' ' 148' ' ' ARG . 17.4 m120 -59.21 -15.06 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.44 ' NH1' ' HB2' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -74.96 -23.65 58.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.974 0.51 . . . . 0.0 110.101 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.36 -55.63 32.27 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.26 0.624 . . . . 0.0 110.695 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -73.93 -32.34 63.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 111.161 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 155' ' ' VAL . 19.3 tt0 -67.37 -56.75 8.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.165 0.586 . . . . 0.0 110.224 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -69.58 -25.91 64.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.523 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 32.4 tt0 -59.35 -49.61 77.14 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 123.821 0.7 . . . . 0.0 109.442 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.53 77.69 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.553 -171.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.52 HG21 HD21 ' A' ' 134' ' ' LEU . 92.6 t -61.91 -32.64 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 124.173 0.989 . . . . 0.0 112.673 -174.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.417 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 44.0 m-85 -115.55 -11.99 11.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 112.909 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.523 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 14.4 ptm180 -74.1 -26.56 60.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.555 0.616 . . . . 0.0 111.591 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -73.84 -8.8 57.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.571 0.348 . . . . 0.0 111.906 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.412 HD11 HD12 ' A' ' 16' ' ' ILE . 80.8 mt -70.26 -12.21 61.43 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.338 0.655 . . . . 0.0 112.732 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -90.37 -1.99 57.94 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.036 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 . . . . . 0 CA--C 1.555 1.148 0 C-N-CA 125.561 1.544 . . . . 0.0 110.435 -175.01 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mm . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 25' ' ' ASP . 11.1 mptt -87.61 117.51 26.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -100.12 134.04 43.62 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.366 0.667 . . . . 0.0 110.558 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.512 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.2 -174.03 17.55 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.384 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -117.03 144.23 33.16 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 122.948 0.499 . . . . 0.0 110.281 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.42 145.42 16.13 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.024 2.483 . . . . 0.0 112.003 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.11 128.85 38.46 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.825 0.703 . . . . 0.0 111.124 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 62' ' ' LEU . 48.7 t -93.75 78.88 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.472 HD11 ' CG1' ' A' ' 104' ' ' VAL . 41.9 tp -128.71 154.07 46.69 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 112.164 -161.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.51 154.92 37.21 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.435 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 9.9 pt-20 -65.13 -10.68 32.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.15 0.58 . . . . 0.0 112.222 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.435 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 20.7 m-80 -120.08 97.38 5.57 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.46 ' HB ' HG12 ' A' ' 104' ' ' VAL . 52.6 m -144.04 112.93 6.71 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.387 0.675 . . . . 0.0 110.205 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.56 -36.21 29.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.053 . . . . 0.0 110.75 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.16 116.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.241 0.616 . . . . 0.0 109.484 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -104.95 115.51 30.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.0 mt -98.38 109.32 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.736 0.814 . . . . 0.0 109.046 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.432 HD23 ' HB3' ' A' ' 73' ' ' TRP . 80.8 mt -98.08 108.93 21.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 109.026 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.72 -177.9 11.99 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 166.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 p -89.61 -82.17 0.27 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -136.12 114.92 10.88 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.5 Cg_exo -52.89 136.77 60.62 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.958 2.438 . . . . 0.0 112.846 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 m -61.22 145.64 50.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.105 0.878 . . . . 0.0 109.634 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 7.8 p-10 -61.89 -31.26 71.53 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.158 0.436 . . . . 0.0 110.73 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.75 -36.24 76.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.87 0.868 . . . . 0.0 110.793 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.1 m -66.5 -47.08 74.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.45 -26.57 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.763 1.225 . . . . 0.0 112.832 -171.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 18.7 mmt85 -69.4 -36.36 76.68 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 110.089 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.64 -16.12 35.33 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.281 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 65.38 21.59 11.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.695 1.598 . . . . 0.0 111.597 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.89 135.9 40.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.842 1.257 . . . . 0.0 108.873 -173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -57.98 -40.49 80.79 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 122.936 0.495 . . . . 0.0 110.817 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.98 -13.33 45.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.512 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.89 16.41 Favored Glycine 0 C--N 1.362 1.984 0 C-N-CA 124.02 0.819 . . . . 0.0 113.523 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -109.78 112.29 58.39 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 165.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.07 0.56 3.1 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.794 2.996 . . . . 0.0 114.273 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.29 -14.2 80.89 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -72.82 97.64 2.28 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 168.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -80.07 -1.65 40.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.971 0.909 . . . . 0.0 110.885 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -36.03 -41.91 0.26 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.916 2.087 . . . . 0.0 113.443 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.36 -28.9 64.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.57 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -84.11 -37.84 21.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.106 0.562 . . . . 0.0 111.117 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.68 -48.24 80.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 0.0 110.224 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -74.02 -37.26 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.416 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.08 -41.11 99.88 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.071 0.388 . . . . 0.0 114.071 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -71.41 -30.63 66.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.745 0.418 . . . . 0.0 110.363 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -75.82 -36.91 59.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.807 0.843 . . . . 0.0 112.465 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 pt -91.11 -10.46 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.396 0.678 . . . . 0.0 111.143 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.18 19.81 79.75 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.588 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -135.7 112.64 10.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -71.53 96.44 1.53 Allowed 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.588 0.709 . . . . 0.0 111.696 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.68 -35.87 81.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.013 0.925 . . . . 0.0 110.917 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -53.29 -50.44 64.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.627 1.171 . . . . 0.0 112.626 -170.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -81.96 -6.31 59.02 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.275 0.63 . . . . 0.0 112.097 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtt -86.11 139.62 30.95 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 151.35 33.56 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.081 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.517 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 53.6 t80 -50.0 -42.94 50.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -167.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 42.5 mt-10 -60.31 -46.2 90.73 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.305 0.378 . . . . 0.0 110.758 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -68.53 -45.13 73.02 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -59.71 -32.99 71.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.14 0.427 . . . . 0.0 110.885 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.565 HD22 HG11 ' A' ' 9' ' ' VAL . 47.2 mt -66.77 -43.15 84.8 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.81 172.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 74.7 mmtt -57.06 -41.17 78.27 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.216 0.606 . . . . 0.0 110.233 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -65.27 -39.25 92.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.498 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.05 -46.25 85.22 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.851 0.461 . . . . 0.0 110.228 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 28.6 mmtp -59.88 -39.77 86.43 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.104 0.561 . . . . 0.0 109.882 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.05 -45.65 90.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.992 1.317 . . . . 0.0 111.335 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -86.25 7.78 23.86 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.328 0.251 . . . . 0.0 111.035 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 67.85 38.5 2.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.479 1.111 . . . . 0.0 110.988 171.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.63 132.92 57.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.15 1.38 . . . . 0.0 109.504 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.5 151.6 18.03 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 46.5 mt -119.84 141.06 49.87 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.341 0.656 . . . . 0.0 109.29 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.432 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.9 t90 -165.09 -168.96 1.53 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -133.54 177.91 7.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.956 0.902 . . . . 0.0 109.888 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.7 t -95.64 -56.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.675 0.79 . . . . 0.0 109.647 172.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 57.3 m-85 -84.21 107.98 16.84 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.095 0.558 . . . . 0.0 110.607 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.501 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 3.7 tmtm? -66.82 -31.14 71.57 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.813 0.845 . . . . 0.0 109.044 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -152.86 130.87 11.81 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.061 0.544 . . . . 0.0 109.742 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 91' ' ' ASP . . . -151.03 144.21 11.49 Favored Glycine 0 C--O 1.238 0.4 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.825 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.059 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.37 -70.1 1.3 Allowed Glycine 0 C--N 1.344 0.989 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.759 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.528 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 1.1 m-20 -38.88 133.41 1.12 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.873 1.269 . . . . 0.0 113.349 173.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -114.62 25.87 10.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.438 -165.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 8.4 tp10 -78.88 111.96 15.57 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.72 144.07 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.88 0.872 . . . . 0.0 109.134 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -68.95 149.61 48.65 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.233 1.013 . . . . 0.0 110.796 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -78.27 130.94 36.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.516 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 35.3 m-85 -120.67 3.88 10.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.252 0.621 . . . . 0.0 111.395 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.0 t -74.63 -14.69 60.79 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.007 0.523 . . . . 0.0 109.817 173.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.88 -4.04 61.87 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.148 -0.807 . . . . 0.0 113.094 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 mt -52.8 -32.88 46.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 117.732 0.766 . . . . 0.0 112.879 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -68.59 -27.19 65.82 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.779 0.323 . . . . 0.0 111.444 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -83.31 -53.0 6.07 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.696 0.799 . . . . 0.0 111.466 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.534 ' HG3' HG22 ' A' ' 104' ' ' VAL . 25.4 ptm -73.32 -29.41 62.66 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.305 0.642 . . . . 0.0 111.341 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -139.24 86.96 14.12 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.449 0.7 . . . . 0.0 111.209 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.69 -25.97 8.78 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.469 2.113 . . . . 0.0 112.554 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -77.8 -10.13 59.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.4 0.68 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 36.2 tp -54.39 131.09 41.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.81 0.694 . . . . 0.0 110.673 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.41 ' HD2' ' NE2' ' A' ' 158' ' ' HIS . 18.0 ptp180 -128.56 -37.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.004 0.921 . . . . 0.0 108.707 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 tp -132.29 125.34 30.75 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.255 0.622 . . . . 0.0 110.432 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.508 HG12 HD21 ' A' ' 107' ' ' LEU . 32.9 mt -101.69 109.53 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.531 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.5 m -95.12 112.98 24.62 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.165 0.507 . . . . 0.0 109.928 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.1 114.49 25.75 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.189 0.996 . . . . 0.0 109.396 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -90.51 107.16 18.98 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.34 28.45 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.327 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -56.07 -50.7 70.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 112.851 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 76' ' ' PHE . 26.3 mmmt -50.26 -37.22 34.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.41 -46.03 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.018 0.527 . . . . 0.0 110.103 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.73 -14.59 70.25 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 114.736 -1.12 . . . . 0.0 114.705 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.64 -28.38 69.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.974 0.51 . . . . 0.0 110.837 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.19 19.99 12.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.271 1.028 . . . . 0.0 111.227 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 41.2 tt0 -61.6 -54.71 49.36 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.627 170.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.23 -20.59 55.78 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 122.262 1.975 . . . . 0.0 113.438 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.56 -50.31 70.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.932 0.893 . . . . 0.0 110.163 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.49 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 9.8 mt -89.46 -6.67 56.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 29.3 mtp180 -69.62 -20.04 63.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.966 0.507 . . . . 0.0 109.944 168.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.35 -16.74 80.15 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.402 -0.666 . . . . 0.0 113.42 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.2 mpt? -85.73 9.97 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.702 0.751 . . . . 0.0 112.183 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.96 17.28 71.45 Favored Glycine 0 C--N 1.352 1.441 0 C-N-CA 122.869 0.271 . . . . 0.0 113.633 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -111.07 134.34 52.74 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.548 0.739 . . . . 0.0 109.611 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.99 143.28 56.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.446 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.4 p -127.85 139.59 52.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.706 0.802 . . . . 0.0 110.16 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -132.14 118.7 19.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.668 1.187 . . . . 0.0 108.928 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.96 95.11 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.9 mt -75.42 150.99 85.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 73.0 Cg_endo -72.5 163.88 37.25 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.084 1.856 . . . . 0.0 110.359 171.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -63.4 133.09 53.43 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.7 p -79.31 -3.97 48.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.264 0.626 . . . . 0.0 112.026 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -66.68 159.52 27.55 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 111.059 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 142' ' ' ARG . . . -58.43 -28.93 62.77 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.501 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.9 76.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.837 0.855 . . . . 0.0 112.002 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 135' ' ' PRO . 49.1 t30 -89.94 -33.76 16.29 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.063 0.545 . . . . 0.0 110.982 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.539 HH21 ' HA ' ' A' ' 146' ' ' LYS . 6.5 tpm_? -51.61 -44.42 62.88 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.089 1.356 . . . . 0.0 112.458 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -60.87 -12.88 12.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.745 1.218 . . . . 0.0 113.317 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -121.06 -40.63 2.59 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.155 0.982 . . . . 0.0 110.823 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 65.4 m -93.3 85.64 5.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.697 0.799 . . . . 0.0 110.407 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.539 ' HA ' HH21 ' A' ' 142' ' ' ARG . 34.0 mmtp -93.99 -50.64 5.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.51 0.724 . . . . 0.0 111.475 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -86.05 -4.15 59.1 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.932 0.493 . . . . 0.0 111.506 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.3 tpt180 -78.31 -24.62 46.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.675 0.39 . . . . 0.0 110.097 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 11.3 pt-20 -62.12 -13.46 27.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 m -65.68 -30.5 71.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.37 0.668 . . . . 0.0 112.194 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 155' ' ' VAL . 14.7 pt-20 -72.61 -29.6 63.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.795 0.438 . . . . 0.0 109.925 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -67.35 -37.65 83.56 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 31.5 tt0 -67.55 -37.69 83.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.978 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.48 72.63 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.793 0.683 . . . . 0.0 111.168 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 151' ' ' GLU . 80.2 t -71.87 -60.39 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.567 0.747 . . . . 0.0 111.03 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.432 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 50.1 m-85 -88.09 -7.56 56.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.77 -28.57 66.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.1 0.409 . . . . 0.0 110.86 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.41 ' NE2' ' HD2' ' A' ' 108' ' ' ARG . 0.6 OUTLIER -67.88 -21.66 65.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.596 0.758 . . . . 0.0 111.219 -175.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.4 mt -64.85 -14.28 58.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.428 1.091 . . . . 0.0 113.277 -170.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -98.48 -62.52 1.23 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 166.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 124.565 1.146 . . . . 0.0 108.179 178.132 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 80' ' ' SER . 40.5 mm . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -97.21 111.95 23.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -95.15 133.8 38.58 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.579 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.67 -166.66 9.71 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.948 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -117.97 147.77 41.99 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.384 0.674 . . . . 0.0 109.318 -172.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.06 162.16 27.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.196 1.931 . . . . 0.0 110.668 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.55 120.43 10.54 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.24 0.616 . . . . 0.0 111.486 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 62' ' ' LEU . 41.0 t -94.56 84.6 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.545 HD11 HG12 ' A' ' 104' ' ' VAL . 48.8 tp -129.47 154.56 46.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.246 -159.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -123.62 159.31 29.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.936 0.894 . . . . 0.0 108.623 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HG3' HD22 ' A' ' 13' ' ' ASN . 11.4 pt-20 -59.57 -28.12 66.85 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.433 HD22 ' HG3' ' A' ' 12' ' ' GLU . 43.7 m-80 -111.18 86.84 2.4 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -131.1 112.11 12.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.692 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.1 tt0 -91.56 -31.97 15.71 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.748 1.219 . . . . 0.0 110.091 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 69.1 mt -125.58 122.16 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.796 0.838 . . . . 0.0 109.465 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.2 tp -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -95.41 106.35 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.411 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 75.7 mt -95.79 108.5 20.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 108.85 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.84 178.32 9.13 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 166.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 15.5 t -89.81 -75.59 0.45 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 tp -130.58 124.01 20.69 Favored Pre-proline 0 C--O 1.244 0.8 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.76 155.18 11.06 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -59.32 124.12 18.96 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -61.88 -22.37 65.49 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.121 0.568 . . . . 0.0 112.157 -171.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.29 -51.48 56.97 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.646 0.591 . . . . 0.0 110.111 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 t -55.04 -30.74 60.22 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.728 0.811 . . . . 0.0 111.872 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.8 mt -77.56 -26.75 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.893 0.877 . . . . 0.0 110.873 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -61.84 -27.63 68.92 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.256 0.623 . . . . 0.0 111.45 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -102.71 -3.48 26.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.474 0.71 . . . . 0.0 110.396 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 50.34 28.0 3.01 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.837 1.255 . . . . 0.0 113.168 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 34' ' ' TYR . 7.6 tt0 -149.09 141.78 24.5 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.001 0.521 . . . . 0.0 110.708 -170.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.456 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 66.1 m-85 -67.62 -6.03 18.43 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 123.94 0.896 . . . . 0.0 112.437 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 90.9 t80 -82.07 -24.85 35.02 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 109.357 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.3 -31.39 79.08 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.877 0.736 . . . . 0.0 114.84 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -123.24 111.98 30.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.995 0.398 . . . . 0.0 110.462 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -88.35 -0.94 6.86 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.445 2.764 . . . . 0.0 112.566 170.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.57 -6.39 89.35 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 41' ' ' PHE . 11.7 m120 -76.19 126.21 30.57 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.52 4.94 50.25 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 124.246 1.018 . . . . 0.0 110.027 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.562 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 86.6 m-85 -50.1 -36.56 30.07 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 109.674 163.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -73.56 -26.75 60.98 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.616 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -79.28 -44.84 20.89 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.727 0.811 . . . . 0.0 111.736 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.95 -38.64 57.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 0.0 111.473 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.25 -30.31 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.49 -53.29 36.51 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.559 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 149' ' ' GLU . 14.4 p-80 -65.84 -30.3 70.9 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.006 0.431 . . . . 0.0 110.356 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -68.88 -34.44 75.43 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.093 0.957 . . . . 0.0 112.145 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 64' ' ' THR . 11.4 pt -96.33 -10.39 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.987 0.915 . . . . 0.0 110.405 176.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.62 39.15 22.36 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 115.039 0.776 . . . . 0.0 115.039 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.92 127.68 1.31 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.425 1.09 . . . . 0.0 108.769 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -72.0 102.78 3.04 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.043 0.937 . . . . 0.0 112.556 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.3 mt -61.03 -25.55 66.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.478 1.111 . . . . 0.0 111.809 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -68.78 -31.24 70.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.657 0.783 . . . . 0.0 111.238 -172.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.36 -11.04 53.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.973 0.909 . . . . 0.0 110.962 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 56.8 mtt -85.08 137.66 32.9 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 152.4 38.4 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.327 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 34.4 t80 -40.28 -51.12 2.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.259 1.424 . . . . 0.0 113.331 -171.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.53 -52.17 62.32 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.1 0.96 . . . . 0.0 111.311 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.92 -42.71 90.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.591 0.756 . . . . 0.0 110.797 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -56.5 -53.34 58.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.829 1.252 . . . . 0.0 110.911 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.602 HD22 HG11 ' A' ' 9' ' ' VAL . 84.5 mt -65.48 -41.69 93.05 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.814 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -71.89 -28.14 63.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.698 0.399 . . . . 0.0 111.769 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.428 HG22 HD12 ' A' ' 49' ' ' ILE . 41.3 m -60.9 -42.32 97.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.109 0.48 . . . . 0.0 109.755 169.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.4 -50.29 66.05 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.013 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 30.8 mmtp -57.01 -44.78 83.13 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.454 0.702 . . . . 0.0 109.932 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -53.75 -41.29 66.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.243 1.417 . . . . 0.0 112.226 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -84.1 0.88 46.65 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.92 0.888 . . . . 0.0 111.746 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 66.9 42.73 2.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.852 1.261 . . . . 0.0 110.387 -178.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.38 136.92 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.806 1.242 . . . . 0.0 109.191 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.25 163.17 14.06 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 170.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -124.39 144.4 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.929 0.892 . . . . 0.0 109.162 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.411 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.1 t90 -165.29 -169.14 1.54 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -134.8 170.33 16.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 61.4 t -97.05 -35.39 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.478 0.711 . . . . 0.0 110.549 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -111.43 105.2 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.52 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 50.7 tptt -64.97 -26.98 68.53 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.362 1.065 . . . . 0.0 111.748 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.28 138.53 25.15 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.7 114.39 0.86 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.403 ' HB3' HD13 ' A' ' 2' ' ' ILE . 87.3 p . . . . . 0 C--O 1.239 0.543 0 CA-C-N 117.562 0.681 . . . . 0.0 109.925 -171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 mt . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.06 54.99 0.8 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 16.7 t70 -176.45 150.44 0.88 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -172.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.92 17.85 14.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.309 0.644 . . . . 0.0 112.623 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 77' ' ' LYS . 24.6 tt0 -77.76 105.67 9.08 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 mm -89.71 147.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.113 0.965 . . . . 0.0 109.392 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -74.6 143.92 44.17 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 168.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -82.88 127.4 33.46 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.447 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 64.2 m-85 -114.92 10.97 16.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.369 0.667 . . . . 0.0 110.998 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.1 t -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.696 0.398 . . . . 0.0 110.818 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.26 -4.76 86.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.738 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 104' ' ' VAL . 16.6 mt -49.41 -53.11 24.36 Favored 'General case' 0 C--N 1.368 1.392 0 C-N-CA 123.676 0.79 . . . . 0.0 111.212 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -59.35 -18.7 40.63 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.467 0.707 . . . . 0.0 112.58 -168.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.38 -42.74 13.41 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.501 1.121 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -94.97 -16.02 23.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 10' ' ' LEU . 17.1 m -122.35 88.12 48.8 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.168 0.587 . . . . 0.0 110.48 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.1 -39.12 3.3 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.184 1.923 . . . . 0.0 112.101 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -86.2 -6.12 59.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.765 0.826 . . . . 0.0 113.117 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.1 tp -61.85 117.45 5.91 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.611 0.569 . . . . 0.0 111.073 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -111.47 -40.53 4.35 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.941 0.896 . . . . 0.0 109.52 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 56.2 tp -129.35 133.08 47.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.925 0.89 . . . . 0.0 110.875 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.4 mt -112.7 146.31 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 134' ' ' LEU . 81.7 m -125.69 113.51 17.44 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.598 0.759 . . . . 0.0 110.317 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.64 107.93 19.59 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.595 1.158 . . . . 0.0 109.086 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -98.79 88.24 3.98 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.65 139.1 3.96 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.625 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.0 -50.84 65.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 111.695 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.48 -38.43 69.1 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.461 1.104 . . . . 0.0 112.008 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 21' ' ' SER . . . -65.57 -36.19 83.04 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.996 0.518 . . . . 0.0 110.823 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.85 -16.37 59.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 115.099 -0.955 . . . . 0.0 114.556 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.59 -29.73 70.75 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.11 0.481 . . . . 0.0 110.947 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -111.31 25.33 11.83 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.722 0.809 . . . . 0.0 111.084 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.52 -44.22 24.48 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.066 0.946 . . . . 0.0 112.543 170.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.426 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 71.9 Cg_endo -70.72 -13.77 32.53 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 121.8 1.667 . . . . 0.0 112.828 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 tp -58.91 -41.03 86.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.562 1.145 . . . . 0.0 110.191 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -96.98 -10.55 26.01 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.489 -174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 122' ' ' PRO . 19.6 mtm180 -63.93 -34.91 79.03 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.078 0.466 . . . . 0.0 110.244 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.93 -12.26 70.95 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.446 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.3 mtt -94.94 9.67 38.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 0.0 111.708 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.01 17.87 77.7 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 113.878 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -110.0 133.59 53.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.437 0.695 . . . . 0.0 110.071 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.68 143.74 55.82 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.0 p -132.93 149.73 52.22 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.707 0.803 . . . . 0.0 110.351 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -145.5 129.23 17.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.353 1.061 . . . . 0.0 109.369 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.64 97.07 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 111' ' ' CYS . 39.6 mt -77.62 144.34 69.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.951 176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.461 ' HD2' ' HE1' ' A' ' 152' ' ' TRP . 44.7 Cg_exo -59.3 154.82 44.14 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.521 2.814 . . . . 0.0 113.269 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.5 m -68.91 108.88 3.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 m -84.69 21.03 1.61 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.422 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.1 t -59.73 154.14 18.76 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.454 0.702 . . . . 0.0 110.522 171.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.19 69.69 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.149 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.48 -15.37 61.32 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.962 0.905 . . . . 0.0 111.452 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 144' ' ' PHE . 9.5 t30 -132.51 8.55 4.25 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.324 0.65 . . . . 0.0 111.204 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -65.77 -36.22 82.92 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.899 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -66.03 -25.88 67.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.725 1.21 . . . . 0.0 111.47 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.488 ' HD2' ' HA ' ' A' ' 141' ' ' ASN . 56.2 m-85 -92.56 -35.89 13.33 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.595 0.758 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 t -86.85 30.08 0.77 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.36 1.064 . . . . 0.0 111.425 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -67.71 -70.57 0.25 Allowed 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.79 -4.69 17.03 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 17.0 mmt180 -73.2 -22.92 60.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.167 0.587 . . . . 0.0 110.41 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 47' ' ' HIS . 12.7 pt-20 -55.54 -24.59 33.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.824 0.85 . . . . 0.0 112.592 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.7 t -67.53 -46.97 71.27 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 111.724 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 10.9 pt-20 -66.47 -31.97 73.05 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.461 ' HE1' ' HD2' ' A' ' 135' ' ' PRO . 35.8 m95 -68.66 -46.73 68.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 27.2 tt0 -62.47 -37.87 87.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.762 -173.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.29 82.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.153 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 151' ' ' GLU . 55.4 t -66.41 -35.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.901 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.565 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 45.9 m-85 -104.62 -1.73 26.03 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.489 -0.757 . . . . 0.0 112.648 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -81.17 -36.82 29.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.928 0.491 . . . . 0.0 110.768 170.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.409 ' HE1' HD11 ' A' ' 16' ' ' ILE . 4.3 p-80 -67.23 -17.74 64.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.034 0.209 . . . . 0.0 110.648 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.46 -30.75 71.78 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.523 0.729 . . . . 0.0 110.38 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.68 -44.92 95.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.563 0.745 . . . . 0.0 110.228 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.56 1.338 0 C-N-CA 124.415 1.086 . . . . 0.0 109.997 -179.652 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.53 HD13 ' HB3' ' A' ' 80' ' ' SER . 39.2 mm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -124.39 123.72 40.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.648 1.179 . . . . 0.0 108.88 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -89.64 139.35 30.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 122.755 0.422 . . . . 0.0 110.893 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -72.73 166.39 54.26 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.663 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -95.21 139.94 22.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.952 0.501 . . . . 0.0 111.174 -172.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.86 134.26 54.13 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.719 2.279 . . . . 0.0 110.251 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.73 143.35 54.54 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.005 0.816 . . . . 0.0 112.257 -169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 62' ' ' LEU . 34.5 t -97.92 61.35 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.502 HD11 ' CG1' ' A' ' 104' ' ' VAL . 64.4 tp -104.13 145.75 29.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.837 -171.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.659 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 5.2 t70 -116.38 158.42 23.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 9.8 pt-20 -63.86 -21.87 66.65 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.406 0.622 . . . . 0.0 111.084 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.405 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 42.0 m-80 -110.46 84.12 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.755 1.622 . . . . 0.0 107.754 174.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -135.56 123.73 23.02 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.515 0.726 . . . . 0.0 110.282 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 38.9 tt0 -106.36 -29.69 9.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.734 1.214 . . . . 0.0 110.677 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.658 HD12 HD11 ' A' ' 159' ' ' LEU . 37.9 mt -131.82 125.18 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.963 0.905 . . . . 0.0 109.628 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.0 tp -110.86 124.82 52.81 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.348 1.059 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' CYS . 47.1 mt -102.45 111.27 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.211 0.604 . . . . 0.0 109.66 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 73' ' ' TRP . 97.4 mt -99.07 127.94 45.1 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.2 -175.13 49.77 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 162.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -94.64 -71.78 0.65 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -134.82 124.59 16.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 71.0 Cg_exo -52.09 137.26 54.02 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.593 2.195 . . . . 0.0 112.442 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 28' ' ' ILE . 30.1 m -61.01 146.17 48.07 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.775 0.672 . . . . 0.0 110.537 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.6 t70 -58.07 -41.72 84.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.799 0.44 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -47.63 -40.54 19.89 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.973 1.309 . . . . 0.0 111.72 171.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -78.34 -39.67 38.81 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.137 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 24' ' ' SER . 74.8 mt -68.12 -25.62 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 124.365 1.066 . . . . 0.0 111.691 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 23.7 mmt180 -65.29 -28.01 69.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.475 0.31 . . . . 0.0 111.349 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -114.62 0.25 13.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.962 0.505 . . . . 0.0 111.393 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 62.69 24.96 14.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.901 1.28 . . . . 0.0 112.878 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -129.63 134.37 47.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.286 1.034 . . . . 0.0 108.806 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -56.51 -46.1 80.71 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.418 0.687 . . . . 0.0 110.513 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -64.15 -0.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.229 1.412 . . . . 0.0 112.889 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.24 -26.45 9.37 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.743 0.687 . . . . 0.0 113.609 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -102.74 108.85 59.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 163.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -26.75 41.21 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.68 2.253 . . . . 0.0 112.019 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.33 -6.53 40.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.791 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.86 129.21 38.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.61 -6.73 59.52 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.396 0.679 . . . . 0.0 111.723 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -37.91 -41.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.555 1.542 . . . . 0.0 113.541 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.603 0.761 . . . . 0.0 112.216 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.3 mtp-105 -75.63 -40.9 55.53 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.403 0.281 . . . . 0.0 110.797 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.77 -55.22 15.96 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.62 -34.32 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.496 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.77 88.42 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.346 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.77 -37.91 89.19 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.769 0.828 . . . . 0.0 109.754 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HA ' ' HG2' ' A' ' 153' ' ' GLU . . . -65.02 -47.78 76.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.296 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.8 pt -89.48 -14.79 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.536 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.99 39.45 20.04 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.034 0.374 . . . . 0.0 114.034 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -133.0 146.27 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.317 1.047 . . . . 0.0 109.361 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -85.15 91.46 8.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.43 -1.29 49.69 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.228 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.15 -48.99 11.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.32 -30.22 60.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.485 1.114 . . . . 0.0 112.307 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.3 mtt -61.23 156.43 18.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.973 0.509 . . . . 0.0 111.001 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.66 162.45 20.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.574 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 31.3 t80 -49.42 -55.37 13.32 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.929 0.892 . . . . 0.0 112.765 -173.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.59 -40.31 82.86 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.7 0.8 . . . . 0.0 111.526 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -66.56 -53.62 32.67 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.971 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 15.9 ptpt -64.86 -30.34 71.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.676 0.61 . . . . 0.0 112.074 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 80.8 mt -61.48 -49.56 76.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.124 0.57 . . . . 0.0 110.612 171.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -64.59 -28.59 69.73 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.447 0.467 . . . . 0.0 111.356 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -68.93 -39.23 79.72 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.371 0.668 . . . . 0.0 110.671 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 72.0 mt -65.15 -49.58 69.3 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 122.913 0.485 . . . . 0.0 110.479 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 4.5 mtpp -68.65 -27.4 65.96 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.945 0.898 . . . . 0.0 112.671 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -58.37 -40.9 83.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.623 0.769 . . . . 0.0 110.349 165.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 87.0 m-20 -93.6 19.28 8.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.397 1.079 . . . . 0.0 110.078 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 64.99 32.89 10.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.124 0.97 . . . . 0.0 111.693 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 72.3 mt -108.59 126.08 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.86 0.864 . . . . 0.0 109.514 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.8 156.04 16.22 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.4 mt -120.98 133.25 55.26 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.469 ' HB3' HD23 ' A' ' 19' ' ' LEU . 6.9 t90 -162.62 -169.16 2.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -145.64 165.25 29.25 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.287 1.035 . . . . 0.0 110.34 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.49 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.9 t -80.77 -47.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.644 0.778 . . . . 0.0 110.805 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -98.14 110.86 23.37 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.355 0.662 . . . . 0.0 111.711 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.09 -24.64 65.06 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.027 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.12 135.0 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.492 0.717 . . . . 0.0 109.609 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.29 146.46 15.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB3' HD13 ' A' ' 2' ' ' ILE . 79.1 p . . . . . 0 N--CA 1.477 0.887 0 CA-C-N 117.87 0.835 . . . . 0.0 110.344 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 51.2 mt . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.78 54.81 4.98 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.42 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.704 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.2 t70 -170.42 148.98 3.25 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.51 17.38 12.1 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.474 0.71 . . . . 0.0 112.434 -166.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -89.71 118.13 29.09 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.312 0.577 . . . . 0.0 109.49 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.1 mt -122.55 146.73 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 109.248 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -64.38 147.33 52.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.921 0.888 . . . . 0.0 110.173 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -81.52 117.48 21.96 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.49 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 59.9 m-85 -105.65 0.65 26.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.509 0.724 . . . . 0.0 111.107 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.9 p -75.4 -16.81 60.33 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.98 -5.82 70.27 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.385 -0.675 . . . . 0.0 112.396 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' O ' HG22 ' A' ' 104' ' ' VAL . 15.3 mt -48.16 -55.08 11.25 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 123.857 0.863 . . . . 0.0 111.107 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -60.29 -26.99 66.92 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.334 0.653 . . . . 0.0 111.77 -167.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -76.16 -41.12 50.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.084 0.954 . . . . 0.0 111.881 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -91.4 -23.15 20.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.502 ' CG1' HD11 ' A' ' 10' ' ' LEU . 15.0 m -122.08 107.95 34.81 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.363 0.529 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.98 -36.49 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.32 2.013 . . . . 0.0 111.961 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -86.35 -10.06 55.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -170.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.35 116.49 5.56 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 121.147 0.499 . . . . 0.0 110.756 -171.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.435 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 5.9 ptm180 -111.06 -43.63 3.72 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.338 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.466 ' HB3' HG12 ' A' ' 16' ' ' ILE . 47.5 tp -126.11 127.58 46.0 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 122.933 0.493 . . . . 0.0 110.009 -167.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.8 mt -110.99 114.15 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.6 m -96.55 115.8 28.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.952 0.901 . . . . 0.0 110.993 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.05 116.26 28.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.655 1.182 . . . . 0.0 109.04 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -93.75 119.35 32.62 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.43 143.05 11.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.103 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 57.2 ttp180 -50.98 -48.75 61.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.45 1.1 . . . . 0.0 112.068 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -49.21 -36.01 18.8 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.73 1.212 . . . . 0.0 112.761 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.88 -42.7 23.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.174 0.59 . . . . 0.0 109.9 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.58 -10.13 47.82 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.54 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 76.4 mt-10 -68.24 -34.59 76.5 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.041 0.536 . . . . 0.0 110.701 172.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -100.71 19.49 16.97 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.931 0.893 . . . . 0.0 110.885 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.1 tm-20 -63.07 -49.34 81.55 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.344 1.058 . . . . 0.0 112.933 170.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.85 -16.27 49.48 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.73 1.62 . . . . 0.0 112.887 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.09 -52.13 67.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.278 1.031 . . . . 0.0 110.868 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.0 -5.06 58.95 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.011 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -66.55 -32.62 74.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.7 0.4 . . . . 0.0 110.331 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.59 -12.6 61.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.536 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.2 mtt -96.17 11.97 32.46 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.175 0.99 . . . . 0.0 111.433 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.33 73.77 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.323 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -105.49 136.18 45.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.301 0.641 . . . . 0.0 110.325 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.67 140.07 57.88 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 167.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.519 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 29.3 p -128.82 141.86 51.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.252 0.548 . . . . 0.0 110.816 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -135.28 126.85 28.85 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.765 1.226 . . . . 0.0 108.83 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.94 106.81 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 111' ' ' CYS . 90.5 mt -88.63 153.33 50.18 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.109 0.964 . . . . 0.0 109.516 170.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.598 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 49.0 Cg_exo -58.63 164.48 9.32 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.131 2.554 . . . . 0.0 113.195 172.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.7 t -65.69 110.7 2.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 p -80.66 25.16 0.44 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.031 0.932 . . . . 0.0 112.088 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.8 t -63.0 147.79 49.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.967 0.907 . . . . 0.0 110.337 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 142' ' ' ARG . . . -69.21 -20.88 75.42 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.343 -0.389 . . . . 0.0 113.343 174.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.73 -8.45 56.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.018 0.527 . . . . 0.0 111.129 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.02 13.19 10.51 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.391 1.076 . . . . 0.0 109.598 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.473 ' HA ' ' OG ' ' A' ' 145' ' ' SER . 48.9 ttp180 -66.77 -31.9 72.84 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.493 0.717 . . . . 0.0 110.558 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -57.3 -32.71 66.94 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.091 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.63 -22.92 16.21 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.491 1.117 . . . . 0.0 110.674 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 84.0 p -90.43 11.64 20.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.024 0.529 . . . . 0.0 112.092 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.07 -69.79 0.18 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.112 0.965 . . . . 0.0 111.949 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -90.4 -2.97 57.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.298 0.639 . . . . 0.0 111.134 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.603 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 13.1 tpt180 -72.61 -18.36 61.6 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.744 0.818 . . . . 0.0 109.499 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -25.24 0.79 Allowed 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.58 1.152 . . . . 0.0 113.079 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.5 t -60.89 -44.95 96.41 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.089 0.955 . . . . 0.0 111.928 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 155' ' ' VAL . 9.5 pt-20 -72.95 -32.25 65.13 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -67.01 -40.19 87.26 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 4.7 tm-20 -71.15 -33.3 69.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.45 63.95 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.153 0.581 . . . . 0.0 111.531 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 151' ' ' GLU . 71.5 t -81.64 -57.62 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.877 0.471 . . . . 0.0 110.746 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.402 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 39.4 m-85 -92.78 1.6 57.2 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -166.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -61.76 -41.46 97.71 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -77.69 -10.75 59.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.419 0.687 . . . . 0.0 111.831 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 16' ' ' ILE . 38.7 mt -78.99 -25.21 43.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.586 -168.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.39 -45.08 89.2 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 166.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 CA--C 1.556 1.193 0 C-N-CA 124.985 1.314 . . . . 0.0 111.578 174.607 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.1 mm . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HB2' HD21 ' A' ' 22' ' ' LEU . 56.9 mtpt -84.91 125.69 32.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.61 0.764 . . . . 0.0 109.975 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.75 135.27 35.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.281 0.633 . . . . 0.0 111.69 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -76.43 -177.01 43.13 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.986 165.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.75 144.67 37.64 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.225 -172.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.96 151.72 32.42 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.83 2.353 . . . . 0.0 112.254 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 139.33 58.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.644 0.778 . . . . 0.0 112.65 -172.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.672 HG11 HD22 ' A' ' 62' ' ' LEU . 65.9 t -104.84 88.59 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.512 HD11 HG12 ' A' ' 104' ' ' VAL . 54.1 tp -138.46 153.37 48.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.808 -160.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.07 165.23 19.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.306 1.042 . . . . 0.0 110.189 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 8.9 pt-20 -65.72 -17.66 64.78 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.99 0.916 . . . . 0.0 111.957 171.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.47 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 46.2 m-80 -120.55 91.57 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.2 m -141.07 118.8 11.68 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.059 0.944 . . . . 0.0 109.074 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.24 -37.75 19.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.685 0.794 . . . . 0.0 110.659 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.438 HD12 HD11 ' A' ' 159' ' ' LEU . 66.4 mt -125.83 124.44 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.246 0.618 . . . . 0.0 109.889 -174.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.52 115.25 29.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.459 HG22 ' ND2' ' A' ' 113' ' ' ASN . 47.8 mt -94.2 102.98 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 73' ' ' TRP . 98.2 mt -94.67 119.15 32.85 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.034 0.933 . . . . 0.0 110.233 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.62 -178.78 37.52 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -93.94 -78.55 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 3' ' ' LYS . 64.1 tp -134.3 116.34 13.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 170.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.478 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.7 Cg_exo -53.63 148.39 35.75 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.207 2.605 . . . . 0.0 113.584 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' ILE . 29.0 t -61.55 150.7 35.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.623 1.169 . . . . 0.0 111.918 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 10.4 m-20 -55.03 -43.49 73.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.877 0.871 . . . . 0.0 110.71 175.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.627 ' HB3' HD21 ' A' ' 36' ' ' ASN . 15.2 tp10 -66.55 -26.06 66.95 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.454 1.096 . . . . 0.0 111.0 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.576 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 69.4 m -73.54 -40.91 63.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 24' ' ' SER . 64.1 mt -71.32 -21.69 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.501 1.12 . . . . 0.0 111.413 -176.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 20.3 mmt85 -61.31 -33.12 73.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.035 0.534 . . . . 0.0 110.915 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 80.6 mttt -110.46 -2.47 16.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.011 0.924 . . . . 0.0 111.116 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 58.57 27.73 16.1 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.639 1.576 . . . . 0.0 112.748 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -138.27 156.35 47.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.959 0.904 . . . . 0.0 110.231 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -71.35 -5.51 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.597 0.759 . . . . 0.0 110.288 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -77.34 -16.93 58.66 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.969 1.708 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.83 -30.72 73.6 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 0.0 114.307 -175.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.627 HD21 ' HB3' ' A' ' 26' ' ' GLU . 36.8 m-80 -124.09 99.38 37.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.334 0.654 . . . . 0.0 110.437 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.08 -7.51 15.28 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.676 164.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' HH12 ' A' ' 43' ' ' ARG . . . -85.13 -15.76 66.3 Favored Glycine 0 C--N 1.357 1.741 0 O-C-N 123.525 0.516 . . . . 0.0 112.214 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -73.79 125.76 28.86 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 137' ' ' SER . 1.3 t0 -79.43 -4.88 53.19 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.926 0.891 . . . . 0.0 112.088 -158.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 113' ' ' ASN . 38.0 m-85 -48.48 -36.19 14.61 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.193 0.997 . . . . 0.0 111.663 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -73.25 -32.36 64.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.432 0.693 . . . . 0.0 112.192 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.592 ' HD2' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -88.48 -23.51 23.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.754 0.422 . . . . 0.0 111.511 177.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 149' ' ' GLU . 49.4 mt -86.38 -45.67 10.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.939 0.496 . . . . 0.0 111.051 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.95 -32.48 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.54 94.49 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.476 0.485 . . . . 0.0 112.971 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -61.81 -43.59 98.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.75 0.82 . . . . 0.0 109.809 171.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -71.61 -33.32 68.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.596 -1.183 . . . . 0.0 113.978 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -94.43 -11.37 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.991 0.517 . . . . 0.0 111.146 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 27.54 63.61 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.423 0.452 . . . . 0.0 113.314 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.14 113.0 6.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.3 99.82 0.97 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.202 0.601 . . . . 0.0 111.086 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.465 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 77.0 mt -67.66 -27.89 67.24 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.303 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.592 ' HG3' ' HD2' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -65.17 -37.85 88.69 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.443 0.697 . . . . 0.0 111.438 -173.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.5 -36.9 63.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.02 0.528 . . . . 0.0 112.081 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.9 mtt -62.83 149.15 44.97 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -171.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 153.92 40.61 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.208 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.505 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 t80 -44.34 -50.57 9.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.144 0.978 . . . . 0.0 113.501 -171.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 43.1 mt-10 -61.83 -54.17 45.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.504 0.722 . . . . 0.0 111.44 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -58.06 -37.2 73.97 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.639 0.776 . . . . 0.0 111.127 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 35.5 ttmt -62.54 -45.97 90.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.11 0.964 . . . . 0.0 110.132 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.672 HD22 HG11 ' A' ' 9' ' ' VAL . 25.8 mt -61.73 -47.28 85.97 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.134 0.896 . . . . 0.0 110.957 175.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 66.9 mttm -55.02 -38.05 67.42 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -66.79 -51.46 55.46 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.156 0.91 . . . . 0.0 110.238 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 62' ' ' LEU . 57.2 mt -52.8 -56.72 13.67 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.936 0.894 . . . . 0.0 111.395 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.14 -30.54 71.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.315 0.646 . . . . 0.0 111.947 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.28 -36.89 85.17 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.272 0.629 . . . . 0.0 111.175 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -90.94 6.51 44.35 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.385 0.674 . . . . 0.0 110.959 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 65.57 37.44 5.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 111.359 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.24 132.37 56.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 109.46 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.3 154.02 17.24 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -121.26 132.38 54.77 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.439 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.2 t90 -156.08 -169.76 3.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -143.24 165.54 27.18 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.54 0.736 . . . . 0.0 110.2 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.45 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 72.5 t -82.23 -62.29 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.468 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.66 107.7 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.326 0.584 . . . . 0.0 111.374 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.2 ttmt -64.31 -31.92 73.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.032 170.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -152.55 126.85 9.23 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.14 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -134.3 135.45 7.99 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 123.171 0.588 . . . . 0.0 110.052 -176.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.25 -23.57 77.2 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.312 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 7.0 t70 -84.07 157.8 21.64 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.123 0.487 . . . . 0.0 110.744 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.3 24.13 8.84 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.904 -170.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 10.8 tp10 -85.75 111.48 20.18 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.36 155.38 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.112 0.965 . . . . 0.0 109.056 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 73' ' ' TRP . 59.0 m-80 -76.63 149.31 36.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.169 0.988 . . . . 0.0 110.484 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.26 116.48 19.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 0.0 110.494 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.45 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.4 m-85 -103.6 4.05 35.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.652 0.781 . . . . 0.0 111.351 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.1 m -74.48 -29.95 61.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.698 0.399 . . . . 0.0 110.746 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.88 -10.79 85.27 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.014 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.405 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.6 mt -47.4 -54.15 12.02 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.133 0.973 . . . . 0.0 111.592 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.442 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.1 mtpt -61.43 -18.76 60.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -167.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.05 -39.15 17.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.282 0.633 . . . . 0.0 111.485 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -96.26 -15.49 21.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 11.1 m -126.95 91.16 47.68 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-N 118.758 0.708 . . . . 0.0 111.023 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.88 -28.78 3.79 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.387 2.058 . . . . 0.0 113.251 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 11.4 mmpt? -94.73 -0.5 54.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.1 tp -60.89 104.42 0.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.518 0.675 . . . . 0.0 111.395 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -93.42 -49.36 5.96 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.841 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 42.7 tp -131.58 133.41 44.99 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.276 0.63 . . . . 0.0 110.056 -173.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.5 HG12 HD21 ' A' ' 107' ' ' LEU . 38.4 mt -105.12 115.67 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 92.4 m -96.09 113.25 24.84 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.448 0.299 . . . . 0.0 110.336 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 133' ' ' VAL . 84.2 m-85 -90.35 107.74 19.33 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.459 ' ND2' HG22 ' A' ' 18' ' ' ILE . 7.6 p30 -86.12 110.48 19.58 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.58 134.62 7.56 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.496 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HA ' HG11 ' A' ' 133' ' ' VAL . 33.4 ttm180 -72.11 -3.25 22.04 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.231 1.012 . . . . 0.0 113.421 -175.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.54 -29.85 41.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.827 0.451 . . . . 0.0 110.307 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.373 0.669 . . . . 0.0 109.664 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.8 -16.02 58.65 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 114.925 -1.034 . . . . 0.0 115.194 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -56.34 -29.58 61.52 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.522 0.729 . . . . 0.0 111.789 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -116.51 20.29 14.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.815 0.846 . . . . 0.0 111.247 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.36 -53.85 54.3 Favored Pre-proline 0 CA--C 1.567 1.622 0 C-N-CA 123.302 0.641 . . . . 0.0 112.23 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.75 -15.49 33.37 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 121.851 1.701 . . . . 0.0 112.727 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.08 -44.87 91.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.534 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 10.0 mt -82.4 -5.38 58.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.244 -172.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -72.43 -22.5 61.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.93 -21.52 67.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.628 0.58 . . . . 0.0 113.197 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.6 mpt? -86.66 7.62 25.81 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.76 0.824 . . . . 0.0 111.026 175.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.63 20.94 70.25 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.153 0.406 . . . . 0.0 113.959 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.442 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 35.5 m-85 -110.62 145.51 37.76 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.193 0.597 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.26 143.62 40.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.3 p -130.32 151.12 51.18 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.531 0.732 . . . . 0.0 110.131 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.44 121.82 4.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 109.313 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 112' ' ' PHE . 52.2 t -85.84 130.56 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.132 0.492 . . . . 0.0 110.084 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.6 mt -101.09 152.74 37.96 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.961 1.304 . . . . 0.0 108.274 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.14 153.03 78.79 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.434 2.09 . . . . 0.0 112.575 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 m -59.52 114.46 2.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.411 1.084 . . . . 0.0 110.339 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' A' ' 40' ' ' ASP . 19.4 m -86.34 49.12 1.73 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.556 0.693 . . . . 0.0 111.894 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 p -68.96 139.44 55.04 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 154.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.82 57.88 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 123.474 0.484 . . . . 0.0 113.445 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.56 86.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.108 0.563 . . . . 0.0 110.567 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.82 -41.66 67.95 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.108 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -53.93 -34.02 58.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.692 0.62 . . . . 0.0 111.76 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -69.0 -29.83 68.11 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -98.82 22.49 10.04 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.987 1.315 . . . . 0.0 110.697 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 66.6 m -157.32 34.98 0.28 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.096 0.959 . . . . 0.0 109.697 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -66.8 -35.09 79.27 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.799 1.036 . . . . 0.0 113.799 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.28 -13.86 26.05 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.586 0.355 . . . . 0.0 110.249 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.9 tpt180 -79.73 -38.7 32.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.302 0.641 . . . . 0.0 109.776 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.478 ' HB2' HD22 ' A' ' 44' ' ' LEU . 12.5 pt-20 -62.68 -18.19 61.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.479 1.112 . . . . 0.0 112.212 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.1 t -58.88 -23.05 60.49 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.42 0.688 . . . . 0.0 111.651 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 155' ' ' VAL . 9.4 pt-20 -65.6 -32.14 73.56 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 122.996 0.518 . . . . 0.0 110.654 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -65.62 -43.11 90.57 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.44 -37.72 88.38 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.695 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.13 -14.36 59.81 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.072 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 151' ' ' GLU . 48.5 t -87.13 -54.58 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.411 0.685 . . . . 0.0 110.601 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.548 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 71.9 m-85 -91.77 2.87 56.21 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -168.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -72.62 -28.18 62.6 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.271 0.487 . . . . 0.0 112.163 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -74.6 -6.87 51.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.438 HD11 HD12 ' A' ' 16' ' ' ILE . 95.4 mt -76.08 -22.6 55.41 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.98 0.512 . . . . 0.0 111.603 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.58 -15.39 62.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.871 0.468 . . . . 0.0 111.129 166.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 125.594 1.558 . . . . 0.0 110.252 175.266 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 80' ' ' SER . 46.1 mm . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -94.81 131.88 40.2 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -91.61 130.82 37.36 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 110.305 171.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 158.96 53.62 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 162.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -82.72 143.5 47.03 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 117.779 0.789 . . . . 0.0 110.084 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 162.44 1.55 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.206 2.604 . . . . 0.0 112.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -66.22 125.74 26.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.37 0.605 . . . . 0.0 110.513 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.646 HG11 HD22 ' A' ' 62' ' ' LEU . 21.2 t -91.03 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.556 HD11 ' CG1' ' A' ' 104' ' ' VAL . 49.9 tp -110.27 143.94 39.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.982 -162.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -125.89 163.62 22.55 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.8 -22.17 66.55 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.194 0.521 . . . . 0.0 110.968 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.617 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 45.1 m-80 -103.43 77.64 1.53 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.5 m -133.53 104.68 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.03 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.544 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 84.3 mt-10 -89.72 -30.15 18.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.549 1.14 . . . . 0.0 109.827 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.8 mt -126.68 118.18 50.13 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 123.886 0.874 . . . . 0.0 109.023 174.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -103.72 117.05 33.47 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.465 HG12 ' HB2' ' A' ' 111' ' ' CYS . 44.1 mt -99.54 110.33 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.79 118.14 35.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.47 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -72.94 -168.59 12.89 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 164.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -103.99 -72.46 0.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 tp -147.31 124.62 5.79 Favored Pre-proline 0 C--O 1.243 0.763 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.58 150.31 70.18 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.935 2.423 . . . . 0.0 112.452 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.0 t -68.92 163.41 24.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.981 0.912 . . . . 0.0 110.758 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 m-20 -53.77 -48.28 69.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.417 0.687 . . . . 0.0 110.46 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.18 -39.91 80.12 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.316 1.01 . . . . 0.0 111.361 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -67.35 -45.76 75.42 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.14 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.1 mt -71.6 -19.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.298 1.039 . . . . 0.0 111.976 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 28.5 mmm180 -70.39 -46.76 63.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -90.76 -6.54 54.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.447 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 65.97 22.08 11.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.175 1.39 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -129.32 142.92 50.7 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 109.377 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -60.79 -44.24 97.08 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.027 0.918 . . . . 0.0 108.569 165.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.87 -8.62 5.22 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.389 171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.98 -31.69 58.84 Favored Glycine 0 C--N 1.351 1.397 0 C-N-CA 123.54 0.59 . . . . 0.0 112.979 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -100.79 104.8 33.94 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.66 -10.92 29.77 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.404 2.736 . . . . 0.0 112.719 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.75 -6.84 64.11 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.06 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -79.7 116.81 20.1 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -83.24 -0.5 49.78 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.262 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -42.47 -42.66 3.35 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.454 1.901 . . . . 0.0 112.974 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -74.36 -21.71 59.55 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.697 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.54 -37.12 17.17 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.763 0.825 . . . . 0.0 111.222 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.41 -52.61 15.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.79 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.05 -39.11 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.051 0.54 . . . . 0.0 109.557 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.76 99.6 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.911 0.757 . . . . 0.0 113.982 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -69.02 -34.91 76.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.654 . . . . 0.0 110.24 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -71.6 -38.78 70.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.045 0.938 . . . . 0.0 112.81 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.478 HD12 ' ND2' ' A' ' 68' ' ' ASN . 13.8 pt -89.72 -9.98 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.952 0.501 . . . . 0.0 111.563 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.3 29.55 66.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.211 0.32 . . . . 0.0 113.022 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -133.71 112.97 11.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -66.27 93.07 0.2 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.283 0.563 . . . . 0.0 110.298 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.17 -39.42 89.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.78 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -57.12 -46.5 82.59 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.581 1.152 . . . . 0.0 111.709 -166.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -69.59 -37.47 76.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.392 0.677 . . . . 0.0 112.195 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.13 145.74 49.95 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.497 0.719 . . . . 0.0 112.369 -172.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.18 138.82 55.91 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.29 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.534 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 57.1 t80 -43.94 -46.49 8.19 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.532 1.133 . . . . 0.0 113.529 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.13 -47.99 80.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 111.857 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -63.93 -37.99 89.45 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.251 1.021 . . . . 0.0 110.701 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 58' ' ' TYR . 19.5 ttmm -60.45 -43.15 97.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.707 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.646 HD22 HG11 ' A' ' 9' ' ' VAL . 72.7 mt -65.88 -42.53 90.18 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.015 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -61.21 -33.38 73.38 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.6 m -64.22 -45.08 89.82 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.225 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.8 mt -57.59 -47.83 81.06 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.476 0.485 . . . . 0.0 110.371 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HE2' HG12 ' A' ' 9' ' ' VAL . 26.3 mmtp -61.95 -37.68 85.62 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.204 0.602 . . . . 0.0 110.417 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -58.21 -40.83 82.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.159 0.983 . . . . 0.0 111.456 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.478 ' ND2' HD12 ' A' ' 49' ' ' ILE . 64.3 m-80 -89.88 3.5 52.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.141 0.576 . . . . 0.0 110.868 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.544 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 1.1 mpp_? 65.68 45.65 2.59 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.218 1.407 . . . . 0.0 111.592 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.8 mt -114.09 131.86 64.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 109.168 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.15 160.33 13.29 Favored Glycine 0 N--CA 1.462 0.411 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 169.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.5 mt -124.49 145.34 49.59 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -165.88 -168.9 1.38 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -128.43 170.16 13.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.077 0.551 . . . . 0.0 109.639 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 77.3 t -83.0 -45.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -95.77 112.28 24.04 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.179 0.591 . . . . 0.0 109.79 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -67.37 -24.52 65.71 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.777 0.831 . . . . 0.0 110.462 171.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.94 140.64 19.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.96 0.904 . . . . 0.0 109.854 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -150.03 134.14 4.69 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.524 ' HB3' HD13 ' A' ' 2' ' ' ILE . 47.4 p . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--O 1.241 0.642 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.32 59.01 4.89 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.529 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.4 t70 179.05 154.56 0.44 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.126 0.971 . . . . 0.0 110.26 -173.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.02 28.91 6.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.816 1.246 . . . . 0.0 112.237 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.2 100.01 6.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.716 0.689 . . . . 0.0 109.256 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.3 mt -101.86 147.76 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.346 1.059 . . . . 0.0 110.354 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.93 151.17 46.88 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.643 0.777 . . . . 0.0 110.166 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.96 103.66 10.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 54.8 m-85 -93.54 1.85 56.6 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.606 0.762 . . . . 0.0 111.032 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.3 m -74.76 -9.45 58.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.658 0.383 . . . . 0.0 111.752 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.31 -5.28 70.06 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.739 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.441 HD12 ' SD ' ' A' ' 127' ' ' MET . 17.2 mt -47.38 -58.01 4.64 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 123.898 0.879 . . . . 0.0 113.252 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -63.63 -14.52 52.54 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -164.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.21 -46.88 8.14 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.179 0.992 . . . . 0.0 111.168 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -83.23 -23.41 32.78 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 9.8 m -123.67 90.51 50.53 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 123.08 0.552 . . . . 0.0 110.629 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.06 -34.84 4.65 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.462 2.108 . . . . 0.0 111.695 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.617 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.1 mmpt? -73.41 -17.9 61.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.138 0.975 . . . . 0.0 113.471 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 33.2 tp -62.16 133.32 55.07 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 123.518 0.511 . . . . 0.0 111.445 -170.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -142.64 -28.93 0.58 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.882 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 58.1 tp -134.62 138.87 44.88 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.642 0.777 . . . . 0.0 109.715 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 131' ' ' THR . 72.2 mt -113.98 143.64 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.469 ' HB3' HD12 ' A' ' 134' ' ' LEU . 72.3 m -126.64 130.31 50.2 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.492 0.717 . . . . 0.0 109.521 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.441 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 92.3 m-85 -105.04 130.18 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.191 0.596 . . . . 0.0 111.09 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.438 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 94.4 m-20 -85.29 88.81 7.53 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.141 0.576 . . . . 0.0 109.943 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 170.82 26.22 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.153 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 65.1 ttt180 -53.48 -63.65 1.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.112 0.965 . . . . 0.0 112.064 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -61.17 -12.41 12.56 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -84.65 -50.04 8.0 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.12 -9.77 72.43 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.962 -1.017 . . . . 0.0 115.108 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.1 mt-10 -64.62 -18.46 64.94 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.833 0.816 . . . . 0.0 111.762 176.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.36 25.15 12.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.199 1.0 . . . . 0.0 110.664 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.5 -52.32 73.7 Favored Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 123.628 0.771 . . . . 0.0 112.738 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.17 -19.19 51.07 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.082 1.855 . . . . 0.0 112.845 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.58 -46.02 87.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.054 0.942 . . . . 0.0 110.34 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.492 ' HB2' HG21 ' A' ' 131' ' ' THR . 18.7 mt -86.65 -9.69 55.46 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.461 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.66 -26.29 64.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.123 0.569 . . . . 0.0 110.782 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.37 -10.56 70.32 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.964 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.441 ' SD ' HD12 ' A' ' 100' ' ' LEU . 59.9 mtt -94.99 12.11 29.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.983 0.913 . . . . 0.0 110.696 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.79 -4.39 74.82 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -91.23 144.8 25.23 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.946 0.498 . . . . 0.0 110.921 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -74.32 145.85 43.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' HB ' ' A' ' 110' ' ' ILE . 18.6 p -134.98 148.61 50.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.066 0.946 . . . . 0.0 108.901 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -142.0 127.48 18.92 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.092 0.957 . . . . 0.0 108.697 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.74 110.87 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 111' ' ' CYS . 92.9 mt -95.11 154.68 39.53 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.87 154.29 58.47 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.936 1.757 . . . . 0.0 111.586 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -66.64 113.77 5.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.8 t -79.33 36.34 0.3 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -167.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -74.67 159.6 31.87 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.286 0.634 . . . . 0.0 110.559 172.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.62 47.05 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.96 14.67 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.583 0.692 . . . . 0.0 110.737 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -74.14 -23.8 59.32 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.139 0.576 . . . . 0.0 110.923 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.575 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 37.8 ptt180 -66.88 -25.74 66.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.805 0.336 . . . . 0.0 110.625 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -63.2 -26.22 68.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.234 1.014 . . . . 0.0 110.965 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -99.13 -24.85 14.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.632 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 49.5 m -82.97 22.55 0.93 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.809 0.844 . . . . 0.0 112.59 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.95 -61.06 2.06 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.56 -30.89 67.49 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 167.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.632 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 48.0 mtp180 -83.71 -11.3 57.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.37 0.268 . . . . 0.0 111.288 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.1 -34.35 30.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.059 0.544 . . . . 0.0 111.05 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.3 m -60.25 -39.55 87.13 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.925 0.89 . . . . 0.0 112.466 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -72.31 -36.28 68.85 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -64.59 -47.51 78.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 26.7 tt0 -64.12 -37.35 87.14 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.883 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.75 -37.3 62.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.903 0.752 . . . . 0.0 111.276 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.46 HG11 ' SG ' ' A' ' 111' ' ' CYS . 20.9 t -61.88 -39.22 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.701 0.801 . . . . 0.0 111.362 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -106.36 1.21 25.57 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 122.12 -0.362 . . . . 0.0 110.44 -171.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 ttm180 -71.88 -40.11 69.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.486 0.715 . . . . 0.0 110.108 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -76.67 -4.77 44.86 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.73 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.7 -30.19 62.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.002 0.521 . . . . 0.0 109.717 172.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -94.92 -55.37 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.942 -176.107 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -92.06 113.81 26.18 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -87.37 123.08 31.94 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 122.613 0.365 . . . . 0.0 111.126 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.71 166.57 54.85 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.256 168.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -94.18 145.94 30.68 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 119.284 -0.389 . . . . 0.0 111.195 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.84 159.68 32.4 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.821 2.347 . . . . 0.0 111.439 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -67.15 130.08 41.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.262 0.554 . . . . 0.0 111.532 -174.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.597 HG11 HD22 ' A' ' 62' ' ' LEU . 46.5 t -95.7 60.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.454 HD11 ' CG1' ' A' ' 104' ' ' VAL . 42.0 tp -106.58 153.95 21.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.339 -161.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.649 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 22.7 t0 -126.07 154.83 42.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.89 1.276 . . . . 0.0 108.056 170.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.07 -11.22 60.59 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.853 0.461 . . . . 0.0 111.667 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.471 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . 23.8 m-80 -108.83 17.92 21.3 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.869 0.467 . . . . 0.0 110.79 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -72.78 117.73 14.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.194 0.598 . . . . 0.0 111.154 -174.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.07 -36.29 17.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.073 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.1 mt -126.1 112.1 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.428 HD13 HD13 ' A' ' 10' ' ' LEU . 59.9 tp -103.43 118.61 37.15 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.54 HG12 ' HB2' ' A' ' 111' ' ' CYS . 41.9 mt -104.18 110.17 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 109.178 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 82.8 mt -100.27 124.77 46.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.337 1.055 . . . . 0.0 109.901 -177.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -78.84 -171.86 40.75 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 164.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.4 p -100.39 -68.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.417 HD12 ' HD2' ' A' ' 23' ' ' PRO . 39.0 tp -149.35 116.96 3.73 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 173.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD2' HD12 ' A' ' 22' ' ' LEU . 58.9 Cg_endo -66.48 166.02 23.14 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.004 2.469 . . . . 0.0 113.423 -167.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -65.39 147.2 53.84 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.327 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.8 m-20 -57.63 -39.15 76.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.137 0.975 . . . . 0.0 111.358 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.81 -28.35 69.8 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 124.142 0.901 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.533 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 39.2 m -84.73 -38.28 19.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.584 0.753 . . . . 0.0 110.401 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.415 HG23 ' NE2' ' A' ' 31' ' ' GLN . 75.2 mt -66.2 -29.19 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.832 0.853 . . . . 0.0 111.158 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.2 mmt180 -54.16 -38.17 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 170.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -94.25 -16.34 23.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.096 0.958 . . . . 0.0 110.514 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' NE2' HG23 ' A' ' 28' ' ' ILE . 20.5 mm-40 56.46 24.96 9.11 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.927 1.291 . . . . 0.0 111.729 -170.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -144.16 151.49 39.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.032 0.933 . . . . 0.0 110.208 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.452 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 87.8 m-85 -70.41 -0.38 8.16 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.983 1.313 . . . . 0.0 114.52 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.415 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 2.5 p90 -96.94 -12.06 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.64 -33.07 80.72 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.845 0.715 . . . . 0.0 113.143 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -103.25 100.01 16.53 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.38 0.672 . . . . 0.0 109.525 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.25 -21.07 23.83 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.189 2.593 . . . . 0.0 111.638 171.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.57 -1.75 66.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.435 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -79.38 112.49 16.66 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -87.64 -1.36 57.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.837 0.855 . . . . 0.0 110.806 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.425 ' HE1' HG21 ' A' ' 18' ' ' ILE . 82.3 t80 -39.83 -45.08 1.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.979 1.711 . . . . 0.0 112.602 172.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.472 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 80.3 m95 -70.74 -27.78 64.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.311 -173.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -74.81 -48.4 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.414 0.286 . . . . 0.0 110.255 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.34 -47.07 83.69 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.936 0.773 . . . . 0.0 110.83 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.25 -40.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.43 0.692 . . . . 0.0 109.96 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.58 85.42 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.922 0.764 . . . . 0.0 113.636 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -73.52 -44.11 58.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.695 0.798 . . . . 0.0 110.146 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -64.35 -38.99 92.99 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.541 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.9 pt -88.29 -15.25 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.34 28.43 63.88 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 116.477 -0.329 . . . . 0.0 113.828 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -143.65 96.97 2.99 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.9 105.95 0.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.011 0.924 . . . . 0.0 111.971 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.27 -23.31 40.86 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.408 0.683 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.36 -38.27 86.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.461 0.705 . . . . 0.0 111.474 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -94.13 6.13 49.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.542 0.737 . . . . 0.0 111.108 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.5 mtt -95.41 146.01 24.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.124 0.569 . . . . 0.0 110.567 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.9 158.45 35.54 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.071 170.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.578 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 32.8 t80 -47.76 -63.4 1.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.851 0.86 . . . . 0.0 113.141 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 29.8 mt-10 -59.89 -32.85 71.12 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.191 0.597 . . . . 0.0 111.095 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -54.98 12.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.925 0.89 . . . . 0.0 111.692 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HE2' ' CD2' ' A' ' 42' ' ' TRP . 8.2 ptmt -59.99 -29.75 68.67 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.473 -176.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.597 HD22 HG11 ' A' ' 9' ' ' VAL . 39.6 mt -64.95 -47.87 76.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.705 0.802 . . . . 0.0 111.476 173.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.9 mmmm -55.57 -38.16 68.99 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.234 0.54 . . . . 0.0 110.358 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.1 m -69.63 -39.53 77.09 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.355 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 62' ' ' LEU . 89.8 mt -57.4 -50.09 74.1 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.926 0.49 . . . . 0.0 110.529 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.649 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 1.8 mptm? -60.98 -37.07 81.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.72 0.637 . . . . 0.0 110.833 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -64.36 -42.09 96.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.877 0.871 . . . . 0.0 111.154 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.429 ' O ' HD13 ' A' ' 159' ' ' LEU . 59.7 m-80 -88.79 3.32 51.46 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.067 0.547 . . . . 0.0 110.903 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.471 ' HD2' ' HB2' ' A' ' 13' ' ' ASN . 24.3 mmt180 67.05 35.13 4.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.356 1.062 . . . . 0.0 111.394 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -106.22 134.05 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.55 1.14 . . . . 0.0 108.797 174.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.16 151.15 18.01 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 172.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 mt -124.38 131.9 53.52 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 117.862 0.831 . . . . 0.0 109.833 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 2.8 t90 -152.74 -175.99 5.54 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -130.93 158.18 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.539 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.3 t -70.85 -44.33 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 173.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -101.79 108.28 19.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.432 0.634 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.7 ptmt -65.63 -24.71 67.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.528 167.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.94 137.52 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.919 0.888 . . . . 0.0 109.208 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -154.79 150.76 22.39 Favored Glycine 0 C--O 1.212 -1.234 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.479 0.977 0 CA-C-N 118.17 0.985 . . . . 0.0 109.544 -179.598 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.02 59.99 0.4 Allowed Glycine 0 N--CA 1.461 0.307 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.603 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 23.1 t70 -177.14 158.5 1.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.111 -1.544 . . . . 0.0 107.698 -164.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.27 20.71 11.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -167.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.7 tp10 -89.58 98.93 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 mt -110.53 150.0 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.867 0.867 . . . . 0.0 109.54 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -71.32 148.53 46.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.001 0.92 . . . . 0.0 110.632 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -79.0 96.78 5.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.822 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.539 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 31.6 m-85 -80.23 -8.45 59.46 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.23 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -72.12 -18.85 61.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.898 0.479 . . . . 0.0 110.753 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 -5.88 62.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.467 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 21.9 mt -52.57 -51.34 60.24 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.241 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -58.94 -26.2 64.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.134 0.574 . . . . 0.0 112.268 -171.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.72 -35.9 65.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.5 0.72 . . . . 0.0 111.332 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -106.98 -14.56 14.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -172.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 19.2 m -125.29 86.64 56.73 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.211 0.914 . . . . 0.0 111.443 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.83 -33.13 4.01 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.714 2.276 . . . . 0.0 112.211 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.39 -7.72 58.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.107 0.563 . . . . 0.0 112.235 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 56.9 tp -58.67 104.12 0.2 Allowed 'General case' 0 C--N 1.355 0.805 0 O-C-N 123.659 0.6 . . . . 0.0 111.282 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.95 -47.2 7.13 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.5 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 49.7 tp -128.45 133.79 48.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.232 0.613 . . . . 0.0 110.967 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mt -108.46 126.39 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.54 ' HB2' HG12 ' A' ' 18' ' ' ILE . 78.9 m -109.46 115.99 30.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.513 0.725 . . . . 0.0 110.327 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.51 122.02 37.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.648 0.779 . . . . 0.0 110.549 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.544 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 84.5 m-20 -76.58 89.57 3.31 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 110.283 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.22 172.46 45.93 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.532 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 88.9 mtm180 -55.62 -50.93 68.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.467 1.107 . . . . 0.0 113.127 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 62.9 mmtt -62.32 -17.33 58.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.32 -37.76 13.82 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.65 -9.98 75.32 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.904 -1.044 . . . . 0.0 115.23 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.3 mt-10 -61.03 -26.07 67.36 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.455 0.645 . . . . 0.0 110.786 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -99.55 10.07 42.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.638 1.175 . . . . 0.0 111.405 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 35.9 tt0 -55.11 -54.06 54.57 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.698 171.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.25 -25.18 36.96 Favored 'Trans proline' 0 C--N 1.397 3.095 0 CA-C-N 121.075 1.42 . . . . 0.0 111.805 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.17 -41.74 98.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.67 0.788 . . . . 0.0 110.385 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 mt -96.34 -15.05 22.1 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.819 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -69.54 -32.07 70.65 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.456 0.646 . . . . 0.0 109.59 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.1 -5.0 64.6 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.454 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.5 mtt -93.98 13.03 24.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.693 0.797 . . . . 0.0 111.25 172.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.51 10.62 84.63 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.415 0.526 . . . . 0.0 114.415 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.07 145.75 27.58 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 122.869 0.468 . . . . 0.0 110.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.88 135.76 49.91 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.446 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 16.0 p -128.9 139.3 52.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.911 0.884 . . . . 0.0 109.531 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -146.36 131.12 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.15 104.37 15.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 111' ' ' CYS . 54.6 mt -82.29 147.43 56.82 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.399 172.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.662 ' HG3' ' HG3' ' A' ' 148' ' ' ARG . 42.5 Cg_endo -63.6 152.12 81.83 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 122.583 2.189 . . . . 0.0 111.727 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.0 m -60.08 123.24 16.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 m -86.16 12.4 9.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.944 0.498 . . . . 0.0 111.645 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p -60.85 149.0 37.44 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.13 0.572 . . . . 0.0 109.528 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.66 -28.72 60.35 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.328 0.393 . . . . 0.0 112.975 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.08 -35.22 79.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.909 0.884 . . . . 0.0 112.195 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -98.74 5.66 47.42 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.538 0.735 . . . . 0.0 111.43 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -73.93 -10.56 59.77 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.3 0.572 . . . . 0.0 110.699 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -52.29 -26.11 11.19 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.042 0.937 . . . . 0.0 112.994 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -96.47 2.82 52.87 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.599 0.76 . . . . 0.0 111.949 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.701 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 97.8 p -73.27 15.37 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -162.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.39 -74.21 0.17 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.284 0.947 . . . . 0.0 109.39 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.88 -25.21 63.59 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 112.002 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.701 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -69.42 -49.62 53.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.73 0.812 . . . . 0.0 110.158 -177.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -60.52 -36.53 78.62 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.264 0.626 . . . . 0.0 110.632 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -63.95 -40.78 97.21 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.535 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 6.9 pt-20 -70.06 -28.05 65.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.331 0.253 . . . . 0.0 110.715 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -71.63 -35.76 70.53 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.321 0.648 . . . . 0.0 109.745 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.1 -37.03 83.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.12 -17.62 64.94 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.456 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 151' ' ' GLU . 87.7 t -89.72 -61.94 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.316 0.646 . . . . 0.0 110.798 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.485 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 62.9 m-85 -86.51 2.45 47.91 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -164.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -75.55 -21.24 58.08 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.415 ' HE1' HD11 ' A' ' 16' ' ' ILE . 7.8 p-80 -77.14 -10.86 59.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.775 0.43 . . . . 0.0 111.493 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 68' ' ' ASN . 81.2 mt -69.34 -14.78 63.11 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.639 0.775 . . . . 0.0 112.695 -170.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.64 -34.4 60.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.989 0.516 . . . . 0.0 111.003 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 124.944 1.298 . . . . 0.0 110.29 -173.235 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.471 HG23 ' HB1' ' A' ' 78' ' ' ALA . 41.0 mm . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 2.9 mptp? -94.64 111.57 23.33 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -86.6 143.41 27.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.97 -131.31 0.04 OUTLIER Glycine 0 CA--C 1.532 1.151 0 CA-C-O 121.281 0.379 . . . . 0.0 113.434 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -136.76 145.01 49.19 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.964 -0.727 . . . . 0.0 110.234 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.04 135.81 65.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.163 1.909 . . . . 0.0 108.956 166.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 135.44 57.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.655 0.597 . . . . 0.0 110.992 -170.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.647 HG11 HD22 ' A' ' 62' ' ' LEU . 74.9 t -96.32 88.31 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.508 HD11 ' CG1' ' A' ' 104' ' ' VAL . 16.8 tp -140.0 150.41 44.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -161.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.701 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 13.6 t70 -127.17 160.17 32.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.524 1.13 . . . . 0.0 108.396 171.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -67.28 -16.86 64.52 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.972 0.509 . . . . 0.0 111.88 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -102.37 17.57 23.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.986 0.914 . . . . 0.0 110.734 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.417 ' HB ' HG12 ' A' ' 104' ' ' VAL . 85.5 m -79.22 122.84 26.8 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.938 0.495 . . . . 0.0 110.167 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 30.7 tt0 -97.21 -32.23 12.04 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.546 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.597 HD12 HD11 ' A' ' 159' ' ' LEU . 42.1 mt -130.25 123.91 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.11 121.26 44.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -96.42 113.1 29.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.3 mt -99.91 111.64 23.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 109.384 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.4 177.36 21.31 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 167.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 t -90.57 -89.96 0.16 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.15 0.975 . . . . 0.0 108.789 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.77 112.31 14.93 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.93 149.11 83.01 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.172 1.915 . . . . 0.0 111.705 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.67 135.78 50.29 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.5 p-10 -61.75 -19.6 62.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -171.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -52.66 -36.57 57.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.719 1.208 . . . . 0.0 111.921 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 p -90.33 -33.97 15.88 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.294 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 81.7 mt -64.32 -37.66 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.224 1.01 . . . . 0.0 112.923 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 26.5 mmt180 -61.4 -28.59 69.36 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.204 0.526 . . . . 0.0 110.042 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -89.93 -23.28 21.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 111.131 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.08 28.02 14.27 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.994 1.317 . . . . 0.0 111.913 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.88 137.82 49.53 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.457 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.661 ' HB3' ' HZ2' ' A' ' 42' ' ' TRP . 93.5 m-85 -77.03 -2.96 36.67 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.699 167.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -97.38 -18.68 18.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.424 1.09 . . . . 0.0 110.927 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.85 -108.44 0.03 OUTLIER Glycine 0 C--N 1.344 0.994 0 O-C-N 123.307 0.379 . . . . 0.0 112.331 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.69 93.22 46.55 Favored Pre-proline 0 N--CA 1.484 1.23 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HG2' ' HE1' ' A' ' 42' ' ' TRP . 7.7 Cg_exo -75.02 -52.43 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.916 2.411 . . . . 0.0 111.494 175.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.23 34.33 5.91 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -131.59 135.61 47.12 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.298 1.039 . . . . 0.0 111.838 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.99 0.28 28.24 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 124.946 1.299 . . . . 0.0 109.998 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -39.3 -50.3 2.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.254 2.222 . . . . 0.0 113.533 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.661 ' HZ2' ' HB3' ' A' ' 33' ' ' TYR . 72.9 m95 -69.11 -20.87 64.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.279 0.631 . . . . 0.0 112.21 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 4.6 mpt_? -86.77 -39.85 15.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.931 0.892 . . . . 0.0 110.339 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.76 -51.8 30.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.063 0.545 . . . . 0.0 111.053 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 t -73.16 -35.55 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.059 0.944 . . . . 0.0 109.61 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.74 -38.58 95.79 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.67 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -69.16 -40.6 78.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.245 0.618 . . . . 0.0 109.943 173.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -60.77 -42.69 97.96 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.737 0.815 . . . . 0.0 112.925 -175.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -95.15 -10.0 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.211 0.604 . . . . 0.0 112.162 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.55 59.19 Favored Glycine 0 C--N 1.353 1.496 0 O-C-N 123.266 0.354 . . . . 0.0 113.44 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.48 117.64 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.12 1.368 . . . . 0.0 108.389 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -68.47 88.73 0.34 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.597 0.713 . . . . 0.0 111.345 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.159 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -55.35 -50.94 68.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.226 1.01 . . . . 0.0 112.524 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.43 -5.78 59.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.713 0.805 . . . . 0.0 111.366 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.5 mtt -80.42 141.32 35.42 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.9 154.42 12.32 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.336 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.64 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 39.8 t80 -39.02 -50.65 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.824 0.85 . . . . 0.0 112.205 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 39.0 mt-10 -54.55 -55.72 26.34 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.154 0.909 . . . . 0.0 111.596 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.36 -39.49 74.59 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -61.18 -41.56 97.01 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.018 0.372 . . . . 0.0 110.575 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.647 HD22 HG11 ' A' ' 9' ' ' VAL . 17.0 mt -63.68 -43.94 95.2 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.887 0.742 . . . . 0.0 110.714 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 34.6 mmtp -56.76 -41.51 77.7 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.6 m -68.57 -39.55 80.97 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.042 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 61' ' ' LYS . 91.9 mt -57.35 -50.32 73.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 123.055 0.542 . . . . 0.0 109.942 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.701 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -56.79 -41.57 77.96 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 111.306 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.701 0.8 . . . . 0.0 111.278 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 56.7 m-80 -97.34 17.56 17.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.23 0.612 . . . . 0.0 110.784 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER 62.72 29.39 16.78 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.452 1.101 . . . . 0.0 111.308 169.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.95 134.87 42.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.327 1.051 . . . . 0.0 108.626 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.46 157.57 15.39 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.17 131.74 53.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.569 0.748 . . . . 0.0 109.459 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -161.8 -168.07 1.85 Allowed 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.65 162.91 33.97 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.687 0.676 . . . . 0.0 111.569 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 68.9 t -88.21 -45.46 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.438 1.095 . . . . 0.0 110.222 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -100.56 109.69 21.8 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.527 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.3 ttmt -64.37 -39.96 94.9 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 124.368 1.043 . . . . 0.0 110.294 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 2' ' ' ILE . . . -150.21 133.48 16.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.899 -176.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.72 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -155.15 144.22 10.8 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.48 1.06 0 CA-C-N 117.452 0.626 . . . . 0.0 110.127 -175.893 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 mt . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.65 58.6 0.41 Allowed Glycine 0 C--O 1.244 0.737 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.887 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 15.2 t70 -178.78 146.68 0.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 107.964 -174.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -105.18 16.82 25.11 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -167.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 15.4 tp10 -82.47 101.01 10.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.787 0.803 . . . . 0.0 109.785 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.38 145.71 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.575 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.8 156.27 34.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.867 0.467 . . . . 0.0 110.37 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.91 110.71 13.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.898 0.879 . . . . 0.0 110.367 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.7 m-85 -106.05 -9.42 17.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.281 0.632 . . . . 0.0 112.488 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.2 p -68.19 -13.49 62.27 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.62 0.368 . . . . 0.0 111.797 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -2.14 56.72 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 118.806 -0.997 . . . . 0.0 113.695 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -49.76 -37.4 29.59 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.445 0.698 . . . . 0.0 112.572 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.26 -31.5 72.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.52 0.328 . . . . 0.0 111.739 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.26 -50.95 8.92 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.033 0.933 . . . . 0.0 111.748 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.418 ' HG3' HG22 ' A' ' 104' ' ' VAL . 21.2 ptm -72.67 -33.54 66.6 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.302 0.641 . . . . 0.0 111.948 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -128.85 87.19 55.4 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.803 0.841 . . . . 0.0 109.64 176.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.09 -28.03 13.28 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.709 2.273 . . . . 0.0 112.501 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 0.24 56.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.316 0.646 . . . . 0.0 111.753 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 44.7 tp -57.23 110.18 0.8 Allowed 'General case' 0 C--N 1.354 0.762 0 O-C-N 123.806 0.691 . . . . 0.0 111.222 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.595 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 12.2 ptm180 -101.59 -43.47 5.88 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.67 170.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.468 ' HB3' HG12 ' A' ' 16' ' ' ILE . 59.8 tp -131.05 128.55 40.51 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.786 0.835 . . . . 0.0 110.245 -168.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.74 113.93 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.453 1.101 . . . . 0.0 108.501 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.424 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.3 m -96.48 113.73 25.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.858 0.463 . . . . 0.0 110.405 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.24 109.25 19.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.073 0.949 . . . . 0.0 110.088 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.445 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 7.2 t30 -81.85 90.4 6.41 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.95 143.25 7.32 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.768 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -54.86 -49.04 72.12 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.314 1.046 . . . . 0.0 112.141 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -49.26 -38.33 26.58 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.583 1.153 . . . . 0.0 112.744 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.77 -42.98 66.5 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.663 0.785 . . . . 0.0 110.102 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.7 -9.33 69.63 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 114.601 -1.181 . . . . 0.0 114.451 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.98 -28.99 70.47 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.138 0.469 . . . . 0.0 110.855 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.6 22.86 12.86 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.454 1.102 . . . . 0.0 110.937 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.14 -55.15 46.92 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.427 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.79 -19.18 66.61 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 122.014 1.809 . . . . 0.0 111.979 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.65 -49.04 74.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.384 1.074 . . . . 0.0 109.389 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 mt -87.59 -15.97 35.88 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.081 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -66.73 -31.71 72.53 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.24 -12.07 60.11 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.639 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.0 mtt -96.25 16.79 17.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.837 0.855 . . . . 0.0 111.338 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.94 22.51 78.75 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.04 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -111.26 138.38 47.79 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.9 0.48 . . . . 0.0 111.225 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -62.85 142.85 58.07 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.7 p -132.46 142.07 49.08 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.988 0.515 . . . . 0.0 110.85 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -130.36 114.19 15.29 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.582 1.153 . . . . 0.0 108.325 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.0 94.44 2.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.85 140.39 88.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.013 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.505 ' HG3' ' HD3' ' A' ' 148' ' ' ARG . 21.2 Cg_endo -57.97 158.08 22.46 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.424 2.083 . . . . 0.0 111.57 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.3 m -56.29 113.58 1.63 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -80.28 18.41 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.556 0.343 . . . . 0.0 111.837 -175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.0 m -57.95 149.63 22.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.108 0.963 . . . . 0.0 110.603 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.45 -24.35 65.71 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.584 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.07 70.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.384 0.673 . . . . 0.0 111.497 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -87.5 4.85 41.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.648 0.779 . . . . 0.0 111.615 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 12.7 ttm180 -62.69 -25.5 68.19 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.419 0.554 . . . . 0.0 111.984 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.53 -23.59 27.39 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.026 0.531 . . . . 0.0 111.811 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -108.04 5.94 26.55 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.105 0.962 . . . . 0.0 112.111 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.556 ' HB2' ' HA ' ' A' ' 142' ' ' ARG . 41.0 t -64.23 -35.54 81.17 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -164.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -62.88 -62.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.428 0.558 . . . . 0.0 111.733 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.68 -39.91 78.22 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.428 0.691 . . . . 0.0 111.127 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.505 ' HD3' ' HG3' ' A' ' 135' ' ' PRO . 72.0 mtt-85 -74.78 -27.42 60.32 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.579 -175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.38 -35.52 79.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.985 0.514 . . . . 0.0 109.997 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.4 t -72.0 -30.08 64.87 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.984 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 4.3 pt-20 -76.66 -34.37 58.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -70.54 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.577 0.751 . . . . 0.0 109.126 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.421 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 25.0 tt0 -66.52 -37.63 85.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.658 0.783 . . . . 0.0 109.332 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.96 -13.73 62.4 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.42 HG11 ' SG ' ' A' ' 111' ' ' CYS . 85.7 t -89.48 -52.76 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.523 0.729 . . . . 0.0 110.581 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.445 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 51.5 m-85 -96.09 -1.41 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -164.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.421 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 18.7 mtp180 -68.34 -38.85 81.89 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.823 0.738 . . . . 0.0 112.175 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -74.93 -9.9 58.97 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.705 0.402 . . . . 0.0 111.355 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.597 HD11 HD12 ' A' ' 16' ' ' ILE . 88.2 mt -82.51 -35.65 27.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.209 1.004 . . . . 0.0 110.221 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.04 -49.99 11.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.4 t60 . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.163 1.385 . . . . 0.0 112.384 170.554 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 80' ' ' SER . 32.8 mm . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -95.07 118.47 31.94 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -93.57 142.72 27.03 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 110.552 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.446 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -69.97 171.59 41.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.419 167.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.79 145.78 31.19 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 122.262 -0.552 . . . . 0.0 110.561 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.45 132.52 49.06 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.312 2.008 . . . . 0.0 109.654 170.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.9 147.72 45.85 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.299 1.0 . . . . 0.0 112.755 -166.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.628 HG11 HD22 ' A' ' 62' ' ' LEU . 26.2 t -92.4 47.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.457 HD11 ' CG1' ' A' ' 104' ' ' VAL . 35.6 tp -89.67 147.6 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.898 -167.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.13 151.86 41.69 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.73 -16.61 64.22 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.832 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.557 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 30.3 m-80 -105.88 21.05 17.93 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -70.53 109.95 5.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.485 0.66 . . . . 0.0 110.238 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.04 -38.86 26.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.257 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.428 HD12 HD11 ' A' ' 159' ' ' LEU . 55.2 mt -124.72 120.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.691 0.796 . . . . 0.0 108.995 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.451 HD13 HD13 ' A' ' 10' ' ' LEU . 59.7 tp -103.41 117.41 34.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 111' ' ' CYS . 50.0 mt -95.99 108.69 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 73' ' ' TRP . 88.9 mt -95.52 108.7 20.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 109.147 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.42 -174.54 7.28 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 167.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 m -87.77 -82.02 0.23 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 ' HD2' ' A' ' 23' ' ' PRO . 51.5 tp -148.28 124.64 5.36 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.4 Cg_exo -43.26 135.35 6.06 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.897 3.065 . . . . 0.0 114.194 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 m -72.2 169.58 15.84 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 111.107 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.92 -49.18 69.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.747 0.819 . . . . 0.0 111.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.19 -31.44 67.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.322 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.7 p -70.71 -38.89 73.69 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.7 mt -68.57 -24.85 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.138 0.975 . . . . 0.0 111.746 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.32 -44.67 87.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.017 0.436 . . . . 0.0 109.905 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -95.26 -1.54 51.31 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.019 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 64.04 24.65 13.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.692 1.197 . . . . 0.0 113.123 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.86 144.12 30.03 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.933 0.893 . . . . 0.0 109.574 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -58.27 -47.51 83.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.686 0.794 . . . . 0.0 110.334 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.412 ' HE1' HE22 ' A' ' 54' ' ' GLN . 30.3 t80 -60.86 -16.48 41.92 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.625 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -14.17 65.21 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 122.694 0.188 . . . . 0.0 113.438 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.03 101.5 11.15 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.697 0.799 . . . . 0.0 108.856 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.4 148.63 89.87 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.806 2.337 . . . . 0.0 111.42 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.18 -21.08 25.17 Favored Glycine 0 N--CA 1.464 0.535 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.48 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -73.15 102.13 3.51 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.845 0.831 . . . . 0.0 109.408 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -79.98 -3.97 50.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.827 1.651 . . . . 0.0 110.133 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -35.21 -53.92 0.62 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.871 2.069 . . . . 0.0 113.628 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -69.73 -28.33 65.72 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.331 0.652 . . . . 0.0 111.766 -172.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -68.21 -43.82 77.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 110.412 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.0 mt -72.31 -52.64 15.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.696 1.198 . . . . 0.0 111.225 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.97 -43.28 92.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 C-N-CA 124.048 0.939 . . . . 0.0 109.336 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.74 94.56 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.151 0.907 . . . . 0.0 113.469 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -69.41 -39.76 77.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.994 0.518 . . . . 0.0 110.318 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -69.94 -38.24 76.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.89 0.876 . . . . 0.0 112.811 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.05 -11.72 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.072 0.549 . . . . 0.0 110.938 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.94 19.15 79.06 Favored Glycine 0 C--N 1.36 1.909 0 O-C-N 123.807 0.692 . . . . 0.0 113.787 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.68 110.7 11.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 108.318 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -69.55 101.22 1.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.86 0.838 . . . . 0.0 111.553 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.48 -34.08 47.83 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.025 0.93 . . . . 0.0 111.897 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.412 HE22 ' HE1' ' A' ' 34' ' ' TYR . 60.5 tp60 -62.7 -31.0 71.83 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -168.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -83.15 -5.86 59.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.083 0.553 . . . . 0.0 112.393 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.4 mtt -86.42 154.98 20.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.213 0.605 . . . . 0.0 109.455 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.5 152.52 45.52 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 165.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.528 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 70.0 t80 -51.08 -42.21 60.44 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.003 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.92 -45.07 93.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.946 0.898 . . . . 0.0 111.486 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -67.98 -38.09 82.29 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.637 0.775 . . . . 0.0 110.569 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -53.53 -49.48 67.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.722 0.809 . . . . 0.0 109.902 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD22 HG11 ' A' ' 9' ' ' VAL . 19.2 mt -61.98 -45.41 93.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 124.655 1.222 . . . . 0.0 110.986 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -57.12 -40.61 77.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.89 0.476 . . . . 0.0 111.421 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.2 m -66.37 -36.82 83.83 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.75 -37.13 84.03 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.13 0.572 . . . . 0.0 111.085 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -57.46 -44.3 84.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -65.06 -35.39 80.99 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.413 1.085 . . . . 0.0 111.555 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -85.14 -8.59 58.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.782 0.833 . . . . 0.0 111.018 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 62.87 38.05 11.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.669 1.188 . . . . 0.0 110.462 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.78 134.17 48.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.78 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.64 142.24 17.44 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.0 128.8 54.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.448 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.1 t90 -153.26 -169.93 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.96 176.83 8.33 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.702 0.801 . . . . 0.0 109.187 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.583 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.8 t -90.87 -46.76 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.137 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -94.29 118.31 31.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.866 0.467 . . . . 0.0 110.385 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 36.9 ttmt -64.77 -41.91 95.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.322 1.049 . . . . 0.0 110.45 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.86 131.04 12.73 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.348 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.667 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.61 138.63 6.64 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.533 ' HB3' HD13 ' A' ' 2' ' ' ILE . 31.2 p . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 123.114 0.566 . . . . 0.0 111.063 -171.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.4 mt . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.92 71.65 2.16 Favored Glycine 0 C--O 1.242 0.642 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.667 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.7 t70 176.48 158.31 0.29 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 108.61 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.28 23.74 8.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.861 0.864 . . . . 0.0 111.866 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 16.4 tp10 -83.06 102.56 11.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 54.9 mt -102.59 155.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.682 1.193 . . . . 0.0 109.728 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -74.26 145.19 44.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.437 1.095 . . . . 0.0 110.168 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.01 101.16 1.34 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.356 0.662 . . . . 0.0 110.377 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.583 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 22.7 m-85 -91.95 -10.27 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.065 0.546 . . . . 0.0 112.04 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.6 p -67.67 -21.73 65.33 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.134 0.174 . . . . 0.0 110.622 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.08 -3.7 75.77 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.369 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.8 mt -48.96 -46.23 43.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -64.27 -23.78 67.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.101 0.41 . . . . 0.0 111.471 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.03 -58.3 3.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.922 0.889 . . . . 0.0 111.029 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.4 ptm -71.0 -33.77 70.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.066 0.947 . . . . 0.0 112.508 -168.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.3 m -124.32 84.04 56.54 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.698 0.799 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.76 -32.38 14.49 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.889 2.393 . . . . 0.0 111.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.557 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.6 mmpt? -87.87 -0.94 57.62 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.884 0.874 . . . . 0.0 112.482 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.6 tp -59.28 107.97 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -99.27 -41.75 7.32 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.829 0.852 . . . . 0.0 109.79 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.3 tp -136.91 132.82 35.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 110.64 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.518 HG12 HD21 ' A' ' 107' ' ' LEU . 15.7 mt -104.61 123.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.525 ' HB2' HG12 ' A' ' 18' ' ' ILE . 70.9 m -101.7 114.4 28.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.977 0.511 . . . . 0.0 110.508 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HZ ' HD12 ' A' ' 124' ' ' LEU . 95.8 m-85 -93.49 109.45 21.05 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.886 0.875 . . . . 0.0 110.225 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 22.7 t-20 -82.96 94.33 7.72 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.61 149.8 13.05 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.069 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -57.51 -43.17 84.04 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.866 1.267 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -51.41 -44.06 62.14 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.708 0.803 . . . . 0.0 112.73 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.78 85.91 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.149 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.5 -11.76 60.23 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.259 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.74 -27.89 69.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.99 0.895 . . . . 0.0 111.908 172.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -108.54 16.12 23.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.247 0.619 . . . . 0.0 111.253 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.509 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.8 tm-20 -66.4 -47.36 59.2 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.461 167.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.5 -35.29 75.78 Favored 'Trans proline' 0 C--N 1.403 3.418 0 C-N-CA 122.49 2.127 . . . . 0.0 113.18 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.54 -52.6 64.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.352 1.061 . . . . 0.0 112.014 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.459 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 15.9 mt -79.45 -6.12 56.2 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -65.6 -36.18 82.97 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.91 -17.55 71.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.214 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 62.8 mtt -86.58 9.35 18.78 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.61 0.764 . . . . 0.0 111.268 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.19 16.03 70.48 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.413 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -99.67 143.18 30.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 120.745 0.307 . . . . 0.0 110.777 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -75.84 133.2 40.67 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 161.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 36.1 p -127.62 141.1 51.72 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.999 0.92 . . . . 0.0 108.619 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -142.77 125.64 16.11 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.62 1.168 . . . . 0.0 108.17 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.31 112.82 24.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 155' ' ' VAL . 62.8 mt -89.21 131.69 39.95 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.86 147.02 33.82 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.513 2.809 . . . . 0.0 112.772 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.6 t -54.79 116.95 3.0 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.149 0.905 . . . . 0.0 110.072 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.2 p -72.37 0.15 10.87 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.544 0.738 . . . . 0.0 112.546 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 m -60.43 143.18 53.91 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.969 0.908 . . . . 0.0 110.273 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.61 69.84 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.796 0.685 . . . . 0.0 114.368 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.54 -42.85 98.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.209 0.604 . . . . 0.0 110.436 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -81.56 -32.3 32.25 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.346 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -59.99 -23.66 63.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.42 0.45 . . . . 0.0 111.262 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -71.26 -48.9 48.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.848 0.859 . . . . 0.0 110.092 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.23 23.73 3.2 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.457 1.103 . . . . 0.0 110.382 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -169.37 70.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -91.96 -51.48 5.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.625 1.17 . . . . 0.0 108.016 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -66.0 -6.34 12.44 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.363 1.065 . . . . 0.0 112.666 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -71.43 -20.06 62.16 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.763 0.825 . . . . 0.0 110.732 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.38 -30.88 67.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.338 0.655 . . . . 0.0 111.118 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.1 t -64.52 -44.29 91.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.253 1.021 . . . . 0.0 112.445 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.2 pt-20 -75.26 -30.62 60.52 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.351 0.26 . . . . 0.0 110.485 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.59 -40.58 88.95 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 4.0 tm-20 -67.06 -39.81 86.98 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.702 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.13 64.59 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.412 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 151' ' ' GLU . 73.1 t -84.72 -53.88 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.009 0.523 . . . . 0.0 111.001 177.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.408 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 40.0 m-85 -96.61 2.96 52.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -168.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.41 -32.28 73.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.276 0.489 . . . . 0.0 111.137 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 16' ' ' ILE . 15.4 p-80 -73.74 -12.36 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.623 0.369 . . . . 0.0 111.155 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 16' ' ' ILE . 86.7 mt -78.3 -26.06 46.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -82.7 -39.49 21.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.456 0.702 . . . . 0.0 109.121 167.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 19.9 t60 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 125.403 1.481 . . . . 0.0 110.596 -179.262 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 80' ' ' SER . 46.5 mm . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 120.764 0.316 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -93.22 111.0 22.52 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -79.33 125.62 29.74 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.486 0.315 . . . . 0.0 110.739 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.23 170.74 51.92 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 124.234 0.959 . . . . 0.0 111.629 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.427 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 8.0 m-30 -89.36 141.74 29.2 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.451 -168.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.32 164.23 29.04 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.726 2.284 . . . . 0.0 111.104 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.33 128.93 37.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.358 0.663 . . . . 0.0 111.867 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.535 HG11 HD22 ' A' ' 62' ' ' LEU . 58.7 t -100.03 72.86 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.572 HD11 ' CG1' ' A' ' 104' ' ' VAL . 60.4 tp -124.86 149.56 47.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.02 -162.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.7 160.6 25.53 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 109.194 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HG3' HD22 ' A' ' 13' ' ' ASN . 11.1 pt-20 -61.15 -20.19 62.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.462 1.105 . . . . 0.0 111.882 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.433 HD22 ' HG3' ' A' ' 12' ' ' GLU . 45.5 m-80 -122.53 91.07 3.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.496 ' HB ' HG12 ' A' ' 104' ' ' VAL . 99.5 m -131.8 114.28 14.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.925 0.89 . . . . 0.0 108.769 175.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 12.9 tt0 -87.75 -33.84 18.55 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.278 1.031 . . . . 0.0 110.9 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 159' ' ' LEU . 60.4 mt -128.57 125.66 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.079 0.552 . . . . 0.0 109.6 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.01 123.51 49.79 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 mt -100.13 115.63 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' A' ' 73' ' ' TRP . 97.8 mt -103.74 124.42 48.85 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.946 0.898 . . . . 0.0 110.181 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.3 -178.61 39.51 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 123.3 0.375 . . . . 0.0 112.365 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 116' ' ' LYS . 6.9 p -100.43 -71.43 0.7 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.9 119.46 2.78 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.35 167.84 8.88 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.689 2.26 . . . . 0.0 112.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.6 p -63.69 154.42 33.13 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.801 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 33.7 t70 -57.84 -37.61 74.16 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.275 0.359 . . . . 0.0 110.837 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.89 -36.0 64.71 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.187 0.995 . . . . 0.0 111.516 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.603 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 8.7 t -86.9 -39.71 15.53 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.27 -174.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.427 ' HA ' ' HE1' ' A' ' 6' ' ' PHE . 70.8 mt -66.55 -38.53 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.079 0.951 . . . . 0.0 112.0 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 24.9 mmm180 -66.73 -16.59 64.35 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.579 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 93.2 mttt -106.49 -1.5 23.02 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.662 0.785 . . . . 0.0 111.566 175.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 56.16 18.24 3.15 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.436 1.494 . . . . 0.0 114.693 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -145.05 161.92 38.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.951 0.501 . . . . 0.0 110.98 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -76.6 -1.56 28.21 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.894 1.278 . . . . 0.0 112.723 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -90.54 -14.24 32.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -52.34 -40.98 54.2 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.566 1.166 . . . . 0.0 115.717 -162.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -122.11 98.01 45.05 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.979 0.512 . . . . 0.0 110.309 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.03 2.44 4.24 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.568 2.845 . . . . 0.0 113.352 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.64 -17.73 79.98 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 120.357 -0.135 . . . . 0.0 112.898 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.97 127.47 33.58 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.34 0.591 . . . . 0.0 109.983 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.444 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 6.9 m-20 -81.01 0.32 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.61 1.164 . . . . 0.0 112.304 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -38.94 -47.47 1.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.819 1.248 . . . . 0.0 112.649 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -74.85 -26.78 59.93 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.918 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -79.31 -28.23 42.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.231 0.612 . . . . 0.0 111.594 175.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 33.4 mt -85.93 -48.54 8.62 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.818 0.447 . . . . 0.0 110.432 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.08 -30.96 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.275 0.63 . . . . 0.0 109.505 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.68 -44.52 70.49 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.573 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -60.72 -37.28 81.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.476 0.71 . . . . 0.0 110.298 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.58 -45.96 88.02 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.183 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.47 HD11 HD21 ' A' ' 53' ' ' LEU . 19.9 pt -91.37 -4.79 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.684 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.43 36.22 69.18 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.546 0.529 . . . . 0.0 112.838 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -149.3 105.91 3.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.675 1.59 . . . . 0.0 107.423 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -68.42 110.84 4.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.779 0.799 . . . . 0.0 109.506 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.47 HD21 HD11 ' A' ' 49' ' ' ILE . 85.1 mt -82.3 -30.72 30.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.042 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -60.32 -38.84 84.99 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.73 3.92 52.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.136 0.574 . . . . 0.0 111.337 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.552 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 66.6 mtt -85.25 150.4 24.81 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.39 45.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.751 0.657 . . . . 0.0 109.402 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.482 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 35.0 t80 -43.15 -48.99 6.48 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.362 1.065 . . . . 0.0 113.695 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 -61.31 -49.91 75.12 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 122.577 0.351 . . . . 0.0 111.322 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.25 -48.72 80.56 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.69 0.796 . . . . 0.0 112.662 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 7.6 ptmt -62.18 -36.52 82.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.489 0.316 . . . . 0.0 111.619 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.535 HD22 HG11 ' A' ' 9' ' ' VAL . 77.5 mt -68.99 -40.34 78.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.082 0.553 . . . . 0.0 111.557 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 30.3 mmmt -55.89 -44.72 78.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.386 0.674 . . . . 0.0 110.805 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -64.07 -40.06 95.44 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.285 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.98 -55.11 36.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.407 0.683 . . . . 0.0 111.688 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -22.49 64.27 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.092 0.245 . . . . 0.0 111.449 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -62.87 -33.91 76.28 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.692 0.397 . . . . 0.0 111.757 167.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -88.94 1.94 54.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.232 0.613 . . . . 0.0 110.977 172.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 8.0 mpt_? 64.59 46.51 3.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.683 1.193 . . . . 0.0 110.514 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.08 133.19 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.359 1.063 . . . . 0.0 108.697 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.35 17.86 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.62 132.15 56.55 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.42 0.688 . . . . 0.0 109.15 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.447 ' HB3' HD23 ' A' ' 19' ' ' LEU . 3.6 t90 -158.13 -170.2 3.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -134.32 162.74 31.34 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 48.4 t -79.09 -51.84 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 42.0 m-85 -82.2 126.66 32.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 0.0 110.58 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.591 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.3 tmtp? -68.01 -32.17 72.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.76 149.67 16.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.039 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.92 135.71 7.86 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.479 ' HB2' HD13 ' A' ' 2' ' ' ILE . 27.9 t . . . . . 0 N--CA 1.468 0.439 0 C-N-CA 123.575 0.75 . . . . 0.0 109.537 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.7 mt . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.79 57.12 5.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.38 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -173.69 154.66 2.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.492 1.117 . . . . 0.0 108.759 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -124.25 25.92 7.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.212 1.005 . . . . 0.0 111.394 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.3 tp10 -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.468 0.707 . . . . 0.0 109.26 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 77.2 mt -127.0 140.62 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.418 1.087 . . . . 0.0 109.192 -168.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -62.39 151.54 36.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.792 0.837 . . . . 0.0 110.869 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.17 130.65 36.59 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.8 m-85 -118.94 -2.23 10.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.058 0.543 . . . . 0.0 111.091 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 86.2 p -63.99 -31.11 72.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.13 -3.97 90.58 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 118.775 -1.014 . . . . 0.0 113.878 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 mt -49.8 -49.9 46.96 Favored 'General case' 0 C--N 1.369 1.444 0 C-N-CA 123.796 0.838 . . . . 0.0 111.711 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -60.77 -16.0 35.59 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -102.92 -41.41 6.15 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.306 1.042 . . . . 0.0 112.443 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -83.09 -24.65 32.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.572 ' CG1' HD11 ' A' ' 10' ' ' LEU . 9.0 m -127.75 84.88 62.13 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.608 0.763 . . . . 0.0 110.384 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 -34.07 22.04 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.628 2.219 . . . . 0.0 111.712 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.28 -12.31 59.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.947 0.899 . . . . 0.0 112.536 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 52.7 tp -62.1 130.52 45.85 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 123.713 0.633 . . . . 0.0 110.545 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -136.68 -34.5 0.75 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.246 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.4 tp -128.48 131.23 48.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.618 0.767 . . . . 0.0 109.576 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.552 ' HB ' HG22 ' A' ' 131' ' ' THR . 61.3 mt -115.94 138.01 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.522 1.129 . . . . 0.0 108.422 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.579 ' SG ' HG11 ' A' ' 155' ' ' VAL . 83.8 m -120.57 116.95 26.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.861 0.864 . . . . 0.0 109.926 -174.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 95.7 m-85 -93.91 114.74 27.03 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -98.03 76.69 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.493 1.139 . . . . 0.0 108.851 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.19 135.61 2.71 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.265 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -52.1 -52.73 49.53 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.083 0.953 . . . . 0.0 112.382 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 28.8 mmmt -48.81 -37.44 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.039 0.936 . . . . 0.0 113.054 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.61 -34.46 77.04 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.283 0.633 . . . . 0.0 110.839 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.89 73.73 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 114.778 -1.101 . . . . 0.0 115.004 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -103.87 14.89 29.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.498 1.119 . . . . 0.0 111.097 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.405 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.7 tt0 -58.74 -49.27 94.33 Favored Pre-proline 0 CA--C 1.565 1.535 0 CA-C-O 118.049 -0.977 . . . . 0.0 112.244 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -57.84 -23.29 58.17 Favored 'Trans proline' 0 C--N 1.409 3.742 0 C-N-CA 122.579 2.186 . . . . 0.0 113.32 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.27 -40.02 95.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.73 0.812 . . . . 0.0 110.26 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 mt -95.22 -19.43 20.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.365 0.666 . . . . 0.0 111.248 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -63.05 -40.16 96.87 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.052 0.541 . . . . 0.0 109.911 169.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.28 -19.6 66.5 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.39 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.8 11.75 19.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.15 73.97 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -106.8 137.82 44.13 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.371 0.585 . . . . 0.0 110.248 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.77 134.72 53.73 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 167.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.552 HG22 ' HB ' ' A' ' 110' ' ' ILE . 14.7 p -137.6 152.03 48.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 123.707 0.803 . . . . 0.0 108.968 -174.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -154.04 131.73 11.48 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.131 0.572 . . . . 0.0 109.8 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 17.2 t -90.31 93.85 4.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.52 149.53 95.55 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.203 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.11 152.66 81.54 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.619 1.546 . . . . 0.0 110.908 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.3 p -59.19 119.23 6.97 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.2 p -76.97 33.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.969 1.308 . . . . 0.0 113.994 -167.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.9 m -85.0 151.56 24.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.014 0.925 . . . . 0.0 109.204 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -20.34 58.76 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.792 0.682 . . . . 0.0 114.349 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.77 91.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.641 0.776 . . . . 0.0 111.103 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.27 -25.26 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.569 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -74.27 -25.58 59.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 123.753 0.658 . . . . 0.0 110.539 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -66.46 -27.38 67.76 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.173 0.511 . . . . 0.0 111.383 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.26 -42.41 8.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.666 0.786 . . . . 0.0 109.559 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -103.73 45.59 0.95 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.233 1.413 . . . . 0.0 110.25 -171.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -73.5 -27.47 61.4 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.333 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -86.57 -6.15 58.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.574 0.75 . . . . 0.0 111.804 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -86.14 -26.82 24.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.728 . . . . 0.0 110.399 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.79 -14.56 61.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.491 0.716 . . . . 0.0 112.171 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -34.63 77.7 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.39 0.676 . . . . 0.0 110.67 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 155' ' ' VAL . 4.1 pt-20 -72.16 -31.11 65.65 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 119.195 -0.431 . . . . 0.0 110.072 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -65.47 -38.01 88.51 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.58 -42.81 98.26 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.522 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.32 -9.67 58.83 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.77 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.579 HG11 ' SG ' ' A' ' 111' ' ' CYS . 75.7 t -83.87 -50.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 110.243 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.548 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 47.5 m-85 -103.2 0.82 32.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -77.36 -26.83 52.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 119.156 0.889 . . . . 0.0 112.298 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.422 ' HE1' HD11 ' A' ' 16' ' ' ILE . 15.9 p-80 -74.95 -10.85 59.87 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.444 0.698 . . . . 0.0 111.326 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.512 HD11 HD12 ' A' ' 16' ' ' ILE . 95.0 mt -73.38 -10.99 60.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.7 0.8 . . . . 0.0 111.001 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -45.96 -39.51 9.02 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.824 1.249 . . . . 0.0 111.359 164.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.689 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 80' ' ' SER . 22.7 mm . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.59 119.6 25.39 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 169.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -84.56 132.11 34.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.671 0.389 . . . . 0.0 111.013 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.98 -179.92 26.24 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.207 0.317 . . . . 0.0 112.585 167.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -108.87 135.0 20.16 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 122.355 -0.497 . . . . 0.0 109.726 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 157.72 33.12 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.531 2.154 . . . . 0.0 110.941 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.81 127.02 29.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.314 0.645 . . . . 0.0 112.071 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 62' ' ' LEU . 21.6 t -91.76 88.32 2.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.534 HD21 HG13 ' A' ' 104' ' ' VAL . 34.5 tp -140.14 155.73 46.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.393 -158.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.51 159.99 27.93 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.86 -14.5 63.01 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.107 0.479 . . . . 0.0 110.945 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -111.75 84.69 2.0 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.537 ' HB ' HG12 ' A' ' 104' ' ' VAL . 98.7 m -138.92 121.43 16.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.349 0.66 . . . . 0.0 110.003 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 3.4 tp10 -85.02 -41.45 15.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.551 1.54 . . . . 0.0 109.69 -173.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.447 HG12 ' HB3' ' A' ' 109' ' ' LEU . 34.2 mt -129.52 128.9 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.638 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.53 HD13 HD13 ' A' ' 10' ' ' LEU . 56.8 tp -109.89 124.91 52.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -95.67 118.26 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.404 HD23 ' HB3' ' A' ' 73' ' ' TRP . 75.0 mt -102.43 118.96 38.0 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.581 0.752 . . . . 0.0 109.557 174.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -75.66 -166.09 19.2 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 165.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -108.78 -73.57 0.68 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -147.68 119.98 4.65 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 161.03 46.97 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.444 2.096 . . . . 0.0 111.933 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.5 t -85.7 158.22 20.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.199 0.599 . . . . 0.0 110.399 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 5.1 p-10 -57.67 -29.97 65.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.363 0.665 . . . . 0.0 112.638 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.14 -38.17 67.88 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.381 0.673 . . . . 0.0 111.59 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.705 ' HB3' HD22 ' A' ' 36' ' ' ASN . 32.4 p -86.63 -38.01 17.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.042 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.2 mt -64.91 -38.76 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.921 0.889 . . . . 0.0 113.282 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 30.2 mmm180 -61.41 -30.78 70.77 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 0.0 110.375 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -97.29 -6.03 35.34 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.322 1.049 . . . . 0.0 112.082 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 62.1 22.39 13.08 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.813 1.245 . . . . 0.0 113.571 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.76 144.01 35.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.939 0.496 . . . . 0.0 110.453 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -55.3 -46.91 76.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.326 1.05 . . . . 0.0 110.107 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.29 -13.11 4.47 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 114.003 -1.453 . . . . 0.0 113.582 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.72 -19.91 73.65 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 114.346 0.498 . . . . 0.0 114.346 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.705 HD22 ' HB3' ' A' ' 27' ' ' SER . 4.5 p30 -110.77 135.16 20.78 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.27 -10.85 30.07 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.053 2.502 . . . . 0.0 113.018 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.14 -8.81 65.93 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.478 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.436 ' ND2' HD21 ' A' ' 36' ' ' ASN . 0.9 OUTLIER -94.29 82.02 4.06 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.685 0.755 . . . . 0.0 109.434 173.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -99.62 4.76 45.87 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.349 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -42.46 -30.06 0.32 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.094 1.357 . . . . 0.0 112.44 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.447 ' CE3' ' HD3' ' A' ' 61' ' ' LYS . 63.7 m95 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.713 1.205 . . . . 0.0 113.103 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -77.89 -32.54 51.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.818 0.447 . . . . 0.0 111.1 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' A' ' 149' ' ' GLU . 43.3 mt -86.87 -47.78 8.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.798 0.839 . . . . 0.0 110.354 -170.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 -35.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.839 0.856 . . . . 0.0 109.035 172.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.34 -39.35 95.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.042 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.59 -36.32 83.4 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.947 0.899 . . . . 0.0 110.033 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.99 -53.64 46.86 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.728 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.458 HD12 HD22 ' A' ' 68' ' ' ASN . 15.4 pt -84.45 -7.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.032 0.533 . . . . 0.0 111.809 -175.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.48 73.24 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.574 0.546 . . . . 0.0 112.713 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -133.57 106.66 7.54 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -63.31 97.11 0.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 110.667 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.2 mt -75.6 -19.45 59.24 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -70.03 -27.56 64.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.804 0.842 . . . . 0.0 112.369 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -95.62 -3.15 46.8 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.73 -0.606 . . . . 0.0 110.832 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtt -88.66 159.18 17.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.005 0.522 . . . . 0.0 111.207 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.46 151.22 47.13 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.524 0.73 . . . . 0.0 109.344 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.568 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 30.3 t80 -51.91 -49.78 62.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 47.1 mt-10 -63.6 -37.04 85.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.025 0.375 . . . . 0.0 111.08 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.81 -53.32 33.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HD3' ' CE3' ' A' ' 42' ' ' TRP . 17.3 ptpt -58.44 -32.13 68.41 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.307 0.643 . . . . 0.0 111.648 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 94.0 mt -66.83 -43.04 84.8 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.196 0.598 . . . . 0.0 111.318 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 33.8 mmtp -64.55 -31.61 72.9 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.005 0.431 . . . . 0.0 110.615 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.5 m -67.16 -39.41 86.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.145 173.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.97 -49.96 70.48 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.609 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 29.7 mmtp -57.28 -40.93 78.77 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 123.299 0.64 . . . . 0.0 110.546 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -60.82 -42.83 98.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.304 1.041 . . . . 0.0 111.11 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.458 HD22 HD12 ' A' ' 49' ' ' ILE . 90.8 m-20 -87.52 5.46 39.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.773 0.829 . . . . 0.0 110.634 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 25.8 mmt180 64.93 39.74 5.69 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 125.232 1.413 . . . . 0.0 110.92 171.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.03 135.96 48.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 124.917 1.287 . . . . 0.0 108.793 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.39 162.19 14.42 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 173.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.68 142.36 50.76 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.404 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.5 t90 -162.98 -170.74 2.43 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -131.53 166.38 21.51 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 0.0 109.379 172.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 54.2 t -78.1 -38.88 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.97 123.97 48.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.543 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -71.61 -24.0 61.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 170.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.83 140.43 14.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -152.16 155.7 26.28 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB3' HD13 ' A' ' 2' ' ' ILE . 40.7 p . . . . . 0 N--CA 1.474 0.763 0 CA-C-N 117.587 0.693 . . . . 0.0 109.998 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 C--O 1.243 0.751 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.26 65.23 3.88 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.673 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.474 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 8.2 t70 -169.86 160.29 8.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.972 0.509 . . . . 0.0 110.005 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.04 7.19 10.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.648 0.779 . . . . 0.0 112.591 -168.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.56 99.79 12.58 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.119 0.872 . . . . 0.0 109.467 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.36 152.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 109.617 -171.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -72.65 149.02 44.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.514 0.726 . . . . 0.0 110.042 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.51 114.6 16.51 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.496 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 29.0 m-85 -100.37 -5.44 27.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.592 0.757 . . . . 0.0 111.869 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.3 p -75.92 -10.92 59.82 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.71 0.29 . . . . 0.0 110.299 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.8 -5.44 62.84 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.803 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' SD ' ' A' ' 103' ' ' MET . 40.3 mt -50.42 -33.42 20.75 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.191 0.596 . . . . 0.0 112.371 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -62.58 -33.49 75.07 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.061 0.544 . . . . 0.0 112.298 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.25 -47.71 8.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.807 0.843 . . . . 0.0 112.266 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.525 ' HG3' HG22 ' A' ' 104' ' ' VAL . 22.9 ptm -71.64 -32.34 67.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.546 0.739 . . . . 0.0 112.461 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' A' ' 14' ' ' THR . 0.7 OUTLIER -134.39 95.0 16.73 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.49 0.716 . . . . 0.0 110.438 177.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.8 -30.24 14.53 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.623 2.216 . . . . 0.0 111.778 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -87.3 -2.31 58.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.745 0.818 . . . . 0.0 111.758 -173.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 41.5 tp -56.09 104.34 0.13 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.798 0.839 . . . . 0.0 111.541 -175.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 18.7 ptp180 -101.87 -41.98 6.3 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.396 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.447 ' HB3' HG12 ' A' ' 16' ' ' ILE . 29.9 tp -130.73 139.57 50.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.675 0.39 . . . . 0.0 110.349 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.438 HG12 HD11 ' A' ' 107' ' ' LEU . 24.2 mt -112.75 115.99 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.486 ' SG ' HG11 ' A' ' 155' ' ' VAL . 83.6 m -98.71 118.74 36.12 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.456 0.703 . . . . 0.0 110.871 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -95.75 120.72 36.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.655 0.782 . . . . 0.0 110.227 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 95.2 m-20 -75.24 80.74 2.35 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.655 0.782 . . . . 0.0 109.815 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.93 162.94 21.23 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.474 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.5 ttp85 -64.31 -23.61 67.36 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.18 1.392 . . . . 0.0 113.056 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -74.37 -42.4 59.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.506 . . . . 0.0 110.057 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.26 75.89 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.696 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.08 -10.66 62.39 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.933 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -69.36 -20.08 63.84 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 117.402 0.601 . . . . 0.0 110.859 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -108.0 10.17 28.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.386 1.074 . . . . 0.0 111.086 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.2 tm-20 -67.58 -49.31 41.15 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.979 0.912 . . . . 0.0 111.666 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.08 -24.6 79.72 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.028 1.818 . . . . 0.0 112.685 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.92 -50.39 73.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.078 0.951 . . . . 0.0 111.287 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.31 -5.23 55.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -66.54 -31.93 72.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.038 0.535 . . . . 0.0 110.57 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.1 -17.59 70.07 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.69 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 63.7 mtt -88.07 2.17 52.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.847 0.859 . . . . 0.0 111.216 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.45 23.16 63.32 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.56 -0.291 . . . . 0.0 113.333 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -107.4 137.26 45.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 110.668 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 19.6 mm-40 -70.0 136.37 50.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.54 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 33.5 p -132.5 140.5 48.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.773 0.829 . . . . 0.0 109.504 -173.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 109' ' ' LEU . 53.7 tptt -143.02 132.04 22.99 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.389 1.076 . . . . 0.0 109.302 -173.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.7 t -97.99 122.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 155' ' ' VAL . 96.3 mt -102.34 144.61 28.95 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 171.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.8 150.7 75.82 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.042 2.495 . . . . 0.0 112.078 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.5 t -62.14 94.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.824 0.703 . . . . 0.0 109.728 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -87.97 21.17 2.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.5 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.1 t -66.08 156.02 35.1 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.293 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 142' ' ' ARG . . . -62.75 -22.17 63.89 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 123.18 0.419 . . . . 0.0 113.787 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.36 -28.91 70.02 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 111.708 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -126.37 19.12 7.52 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.686 0.795 . . . . 0.0 111.134 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 139' ' ' GLY . 8.9 ptm85 -66.98 -27.63 67.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.011 0.525 . . . . 0.0 111.364 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -55.01 -31.07 60.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.464 1.106 . . . . 0.0 111.384 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.86 -18.26 13.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.001 0.92 . . . . 0.0 110.184 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -97.73 8.31 44.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.617 0.767 . . . . 0.0 112.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -63.23 -64.0 1.03 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.512 0.725 . . . . 0.0 109.356 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.07 -7.47 23.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.16 0.984 . . . . 0.0 112.845 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -82.08 -12.84 58.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.393 0.677 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 44' ' ' LEU . 11.1 pt-20 -54.87 -25.41 28.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.523 0.729 . . . . 0.0 112.316 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -41.17 62.87 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.061 0.944 . . . . 0.0 112.209 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -72.92 -34.02 66.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -66.57 -33.4 75.58 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.987 0.915 . . . . 0.0 109.437 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.8 -42.19 98.69 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.482 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.93 87.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.897 -171.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.486 HG11 ' SG ' ' A' ' 111' ' ' CYS . 74.3 t -68.15 -30.83 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.929 -173.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.532 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 30.9 m-85 -118.15 -10.47 10.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.379 -0.825 . . . . 0.0 113.166 -173.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.0 -29.69 65.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.115 0.416 . . . . 0.0 111.107 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -81.05 -13.58 58.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.949 0.5 . . . . 0.0 111.2 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.42 HD11 HD12 ' A' ' 16' ' ' ILE . 62.7 mt -72.1 -41.06 67.71 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 122.829 0.452 . . . . 0.0 111.077 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -87.79 -53.73 4.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 CA--C 1.554 1.1 0 C-N-CA 125.313 1.445 . . . . 0.0 110.944 -179.396 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 mm . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HB3' HD13 ' A' ' 28' ' ' ILE . 50.4 mtmt -93.4 117.98 30.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.301 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -80.38 126.8 31.64 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 123.743 0.652 . . . . 0.0 110.868 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.77 156.22 53.41 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.409 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 7.3 m-85 -80.62 134.93 53.39 Favored Pre-proline 0 N--CA 1.473 0.68 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.581 -165.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.2 141.59 48.46 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.887 2.391 . . . . 0.0 111.265 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.12 128.61 37.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.571 0.748 . . . . 0.0 111.275 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 62' ' ' LEU . 24.1 t -95.65 79.77 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 174.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.484 HD11 ' CG1' ' A' ' 104' ' ' VAL . 38.5 tp -117.18 149.86 39.69 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.517 -163.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 37.9 t70 -128.02 164.21 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.803 0.841 . . . . 0.0 109.46 169.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.2 -26.66 67.88 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.348 1.059 . . . . 0.0 112.462 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.504 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 61.7 m-80 -95.32 16.17 17.46 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.262 0.625 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.468 ' HB ' HG12 ' A' ' 104' ' ' VAL . 78.1 m -72.05 104.76 3.67 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.637 0.732 . . . . 0.0 110.544 -175.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 108' ' ' ARG . 30.1 tt0 -88.32 -30.21 19.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.286 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 159' ' ' LEU . 39.4 mt -127.66 120.35 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.148 0.979 . . . . 0.0 108.624 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.3 tp -106.97 116.97 32.85 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 111' ' ' CYS . 55.1 mt -91.7 108.27 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 94.9 mt -99.67 108.17 20.46 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 109.071 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.05 177.34 8.66 Favored Glycine 0 N--CA 1.47 0.932 0 O-C-N 123.002 0.189 . . . . 0.0 113.053 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 89' ' ' ILE . 10.7 p -90.79 -72.42 0.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.476 HD22 ' HA3' ' A' ' 79' ' ' GLY . 19.0 tp -151.14 124.68 4.3 Favored Pre-proline 0 C--O 1.246 0.894 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 159.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.5 157.6 30.92 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.118 1.879 . . . . 0.0 111.67 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -62.95 150.29 42.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.605 0.762 . . . . 0.0 110.459 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 6.6 p-10 -58.88 -34.07 71.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.573 0.225 . . . . 0.0 110.452 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.1 -37.96 78.42 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.363 1.065 . . . . 0.0 111.947 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.6 p -81.23 -30.74 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 3' ' ' LYS . 73.1 mt -74.66 -16.0 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 110.882 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 79.1 mtt180 -64.38 -38.3 90.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.569 0.347 . . . . 0.0 110.569 170.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -86.87 -16.22 36.7 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.624 0.77 . . . . 0.0 109.899 177.31 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.443 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER 53.9 23.83 4.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.075 1.35 . . . . 0.0 113.206 -172.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -126.09 160.2 30.78 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.386 0.674 . . . . 0.0 109.561 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -72.43 -2.5 19.72 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.607 0.763 . . . . 0.0 110.746 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -70.13 -45.36 67.0 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.448 1.099 . . . . 0.0 108.294 174.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 31.76 -112.66 0.06 OUTLIER Glycine 0 C--N 1.374 2.678 0 O-C-N 125.086 1.491 . . . . 0.0 114.546 -172.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.65 129.59 23.99 Favored Pre-proline 0 C--O 1.246 0.886 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.06 9.3 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.968 2.446 . . . . 0.0 113.953 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.85 0.28 78.55 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 122.906 0.289 . . . . 0.0 112.566 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -84.08 130.15 34.87 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.88 3.4 29.93 Favored 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 123.852 0.861 . . . . 0.0 111.189 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -42.94 -56.42 3.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.683 0.793 . . . . 0.0 112.126 172.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 75.8 m95 -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.856 0.862 . . . . 0.0 111.897 -177.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -80.99 -42.07 21.74 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.442 1.097 . . . . 0.0 111.415 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.27 -47.54 34.35 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.113 0.965 . . . . 0.0 109.2 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.91 -37.68 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.264 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.8 96.1 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.67 0.606 . . . . 0.0 113.184 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.19 -41.36 85.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.438 0.695 . . . . 0.0 109.961 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -66.92 -40.61 87.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.358 1.063 . . . . 0.0 112.769 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 pt -89.44 -6.57 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.112 0.565 . . . . 0.0 111.645 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.86 22.99 78.61 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 113.178 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -139.87 96.47 3.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.99 109.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.881 0.872 . . . . 0.0 111.083 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.4 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 53.6 mt -75.21 -19.93 59.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.837 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -53.42 -54.53 35.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.724 0.809 . . . . 0.0 112.806 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -83.57 6.25 21.26 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.051 0.54 . . . . 0.0 112.427 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.573 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.1 mtt -88.81 139.6 30.29 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 154.64 40.04 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.499 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 36.9 t80 -48.37 -50.67 29.78 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 41.7 mt-10 -60.37 -38.85 85.18 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.609 0.364 . . . . 0.0 111.155 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -68.26 -53.46 24.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.94 0.896 . . . . 0.0 112.29 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 5.5 ptmt -59.89 -29.98 68.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 9' ' ' VAL . 86.4 mt -65.1 -42.56 93.91 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.252 0.621 . . . . 0.0 111.231 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 43.7 mmtm -59.49 -39.71 84.64 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.673 0.389 . . . . 0.0 110.192 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.3 m -66.96 -38.23 85.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.536 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 61' ' ' LYS . 79.1 mt -58.22 -59.25 5.61 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 111.231 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.413 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -71.61 -22.2 61.74 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.224 0.328 . . . . 0.0 111.842 -174.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -58.87 -43.68 90.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.64 0.776 . . . . 0.0 110.374 164.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -89.74 19.82 4.47 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.729 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.486 ' HB2' HD22 ' A' ' 159' ' ' LEU . 15.1 mmt180 70.28 27.15 4.16 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.289 1.036 . . . . 0.0 111.58 169.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.7 mt -109.63 123.79 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.055 0.942 . . . . 0.0 109.883 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.17 158.45 14.3 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.45 140.93 49.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.435 0.694 . . . . 0.0 109.252 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.475 ' HB3' HD23 ' A' ' 19' ' ' LEU . 8.8 t90 -165.03 -177.27 4.55 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -131.5 161.93 31.42 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 53.3 t -75.73 -48.34 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.72 128.78 41.65 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.258 0.551 . . . . 0.0 110.626 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.682 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 10.2 ptmm? -84.19 -17.56 39.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.733 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.68 134.88 11.26 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.055 0.455 . . . . 0.0 110.463 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -147.78 147.66 18.53 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.485 1.275 0 CA-C-N 117.912 0.856 . . . . 0.0 111.774 -173.223 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 21' ' ' SER . 7.8 mt . . . . . 0 C--O 1.24 0.572 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.92 60.47 0.63 Allowed Glycine 0 N--CA 1.465 0.58 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.568 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.2 t70 -174.72 160.05 2.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.161 0.984 . . . . 0.0 108.908 -172.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.37 18.15 13.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 111.302 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.682 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 11.8 tp10 -85.06 97.46 9.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.4 mt -106.26 150.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.653 1.181 . . . . 0.0 109.54 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -75.1 153.39 38.34 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.45 0.7 . . . . 0.0 109.847 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.42 135.55 35.65 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.445 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 45.7 m-85 -121.55 3.43 10.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.204 0.601 . . . . 0.0 111.435 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.2 p -67.77 -18.16 64.78 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.05 0.386 . . . . 0.0 111.674 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.65 -2.73 64.98 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 118.828 -0.985 . . . . 0.0 113.582 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 103' ' ' MET . 40.0 mt -52.0 -36.15 48.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 117.898 0.849 . . . . 0.0 112.958 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.477 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.7 mtpt -67.7 -17.55 64.61 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -98.46 -50.57 4.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.062 0.945 . . . . 0.0 111.772 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 100' ' ' LEU . 25.5 ptm -71.32 -35.14 71.12 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.218 0.607 . . . . 0.0 111.271 -173.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.1 m -126.01 84.61 60.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.708 0.803 . . . . 0.0 109.922 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.39 -29.04 5.11 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.857 2.371 . . . . 0.0 111.82 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 11.2 mmpt? -74.55 -12.69 60.53 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.241 0.616 . . . . 0.0 111.564 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -56.54 126.65 27.51 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.1 0.875 . . . . 0.0 111.179 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.556 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -134.98 -18.01 1.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.808 174.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.556 ' HB2' HH11 ' A' ' 108' ' ' ARG . 59.1 tp -143.66 131.92 21.99 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.192 0.597 . . . . 0.0 110.367 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 131' ' ' THR . 49.4 mt -107.37 143.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.205 1.002 . . . . 0.0 108.496 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.534 ' SG ' HG11 ' A' ' 155' ' ' VAL . 74.9 m -125.54 116.23 21.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.182 0.593 . . . . 0.0 110.13 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 96.7 m-85 -93.0 111.54 23.2 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.268 0.627 . . . . 0.0 110.394 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -84.53 93.24 8.3 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.15 127.37 3.18 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -50.53 -45.06 56.55 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.382 1.473 . . . . 0.0 113.417 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -58.13 -24.0 57.15 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . . . -73.16 -18.33 61.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.068 0.461 . . . . 0.0 111.075 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.43 -16.9 67.95 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.28 -0.873 . . . . 0.0 114.573 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.63 -26.68 67.93 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.919 0.488 . . . . 0.0 110.018 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.78 8.26 24.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.28 1.032 . . . . 0.0 111.334 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 38.7 tt0 -60.79 -51.08 82.1 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.169 169.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 16.2 Cg_exo -65.43 -17.42 57.6 Favored 'Trans proline' 0 C--N 1.401 3.321 0 C-N-CA 121.83 1.686 . . . . 0.0 113.252 -175.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.09 -41.63 99.44 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.558 1.143 . . . . 0.0 110.755 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.0 -4.98 55.99 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.171 -171.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.424 ' HG3' ' HA ' ' A' ' 122' ' ' PRO . 66.6 mtm180 -66.0 -31.29 72.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.036 0.534 . . . . 0.0 110.226 172.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.21 -1.46 69.41 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.084 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 56.6 mtt -103.87 11.92 35.03 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.459 1.104 . . . . 0.0 110.451 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.33 78.15 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.934 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.477 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 29.8 m-85 -110.72 141.16 44.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.263 0.625 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 13.4 mm-40 -68.43 133.68 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.422 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 41.5 p -126.3 136.91 53.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 109.172 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -141.62 130.97 23.63 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.146 0.978 . . . . 0.0 109.358 -176.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 61.0 t -101.81 130.4 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.406 0.682 . . . . 0.0 109.643 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -115.89 154.59 48.27 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.324 1.45 . . . . 0.0 108.202 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.5 170.1 14.36 Favored 'Trans proline' 0 C--N 1.367 1.539 0 C-N-CA 122.613 2.209 . . . . 0.0 112.187 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.3 m -60.86 127.44 31.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.9 m -77.63 27.68 0.17 Allowed 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.3 m -87.71 159.61 18.43 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.827 0.851 . . . . 0.0 110.369 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 142' ' ' ARG . . . -64.5 -20.78 66.1 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.411 0.925 . . . . 0.0 115.411 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.48 -43.17 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.02 0.528 . . . . 0.0 110.833 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -69.89 -39.81 76.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.516 0.326 . . . . 0.0 110.407 171.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.454 ' HB3' ' HA2' ' A' ' 139' ' ' GLY . 7.3 tmm_? -60.01 -34.11 72.9 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.218 1.007 . . . . 0.0 111.561 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.21 -23.69 37.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.386 1.074 . . . . 0.0 112.047 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -117.76 -23.13 7.69 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.026 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 53.4 m -84.41 39.69 0.74 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.758 1.223 . . . . 0.0 113.012 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 146' ' ' LYS . 71.6 mmtt -76.54 -53.89 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.582 0.353 . . . . 0.0 110.599 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -64.16 -23.14 67.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.386 0.274 . . . . 0.0 111.141 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 55.7 ttm-85 -84.5 -18.83 34.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.0 0.92 . . . . 0.0 110.475 -176.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.03 -27.53 63.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.568 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.0 t -60.36 -43.98 96.01 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.885 0.874 . . . . 0.0 111.585 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -75.9 -27.85 57.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -63.32 -44.89 93.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.73 -35.93 77.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.777 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.28 72.4 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.866 0.466 . . . . 0.0 110.369 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.534 HG11 ' SG ' ' A' ' 111' ' ' CYS . 53.1 t -68.12 -55.49 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.036 0.934 . . . . 0.0 111.083 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.402 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 56.0 m-85 -94.39 -5.73 45.77 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -71.91 -38.45 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 118.255 0.48 . . . . 0.0 110.917 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.46 ' HE1' HD11 ' A' ' 16' ' ' ILE . 7.5 p-80 -76.85 -7.14 54.94 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.148 0.579 . . . . 0.0 110.751 -174.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 16' ' ' ILE . 81.7 mt -74.17 -20.91 60.05 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.554 0.742 . . . . 0.0 111.967 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.78 -29.07 60.99 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 169.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 CA--C 1.561 1.366 0 C-N-CA 124.896 1.279 . . . . 0.0 111.753 171.05 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.7 mm . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -107.53 133.72 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.258 1.023 . . . . 0.0 109.858 -174.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -101.5 135.92 42.2 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.541 0.736 . . . . 0.0 110.848 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.57 174.73 47.68 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.412 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.84 148.77 69.4 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 117.098 0.449 . . . . 0.0 111.228 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.88 163.6 9.16 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.584 2.189 . . . . 0.0 110.741 159.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.75 113.5 3.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.175 0.512 . . . . 0.0 110.585 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.515 HG11 HD22 ' A' ' 62' ' ' LEU . 13.8 t -87.08 74.71 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD21 HG13 ' A' ' 104' ' ' VAL . 28.0 tp -129.38 154.38 46.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -154.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -127.43 162.12 27.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.596 1.158 . . . . 0.0 110.073 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -66.29 -24.49 66.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.054 0.942 . . . . 0.0 112.243 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.452 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 48.7 m-80 -96.27 14.28 24.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.04 0.536 . . . . 0.0 111.056 -175.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -70.16 111.09 5.55 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.419 0.628 . . . . 0.0 110.834 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 24.8 tt0 -89.88 -35.66 15.5 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.038 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 63.1 mt -121.45 114.0 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.555 0.742 . . . . 0.0 109.205 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.453 HD13 HD13 ' A' ' 10' ' ' LEU . 61.1 tp -103.47 111.9 24.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.438 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.9 mt -92.62 116.43 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.1 mt -102.99 125.78 49.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.55 0.74 . . . . 0.0 109.82 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.17 -161.52 24.22 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 163.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 p -106.45 -64.3 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.2 tp -150.67 133.47 8.46 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.1 154.81 71.62 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.524 2.149 . . . . 0.0 110.663 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 27' ' ' SER . 24.7 t -60.77 150.58 32.1 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.907 0.483 . . . . 0.0 109.733 177.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 7.7 p-10 -59.06 -37.31 76.74 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.61 -30.36 68.08 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.357 0.663 . . . . 0.0 110.493 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 24' ' ' SER . 31.4 t -67.07 -45.93 75.84 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.846 0.858 . . . . 0.0 109.693 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.82 -39.34 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.582 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 2.8 mmp_? -61.91 -37.85 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.914 0.486 . . . . 0.0 112.163 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.32 -7.86 24.03 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.023 0.529 . . . . 0.0 111.836 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 67.63 18.47 9.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.442 1.097 . . . . 0.0 113.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -113.67 127.47 56.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.772 0.829 . . . . 0.0 109.056 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.504 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 84.4 m-85 -59.77 -59.77 4.91 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -55.47 -27.13 46.4 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.619 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.36 -21.13 66.17 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 123.065 0.228 . . . . 0.0 112.863 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 4.3 t30 -86.92 108.33 18.07 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.474 1.11 . . . . 0.0 108.406 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.33 142.37 78.94 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.463 2.776 . . . . 0.0 112.412 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.23 -19.3 40.48 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.376 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 36' ' ' ASN . 95.4 m-20 -68.87 98.98 0.99 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.515 0.674 . . . . 0.0 109.572 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -86.39 -6.89 58.82 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 126.538 1.935 . . . . 0.0 110.952 -170.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.457 ' HE1' ' HB3' ' A' ' 113' ' ' ASN . 65.1 m-85 -41.63 -43.83 2.9 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 125.221 1.408 . . . . 0.0 112.681 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.504 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 74.6 m95 -71.5 -24.13 61.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.186 0.994 . . . . 0.0 112.065 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -81.48 -36.36 29.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.873 0.869 . . . . 0.0 110.902 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.09 -45.63 17.91 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.865 0.466 . . . . 0.0 111.385 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 49' ' ' ILE . 59.2 t -69.03 -36.65 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.49 -32.67 75.48 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.889 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.15 -42.91 79.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.452 0.701 . . . . 0.0 110.053 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -67.75 -38.02 82.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.298 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 45' ' ' VAL . 23.7 pt -96.68 -11.73 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.841 0.456 . . . . 0.0 111.137 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.66 32.42 61.64 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.438 0.461 . . . . 0.0 113.579 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -133.35 111.92 11.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -66.99 89.68 0.17 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.939 0.876 . . . . 0.0 111.579 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.37 -30.98 69.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.09 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -73.41 -10.69 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.924 -173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -98.93 -9.17 24.48 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.947 -0.471 . . . . 0.0 111.68 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.479 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 60.0 mtt -87.44 159.28 18.74 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.228 0.611 . . . . 0.0 110.76 -172.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 159.4 31.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.535 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 17.0 t80 -52.12 -54.48 29.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.43 -36.7 83.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.644 0.378 . . . . 0.0 111.214 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -67.91 -51.77 44.0 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.852 0.861 . . . . 0.0 111.654 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 8.9 ptpp? -61.32 -34.43 75.23 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.184 0.303 . . . . 0.0 111.096 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 78.0 mt -65.18 -44.18 89.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 122.657 0.383 . . . . 0.0 111.039 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -55.79 -43.15 76.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.988 0.515 . . . . 0.0 110.624 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.6 m -68.4 -41.8 79.94 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.817 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 62' ' ' LEU . 78.5 mt -56.13 -62.33 1.78 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.719 0.808 . . . . 0.0 110.591 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -23.55 64.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.772 0.67 . . . . 0.0 111.752 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -63.53 -39.14 93.64 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.987 0.515 . . . . 0.0 111.024 167.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.455 ' O ' HD13 ' A' ' 159' ' ' LEU . 60.7 m-80 -85.61 14.92 5.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.042 0.537 . . . . 0.0 110.111 173.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 14.4 mmt-85 69.37 25.17 5.59 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.298 1.439 . . . . 0.0 111.032 173.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.19 118.77 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.652 0.781 . . . . 0.0 109.352 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.52 161.28 15.33 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.35 145.89 48.38 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.9 -170.29 1.72 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -130.65 163.44 27.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.583 0.753 . . . . 0.0 110.117 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 58.4 t -79.43 -54.49 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 0.0 109.89 172.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.12 128.62 35.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -78.31 -35.81 47.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.337 0.655 . . . . 0.0 110.209 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -144.01 140.82 29.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 110.88 178.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.35 160.41 33.43 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.592 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.484 ' O ' ' HA3' ' A' ' 90' ' ' GLY . 58.8 p . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 122.922 0.489 . . . . 0.0 109.83 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.9 tp . . . . . 0 CA--C 1.555 1.151 0 CA-C-O 121.211 0.529 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . 117.53 9.43 10.24 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.232 -175.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -171.74 177.17 3.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.829 1.251 . . . . 0.0 108.185 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.6 12.4 11.48 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.163 0.585 . . . . 0.0 111.864 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 9.1 tp10 -86.73 119.13 26.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.8 mt -124.77 138.97 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.759 1.223 . . . . 0.0 108.731 -173.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -60.76 137.38 58.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.371 0.668 . . . . 0.0 109.677 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -86.07 127.31 34.65 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.929 0.492 . . . . 0.0 109.759 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.416 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 67.0 m-85 -112.82 7.77 18.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.452 0.701 . . . . 0.0 111.35 -176.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.3 m -63.52 -26.5 68.74 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.838 0.455 . . . . 0.0 111.648 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -3.04 89.36 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.706 -1.052 . . . . 0.0 115.044 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.476 HD23 ' SD ' ' A' ' 103' ' ' MET . 29.5 mt -49.02 -38.57 23.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 101' ' ' LYS . 10.0 mmpt? -55.78 -39.38 71.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.429 0.558 . . . . 0.0 111.197 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -85.06 -50.52 7.37 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.236 1.015 . . . . 0.0 112.267 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.549 ' HG3' HG22 ' A' ' 104' ' ' VAL . 24.1 ptm -68.58 -35.26 77.12 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.494 0.718 . . . . 0.0 111.874 -175.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 10' ' ' LEU . 1.1 m -132.74 94.55 21.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.104 0.562 . . . . 0.0 110.871 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.48 -30.99 4.7 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.55 2.167 . . . . 0.0 111.742 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.4 mmmm -88.3 -7.35 56.88 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.167 -174.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.3 tp -58.53 107.72 0.54 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.48 0.657 . . . . 0.0 111.497 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -96.52 -51.43 4.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.335 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.6 tp -126.13 132.53 51.84 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.324 0.65 . . . . 0.0 110.775 -171.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.9 mt -102.95 144.26 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 134' ' ' LEU . 80.1 m -124.9 113.31 17.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.807 0.443 . . . . 0.0 110.701 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.61 111.12 22.6 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.457 ' HB3' ' HE1' ' A' ' 41' ' ' PHE . 86.7 m-20 -91.39 79.49 5.59 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.4 153.39 5.86 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.343 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -62.58 -45.27 93.67 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.17 0.588 . . . . 0.0 110.148 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -31.13 69.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.809 0.843 . . . . 0.0 112.988 172.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.53 -39.57 62.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.116 0.484 . . . . 0.0 110.016 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.68 -11.14 68.56 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.392 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.31 -38.4 65.91 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.908 0.883 . . . . 0.0 112.351 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -107.92 25.3 11.73 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.543 0.737 . . . . 0.0 111.177 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 70.6 tt0 -55.78 -53.09 66.67 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.564 165.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.44 -22.22 73.77 Favored 'Trans proline' 0 C--N 1.403 3.426 0 C-N-CA 122.313 2.009 . . . . 0.0 112.906 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.79 -47.63 82.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.213 0.605 . . . . 0.0 109.661 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.97 -20.02 29.53 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.363 -174.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 34.1 mtp85 -66.65 -42.2 87.03 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.45 -21.07 68.36 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.091 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 63.9 mtt -79.04 -19.35 51.66 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.787 0.435 . . . . 0.0 111.441 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.51 30.59 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.523 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 142.94 27.5 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.215 0.507 . . . . 0.0 110.824 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -65.72 135.13 54.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 170.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 54.6 p -123.57 139.51 53.93 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.257 0.623 . . . . 0.0 110.161 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HB2' HD11 ' A' ' 109' ' ' LEU . 53.1 tptt -134.12 116.75 15.79 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 107.89 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.6 110.63 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 111' ' ' CYS . 93.6 mt -95.71 150.92 38.06 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.226 1.411 . . . . 0.0 109.124 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.463 ' HB2' HD21 ' A' ' 141' ' ' ASN . 94.1 Cg_endo -74.45 130.74 14.19 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.557 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.0 p -54.46 107.91 0.33 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.728 0.811 . . . . 0.0 110.974 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.5 m -79.59 50.28 1.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.214 1.006 . . . . 0.0 112.05 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -73.29 160.45 31.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 109.804 163.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.74 59.73 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 114.758 0.663 . . . . 0.0 114.758 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.0 -37.83 78.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.795 0.438 . . . . 0.0 111.405 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.463 HD21 ' HB2' ' A' ' 135' ' ' PRO . 49.2 t30 -70.65 -20.06 62.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.481 0.712 . . . . 0.0 111.646 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 142' ' ' ARG . 12.5 tpp180 -57.22 -29.04 63.42 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.082 0.553 . . . . 0.0 110.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -53.27 -36.53 61.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.41 1.084 . . . . 0.0 111.084 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -107.33 -22.88 12.42 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.674 1.189 . . . . 0.0 111.697 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 8.2 t -87.47 13.29 10.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -165.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -72.79 -61.12 1.92 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.415 0.286 . . . . 0.0 110.478 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -24.24 64.13 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.123 0.569 . . . . 0.0 112.052 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 0.7 OUTLIER -74.99 -22.24 58.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.713 0.805 . . . . 0.0 111.225 -174.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.61 -23.19 49.64 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 t -63.84 -41.32 97.84 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.798 0.839 . . . . 0.0 111.166 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.4 pt-20 -70.78 -35.64 72.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -65.76 -41.85 91.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.099 0.559 . . . . 0.0 109.995 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -66.86 -34.55 78.04 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.985 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.05 -9.73 59.27 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.982 0.913 . . . . 0.0 111.887 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 151' ' ' GLU . 37.9 t -90.29 -43.3 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.801 0.84 . . . . 0.0 111.171 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.561 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 80.0 m-85 -102.81 4.83 38.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -168.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -86.62 -14.4 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.198 0.908 . . . . 0.0 112.384 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -84.29 -4.9 59.15 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 118.205 0.457 . . . . 0.0 111.669 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 68' ' ' ASN . 71.5 mt -61.27 -10.01 6.15 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.98 0.912 . . . . 0.0 113.113 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -51.36 -41.21 60.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.865 0.866 . . . . 0.0 111.538 164.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 C--O 1.255 1.378 0 C-N-CA 123.991 0.917 . . . . 0.0 109.015 173.622 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 78' ' ' ALA . 47.3 mm . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 120.816 0.341 . . . . 0.0 110.387 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.7 125.8 45.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.324 1.05 . . . . 0.0 108.255 171.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -97.14 141.27 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.039 0.447 . . . . 0.0 111.835 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.4 171.14 51.77 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.977 163.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -107.95 125.48 31.99 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.514 1.157 . . . . 0.0 110.211 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.48 155.16 0.47 Allowed 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 124.178 3.252 . . . . 0.0 113.881 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.46 122.46 14.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.876 0.87 . . . . 0.0 113.042 -167.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.595 HG11 HD22 ' A' ' 62' ' ' LEU . 25.3 t -94.34 81.84 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.528 HD11 ' CG1' ' A' ' 104' ' ' VAL . 28.7 tp -123.35 153.35 40.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -159.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 9.8 t70 -124.88 157.46 35.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.411 170.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.66 -18.62 65.01 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.097 0.559 . . . . 0.0 112.125 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 52.0 m-80 -97.04 13.64 28.35 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.914 0.886 . . . . 0.0 111.628 -176.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.428 ' HB ' HG12 ' A' ' 104' ' ' VAL . 83.0 m -77.39 116.22 17.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.922 0.489 . . . . 0.0 111.432 -171.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -99.4 -26.2 14.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.459 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.479 HD12 HD21 ' A' ' 159' ' ' LEU . 42.8 mt -121.45 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -104.16 111.09 23.55 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 111' ' ' CYS . 47.3 mt -93.62 113.23 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.8 mt -103.72 110.99 23.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.885 0.874 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.36 175.44 25.26 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.018 -0.433 . . . . 0.0 112.018 169.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -87.14 -77.57 0.33 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -140.99 123.35 9.52 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -55.14 156.74 15.47 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.745 2.297 . . . . 0.0 112.445 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 28' ' ' ILE . 42.2 t -60.38 145.26 48.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.102 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.46 -39.85 70.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.239 0.616 . . . . 0.0 110.782 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.83 -23.71 62.4 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.355 1.062 . . . . 0.0 111.437 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.9 m -77.68 -37.4 49.81 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 24' ' ' SER . 43.6 mt -74.31 -19.25 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.599 0.76 . . . . 0.0 110.992 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.72 -33.26 75.54 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 120.953 0.406 . . . . 0.0 110.357 172.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.88 -8.43 30.88 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.203 1.001 . . . . 0.0 111.183 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 60.14 30.28 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 111.366 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -146.51 132.91 19.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.925 0.89 . . . . 0.0 110.148 -168.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -64.4 -44.96 89.64 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.384 0.612 . . . . 0.0 109.753 173.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.01 -4.42 7.13 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.227 172.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.96 -37.2 53.08 Favored Glycine 0 C--N 1.361 1.958 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -103.23 102.09 26.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.0 0.92 . . . . 0.0 108.873 165.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.17 -10.44 28.93 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.969 2.446 . . . . 0.0 112.61 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.58 -9.66 86.08 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -71.51 117.89 13.64 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 5.2 m-20 -75.27 -4.17 37.51 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.647 0.779 . . . . 0.0 112.139 -167.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -43.94 -44.84 7.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.104 1.762 . . . . 0.0 112.847 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.44 ' HZ3' HD11 ' A' ' 65' ' ' LEU . 54.4 m95 -72.25 -22.35 61.24 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.443 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -86.91 -32.81 19.98 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 124.169 0.988 . . . . 0.0 111.697 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 96.9 mt -75.9 -53.95 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.391 0.676 . . . . 0.0 110.016 -174.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.38 -36.05 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.402 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.1 -36.98 91.3 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.024 0.828 . . . . 0.0 112.678 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -67.68 -41.88 83.0 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.596 0.759 . . . . 0.0 109.93 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.01 -37.19 86.19 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.652 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 pt -96.52 -11.72 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.097 0.559 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.97 -59.26 2.8 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -50.24 111.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.367 1.067 . . . . 0.0 112.966 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -70.64 116.87 11.46 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.53 -30.75 57.26 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.428 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -60.24 -52.38 65.55 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -164.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.89 -22.17 63.25 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.361 0.413 . . . . 0.0 111.708 -170.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.1 mtt -60.25 152.02 25.9 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.313 0.645 . . . . 0.0 110.823 174.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.38 152.77 44.38 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 52.4 t80 -46.22 -52.27 12.75 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 0.0 112.589 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.88 -34.81 78.17 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.92 0.488 . . . . 0.0 111.704 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -73.38 -47.33 42.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.842 0.457 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -32.27 72.9 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.853 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.595 HD22 HG11 ' A' ' 9' ' ' VAL . 42.1 mt -63.24 -49.07 75.61 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.437 0.461 . . . . 0.0 110.377 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -55.54 -38.89 69.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 123.803 0.689 . . . . 0.0 111.313 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -63.78 -46.34 85.66 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.862 0.726 . . . . 0.0 109.625 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD11 ' HZ3' ' A' ' 42' ' ' TRP . 95.4 mt -59.79 -43.28 94.51 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.738 0.815 . . . . 0.0 110.889 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.564 ' HD2' ' HB2' ' A' ' 11' ' ' ASP . 28.6 mmtp -61.32 -38.09 85.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.865 0.466 . . . . 0.0 110.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -74.86 -23.11 58.37 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.228 1.011 . . . . 0.0 110.966 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.427 ' O ' HD13 ' A' ' 159' ' ' LEU . 18.5 m120 -88.74 0.04 56.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.612 0.765 . . . . 0.0 110.256 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 65.34 32.92 9.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.777 1.231 . . . . 0.0 110.67 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.76 136.64 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 0.0 109.405 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.72 154.32 16.68 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.3 mt -120.13 129.26 54.07 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.483 0.642 . . . . 0.0 109.81 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -155.97 -168.88 2.9 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -133.25 170.38 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.206 1.003 . . . . 0.0 109.306 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.54 -61.2 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.401 ' CD1' HG21 ' A' ' 89' ' ' ILE . 70.9 m-85 -74.18 102.07 4.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -65.08 -28.89 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.663 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -149.15 141.79 24.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.957 172.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.585 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.44 134.39 6.05 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.328 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB2' HD13 ' A' ' 2' ' ' ILE . 39.8 t . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 123.756 0.822 . . . . 0.0 109.275 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' A' ' 76' ' ' PHE . 3.4 mp . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.15 61.68 4.11 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.116 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.585 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 11.8 t70 -176.04 153.44 1.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.445 1.098 . . . . 0.0 108.218 -172.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -125.27 26.37 6.9 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 8.3 tp10 -80.3 102.82 9.76 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.5 149.9 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.047 0.939 . . . . 0.0 108.699 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.453 ' OD1' ' HD2' ' A' ' 77' ' ' LYS . 88.8 m-20 -66.7 141.03 57.91 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.794 0.684 . . . . 0.0 110.117 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.79 116.63 26.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -101.45 18.48 20.03 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.167 0.587 . . . . 0.0 112.087 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.4 p -69.61 -18.34 63.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.37 -3.34 63.19 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.361 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.95 -38.5 36.85 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.982 0.891 . . . . 0.0 113.139 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.75 -24.27 67.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.842 0.457 . . . . 0.0 111.571 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -93.56 -50.28 5.49 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.691 0.797 . . . . 0.0 111.835 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.557 ' HG3' HG22 ' A' ' 104' ' ' VAL . 24.1 ptm -70.86 -38.74 73.16 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.575 0.75 . . . . 0.0 111.942 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -122.57 89.1 49.7 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 123.375 0.67 . . . . 0.0 110.262 178.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.24 -29.5 17.14 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.826 2.351 . . . . 0.0 111.997 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.8 mmpt? -82.7 -8.65 59.58 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.832 0.853 . . . . 0.0 112.708 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.575 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.0 tp -57.54 127.95 34.61 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.604 0.565 . . . . 0.0 111.698 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -134.76 -37.48 0.82 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.639 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 26.0 tp -129.57 125.34 35.99 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.054 0.542 . . . . 0.0 110.057 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.518 ' HB ' HG22 ' A' ' 131' ' ' THR . 57.0 mt -107.2 110.82 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.524 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.9 m -96.69 115.23 27.07 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 122.612 0.365 . . . . 0.0 110.606 -175.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.11 123.03 33.0 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.403 0.681 . . . . 0.0 109.726 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -90.99 99.27 12.34 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.05 138.88 8.13 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.447 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -52.71 -42.1 64.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.753 1.221 . . . . 0.0 112.19 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HB3' ' NZ ' ' A' ' 116' ' ' LYS . 5.1 mtpm? -59.8 -30.65 69.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.59 -38.97 64.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.286 0.565 . . . . 0.0 109.943 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.77 -9.45 62.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.707 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.12 -26.29 67.57 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.562 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -102.55 14.03 33.0 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.034 1.334 . . . . 0.0 111.373 -176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.4 ' HG3' ' OG1' ' A' ' 131' ' ' THR . 41.3 tt0 -58.5 -53.19 68.7 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.242 172.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.65 -18.09 53.36 Favored 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 121.742 1.628 . . . . 0.0 113.15 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 tp -66.93 -46.35 75.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.501 0.72 . . . . 0.0 109.705 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.92 -18.98 31.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.168 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -69.2 -33.0 72.66 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.124 0.569 . . . . 0.0 109.966 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.68 -22.92 64.63 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.741 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 49.3 mtt -90.21 10.7 23.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.056 0.942 . . . . 0.0 111.401 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.3 25.56 75.22 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.899 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -109.56 132.65 53.94 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.282 0.633 . . . . 0.0 110.82 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -70.2 142.5 52.41 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.518 HG22 ' HB ' ' A' ' 110' ' ' ILE . 32.2 p -133.65 150.67 51.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.524 1.13 . . . . 0.0 110.159 -173.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -142.12 119.22 11.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.704 1.201 . . . . 0.0 108.866 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.9 t -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.642 0.735 . . . . 0.0 109.765 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.86 154.39 94.29 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.711 1.204 . . . . 0.0 110.287 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.96 165.51 27.87 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.277 1.985 . . . . 0.0 112.191 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.1 t -67.35 143.74 56.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.0 t -74.02 5.92 3.85 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.125 0.97 . . . . 0.0 113.513 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -64.26 140.35 58.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.139 0.576 . . . . 0.0 110.371 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.95 -28.98 73.56 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.212 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.04 98.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.555 0.742 . . . . 0.0 110.29 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -65.93 -22.9 66.52 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.003 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.519 HH12 ' HB3' ' A' ' 149' ' ' GLU . 18.7 mmm180 -81.99 -16.74 49.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.644 0.778 . . . . 0.0 111.504 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -67.0 -36.58 82.47 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -91.54 -34.14 14.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.659 0.783 . . . . 0.0 110.397 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.1 m -101.43 29.76 4.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.509 1.123 . . . . 0.0 112.038 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.31 -62.02 2.07 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.3 -4.93 32.62 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.252 1.021 . . . . 0.0 112.464 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 64.6 mtm-85 -88.91 -8.14 54.77 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.631 0.773 . . . . 0.0 111.84 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.519 ' HB3' HH12 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -59.64 -23.99 63.5 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.589 0.632 . . . . 0.0 110.665 172.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -61.19 -32.24 72.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.851 1.26 . . . . 0.0 111.481 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 155' ' ' VAL . 7.5 pt-20 -74.34 -27.03 60.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -70.82 -37.91 73.23 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.93 -36.71 84.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.618 0.767 . . . . 0.0 110.168 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.6 -12.55 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.342 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 151' ' ' GLU . 41.6 t -95.1 -44.93 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.435 1.094 . . . . 0.0 111.157 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.44 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 56.3 m-85 -99.37 3.12 45.83 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -69.75 -34.6 74.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.459 ' HE1' HD11 ' A' ' 16' ' ' ILE . 11.5 p-80 -82.1 -9.73 59.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 16' ' ' ILE . 99.3 mt -51.21 -61.79 2.02 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 124.164 0.915 . . . . 0.0 111.979 -168.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.85 -60.8 2.24 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 172.502 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 80' ' ' SER . 34.2 mm . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.259 0.552 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 22' ' ' LEU . 33.5 mtmm -95.51 118.79 32.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.744 -1.116 . . . . 0.0 107.989 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -87.82 134.19 33.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.203 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.18 171.8 48.16 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.953 170.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -98.26 143.85 27.02 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 117.353 0.576 . . . . 0.0 110.031 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.78 150.11 79.2 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.219 1.946 . . . . 0.0 110.449 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -61.96 143.32 56.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 112.325 -174.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.519 HG12 ' HE2' ' A' ' 66' ' ' LYS . 11.8 t -101.21 61.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 168.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.518 HD11 ' CG1' ' A' ' 104' ' ' VAL . 42.3 tp -98.18 146.36 25.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.162 -165.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.06 159.73 29.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.85 -19.32 63.45 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.773 0.429 . . . . 0.0 111.696 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -95.49 6.99 47.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.642 0.377 . . . . 0.0 111.792 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 m -66.84 114.58 5.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.227 0.611 . . . . 0.0 111.223 -171.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 40.6 tt0 -94.23 -35.44 12.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.384 1.474 . . . . 0.0 110.223 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.9 mt -121.42 118.47 56.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.431 HD13 HD13 ' A' ' 10' ' ' LEU . 63.7 tp -105.01 116.5 32.05 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.524 HG21 ' HE1' ' A' ' 41' ' ' PHE . 52.6 mt -92.84 107.63 19.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 73' ' ' TRP . 96.0 mt -99.24 108.45 21.02 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.065 0.946 . . . . 0.0 109.152 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.83 179.66 12.78 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 123.281 0.363 . . . . 0.0 112.26 170.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 m -86.89 -69.04 0.7 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.486 HD22 ' HA3' ' A' ' 79' ' ' GLY . 27.6 tp -146.21 131.81 9.31 Favored Pre-proline 0 C--O 1.246 0.917 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 163.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 22' ' ' LEU . 18.4 Cg_endo -56.96 159.28 15.03 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.087 1.858 . . . . 0.0 112.075 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 m -60.37 136.94 58.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.893 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.66 -29.09 58.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.682 0.393 . . . . 0.0 110.927 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.46 -63.1 1.27 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.934 1.293 . . . . 0.0 110.549 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' GLN . 51.0 p -57.24 -28.2 62.73 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.626 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.8 mt -73.28 -28.02 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -59.9 -29.13 68.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.888 0.475 . . . . 0.0 111.095 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 67.0 mttm -111.69 -0.55 15.98 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.115 0.966 . . . . 0.0 111.318 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 51.09 34.16 10.48 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.416 1.486 . . . . 0.0 113.832 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 27' ' ' SER . 13.3 pt20 -138.67 151.64 47.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.706 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -70.27 -2.51 13.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.836 0.854 . . . . 0.0 111.433 174.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -103.11 -4.85 23.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.428 1.091 . . . . 0.0 109.843 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -72.91 -25.43 73.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.996 0.358 . . . . 0.0 113.996 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -106.83 103.27 46.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.254 0.622 . . . . 0.0 109.662 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.03 -19.71 29.76 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.724 2.283 . . . . 0.0 111.791 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.36 31.07 5.61 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.655 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -115.5 116.33 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.783 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 37.0 m-20 -85.11 3.51 38.61 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.658 0.783 . . . . 0.0 112.299 -175.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.524 ' HE1' HG21 ' A' ' 18' ' ' ILE . 86.0 t80 -40.95 -51.08 3.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.282 1.033 . . . . 0.0 112.899 172.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.419 ' HE3' ' HB3' ' A' ' 53' ' ' LEU . 86.1 m95 -71.66 -23.21 61.63 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.236 -175.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.783 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 2.9 mpt_? -79.12 -42.63 25.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.957 0.903 . . . . 0.0 110.219 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.14 -49.78 16.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.957 0.903 . . . . 0.0 110.649 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.1 -31.54 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.329 0.652 . . . . 0.0 109.655 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.03 -40.54 88.58 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.485 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -62.72 -39.68 94.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.833 0.853 . . . . 0.0 109.753 172.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.63 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -72.62 -30.06 64.01 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.892 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.5 pt -102.75 -4.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.58 38.59 86.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.314 0.384 . . . . 0.0 113.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -137.15 136.26 38.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.111 1.364 . . . . 0.0 108.265 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 56' ' ' MET . 14.8 p-10 -74.38 87.07 2.02 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.307 0.575 . . . . 0.0 109.866 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 92.0 mt -68.14 -51.85 41.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -46.87 -39.34 11.91 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.528 1.531 . . . . 0.0 113.258 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.45 -33.15 48.62 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.434 1.093 . . . . 0.0 111.343 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.53 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.0 mtt -66.01 151.58 46.51 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 123.103 0.561 . . . . 0.0 111.842 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.15 157.39 37.69 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.491 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.502 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 21.2 t80 -43.63 -56.43 3.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.968 1.307 . . . . 0.0 113.862 -171.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.07 -31.49 72.74 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.923 0.489 . . . . 0.0 111.668 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -72.53 -52.15 16.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 0.0 111.439 -175.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 6.4 ptmt -61.54 -32.6 72.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.528 0.731 . . . . 0.0 112.491 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 89.8 mt -64.84 -42.99 94.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.438 0.695 . . . . 0.0 111.504 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.25 -40.75 95.2 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.936 0.495 . . . . 0.0 110.853 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.411 ' HA ' ' CD2' ' A' ' 67' ' ' HIS . 17.8 m -60.8 -41.23 95.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.105 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 90.4 mt -61.35 -46.93 88.16 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.828 0.705 . . . . 0.0 110.782 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.519 ' HE2' HG12 ' A' ' 9' ' ' VAL . 23.0 mttm -65.77 -28.0 68.7 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.016 0.926 . . . . 0.0 112.617 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.411 ' CD2' ' HA ' ' A' ' 64' ' ' THR . 12.2 m-70 -57.54 -43.28 84.26 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.319 0.581 . . . . 0.0 111.061 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -90.69 11.41 22.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.417 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.508 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER 66.66 39.28 3.7 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.09 1.356 . . . . 0.0 111.26 174.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 69.1 mt -109.72 131.56 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.01 152.83 17.15 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 171.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.5 mt -116.98 137.58 52.12 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.509 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.6 t90 -165.6 -169.1 1.47 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -140.59 171.92 13.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.741 0.816 . . . . 0.0 110.852 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.571 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 78.9 t -88.15 -56.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 123.841 0.857 . . . . 0.0 109.616 176.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.67 104.37 16.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.113 0.565 . . . . 0.0 110.22 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.736 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.6 ptmt -71.34 -14.74 62.29 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.758 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -149.89 123.91 9.39 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.486 ' HA3' HD22 ' A' ' 22' ' ' LEU . . . -128.7 125.8 5.09 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 2' ' ' ILE . 30.3 t . . . . . 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 110.315 -174.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.93 -59.05 1.82 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.89 142.51 1.32 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.097 1.359 . . . . 0.0 114.124 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -111.01 24.27 13.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.167 -161.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.736 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.5 tp10 -80.83 102.76 10.22 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.6 153.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.126 0.971 . . . . 0.0 110.622 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -80.56 151.9 28.89 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.37 1.068 . . . . 0.0 110.161 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.94 119.87 24.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.571 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.5 m-85 -104.28 -19.48 14.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.655 0.782 . . . . 0.0 111.582 -175.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 p -62.89 -19.89 64.61 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.29 -19.24 53.45 Favored Glycine 0 C--N 1.356 1.648 0 CA-C-O 119.773 -0.46 . . . . 0.0 112.484 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -38.89 -45.98 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.996 1.318 . . . . 0.0 113.727 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -65.87 -20.79 66.36 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -163.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -74.25 -45.21 49.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.515 0.726 . . . . 0.0 110.85 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -90.77 -18.16 25.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 13.6 m -130.12 90.06 43.32 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 121.348 0.594 . . . . 0.0 110.566 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.92 -36.59 2.53 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.116 1.878 . . . . 0.0 111.17 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 13.4 mmmm -81.1 -9.15 59.86 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 123.895 0.878 . . . . 0.0 112.551 -171.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 38.2 tp -58.36 104.28 0.2 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.848 0.718 . . . . 0.0 110.791 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 106' ' ' LYS . 23.6 mtp180 -98.33 -42.89 7.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.604 0.762 . . . . 0.0 110.019 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 37.9 tp -128.93 139.77 51.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.133 0.573 . . . . 0.0 110.531 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.45 127.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.3 m -106.98 115.56 30.4 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.291 0.636 . . . . 0.0 109.717 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 95.6 m-85 -89.16 114.61 25.92 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.451 0.7 . . . . 0.0 109.819 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.554 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 11.8 t-20 -83.11 89.54 6.95 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.87 144.56 8.82 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.335 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.45 -37.66 81.68 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.052 0.941 . . . . 0.0 112.358 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -60.06 -31.63 70.17 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.17 -43.56 56.86 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.323 0.582 . . . . 0.0 109.512 170.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -9.73 52.79 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.281 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.9 -35.64 66.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.326 0.65 . . . . 0.0 111.113 171.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.07 23.79 12.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.72 1.208 . . . . 0.0 110.945 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.485 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -65.29 -55.96 22.58 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.386 0.675 . . . . 0.0 111.29 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.6 -16.35 34.01 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.714 1.61 . . . . 0.0 112.035 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.53 -43.76 88.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.971 0.909 . . . . 0.0 109.977 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.554 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 8.1 mt -82.27 -9.88 59.32 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.813 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 75.5 mtt180 -67.56 -22.07 65.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.312 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.28 69.29 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.823 0.702 . . . . 0.0 113.481 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.554 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -84.18 7.09 20.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.462 0.705 . . . . 0.0 111.094 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.1 28.33 68.57 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 116.876 -0.147 . . . . 0.0 112.738 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 21.0 m-85 -108.43 145.46 34.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.602 0.761 . . . . 0.0 110.866 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -79.72 139.12 37.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 51.4 p -134.85 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.914 0.486 . . . . 0.0 110.57 -174.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -140.32 130.59 25.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 -174.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.13 113.02 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 111' ' ' CYS . 85.5 mt -96.49 150.8 37.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 166.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.35 167.42 23.96 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.118 1.879 . . . . 0.0 111.277 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.9 t -62.52 115.03 3.9 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.3 p -75.21 5.9 4.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.286 0.634 . . . . 0.0 112.359 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.9 p -62.23 152.58 33.01 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.854 0.862 . . . . 0.0 110.919 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.29 65.72 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.737 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.07 -23.64 51.94 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.814 0.846 . . . . 0.0 111.705 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -110.23 4.51 21.01 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.97 0.908 . . . . 0.0 110.314 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -59.95 -34.67 73.58 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.325 0.65 . . . . 0.0 111.152 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.85 -37.4 63.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 111.595 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.26 -25.51 15.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.699 0.8 . . . . 0.0 111.009 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -80.45 22.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -67.84 0.38 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.021 0.928 . . . . 0.0 110.952 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.48 -10.74 27.51 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.084 0.954 . . . . 0.0 113.142 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.427 ' O ' ' HD1' ' A' ' 152' ' ' TRP . 35.1 mmt180 -86.34 -18.75 31.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.301 0.64 . . . . 0.0 110.489 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -54.39 -36.52 64.01 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.244 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -62.19 -46.35 89.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.418 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.35 -30.67 63.48 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 119.462 -0.304 . . . . 0.0 110.471 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.427 ' HD1' ' O ' ' A' ' 148' ' ' ARG . 44.3 m95 -66.29 -43.3 86.74 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -59.13 -42.72 91.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.083 0.864 . . . . 0.0 109.512 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.33 77.45 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 124.242 0.963 . . . . 0.0 111.522 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.6 t -62.5 -34.6 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.959 0.903 . . . . 0.0 111.936 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.63 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 83.6 m-85 -110.24 2.42 19.24 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -65.7 -40.91 92.78 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.368 1.067 . . . . 0.0 110.793 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.466 ' HE1' HD11 ' A' ' 16' ' ' ILE . 19.5 p-80 -69.84 -6.79 34.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 112.424 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.413 HD11 HD12 ' A' ' 16' ' ' ILE . 96.6 mt -75.4 -18.11 60.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.907 0.483 . . . . 0.0 111.051 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -89.43 -3.39 58.43 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 122.434 0.294 . . . . 0.0 110.237 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 . . . . . 0 N--CA 1.484 1.262 0 C-N-CA 126.123 1.769 . . . . 0.0 111.048 177.657 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 80' ' ' SER . 42.3 mm . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 121.062 0.458 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -110.11 116.28 31.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.398 1.079 . . . . 0.0 108.701 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -83.26 135.38 34.77 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 122.704 0.402 . . . . 0.0 110.233 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.4 150.17 44.8 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.817 0.698 . . . . 0.0 112.952 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -79.17 132.42 63.22 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 147.83 22.1 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.287 2.658 . . . . 0.0 112.275 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.95 133.19 50.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.039 0.536 . . . . 0.0 111.597 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.635 HG11 HD22 ' A' ' 62' ' ' LEU . 94.6 t -95.59 88.07 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.498 HD11 ' CG1' ' A' ' 104' ' ' VAL . 18.0 tp -136.58 149.54 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -163.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 13.9 t70 -128.99 163.79 24.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.407 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.16 -12.44 61.19 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.943 0.897 . . . . 0.0 112.567 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.3 12.44 37.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.217 0.607 . . . . 0.0 111.42 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -75.79 118.75 18.93 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 108' ' ' ARG . 56.7 mt-10 -93.49 -33.75 13.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.366 1.067 . . . . 0.0 111.366 -177.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mt -126.72 120.22 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 10' ' ' LEU . 63.0 tp -104.57 121.77 44.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 111' ' ' CYS . 48.6 mt -99.55 109.65 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.659 0.784 . . . . 0.0 109.378 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 76.1 mt -93.59 118.49 31.44 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -74.38 0.32 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.895 0.747 . . . . 0.0 113.121 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 117' ' ' ALA . 10.8 p 151.25 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -165.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.7 136.23 14.27 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 164.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 129.75 36.47 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.078 1.852 . . . . 0.0 111.917 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.7 p -69.04 140.21 54.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -49.84 -42.77 48.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.214 1.005 . . . . 0.0 112.848 -174.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 11.8 tp10 -63.38 -29.53 70.82 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -74.39 -33.26 62.99 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.5 mt -74.47 -14.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.064 0.946 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' A' ' 26' ' ' GLU . 2.5 mmp_? -66.18 -35.28 80.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.62 -3.28 26.91 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.759 0.824 . . . . 0.0 111.484 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.48 18.98 9.91 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.008 1.323 . . . . 0.0 114.034 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -146.18 161.14 40.89 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -71.61 -12.95 61.61 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.524 1.129 . . . . 0.0 110.91 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.476 ' HD1' ' HZ1' ' A' ' 61' ' ' LYS . 85.0 t80 -87.2 -9.16 55.89 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.831 1.252 . . . . 0.0 109.731 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.3 -44.3 20.53 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 124.499 1.124 . . . . 0.0 115.589 -170.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -125.95 115.53 24.23 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -63.06 99.26 0.22 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.484 2.123 . . . . 0.0 108.196 154.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.7 -38.1 0.57 Allowed Glycine 0 C--O 1.241 0.541 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.575 -164.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -72.77 105.5 4.36 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 167.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.85 6.92 14.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.951 0.9 . . . . 0.0 111.938 -168.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -44.11 -43.09 6.71 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.857 0.863 . . . . 0.0 111.975 166.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -75.16 -21.96 58.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 112.158 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.71 -53.53 8.4 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.758 0.823 . . . . 0.0 110.471 170.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -69.84 -47.94 60.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.861 0.864 . . . . 0.0 111.535 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.45 -31.93 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.083 0.553 . . . . 0.0 109.876 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.39 -38.26 93.43 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.323 0.389 . . . . 0.0 112.689 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -72.22 -36.71 69.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.305 1.042 . . . . 0.0 110.198 174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.54 -42.28 98.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.573 0.749 . . . . 0.0 112.52 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -94.08 -15.17 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.642 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 35.31 61.12 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -136.14 127.69 28.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -70.0 89.76 0.62 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.014 0.911 . . . . 0.0 110.98 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -74.68 -0.44 18.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.76 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -84.6 -39.22 18.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.646 0.379 . . . . 0.0 111.18 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -99.12 0.37 43.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.693 0.797 . . . . 0.0 112.089 -166.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -90.78 141.77 28.46 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.033 0.533 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.51 147.23 53.59 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.715 0.634 . . . . 0.0 109.373 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.488 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 56.0 t80 -45.28 -51.62 10.67 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.539 1.135 . . . . 0.0 113.776 -169.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.78 -46.15 90.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.826 0.851 . . . . 0.0 111.63 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -66.04 -38.89 89.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.652 0.781 . . . . 0.0 110.572 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.476 ' HZ1' ' HD1' ' A' ' 34' ' ' TYR . 30.9 ttmt -59.94 -40.42 88.9 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.523 1.129 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.635 HD22 HG11 ' A' ' 9' ' ' VAL . 27.0 mt -61.13 -49.03 78.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.355 174.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.16 -29.2 70.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.757 0.823 . . . . 0.0 111.516 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 67' ' ' HIS . 85.1 m -62.19 -50.02 73.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 0.0 109.985 170.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.78 -40.34 79.61 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.046 0.841 . . . . 0.0 109.961 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HE3' HG12 ' A' ' 9' ' ' VAL . 2.3 mptm? -59.39 -39.04 82.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.71 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.48 ' CD2' ' HA ' ' A' ' 64' ' ' THR . 79.8 m-70 -55.44 -41.18 72.48 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 122.72 0.408 . . . . 0.0 111.367 173.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -90.12 2.18 55.58 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.983 0.913 . . . . 0.0 111.05 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER 64.32 36.76 8.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.847 1.259 . . . . 0.0 110.868 177.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -104.05 132.93 49.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.795 1.238 . . . . 0.0 108.66 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.05 159.88 13.77 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 172.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 87.6 mt -122.53 143.87 49.45 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.839 0.856 . . . . 0.0 108.872 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -163.71 -168.59 1.68 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 171.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -125.84 179.88 4.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.276 0.63 . . . . 0.0 110.34 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.498 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 92.4 t -90.66 -44.49 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 109.884 175.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -99.26 133.19 43.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.874 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.592 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 88.4 tttt -78.56 -25.11 45.29 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.671 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.24 136.43 11.9 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.297 0.639 . . . . 0.0 110.025 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.672 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -145.73 130.17 3.68 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.406 ' HB2' HD13 ' A' ' 2' ' ' ILE . 34.4 t . . . . . 0 N--CA 1.467 0.421 0 CA-C-N 118.367 1.083 . . . . 0.0 109.535 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.498 HD12 ' HD2' ' A' ' 116' ' ' LYS . 37.1 mt . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.16 62.63 4.31 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.247 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.672 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.4 t70 -175.25 156.57 2.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -120.73 21.44 11.48 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 0.0 111.062 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.9 tp10 -85.39 109.14 18.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.49 137.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.077 0.951 . . . . 0.0 109.741 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -59.72 142.11 53.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 111.177 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.23 91.78 0.74 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.52 0.728 . . . . 0.0 111.295 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.525 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 21.6 m-85 -80.18 -13.14 59.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.244 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.1 p -57.03 -31.64 65.35 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.736 0.815 . . . . 0.0 111.154 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.94 -4.24 69.51 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.134 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -51.67 -39.5 58.33 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.181 0.991 . . . . 0.0 112.749 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -56.8 -34.77 68.01 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.419 0.688 . . . . 0.0 111.894 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.79 -46.71 8.39 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.822 0.849 . . . . 0.0 112.031 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptm -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.482 0.713 . . . . 0.0 111.804 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.7 m -121.22 85.92 42.38 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 123.527 0.731 . . . . 0.0 109.189 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.77 -32.54 7.33 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.56 2.173 . . . . 0.0 112.3 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.15 1.9 48.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 42.6 tp -58.14 115.13 2.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.698 0.799 . . . . 0.0 112.223 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.457 ' HD3' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -107.6 -40.06 5.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.651 168.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.06 131.95 37.61 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.118 0.567 . . . . 0.0 110.496 -171.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.457 ' HB ' HG22 ' A' ' 131' ' ' THR . 54.3 mt -102.54 145.08 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.601 ' HB2' HG12 ' A' ' 18' ' ' ILE . 76.9 m -124.56 116.22 22.1 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.346 0.521 . . . . 0.0 110.425 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.455 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 97.9 m-85 -96.72 128.07 43.31 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.646 1.178 . . . . 0.0 110.377 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -97.25 78.86 2.76 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.448 0.642 . . . . 0.0 110.412 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.1 152.48 5.76 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.052 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -65.76 -40.25 91.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.241 0.616 . . . . 0.0 110.604 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.498 ' HD2' HD12 ' A' ' 89' ' ' ILE . 4.7 tmtm? -60.07 -37.12 78.95 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.163 175.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -67.82 -41.75 82.59 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.98 172.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.7 -9.85 59.78 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 114.815 -1.084 . . . . 0.0 114.232 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.61 -33.12 74.9 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.069 0.548 . . . . 0.0 110.566 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -98.87 13.59 31.95 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.968 . . . . 0.0 111.359 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.471 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -67.34 -54.64 18.11 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.57 0.748 . . . . 0.0 111.629 177.274 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.94 -15.61 43.94 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.713 1.609 . . . . 0.0 113.143 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.43 -48.64 76.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.453 0.701 . . . . 0.0 110.886 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.518 ' HB2' HG21 ' A' ' 131' ' ' THR . 17.2 mt -82.12 -9.41 59.54 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.386 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -68.03 -28.59 67.53 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.812 0.445 . . . . 0.0 110.332 165.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.51 -19.35 64.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.53 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.4 mtt -94.07 12.15 27.39 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.098 0.959 . . . . 0.0 111.369 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.98 18.23 79.0 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.727 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.88 131.52 54.98 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.919 0.488 . . . . 0.0 110.706 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.61 140.97 51.76 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.518 HG21 ' HB2' ' A' ' 124' ' ' LEU . 16.3 p -132.8 151.78 51.93 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.952 0.901 . . . . 0.0 109.848 -172.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -134.94 123.58 23.6 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.044 0.538 . . . . 0.0 110.266 -175.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.6 t -83.11 98.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 111' ' ' CYS . 69.8 mt -90.88 156.88 44.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 148' ' ' ARG . 84.2 Cg_endo -71.02 165.03 33.71 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.985 1.79 . . . . 0.0 110.616 177.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 40.6 t -63.93 117.39 6.93 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 170.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.9 p -77.74 19.03 0.41 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.346 0.658 . . . . 0.0 112.578 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.7 p -77.26 153.1 34.29 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.895 0.878 . . . . 0.0 108.905 170.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -9.89 51.2 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.635 0.614 . . . . 0.0 114.635 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.06 -6.85 56.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 111.795 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 135' ' ' PRO . 26.2 t-20 -123.05 -2.64 8.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.696 0.798 . . . . 0.0 110.59 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -75.6 -10.01 59.08 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 120.996 0.427 . . . . 0.0 111.727 -169.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.38 -26.85 13.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.674 1.189 . . . . 0.0 113.463 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -103.29 -5.37 23.12 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 0.0 110.911 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.641 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 66.3 m -88.14 0.36 56.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.654 0.781 . . . . 0.0 111.968 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.26 -70.96 0.09 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.63 0.772 . . . . 0.0 109.906 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.9 -12.05 59.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.112 0.565 . . . . 0.0 111.535 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.641 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 74.4 ttt180 -87.51 -11.71 48.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.395 0.678 . . . . 0.0 110.58 -172.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.49 -23.76 64.77 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.009 0.524 . . . . 0.0 111.298 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.8 t -66.96 -36.33 81.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.031 0.932 . . . . 0.0 109.85 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 155' ' ' VAL . 5.7 tt0 -67.42 -44.69 78.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.554 0.742 . . . . 0.0 110.223 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -60.06 -44.35 94.79 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.115 0.884 . . . . 0.0 109.184 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -60.6 -42.25 96.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.489 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.59 -37.95 70.95 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.4 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 151' ' ' GLU . 52.4 t -59.06 -34.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.115 0.966 . . . . 0.0 111.286 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.525 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 57.1 m-85 -107.98 -8.75 15.81 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -75.16 -48.59 22.91 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.1 0.409 . . . . 0.0 110.317 172.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -62.27 -14.56 40.08 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.03 -13.05 22.19 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.706 1.202 . . . . 0.0 112.329 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.23 -7.31 35.48 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.018 0.927 . . . . 0.0 112.304 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.9 t60 . . . . . 0 C--N 1.362 1.132 0 C-N-CA 125.972 1.709 . . . . 0.0 109.375 -175.165 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 80' ' ' SER . 44.1 mm . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -104.53 116.56 32.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.51 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.1 mmt85 -84.73 133.39 34.37 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.498 0.719 . . . . 0.0 110.027 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.32 -179.79 34.84 Favored Glycine 0 C--O 1.247 0.96 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.739 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.448 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 20.4 m-30 -93.91 139.12 22.56 Favored Pre-proline 0 N--CA 1.47 0.548 0 O-C-N 122.504 -0.41 . . . . 0.0 110.495 -177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.97 162.34 26.18 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.482 2.122 . . . . 0.0 110.752 163.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.457 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -69.74 133.59 47.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.33 0.652 . . . . 0.0 112.606 -172.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.675 HG11 HD22 ' A' ' 62' ' ' LEU . 84.2 t -93.24 80.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 167.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.475 HD11 ' CG1' ' A' ' 104' ' ' VAL . 37.3 tp -128.24 149.41 50.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.23 -161.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.697 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 34.4 t70 -111.5 153.2 26.53 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -53.66 -48.61 69.27 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.283 0.633 . . . . 0.0 112.305 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -105.8 59.83 0.66 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.779 0.799 . . . . 0.0 111.817 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.479 ' HB ' HG12 ' A' ' 104' ' ' VAL . 27.6 m -85.9 135.2 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.37 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.94 -39.57 11.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.836 0.855 . . . . 0.0 111.809 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.419 HD11 ' CE1' ' A' ' 158' ' ' HIS . 44.3 mt -122.31 123.99 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.455 HD13 HD13 ' A' ' 10' ' ' LEU . 51.2 tp -109.37 117.18 33.37 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 111' ' ' CYS . 43.9 mt -98.56 113.35 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 73' ' ' TRP . 88.2 mt -106.08 122.52 46.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.846 0.858 . . . . 0.0 110.176 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 -154.71 10.84 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 164.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.6 p -119.16 -66.88 1.03 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.067 0.933 . . . . 0.0 108.825 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.8 tp -146.72 119.33 4.92 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.63 158.24 56.85 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.116 1.877 . . . . 0.0 111.053 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -67.94 146.46 53.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.16 0.584 . . . . 0.0 109.436 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 36.5 t70 -61.81 -27.04 68.48 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.14 0.275 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.91 -31.48 62.91 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.555 0.742 . . . . 0.0 111.249 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 m -86.6 -41.27 14.4 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.744 0.818 . . . . 0.0 110.489 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 72.3 mt -63.73 -32.09 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 124.107 0.963 . . . . 0.0 112.974 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -62.7 -27.43 69.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.495 0.318 . . . . 0.0 111.283 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -91.02 -26.37 19.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.714 0.806 . . . . 0.0 110.596 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 61.51 34.5 17.94 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 125.25 1.42 . . . . 0.0 110.728 -165.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -135.7 133.25 37.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 109.672 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -60.59 -54.83 40.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.751 0.82 . . . . 0.0 110.547 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 83.7 t80 -65.41 -15.16 62.31 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.618 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.48 -30.33 49.61 Favored Glycine 0 C--N 1.359 1.859 0 O-C-N 123.249 0.343 . . . . 0.0 112.854 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -99.47 106.98 42.87 Favored Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.14 179.61 6.05 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.303 2.002 . . . . 0.0 110.644 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.18 -11.53 65.03 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -170.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' A' ' 41' ' ' PHE . 28.8 t-20 -80.77 122.78 27.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.893 1.277 . . . . 0.0 109.5 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.06 -3.9 50.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.543 0.737 . . . . 0.0 111.986 -170.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 87.6 t80 -48.07 -45.24 32.24 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.306 1.042 . . . . 0.0 112.451 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -60.97 -37.03 81.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.482 0.713 . . . . 0.0 111.374 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.62 -41.64 71.96 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.616 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.03 -55.04 25.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.725 0.81 . . . . 0.0 111.057 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 49' ' ' ILE . 63.2 t -66.48 -44.73 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.68 -177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -34.44 88.61 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.179 0.924 . . . . 0.0 113.975 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -68.33 -43.22 78.02 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.544 0.738 . . . . 0.0 110.313 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -70.52 -41.35 72.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.005 0.922 . . . . 0.0 112.474 -174.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.475 HD12 ' ND2' ' A' ' 68' ' ' ASN . 17.1 pt -85.12 -14.88 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.23 0.612 . . . . 0.0 110.141 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.14 78.42 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.661 0.601 . . . . 0.0 113.933 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HG3' HD21 ' A' ' 68' ' ' ASN . 11.6 mm-40 -115.65 142.81 46.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.012 0.925 . . . . 0.0 109.282 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.82 88.83 6.3 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.25 -47.47 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.88 -48.58 81.1 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.747 1.279 . . . . 0.0 112.248 -165.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.37 -32.44 64.5 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.7 137.0 57.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.507 0.323 . . . . 0.0 110.733 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.92 31.51 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.397 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.558 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 42.9 t80 -44.1 -43.75 7.12 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.82 -49.1 78.97 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.816 0.846 . . . . 0.0 111.101 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.1 -34.75 76.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.862 1.265 . . . . 0.0 111.473 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.33 -45.5 94.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.764 1.226 . . . . 0.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.675 HD22 HG11 ' A' ' 9' ' ' VAL . 80.7 mt -63.14 -42.78 99.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 110.816 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -63.08 -31.21 72.3 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.707 0.403 . . . . 0.0 111.339 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -74.4 -28.05 60.91 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.954 0.502 . . . . 0.0 110.948 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.27 -48.36 80.25 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.697 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -57.11 -39.28 74.78 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.617 0.767 . . . . 0.0 111.019 176.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -57.68 -40.58 79.74 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.295 1.038 . . . . 0.0 112.15 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.499 HD21 ' HG3' ' A' ' 51' ' ' GLU . 52.8 m-80 -92.15 4.76 52.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.644 0.378 . . . . 0.0 111.671 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 63.39 40.6 8.32 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.18 1.392 . . . . 0.0 111.15 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.86 138.69 29.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 125.066 1.346 . . . . 0.0 109.065 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.08 154.77 16.41 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 170.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -126.33 134.19 51.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.692 0.797 . . . . 0.0 108.866 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.431 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.8 t90 -160.71 -170.27 2.69 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -134.75 162.88 31.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.345 1.058 . . . . 0.0 109.236 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.39 -48.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 52.6 m-85 -87.45 133.75 33.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.537 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.7 tmmm? -75.17 -32.64 61.33 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.51 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -159.82 152.93 21.89 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.695 0.798 . . . . 0.0 110.817 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -146.54 128.44 3.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' ' 2' ' ' ILE . 43.5 p . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -173.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 CA--C 1.541 0.619 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.03 55.32 0.4 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 18.7 t70 174.77 158.57 0.17 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.577 1.151 . . . . 0.0 108.813 -167.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.86 25.56 10.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.953 0.901 . . . . 0.0 111.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 6.1 tp10 -79.82 102.81 9.31 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 87.5 mt -114.81 146.81 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.744 1.218 . . . . 0.0 109.735 -173.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -68.26 141.82 55.78 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.833 0.853 . . . . 0.0 108.981 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.17 114.56 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.78 6.37 43.83 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.86 0.464 . . . . 0.0 112.124 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.1 t -63.73 -26.05 68.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 0.0 111.615 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.83 -1.88 84.7 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 118.898 -0.946 . . . . 0.0 114.302 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' SD ' ' A' ' 103' ' ' MET . 35.9 mt -50.03 -34.84 22.65 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 117.87 0.835 . . . . 0.0 113.071 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -65.42 -22.43 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -99.33 -45.97 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.525 ' HG3' HG22 ' A' ' 104' ' ' VAL . 17.4 ptm -69.81 -35.85 75.17 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.874 0.87 . . . . 0.0 111.314 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 2.0 m -132.87 88.11 38.49 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.336 0.654 . . . . 0.0 109.698 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 94.9 Cg_endo -72.59 -25.3 17.76 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.013 2.475 . . . . 0.0 111.771 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.2 mmmt -91.72 -6.65 51.61 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.553 1.141 . . . . 0.0 111.537 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -58.82 109.62 0.85 Allowed 'General case' 0 C--N 1.356 0.861 0 O-C-N 123.771 0.669 . . . . 0.0 110.253 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -108.38 -40.14 5.23 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.659 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 130' ' ' GLU . 47.7 tp -125.45 130.12 51.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -174.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.6 mt -110.2 116.59 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.909 0.884 . . . . 0.0 108.793 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.506 ' HB3' HD12 ' A' ' 134' ' ' LEU . 68.1 m -97.9 117.33 31.99 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 123.417 0.687 . . . . 0.0 109.699 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 91.2 m-85 -93.34 123.05 36.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.206 0.602 . . . . 0.0 110.57 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -79.95 79.62 6.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.166 0.586 . . . . 0.0 109.564 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.64 175.3 19.98 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.379 -0.828 . . . . 0.0 115.02 169.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 73.5 ttt180 -57.31 -61.04 2.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.709 1.204 . . . . 0.0 111.52 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.24 -27.66 36.22 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.86 0.864 . . . . 0.0 113.316 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.16 -50.74 15.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.443 0.697 . . . . 0.0 109.914 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.17 -10.53 84.26 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.63 -1.168 . . . . 0.0 114.789 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 96.1 mt-10 -66.24 -22.58 66.33 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.667 0.734 . . . . 0.0 110.265 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -103.53 19.63 19.41 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.347 1.059 . . . . 0.0 110.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 37.2 tt0 -60.68 -51.54 78.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 118.146 -0.931 . . . . 0.0 112.0 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 121' ' ' GLU . 18.2 Cg_endo -54.99 -27.56 55.11 Favored 'Trans proline' 0 C--N 1.406 3.563 0 C-N-CA 122.76 2.307 . . . . 0.0 113.571 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -62.2 -42.84 99.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.299 1.04 . . . . 0.0 110.444 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.415 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 20.0 mt -93.5 -15.04 25.94 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.633 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 37.6 mtp85 -66.85 -34.3 77.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.863 0.465 . . . . 0.0 109.975 171.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.44 -13.02 70.5 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.758 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.5 mtt -93.36 12.25 25.43 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.154 0.982 . . . . 0.0 111.292 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.0 27.83 69.68 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.387 0.429 . . . . 0.0 114.028 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.86 137.96 45.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.715 0.406 . . . . 0.0 111.306 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 28.1 mt-10 -65.1 129.83 41.12 Favored 'General case' 0 C--N 1.345 0.406 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 165.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.488 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.9 p -130.66 144.45 51.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.88 0.472 . . . . 0.0 110.16 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -139.64 125.56 19.69 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.095 0.958 . . . . 0.0 109.835 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 46.3 t -87.13 104.62 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 111' ' ' CYS . 74.3 mt -90.14 154.08 46.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.4 145.14 70.33 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 111.164 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.5 t -59.91 107.39 0.61 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.71 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.5 p -57.97 85.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 O-C-N 124.447 1.092 . . . . 0.0 111.04 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.7 t -129.81 161.0 31.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.616 1.566 . . . . 0.0 108.395 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -42.92 95.84 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.414 0.446 . . . . 0.0 112.865 167.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.0 82.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.41 0.684 . . . . 0.0 111.23 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -65.02 -44.4 89.3 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.979 172.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -67.9 -23.54 65.11 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.417 1.073 . . . . 0.0 110.309 -172.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -56.94 -28.34 62.01 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.819 1.247 . . . . 0.0 111.684 171.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -118.17 -20.04 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.301 1.04 . . . . 0.0 111.496 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.427 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 22.2 t -98.28 31.71 2.7 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.834 0.853 . . . . 0.0 110.973 -173.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -65.35 0.68 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.77 -6.94 59.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.642 0.777 . . . . 0.0 111.965 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.427 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 13.8 tpt180 -85.85 -14.22 45.62 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.318 0.647 . . . . 0.0 110.042 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -51.76 -23.52 4.72 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.862 0.865 . . . . 0.0 112.57 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -63.63 -29.6 70.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.619 0.768 . . . . 0.0 111.376 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 155' ' ' VAL . 8.3 pt-20 -73.22 -35.2 66.27 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -68.03 -35.9 79.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 2.1 tm-20 -70.8 -33.12 70.4 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.751 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.72 -11.95 60.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.858 0.863 . . . . 0.0 112.307 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 151' ' ' GLU . 53.2 t -89.61 -49.17 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.002 0.521 . . . . 0.0 110.29 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -99.36 2.17 45.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -71.19 -35.03 71.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.651 0.66 . . . . 0.0 111.469 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.419 ' CE1' HD11 ' A' ' 16' ' ' ILE . 31.7 p-80 -69.44 -11.77 61.1 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.803 0.441 . . . . 0.0 111.441 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.39 -35.71 71.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.38 -45.81 24.78 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.601 0.761 . . . . 0.0 109.273 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 . . . . . 0 CA--C 1.563 1.468 0 C-N-CA 126.077 1.751 . . . . 0.0 112.518 -176.506 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.5 ' HB2' HD21 ' A' ' 22' ' ' LEU . 3.4 mptp? -100.1 117.55 34.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -93.38 130.94 38.98 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.974 0.51 . . . . 0.0 111.766 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.87 165.05 45.63 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.942 0.776 . . . . 0.0 112.502 172.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.45 149.23 38.54 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.295 0.638 . . . . 0.0 111.544 -165.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -56.74 137.29 80.64 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.519 2.146 . . . . 0.0 110.311 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 142.99 56.6 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.87 0.731 . . . . 0.0 112.419 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 62' ' ' LEU . 59.9 t -91.06 86.61 2.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.25 139.76 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.839 -162.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.89 162.26 23.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.426 1.091 . . . . 0.0 108.353 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.65 -24.39 67.59 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.758 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -104.14 36.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.128 0.571 . . . . 0.0 111.075 -175.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 m -89.53 106.63 18.58 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.268 0.556 . . . . 0.0 110.334 -176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.63 -29.98 17.44 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.95 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 159' ' ' LEU . 43.2 mt -123.95 121.49 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 tp -107.98 115.12 29.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 111' ' ' CYS . 39.9 mt -97.31 119.91 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.328 0.651 . . . . 0.0 109.268 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 60.7 mt -111.0 115.87 30.22 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.669 0.788 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -70.99 178.32 33.57 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 167.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 p -86.24 -80.28 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 3' ' ' LYS . 45.9 tp -131.68 122.39 18.67 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 171.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.12 149.42 44.13 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.901 2.4 . . . . 0.0 113.25 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.517 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.9 m -60.78 152.2 27.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.693 1.197 . . . . 0.0 111.12 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 54.2 m-20 -58.98 -40.56 85.18 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.185 0.594 . . . . 0.0 111.35 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.04 -25.54 67.88 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.838 1.255 . . . . 0.0 110.506 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.2 m -83.36 -38.59 21.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.718 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 24' ' ' SER . 48.6 mm -61.34 -41.03 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.346 1.058 . . . . 0.0 110.795 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.5 mmm180 -58.68 -30.95 67.77 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.717 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -106.73 -7.51 17.23 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.896 0.878 . . . . 0.0 112.33 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 58.74 30.95 20.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.814 1.246 . . . . 0.0 113.421 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -145.9 141.67 28.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.97 0.908 . . . . 0.0 109.554 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -59.69 -42.73 93.62 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.688 0.795 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -62.14 -12.63 20.72 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.404 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.45 -21.94 55.29 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.277 0.465 . . . . 0.0 113.615 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -115.77 96.69 47.26 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.65 131.87 4.05 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.38 2.72 . . . . 0.0 110.032 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.14 -13.38 5.48 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -171.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -75.17 126.44 31.03 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 171.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.4 m-20 -82.18 1.88 34.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.326 0.512 . . . . 0.0 111.025 -169.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -46.52 -44.21 17.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.161 0.984 . . . . 0.0 112.179 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -71.55 -26.42 62.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.813 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -76.58 -40.12 50.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.233 1.013 . . . . 0.0 111.495 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 149' ' ' GLU . 80.3 mt -79.56 -46.71 16.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.59 0.756 . . . . 0.0 110.9 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 49' ' ' ILE . 98.7 t -72.64 -32.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.75 -40.97 93.95 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.804 0.69 . . . . 0.0 112.325 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -67.22 -36.07 80.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.421 0.689 . . . . 0.0 110.113 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -70.95 -32.33 69.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.421 HD12 HD22 ' A' ' 68' ' ' ASN . 18.5 pt -103.09 -10.93 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.241 0.617 . . . . 0.0 111.732 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.7 40.99 44.33 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.37 0.419 . . . . 0.0 113.76 177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -134.02 142.63 47.69 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.668 1.187 . . . . 0.0 108.794 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -86.48 87.8 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.522 0.677 . . . . 0.0 109.976 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.8 -31.94 67.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.831 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -62.13 -39.19 91.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.639 0.776 . . . . 0.0 112.399 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.38 -36.76 66.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.856 0.462 . . . . 0.0 110.638 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.3 mtt -57.67 130.39 46.17 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.19 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.63 151.79 19.96 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.479 166.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.494 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 69.1 t80 -48.11 -49.58 31.47 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.501 0.72 . . . . 0.0 112.524 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.24 -40.65 94.32 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.767 0.827 . . . . 0.0 112.249 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.47 -39.49 92.04 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.573 0.702 . . . . 0.0 110.567 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -62.2 -40.59 96.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.011 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 28.8 mt -57.91 -52.33 65.94 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.012 0.82 . . . . 0.0 109.398 174.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -52.52 -46.62 66.78 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.18 0.992 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.7 m -63.19 -54.74 32.75 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.058 0.943 . . . . 0.0 112.304 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.24 -50.37 70.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.498 0.719 . . . . 0.0 110.739 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -66.0 -32.24 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 112.105 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -60.34 -42.39 95.59 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.546 0.738 . . . . 0.0 110.628 168.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.443 ' O ' HD13 ' A' ' 159' ' ' LEU . 92.0 m-20 -81.32 8.08 9.99 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.984 0.914 . . . . 0.0 110.83 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HB2' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER 68.51 31.57 4.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 0.0 111.161 176.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.7 mt -111.09 136.85 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.489 1.115 . . . . 0.0 109.349 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.55 160.63 19.14 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 74.5 mt -123.6 144.18 49.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.462 0.705 . . . . 0.0 109.187 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.427 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.5 t90 -167.07 -169.27 1.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -137.68 -177.89 5.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.43 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 97.1 t -98.67 -55.48 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.522 0.729 . . . . 0.0 110.289 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -80.46 107.82 13.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.986 0.514 . . . . 0.0 111.552 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -64.53 -36.4 84.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.194 0.998 . . . . 0.0 110.519 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.44 122.95 10.41 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.713 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.89 116.26 1.94 Allowed Glycine 0 C--N 1.33 0.236 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.236 0.375 0 C-N-CA 123.196 0.598 . . . . 0.0 110.878 -170.664 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.405 HG23 HD22 ' A' ' 22' ' ' LEU . 29.5 mt . . . . . 0 CA--C 1.549 0.908 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.44 -75.9 1.13 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -38.96 137.79 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.214 1.406 . . . . 0.0 114.208 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.24 28.08 7.65 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.491 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -75.64 106.09 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.2 mm -97.4 155.27 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.22 0.608 . . . . 0.0 110.013 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -78.7 158.33 28.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.868 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.6 121.69 24.97 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.43 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 58.9 m-85 -117.71 -0.01 11.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.2 p -74.96 -19.59 60.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.13 79.1 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.575 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 103' ' ' MET . 69.2 mt -52.93 -29.43 28.63 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 123.444 0.698 . . . . 0.0 112.855 176.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.493 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 36.8 mtpt -65.09 -27.6 68.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -85.59 -55.28 4.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.196 0.998 . . . . 0.0 111.405 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.413 ' HG2' ' HA ' ' A' ' 100' ' ' LEU . 24.7 ptm -74.52 -33.82 62.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.21 0.604 . . . . 0.0 112.594 -169.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.1 m -127.08 90.77 48.46 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.221 0.608 . . . . 0.0 110.933 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.93 -32.54 2.55 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.512 2.141 . . . . 0.0 112.325 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.758 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 8.1 mmpt? -76.51 -9.49 58.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 112.241 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.2 tp -59.97 112.46 1.88 Allowed 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.687 0.617 . . . . 0.0 111.218 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -101.71 -45.38 5.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.413 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 132' ' ' LYS . 40.8 tp -134.39 133.49 40.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.2 mt -105.53 115.76 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.161 0.984 . . . . 0.0 108.487 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 134' ' ' LEU . 80.0 m -98.97 116.15 30.55 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.022 0.529 . . . . 0.0 110.466 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.22 127.98 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.702 0.801 . . . . 0.0 110.195 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.498 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 14.4 m120 -90.2 102.28 15.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.59 155.05 29.89 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.586 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 78.6 ttt180 -55.84 -48.05 76.17 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.4 1.08 . . . . 0.0 112.359 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.25 -29.61 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.45 27.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 173.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.82 -9.55 62.8 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.874 -1.057 . . . . 0.0 114.597 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 115' ' ' ARG . 15.2 mm-40 -62.13 -19.97 63.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.56 0.744 . . . . 0.0 111.703 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.4 ' CD2' HG11 ' A' ' 75' ' ' VAL . 59.4 m-85 -110.13 22.11 15.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 110.674 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.442 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.8 tt0 -59.02 -55.84 42.34 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.367 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.29 -17.71 23.98 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.458 1.438 . . . . 0.0 111.801 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.5 -48.1 78.97 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 109.83 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.503 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 6.7 mt -84.17 -16.64 42.75 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.533 -176.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 7.9 ttt180 -73.54 -17.81 61.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 176.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.88 -16.66 78.19 Favored Glycine 0 C--N 1.355 1.637 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.021 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.503 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -83.38 4.55 26.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.633 0.773 . . . . 0.0 111.197 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.97 14.56 72.07 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.542 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 36.2 m-85 -110.95 130.43 55.59 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.305 0.642 . . . . 0.0 111.222 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.42 139.1 58.74 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 15.2 p -128.13 147.01 50.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.553 0.741 . . . . 0.0 109.967 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 109' ' ' LEU . 51.9 tptt -140.38 124.72 17.76 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 109.164 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.0 t -90.39 118.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.6 mt -102.9 147.79 34.62 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.19 167.45 16.31 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.328 2.019 . . . . 0.0 112.87 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.7 m -65.46 126.55 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.48 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.6 m -77.12 12.75 1.31 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.028 0.931 . . . . 0.0 112.94 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 m -72.93 145.8 46.54 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.862 0.865 . . . . 0.0 109.975 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.57 -26.9 71.2 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-O 121.298 0.388 . . . . 0.0 112.185 173.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.97 -10.87 54.04 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.501 1.121 . . . . 0.0 112.667 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -119.17 -15.85 9.15 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.764 0.826 . . . . 0.0 109.216 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.71 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 39.6 ttp85 -83.54 -17.74 40.8 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.629 0.772 . . . . 0.0 110.705 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.7 mtp-105 -61.14 -27.12 68.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.701 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -106.46 -28.92 10.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.233 1.013 . . . . 0.0 110.12 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.71 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 23.1 t -81.49 37.73 0.47 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.176 0.991 . . . . 0.0 111.501 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 54.0 mtmt -69.82 -54.11 15.11 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.744 0.818 . . . . 0.0 110.626 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.39 -15.04 57.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 5.0 mpt_? -88.44 -13.73 39.69 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.107 0.563 . . . . 0.0 111.459 -174.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.552 ' HB2' HD22 ' A' ' 44' ' ' LEU . 12.9 pt-20 -80.42 -22.66 40.97 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 120.654 0.264 . . . . 0.0 110.605 172.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -66.5 -28.49 68.61 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.426 0.69 . . . . 0.0 111.309 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.8 pt-20 -71.27 -21.37 62.1 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 122.848 0.459 . . . . 0.0 110.819 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -67.52 -42.09 83.33 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.724 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.63 -36.45 78.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.7 63.65 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.782 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.435 HG11 ' SG ' ' A' ' 111' ' ' CYS . 45.8 t -89.54 -45.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.583 0.753 . . . . 0.0 111.195 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.59 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 72.0 m-85 -96.46 -20.36 18.47 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -166.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -76.18 -6.13 49.9 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.85 1.205 . . . . 0.0 113.156 -171.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -73.54 -5.83 42.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.986 -0.447 . . . . 0.0 110.632 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.469 HD11 HD12 ' A' ' 16' ' ' ILE . 39.1 mt -87.57 -17.41 32.03 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.44 1.096 . . . . 0.0 108.787 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.59 -44.29 10.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.625 1.17 . . . . 0.0 109.904 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 70.4 m80 . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 125.46 1.504 . . . . 0.0 110.771 -175.769 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mm . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.789 0.328 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -107.97 114.18 27.9 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 168.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.3 mmt85 -78.69 129.73 35.03 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.821 0.701 . . . . 0.0 109.995 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.62 151.03 52.23 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -80.6 145.32 58.37 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.787 0.294 . . . . 0.0 111.269 -167.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.5 149.17 68.18 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.322 2.015 . . . . 0.0 110.248 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 131.93 50.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.247 0.619 . . . . 0.0 112.58 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 57.7 t -89.92 86.15 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.506 HD21 HG13 ' A' ' 104' ' ' VAL . 19.9 tp -144.41 153.67 42.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -160.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -128.27 168.32 15.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.433 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.47 -13.65 61.1 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.446 0.698 . . . . 0.0 112.277 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.86 38.09 2.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.616 . . . . 0.0 111.464 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.63 ' HB ' HG12 ' A' ' 104' ' ' VAL . 94.9 m -101.61 130.96 48.05 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.458 0.303 . . . . 0.0 110.899 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -98.2 -39.7 8.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.258 1.023 . . . . 0.0 111.21 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 159' ' ' LEU . 51.9 mt -120.21 119.81 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 tp -106.94 118.21 36.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.478 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -94.43 109.94 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -98.0 109.3 22.08 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.8 -168.92 3.4 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 169.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 p -103.76 -76.12 0.6 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.54 HD22 HG23 ' A' ' 89' ' ' ILE . 31.1 tp -155.34 121.78 2.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 22' ' ' LEU . 9.8 Cg_exo -72.23 151.59 54.93 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.949 2.433 . . . . 0.0 112.707 -174.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 28' ' ' ILE . 18.3 m -67.31 157.77 33.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.088 0.955 . . . . 0.0 111.092 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.17 -24.57 67.95 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.14 -45.33 95.08 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.549 0.74 . . . . 0.0 110.437 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 m -68.53 -41.13 80.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.307 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 24' ' ' SER . 19.2 mm -57.35 -34.96 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 124.265 0.978 . . . . 0.0 111.647 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -58.11 -38.0 75.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.116 0.566 . . . . 0.0 112.258 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -94.77 -17.01 22.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.252 0.621 . . . . 0.0 111.168 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 64.19 30.34 13.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.514 1.125 . . . . 0.0 111.264 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -145.68 143.64 29.91 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.784 0.834 . . . . 0.0 109.851 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.32 -41.68 97.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.181 0.992 . . . . 0.0 110.113 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.25 -24.16 62.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.733 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.5 -14.4 41.97 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.368 0.418 . . . . 0.0 113.725 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.25 104.59 30.7 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.851 0.86 . . . . 0.0 109.468 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.42 97.79 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.27 2.646 . . . . 0.0 109.539 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.08 -30.14 0.72 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -170.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -67.45 103.65 1.36 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.049 0.94 . . . . 0.0 108.467 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -84.83 -0.94 55.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.418 0.687 . . . . 0.0 112.01 -166.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -42.78 -46.1 5.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.22 1.408 . . . . 0.0 113.135 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -79.4 -18.66 51.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.87 0.868 . . . . 0.0 111.254 -170.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 4.6 mmp_? -72.72 -47.71 44.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.114 0.565 . . . . 0.0 110.12 167.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.7 -46.63 71.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.962 0.905 . . . . 0.0 111.413 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.9 t -73.68 -41.46 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.66 0.784 . . . . 0.0 109.685 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.92 91.2 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.793 0.683 . . . . 0.0 112.453 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -66.77 -45.1 79.57 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.288 1.035 . . . . 0.0 109.83 174.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -67.03 -36.64 82.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.815 0.846 . . . . 0.0 112.816 -173.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.2 pt -93.78 -11.26 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.164 0.585 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.61 78.8 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.25 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.33 117.4 18.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.48 96.56 2.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.359 0.664 . . . . 0.0 110.432 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.34 -22.16 61.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.285 1.034 . . . . 0.0 113.035 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -19.87 59.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -168.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -85.18 -36.18 21.2 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.425 0.557 . . . . 0.0 110.325 169.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.1 mtt -63.18 120.55 11.73 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.553 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 160.07 2.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.087 0.555 . . . . 0.0 110.884 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.605 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 47.5 t80 -42.23 -53.59 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.708 0.803 . . . . 0.0 112.85 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 37.2 mt-10 -60.05 -35.78 75.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.635 0.774 . . . . 0.0 112.295 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.02 -48.88 13.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.944 0.897 . . . . 0.0 112.092 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -59.6 -34.96 73.4 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.837 0.455 . . . . 0.0 112.203 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 15.3 mt -64.94 -41.35 95.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.54 0.336 . . . . 0.0 110.492 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 47.7 mmtm -56.83 -37.37 71.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.273 0.629 . . . . 0.0 110.835 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -64.35 -44.16 92.32 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 123.754 0.658 . . . . 0.0 110.741 177.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.65 -57.33 13.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.56 0.744 . . . . 0.0 111.538 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -21.77 60.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -60.07 -40.29 89.01 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 110.442 165.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -86.59 7.57 25.8 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.99 0.916 . . . . 0.0 110.676 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 68.69 29.89 5.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.495 1.518 . . . . 0.0 110.864 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.5 mt -102.29 133.95 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.518 1.127 . . . . 0.0 108.838 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.81 158.15 18.33 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.663 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 66.6 mt -126.39 143.3 51.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.681 0.792 . . . . 0.0 108.995 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.65 -171.54 2.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.13 169.71 10.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.412 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 52.8 t -83.93 -34.97 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.268 0.627 . . . . 0.0 109.534 169.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 55.2 m-85 -101.92 141.65 34.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.846 0.458 . . . . 0.0 111.153 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.662 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 6.7 tmtm? -81.1 -41.87 21.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.953 0.901 . . . . 0.0 108.898 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.512 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -156.47 150.82 25.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.937 0.895 . . . . 0.0 109.768 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -160.23 139.7 6.28 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 121.527 0.679 . . . . 0.0 111.935 -168.483 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.54 HG23 HD22 ' A' ' 22' ' ' LEU . 16.0 mt . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.9 57.5 4.29 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.605 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.694 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 10.2 t70 174.17 159.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -119.38 23.82 11.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.612 0.765 . . . . 0.0 112.058 -173.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 14.9 tp10 -80.4 101.85 9.26 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 54.8 mt -105.97 149.12 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.669 1.188 . . . . 0.0 110.033 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -69.51 147.18 51.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.922 0.889 . . . . 0.0 110.008 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.62 131.8 34.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.412 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 50.3 m-85 -110.0 9.72 24.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.529 0.731 . . . . 0.0 111.779 -175.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 t -69.21 -20.62 63.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.682 0.393 . . . . 0.0 110.843 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -4.52 63.87 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 118.941 -0.921 . . . . 0.0 113.714 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.424 HD23 ' SD ' ' A' ' 103' ' ' MET . 31.1 mt -50.04 -37.3 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -63.73 -31.28 72.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.591 0.356 . . . . 0.0 111.165 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -82.01 -53.12 6.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.817 0.847 . . . . 0.0 111.42 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.485 ' HG3' HG22 ' A' ' 104' ' ' VAL . 23.4 ptm -67.24 -34.95 78.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.534 0.733 . . . . 0.0 111.527 -173.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.63 HG12 ' HB ' ' A' ' 14' ' ' THR . 1.6 m -129.25 84.98 60.77 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.003 0.921 . . . . 0.0 108.857 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.4 -23.74 20.11 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.736 2.29 . . . . 0.0 112.79 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 7.45 38.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.42 0.688 . . . . 0.0 111.827 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 40.2 tp -61.4 125.44 23.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.833 0.349 . . . . 0.0 111.397 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -132.09 -30.58 1.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.13 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.7 tp -130.98 129.61 42.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.047 0.539 . . . . 0.0 110.039 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.56 122.16 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.3 1.04 . . . . 0.0 108.245 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.478 ' HB2' HG12 ' A' ' 18' ' ' ILE . 77.4 m -100.41 114.26 27.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.827 0.451 . . . . 0.0 109.881 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.412 ' HZ ' HD12 ' A' ' 124' ' ' LEU . 96.2 m-85 -89.88 115.5 27.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.983 0.913 . . . . 0.0 109.902 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.595 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 23.3 t30 -89.11 99.98 12.85 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.92 0.888 . . . . 0.0 109.124 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.89 156.43 20.8 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.811 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.54 -50.39 72.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.717 1.207 . . . . 0.0 111.681 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -55.06 -31.47 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.0 -43.91 51.14 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.037 0.535 . . . . 0.0 109.757 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.43 -11.43 64.85 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.007 -0.997 . . . . 0.0 114.149 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -60.43 -34.32 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.038 0.535 . . . . 0.0 110.955 170.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -107.16 18.26 21.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.12 0.968 . . . . 0.0 110.743 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.555 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.9 tm-20 -70.4 -48.79 17.71 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.631 0.772 . . . . 0.0 111.197 170.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.23 -28.77 72.88 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 122.322 2.014 . . . . 0.0 113.192 172.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.7 -48.95 79.47 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.645 0.778 . . . . 0.0 111.12 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.412 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 14.0 mt -85.61 -5.23 59.3 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -171.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -65.21 -34.44 78.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.75 -14.36 67.45 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.156 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 54.9 mtt -90.59 8.0 36.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.806 0.842 . . . . 0.0 111.4 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.48 0.75 89.58 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.33 0.492 . . . . 0.0 114.33 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -92.22 137.4 32.4 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 117.105 0.453 . . . . 0.0 110.331 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.43 131.31 45.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 49.5 p -120.69 136.83 54.74 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.303 0.641 . . . . 0.0 109.403 -176.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -134.51 115.79 14.34 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.304 1.042 . . . . 0.0 109.173 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.7 94.79 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 111' ' ' CYS . 73.6 mt -77.11 139.07 64.81 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 169.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.01 159.46 29.62 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.522 2.148 . . . . 0.0 112.505 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t -65.39 104.15 0.92 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.427 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.8 p -73.29 77.21 1.33 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.162 0.982 . . . . 0.0 109.037 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.8 p -129.1 159.77 34.94 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.98 29.7 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.04 -45.42 8.32 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.206 0.602 . . . . 0.0 112.143 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.82 -9.88 52.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.626 0.37 . . . . 0.0 111.896 -169.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -65.15 -33.18 75.41 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 0.0 110.369 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.13 -30.88 70.99 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.836 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.37 23.3 6.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.182 . . . . 0.0 110.596 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.5 t -139.42 24.4 2.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.294 1.038 . . . . 0.0 108.818 -170.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 49.2 tptt -66.8 -55.93 12.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 -175.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.53 -25.55 52.19 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.244 0.618 . . . . 0.0 112.355 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.576 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -88.54 -17.52 30.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.597 0.759 . . . . 0.0 111.146 -168.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 10.9 pt-20 -65.8 -19.91 66.06 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.21 0.459 . . . . 0.0 110.424 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.6 t -67.98 -44.86 75.69 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.075 0.95 . . . . 0.0 111.172 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.8 pt-20 -73.77 -29.42 62.19 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -62.68 -48.54 78.84 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 1.2 tm-20 -60.89 -38.01 84.19 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.782 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.88 -19.89 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.088 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 151' ' ' GLU . 43.7 t -68.77 -47.14 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.512 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 33.7 m-85 -91.82 2.74 56.31 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -174.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -60.78 -55.51 32.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.475 0.71 . . . . 0.0 112.128 177.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -70.3 -9.73 56.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 16' ' ' ILE . 93.8 mt -73.53 -31.18 63.54 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.995 0.518 . . . . 0.0 109.896 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.4 -52.21 3.57 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 . . . . . 0 CA--C 1.554 1.134 0 C-N-CA 125.456 1.502 . . . . 0.0 111.167 177.28 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 80' ' ' SER . 38.0 mm . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -91.31 112.41 24.31 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.06 138.03 35.21 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.019 0.527 . . . . 0.0 111.367 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.18 152.44 49.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.536 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -84.53 138.56 38.41 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.029 0.531 . . . . 0.0 110.267 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.61 154.94 11.05 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 123.046 2.497 . . . . 0.0 112.22 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -64.83 129.75 40.92 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -167.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG11 HD22 ' A' ' 62' ' ' LEU . 97.4 t -91.12 76.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.518 HD13 HD13 ' A' ' 17' ' ' LEU . 26.9 tp -135.6 153.64 51.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -158.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.585 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 9.2 t70 -126.5 167.46 15.58 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.595 0.758 . . . . 0.0 109.09 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.26 -12.77 61.63 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.799 0.84 . . . . 0.0 111.085 170.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -119.45 73.72 0.96 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.565 ' HB ' HG12 ' A' ' 104' ' ' VAL . 99.9 m -125.15 122.63 37.66 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.508 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.0 tt0 -93.34 -39.27 11.04 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.966 1.306 . . . . 0.0 110.283 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 109' ' ' LEU . 52.5 mt -120.11 113.67 41.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 HD13 ' A' ' 10' ' ' LEU . 52.3 tp -103.84 116.18 31.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.504 ' HB ' HD23 ' A' ' 72' ' ' LEU . 46.2 mt -94.38 114.1 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.288 0.635 . . . . 0.0 109.372 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -104.25 113.7 27.43 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.552 0.741 . . . . 0.0 110.424 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -67.54 174.09 28.55 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.9 m -86.91 -79.8 0.26 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 tp -136.46 122.34 13.53 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.437 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.7 Cg_exo -58.04 135.3 67.75 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.073 1.849 . . . . 0.0 111.371 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.3 t -60.89 146.12 47.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.765 0.665 . . . . 0.0 109.58 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 4.9 p-10 -58.08 -34.3 69.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.431 0.292 . . . . 0.0 111.339 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.06 -43.01 69.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.272 1.029 . . . . 0.0 111.722 172.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.554 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 26.3 t -68.99 -39.19 79.5 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.011 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 24' ' ' SER . 40.3 mt -76.97 -15.62 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.27 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 13.7 mmt180 -60.63 -36.27 78.25 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.353 0.597 . . . . 0.0 109.599 176.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.76 -0.14 40.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.204 1.002 . . . . 0.0 111.288 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 61.93 21.87 12.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.35 1.06 . . . . 0.0 112.737 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.589 HE21 ' HB3' ' A' ' 34' ' ' TYR . 18.4 pt20 -146.52 158.69 43.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.491 0.316 . . . . 0.0 111.689 -173.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.584 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 83.5 m-85 -68.6 -0.88 5.68 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.745 1.218 . . . . 0.0 112.564 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.589 ' HB3' HE21 ' A' ' 32' ' ' GLN . 63.3 t80 -105.41 1.77 28.08 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.689 1.196 . . . . 0.0 110.024 -176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -38.22 -42.42 1.24 Allowed Glycine 0 C--N 1.361 1.961 0 C-N-CA 124.917 1.246 . . . . 0.0 116.083 -174.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -126.78 146.38 56.97 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.5 2.133 . . . . 0.0 112.762 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.9 -6.36 85.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.02 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -67.58 104.78 1.68 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.58 6.39 41.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.267 0.627 . . . . 0.0 111.131 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -42.77 -43.24 3.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.898 0.879 . . . . 0.0 111.045 164.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.584 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 57.3 m95 -82.71 -28.13 30.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.868 0.867 . . . . 0.0 111.966 -177.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -68.79 -45.81 70.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.812 0.845 . . . . 0.0 111.071 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 mt -87.03 -39.03 16.01 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.133 0.573 . . . . 0.0 111.96 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.3 t -71.39 -36.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 -39.72 95.61 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.891 0.745 . . . . 0.0 112.471 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -67.96 -39.29 83.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.15 0.58 . . . . 0.0 110.496 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -68.89 -32.93 72.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.022 0.929 . . . . 0.0 113.07 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 pt -94.74 -11.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.929 0.492 . . . . 0.0 111.151 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.78 72.83 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 0.0 113.574 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -142.98 104.26 4.29 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.09 99.91 0.19 Allowed 'General case' 0 C--N 1.352 0.703 0 CA-C-O 121.453 0.644 . . . . 0.0 110.993 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 73.2 mt -67.06 -34.49 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -66.17 -21.21 66.32 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.227 1.011 . . . . 0.0 112.539 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -95.39 -31.55 13.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.87 0.468 . . . . 0.0 111.229 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.4 mtt -58.1 141.09 51.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.236 0.614 . . . . 0.0 111.176 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.41 137.69 57.1 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.141 -0.933 . . . . 0.0 109.395 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.491 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 38.4 t80 -45.66 -38.82 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -167.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 40.3 mt-10 -58.79 -59.93 4.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.534 0.734 . . . . 0.0 110.923 175.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -60.11 -34.15 73.1 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.971 0.908 . . . . 0.0 111.729 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 53' ' ' LEU . 2.3 ttmp? -60.17 -47.5 85.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.875 1.27 . . . . 0.0 110.006 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.629 HD22 HG11 ' A' ' 9' ' ' VAL . 46.0 mt -67.5 -40.35 85.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.001 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 57.7 mtpt -60.2 -31.34 70.06 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.574 0.35 . . . . 0.0 111.736 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -67.88 -34.52 76.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.072 0.549 . . . . 0.0 110.58 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.55 -57.31 11.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.585 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -58.73 -36.78 74.87 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.137 0.575 . . . . 0.0 111.264 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -53.51 -46.58 70.13 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 111.9 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -87.06 8.41 23.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.0 0.92 . . . . 0.0 111.852 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 60.53 37.3 19.67 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.595 1.158 . . . . 0.0 110.353 -178.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.81 140.41 21.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.383 1.073 . . . . 0.0 109.225 174.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.35 162.88 17.07 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 170.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.504 HD23 ' HB ' ' A' ' 18' ' ' ILE . 98.0 mt -128.76 138.95 52.38 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -164.69 -168.74 1.55 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -131.29 160.98 33.35 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.61 0.641 . . . . 0.0 111.553 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.504 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.6 t -94.04 -48.28 13.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 124.204 1.002 . . . . 0.0 110.809 175.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -93.78 113.35 25.38 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 87.9 tttt -64.28 -37.29 86.95 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.252 0.97 . . . . 0.0 110.513 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.86 134.97 17.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.849 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -143.66 136.26 6.81 Favored Glycine 0 C--O 1.218 -0.892 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.513 ' HB3' HD13 ' A' ' 2' ' ' ILE . 23.9 p . . . . . 0 N--CA 1.473 0.69 0 CA-C-N 117.958 0.879 . . . . 0.0 110.594 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mt . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.36 65.05 4.07 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.802 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.593 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.0 t70 -177.87 153.85 0.87 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.075 0.95 . . . . 0.0 108.577 -169.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -121.62 22.07 10.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.574 0.75 . . . . 0.0 111.746 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.0 tp10 -80.28 101.32 8.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.0 mt -94.61 153.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.18 0.992 . . . . 0.0 110.162 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.97 156.33 19.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.947 0.899 . . . . 0.0 109.429 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.01 122.12 34.22 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.515 0.726 . . . . 0.0 110.312 -174.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.504 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 48.2 m-85 -109.0 6.85 25.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.52 0.728 . . . . 0.0 112.007 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -70.45 -17.14 62.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.63 0.372 . . . . 0.0 111.048 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.94 -5.19 77.69 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.657 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -47.89 -49.06 31.02 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.561 0.745 . . . . 0.0 112.666 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -62.0 -27.8 69.12 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -82.91 -54.36 5.14 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.444 0.698 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -75.45 -27.72 59.02 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' A' ' 14' ' ' THR . 4.1 m -132.54 92.61 27.04 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.285 0.634 . . . . 0.0 110.851 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 71.5 Cg_endo -74.19 -36.89 2.95 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.907 2.405 . . . . 0.0 111.781 172.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.3 mmmt -79.83 -5.93 56.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.095 0.958 . . . . 0.0 111.392 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.3 tp -57.84 128.91 39.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.842 0.857 . . . . 0.0 111.316 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.528 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -137.7 -22.61 1.09 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.328 171.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB2' HH11 ' A' ' 108' ' ' ARG . 23.6 tp -129.64 126.57 38.72 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.883 0.473 . . . . 0.0 110.577 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.551 ' HB ' HG22 ' A' ' 131' ' ' THR . 33.7 mt -113.78 110.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.458 ' HB3' HD12 ' A' ' 134' ' ' LEU . 76.8 m -96.12 114.21 25.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 110.509 -175.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.47 116.19 28.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.023 0.929 . . . . 0.0 110.742 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.538 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 83.1 m-20 -82.92 102.39 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.75 138.32 9.48 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -58.83 -32.1 69.08 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.144 0.578 . . . . 0.0 111.513 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -53.31 -42.89 67.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.892 0.877 . . . . 0.0 112.303 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.29 -38.72 71.8 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.426 0.631 . . . . 0.0 110.314 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.57 -9.53 55.7 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.561 -1.2 . . . . 0.0 114.44 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -24.64 66.91 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 117.374 0.587 . . . . 0.0 110.547 172.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.4 21.5 16.59 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.198 0.999 . . . . 0.0 111.215 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -66.24 -52.16 39.79 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.17 0.988 . . . . 0.0 112.405 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.46 -14.61 30.89 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.608 1.539 . . . . 0.0 112.357 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -66.1 -44.98 82.82 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.905 0.882 . . . . 0.0 109.668 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 -20.49 29.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 50.5 ttt180 -72.24 -29.13 63.63 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.06 -22.28 75.87 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 58.4 mtt -76.66 -9.9 59.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.195 0.598 . . . . 0.0 111.719 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.89 14.75 16.4 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 120.175 -0.236 . . . . 0.0 113.412 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.2 m-85 -109.12 145.72 35.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 0.0 109.734 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 mm-40 -70.55 137.11 49.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 163.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.551 HG22 ' HB ' ' A' ' 110' ' ' ILE . 25.8 p -128.43 138.4 52.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -129.33 117.99 21.54 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.785 1.234 . . . . 0.0 108.849 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.41 103.33 9.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 111' ' ' CYS . 48.0 mt -88.53 131.92 40.53 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 148' ' ' ARG . 45.8 Cg_exo -59.57 136.3 70.24 Favored 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.687 2.258 . . . . 0.0 111.133 176.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.6 t -50.24 118.99 3.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.261 0.975 . . . . 0.0 111.013 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 p -83.65 30.17 0.5 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.901 0.881 . . . . 0.0 111.529 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 p -61.05 149.52 36.73 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.715 0.806 . . . . 0.0 110.576 165.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -53.14 -42.97 62.89 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.729 0.643 . . . . 0.0 114.4 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.01 93.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.329 0.652 . . . . 0.0 111.782 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -78.27 -28.51 47.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.168 0.587 . . . . 0.0 110.065 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.98 -36.62 77.55 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.322 0.649 . . . . 0.0 110.952 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -57.02 -20.78 26.19 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.118 0.967 . . . . 0.0 112.565 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -112.5 -33.69 6.08 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.243 0.617 . . . . 0.0 110.847 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.7 m -69.5 83.12 0.41 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -95.8 -57.18 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.396 1.079 . . . . 0.0 110.586 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.05 -32.41 69.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.182 0.593 . . . . 0.0 110.399 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.514 ' HB3' ' HG2' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -86.95 -31.81 20.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.908 -172.599 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.75 -28.85 67.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.006 0.821 . . . . 0.0 109.01 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -65.87 -42.91 89.74 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.1 pt-20 -71.9 -26.96 62.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -67.52 -43.21 81.38 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.69 -39.12 84.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.401 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.497 -175.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 151' ' ' GLU . 54.8 t -80.73 -62.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.003 0.521 . . . . 0.0 110.407 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 54.6 m-85 -85.08 2.45 43.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -165.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -25.62 62.84 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -78.21 -8.15 57.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.558 0.343 . . . . 0.0 111.814 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.81 -38.8 76.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.815 0.446 . . . . 0.0 111.312 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.25 -41.68 40.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 C--O 1.243 0.733 0 C-N-CA 125.566 1.547 . . . . 0.0 106.89 175.552 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.2 mm . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -88.34 110.14 20.54 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.2 mmt-85 -84.25 136.42 33.94 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.182 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.538 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -68.22 162.46 49.32 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 123.634 0.584 . . . . 0.0 112.052 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -101.47 146.14 31.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.05 137.09 17.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.741 2.294 . . . . 0.0 111.866 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.4 138.79 58.27 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.94 0.896 . . . . 0.0 111.625 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.63 81.29 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.537 HD11 ' CG1' ' A' ' 104' ' ' VAL . 40.8 tp -128.0 145.36 51.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.358 -163.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -123.41 159.67 28.46 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.603 1.161 . . . . 0.0 107.909 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.13 -26.73 64.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.987 0.515 . . . . 0.0 111.202 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -111.46 89.53 3.08 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -135.48 107.64 7.21 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.303 0.641 . . . . 0.0 109.61 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 69' ' ' ARG . 59.7 mm-40 -80.47 -35.74 34.39 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.396 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 24.3 mt -129.09 124.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 123.461 0.704 . . . . 0.0 109.857 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.79 117.4 34.02 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mt -94.15 112.83 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.52 119.66 39.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.727 0.811 . . . . 0.0 109.981 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.24 177.11 46.39 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 164.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.508 ' OG ' ' HB3' ' A' ' 116' ' ' LYS . 47.4 t -90.16 -75.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 tp -129.59 125.2 22.26 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 175.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.538 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 50.6 Cg_exo -59.28 125.0 16.78 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.033 1.822 . . . . 0.0 110.509 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -78.76 173.07 12.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.8 -37.28 78.69 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.046 0.539 . . . . 0.0 111.578 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.57 -42.95 89.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.871 0.868 . . . . 0.0 111.475 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.5 m -65.4 -41.9 93.15 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.024 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.02 -26.78 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.852 1.261 . . . . 0.0 112.304 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -63.37 -39.56 94.86 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.892 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -5.18 22.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.149 0.58 . . . . 0.0 111.186 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 62.5 31.22 17.13 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.688 1.195 . . . . 0.0 111.253 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -127.68 139.34 52.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.908 1.283 . . . . 0.0 108.887 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -57.56 -40.48 78.99 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.378 0.609 . . . . 0.0 109.535 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HA ' ' HE1' ' A' ' 42' ' ' TRP . 24.6 t80 -47.71 -44.76 27.98 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.422 169.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.39 -107.29 0.1 Allowed Glycine 0 C--N 1.362 2.012 0 O-C-N 124.043 0.839 . . . . 0.0 113.301 -170.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -122.72 146.6 48.44 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.294 1.037 . . . . 0.0 109.794 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -40.54 119.04 0.67 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.821 3.68 . . . . 0.0 114.216 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.29 -33.12 0.09 OUTLIER Glycine 0 N--CA 1.472 1.071 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.431 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -93.46 126.9 38.85 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.52 0.728 . . . . 0.0 109.245 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -81.64 1.49 33.81 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.399 1.08 . . . . 0.0 111.017 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -37.51 -49.48 1.06 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.918 1.687 . . . . 0.0 113.073 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.418 ' HE1' ' HA ' ' A' ' 34' ' ' TYR . 74.7 m95 -73.37 -24.21 60.3 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.402 -173.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 ttm-85 -88.29 -27.17 21.88 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 111.117 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.35 -51.36 9.52 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 110.569 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.96 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.27 -36.79 85.55 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.069 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -64.23 -40.97 97.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.631 . . . . 0.0 109.498 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 156' ' ' PHE . . . -62.81 -50.32 71.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.585 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.3 pt -88.19 -4.98 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.49 0.316 . . . . 0.0 111.212 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.3 28.99 64.93 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.147 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -146.15 92.28 2.17 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.01 101.16 0.14 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.243 0.617 . . . . 0.0 109.868 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.402 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 54.3 mt -68.73 -17.43 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.401 1.081 . . . . 0.0 112.229 -167.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.02 -41.93 93.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.543 0.737 . . . . 0.0 112.044 -169.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.38 -32.64 71.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.58 0.752 . . . . 0.0 112.459 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -60.37 148.85 35.73 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.307 0.643 . . . . 0.0 112.55 -175.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 153.72 32.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 167.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.521 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 33.5 t80 -54.45 -45.61 73.12 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -164.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -63.8 -45.2 90.75 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.044 0.538 . . . . 0.0 111.271 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -34.59 78.74 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.06 0.944 . . . . 0.0 110.333 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 29.7 ttmt -65.46 -41.44 93.37 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.814 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 29.2 mt -58.06 -48.46 80.04 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.07 0.856 . . . . 0.0 109.625 173.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -55.92 -45.23 78.78 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.237 0.96 . . . . 0.0 111.693 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -67.41 -45.64 75.57 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 123.543 0.527 . . . . 0.0 110.691 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.7 mt -55.84 -56.56 19.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.752 0.821 . . . . 0.0 110.527 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -67.95 -30.65 70.0 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.296 1.039 . . . . 0.0 111.58 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -63.45 -35.94 82.1 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.815 0.846 . . . . 0.0 110.884 170.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -84.82 5.13 29.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.388 0.675 . . . . 0.0 111.254 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 2.0 mpt_? 65.36 34.47 8.19 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-O 122.25 1.024 . . . . 0.0 110.197 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.06 135.65 49.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 108.731 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.61 169.04 13.66 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.0 mt -126.73 147.42 49.97 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.759 0.824 . . . . 0.0 109.127 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -166.18 -169.02 1.34 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.33 164.34 30.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.312 0.645 . . . . 0.0 110.565 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.414 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.7 t -86.14 -42.38 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.037 0.935 . . . . 0.0 111.074 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -100.22 115.78 30.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.095 0.558 . . . . 0.0 110.625 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 1.6 tmtp? -66.47 -34.75 78.64 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -144.82 135.26 24.35 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.684 -0.635 . . . . 0.0 110.614 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -157.26 148.72 18.78 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.547 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.476 0.84 0 C-N-CA 124.303 1.041 . . . . 0.0 109.119 177.444 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.376 0.608 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.38 58.09 4.18 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.519 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.542 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.9 t0 -171.19 144.05 2.0 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -110.43 17.67 20.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.887 0.875 . . . . 0.0 111.59 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 45.8 tt0 -85.01 103.01 13.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.488 0.661 . . . . 0.0 109.376 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.55 154.01 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.809 1.244 . . . . 0.0 109.451 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -79.58 157.2 27.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.686 0.794 . . . . 0.0 109.748 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.22 139.78 30.14 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.414 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 80.8 m-85 -130.48 11.58 5.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.713 0.805 . . . . 0.0 110.951 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 99.2 p -77.62 -12.1 59.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.969 -0.457 . . . . 0.0 110.469 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.03 -4.87 68.55 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.532 -0.593 . . . . 0.0 112.307 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 mt -51.23 -49.47 61.02 Favored 'General case' 0 C--N 1.37 1.494 0 C-N-CA 123.729 0.812 . . . . 0.0 111.362 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.549 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 44.6 mtpt -64.92 -16.18 62.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -171.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.94 -40.13 9.04 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 111.611 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -85.44 -26.61 26.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.537 ' CG1' HD11 ' A' ' 10' ' ' LEU . 2.2 m -129.02 89.5 48.46 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 122.868 0.467 . . . . 0.0 110.04 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.64 -28.7 20.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.296 1.997 . . . . 0.0 110.969 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -84.61 -11.95 54.97 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 112.864 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 32.3 tp -57.69 101.85 0.08 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.033 0.833 . . . . 0.0 110.665 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -93.21 -43.97 8.57 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.588 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.7 tp -134.19 135.66 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.555 0.742 . . . . 0.0 109.894 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.4 mt -105.08 136.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 86.3 m -117.75 115.39 24.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.14 0.427 . . . . 0.0 110.251 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -93.56 123.06 36.62 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -101.81 111.35 23.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.18 134.99 8.62 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -53.17 -47.17 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.304 1.042 . . . . 0.0 112.18 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.508 ' HB3' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -60.22 -20.83 60.53 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.805 0.842 . . . . 0.0 112.641 -178.13 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.56 -46.36 17.47 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.372 0.606 . . . . 0.0 109.476 170.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.26 -9.76 68.33 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.95 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -68.35 -17.52 64.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.009 0.524 . . . . 0.0 110.636 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.79 21.47 17.45 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.183 0.993 . . . . 0.0 110.988 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.44 -51.48 59.96 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.15 -0.928 . . . . 0.0 112.357 171.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.28 -24.44 67.7 Favored 'Trans proline' 0 C--N 1.405 3.551 0 C-N-CA 122.084 1.856 . . . . 0.0 112.698 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.81 -57.21 8.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.914 0.886 . . . . 0.0 110.181 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.48 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 12.2 mt -79.18 -21.03 46.96 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 6.9 ptm180 -75.22 -11.65 60.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 120.703 0.287 . . . . 0.0 110.715 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.59 -15.14 81.44 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.405 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.48 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -81.94 10.71 5.98 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 174.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.24 19.74 79.76 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 122.749 0.214 . . . . 0.0 112.716 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.549 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 18.3 m-85 -108.79 139.59 43.39 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.304 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -73.48 142.42 46.8 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -129.99 148.15 51.82 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.401 ' HB2' HD11 ' A' ' 109' ' ' LEU . 54.3 tptt -139.37 123.54 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.215 1.006 . . . . 0.0 108.864 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.04 122.81 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.52 HD21 HG21 ' A' ' 155' ' ' VAL . 90.4 mt -113.02 150.15 42.44 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.58 177.37 4.08 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.772 2.314 . . . . 0.0 111.561 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 m -66.02 130.29 42.74 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -83.89 14.91 3.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.834 0.854 . . . . 0.0 112.044 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -69.88 156.26 39.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.147 0.979 . . . . 0.0 111.78 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.17 -18.61 69.38 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.693 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.22 83.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.362 0.665 . . . . 0.0 111.056 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -76.56 -2.59 33.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.7 0.8 . . . . 0.0 112.477 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.446 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 20.1 ttm-85 -56.13 -33.68 65.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.039 0.935 . . . . 0.0 113.317 -172.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -33.38 72.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.643 0.589 . . . . 0.0 110.606 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.01 5.94 20.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.774 0.829 . . . . 0.0 111.994 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 13.7 t -91.07 14.8 13.05 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.151 0.58 . . . . 0.0 112.195 -175.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.98 -58.06 5.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.44 ' HB2' ' NH1' ' A' ' 148' ' ' ARG . 17.4 m120 -59.21 -15.06 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.44 ' NH1' ' HB2' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -74.96 -23.65 58.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.974 0.51 . . . . 0.0 110.101 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.36 -55.63 32.27 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.26 0.624 . . . . 0.0 110.695 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -73.93 -32.34 63.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 111.161 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 155' ' ' VAL . 19.3 tt0 -67.37 -56.75 8.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.165 0.586 . . . . 0.0 110.224 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -69.58 -25.91 64.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.523 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 32.4 tt0 -59.35 -49.61 77.14 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 123.821 0.7 . . . . 0.0 109.442 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.53 77.69 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.553 -171.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.52 HG21 HD21 ' A' ' 134' ' ' LEU . 92.6 t -61.91 -32.64 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 124.173 0.989 . . . . 0.0 112.673 -174.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.417 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 44.0 m-85 -115.55 -11.99 11.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 112.909 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.523 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 14.4 ptm180 -74.1 -26.56 60.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.555 0.616 . . . . 0.0 111.591 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -73.84 -8.8 57.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.571 0.348 . . . . 0.0 111.906 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.412 HD11 HD12 ' A' ' 16' ' ' ILE . 80.8 mt -70.26 -12.21 61.43 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.338 0.655 . . . . 0.0 112.732 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -90.37 -1.99 57.94 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.036 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 . . . . . 0 CA--C 1.555 1.148 0 C-N-CA 125.561 1.544 . . . . 0.0 110.435 -175.01 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptp . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.812 0.339 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.0 mm -76.89 139.75 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 171.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 25' ' ' ASP . 11.1 mptt -87.61 117.51 26.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -100.12 134.04 43.62 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.366 0.667 . . . . 0.0 110.558 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.512 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.2 -174.03 17.55 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.384 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -117.03 144.23 33.16 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 122.948 0.499 . . . . 0.0 110.281 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.42 145.42 16.13 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.024 2.483 . . . . 0.0 112.003 166.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.11 128.85 38.46 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 123.825 0.703 . . . . 0.0 111.124 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 62' ' ' LEU . 48.7 t -93.75 78.88 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.472 HD11 ' CG1' ' A' ' 104' ' ' VAL . 41.9 tp -128.71 154.07 46.69 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 112.164 -161.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -122.51 154.92 37.21 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.435 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 9.9 pt-20 -65.13 -10.68 32.72 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.15 0.58 . . . . 0.0 112.222 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.435 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 20.7 m-80 -120.08 97.38 5.57 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.46 ' HB ' HG12 ' A' ' 104' ' ' VAL . 52.6 m -144.04 112.93 6.71 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.387 0.675 . . . . 0.0 110.205 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -81.56 -36.21 29.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.053 . . . . 0.0 110.75 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.16 116.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.241 0.616 . . . . 0.0 109.484 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.2 tp -104.95 115.51 30.41 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.0 mt -98.38 109.32 23.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.736 0.814 . . . . 0.0 109.046 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.432 HD23 ' HB3' ' A' ' 73' ' ' TRP . 80.8 mt -98.08 108.93 21.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 109.026 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.72 -177.9 11.99 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 166.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 p -89.61 -82.17 0.27 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -136.12 114.92 10.88 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.5 Cg_exo -52.89 136.77 60.62 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.958 2.438 . . . . 0.0 112.846 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.3 m -61.22 145.64 50.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.105 0.878 . . . . 0.0 109.634 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 7.8 p-10 -61.89 -31.26 71.53 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.158 0.436 . . . . 0.0 110.73 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.75 -36.24 76.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.87 0.868 . . . . 0.0 110.793 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.1 m -66.5 -47.08 74.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.45 -26.57 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.763 1.225 . . . . 0.0 112.832 -171.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 18.7 mmt85 -69.4 -36.36 76.68 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 110.089 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.64 -16.12 35.33 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.281 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 65.38 21.59 11.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.695 1.598 . . . . 0.0 111.597 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.89 135.9 40.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.842 1.257 . . . . 0.0 108.873 -173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -57.98 -40.49 80.79 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 122.936 0.495 . . . . 0.0 110.817 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -63.98 -13.33 45.53 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.512 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.96 -37.89 16.41 Favored Glycine 0 C--N 1.362 1.984 0 C-N-CA 124.02 0.819 . . . . 0.0 113.523 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -109.78 112.29 58.39 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 165.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.07 0.56 3.1 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.794 2.996 . . . . 0.0 114.273 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.29 -14.2 80.89 Favored Glycine 0 C--N 1.354 1.529 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -72.82 97.64 2.28 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 168.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -80.07 -1.65 40.89 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.971 0.909 . . . . 0.0 110.885 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -36.03 -41.91 0.26 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.916 2.087 . . . . 0.0 113.443 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -71.36 -28.9 64.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.57 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -84.11 -37.84 21.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.106 0.562 . . . . 0.0 111.117 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.68 -48.24 80.18 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.499 0.72 . . . . 0.0 110.224 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.7 t -74.02 -37.26 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.416 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.08 -41.11 99.88 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 114.071 0.388 . . . . 0.0 114.071 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -71.41 -30.63 66.31 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.745 0.418 . . . . 0.0 110.363 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -75.82 -36.91 59.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.807 0.843 . . . . 0.0 112.465 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 pt -91.11 -10.46 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.396 0.678 . . . . 0.0 111.143 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.18 19.81 79.75 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.588 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -135.7 112.64 10.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -71.53 96.44 1.53 Allowed 'General case' 0 CA--C 1.551 1.01 0 CA-C-O 121.588 0.709 . . . . 0.0 111.696 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.1 mt -62.68 -35.87 81.06 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.013 0.925 . . . . 0.0 110.917 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -53.29 -50.44 64.89 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.627 1.171 . . . . 0.0 112.626 -170.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -81.96 -6.31 59.02 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.275 0.63 . . . . 0.0 112.097 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtt -86.11 139.62 30.95 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 151.35 33.56 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.081 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.517 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 53.6 t80 -50.0 -42.94 50.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -167.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 42.5 mt-10 -60.31 -46.2 90.73 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.305 0.378 . . . . 0.0 110.758 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -68.53 -45.13 73.02 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -59.71 -32.99 71.03 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 118.14 0.427 . . . . 0.0 110.885 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.565 HD22 HG11 ' A' ' 9' ' ' VAL . 47.2 mt -66.77 -43.15 84.8 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.81 172.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 74.7 mmtt -57.06 -41.17 78.27 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.216 0.606 . . . . 0.0 110.233 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -65.27 -39.25 92.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.498 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 99.7 mt -64.05 -46.25 85.22 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.851 0.461 . . . . 0.0 110.228 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 28.6 mmtp -59.88 -39.77 86.43 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.104 0.561 . . . . 0.0 109.882 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.05 -45.65 90.25 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.992 1.317 . . . . 0.0 111.335 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -86.25 7.78 23.86 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.328 0.251 . . . . 0.0 111.035 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 67.85 38.5 2.86 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.479 1.111 . . . . 0.0 110.988 171.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.63 132.92 57.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.15 1.38 . . . . 0.0 109.504 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.5 151.6 18.03 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 46.5 mt -119.84 141.06 49.87 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.341 0.656 . . . . 0.0 109.29 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.432 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.9 t90 -165.09 -168.96 1.53 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 176.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -133.54 177.91 7.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.956 0.902 . . . . 0.0 109.888 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.7 t -95.64 -56.46 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.675 0.79 . . . . 0.0 109.647 172.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HE2' ' HB3' ' A' ' 116' ' ' LYS . 57.3 m-85 -84.21 107.98 16.84 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.095 0.558 . . . . 0.0 110.607 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 3.7 tmtm? -66.82 -31.14 71.57 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.813 0.845 . . . . 0.0 109.044 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -152.86 130.87 11.81 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.061 0.544 . . . . 0.0 109.742 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 91' ' ' ASP . . . -151.03 144.21 11.49 Favored Glycine 0 C--O 1.238 0.4 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.825 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -90.04 105.37 17.76 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -119.06 92.72 3.87 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 170.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -133.24 168.37 18.67 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.859 -0.525 . . . . 0.0 109.964 -171.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.61 92.88 0.36 Allowed Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.572 -175.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 p -143.9 -171.02 3.46 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.012 0.925 . . . . 0.0 109.904 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -68.04 -62.41 1.41 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.388 0.675 . . . . 0.0 109.973 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.467 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 4.1 m-20 -72.87 -46.44 52.83 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.702 -175.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.2 m 56.07 36.36 27.26 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.582 1.153 . . . . 0.0 111.161 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 86' ' ' ASP . 31.9 mmmt -92.29 153.2 19.38 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.007 0.923 . . . . 0.0 110.097 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 73.6 mt -70.04 97.14 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.37 -70.1 1.3 Allowed Glycine 0 C--N 1.344 0.989 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.759 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.528 ' HB2' ' HA2' ' A' ' 79' ' ' GLY . 1.1 m-20 -38.88 133.41 1.12 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.873 1.269 . . . . 0.0 113.349 173.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -114.62 25.87 10.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.438 -165.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 8.4 tp10 -78.88 111.96 15.57 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.72 144.07 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.88 0.872 . . . . 0.0 109.134 -170.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -68.95 149.61 48.65 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.233 1.013 . . . . 0.0 110.796 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -78.27 130.94 36.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.516 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 35.3 m-85 -120.67 3.88 10.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.252 0.621 . . . . 0.0 111.395 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.0 t -74.63 -14.69 60.79 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.007 0.523 . . . . 0.0 109.817 173.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.88 -4.04 61.87 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.148 -0.807 . . . . 0.0 113.094 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 mt -52.8 -32.88 46.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 117.732 0.766 . . . . 0.0 112.879 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -68.59 -27.19 65.82 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.779 0.323 . . . . 0.0 111.444 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -83.31 -53.0 6.07 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.696 0.799 . . . . 0.0 111.466 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.534 ' HG3' HG22 ' A' ' 104' ' ' VAL . 25.4 ptm -73.32 -29.41 62.66 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.305 0.642 . . . . 0.0 111.341 -173.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -139.24 86.96 14.12 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 123.449 0.7 . . . . 0.0 111.209 177.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.69 -25.97 8.78 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.469 2.113 . . . . 0.0 112.554 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -77.8 -10.13 59.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.4 0.68 . . . . 0.0 111.785 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 36.2 tp -54.39 131.09 41.48 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.81 0.694 . . . . 0.0 110.673 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.41 ' HD2' ' NE2' ' A' ' 158' ' ' HIS . 18.0 ptp180 -128.56 -37.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.004 0.921 . . . . 0.0 108.707 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 tp -132.29 125.34 30.75 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 123.255 0.622 . . . . 0.0 110.432 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.508 HG12 HD21 ' A' ' 107' ' ' LEU . 32.9 mt -101.69 109.53 26.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.531 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.5 m -95.12 112.98 24.62 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.165 0.507 . . . . 0.0 109.928 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.1 114.49 25.75 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.189 0.996 . . . . 0.0 109.396 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -90.51 107.16 18.98 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.34 28.45 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.327 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -56.07 -50.7 70.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.837 0.855 . . . . 0.0 112.851 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 76' ' ' PHE . 26.3 mmmt -50.26 -37.22 34.82 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.41 -46.03 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.018 0.527 . . . . 0.0 110.103 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.73 -14.59 70.25 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 114.736 -1.12 . . . . 0.0 114.705 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.64 -28.38 69.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.974 0.51 . . . . 0.0 110.837 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -97.19 19.99 12.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.271 1.028 . . . . 0.0 111.227 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 41.2 tt0 -61.6 -54.71 49.36 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.627 170.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.23 -20.59 55.78 Favored 'Trans proline' 0 C--N 1.401 3.318 0 C-N-CA 122.262 1.975 . . . . 0.0 113.438 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.1 tp -63.56 -50.31 70.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.932 0.893 . . . . 0.0 110.163 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.49 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 9.8 mt -89.46 -6.67 56.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -171.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 29.3 mtp180 -69.62 -20.04 63.62 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.966 0.507 . . . . 0.0 109.944 168.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.35 -16.74 80.15 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.402 -0.666 . . . . 0.0 113.42 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.2 mpt? -85.73 9.97 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.702 0.751 . . . . 0.0 112.183 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.96 17.28 71.45 Favored Glycine 0 C--N 1.352 1.441 0 C-N-CA 122.869 0.271 . . . . 0.0 113.633 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -111.07 134.34 52.74 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.548 0.739 . . . . 0.0 109.611 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -61.99 143.28 56.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.446 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.4 p -127.85 139.59 52.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.706 0.802 . . . . 0.0 110.16 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -132.14 118.7 19.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.668 1.187 . . . . 0.0 108.928 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.96 95.11 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.9 mt -75.42 150.99 85.22 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 73.0 Cg_endo -72.5 163.88 37.25 Favored 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.084 1.856 . . . . 0.0 110.359 171.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.9 t -63.4 133.09 53.43 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.7 p -79.31 -3.97 48.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.264 0.626 . . . . 0.0 112.026 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -66.68 159.52 27.55 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 111.059 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 142' ' ' ARG . . . -58.43 -28.93 62.77 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.501 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.83 -40.9 76.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.837 0.855 . . . . 0.0 112.002 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 135' ' ' PRO . 49.1 t30 -89.94 -33.76 16.29 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.063 0.545 . . . . 0.0 110.982 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.539 HH21 ' HA ' ' A' ' 146' ' ' LYS . 6.5 tpm_? -51.61 -44.42 62.88 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 125.089 1.356 . . . . 0.0 112.458 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -60.87 -12.88 12.44 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.745 1.218 . . . . 0.0 113.317 -177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -121.06 -40.63 2.59 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.155 0.982 . . . . 0.0 110.823 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 65.4 m -93.3 85.64 5.06 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.697 0.799 . . . . 0.0 110.407 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.539 ' HA ' HH21 ' A' ' 142' ' ' ARG . 34.0 mmtp -93.99 -50.64 5.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.51 0.724 . . . . 0.0 111.475 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -86.05 -4.15 59.1 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.932 0.493 . . . . 0.0 111.506 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.3 tpt180 -78.31 -24.62 46.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.675 0.39 . . . . 0.0 110.097 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 11.3 pt-20 -62.12 -13.46 27.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 m -65.68 -30.5 71.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.37 0.668 . . . . 0.0 112.194 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 155' ' ' VAL . 14.7 pt-20 -72.61 -29.6 63.63 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.795 0.438 . . . . 0.0 109.925 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -67.35 -37.65 83.56 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 31.5 tt0 -67.55 -37.69 83.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.978 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.48 72.63 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.793 0.683 . . . . 0.0 111.168 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 151' ' ' GLU . 80.2 t -71.87 -60.39 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 C-N-CA 123.567 0.747 . . . . 0.0 111.03 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.432 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 50.1 m-85 -88.09 -7.56 56.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.77 -28.57 66.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.1 0.409 . . . . 0.0 110.86 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.41 ' NE2' ' HD2' ' A' ' 108' ' ' ARG . 0.6 OUTLIER -67.88 -21.66 65.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.596 0.758 . . . . 0.0 111.219 -175.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.4 mt -64.85 -14.28 58.9 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.428 1.091 . . . . 0.0 113.277 -170.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -98.48 -62.52 1.23 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 166.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 124.565 1.146 . . . . 0.0 108.179 178.132 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.403 HD13 ' HB3' ' A' ' 80' ' ' SER . 40.5 mm -72.91 108.03 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.179 0.592 . . . . 0.0 109.967 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -97.21 111.95 23.97 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -95.15 133.8 38.58 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.579 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.67 -166.66 9.71 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.948 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -117.97 147.77 41.99 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 123.384 0.674 . . . . 0.0 109.318 -172.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.06 162.16 27.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.196 1.931 . . . . 0.0 110.668 170.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.55 120.43 10.54 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.24 0.616 . . . . 0.0 111.486 -173.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 62' ' ' LEU . 41.0 t -94.56 84.6 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.545 HD11 HG12 ' A' ' 104' ' ' VAL . 48.8 tp -129.47 154.56 46.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.246 -159.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -123.62 159.31 29.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.936 0.894 . . . . 0.0 108.623 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HG3' HD22 ' A' ' 13' ' ' ASN . 11.4 pt-20 -59.57 -28.12 66.85 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.723 0.809 . . . . 0.0 111.729 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.433 HD22 ' HG3' ' A' ' 12' ' ' GLU . 43.7 m-80 -111.18 86.84 2.4 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -131.1 112.11 12.58 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.692 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.1 tt0 -91.56 -31.97 15.71 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.748 1.219 . . . . 0.0 110.091 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 69.1 mt -125.58 122.16 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.796 0.838 . . . . 0.0 109.465 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.2 tp -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.6 mt -95.41 106.35 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.411 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 75.7 mt -95.79 108.5 20.84 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.466 1.106 . . . . 0.0 108.85 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.84 178.32 9.13 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 166.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 117' ' ' ALA . 15.5 t -89.81 -75.59 0.45 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 tp -130.58 124.01 20.69 Favored Pre-proline 0 C--O 1.244 0.8 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -52.76 155.18 11.06 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -59.32 124.12 18.96 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -61.88 -22.37 65.49 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.121 0.568 . . . . 0.0 112.157 -171.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.29 -51.48 56.97 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.646 0.591 . . . . 0.0 110.111 170.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.6 t -55.04 -30.74 60.22 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.728 0.811 . . . . 0.0 111.872 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.8 mt -77.56 -26.75 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.893 0.877 . . . . 0.0 110.873 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -61.84 -27.63 68.92 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.256 0.623 . . . . 0.0 111.45 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -102.71 -3.48 26.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.474 0.71 . . . . 0.0 110.396 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 50.34 28.0 3.01 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.837 1.255 . . . . 0.0 113.168 -173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 34' ' ' TYR . 7.6 tt0 -149.09 141.78 24.5 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.001 0.521 . . . . 0.0 110.708 -170.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.456 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 66.1 m-85 -67.62 -6.03 18.43 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 123.94 0.896 . . . . 0.0 112.437 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 58' ' ' TYR . 90.9 t80 -82.07 -24.85 35.02 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.383 0.673 . . . . 0.0 109.357 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.3 -31.39 79.08 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.877 0.736 . . . . 0.0 114.84 -171.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -123.24 111.98 30.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 116.995 0.398 . . . . 0.0 110.462 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -88.35 -0.94 6.86 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.445 2.764 . . . . 0.0 112.566 170.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.57 -6.39 89.35 Favored Glycine 0 C--N 1.356 1.67 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 41' ' ' PHE . 11.7 m120 -76.19 126.21 30.57 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.52 4.94 50.25 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 124.246 1.018 . . . . 0.0 110.027 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.562 ' HD2' ' HB3' ' A' ' 39' ' ' ASN . 86.6 m-85 -50.1 -36.56 30.07 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.399 0.619 . . . . 0.0 109.674 163.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -73.56 -26.75 60.98 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.616 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -79.28 -44.84 20.89 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.727 0.811 . . . . 0.0 111.736 171.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.95 -38.64 57.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.057 0.543 . . . . 0.0 111.473 -169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.25 -30.31 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.49 -53.29 36.51 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.559 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 149' ' ' GLU . 14.4 p-80 -65.84 -30.3 70.9 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.006 0.431 . . . . 0.0 110.356 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -68.88 -34.44 75.43 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.093 0.957 . . . . 0.0 112.145 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 64' ' ' THR . 11.4 pt -96.33 -10.39 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.987 0.915 . . . . 0.0 110.405 176.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.62 39.15 22.36 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 115.039 0.776 . . . . 0.0 115.039 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.92 127.68 1.31 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.425 1.09 . . . . 0.0 108.769 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -72.0 102.78 3.04 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.043 0.937 . . . . 0.0 112.556 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.3 mt -61.03 -25.55 66.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.478 1.111 . . . . 0.0 111.809 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -68.78 -31.24 70.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.657 0.783 . . . . 0.0 111.238 -172.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.36 -11.04 53.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.973 0.909 . . . . 0.0 110.962 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 56.8 mtt -85.08 137.66 32.9 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -174.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 152.4 38.4 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.327 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 34.4 t80 -40.28 -51.12 2.76 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.259 1.424 . . . . 0.0 113.331 -171.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.53 -52.17 62.32 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.1 0.96 . . . . 0.0 111.311 -175.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -58.92 -42.71 90.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.591 0.756 . . . . 0.0 110.797 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -56.5 -53.34 58.59 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.829 1.252 . . . . 0.0 110.911 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.602 HD22 HG11 ' A' ' 9' ' ' VAL . 84.5 mt -65.48 -41.69 93.05 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.814 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -71.89 -28.14 63.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.698 0.399 . . . . 0.0 111.769 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.428 HG22 HD12 ' A' ' 49' ' ' ILE . 41.3 m -60.9 -42.32 97.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.109 0.48 . . . . 0.0 109.755 169.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.4 -50.29 66.05 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.013 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 30.8 mmtp -57.01 -44.78 83.13 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.454 0.702 . . . . 0.0 109.932 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -53.75 -41.29 66.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.243 1.417 . . . . 0.0 112.226 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -84.1 0.88 46.65 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.92 0.888 . . . . 0.0 111.746 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 66.9 42.73 2.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.852 1.261 . . . . 0.0 110.387 -178.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 48.2 mt -112.38 136.92 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.806 1.242 . . . . 0.0 109.191 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.25 163.17 14.06 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 170.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.0 mt -124.39 144.4 50.06 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.929 0.892 . . . . 0.0 109.162 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.411 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.1 t90 -165.29 -169.14 1.54 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -134.8 170.33 16.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.768 0.827 . . . . 0.0 109.666 175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 61.4 t -97.05 -35.39 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.478 0.711 . . . . 0.0 110.549 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -111.43 105.2 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.52 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 50.7 tptt -64.97 -26.98 68.53 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.362 1.065 . . . . 0.0 111.748 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.28 138.53 25.15 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.7 114.39 0.86 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.403 ' HB3' HD13 ' A' ' 2' ' ' ILE . 87.3 p -93.97 123.95 37.67 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.562 0.681 . . . . 0.0 109.925 -171.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -85.69 96.47 9.71 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -17.34 20.42 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.511 1.124 . . . . 0.0 111.649 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 148.51 -15.62 1.26 Allowed Glycine 0 C--N 1.353 1.477 0 CA-C-O 119.738 -0.479 . . . . 0.0 114.131 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.7 t -69.28 133.91 48.48 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.177 0.591 . . . . 0.0 111.251 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -88.55 138.61 31.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.125 0.97 . . . . 0.0 110.203 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 73.24 -24.82 0.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 126.441 1.896 . . . . 0.0 113.154 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 m -74.42 96.23 2.85 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -77.58 -42.29 35.71 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.542 0.737 . . . . 0.0 109.788 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 mt -104.54 97.86 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.444 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -101.06 54.99 0.8 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.646 -0.581 . . . . 0.0 111.646 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 16.7 t70 -176.45 150.44 0.88 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -172.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.92 17.85 14.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.309 0.644 . . . . 0.0 112.623 -169.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 77' ' ' LYS . 24.6 tt0 -77.76 105.67 9.08 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.5 mm -89.71 147.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.113 0.965 . . . . 0.0 109.392 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -74.6 143.92 44.17 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 168.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -82.88 127.4 33.46 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.447 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 64.2 m-85 -114.92 10.97 16.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.369 0.667 . . . . 0.0 110.998 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.1 t -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.696 0.398 . . . . 0.0 110.818 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.26 -4.76 86.08 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.738 -176.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 104' ' ' VAL . 16.6 mt -49.41 -53.11 24.36 Favored 'General case' 0 C--N 1.368 1.392 0 C-N-CA 123.676 0.79 . . . . 0.0 111.212 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -59.35 -18.7 40.63 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.467 0.707 . . . . 0.0 112.58 -168.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -86.38 -42.74 13.41 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.501 1.121 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -94.97 -16.02 23.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 10' ' ' LEU . 17.1 m -122.35 88.12 48.8 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.168 0.587 . . . . 0.0 110.48 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.1 -39.12 3.3 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 122.184 1.923 . . . . 0.0 112.101 174.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -86.2 -6.12 59.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.765 0.826 . . . . 0.0 113.117 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.1 tp -61.85 117.45 5.91 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.611 0.569 . . . . 0.0 111.073 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -111.47 -40.53 4.35 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.941 0.896 . . . . 0.0 109.52 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 56.2 tp -129.35 133.08 47.24 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.925 0.89 . . . . 0.0 110.875 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.4 mt -112.7 146.31 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 134' ' ' LEU . 81.7 m -125.69 113.51 17.44 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.598 0.759 . . . . 0.0 110.317 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -92.64 107.93 19.59 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.595 1.158 . . . . 0.0 109.086 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -98.79 88.24 3.98 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -171.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.65 139.1 3.96 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.625 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.0 -50.84 65.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 111.695 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -55.48 -38.43 69.1 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.461 1.104 . . . . 0.0 112.008 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 21' ' ' SER . . . -65.57 -36.19 83.04 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.996 0.518 . . . . 0.0 110.823 175.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.85 -16.37 59.24 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 115.099 -0.955 . . . . 0.0 114.556 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.59 -29.73 70.75 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.11 0.481 . . . . 0.0 110.947 174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -111.31 25.33 11.83 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.722 0.809 . . . . 0.0 111.084 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.52 -44.22 24.48 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.066 0.946 . . . . 0.0 112.543 170.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.426 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 71.9 Cg_endo -70.72 -13.77 32.53 Favored 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 121.8 1.667 . . . . 0.0 112.828 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.7 tp -58.91 -41.03 86.28 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.562 1.145 . . . . 0.0 110.191 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -96.98 -10.55 26.01 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.489 -174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 122' ' ' PRO . 19.6 mtm180 -63.93 -34.91 79.03 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 121.078 0.466 . . . . 0.0 110.244 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.93 -12.26 70.95 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.446 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.3 mtt -94.94 9.67 38.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 0.0 111.708 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.01 17.87 77.7 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.414 -0.357 . . . . 0.0 113.878 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -110.0 133.59 53.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.437 0.695 . . . . 0.0 110.071 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -67.68 143.74 55.82 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 66.0 p -132.93 149.73 52.22 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.707 0.803 . . . . 0.0 110.351 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -145.5 129.23 17.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.353 1.061 . . . . 0.0 109.369 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.6 t -88.64 97.07 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 111' ' ' CYS . 39.6 mt -77.62 144.34 69.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.951 176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.461 ' HD2' ' HE1' ' A' ' 152' ' ' TRP . 44.7 Cg_exo -59.3 154.82 44.14 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 123.521 2.814 . . . . 0.0 113.269 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.5 m -68.91 108.88 3.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.976 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.0 m -84.69 21.03 1.61 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.422 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.1 t -59.73 154.14 18.76 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.454 0.702 . . . . 0.0 110.522 171.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.02 -19.19 69.69 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.149 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.48 -15.37 61.32 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.962 0.905 . . . . 0.0 111.452 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 144' ' ' PHE . 9.5 t30 -132.51 8.55 4.25 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.324 0.65 . . . . 0.0 111.204 -173.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -65.77 -36.22 82.92 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.271 0.558 . . . . 0.0 110.899 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -66.03 -25.88 67.26 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.725 1.21 . . . . 0.0 111.47 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.488 ' HD2' ' HA ' ' A' ' 141' ' ' ASN . 56.2 m-85 -92.56 -35.89 13.33 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.595 0.758 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 t -86.85 30.08 0.77 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.36 1.064 . . . . 0.0 111.425 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -67.71 -70.57 0.25 Allowed 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -68.79 -4.69 17.03 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.481 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 17.0 mmt180 -73.2 -22.92 60.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.167 0.587 . . . . 0.0 110.41 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.514 ' HB2' ' CE1' ' A' ' 47' ' ' HIS . 12.7 pt-20 -55.54 -24.59 33.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.824 0.85 . . . . 0.0 112.592 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.7 t -67.53 -46.97 71.27 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.831 0.852 . . . . 0.0 111.724 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 10.9 pt-20 -66.47 -31.97 73.05 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.461 ' HE1' ' HD2' ' A' ' 135' ' ' PRO . 35.8 m95 -68.66 -46.73 68.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 48' ' ' ALA . 27.2 tt0 -62.47 -37.87 87.63 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.762 -173.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.81 -36.29 82.02 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.153 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 151' ' ' GLU . 55.4 t -66.41 -35.84 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.901 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.565 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 45.9 m-85 -104.62 -1.73 26.03 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.489 -0.757 . . . . 0.0 112.648 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -81.17 -36.82 29.69 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.928 0.491 . . . . 0.0 110.768 170.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.409 ' HE1' HD11 ' A' ' 16' ' ' ILE . 4.3 p-80 -67.23 -17.74 64.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.034 0.209 . . . . 0.0 110.648 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.46 -30.75 71.78 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.523 0.729 . . . . 0.0 110.38 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -60.68 -44.92 95.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.563 0.745 . . . . 0.0 110.228 175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 CA--C 1.56 1.338 0 C-N-CA 124.415 1.086 . . . . 0.0 109.997 -179.652 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptp . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 111.05 0.019 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.53 HD13 ' HB3' ' A' ' 80' ' ' SER . 39.2 mm -75.26 135.3 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 122.849 0.459 . . . . 0.0 110.063 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -124.39 123.72 40.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.648 1.179 . . . . 0.0 108.88 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -89.64 139.35 30.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 122.755 0.422 . . . . 0.0 110.893 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -72.73 166.39 54.26 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.663 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 m-30 -95.21 139.94 22.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.952 0.501 . . . . 0.0 111.174 -172.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.86 134.26 54.13 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.719 2.279 . . . . 0.0 110.251 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.73 143.35 54.54 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.005 0.816 . . . . 0.0 112.257 -169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 62' ' ' LEU . 34.5 t -97.92 61.35 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 172.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.502 HD11 ' CG1' ' A' ' 104' ' ' VAL . 64.4 tp -104.13 145.75 29.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.837 -171.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.659 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 5.2 t70 -116.38 158.42 23.51 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 9.8 pt-20 -63.86 -21.87 66.65 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.406 0.622 . . . . 0.0 111.084 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.405 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 42.0 m-80 -110.46 84.12 1.87 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.755 1.622 . . . . 0.0 107.754 174.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -135.56 123.73 23.02 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.515 0.726 . . . . 0.0 110.282 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 38.9 tt0 -106.36 -29.69 9.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.734 1.214 . . . . 0.0 110.677 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.658 HD12 HD11 ' A' ' 159' ' ' LEU . 37.9 mt -131.82 125.18 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.963 0.905 . . . . 0.0 109.628 178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.0 tp -110.86 124.82 52.81 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.348 1.059 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' CYS . 47.1 mt -102.45 111.27 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.211 0.604 . . . . 0.0 109.66 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 73' ' ' TRP . 97.4 mt -99.07 127.94 45.1 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.165 0.986 . . . . 0.0 110.363 178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.2 -175.13 49.77 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 162.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 p -94.64 -71.78 0.65 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -134.82 124.59 16.82 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 71.0 Cg_exo -52.09 137.26 54.02 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.593 2.195 . . . . 0.0 112.442 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 28' ' ' ILE . 30.1 m -61.01 146.17 48.07 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.775 0.672 . . . . 0.0 110.537 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 37.6 t70 -58.07 -41.72 84.01 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.799 0.44 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -47.63 -40.54 19.89 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.973 1.309 . . . . 0.0 111.72 171.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -78.34 -39.67 38.81 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.137 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 24' ' ' SER . 74.8 mt -68.12 -25.62 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 124.365 1.066 . . . . 0.0 111.691 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 23.7 mmt180 -65.29 -28.01 69.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.475 0.31 . . . . 0.0 111.349 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -114.62 0.25 13.87 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.962 0.505 . . . . 0.0 111.393 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 62.69 24.96 14.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.901 1.28 . . . . 0.0 112.878 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -129.63 134.37 47.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.286 1.034 . . . . 0.0 108.806 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -56.51 -46.1 80.71 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.418 0.687 . . . . 0.0 110.513 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -64.15 -0.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.229 1.412 . . . . 0.0 112.889 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -50.24 -26.45 9.37 Favored Glycine 0 C--N 1.357 1.736 0 C-N-CA 123.743 0.687 . . . . 0.0 113.609 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -102.74 108.85 59.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 163.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -26.75 41.21 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.68 2.253 . . . . 0.0 112.019 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.33 -6.53 40.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.791 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.86 129.21 38.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -82.61 -6.73 59.52 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.396 0.679 . . . . 0.0 111.723 -173.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -37.91 -41.51 0.54 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.555 1.542 . . . . 0.0 113.541 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.603 0.761 . . . . 0.0 112.216 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.3 mtp-105 -75.63 -40.9 55.53 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.403 0.281 . . . . 0.0 110.797 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.77 -55.22 15.96 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.597 0.759 . . . . 0.0 110.895 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.8 t -72.62 -34.32 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.496 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.77 88.42 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.346 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -64.77 -37.91 89.19 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.769 0.828 . . . . 0.0 109.754 175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.542 ' HA ' ' HG2' ' A' ' 153' ' ' GLU . . . -65.02 -47.78 76.24 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.296 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.8 pt -89.48 -14.79 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.536 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.99 39.45 20.04 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.034 0.374 . . . . 0.0 114.034 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -133.0 146.27 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.317 1.047 . . . . 0.0 109.361 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -85.15 91.46 8.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -82.43 -1.29 49.69 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.228 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.15 -48.99 11.37 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.32 -30.22 60.25 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.485 1.114 . . . . 0.0 112.307 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.3 mtt -61.23 156.43 18.58 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.973 0.509 . . . . 0.0 111.001 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.66 162.45 20.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.574 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 31.3 t80 -49.42 -55.37 13.32 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.929 0.892 . . . . 0.0 112.765 -173.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -58.59 -40.31 82.86 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.7 0.8 . . . . 0.0 111.526 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -66.56 -53.62 32.67 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.971 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 15.9 ptpt -64.86 -30.34 71.33 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.676 0.61 . . . . 0.0 112.074 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 80.8 mt -61.48 -49.56 76.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.124 0.57 . . . . 0.0 110.612 171.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -64.59 -28.59 69.73 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.447 0.467 . . . . 0.0 111.356 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -68.93 -39.23 79.72 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.371 0.668 . . . . 0.0 110.671 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 72.0 mt -65.15 -49.58 69.3 Favored 'General case' 0 C--O 1.21 -0.98 0 C-N-CA 122.913 0.485 . . . . 0.0 110.479 175.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.659 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 4.5 mtpp -68.65 -27.4 65.96 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.945 0.898 . . . . 0.0 112.671 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -58.37 -40.9 83.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.623 0.769 . . . . 0.0 110.349 165.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 87.0 m-20 -93.6 19.28 8.76 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.397 1.079 . . . . 0.0 110.078 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 64.99 32.89 10.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.124 0.97 . . . . 0.0 111.693 168.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 72.3 mt -108.59 126.08 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.86 0.864 . . . . 0.0 109.514 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.8 156.04 16.22 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.4 mt -120.98 133.25 55.26 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.469 ' HB3' HD23 ' A' ' 19' ' ' LEU . 6.9 t90 -162.62 -169.16 2.01 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -145.64 165.25 29.25 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.287 1.035 . . . . 0.0 110.34 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.49 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.9 t -80.77 -47.67 20.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.705 0 C-N-CA 123.644 0.778 . . . . 0.0 110.805 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -98.14 110.86 23.37 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.355 0.662 . . . . 0.0 111.711 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.09 -24.64 65.06 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.027 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.12 135.0 16.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.492 0.717 . . . . 0.0 109.609 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.29 146.46 15.33 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB3' HD13 ' A' ' 2' ' ' ILE . 79.1 p -115.06 168.9 9.52 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 117.87 0.835 . . . . 0.0 110.344 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -137.15 97.11 3.41 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -134.51 -72.92 0.48 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.44 0.462 . . . . 0.0 110.998 -171.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.31 91.35 0.13 Allowed Glycine 0 C--N 1.345 1.042 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.7 p -153.72 168.41 26.35 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.811 0.845 . . . . 0.0 109.97 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -121.6 156.16 33.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.706 1.203 . . . . 0.0 109.796 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 66.57 -72.44 0.08 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.282 1.433 . . . . 0.0 110.914 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 t -98.48 118.42 35.13 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 167.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -81.39 -5.63 58.08 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.005 0.922 . . . . 0.0 111.584 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 51.2 mt -72.81 90.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.78 54.81 4.98 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.42 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.704 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.2 t70 -170.42 148.98 3.25 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -171.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.51 17.38 12.1 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.474 0.71 . . . . 0.0 112.434 -166.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -89.71 118.13 29.09 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.312 0.577 . . . . 0.0 109.49 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.1 mt -122.55 146.73 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.395 1.078 . . . . 0.0 109.248 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -64.38 147.33 52.83 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.921 0.888 . . . . 0.0 110.173 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -81.52 117.48 21.96 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.49 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 59.9 m-85 -105.65 0.65 26.57 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.509 0.724 . . . . 0.0 111.107 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.9 p -75.4 -16.81 60.33 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.98 -5.82 70.27 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-O 119.385 -0.675 . . . . 0.0 112.396 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' O ' HG22 ' A' ' 104' ' ' VAL . 15.3 mt -48.16 -55.08 11.25 Favored 'General case' 0 C--N 1.371 1.527 0 C-N-CA 123.857 0.863 . . . . 0.0 111.107 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 mtpt -60.29 -26.99 66.92 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.334 0.653 . . . . 0.0 111.77 -167.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -76.16 -41.12 50.83 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.084 0.954 . . . . 0.0 111.881 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -91.4 -23.15 20.14 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.502 ' CG1' HD11 ' A' ' 10' ' ' LEU . 15.0 m -122.08 107.95 34.81 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 118.363 0.529 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -82.98 -36.49 0.22 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.32 2.013 . . . . 0.0 111.961 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -86.35 -10.06 55.15 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.356 0.662 . . . . 0.0 111.624 -170.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.35 116.49 5.56 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 121.147 0.499 . . . . 0.0 110.756 -171.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.435 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 5.9 ptm180 -111.06 -43.63 3.72 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.338 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.466 ' HB3' HG12 ' A' ' 16' ' ' ILE . 47.5 tp -126.11 127.58 46.0 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 122.933 0.493 . . . . 0.0 110.009 -167.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.8 mt -110.99 114.15 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.6 m -96.55 115.8 28.03 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.952 0.901 . . . . 0.0 110.993 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.05 116.26 28.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.655 1.182 . . . . 0.0 109.04 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -93.75 119.35 32.62 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.43 143.05 11.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.103 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 57.2 ttp180 -50.98 -48.75 61.17 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.45 1.1 . . . . 0.0 112.068 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -49.21 -36.01 18.8 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.73 1.212 . . . . 0.0 112.761 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.88 -42.7 23.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.174 0.59 . . . . 0.0 109.9 176.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.58 -10.13 47.82 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.54 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 76.4 mt-10 -68.24 -34.59 76.5 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.041 0.536 . . . . 0.0 110.701 172.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -100.71 19.49 16.97 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.931 0.893 . . . . 0.0 110.885 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.1 tm-20 -63.07 -49.34 81.55 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.344 1.058 . . . . 0.0 112.933 170.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -66.85 -16.27 49.48 Favored 'Trans proline' 0 C--N 1.397 3.081 0 C-N-CA 121.73 1.62 . . . . 0.0 112.887 -175.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.09 -52.13 67.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.278 1.031 . . . . 0.0 110.868 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.0 -5.06 58.95 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.011 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -66.55 -32.62 74.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.7 0.4 . . . . 0.0 110.331 170.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.59 -12.6 61.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.536 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.2 mtt -96.17 11.97 32.46 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.175 0.99 . . . . 0.0 111.433 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.29 27.33 73.77 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.323 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -105.49 136.18 45.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.301 0.641 . . . . 0.0 110.325 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.67 140.07 57.88 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 167.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.519 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 29.3 p -128.82 141.86 51.16 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 121.252 0.548 . . . . 0.0 110.816 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -135.28 126.85 28.85 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.765 1.226 . . . . 0.0 108.83 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.94 106.81 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 111' ' ' CYS . 90.5 mt -88.63 153.33 50.18 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 124.109 0.964 . . . . 0.0 109.516 170.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.598 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 49.0 Cg_exo -58.63 164.48 9.32 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.131 2.554 . . . . 0.0 113.195 172.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.7 t -65.69 110.7 2.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 166.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.0 p -80.66 25.16 0.44 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.031 0.932 . . . . 0.0 112.088 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.8 t -63.0 147.79 49.6 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.967 0.907 . . . . 0.0 110.337 167.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 142' ' ' ARG . . . -69.21 -20.88 75.42 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.343 -0.389 . . . . 0.0 113.343 174.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.73 -8.45 56.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.018 0.527 . . . . 0.0 111.129 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -122.02 13.19 10.51 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.391 1.076 . . . . 0.0 109.598 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.473 ' HA ' ' OG ' ' A' ' 145' ' ' SER . 48.9 ttp180 -66.77 -31.9 72.84 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.493 0.717 . . . . 0.0 110.558 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -57.3 -32.71 66.94 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.091 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -97.63 -22.92 16.21 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.491 1.117 . . . . 0.0 110.674 -175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 84.0 p -90.43 11.64 20.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.024 0.529 . . . . 0.0 112.092 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.07 -69.79 0.18 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.112 0.965 . . . . 0.0 111.949 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -90.4 -2.97 57.99 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.298 0.639 . . . . 0.0 111.134 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.603 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 13.1 tpt180 -72.61 -18.36 61.6 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.744 0.818 . . . . 0.0 109.499 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -25.24 0.79 Allowed 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.58 1.152 . . . . 0.0 113.079 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.5 t -60.89 -44.95 96.41 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.089 0.955 . . . . 0.0 111.928 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 155' ' ' VAL . 9.5 pt-20 -72.95 -32.25 65.13 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -67.01 -40.19 87.26 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.542 ' HG2' ' HA ' ' A' ' 48' ' ' ALA . 4.7 tm-20 -71.15 -33.3 69.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.615 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.45 63.95 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.153 0.581 . . . . 0.0 111.531 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 151' ' ' GLU . 71.5 t -81.64 -57.62 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.877 0.471 . . . . 0.0 110.746 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.402 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 39.4 m-85 -92.78 1.6 57.2 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -166.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -61.76 -41.46 97.71 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -77.69 -10.75 59.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.419 0.687 . . . . 0.0 111.831 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 16' ' ' ILE . 38.7 mt -78.99 -25.21 43.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.753 0.821 . . . . 0.0 112.586 -168.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -64.39 -45.08 89.2 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 166.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 CA--C 1.556 1.193 0 C-N-CA 124.985 1.314 . . . . 0.0 111.578 174.607 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.1 mm -78.62 122.18 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.557 0.743 . . . . 0.0 109.738 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HB2' HD21 ' A' ' 22' ' ' LEU . 56.9 mtpt -84.91 125.69 32.87 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.61 0.764 . . . . 0.0 109.975 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -93.75 135.27 35.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.281 0.633 . . . . 0.0 111.69 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.478 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -76.43 -177.01 43.13 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.986 165.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.75 144.67 37.64 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.225 -172.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.96 151.72 32.42 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.83 2.353 . . . . 0.0 112.254 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 139.33 58.57 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.644 0.778 . . . . 0.0 112.65 -172.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.672 HG11 HD22 ' A' ' 62' ' ' LEU . 65.9 t -104.84 88.59 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.512 HD11 HG12 ' A' ' 104' ' ' VAL . 54.1 tp -138.46 153.37 48.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.808 -160.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -126.07 165.23 19.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.306 1.042 . . . . 0.0 110.189 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HG3' ' ND2' ' A' ' 13' ' ' ASN . 8.9 pt-20 -65.72 -17.66 64.78 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.99 0.916 . . . . 0.0 111.957 171.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.47 ' ND2' ' HG3' ' A' ' 12' ' ' GLU . 46.2 m-80 -120.55 91.57 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.2 m -141.07 118.8 11.68 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.059 0.944 . . . . 0.0 109.074 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.24 -37.75 19.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.685 0.794 . . . . 0.0 110.659 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.438 HD12 HD11 ' A' ' 159' ' ' LEU . 66.4 mt -125.83 124.44 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.246 0.618 . . . . 0.0 109.889 -174.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.4 tp -107.52 115.25 29.82 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.459 HG22 ' ND2' ' A' ' 113' ' ' ASN . 47.8 mt -94.2 102.98 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 73' ' ' TRP . 98.2 mt -94.67 119.15 32.85 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 124.034 0.933 . . . . 0.0 110.233 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.62 -178.78 37.52 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 171.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 m -93.94 -78.55 0.43 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 3' ' ' LYS . 64.1 tp -134.3 116.34 13.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 170.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.478 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 73.7 Cg_exo -53.63 148.39 35.75 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.207 2.605 . . . . 0.0 113.584 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 28' ' ' ILE . 29.0 t -61.55 150.7 35.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.623 1.169 . . . . 0.0 111.918 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 10.4 m-20 -55.03 -43.49 73.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.877 0.871 . . . . 0.0 110.71 175.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.627 ' HB3' HD21 ' A' ' 36' ' ' ASN . 15.2 tp10 -66.55 -26.06 66.95 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.454 1.096 . . . . 0.0 111.0 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.576 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 69.4 m -73.54 -40.91 63.62 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 24' ' ' SER . 64.1 mt -71.32 -21.69 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 124.501 1.12 . . . . 0.0 111.413 -176.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 20.3 mmt85 -61.31 -33.12 73.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.035 0.534 . . . . 0.0 110.915 174.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 80.6 mttt -110.46 -2.47 16.53 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.011 0.924 . . . . 0.0 111.116 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 58.57 27.73 16.1 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.639 1.576 . . . . 0.0 112.748 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -138.27 156.35 47.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.959 0.904 . . . . 0.0 110.231 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -71.35 -5.51 33.09 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.597 0.759 . . . . 0.0 110.288 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -77.34 -16.93 58.66 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.969 1.708 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.83 -30.72 73.6 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 0.0 114.307 -175.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.627 HD21 ' HB3' ' A' ' 26' ' ' GLU . 36.8 m-80 -124.09 99.38 37.68 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.334 0.654 . . . . 0.0 110.437 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.08 -7.51 15.28 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.676 164.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' HH12 ' A' ' 43' ' ' ARG . . . -85.13 -15.76 66.3 Favored Glycine 0 C--N 1.357 1.741 0 O-C-N 123.525 0.516 . . . . 0.0 112.214 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -73.79 125.76 28.86 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 137' ' ' SER . 1.3 t0 -79.43 -4.88 53.19 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.926 0.891 . . . . 0.0 112.088 -158.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 113' ' ' ASN . 38.0 m-85 -48.48 -36.19 14.61 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.193 0.997 . . . . 0.0 111.663 177.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -73.25 -32.36 64.66 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.432 0.693 . . . . 0.0 112.192 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.592 ' HD2' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -88.48 -23.51 23.22 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.754 0.422 . . . . 0.0 111.511 177.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 149' ' ' GLU . 49.4 mt -86.38 -45.67 10.98 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.939 0.496 . . . . 0.0 111.051 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.95 -32.48 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.42 -40.54 94.49 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.476 0.485 . . . . 0.0 112.971 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -61.81 -43.59 98.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.75 0.82 . . . . 0.0 109.809 171.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -71.61 -33.32 68.89 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.596 -1.183 . . . . 0.0 113.978 -171.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -94.43 -11.37 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 122.991 0.517 . . . . 0.0 111.146 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.31 27.54 63.61 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 123.423 0.452 . . . . 0.0 113.314 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.14 113.0 6.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.3 99.82 0.97 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.202 0.601 . . . . 0.0 111.086 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.465 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 77.0 mt -67.66 -27.89 67.24 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.303 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.592 ' HG3' ' HD2' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -65.17 -37.85 88.69 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.443 0.697 . . . . 0.0 111.438 -173.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.5 -36.9 63.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.02 0.528 . . . . 0.0 112.081 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.9 mtt -62.83 149.15 44.97 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -171.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.09 153.92 40.61 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.208 168.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.505 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 46.1 t80 -44.34 -50.57 9.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.144 0.978 . . . . 0.0 113.501 -171.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 43.1 mt-10 -61.83 -54.17 45.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.504 0.722 . . . . 0.0 111.44 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -58.06 -37.2 73.97 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.639 0.776 . . . . 0.0 111.127 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 35.5 ttmt -62.54 -45.97 90.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.11 0.964 . . . . 0.0 110.132 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.672 HD22 HG11 ' A' ' 9' ' ' VAL . 25.8 mt -61.73 -47.28 85.97 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.134 0.896 . . . . 0.0 110.957 175.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 66.9 mttm -55.02 -38.05 67.42 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -66.79 -51.46 55.46 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.156 0.91 . . . . 0.0 110.238 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 62' ' ' LEU . 57.2 mt -52.8 -56.72 13.67 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.936 0.894 . . . . 0.0 111.395 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -65.14 -30.54 71.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.315 0.646 . . . . 0.0 111.947 -178.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -63.28 -36.89 85.17 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.272 0.629 . . . . 0.0 111.175 170.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -90.94 6.51 44.35 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.385 0.674 . . . . 0.0 110.959 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 65.57 37.44 5.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.355 1.062 . . . . 0.0 111.359 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.24 132.37 56.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 109.46 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -114.3 154.02 17.24 Favored Glycine 0 C--N 1.33 0.202 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.1 mt -121.26 132.38 54.77 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.439 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.2 t90 -156.08 -169.76 3.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -143.24 165.54 27.18 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.54 0.736 . . . . 0.0 110.2 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.45 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 72.5 t -82.23 -62.29 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.468 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -79.66 107.7 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.326 0.584 . . . . 0.0 111.374 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.2 ttmt -64.31 -31.92 73.31 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.032 170.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -152.55 126.85 9.23 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.14 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -134.3 135.45 7.99 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.8 p -86.77 105.18 16.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.171 0.588 . . . . 0.0 110.052 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -99.09 103.15 15.04 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' HG3' ' H ' ' A' ' 84' ' ' SER . 10.7 tp10 -120.53 154.57 35.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.699 0.8 . . . . 0.0 109.379 -172.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.78 -31.18 77.59 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.52 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 45.8 t -73.14 -17.38 61.39 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.989 0.916 . . . . 0.0 111.361 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.672 ' HG3' ' HB2' ' A' ' 88' ' ' LYS . 6.2 tp-100 -126.58 99.03 5.63 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.437 0.695 . . . . 0.0 109.485 -176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.09 77.39 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 125.444 1.497 . . . . 0.0 114.353 -164.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.5 m 56.04 16.8 2.34 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.482 1.513 . . . . 0.0 113.061 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.672 ' HB2' ' HG3' ' A' ' 85' ' ' GLN . 73.8 mmtt -86.26 142.35 28.62 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.4 mt -82.09 82.34 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.25 -23.57 77.2 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.312 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 7.0 t70 -84.07 157.8 21.64 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.123 0.487 . . . . 0.0 110.744 -175.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -123.3 24.13 8.84 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.904 -170.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 10.8 tp10 -85.75 111.48 20.18 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.36 155.38 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.112 0.965 . . . . 0.0 109.056 -169.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.42 ' HB3' ' CZ2' ' A' ' 73' ' ' TRP . 59.0 m-80 -76.63 149.31 36.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.169 0.988 . . . . 0.0 110.484 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.26 116.48 19.55 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.94 0.4 . . . . 0.0 110.494 -176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.45 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.4 m-85 -103.6 4.05 35.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.652 0.781 . . . . 0.0 111.351 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.1 m -74.48 -29.95 61.64 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.698 0.399 . . . . 0.0 110.746 170.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.88 -10.79 85.27 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.014 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.405 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.6 mt -47.4 -54.15 12.02 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.133 0.973 . . . . 0.0 111.592 175.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.442 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.1 mtpt -61.43 -18.76 60.37 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -167.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -86.05 -39.15 17.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.282 0.633 . . . . 0.0 111.485 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -96.26 -15.49 21.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 11.1 m -126.95 91.16 47.68 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-N 118.758 0.708 . . . . 0.0 111.023 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.88 -28.78 3.79 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.387 2.058 . . . . 0.0 113.251 175.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 11.4 mmpt? -94.73 -0.5 54.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.1 tp -60.89 104.42 0.36 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.518 0.675 . . . . 0.0 111.395 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -93.42 -49.36 5.96 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.841 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 42.7 tp -131.58 133.41 44.99 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.276 0.63 . . . . 0.0 110.056 -173.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.5 HG12 HD21 ' A' ' 107' ' ' LEU . 38.4 mt -105.12 115.67 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 92.4 m -96.09 113.25 24.84 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.448 0.299 . . . . 0.0 110.336 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 133' ' ' VAL . 84.2 m-85 -90.35 107.74 19.33 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.459 ' ND2' HG22 ' A' ' 18' ' ' ILE . 7.6 p30 -86.12 110.48 19.58 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.58 134.62 7.56 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.496 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HA ' HG11 ' A' ' 133' ' ' VAL . 33.4 ttm180 -72.11 -3.25 22.04 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.231 1.012 . . . . 0.0 113.421 -175.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.54 -29.85 41.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.827 0.451 . . . . 0.0 110.307 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.75 -25.2 60.05 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.373 0.669 . . . . 0.0 109.664 169.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.8 -16.02 58.65 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 114.925 -1.034 . . . . 0.0 115.194 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -56.34 -29.58 61.52 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.522 0.729 . . . . 0.0 111.789 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -116.51 20.29 14.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.815 0.846 . . . . 0.0 111.247 -175.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -62.36 -53.85 54.3 Favored Pre-proline 0 CA--C 1.567 1.622 0 C-N-CA 123.302 0.641 . . . . 0.0 112.23 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.75 -15.49 33.37 Favored 'Trans proline' 0 C--N 1.397 3.11 0 C-N-CA 121.851 1.701 . . . . 0.0 112.727 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.08 -44.87 91.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.534 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 10.0 mt -82.4 -5.38 58.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.244 -172.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -72.43 -22.5 61.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.93 -21.52 67.73 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.628 0.58 . . . . 0.0 113.197 171.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.6 mpt? -86.66 7.62 25.81 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.76 0.824 . . . . 0.0 111.026 175.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.63 20.94 70.25 Favored Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.153 0.406 . . . . 0.0 113.959 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.442 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 35.5 m-85 -110.62 145.51 37.76 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.193 0.597 . . . . 0.0 110.876 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -76.26 143.62 40.83 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.3 p -130.32 151.12 51.18 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.531 0.732 . . . . 0.0 110.131 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.44 121.82 4.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 109.313 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 112' ' ' PHE . 52.2 t -85.84 130.56 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.132 0.492 . . . . 0.0 110.084 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.6 mt -101.09 152.74 37.96 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.961 1.304 . . . . 0.0 108.274 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.14 153.03 78.79 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.434 2.09 . . . . 0.0 112.575 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.0 m -59.52 114.46 2.72 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.411 1.084 . . . . 0.0 110.339 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' A' ' 40' ' ' ASP . 19.4 m -86.34 49.12 1.73 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.556 0.693 . . . . 0.0 111.894 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.2 p -68.96 139.44 55.04 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 154.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.82 57.88 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 123.474 0.484 . . . . 0.0 113.445 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.56 86.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.108 0.563 . . . . 0.0 110.567 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.82 -41.66 67.95 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.108 -174.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -53.93 -34.02 58.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.692 0.62 . . . . 0.0 111.76 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -69.0 -29.83 68.11 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-O 121.603 0.716 . . . . 0.0 110.322 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -98.82 22.49 10.04 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.987 1.315 . . . . 0.0 110.697 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 148' ' ' ARG . 66.6 m -157.32 34.98 0.28 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.096 0.959 . . . . 0.0 109.697 -170.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -66.8 -35.09 79.27 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.799 1.036 . . . . 0.0 113.799 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -94.28 -13.86 26.05 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.586 0.355 . . . . 0.0 110.249 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 145' ' ' SER . 17.9 tpt180 -79.73 -38.7 32.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.302 0.641 . . . . 0.0 109.776 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.478 ' HB2' HD22 ' A' ' 44' ' ' LEU . 12.5 pt-20 -62.68 -18.19 61.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.479 1.112 . . . . 0.0 112.212 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.1 t -58.88 -23.05 60.49 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.42 0.688 . . . . 0.0 111.651 173.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 155' ' ' VAL . 9.4 pt-20 -65.6 -32.14 73.56 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 122.996 0.518 . . . . 0.0 110.654 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -65.62 -43.11 90.57 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.44 -37.72 88.38 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.695 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -77.13 -14.36 59.81 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.072 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 151' ' ' GLU . 48.5 t -87.13 -54.58 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.411 0.685 . . . . 0.0 110.601 175.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.548 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 71.9 m-85 -91.77 2.87 56.21 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -168.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -72.62 -28.18 62.6 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.271 0.487 . . . . 0.0 112.163 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -74.6 -6.87 51.04 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.438 HD11 HD12 ' A' ' 16' ' ' ILE . 95.4 mt -76.08 -22.6 55.41 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.98 0.512 . . . . 0.0 111.603 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -70.58 -15.39 62.76 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.871 0.468 . . . . 0.0 111.129 166.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.247 0.935 0 C-N-CA 125.594 1.558 . . . . 0.0 110.252 175.266 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.765 0.317 . . . . 0.0 110.734 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 80' ' ' SER . 46.1 mm -92.65 126.1 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.702 0.801 . . . . 0.0 109.596 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.589 ' HE2' ' HB3' ' A' ' 81' ' ' ARG . 65.6 mttm -94.81 131.88 40.2 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 169.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -91.61 130.82 37.36 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 120.982 0.42 . . . . 0.0 110.305 171.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.93 158.96 53.62 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 162.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -82.72 143.5 47.03 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 117.779 0.789 . . . . 0.0 110.084 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.57 162.44 1.55 Allowed 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.206 2.604 . . . . 0.0 112.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -66.22 125.74 26.51 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.37 0.605 . . . . 0.0 110.513 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.646 HG11 HD22 ' A' ' 62' ' ' LEU . 21.2 t -91.03 58.24 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 172.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.556 HD11 ' CG1' ' A' ' 104' ' ' VAL . 49.9 tp -110.27 143.94 39.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.982 -162.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -125.89 163.62 22.55 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -65.8 -22.17 66.55 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.194 0.521 . . . . 0.0 110.968 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.617 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 45.1 m-80 -103.43 77.64 1.53 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.5 m -133.53 104.68 6.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.03 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.544 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 84.3 mt-10 -89.72 -30.15 18.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.549 1.14 . . . . 0.0 109.827 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 56.8 mt -126.68 118.18 50.13 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 C-N-CA 123.886 0.874 . . . . 0.0 109.023 174.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -103.72 117.05 33.47 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.465 HG12 ' HB2' ' A' ' 111' ' ' CYS . 44.1 mt -99.54 110.33 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.8 mt -99.79 118.14 35.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.47 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -72.94 -168.59 12.89 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 164.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -103.99 -72.46 0.7 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.3 tp -147.31 124.62 5.79 Favored Pre-proline 0 C--O 1.243 0.763 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 174.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.58 150.31 70.18 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.935 2.423 . . . . 0.0 112.452 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.0 t -68.92 163.41 24.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.981 0.912 . . . . 0.0 110.758 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 m-20 -53.77 -48.28 69.91 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.417 0.687 . . . . 0.0 110.46 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -58.18 -39.91 80.12 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.316 1.01 . . . . 0.0 111.361 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.2 m -67.35 -45.76 75.42 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.14 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.1 mt -71.6 -19.79 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.298 1.039 . . . . 0.0 111.976 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 28.5 mmm180 -70.39 -46.76 63.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -90.76 -6.54 54.24 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.447 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 65.97 22.08 11.29 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.175 1.39 . . . . 0.0 112.762 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -129.32 142.92 50.7 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.768 0.827 . . . . 0.0 109.377 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -60.79 -44.24 97.08 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.027 0.918 . . . . 0.0 108.569 165.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.87 -8.62 5.22 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.389 171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.98 -31.69 58.84 Favored Glycine 0 C--N 1.351 1.397 0 C-N-CA 123.54 0.59 . . . . 0.0 112.979 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -100.79 104.8 33.94 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.66 -10.92 29.77 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.404 2.736 . . . . 0.0 112.719 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.75 -6.84 64.11 Favored Glycine 0 C--N 1.354 1.57 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.06 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -79.7 116.81 20.1 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -83.24 -0.5 49.78 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.504 1.121 . . . . 0.0 110.262 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -42.47 -42.66 3.35 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.454 1.901 . . . . 0.0 112.974 176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -74.36 -21.71 59.55 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.697 -174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.54 -37.12 17.17 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.763 0.825 . . . . 0.0 111.222 174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.41 -52.61 15.2 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.289 0.636 . . . . 0.0 110.79 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.05 -39.11 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.051 0.54 . . . . 0.0 109.557 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.76 99.6 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.911 0.757 . . . . 0.0 113.982 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -69.02 -34.91 76.0 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.336 0.654 . . . . 0.0 110.24 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -71.6 -38.78 70.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.045 0.938 . . . . 0.0 112.81 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.478 HD12 ' ND2' ' A' ' 68' ' ' ASN . 13.8 pt -89.72 -9.98 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 122.952 0.501 . . . . 0.0 111.563 177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.3 29.55 66.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.211 0.32 . . . . 0.0 113.022 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -133.71 112.97 11.83 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -66.27 93.07 0.2 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.283 0.563 . . . . 0.0 110.298 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.17 -39.42 89.75 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.78 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -57.12 -46.5 82.59 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.581 1.152 . . . . 0.0 111.709 -166.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -69.59 -37.47 76.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.392 0.677 . . . . 0.0 112.195 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.13 145.74 49.95 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.497 0.719 . . . . 0.0 112.369 -172.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.18 138.82 55.91 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.29 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.534 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 57.1 t80 -43.94 -46.49 8.19 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.532 1.133 . . . . 0.0 113.529 -171.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.13 -47.99 80.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.712 0.805 . . . . 0.0 111.857 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -63.93 -37.99 89.45 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.251 1.021 . . . . 0.0 110.701 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 58' ' ' TYR . 19.5 ttmm -60.45 -43.15 97.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.093 1.757 . . . . 0.0 110.707 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.646 HD22 HG11 ' A' ' 9' ' ' VAL . 72.7 mt -65.88 -42.53 90.18 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.015 175.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -61.21 -33.38 73.38 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.6 m -64.22 -45.08 89.82 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.225 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.8 mt -57.59 -47.83 81.06 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.476 0.485 . . . . 0.0 110.371 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HE2' HG12 ' A' ' 9' ' ' VAL . 26.3 mmtp -61.95 -37.68 85.62 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.204 0.602 . . . . 0.0 110.417 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -58.21 -40.83 82.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.159 0.983 . . . . 0.0 111.456 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.478 ' ND2' HD12 ' A' ' 49' ' ' ILE . 64.3 m-80 -89.88 3.5 52.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.141 0.576 . . . . 0.0 110.868 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.544 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 1.1 mpp_? 65.68 45.65 2.59 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.218 1.407 . . . . 0.0 111.592 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.8 mt -114.09 131.86 64.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 109.168 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.15 160.33 13.29 Favored Glycine 0 N--CA 1.462 0.411 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 169.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 94.5 mt -124.49 145.34 49.59 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -165.88 -168.9 1.38 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -128.43 170.16 13.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.077 0.551 . . . . 0.0 109.639 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 77.3 t -83.0 -45.0 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -95.77 112.28 24.04 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.179 0.591 . . . . 0.0 109.79 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -67.37 -24.52 65.71 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.777 0.831 . . . . 0.0 110.462 171.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.94 140.64 19.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.96 0.904 . . . . 0.0 109.854 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -150.03 134.14 4.69 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.524 ' HB3' HD13 ' A' ' 2' ' ' ILE . 47.4 p -102.7 111.73 24.18 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.589 ' HB3' ' HE2' ' A' ' 3' ' ' LYS . 43.9 ttm180 -102.29 141.75 34.62 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.472 0.709 . . . . 0.0 110.004 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.42 -161.42 1.33 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.339 1.456 . . . . 0.0 107.316 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.19 69.99 2.43 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 112.049 -0.421 . . . . 0.0 112.049 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.4 m -125.05 115.08 19.95 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.141 0.977 . . . . 0.0 110.609 -174.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.09 145.68 30.97 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 172.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 79.52 -38.62 0.19 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.628 1.571 . . . . 0.0 111.826 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.5 t -86.54 115.74 24.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.05 0.54 . . . . 0.0 109.877 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -84.65 -37.8 20.61 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.8 mt -130.88 103.39 7.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.32 59.01 4.89 Favored Glycine 0 N--CA 1.469 0.837 0 N-CA-C 112.242 -0.343 . . . . 0.0 112.242 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.529 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 12.4 t70 179.05 154.56 0.44 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.126 0.971 . . . . 0.0 110.26 -173.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -125.02 28.91 6.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.816 1.246 . . . . 0.0 112.237 -174.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -78.2 100.01 6.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 118.716 0.689 . . . . 0.0 109.256 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.3 mt -101.86 147.76 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.346 1.059 . . . . 0.0 110.354 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.93 151.17 46.88 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.643 0.777 . . . . 0.0 110.166 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.96 103.66 10.0 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 54.8 m-85 -93.54 1.85 56.6 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.606 0.762 . . . . 0.0 111.032 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 67.3 m -74.76 -9.45 58.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.658 0.383 . . . . 0.0 111.752 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.31 -5.28 70.06 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.739 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.441 HD12 ' SD ' ' A' ' 127' ' ' MET . 17.2 mt -47.38 -58.01 4.64 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 123.898 0.879 . . . . 0.0 113.252 -175.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -63.63 -14.52 52.54 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -164.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.21 -46.88 8.14 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.179 0.992 . . . . 0.0 111.168 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -83.23 -23.41 32.78 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 9.8 m -123.67 90.51 50.53 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 123.08 0.552 . . . . 0.0 110.629 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.06 -34.84 4.65 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.462 2.108 . . . . 0.0 111.695 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.617 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.1 mmpt? -73.41 -17.9 61.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.138 0.975 . . . . 0.0 113.471 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 33.2 tp -62.16 133.32 55.07 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 123.518 0.511 . . . . 0.0 111.445 -170.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -142.64 -28.93 0.58 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.882 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 58.1 tp -134.62 138.87 44.88 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.642 0.777 . . . . 0.0 109.715 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.59 ' HB ' HG22 ' A' ' 131' ' ' THR . 72.2 mt -113.98 143.64 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.469 ' HB3' HD12 ' A' ' 134' ' ' LEU . 72.3 m -126.64 130.31 50.2 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 123.492 0.717 . . . . 0.0 109.521 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.441 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 92.3 m-85 -105.04 130.18 53.3 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.191 0.596 . . . . 0.0 111.09 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.438 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 94.4 m-20 -85.29 88.81 7.53 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.141 0.576 . . . . 0.0 109.943 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 170.82 26.22 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.153 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 65.1 ttt180 -53.48 -63.65 1.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.112 0.965 . . . . 0.0 112.064 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -61.17 -12.41 12.56 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -84.65 -50.04 8.0 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.12 -9.77 72.43 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 114.962 -1.017 . . . . 0.0 115.108 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.1 mt-10 -64.62 -18.46 64.94 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 117.833 0.816 . . . . 0.0 111.762 176.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -108.36 25.15 12.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.199 1.0 . . . . 0.0 110.664 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.5 -52.32 73.7 Favored Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 123.628 0.771 . . . . 0.0 112.738 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.17 -19.19 51.07 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.082 1.855 . . . . 0.0 112.845 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.58 -46.02 87.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.054 0.942 . . . . 0.0 110.34 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.492 ' HB2' HG21 ' A' ' 131' ' ' THR . 18.7 mt -86.65 -9.69 55.46 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.461 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.66 -26.29 64.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.123 0.569 . . . . 0.0 110.782 169.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.37 -10.56 70.32 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.964 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.441 ' SD ' HD12 ' A' ' 100' ' ' LEU . 59.9 mtt -94.99 12.11 29.59 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.983 0.913 . . . . 0.0 110.696 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.79 -4.39 74.82 Favored Glycine 0 C--N 1.357 1.697 0 N-CA-C 114.194 0.438 . . . . 0.0 114.194 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -91.23 144.8 25.23 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.946 0.498 . . . . 0.0 110.921 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -74.32 145.85 43.59 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 165.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.59 HG22 ' HB ' ' A' ' 110' ' ' ILE . 18.6 p -134.98 148.61 50.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.066 0.946 . . . . 0.0 108.901 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -142.0 127.48 18.92 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.092 0.957 . . . . 0.0 108.697 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.74 110.87 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 111' ' ' CYS . 92.9 mt -95.11 154.68 39.53 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.87 154.29 58.47 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.936 1.757 . . . . 0.0 111.586 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.2 t -66.64 113.77 5.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 20.8 t -79.33 36.34 0.3 Allowed 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -167.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -74.67 159.6 31.87 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.286 0.634 . . . . 0.0 110.559 172.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.83 -18.62 47.05 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -168.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.59 -40.96 14.67 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 117.583 0.692 . . . . 0.0 110.737 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -74.14 -23.8 59.32 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.139 0.576 . . . . 0.0 110.923 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.575 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 37.8 ptt180 -66.88 -25.74 66.55 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 120.805 0.336 . . . . 0.0 110.625 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -63.2 -26.22 68.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.234 1.014 . . . . 0.0 110.965 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -99.13 -24.85 14.73 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.54 1.136 . . . . 0.0 109.72 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.632 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 49.5 m -82.97 22.55 0.93 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.809 0.844 . . . . 0.0 112.59 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -75.95 -61.06 2.06 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.56 -30.89 67.49 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 167.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.632 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 48.0 mtp180 -83.71 -11.3 57.36 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.37 0.268 . . . . 0.0 111.288 -177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -51.1 -34.35 30.07 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.059 0.544 . . . . 0.0 111.05 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.3 m -60.25 -39.55 87.13 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.925 0.89 . . . . 0.0 112.466 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -72.31 -36.28 68.85 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -64.59 -47.51 78.37 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 26.7 tt0 -64.12 -37.35 87.14 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.883 -173.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.75 -37.3 62.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.903 0.752 . . . . 0.0 111.276 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.46 HG11 ' SG ' ' A' ' 111' ' ' CYS . 20.9 t -61.88 -39.22 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.701 0.801 . . . . 0.0 111.362 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -106.36 1.21 25.57 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 122.12 -0.362 . . . . 0.0 110.44 -171.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 153' ' ' GLU . 36.5 ttm180 -71.88 -40.11 69.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.486 0.715 . . . . 0.0 110.108 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -76.67 -4.77 44.86 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.73 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.7 -30.19 62.71 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.002 0.521 . . . . 0.0 109.717 172.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -94.92 -55.37 3.12 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.942 -176.107 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.5 mm -69.56 108.47 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -92.06 113.81 26.18 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -87.37 123.08 31.94 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 122.613 0.365 . . . . 0.0 111.126 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.71 166.57 54.85 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.256 168.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -94.18 145.94 30.68 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-O 119.284 -0.389 . . . . 0.0 111.195 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.84 159.68 32.4 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.821 2.347 . . . . 0.0 111.439 173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -67.15 130.08 41.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.262 0.554 . . . . 0.0 111.532 -174.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.597 HG11 HD22 ' A' ' 62' ' ' LEU . 46.5 t -95.7 60.41 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.454 HD11 ' CG1' ' A' ' 104' ' ' VAL . 42.0 tp -106.58 153.95 21.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.066 -1.425 . . . . 0.0 111.339 -161.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.649 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 22.7 t0 -126.07 154.83 42.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.89 1.276 . . . . 0.0 108.056 170.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.07 -11.22 60.59 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.853 0.461 . . . . 0.0 111.667 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.471 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . 23.8 m-80 -108.83 17.92 21.3 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.869 0.467 . . . . 0.0 110.79 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.2 m -72.78 117.73 14.84 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.194 0.598 . . . . 0.0 111.154 -174.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.07 -36.29 17.03 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.073 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.1 mt -126.1 112.1 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.428 HD13 HD13 ' A' ' 10' ' ' LEU . 59.9 tp -103.43 118.61 37.15 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.54 HG12 ' HB2' ' A' ' 111' ' ' CYS . 41.9 mt -104.18 110.17 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.745 0.818 . . . . 0.0 109.178 -173.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 82.8 mt -100.27 124.77 46.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.337 1.055 . . . . 0.0 109.901 -177.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -78.84 -171.86 40.75 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 164.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.4 p -100.39 -68.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.417 HD12 ' HD2' ' A' ' 23' ' ' PRO . 39.0 tp -149.35 116.96 3.73 Favored Pre-proline 0 C--O 1.242 0.705 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 173.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD2' HD12 ' A' ' 22' ' ' LEU . 58.9 Cg_endo -66.48 166.02 23.14 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.004 2.469 . . . . 0.0 113.423 -167.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -65.39 147.2 53.84 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.327 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 1.8 m-20 -57.63 -39.15 76.3 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.137 0.975 . . . . 0.0 111.358 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.81 -28.35 69.8 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 124.142 0.901 . . . . 0.0 110.573 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.533 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 39.2 m -84.73 -38.28 19.87 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.584 0.753 . . . . 0.0 110.401 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.415 HG23 ' NE2' ' A' ' 31' ' ' GLN . 75.2 mt -66.2 -29.19 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.832 0.853 . . . . 0.0 111.158 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.2 mmt180 -54.16 -38.17 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 170.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -94.25 -16.34 23.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.096 0.958 . . . . 0.0 110.514 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' NE2' HG23 ' A' ' 28' ' ' ILE . 20.5 mm-40 56.46 24.96 9.11 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.927 1.291 . . . . 0.0 111.729 -170.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -144.16 151.49 39.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.032 0.933 . . . . 0.0 110.208 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.452 ' HB2' ' HE1' ' A' ' 58' ' ' TYR . 87.8 m-85 -70.41 -0.38 8.16 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.983 1.313 . . . . 0.0 114.52 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.415 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 2.5 p90 -96.94 -12.06 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -60.64 -33.07 80.72 Favored Glycine 0 C--N 1.353 1.521 0 O-C-N 123.845 0.715 . . . . 0.0 113.143 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -103.25 100.01 16.53 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.38 0.672 . . . . 0.0 109.525 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.25 -21.07 23.83 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.189 2.593 . . . . 0.0 111.638 171.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.57 -1.75 66.89 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.435 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -79.38 112.49 16.66 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -87.64 -1.36 57.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.837 0.855 . . . . 0.0 110.806 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.425 ' HE1' HG21 ' A' ' 18' ' ' ILE . 82.3 t80 -39.83 -45.08 1.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.979 1.711 . . . . 0.0 112.602 172.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.472 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 80.3 m95 -70.74 -27.78 64.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.311 -173.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -74.81 -48.4 25.49 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.414 0.286 . . . . 0.0 110.255 173.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.34 -47.07 83.69 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.936 0.773 . . . . 0.0 110.83 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.0 t -70.25 -40.63 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.43 0.692 . . . . 0.0 109.96 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.58 85.42 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 123.922 0.764 . . . . 0.0 113.636 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -73.52 -44.11 58.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.695 0.798 . . . . 0.0 110.146 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -64.35 -38.99 92.99 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.561 -1.2 . . . . 0.0 112.541 -176.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.9 pt -88.29 -15.25 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.34 28.43 63.88 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-N 116.477 -0.329 . . . . 0.0 113.828 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -143.65 96.97 2.99 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.9 105.95 0.52 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.011 0.924 . . . . 0.0 111.971 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.27 -23.31 40.86 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.408 0.683 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.36 -38.27 86.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.461 0.705 . . . . 0.0 111.474 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -94.13 6.13 49.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.542 0.737 . . . . 0.0 111.108 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.5 mtt -95.41 146.01 24.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.124 0.569 . . . . 0.0 110.567 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.9 158.45 35.54 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.071 170.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.578 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 32.8 t80 -47.76 -63.4 1.07 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.851 0.86 . . . . 0.0 113.141 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 29.8 mt-10 -59.89 -32.85 71.12 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.191 0.597 . . . . 0.0 111.095 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -54.98 12.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.925 0.89 . . . . 0.0 111.692 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HE2' ' CD2' ' A' ' 42' ' ' TRP . 8.2 ptmt -59.99 -29.75 68.67 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.473 -176.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.597 HD22 HG11 ' A' ' 9' ' ' VAL . 39.6 mt -64.95 -47.87 76.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.705 0.802 . . . . 0.0 111.476 173.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.9 mmmm -55.57 -38.16 68.99 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.234 0.54 . . . . 0.0 110.358 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.1 m -69.63 -39.53 77.09 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.355 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 62' ' ' LEU . 89.8 mt -57.4 -50.09 74.1 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.926 0.49 . . . . 0.0 110.529 174.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.649 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 1.8 mptm? -60.98 -37.07 81.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.72 0.637 . . . . 0.0 110.833 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -64.36 -42.09 96.39 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.877 0.871 . . . . 0.0 111.154 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.429 ' O ' HD13 ' A' ' 159' ' ' LEU . 59.7 m-80 -88.79 3.32 51.46 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.067 0.547 . . . . 0.0 110.903 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.471 ' HD2' ' HB2' ' A' ' 13' ' ' ASN . 24.3 mmt180 67.05 35.13 4.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.356 1.062 . . . . 0.0 111.394 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -106.22 134.05 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.55 1.14 . . . . 0.0 108.797 174.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.16 151.15 18.01 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 172.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.8 mt -124.38 131.9 53.52 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 117.862 0.831 . . . . 0.0 109.833 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 2.8 t90 -152.74 -175.99 5.54 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -130.93 158.18 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.539 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.3 t -70.85 -44.33 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 173.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -101.79 108.28 19.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.432 0.634 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.547 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.7 ptmt -65.63 -24.71 67.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.528 167.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.94 137.52 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.919 0.888 . . . . 0.0 109.208 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -154.79 150.76 22.39 Favored Glycine 0 C--O 1.212 -1.234 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p -123.61 165.81 16.54 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 118.17 0.985 . . . . 0.0 109.544 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.486 ' HD2' ' HA ' ' A' ' 88' ' ' LYS . 73.9 ttt180 -137.8 123.67 20.07 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.759 0.423 . . . . 0.0 110.297 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' HB3' ' HG3' ' A' ' 85' ' ' GLN . 25.3 tt0 -87.41 163.37 16.79 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.303 1.041 . . . . 0.0 109.034 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.49 -35.56 89.22 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 123.246 0.341 . . . . 0.0 113.779 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.5 m -73.38 -34.13 65.39 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.974 0.51 . . . . 0.0 111.288 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.426 ' HG3' ' HB3' ' A' ' 82' ' ' GLU . 96.5 mt-30 -72.07 130.94 42.12 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.314 0.646 . . . . 0.0 110.535 -175.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' HA ' HH21 ' A' ' 81' ' ' ARG . 6.2 m-20 -87.36 -36.79 17.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.931 0.892 . . . . 0.0 109.994 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 t -69.25 140.01 54.46 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.742 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 34.9 mmtp -62.73 -25.85 68.4 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.056 0.847 . . . . 0.0 110.101 172.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.57 122.43 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.287 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.02 59.99 0.4 Allowed Glycine 0 N--CA 1.461 0.307 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.603 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 23.1 t70 -177.14 158.5 1.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 113.111 -1.544 . . . . 0.0 107.698 -164.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.27 20.71 11.93 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -167.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.547 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.7 tp10 -89.58 98.93 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.5 mt -110.53 150.0 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.867 0.867 . . . . 0.0 109.54 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -71.32 148.53 46.99 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.001 0.92 . . . . 0.0 110.632 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -79.0 96.78 5.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.822 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.539 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 31.6 m-85 -80.23 -8.45 59.46 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.23 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 55.3 m -72.12 -18.85 61.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 122.898 0.479 . . . . 0.0 110.753 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 -5.88 62.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.467 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 21.9 mt -52.57 -51.34 60.24 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.241 174.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -58.94 -26.2 64.19 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.134 0.574 . . . . 0.0 112.268 -171.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.72 -35.9 65.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.5 0.72 . . . . 0.0 111.332 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -106.98 -14.56 14.92 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -172.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 19.2 m -125.29 86.64 56.73 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 119.211 0.914 . . . . 0.0 111.443 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.83 -33.13 4.01 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.714 2.276 . . . . 0.0 112.211 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.39 -7.72 58.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.107 0.563 . . . . 0.0 112.235 -175.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 56.9 tp -58.67 104.12 0.2 Allowed 'General case' 0 C--N 1.355 0.805 0 O-C-N 123.659 0.6 . . . . 0.0 111.282 -176.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.95 -47.2 7.13 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.5 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 49.7 tp -128.45 133.79 48.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.232 0.613 . . . . 0.0 110.967 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mt -108.46 126.39 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.54 ' HB2' HG12 ' A' ' 18' ' ' ILE . 78.9 m -109.46 115.99 30.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.513 0.725 . . . . 0.0 110.327 -177.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.51 122.02 37.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.648 0.779 . . . . 0.0 110.549 -178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.544 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 84.5 m-20 -76.58 89.57 3.31 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 110.283 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.22 172.46 45.93 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.532 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 88.9 mtm180 -55.62 -50.93 68.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.467 1.107 . . . . 0.0 113.127 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 62.9 mmtt -62.32 -17.33 58.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.32 -37.76 13.82 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.65 -9.98 75.32 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 114.904 -1.044 . . . . 0.0 115.23 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 56.3 mt-10 -61.03 -26.07 67.36 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.455 0.645 . . . . 0.0 110.786 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -99.55 10.07 42.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.638 1.175 . . . . 0.0 111.405 -174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 35.9 tt0 -55.11 -54.06 54.57 Favored Pre-proline 0 CA--C 1.56 1.349 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.698 171.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.25 -25.18 36.96 Favored 'Trans proline' 0 C--N 1.397 3.095 0 CA-C-N 121.075 1.42 . . . . 0.0 111.805 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.17 -41.74 98.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.67 0.788 . . . . 0.0 110.385 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.7 mt -96.34 -15.05 22.1 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.819 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -69.54 -32.07 70.65 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.456 0.646 . . . . 0.0 109.59 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.1 -5.0 64.6 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.454 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.5 mtt -93.98 13.03 24.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.693 0.797 . . . . 0.0 111.25 172.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.51 10.62 84.63 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.415 0.526 . . . . 0.0 114.415 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.07 145.75 27.58 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 122.869 0.468 . . . . 0.0 110.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -69.88 135.76 49.91 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.446 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 16.0 p -128.9 139.3 52.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.911 0.884 . . . . 0.0 109.531 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -146.36 131.12 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.1 t -91.15 104.37 15.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 111' ' ' CYS . 54.6 mt -82.29 147.43 56.82 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.399 172.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.662 ' HG3' ' HG3' ' A' ' 148' ' ' ARG . 42.5 Cg_endo -63.6 152.12 81.83 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 122.583 2.189 . . . . 0.0 111.727 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.0 m -60.08 123.24 16.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 32.5 m -86.16 12.4 9.82 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.944 0.498 . . . . 0.0 111.645 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 78.4 p -60.85 149.0 37.44 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.13 0.572 . . . . 0.0 109.528 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.66 -28.72 60.35 Favored Glycine 0 C--N 1.342 0.897 0 O-C-N 123.328 0.393 . . . . 0.0 112.975 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.08 -35.22 79.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.909 0.884 . . . . 0.0 112.195 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -98.74 5.66 47.42 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.538 0.735 . . . . 0.0 111.43 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.5 ttt-85 -73.93 -10.56 59.77 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.3 0.572 . . . . 0.0 110.699 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -52.29 -26.11 11.19 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.042 0.937 . . . . 0.0 112.994 170.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -96.47 2.82 52.87 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.599 0.76 . . . . 0.0 111.949 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.701 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 97.8 p -73.27 15.37 0.24 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -162.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -72.39 -74.21 0.17 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 119.284 0.947 . . . . 0.0 109.39 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -69.88 -25.21 63.59 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.094 0.958 . . . . 0.0 112.002 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.701 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 0.0 OUTLIER -69.42 -49.62 53.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.73 0.812 . . . . 0.0 110.158 -177.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -60.52 -36.53 78.62 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.264 0.626 . . . . 0.0 110.632 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -63.95 -40.78 97.21 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.535 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 6.9 pt-20 -70.06 -28.05 65.13 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.331 0.253 . . . . 0.0 110.715 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -71.63 -35.76 70.53 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.321 0.648 . . . . 0.0 109.745 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -67.1 -37.03 83.21 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.12 -17.62 64.94 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.456 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 151' ' ' GLU . 87.7 t -89.72 -61.94 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.316 0.646 . . . . 0.0 110.798 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.485 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 62.9 m-85 -86.51 2.45 47.91 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -164.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -75.55 -21.24 58.08 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.415 ' HE1' HD11 ' A' ' 16' ' ' ILE . 7.8 p-80 -77.14 -10.86 59.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.775 0.43 . . . . 0.0 111.493 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 68' ' ' ASN . 81.2 mt -69.34 -14.78 63.11 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.639 0.775 . . . . 0.0 112.695 -170.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -75.64 -34.4 60.53 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.989 0.516 . . . . 0.0 111.003 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 124.944 1.298 . . . . 0.0 110.29 -173.235 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.471 HG23 ' HB1' ' A' ' 78' ' ' ALA . 41.0 mm -78.74 128.35 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.12 0.968 . . . . 0.0 112.443 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 78' ' ' ALA . 2.9 mptp? -94.64 111.57 23.33 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 167.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -86.6 143.41 27.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.97 -131.31 0.04 OUTLIER Glycine 0 CA--C 1.532 1.151 0 CA-C-O 121.281 0.379 . . . . 0.0 113.434 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -136.76 145.01 49.19 Favored Pre-proline 0 C--O 1.241 0.64 0 O-C-N 121.964 -0.727 . . . . 0.0 110.234 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.04 135.81 65.15 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.163 1.909 . . . . 0.0 108.956 166.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.51 135.44 57.66 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.655 0.597 . . . . 0.0 110.992 -170.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.647 HG11 HD22 ' A' ' 62' ' ' LEU . 74.9 t -96.32 88.31 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.508 HD11 ' CG1' ' A' ' 104' ' ' VAL . 16.8 tp -140.0 150.41 44.41 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -161.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.701 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 13.6 t70 -127.17 160.17 32.05 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.524 1.13 . . . . 0.0 108.396 171.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -67.28 -16.86 64.52 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.972 0.509 . . . . 0.0 111.88 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -102.37 17.57 23.18 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.986 0.914 . . . . 0.0 110.734 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.417 ' HB ' HG12 ' A' ' 104' ' ' VAL . 85.5 m -79.22 122.84 26.8 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.938 0.495 . . . . 0.0 110.167 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.595 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 30.7 tt0 -97.21 -32.23 12.04 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.546 -172.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.597 HD12 HD11 ' A' ' 159' ' ' LEU . 42.1 mt -130.25 123.91 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.11 121.26 44.85 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.424 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -96.42 113.1 29.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.3 mt -99.91 111.64 23.94 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.587 0.755 . . . . 0.0 109.384 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.4 177.36 21.31 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 167.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.3 t -90.57 -89.96 0.16 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.15 0.975 . . . . 0.0 108.789 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.77 112.31 14.93 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.93 149.11 83.01 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.172 1.915 . . . . 0.0 111.705 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.0 m -69.67 135.78 50.29 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 2.5 p-10 -61.75 -19.6 62.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -171.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -52.66 -36.57 57.12 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.719 1.208 . . . . 0.0 111.921 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 p -90.33 -33.97 15.88 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.294 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 81.7 mt -64.32 -37.66 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.224 1.01 . . . . 0.0 112.923 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 26.5 mmt180 -61.4 -28.59 69.36 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.204 0.526 . . . . 0.0 110.042 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -89.93 -23.28 21.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 111.131 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 57.08 28.02 14.27 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.994 1.317 . . . . 0.0 111.913 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -130.88 137.82 49.53 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.457 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.661 ' HB3' ' HZ2' ' A' ' 42' ' ' TRP . 93.5 m-85 -77.03 -2.96 36.67 Favored 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.699 167.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -97.38 -18.68 18.97 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.424 1.09 . . . . 0.0 110.927 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.85 -108.44 0.03 OUTLIER Glycine 0 C--N 1.344 0.994 0 O-C-N 123.307 0.379 . . . . 0.0 112.331 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.69 93.22 46.55 Favored Pre-proline 0 N--CA 1.484 1.23 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HG2' ' HE1' ' A' ' 42' ' ' TRP . 7.7 Cg_exo -75.02 -52.43 0.11 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.916 2.411 . . . . 0.0 111.494 175.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.23 34.33 5.91 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -131.59 135.61 47.12 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.298 1.039 . . . . 0.0 111.838 -168.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.99 0.28 28.24 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 124.946 1.299 . . . . 0.0 109.998 169.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -39.3 -50.3 2.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 127.254 2.222 . . . . 0.0 113.533 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.661 ' HZ2' ' HB3' ' A' ' 33' ' ' TYR . 72.9 m95 -69.11 -20.87 64.07 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.279 0.631 . . . . 0.0 112.21 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 4.6 mpt_? -86.77 -39.85 15.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.931 0.892 . . . . 0.0 110.339 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.76 -51.8 30.92 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.063 0.545 . . . . 0.0 111.053 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 t -73.16 -35.55 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.059 0.944 . . . . 0.0 109.61 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.74 -38.58 95.79 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.67 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.3 t60 -69.16 -40.6 78.06 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.245 0.618 . . . . 0.0 109.943 173.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -60.77 -42.69 97.96 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.737 0.815 . . . . 0.0 112.925 -175.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 pt -95.15 -10.0 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.211 0.604 . . . . 0.0 112.162 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.55 59.19 Favored Glycine 0 C--N 1.353 1.496 0 O-C-N 123.266 0.354 . . . . 0.0 113.44 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.48 117.64 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.12 1.368 . . . . 0.0 108.389 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -68.47 88.73 0.34 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.597 0.713 . . . . 0.0 111.345 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.58 -34.34 78.02 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.159 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -55.35 -50.94 68.36 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.226 1.01 . . . . 0.0 112.524 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -85.43 -5.78 59.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.713 0.805 . . . . 0.0 111.366 -168.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.5 mtt -80.42 141.32 35.42 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.9 154.42 12.32 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.336 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.64 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 39.8 t80 -39.02 -50.65 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.824 0.85 . . . . 0.0 112.205 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 39.0 mt-10 -54.55 -55.72 26.34 Favored 'General case' 0 CA--C 1.552 1.052 0 O-C-N 124.154 0.909 . . . . 0.0 111.596 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -70.36 -39.49 74.59 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -168.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -61.18 -41.56 97.01 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.018 0.372 . . . . 0.0 110.575 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.647 HD22 HG11 ' A' ' 9' ' ' VAL . 17.0 mt -63.68 -43.94 95.2 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.887 0.742 . . . . 0.0 110.714 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 34.6 mmtp -56.76 -41.51 77.7 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.6 m -68.57 -39.55 80.97 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.042 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 61' ' ' LYS . 91.9 mt -57.35 -50.32 73.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 123.055 0.542 . . . . 0.0 109.942 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.701 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -56.79 -41.57 77.96 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 111.306 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -59.01 -40.45 84.97 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.701 0.8 . . . . 0.0 111.278 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 56.7 m-80 -97.34 17.56 17.14 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.23 0.612 . . . . 0.0 110.784 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.4 OUTLIER 62.72 29.39 16.78 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.452 1.101 . . . . 0.0 111.308 169.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.95 134.87 42.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.327 1.051 . . . . 0.0 108.626 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.46 157.57 15.39 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.17 131.74 53.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.569 0.748 . . . . 0.0 109.459 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -161.8 -168.07 1.85 Allowed 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.65 162.91 33.97 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.687 0.676 . . . . 0.0 111.569 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 68.9 t -88.21 -45.46 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.438 1.095 . . . . 0.0 110.222 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -100.56 109.69 21.8 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.527 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 34.3 ttmt -64.37 -39.96 94.9 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 124.368 1.043 . . . . 0.0 110.294 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 2' ' ' ILE . . . -150.21 133.48 16.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.899 -176.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.72 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -155.15 144.22 10.8 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.8 t -116.0 168.15 10.34 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 117.452 0.626 . . . . 0.0 110.127 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -130.74 140.05 50.3 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -27.47 68.38 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.287 0.635 . . . . 0.0 112.59 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 142.25 4.15 0.97 Allowed Glycine 0 N--CA 1.474 1.218 0 N-CA-C 114.195 0.438 . . . . 0.0 114.195 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 t -83.31 -157.69 0.25 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 117.152 0.476 . . . . 0.0 109.845 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -56.37 150.07 15.54 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.46 0.704 . . . . 0.0 111.458 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.78 60.72 6.07 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.616 0.722 . . . . 0.0 111.731 -167.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 m -142.99 9.89 1.73 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.758 1.223 . . . . 0.0 109.33 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -78.28 124.64 28.32 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 124.088 0.955 . . . . 0.0 109.935 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 46.3 mt -104.72 89.73 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.65 58.6 0.41 Allowed Glycine 0 C--O 1.244 0.737 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.887 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 15.2 t70 -178.78 146.68 0.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 107.964 -174.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -105.18 16.82 25.11 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -167.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 15.4 tp10 -82.47 101.01 10.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.787 0.803 . . . . 0.0 109.785 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 57.9 mt -97.38 145.71 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.575 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -75.8 156.27 34.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 122.867 0.467 . . . . 0.0 110.37 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.91 110.71 13.06 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.898 0.879 . . . . 0.0 110.367 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.7 m-85 -106.05 -9.42 17.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.281 0.632 . . . . 0.0 112.488 -175.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 33.2 p -68.19 -13.49 62.27 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.62 0.368 . . . . 0.0 111.797 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -2.14 56.72 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 118.806 -0.997 . . . . 0.0 113.695 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 39.9 mt -49.76 -37.4 29.59 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.445 0.698 . . . . 0.0 112.572 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.26 -31.5 72.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.52 0.328 . . . . 0.0 111.739 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -81.26 -50.95 8.92 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.033 0.933 . . . . 0.0 111.748 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.418 ' HG3' HG22 ' A' ' 104' ' ' VAL . 21.2 ptm -72.67 -33.54 66.6 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.302 0.641 . . . . 0.0 111.948 -173.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -128.85 87.19 55.4 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.803 0.841 . . . . 0.0 109.64 176.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.09 -28.03 13.28 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.709 2.273 . . . . 0.0 112.501 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 0.24 56.05 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.316 0.646 . . . . 0.0 111.753 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 44.7 tp -57.23 110.18 0.8 Allowed 'General case' 0 C--N 1.354 0.762 0 O-C-N 123.806 0.691 . . . . 0.0 111.222 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.595 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 12.2 ptm180 -101.59 -43.47 5.88 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.67 170.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.468 ' HB3' HG12 ' A' ' 16' ' ' ILE . 59.8 tp -131.05 128.55 40.51 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.786 0.835 . . . . 0.0 110.245 -168.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.74 113.93 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.453 1.101 . . . . 0.0 108.501 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.424 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.3 m -96.48 113.73 25.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.858 0.463 . . . . 0.0 110.405 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.24 109.25 19.78 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.073 0.949 . . . . 0.0 110.088 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.445 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 7.2 t30 -81.85 90.4 6.41 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 117.95 143.25 7.32 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.768 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -54.86 -49.04 72.12 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.314 1.046 . . . . 0.0 112.141 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -49.26 -38.33 26.58 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 124.583 1.153 . . . . 0.0 112.744 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.77 -42.98 66.5 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.663 0.785 . . . . 0.0 110.102 175.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.7 -9.33 69.63 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 114.601 -1.181 . . . . 0.0 114.451 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -62.98 -28.99 70.47 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.138 0.469 . . . . 0.0 110.855 170.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.6 22.86 12.86 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.454 1.102 . . . . 0.0 110.937 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.14 -55.15 46.92 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.427 169.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.79 -19.18 66.61 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 122.014 1.809 . . . . 0.0 111.979 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.5 tp -63.65 -49.04 74.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.384 1.074 . . . . 0.0 109.389 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.3 mt -87.59 -15.97 35.88 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.081 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -66.73 -31.71 72.53 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.24 -12.07 60.11 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.639 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.0 mtt -96.25 16.79 17.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.837 0.855 . . . . 0.0 111.338 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.94 22.51 78.75 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 114.04 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -111.26 138.38 47.79 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.9 0.48 . . . . 0.0 111.225 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -62.85 142.85 58.07 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.7 p -132.46 142.07 49.08 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.988 0.515 . . . . 0.0 110.85 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -130.36 114.19 15.29 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.582 1.153 . . . . 0.0 108.325 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.0 94.44 2.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 173.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.85 140.39 88.9 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.013 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.505 ' HG3' ' HD3' ' A' ' 148' ' ' ARG . 21.2 Cg_endo -57.97 158.08 22.46 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.424 2.083 . . . . 0.0 111.57 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.3 m -56.29 113.58 1.63 Allowed 'General case' 0 C--N 1.345 0.409 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.4 t -80.28 18.41 0.89 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.556 0.343 . . . . 0.0 111.837 -175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.0 m -57.95 149.63 22.51 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.108 0.963 . . . . 0.0 110.603 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.45 -24.35 65.71 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.584 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.07 70.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.384 0.673 . . . . 0.0 111.497 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -87.5 4.85 41.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.648 0.779 . . . . 0.0 111.615 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 145' ' ' SER . 12.7 ttm180 -62.69 -25.5 68.19 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 118.419 0.554 . . . . 0.0 111.984 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -55.53 -23.59 27.39 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.026 0.531 . . . . 0.0 111.811 170.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -108.04 5.94 26.55 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.105 0.962 . . . . 0.0 112.111 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.556 ' HB2' ' HA ' ' A' ' 142' ' ' ARG . 41.0 t -64.23 -35.54 81.17 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -164.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -62.88 -62.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 118.428 0.558 . . . . 0.0 111.733 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.68 -39.91 78.22 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.428 0.691 . . . . 0.0 111.127 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.505 ' HD3' ' HG3' ' A' ' 135' ' ' PRO . 72.0 mtt-85 -74.78 -27.42 60.32 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.579 -175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.38 -35.52 79.41 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.985 0.514 . . . . 0.0 109.997 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.4 t -72.0 -30.08 64.87 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.984 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 4.3 pt-20 -76.66 -34.37 58.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -70.54 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.577 0.751 . . . . 0.0 109.126 173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.421 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 25.0 tt0 -66.52 -37.63 85.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.658 0.783 . . . . 0.0 109.332 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.96 -13.73 62.4 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.825 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.42 HG11 ' SG ' ' A' ' 111' ' ' CYS . 85.7 t -89.48 -52.76 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.523 0.729 . . . . 0.0 110.581 176.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.445 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 51.5 m-85 -96.09 -1.41 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -164.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.421 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 18.7 mtp180 -68.34 -38.85 81.89 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.823 0.738 . . . . 0.0 112.175 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -74.93 -9.9 58.97 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.705 0.402 . . . . 0.0 111.355 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.597 HD11 HD12 ' A' ' 16' ' ' ILE . 88.2 mt -82.51 -35.65 27.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.209 1.004 . . . . 0.0 110.221 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.04 -49.99 11.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.4 t60 . . . . . 0 N--CA 1.489 1.525 0 C-N-CA 125.163 1.385 . . . . 0.0 112.384 170.554 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 80' ' ' SER . 32.8 mm -77.94 122.97 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.735 0.814 . . . . 0.0 108.968 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -95.07 118.47 31.94 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -93.57 142.72 27.03 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 110.552 -176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.446 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -69.97 171.59 41.91 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.419 167.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.79 145.78 31.19 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 122.262 -0.552 . . . . 0.0 110.561 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.45 132.52 49.06 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.312 2.008 . . . . 0.0 109.654 170.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.9 147.72 45.85 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.299 1.0 . . . . 0.0 112.755 -166.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.628 HG11 HD22 ' A' ' 62' ' ' LEU . 26.2 t -92.4 47.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.457 HD11 ' CG1' ' A' ' 104' ' ' VAL . 35.6 tp -89.67 147.6 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.898 -167.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.13 151.86 41.69 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.73 -16.61 64.22 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.832 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.557 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 30.3 m-80 -105.88 21.05 17.93 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.522 0.729 . . . . 0.0 110.162 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.6 m -70.53 109.95 5.13 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.485 0.66 . . . . 0.0 110.238 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -81.04 -38.86 26.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.257 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.428 HD12 HD11 ' A' ' 159' ' ' LEU . 55.2 mt -124.72 120.35 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.691 0.796 . . . . 0.0 108.995 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD13 HD13 ' A' ' 10' ' ' LEU . 59.7 tp -103.41 117.41 34.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 111' ' ' CYS . 50.0 mt -95.99 108.69 21.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 73' ' ' TRP . 88.9 mt -95.52 108.7 20.96 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 109.147 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -67.42 -174.54 7.28 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 167.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 m -87.77 -82.02 0.23 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD12 ' HD2' ' A' ' 23' ' ' PRO . 51.5 tp -148.28 124.64 5.36 Favored Pre-proline 0 C--O 1.24 0.597 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 172.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.4 Cg_exo -43.26 135.35 6.06 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.897 3.065 . . . . 0.0 114.194 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.7 m -72.2 169.58 15.84 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.283 1.033 . . . . 0.0 111.107 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -53.92 -49.18 69.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.747 0.819 . . . . 0.0 111.372 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.19 -31.44 67.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.322 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.7 p -70.71 -38.89 73.69 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.7 mt -68.57 -24.85 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.138 0.975 . . . . 0.0 111.746 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.32 -44.67 87.06 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.017 0.436 . . . . 0.0 109.905 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -95.26 -1.54 51.31 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.019 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 64.04 24.65 13.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.692 1.197 . . . . 0.0 113.123 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.86 144.12 30.03 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.933 0.893 . . . . 0.0 109.574 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -58.27 -47.51 83.39 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.686 0.794 . . . . 0.0 110.334 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.412 ' HE1' HE22 ' A' ' 54' ' ' GLN . 30.3 t80 -60.86 -16.48 41.92 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.625 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.93 -14.17 65.21 Favored Glycine 0 C--N 1.344 0.974 0 C-N-CA 122.694 0.188 . . . . 0.0 113.438 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -98.03 101.5 11.15 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.697 0.799 . . . . 0.0 108.856 169.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.4 148.63 89.87 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.806 2.337 . . . . 0.0 111.42 169.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.18 -21.08 25.17 Favored Glycine 0 N--CA 1.464 0.535 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.48 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -73.15 102.13 3.51 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.845 0.831 . . . . 0.0 109.408 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -79.98 -3.97 50.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.827 1.651 . . . . 0.0 110.133 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -35.21 -53.92 0.62 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.871 2.069 . . . . 0.0 113.628 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -69.73 -28.33 65.72 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.331 0.652 . . . . 0.0 111.766 -172.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -68.21 -43.82 77.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.594 0.757 . . . . 0.0 110.412 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.0 mt -72.31 -52.64 15.29 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.696 1.198 . . . . 0.0 111.225 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.97 -43.28 92.77 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 C-N-CA 124.048 0.939 . . . . 0.0 109.336 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.74 94.56 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.151 0.907 . . . . 0.0 113.469 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -69.41 -39.76 77.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.994 0.518 . . . . 0.0 110.318 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -69.94 -38.24 76.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.89 0.876 . . . . 0.0 112.811 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.05 -11.72 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.072 0.549 . . . . 0.0 110.938 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.94 19.15 79.06 Favored Glycine 0 C--N 1.36 1.909 0 O-C-N 123.807 0.692 . . . . 0.0 113.787 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.68 110.7 11.09 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.409 1.084 . . . . 0.0 108.318 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -69.55 101.22 1.56 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.86 0.838 . . . . 0.0 111.553 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.48 -34.08 47.83 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.025 0.93 . . . . 0.0 111.897 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.412 HE22 ' HE1' ' A' ' 34' ' ' TYR . 60.5 tp60 -62.7 -31.0 71.83 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -168.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -83.15 -5.86 59.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.083 0.553 . . . . 0.0 112.393 -178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.4 mtt -86.42 154.98 20.76 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.213 0.605 . . . . 0.0 109.455 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.5 152.52 45.52 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 165.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.528 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 70.0 t80 -51.08 -42.21 60.44 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.791 0.836 . . . . 0.0 112.003 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.92 -45.07 93.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.946 0.898 . . . . 0.0 111.486 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -67.98 -38.09 82.29 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.637 0.775 . . . . 0.0 110.569 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -53.53 -49.48 67.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.722 0.809 . . . . 0.0 109.902 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD22 HG11 ' A' ' 9' ' ' VAL . 19.2 mt -61.98 -45.41 93.75 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 124.655 1.222 . . . . 0.0 110.986 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -57.12 -40.61 77.45 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.89 0.476 . . . . 0.0 111.421 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.2 m -66.37 -36.82 83.83 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.059 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -66.75 -37.13 84.03 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.13 0.572 . . . . 0.0 111.085 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -57.46 -44.3 84.68 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -65.06 -35.39 80.99 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.413 1.085 . . . . 0.0 111.555 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -85.14 -8.59 58.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.782 0.833 . . . . 0.0 111.018 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 62.87 38.05 11.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.669 1.188 . . . . 0.0 110.462 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.0 mt -105.78 134.17 48.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.78 172.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -115.64 142.24 17.44 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.0 128.8 54.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.448 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.1 t90 -153.26 -169.93 3.46 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.96 176.83 8.33 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.702 0.801 . . . . 0.0 109.187 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.583 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 70.8 t -90.87 -46.76 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.137 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -94.29 118.31 31.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.866 0.467 . . . . 0.0 110.385 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 36.9 ttmt -64.77 -41.91 95.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.322 1.049 . . . . 0.0 110.45 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.86 131.04 12.73 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.348 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.667 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -151.61 138.63 6.64 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.533 ' HB3' HD13 ' A' ' 2' ' ' ILE . 31.2 p -118.31 129.37 55.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.114 0.566 . . . . 0.0 111.063 -171.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -87.13 93.11 9.28 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -80.33 -20.0 45.26 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.223 0.609 . . . . 0.0 110.19 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.5 -152.76 5.84 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.925 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.6 m -132.46 33.67 3.79 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.233 1.013 . . . . 0.0 109.32 177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -109.98 68.1 0.66 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 66.06 7.93 5.09 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 125.003 1.321 . . . . 0.0 113.111 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.5 p -82.9 83.45 7.77 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.047 0.939 . . . . 0.0 109.508 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -91.84 -40.58 11.11 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 43.4 mt -134.92 80.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 171.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.92 71.65 2.16 Favored Glycine 0 C--O 1.242 0.642 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.667 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.7 t70 176.48 158.31 0.29 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.566 1.146 . . . . 0.0 108.61 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.28 23.74 8.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.861 0.864 . . . . 0.0 111.866 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 16.4 tp10 -83.06 102.56 11.88 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 54.9 mt -102.59 155.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.682 1.193 . . . . 0.0 109.728 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -74.26 145.19 44.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.437 1.095 . . . . 0.0 110.168 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.01 101.16 1.34 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.356 0.662 . . . . 0.0 110.377 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.583 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 22.7 m-85 -91.95 -10.27 40.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.065 0.546 . . . . 0.0 112.04 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.6 p -67.67 -21.73 65.33 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.134 0.174 . . . . 0.0 110.622 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.08 -3.7 75.77 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.369 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.8 mt -48.96 -46.23 43.14 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -64.27 -23.78 67.42 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.101 0.41 . . . . 0.0 111.471 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.03 -58.3 3.36 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.922 0.889 . . . . 0.0 111.029 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.4 ptm -71.0 -33.77 70.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.066 0.947 . . . . 0.0 112.508 -168.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.3 m -124.32 84.04 56.54 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.698 0.799 . . . . 0.0 110.229 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.76 -32.38 14.49 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.889 2.393 . . . . 0.0 111.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.557 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.6 mmpt? -87.87 -0.94 57.62 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.884 0.874 . . . . 0.0 112.482 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.58 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.6 tp -59.28 107.97 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -99.27 -41.75 7.32 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.829 0.852 . . . . 0.0 109.79 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.3 tp -136.91 132.82 35.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 110.64 -173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.518 HG12 HD21 ' A' ' 107' ' ' LEU . 15.7 mt -104.61 123.54 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.525 ' HB2' HG12 ' A' ' 18' ' ' ILE . 70.9 m -101.7 114.4 28.42 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.977 0.511 . . . . 0.0 110.508 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HZ ' HD12 ' A' ' 124' ' ' LEU . 95.8 m-85 -93.49 109.45 21.05 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.886 0.875 . . . . 0.0 110.225 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 22.7 t-20 -82.96 94.33 7.72 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.61 149.8 13.05 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.069 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -57.51 -43.17 84.04 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.866 1.267 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -51.41 -44.06 62.14 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.708 0.803 . . . . 0.0 112.73 174.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.69 -42.78 85.91 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.149 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.5 -11.76 60.23 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.259 -177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.74 -27.89 69.51 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.99 0.895 . . . . 0.0 111.908 172.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -108.54 16.12 23.25 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.247 0.619 . . . . 0.0 111.253 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.509 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.8 tm-20 -66.4 -47.36 59.2 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.461 167.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.5 -35.29 75.78 Favored 'Trans proline' 0 C--N 1.403 3.418 0 C-N-CA 122.49 2.127 . . . . 0.0 113.18 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.54 -52.6 64.86 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.352 1.061 . . . . 0.0 112.014 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.459 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 15.9 mt -79.45 -6.12 56.2 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -65.6 -36.18 82.97 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.91 -17.55 71.64 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.214 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 62.8 mtt -86.58 9.35 18.78 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.61 0.764 . . . . 0.0 111.268 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.19 16.03 70.48 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.413 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -99.67 143.18 30.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 120.745 0.307 . . . . 0.0 110.777 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -75.84 133.2 40.67 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 161.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 36.1 p -127.62 141.1 51.72 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.999 0.92 . . . . 0.0 108.619 -175.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -142.77 125.64 16.11 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.62 1.168 . . . . 0.0 108.17 -175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.31 112.82 24.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 155' ' ' VAL . 62.8 mt -89.21 131.69 39.95 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.86 147.02 33.82 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.513 2.809 . . . . 0.0 112.772 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.6 t -54.79 116.95 3.0 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.149 0.905 . . . . 0.0 110.072 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.2 p -72.37 0.15 10.87 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.544 0.738 . . . . 0.0 112.546 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 m -60.43 143.18 53.91 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.969 0.908 . . . . 0.0 110.273 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.52 -26.61 69.84 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.796 0.685 . . . . 0.0 114.368 -172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.54 -42.85 98.38 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.209 0.604 . . . . 0.0 110.436 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -81.56 -32.3 32.25 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.346 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -59.99 -23.66 63.81 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 123.42 0.45 . . . . 0.0 111.262 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -71.26 -48.9 48.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.848 0.859 . . . . 0.0 110.092 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.23 23.73 3.2 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.457 1.103 . . . . 0.0 110.382 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -169.37 70.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -171.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -91.96 -51.48 5.18 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.625 1.17 . . . . 0.0 108.016 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -66.0 -6.34 12.44 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.363 1.065 . . . . 0.0 112.666 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -71.43 -20.06 62.16 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.763 0.825 . . . . 0.0 110.732 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.38 -30.88 67.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.338 0.655 . . . . 0.0 111.118 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.1 t -64.52 -44.29 91.34 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.253 1.021 . . . . 0.0 112.445 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.2 pt-20 -75.26 -30.62 60.52 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.351 0.26 . . . . 0.0 110.485 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.59 -40.58 88.95 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 4.0 tm-20 -67.06 -39.81 86.98 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.702 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.13 64.59 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.412 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 151' ' ' GLU . 73.1 t -84.72 -53.88 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.009 0.523 . . . . 0.0 111.001 177.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.408 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 40.0 m-85 -96.61 2.96 52.77 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -168.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -66.41 -32.28 73.56 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 118.276 0.489 . . . . 0.0 111.137 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 16' ' ' ILE . 15.4 p-80 -73.74 -12.36 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.623 0.369 . . . . 0.0 111.155 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 16' ' ' ILE . 86.7 mt -78.3 -26.06 46.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -82.7 -39.49 21.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.456 0.702 . . . . 0.0 109.121 167.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 19.9 t60 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 125.403 1.481 . . . . 0.0 110.596 -179.262 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 80' ' ' SER . 46.5 mm -67.94 111.37 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.275 0.63 . . . . 0.0 110.696 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -93.22 111.0 22.52 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 173.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -79.33 125.62 29.74 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.486 0.315 . . . . 0.0 110.739 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.23 170.74 51.92 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 124.234 0.959 . . . . 0.0 111.629 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 8.0 m-30 -89.36 141.74 29.2 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.451 -168.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.32 164.23 29.04 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.726 2.284 . . . . 0.0 111.104 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.33 128.93 37.92 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.358 0.663 . . . . 0.0 111.867 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG11 HD22 ' A' ' 62' ' ' LEU . 58.7 t -100.03 72.86 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.572 HD11 ' CG1' ' A' ' 104' ' ' VAL . 60.4 tp -124.86 149.56 47.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.02 -162.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.7 160.6 25.53 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 109.194 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.433 ' HG3' HD22 ' A' ' 13' ' ' ASN . 11.1 pt-20 -61.15 -20.19 62.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.462 1.105 . . . . 0.0 111.882 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.433 HD22 ' HG3' ' A' ' 12' ' ' GLU . 45.5 m-80 -122.53 91.07 3.42 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.496 ' HB ' HG12 ' A' ' 104' ' ' VAL . 99.5 m -131.8 114.28 14.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.925 0.89 . . . . 0.0 108.769 175.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 12.9 tt0 -87.75 -33.84 18.55 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.278 1.031 . . . . 0.0 110.9 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 159' ' ' LEU . 60.4 mt -128.57 125.66 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.079 0.552 . . . . 0.0 109.6 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.01 123.51 49.79 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 mt -100.13 115.63 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' A' ' 73' ' ' TRP . 97.8 mt -103.74 124.42 48.85 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.946 0.898 . . . . 0.0 110.181 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.3 -178.61 39.51 Favored Glycine 0 C--N 1.342 0.884 0 O-C-N 123.3 0.375 . . . . 0.0 112.365 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.62 ' HB2' ' HB2' ' A' ' 116' ' ' LYS . 6.9 p -100.43 -71.43 0.7 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.2 tp -153.9 119.46 2.78 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.35 167.84 8.88 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.689 2.26 . . . . 0.0 112.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 98.6 p -63.69 154.42 33.13 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.801 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 33.7 t70 -57.84 -37.61 74.16 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 123.275 0.359 . . . . 0.0 110.837 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.89 -36.0 64.71 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.187 0.995 . . . . 0.0 111.516 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.603 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 8.7 t -86.9 -39.71 15.53 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.27 -174.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.427 ' HA ' ' HE1' ' A' ' 6' ' ' PHE . 70.8 mt -66.55 -38.53 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.079 0.951 . . . . 0.0 112.0 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 24.9 mmm180 -66.73 -16.59 64.35 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.579 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 93.2 mttt -106.49 -1.5 23.02 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.662 0.785 . . . . 0.0 111.566 175.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 56.16 18.24 3.15 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 125.436 1.494 . . . . 0.0 114.693 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -145.05 161.92 38.25 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.951 0.501 . . . . 0.0 110.98 -171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -76.6 -1.56 28.21 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.894 1.278 . . . . 0.0 112.723 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -90.54 -14.24 32.99 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -52.34 -40.98 54.2 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 124.566 1.166 . . . . 0.0 115.717 -162.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -122.11 98.01 45.05 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.979 0.512 . . . . 0.0 110.309 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.03 2.44 4.24 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.568 2.845 . . . . 0.0 113.352 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.64 -17.73 79.98 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 120.357 -0.135 . . . . 0.0 112.898 170.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.97 127.47 33.58 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.34 0.591 . . . . 0.0 109.983 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 6.9 m-20 -81.01 0.32 36.27 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.61 1.164 . . . . 0.0 112.304 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -38.94 -47.47 1.45 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.819 1.248 . . . . 0.0 112.649 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -74.85 -26.78 59.93 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.918 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -79.31 -28.23 42.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.231 0.612 . . . . 0.0 111.594 175.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 33.4 mt -85.93 -48.54 8.62 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.818 0.447 . . . . 0.0 110.432 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.08 -30.96 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.275 0.63 . . . . 0.0 109.505 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.68 -44.52 70.49 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.573 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -60.72 -37.28 81.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.476 0.71 . . . . 0.0 110.298 174.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.58 -45.96 88.02 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.183 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.47 HD11 HD21 ' A' ' 53' ' ' LEU . 19.9 pt -91.37 -4.79 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.684 -177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.43 36.22 69.18 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 123.546 0.529 . . . . 0.0 112.838 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -149.3 105.91 3.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.675 1.59 . . . . 0.0 107.423 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -68.42 110.84 4.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.779 0.799 . . . . 0.0 109.506 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.47 HD21 HD11 ' A' ' 49' ' ' ILE . 85.1 mt -82.3 -30.72 30.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.042 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -60.32 -38.84 84.99 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.73 3.92 52.97 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.136 0.574 . . . . 0.0 111.337 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.552 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 66.6 mtt -85.25 150.4 24.81 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.39 45.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.751 0.657 . . . . 0.0 109.402 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.482 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 35.0 t80 -43.15 -48.99 6.48 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.362 1.065 . . . . 0.0 113.695 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 45.9 mt-10 -61.31 -49.91 75.12 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 122.577 0.351 . . . . 0.0 111.322 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -60.25 -48.72 80.56 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.69 0.796 . . . . 0.0 112.662 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 7.6 ptmt -62.18 -36.52 82.13 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.489 0.316 . . . . 0.0 111.619 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.535 HD22 HG11 ' A' ' 9' ' ' VAL . 77.5 mt -68.99 -40.34 78.83 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.082 0.553 . . . . 0.0 111.557 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 30.3 mmmt -55.89 -44.72 78.44 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.386 0.674 . . . . 0.0 110.805 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.8 m -64.07 -40.06 95.44 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.285 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.98 -55.11 36.82 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.407 0.683 . . . . 0.0 111.688 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 -22.49 64.27 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.092 0.245 . . . . 0.0 111.449 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -62.87 -33.91 76.28 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.692 0.397 . . . . 0.0 111.757 167.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -88.94 1.94 54.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.232 0.613 . . . . 0.0 110.977 172.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 8.0 mpt_? 64.59 46.51 3.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.683 1.193 . . . . 0.0 110.514 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.08 133.19 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.359 1.063 . . . . 0.0 108.697 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.35 17.86 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 173.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.62 132.15 56.55 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.42 0.688 . . . . 0.0 109.15 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.447 ' HB3' HD23 ' A' ' 19' ' ' LEU . 3.6 t90 -158.13 -170.2 3.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -134.32 162.74 31.34 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 48.4 t -79.09 -51.84 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 42.0 m-85 -82.2 126.66 32.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 0.0 110.58 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.591 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.3 tmtp? -68.01 -32.17 72.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.76 149.67 16.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.039 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.92 135.71 7.86 Favored Glycine 0 C--O 1.221 -0.718 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.479 ' HB2' HD13 ' A' ' 2' ' ' ILE . 27.9 t -119.05 170.38 9.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.575 0.75 . . . . 0.0 109.537 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 87' ' ' SER . 3.6 tpm_? -137.83 111.44 8.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.453 ' HB3' ' NH2' ' A' ' 81' ' ' ARG . 35.7 tt0 -55.85 123.34 13.93 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.872 0.869 . . . . 0.0 111.047 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.91 82.13 0.53 Allowed Glycine 0 C--N 1.345 1.059 0 O-C-N 124.493 1.121 . . . . 0.0 112.073 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.1 t -158.76 -44.61 0.06 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -162.85 150.97 13.94 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 124.538 1.135 . . . . 0.0 108.685 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.92 137.58 49.37 Favored 'General case' 0 C--O 1.242 0.675 0 O-C-N 123.432 0.458 . . . . 0.0 110.224 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.498 ' H ' ' HD3' ' A' ' 81' ' ' ARG . 14.7 t -168.73 -160.22 0.28 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.132 0.973 . . . . 0.0 108.595 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -74.1 -171.07 1.05 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.4 1.08 . . . . 0.0 112.064 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.1 100.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.874 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.79 57.12 5.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.38 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -173.69 154.66 2.52 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.492 1.117 . . . . 0.0 108.759 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -124.25 25.92 7.6 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.212 1.005 . . . . 0.0 111.394 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.591 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.3 tp10 -82.11 114.76 20.86 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.468 0.707 . . . . 0.0 109.26 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 77.2 mt -127.0 140.62 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.418 1.087 . . . . 0.0 109.192 -168.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -62.39 151.54 36.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.792 0.837 . . . . 0.0 110.869 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -78.17 130.65 36.59 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 33.8 m-85 -118.94 -2.23 10.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.058 0.543 . . . . 0.0 111.091 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 86.2 p -63.99 -31.11 72.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.995 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.13 -3.97 90.58 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 118.775 -1.014 . . . . 0.0 113.878 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 mt -49.8 -49.9 46.96 Favored 'General case' 0 C--N 1.369 1.444 0 C-N-CA 123.796 0.838 . . . . 0.0 111.711 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -60.77 -16.0 35.59 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -170.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -102.92 -41.41 6.15 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.306 1.042 . . . . 0.0 112.443 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -83.09 -24.65 32.58 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.572 ' CG1' HD11 ' A' ' 10' ' ' LEU . 9.0 m -127.75 84.88 62.13 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.608 0.763 . . . . 0.0 110.384 175.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 -34.07 22.04 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.628 2.219 . . . . 0.0 111.712 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.28 -12.31 59.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.947 0.899 . . . . 0.0 112.536 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 52.7 tp -62.1 130.52 45.85 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 123.713 0.633 . . . . 0.0 110.545 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -136.68 -34.5 0.75 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.246 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.4 tp -128.48 131.23 48.35 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.618 0.767 . . . . 0.0 109.576 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.552 ' HB ' HG22 ' A' ' 131' ' ' THR . 61.3 mt -115.94 138.01 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.522 1.129 . . . . 0.0 108.422 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.579 ' SG ' HG11 ' A' ' 155' ' ' VAL . 83.8 m -120.57 116.95 26.37 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.861 0.864 . . . . 0.0 109.926 -174.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.486 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 95.7 m-85 -93.91 114.74 27.03 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -98.03 76.69 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.493 1.139 . . . . 0.0 108.851 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.19 135.61 2.71 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.265 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -52.1 -52.73 49.53 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.083 0.953 . . . . 0.0 112.382 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 28.8 mmmt -48.81 -37.44 19.29 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.039 0.936 . . . . 0.0 113.054 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.61 -34.46 77.04 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.283 0.633 . . . . 0.0 110.839 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.3 -16.89 73.73 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 114.778 -1.101 . . . . 0.0 115.004 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.63 -27.96 69.29 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -103.87 14.89 29.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.498 1.119 . . . . 0.0 111.097 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.405 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.7 tt0 -58.74 -49.27 94.33 Favored Pre-proline 0 CA--C 1.565 1.535 0 CA-C-O 118.049 -0.977 . . . . 0.0 112.244 168.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -57.84 -23.29 58.17 Favored 'Trans proline' 0 C--N 1.409 3.742 0 C-N-CA 122.579 2.186 . . . . 0.0 113.32 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.27 -40.02 95.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.73 0.812 . . . . 0.0 110.26 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.3 mt -95.22 -19.43 20.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.365 0.666 . . . . 0.0 111.248 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -63.05 -40.16 96.87 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.052 0.541 . . . . 0.0 109.911 169.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.28 -19.6 66.5 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.39 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.3 mtt -89.8 11.75 19.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.52 27.15 73.97 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 114.486 0.554 . . . . 0.0 114.486 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -106.8 137.82 44.13 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 117.371 0.585 . . . . 0.0 110.248 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.77 134.72 53.73 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 167.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.552 HG22 ' HB ' ' A' ' 110' ' ' ILE . 14.7 p -137.6 152.03 48.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 123.707 0.803 . . . . 0.0 108.968 -174.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -154.04 131.73 11.48 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.131 0.572 . . . . 0.0 109.8 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 17.2 t -90.31 93.85 4.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.52 149.53 95.55 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.203 170.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -65.11 152.66 81.54 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 121.619 1.546 . . . . 0.0 110.908 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.3 p -59.19 119.23 6.97 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.2 p -76.97 33.75 0.15 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.969 1.308 . . . . 0.0 113.994 -167.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.9 m -85.0 151.56 24.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.014 0.925 . . . . 0.0 109.204 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -20.34 58.76 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 123.792 0.682 . . . . 0.0 114.349 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.77 91.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.641 0.776 . . . . 0.0 111.103 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.27 -25.26 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.569 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -74.27 -25.58 59.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 123.753 0.658 . . . . 0.0 110.539 -176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -66.46 -27.38 67.76 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.173 0.511 . . . . 0.0 111.383 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -96.26 -42.41 8.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.666 0.786 . . . . 0.0 109.559 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.6 m -103.73 45.59 0.95 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.233 1.413 . . . . 0.0 110.25 -171.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -73.5 -27.47 61.4 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.333 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -86.57 -6.15 58.95 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.574 0.75 . . . . 0.0 111.804 174.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -86.14 -26.82 24.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.521 0.728 . . . . 0.0 110.399 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.79 -14.56 61.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.491 0.716 . . . . 0.0 112.171 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.1 t -62.82 -34.63 77.7 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.39 0.676 . . . . 0.0 110.67 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.519 ' O ' HG23 ' A' ' 155' ' ' VAL . 4.1 pt-20 -72.16 -31.11 65.65 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 119.195 -0.431 . . . . 0.0 110.072 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 32.9 m95 -65.47 -38.01 88.51 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -63.58 -42.81 98.26 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.522 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.32 -9.67 58.83 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.77 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.579 HG11 ' SG ' ' A' ' 111' ' ' CYS . 75.7 t -83.87 -50.99 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 110.243 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.548 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 47.5 m-85 -103.2 0.82 32.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -77.36 -26.83 52.31 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 119.156 0.889 . . . . 0.0 112.298 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.422 ' HE1' HD11 ' A' ' 16' ' ' ILE . 15.9 p-80 -74.95 -10.85 59.87 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.444 0.698 . . . . 0.0 111.326 -176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.512 HD11 HD12 ' A' ' 16' ' ' ILE . 95.0 mt -73.38 -10.99 60.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.7 0.8 . . . . 0.0 111.001 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -45.96 -39.51 9.02 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.824 1.249 . . . . 0.0 111.359 164.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--O 1.252 1.2 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.689 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.986 0.422 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 80' ' ' SER . 22.7 mm -77.02 125.26 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.369 0.668 . . . . 0.0 109.477 175.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -84.59 119.6 25.39 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 169.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -84.56 132.11 34.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.671 0.389 . . . . 0.0 111.013 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.98 -179.92 26.24 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.207 0.317 . . . . 0.0 112.585 167.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -108.87 135.0 20.16 Favored Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 122.355 -0.497 . . . . 0.0 109.726 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 157.72 33.12 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.531 2.154 . . . . 0.0 110.941 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.81 127.02 29.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.314 0.645 . . . . 0.0 112.071 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 62' ' ' LEU . 21.6 t -91.76 88.32 2.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.534 HD21 HG13 ' A' ' 104' ' ' VAL . 34.5 tp -140.14 155.73 46.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.393 -158.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -123.51 159.99 27.93 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -67.86 -14.5 63.01 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.107 0.479 . . . . 0.0 110.945 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -111.75 84.69 2.0 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.537 ' HB ' HG12 ' A' ' 104' ' ' VAL . 98.7 m -138.92 121.43 16.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.349 0.66 . . . . 0.0 110.003 176.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 3.4 tp10 -85.02 -41.45 15.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.551 1.54 . . . . 0.0 109.69 -173.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.447 HG12 ' HB3' ' A' ' 109' ' ' LEU . 34.2 mt -129.52 128.9 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.258 1.023 . . . . 0.0 108.638 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD13 HD13 ' A' ' 10' ' ' LEU . 56.8 tp -109.89 124.91 52.19 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -95.67 118.26 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD23 ' HB3' ' A' ' 73' ' ' TRP . 75.0 mt -102.43 118.96 38.0 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.581 0.752 . . . . 0.0 109.557 174.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -75.66 -166.09 19.2 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 165.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -108.78 -73.57 0.68 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.2 tp -147.68 119.98 4.65 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.66 161.03 46.97 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.444 2.096 . . . . 0.0 111.933 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.5 t -85.7 158.22 20.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.199 0.599 . . . . 0.0 110.399 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 5.1 p-10 -57.67 -29.97 65.07 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.363 0.665 . . . . 0.0 112.638 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -55.14 -38.17 67.88 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.381 0.673 . . . . 0.0 111.59 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.705 ' HB3' HD22 ' A' ' 36' ' ' ASN . 32.4 p -86.63 -38.01 17.5 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.042 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.2 mt -64.91 -38.76 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.921 0.889 . . . . 0.0 113.282 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 30.2 mmm180 -61.41 -30.78 70.77 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.025 0.441 . . . . 0.0 110.375 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -97.29 -6.03 35.34 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.322 1.049 . . . . 0.0 112.082 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 62.1 22.39 13.08 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.813 1.245 . . . . 0.0 113.571 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -140.76 144.01 35.24 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.939 0.496 . . . . 0.0 110.453 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -55.3 -46.91 76.24 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.326 1.05 . . . . 0.0 110.107 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -58.29 -13.11 4.47 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 114.003 -1.453 . . . . 0.0 113.582 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.72 -19.91 73.65 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 114.346 0.498 . . . . 0.0 114.346 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.705 HD22 ' HB3' ' A' ' 27' ' ' SER . 4.5 p30 -110.77 135.16 20.78 Favored Pre-proline 0 N--CA 1.48 1.056 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.27 -10.85 30.07 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.053 2.502 . . . . 0.0 113.018 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.14 -8.81 65.93 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.478 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.436 ' ND2' HD21 ' A' ' 36' ' ' ASN . 0.9 OUTLIER -94.29 82.02 4.06 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.685 0.755 . . . . 0.0 109.434 173.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -99.62 4.76 45.87 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.349 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -42.46 -30.06 0.32 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 125.094 1.357 . . . . 0.0 112.44 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.447 ' CE3' ' HD3' ' A' ' 61' ' ' LYS . 63.7 m95 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.713 1.205 . . . . 0.0 113.103 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -77.89 -32.54 51.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.818 0.447 . . . . 0.0 111.1 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' A' ' 149' ' ' GLU . 43.3 mt -86.87 -47.78 8.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.798 0.839 . . . . 0.0 110.354 -170.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 -35.29 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.839 0.856 . . . . 0.0 109.035 172.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.34 -39.35 95.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.515 -0.766 . . . . 0.0 113.042 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -65.59 -36.32 83.4 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.947 0.899 . . . . 0.0 110.033 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.99 -53.64 46.86 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.728 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.458 HD12 HD22 ' A' ' 68' ' ' ASN . 15.4 pt -84.45 -7.34 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.032 0.533 . . . . 0.0 111.809 -175.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.48 73.24 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.574 0.546 . . . . 0.0 112.713 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -133.57 106.66 7.54 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -63.31 97.11 0.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.407 0.683 . . . . 0.0 110.667 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.2 mt -75.6 -19.45 59.24 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -70.03 -27.56 64.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.804 0.842 . . . . 0.0 112.369 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -95.62 -3.15 46.8 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.73 -0.606 . . . . 0.0 110.832 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtt -88.66 159.18 17.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.005 0.522 . . . . 0.0 111.207 -175.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.46 151.22 47.13 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.524 0.73 . . . . 0.0 109.344 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.568 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 30.3 t80 -51.91 -49.78 62.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 47.1 mt-10 -63.6 -37.04 85.8 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 118.025 0.375 . . . . 0.0 111.08 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.81 -53.32 33.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HD3' ' CE3' ' A' ' 42' ' ' TRP . 17.3 ptpt -58.44 -32.13 68.41 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.307 0.643 . . . . 0.0 111.648 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 94.0 mt -66.83 -43.04 84.8 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 123.196 0.598 . . . . 0.0 111.318 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 33.8 mmtp -64.55 -31.61 72.9 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.005 0.431 . . . . 0.0 110.615 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.5 m -67.16 -39.41 86.49 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.145 173.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.97 -49.96 70.48 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.609 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 62' ' ' LEU . 29.7 mmtp -57.28 -40.93 78.77 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 123.299 0.64 . . . . 0.0 110.546 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -60.82 -42.83 98.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.304 1.041 . . . . 0.0 111.11 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.458 HD22 HD12 ' A' ' 49' ' ' ILE . 90.8 m-20 -87.52 5.46 39.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.773 0.829 . . . . 0.0 110.634 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 25.8 mmt180 64.93 39.74 5.69 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 125.232 1.413 . . . . 0.0 110.92 171.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 57.2 mt -111.03 135.96 48.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 C-N-CA 124.917 1.287 . . . . 0.0 108.793 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -120.39 162.19 14.42 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 173.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.7 mt -122.68 142.36 50.76 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.404 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.5 t90 -162.98 -170.74 2.43 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 174.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -131.53 166.38 21.51 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 0.0 109.379 172.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.496 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 54.2 t -78.1 -38.88 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.97 123.97 48.15 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.044 0.538 . . . . 0.0 110.543 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -71.61 -24.0 61.81 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.768 170.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.83 140.43 14.68 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.474 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -152.16 155.7 26.28 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB3' HD13 ' A' ' 2' ' ' ILE . 40.7 p -134.88 168.38 19.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.587 0.693 . . . . 0.0 109.998 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 ppt_? -139.79 145.87 38.74 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -160.31 -65.56 0.07 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.212 0.46 . . . . 0.0 112.175 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.59 -113.44 0.3 Allowed Glycine 0 CA--C 1.531 1.076 0 O-C-N 123.24 0.337 . . . . 0.0 113.383 -173.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -71.06 -21.53 62.23 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.99 0.916 . . . . 0.0 110.618 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.497 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 11.3 mm100 -84.55 101.64 12.25 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.232 1.013 . . . . 0.0 108.356 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.19 -41.93 4.77 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.161 0.505 . . . . 0.0 110.157 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.4 m -111.79 -5.91 14.36 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.807 0.843 . . . . 0.0 110.002 174.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -102.4 154.78 18.75 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.444 1.098 . . . . 0.0 108.921 -174.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mp -83.15 96.4 3.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 C-N-CA 123.466 0.706 . . . . 0.0 109.311 -172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.26 65.23 3.88 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.673 169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.474 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 8.2 t70 -169.86 160.29 8.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.972 0.509 . . . . 0.0 110.005 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -121.04 7.19 10.31 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.648 0.779 . . . . 0.0 112.591 -168.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.56 99.79 12.58 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 119.119 0.872 . . . . 0.0 109.467 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.36 152.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 109.617 -171.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -72.65 149.02 44.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.514 0.726 . . . . 0.0 110.042 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.51 114.6 16.51 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.496 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 29.0 m-85 -100.37 -5.44 27.26 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.592 0.757 . . . . 0.0 111.869 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.3 p -75.92 -10.92 59.82 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.71 0.29 . . . . 0.0 110.299 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.8 -5.44 62.84 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.803 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' SD ' ' A' ' 103' ' ' MET . 40.3 mt -50.42 -33.42 20.75 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.191 0.596 . . . . 0.0 112.371 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -62.58 -33.49 75.07 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.061 0.544 . . . . 0.0 112.298 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -87.25 -47.71 8.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.807 0.843 . . . . 0.0 112.266 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.525 ' HG3' HG22 ' A' ' 104' ' ' VAL . 22.9 ptm -71.64 -32.34 67.83 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.546 0.739 . . . . 0.0 112.461 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.537 HG12 ' HB ' ' A' ' 14' ' ' THR . 0.7 OUTLIER -134.39 95.0 16.73 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.49 0.716 . . . . 0.0 110.438 177.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.8 -30.24 14.53 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.623 2.216 . . . . 0.0 111.778 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -87.3 -2.31 58.53 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.745 0.818 . . . . 0.0 111.758 -173.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 41.5 tp -56.09 104.34 0.13 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.798 0.839 . . . . 0.0 111.541 -175.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 18.7 ptp180 -101.87 -41.98 6.3 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.396 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.447 ' HB3' HG12 ' A' ' 16' ' ' ILE . 29.9 tp -130.73 139.57 50.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.675 0.39 . . . . 0.0 110.349 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.438 HG12 HD11 ' A' ' 107' ' ' LEU . 24.2 mt -112.75 115.99 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.486 ' SG ' HG11 ' A' ' 155' ' ' VAL . 83.6 m -98.71 118.74 36.12 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.456 0.703 . . . . 0.0 110.871 -177.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -95.75 120.72 36.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.655 0.782 . . . . 0.0 110.227 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 95.2 m-20 -75.24 80.74 2.35 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.655 0.782 . . . . 0.0 109.815 177.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.93 162.94 21.23 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 115.495 -0.775 . . . . 0.0 113.474 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.5 ttp85 -64.31 -23.61 67.36 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.18 1.392 . . . . 0.0 113.056 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -74.37 -42.4 59.4 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.964 0.506 . . . . 0.0 110.057 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.26 75.89 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.696 171.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.08 -10.66 62.39 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.818 -1.083 . . . . 0.0 114.933 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -69.36 -20.08 63.84 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 117.402 0.601 . . . . 0.0 110.859 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -108.0 10.17 28.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.386 1.074 . . . . 0.0 111.086 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.2 tm-20 -67.58 -49.31 41.15 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 123.979 0.912 . . . . 0.0 111.666 174.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -61.08 -24.6 79.72 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.028 1.818 . . . . 0.0 112.685 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.92 -50.39 73.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.078 0.951 . . . . 0.0 111.287 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.5 mt -80.31 -5.23 55.97 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -66.54 -31.93 72.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.038 0.535 . . . . 0.0 110.57 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.1 -17.59 70.07 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.69 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 63.7 mtt -88.07 2.17 52.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.847 0.859 . . . . 0.0 111.216 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.45 23.16 63.32 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.56 -0.291 . . . . 0.0 113.333 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -107.4 137.26 45.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.97 0.508 . . . . 0.0 110.668 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 19.6 mm-40 -70.0 136.37 50.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 170.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.54 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 33.5 p -132.5 140.5 48.37 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.773 0.829 . . . . 0.0 109.504 -173.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 109' ' ' LEU . 53.7 tptt -143.02 132.04 22.99 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.389 1.076 . . . . 0.0 109.302 -173.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.7 t -97.99 122.73 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 155' ' ' VAL . 96.3 mt -102.34 144.61 28.95 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 171.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.8 150.7 75.82 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.042 2.495 . . . . 0.0 112.078 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.5 t -62.14 94.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.856 0 O-C-N 123.824 0.703 . . . . 0.0 109.728 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 70.5 m -87.97 21.17 2.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.5 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 14.1 t -66.08 156.02 35.1 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.293 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 142' ' ' ARG . . . -62.75 -22.17 63.89 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 123.18 0.419 . . . . 0.0 113.787 -176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.36 -28.91 70.02 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.105 0.962 . . . . 0.0 111.708 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -126.37 19.12 7.52 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.686 0.795 . . . . 0.0 111.134 -175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 139' ' ' GLY . 8.9 ptm85 -66.98 -27.63 67.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.011 0.525 . . . . 0.0 111.364 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -55.01 -31.07 60.75 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.464 1.106 . . . . 0.0 111.384 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -107.86 -18.26 13.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.001 0.92 . . . . 0.0 110.184 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.2 m -97.73 8.31 44.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.617 0.767 . . . . 0.0 112.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -63.23 -64.0 1.03 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.512 0.725 . . . . 0.0 109.356 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.07 -7.47 23.15 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.16 0.984 . . . . 0.0 112.845 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -82.08 -12.84 58.01 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.393 0.677 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.49 ' HB3' HD22 ' A' ' 44' ' ' LEU . 11.1 pt-20 -54.87 -25.41 28.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.523 0.729 . . . . 0.0 112.316 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.3 t -73.74 -41.17 62.87 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.061 0.944 . . . . 0.0 112.209 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -72.92 -34.02 66.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -66.57 -33.4 75.58 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.987 0.915 . . . . 0.0 109.437 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -61.8 -42.19 98.69 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.482 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.93 87.48 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.897 -171.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.486 HG11 ' SG ' ' A' ' 111' ' ' CYS . 74.3 t -68.15 -30.83 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.929 -173.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.532 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 30.9 m-85 -118.15 -10.47 10.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.379 -0.825 . . . . 0.0 113.166 -173.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.0 -29.69 65.73 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.115 0.416 . . . . 0.0 111.107 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -81.05 -13.58 58.66 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.949 0.5 . . . . 0.0 111.2 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.42 HD11 HD12 ' A' ' 16' ' ' ILE . 62.7 mt -72.1 -41.06 67.71 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 122.829 0.452 . . . . 0.0 111.077 -176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -87.79 -53.73 4.61 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 CA--C 1.554 1.1 0 C-N-CA 125.313 1.445 . . . . 0.0 110.944 -179.396 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.6 mmm . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 mm -71.05 108.92 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HB3' HD13 ' A' ' 28' ' ' ILE . 50.4 mtmt -93.4 117.98 30.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.301 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -80.38 126.8 31.64 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 123.743 0.652 . . . . 0.0 110.868 -176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.77 156.22 53.41 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.409 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 7.3 m-85 -80.62 134.93 53.39 Favored Pre-proline 0 N--CA 1.473 0.68 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.581 -165.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -52.2 141.59 48.46 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.887 2.391 . . . . 0.0 111.265 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.12 128.61 37.26 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.571 0.748 . . . . 0.0 111.275 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 62' ' ' LEU . 24.1 t -95.65 79.77 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 174.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.484 HD11 ' CG1' ' A' ' 104' ' ' VAL . 38.5 tp -117.18 149.86 39.69 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.517 -163.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.413 ' HB2' ' HG2' ' A' ' 66' ' ' LYS . 37.9 t70 -128.02 164.21 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.803 0.841 . . . . 0.0 109.46 169.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.2 -26.66 67.88 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.348 1.059 . . . . 0.0 112.462 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.504 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 61.7 m-80 -95.32 16.17 17.46 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.262 0.625 . . . . 0.0 111.689 -173.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.468 ' HB ' HG12 ' A' ' 104' ' ' VAL . 78.1 m -72.05 104.76 3.67 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.637 0.732 . . . . 0.0 110.544 -175.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 108' ' ' ARG . 30.1 tt0 -88.32 -30.21 19.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.286 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 159' ' ' LEU . 39.4 mt -127.66 120.35 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.148 0.979 . . . . 0.0 108.624 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.3 tp -106.97 116.97 32.85 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 111' ' ' CYS . 55.1 mt -91.7 108.27 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 94.9 mt -99.67 108.17 20.46 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.954 0.902 . . . . 0.0 109.071 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.05 177.34 8.66 Favored Glycine 0 N--CA 1.47 0.932 0 O-C-N 123.002 0.189 . . . . 0.0 113.053 175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 89' ' ' ILE . 10.7 p -90.79 -72.42 0.58 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.476 HD22 ' HA3' ' A' ' 79' ' ' GLY . 19.0 tp -151.14 124.68 4.3 Favored Pre-proline 0 C--O 1.246 0.894 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 159.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.5 157.6 30.92 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 122.118 1.879 . . . . 0.0 111.67 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 m -62.95 150.29 42.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.605 0.762 . . . . 0.0 110.459 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.421 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 6.6 p-10 -58.88 -34.07 71.22 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.573 0.225 . . . . 0.0 110.452 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.1 -37.96 78.42 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.363 1.065 . . . . 0.0 111.947 175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.6 p -81.23 -30.74 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 3' ' ' LYS . 73.1 mt -74.66 -16.0 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 110.882 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 79.1 mtt180 -64.38 -38.3 90.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.569 0.347 . . . . 0.0 110.569 170.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -86.87 -16.22 36.7 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.624 0.77 . . . . 0.0 109.899 177.31 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.443 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER 53.9 23.83 4.16 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.075 1.35 . . . . 0.0 113.206 -172.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -126.09 160.2 30.78 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.386 0.674 . . . . 0.0 109.561 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -72.43 -2.5 19.72 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.607 0.763 . . . . 0.0 110.746 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -70.13 -45.36 67.0 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.448 1.099 . . . . 0.0 108.294 174.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 31.76 -112.66 0.06 OUTLIER Glycine 0 C--N 1.374 2.678 0 O-C-N 125.086 1.491 . . . . 0.0 114.546 -172.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -107.65 129.59 23.99 Favored Pre-proline 0 C--O 1.246 0.886 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.06 9.3 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.968 2.446 . . . . 0.0 113.953 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.85 0.28 78.55 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 122.906 0.289 . . . . 0.0 112.566 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -84.08 130.15 34.87 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.88 3.4 29.93 Favored 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 123.852 0.861 . . . . 0.0 111.189 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -42.94 -56.42 3.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.683 0.793 . . . . 0.0 112.126 172.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 75.8 m95 -66.58 -23.68 66.23 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.856 0.862 . . . . 0.0 111.897 -177.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -80.99 -42.07 21.74 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.442 1.097 . . . . 0.0 111.415 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.27 -47.54 34.35 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.113 0.965 . . . . 0.0 109.2 -175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.91 -37.68 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.264 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -38.8 96.1 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.67 0.606 . . . . 0.0 113.184 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.19 -41.36 85.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.438 0.695 . . . . 0.0 109.961 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -66.92 -40.61 87.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.358 1.063 . . . . 0.0 112.769 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.6 pt -89.44 -6.57 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.112 0.565 . . . . 0.0 111.645 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.86 22.99 78.61 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 116.527 -0.306 . . . . 0.0 113.178 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -139.87 96.47 3.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -59.99 109.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.881 0.872 . . . . 0.0 111.083 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.4 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 53.6 mt -75.21 -19.93 59.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.837 -174.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -53.42 -54.53 35.52 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.724 0.809 . . . . 0.0 112.806 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -83.57 6.25 21.26 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.051 0.54 . . . . 0.0 112.427 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.573 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.1 mtt -88.81 139.6 30.29 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.64 154.64 40.04 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 169.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.499 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 36.9 t80 -48.37 -50.67 29.78 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -172.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 41.7 mt-10 -60.37 -38.85 85.18 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.609 0.364 . . . . 0.0 111.155 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -68.26 -53.46 24.39 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.94 0.896 . . . . 0.0 112.29 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 5.5 ptmt -59.89 -29.98 68.71 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 9' ' ' VAL . 86.4 mt -65.1 -42.56 93.91 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.252 0.621 . . . . 0.0 111.231 171.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 43.7 mmtm -59.49 -39.71 84.64 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 122.673 0.389 . . . . 0.0 110.192 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.3 m -66.96 -38.23 85.72 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.536 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 61' ' ' LYS . 79.1 mt -58.22 -59.25 5.61 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.936 0.494 . . . . 0.0 111.231 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.413 ' HG2' ' HB2' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -71.61 -22.2 61.74 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 123.224 0.328 . . . . 0.0 111.842 -174.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -58.87 -43.68 90.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.64 0.776 . . . . 0.0 110.374 164.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -89.74 19.82 4.47 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.729 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.486 ' HB2' HD22 ' A' ' 159' ' ' LEU . 15.1 mmt180 70.28 27.15 4.16 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.289 1.036 . . . . 0.0 111.58 169.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 55.7 mt -109.63 123.79 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.055 0.942 . . . . 0.0 109.883 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.17 158.45 14.3 Favored Glycine 0 N--CA 1.464 0.527 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 171.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.45 140.93 49.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.435 0.694 . . . . 0.0 109.252 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.475 ' HB3' HD23 ' A' ' 19' ' ' LEU . 8.8 t90 -165.03 -177.27 4.55 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -131.5 161.93 31.42 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 53.3 t -75.73 -48.34 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -94.72 128.78 41.65 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.258 0.551 . . . . 0.0 110.626 175.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.682 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 10.2 ptmm? -84.19 -17.56 39.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.733 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.68 134.88 11.26 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.055 0.455 . . . . 0.0 110.463 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -147.78 147.66 18.53 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 177.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.8 p -142.21 179.49 6.88 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 117.912 0.856 . . . . 0.0 111.774 -173.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -130.01 107.34 9.27 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 166.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -87.94 -173.2 4.17 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.26 53.77 3.51 Favored Glycine 0 N--CA 1.474 1.2 0 CA-C-N 117.956 0.344 . . . . 0.0 112.555 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -168.39 83.4 0.17 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 74.58 152.87 0.14 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 126.294 1.837 . . . . 0.0 112.273 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -96.48 61.39 1.96 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.11 0.964 . . . . 0.0 108.648 168.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.7 p -77.47 138.29 39.15 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.824 177.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -50.32 -57.92 6.81 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.178 0.991 . . . . 0.0 109.494 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 21' ' ' SER . 7.8 mt -111.09 88.12 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.483 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.92 60.47 0.63 Allowed Glycine 0 N--CA 1.465 0.58 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 174.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.568 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 6.2 t70 -174.72 160.05 2.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.161 0.984 . . . . 0.0 108.908 -172.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.37 18.15 13.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.933 0.893 . . . . 0.0 111.302 -173.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.682 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 11.8 tp10 -85.06 97.46 9.86 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 30.4 mt -106.26 150.7 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.653 1.181 . . . . 0.0 109.54 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -75.1 153.39 38.34 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.45 0.7 . . . . 0.0 109.847 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.42 135.55 35.65 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.445 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 45.7 m-85 -121.55 3.43 10.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.204 0.601 . . . . 0.0 111.435 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.2 p -67.77 -18.16 64.78 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.05 0.386 . . . . 0.0 111.674 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.65 -2.73 64.98 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 118.828 -0.985 . . . . 0.0 113.582 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 103' ' ' MET . 40.0 mt -52.0 -36.15 48.96 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 117.898 0.849 . . . . 0.0 112.958 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.477 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 43.7 mtpt -67.7 -17.55 64.61 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -98.46 -50.57 4.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.062 0.945 . . . . 0.0 111.772 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 100' ' ' LEU . 25.5 ptm -71.32 -35.14 71.12 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.218 0.607 . . . . 0.0 111.271 -173.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 3.1 m -126.01 84.61 60.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.708 0.803 . . . . 0.0 109.922 175.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.39 -29.04 5.11 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.857 2.371 . . . . 0.0 111.82 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 11.2 mmpt? -74.55 -12.69 60.53 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.241 0.616 . . . . 0.0 111.564 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -56.54 126.65 27.51 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.1 0.875 . . . . 0.0 111.179 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.556 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -134.98 -18.01 1.84 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.808 174.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.556 ' HB2' HH11 ' A' ' 108' ' ' ARG . 59.1 tp -143.66 131.92 21.99 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.192 0.597 . . . . 0.0 110.367 177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 131' ' ' THR . 49.4 mt -107.37 143.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.205 1.002 . . . . 0.0 108.496 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.534 ' SG ' HG11 ' A' ' 155' ' ' VAL . 74.9 m -125.54 116.23 21.44 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.182 0.593 . . . . 0.0 110.13 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 96.7 m-85 -93.0 111.54 23.2 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 123.268 0.627 . . . . 0.0 110.394 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -84.53 93.24 8.3 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.15 127.37 3.18 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -50.53 -45.06 56.55 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.382 1.473 . . . . 0.0 113.417 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -58.13 -24.0 57.15 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 112' ' ' PHE . . . -73.16 -18.33 61.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.068 0.461 . . . . 0.0 111.075 173.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.43 -16.9 67.95 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.28 -0.873 . . . . 0.0 114.573 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.63 -26.68 67.93 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.919 0.488 . . . . 0.0 110.018 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -109.78 8.26 24.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.28 1.032 . . . . 0.0 111.334 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 38.7 tt0 -60.79 -51.08 82.1 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.669 -0.682 . . . . 0.0 112.169 169.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 125' ' ' ARG . 16.2 Cg_exo -65.43 -17.42 57.6 Favored 'Trans proline' 0 C--N 1.401 3.321 0 C-N-CA 121.83 1.686 . . . . 0.0 113.252 -175.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.09 -41.63 99.44 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.558 1.143 . . . . 0.0 110.755 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 22.2 mt -91.0 -4.98 55.99 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.171 -171.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.424 ' HG3' ' HA ' ' A' ' 122' ' ' PRO . 66.6 mtm180 -66.0 -31.29 72.11 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.036 0.534 . . . . 0.0 110.226 172.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.21 -1.46 69.41 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.358 -0.837 . . . . 0.0 113.084 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 56.6 mtt -103.87 11.92 35.03 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.459 1.104 . . . . 0.0 110.451 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.33 78.15 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.934 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.477 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 29.8 m-85 -110.72 141.16 44.38 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.263 0.625 . . . . 0.0 111.501 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 108' ' ' ARG . 13.4 mm-40 -68.43 133.68 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.422 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 41.5 p -126.3 136.91 53.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 109.172 -176.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -141.62 130.97 23.63 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.146 0.978 . . . . 0.0 109.358 -176.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 61.0 t -101.81 130.4 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.406 0.682 . . . . 0.0 109.643 176.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.9 mt -115.89 154.59 48.27 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.324 1.45 . . . . 0.0 108.202 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -67.5 170.1 14.36 Favored 'Trans proline' 0 C--N 1.367 1.539 0 C-N-CA 122.613 2.209 . . . . 0.0 112.187 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.3 m -60.86 127.44 31.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.9 m -77.63 27.68 0.17 Allowed 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.3 m -87.71 159.61 18.43 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.827 0.851 . . . . 0.0 110.369 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 142' ' ' ARG . . . -64.5 -20.78 66.1 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.411 0.925 . . . . 0.0 115.411 -170.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.48 -43.17 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.02 0.528 . . . . 0.0 110.833 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -69.89 -39.81 76.03 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.516 0.326 . . . . 0.0 110.407 171.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.454 ' HB3' ' HA2' ' A' ' 139' ' ' GLY . 7.3 tmm_? -60.01 -34.11 72.9 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.218 1.007 . . . . 0.0 111.561 -177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -56.21 -23.69 37.2 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.386 1.074 . . . . 0.0 112.047 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -117.76 -23.13 7.69 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.026 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 53.4 m -84.41 39.69 0.74 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.758 1.223 . . . . 0.0 113.012 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 146' ' ' LYS . 71.6 mmtt -76.54 -53.89 7.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.582 0.353 . . . . 0.0 110.599 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -64.16 -23.14 67.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.386 0.274 . . . . 0.0 111.141 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 55.7 ttm-85 -84.5 -18.83 34.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.0 0.92 . . . . 0.0 110.475 -176.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.03 -27.53 63.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.568 171.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.0 t -60.36 -43.98 96.01 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.885 0.874 . . . . 0.0 111.585 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.3 pt-20 -75.9 -27.85 57.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -63.32 -44.89 93.66 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.73 -35.93 77.77 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.777 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.52 -31.28 72.4 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.866 0.466 . . . . 0.0 110.369 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.534 HG11 ' SG ' ' A' ' 111' ' ' CYS . 53.1 t -68.12 -55.49 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.036 0.934 . . . . 0.0 111.083 175.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.402 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 56.0 m-85 -94.39 -5.73 45.77 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -71.91 -38.45 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 118.255 0.48 . . . . 0.0 110.917 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.46 ' HE1' HD11 ' A' ' 16' ' ' ILE . 7.5 p-80 -76.85 -7.14 54.94 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.148 0.579 . . . . 0.0 110.751 -174.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 16' ' ' ILE . 81.7 mt -74.17 -20.91 60.05 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.554 0.742 . . . . 0.0 111.967 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -74.78 -29.07 60.99 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 169.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 CA--C 1.561 1.366 0 C-N-CA 124.896 1.279 . . . . 0.0 111.753 171.05 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' SD ' ' NZ ' ' A' ' 3' ' ' LYS . 51.2 ttm . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.7 mm -76.0 124.1 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' NZ ' ' SD ' ' A' ' 1' ' ' MET . 65.7 mttm -107.53 133.72 51.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.258 1.023 . . . . 0.0 109.858 -174.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -101.5 135.92 42.2 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.541 0.736 . . . . 0.0 110.848 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.57 174.73 47.68 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.412 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.84 148.77 69.4 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 117.098 0.449 . . . . 0.0 111.228 -176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.88 163.6 9.16 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.584 2.189 . . . . 0.0 110.741 159.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.75 113.5 3.43 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.175 0.512 . . . . 0.0 110.585 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.515 HG11 HD22 ' A' ' 62' ' ' LEU . 13.8 t -87.08 74.71 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD21 HG13 ' A' ' 104' ' ' VAL . 28.0 tp -129.38 154.38 46.97 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -154.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -127.43 162.12 27.09 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.596 1.158 . . . . 0.0 110.073 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -66.29 -24.49 66.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.054 0.942 . . . . 0.0 112.243 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.452 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 48.7 m-80 -96.27 14.28 24.72 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.04 0.536 . . . . 0.0 111.056 -175.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -70.16 111.09 5.55 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.419 0.628 . . . . 0.0 110.834 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 24.8 tt0 -89.88 -35.66 15.5 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.038 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 63.1 mt -121.45 114.0 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.555 0.742 . . . . 0.0 109.205 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.453 HD13 HD13 ' A' ' 10' ' ' LEU . 61.1 tp -103.47 111.9 24.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.438 HG12 ' HB2' ' A' ' 111' ' ' CYS . 51.9 mt -92.62 116.43 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.1 mt -102.99 125.78 49.89 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.55 0.74 . . . . 0.0 109.82 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.17 -161.52 24.22 Favored Glycine 0 C--N 1.337 0.637 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 163.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 p -106.45 -64.3 1.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 171.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.2 tp -150.67 133.47 8.46 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.1 154.81 71.62 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.524 2.149 . . . . 0.0 110.663 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 27' ' ' SER . 24.7 t -60.77 150.58 32.1 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.907 0.483 . . . . 0.0 109.733 177.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 7.7 p-10 -59.06 -37.31 76.74 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -69.61 -30.36 68.08 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.357 0.663 . . . . 0.0 110.493 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 24' ' ' SER . 31.4 t -67.07 -45.93 75.84 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.846 0.858 . . . . 0.0 109.693 174.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.82 -39.34 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.582 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 29' ' ' ARG . 2.8 mmp_? -61.91 -37.85 86.19 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.914 0.486 . . . . 0.0 112.163 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.32 -7.86 24.03 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.023 0.529 . . . . 0.0 111.836 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 67.63 18.47 9.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.442 1.097 . . . . 0.0 113.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -113.67 127.47 56.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.772 0.829 . . . . 0.0 109.056 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.504 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 84.4 m-85 -59.77 -59.77 4.91 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 168.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -55.47 -27.13 46.4 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.619 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.36 -21.13 66.17 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 123.065 0.228 . . . . 0.0 112.863 -175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 4.3 t30 -86.92 108.33 18.07 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 124.474 1.11 . . . . 0.0 108.406 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.33 142.37 78.94 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.463 2.776 . . . . 0.0 112.412 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.23 -19.3 40.48 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.376 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 36' ' ' ASN . 95.4 m-20 -68.87 98.98 0.99 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.515 0.674 . . . . 0.0 109.572 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -86.39 -6.89 58.82 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 126.538 1.935 . . . . 0.0 110.952 -170.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.457 ' HE1' ' HB3' ' A' ' 113' ' ' ASN . 65.1 m-85 -41.63 -43.83 2.9 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 125.221 1.408 . . . . 0.0 112.681 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.504 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 74.6 m95 -71.5 -24.13 61.92 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.186 0.994 . . . . 0.0 112.065 -173.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -81.48 -36.36 29.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.873 0.869 . . . . 0.0 110.902 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.09 -45.63 17.91 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.865 0.466 . . . . 0.0 111.385 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 49' ' ' ILE . 59.2 t -69.03 -36.65 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.49 -32.67 75.48 Favored Glycine 0 C--N 1.353 1.489 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.889 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.15 -42.91 79.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.452 0.701 . . . . 0.0 110.053 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -67.75 -38.02 82.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.298 -174.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 45' ' ' VAL . 23.7 pt -96.68 -11.73 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 122.841 0.456 . . . . 0.0 111.137 178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.66 32.42 61.64 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.438 0.461 . . . . 0.0 113.579 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -133.35 111.92 11.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -66.99 89.68 0.17 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.939 0.876 . . . . 0.0 111.579 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.37 -30.98 69.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.09 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -73.41 -10.69 60.0 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.924 -173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -98.93 -9.17 24.48 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.947 -0.471 . . . . 0.0 111.68 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.479 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 60.0 mtt -87.44 159.28 18.74 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.228 0.611 . . . . 0.0 110.76 -172.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 159.4 31.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.535 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 17.0 t80 -52.12 -54.48 29.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.43 -36.7 83.2 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 122.644 0.378 . . . . 0.0 111.214 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -67.91 -51.77 44.0 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.852 0.861 . . . . 0.0 111.654 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 8.9 ptpp? -61.32 -34.43 75.23 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.184 0.303 . . . . 0.0 111.096 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 78.0 mt -65.18 -44.18 89.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 122.657 0.383 . . . . 0.0 111.039 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -55.79 -43.15 76.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 122.988 0.515 . . . . 0.0 110.624 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.6 m -68.4 -41.8 79.94 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.817 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 62' ' ' LEU . 78.5 mt -56.13 -62.33 1.78 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.719 0.808 . . . . 0.0 110.591 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -23.55 64.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.772 0.67 . . . . 0.0 111.752 -173.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -63.53 -39.14 93.64 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.987 0.515 . . . . 0.0 111.024 167.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.455 ' O ' HD13 ' A' ' 159' ' ' LEU . 60.7 m-80 -85.61 14.92 5.06 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.042 0.537 . . . . 0.0 110.111 173.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 14.4 mmt-85 69.37 25.17 5.59 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.298 1.439 . . . . 0.0 111.032 173.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.19 118.77 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 123.652 0.781 . . . . 0.0 109.352 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.52 161.28 15.33 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.35 145.89 48.38 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.9 -170.29 1.72 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -130.65 163.44 27.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.583 0.753 . . . . 0.0 110.117 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 58.4 t -79.43 -54.49 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 0.0 109.89 172.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -89.12 128.62 35.78 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -78.31 -35.81 47.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.337 0.655 . . . . 0.0 110.209 178.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -144.01 140.82 29.79 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 110.88 178.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.35 160.41 33.43 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.592 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.484 ' O ' ' HA3' ' A' ' 90' ' ' GLY . 58.8 p -133.79 124.4 26.51 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.922 0.489 . . . . 0.0 109.83 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -74.43 97.65 3.12 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -102.69 144.51 30.97 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.485 1.114 . . . . 0.0 108.71 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.92 69.58 2.88 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.9 t -156.16 167.9 28.99 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.929 1.292 . . . . 0.0 108.301 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.33 80.14 3.83 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -113.84 116.81 29.92 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.801 0.84 . . . . 0.0 109.078 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -111.45 23.33 14.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.889 0.875 . . . . 0.0 110.134 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -105.78 -64.81 1.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.619 0.768 . . . . 0.0 109.39 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.9 tp 169.68 -23.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 126.115 1.766 . . . . 0.0 109.609 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 80' ' ' SER . . . 117.53 9.43 10.24 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.232 -175.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -171.74 177.17 3.44 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.829 1.251 . . . . 0.0 108.185 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -120.6 12.4 11.48 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.163 0.585 . . . . 0.0 111.864 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 9.1 tp10 -86.73 119.13 26.64 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.8 mt -124.77 138.97 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.759 1.223 . . . . 0.0 108.731 -173.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -60.76 137.38 58.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.371 0.668 . . . . 0.0 109.677 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -86.07 127.31 34.65 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.929 0.492 . . . . 0.0 109.759 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.416 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 67.0 m-85 -112.82 7.77 18.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.452 0.701 . . . . 0.0 111.35 -176.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.3 m -63.52 -26.5 68.74 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.838 0.455 . . . . 0.0 111.648 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -3.04 89.36 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.706 -1.052 . . . . 0.0 115.044 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.476 HD23 ' SD ' ' A' ' 103' ' ' MET . 29.5 mt -49.02 -38.57 23.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 101' ' ' LYS . 10.0 mmpt? -55.78 -39.38 71.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.429 0.558 . . . . 0.0 111.197 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -85.06 -50.52 7.37 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.236 1.015 . . . . 0.0 112.267 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.549 ' HG3' HG22 ' A' ' 104' ' ' VAL . 24.1 ptm -68.58 -35.26 77.12 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.494 0.718 . . . . 0.0 111.874 -175.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.561 HG13 HD21 ' A' ' 10' ' ' LEU . 1.1 m -132.74 94.55 21.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.104 0.562 . . . . 0.0 110.871 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.48 -30.99 4.7 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.55 2.167 . . . . 0.0 111.742 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.4 mmmm -88.3 -7.35 56.88 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.167 -174.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 53.3 tp -58.53 107.72 0.54 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.48 0.657 . . . . 0.0 111.497 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -96.52 -51.43 4.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.335 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.6 tp -126.13 132.53 51.84 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.324 0.65 . . . . 0.0 110.775 -171.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.9 mt -102.95 144.26 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 134' ' ' LEU . 80.1 m -124.9 113.31 17.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.807 0.443 . . . . 0.0 110.701 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -92.61 111.12 22.6 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.687 0.795 . . . . 0.0 109.349 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.457 ' HB3' ' HE1' ' A' ' 41' ' ' PHE . 86.7 m-20 -91.39 79.49 5.59 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 144.4 153.39 5.86 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.343 176.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -62.58 -45.27 93.67 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.17 0.588 . . . . 0.0 110.148 170.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -31.13 69.4 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.809 0.843 . . . . 0.0 112.988 172.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.53 -39.57 62.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.116 0.484 . . . . 0.0 110.016 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.68 -11.14 68.56 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.392 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.31 -38.4 65.91 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.908 0.883 . . . . 0.0 112.351 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -107.92 25.3 11.73 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.543 0.737 . . . . 0.0 111.177 -175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 125' ' ' ARG . 70.6 tt0 -55.78 -53.09 66.67 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-O 118.238 -0.886 . . . . 0.0 111.564 165.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.44 -22.22 73.77 Favored 'Trans proline' 0 C--N 1.403 3.426 0 C-N-CA 122.313 2.009 . . . . 0.0 112.906 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.79 -47.63 82.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.213 0.605 . . . . 0.0 109.661 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.97 -20.02 29.53 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.363 -174.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 34.1 mtp85 -66.65 -42.2 87.03 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 169.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.45 -21.07 68.36 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.091 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 63.9 mtt -79.04 -19.35 51.66 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.787 0.435 . . . . 0.0 111.441 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.51 30.59 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.523 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -87.37 142.94 27.5 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 117.215 0.507 . . . . 0.0 110.824 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -65.72 135.13 54.54 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 170.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 54.6 p -123.57 139.51 53.93 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.257 0.623 . . . . 0.0 110.161 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HB2' HD11 ' A' ' 109' ' ' LEU . 53.1 tptt -134.12 116.75 15.79 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.342 1.457 . . . . 0.0 107.89 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.2 t -92.6 110.63 23.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 111' ' ' CYS . 93.6 mt -95.71 150.92 38.06 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.226 1.411 . . . . 0.0 109.124 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.463 ' HB2' HD21 ' A' ' 141' ' ' ASN . 94.1 Cg_endo -74.45 130.74 14.19 Favored 'Trans proline' 0 CA--C 1.554 1.479 0 C-N-CA 121.787 1.658 . . . . 0.0 111.557 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.0 p -54.46 107.91 0.33 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.728 0.811 . . . . 0.0 110.974 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.5 m -79.59 50.28 1.12 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.214 1.006 . . . . 0.0 112.05 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.8 m -73.29 160.45 31.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 109.804 163.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.98 -32.74 59.73 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 114.758 0.663 . . . . 0.0 114.758 -176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.0 -37.83 78.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.795 0.438 . . . . 0.0 111.405 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.463 HD21 ' HB2' ' A' ' 135' ' ' PRO . 49.2 t30 -70.65 -20.06 62.75 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.481 0.712 . . . . 0.0 111.646 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 142' ' ' ARG . 12.5 tpp180 -57.22 -29.04 63.42 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.082 0.553 . . . . 0.0 110.34 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -53.27 -36.53 61.24 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.41 1.084 . . . . 0.0 111.084 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -107.33 -22.88 12.42 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.674 1.189 . . . . 0.0 111.697 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' A' ' 148' ' ' ARG . 8.2 t -87.47 13.29 10.34 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -165.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -72.79 -61.12 1.92 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.415 0.286 . . . . 0.0 110.478 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -59.89 -24.24 64.13 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.123 0.569 . . . . 0.0 112.052 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 145' ' ' SER . 0.7 OUTLIER -74.99 -22.24 58.66 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.713 0.805 . . . . 0.0 111.225 -174.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.61 -23.19 49.64 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.1 t -63.84 -41.32 97.84 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.798 0.839 . . . . 0.0 111.166 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 8.4 pt-20 -70.78 -35.64 72.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -65.76 -41.85 91.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.099 0.559 . . . . 0.0 109.995 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -66.86 -34.55 78.04 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.985 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.05 -9.73 59.27 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.982 0.913 . . . . 0.0 111.887 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 151' ' ' GLU . 37.9 t -90.29 -43.3 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.801 0.84 . . . . 0.0 111.171 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.561 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 80.0 m-85 -102.81 4.83 38.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -168.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -86.62 -14.4 42.84 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.198 0.908 . . . . 0.0 112.384 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -84.29 -4.9 59.15 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 118.205 0.457 . . . . 0.0 111.669 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 68' ' ' ASN . 71.5 mt -61.27 -10.01 6.15 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.98 0.912 . . . . 0.0 113.113 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -51.36 -41.21 60.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.865 0.866 . . . . 0.0 111.538 164.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 C--O 1.255 1.378 0 C-N-CA 123.991 0.917 . . . . 0.0 109.015 173.622 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.477 0.909 0 CA-C-O 120.846 0.355 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 78' ' ' ALA . 47.3 mm -82.34 123.39 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 123.773 0.829 . . . . 0.0 110.387 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.7 125.8 45.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.324 1.05 . . . . 0.0 108.255 171.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -97.14 141.27 30.48 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.039 0.447 . . . . 0.0 111.835 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.4 171.14 51.77 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.977 163.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -107.95 125.48 31.99 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 118.514 1.157 . . . . 0.0 110.211 -172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -45.48 155.16 0.47 Allowed 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 124.178 3.252 . . . . 0.0 113.881 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.46 122.46 14.66 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.876 0.87 . . . . 0.0 113.042 -167.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.595 HG11 HD22 ' A' ' 62' ' ' LEU . 25.3 t -94.34 81.84 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.528 HD11 ' CG1' ' A' ' 104' ' ' VAL . 28.7 tp -123.35 153.35 40.42 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -159.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.564 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 9.8 t70 -124.88 157.46 35.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.411 170.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.66 -18.62 65.01 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.097 0.559 . . . . 0.0 112.125 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 52.0 m-80 -97.04 13.64 28.35 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.914 0.886 . . . . 0.0 111.628 -176.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.428 ' HB ' HG12 ' A' ' 104' ' ' VAL . 83.0 m -77.39 116.22 17.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.922 0.489 . . . . 0.0 111.432 -171.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -99.4 -26.2 14.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.459 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.479 HD12 HD21 ' A' ' 159' ' ' LEU . 42.8 mt -121.45 113.52 39.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.9 tp -104.16 111.09 23.55 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 111' ' ' CYS . 47.3 mt -93.62 113.23 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 50.8 mt -103.72 110.99 23.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.885 0.874 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.36 175.44 25.26 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.018 -0.433 . . . . 0.0 112.018 169.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -87.14 -77.57 0.33 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -140.99 123.35 9.52 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -55.14 156.74 15.47 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.745 2.297 . . . . 0.0 112.445 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 28' ' ' ILE . 42.2 t -60.38 145.26 48.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.102 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.46 -39.85 70.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.239 0.616 . . . . 0.0 110.782 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.83 -23.71 62.4 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.355 1.062 . . . . 0.0 111.437 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.9 m -77.68 -37.4 49.81 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 24' ' ' SER . 43.6 mt -74.31 -19.25 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.599 0.76 . . . . 0.0 110.992 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.72 -33.26 75.54 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 120.953 0.406 . . . . 0.0 110.357 172.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.88 -8.43 30.88 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.203 1.001 . . . . 0.0 111.183 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 60.14 30.28 19.75 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.292 1.037 . . . . 0.0 111.366 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -146.51 132.91 19.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.925 0.89 . . . . 0.0 110.148 -168.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -64.4 -44.96 89.64 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.384 0.612 . . . . 0.0 109.753 173.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -66.01 -4.42 7.13 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.227 172.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -52.96 -37.2 53.08 Favored Glycine 0 C--N 1.361 1.958 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -103.23 102.09 26.43 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.0 0.92 . . . . 0.0 108.873 165.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.17 -10.44 28.93 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.969 2.446 . . . . 0.0 112.61 171.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.58 -9.66 86.08 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -71.51 117.89 13.64 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 5.2 m-20 -75.27 -4.17 37.51 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.647 0.779 . . . . 0.0 112.139 -167.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -43.94 -44.84 7.38 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.104 1.762 . . . . 0.0 112.847 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.44 ' HZ3' HD11 ' A' ' 65' ' ' LEU . 54.4 m95 -72.25 -22.35 61.24 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.443 -175.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -86.91 -32.81 19.98 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 124.169 0.988 . . . . 0.0 111.697 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 96.9 mt -75.9 -53.95 7.63 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.391 0.676 . . . . 0.0 110.016 -174.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.38 -36.05 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.402 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.1 -36.98 91.3 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.024 0.828 . . . . 0.0 112.678 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -67.68 -41.88 83.0 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.596 0.759 . . . . 0.0 109.93 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.01 -37.19 86.19 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.652 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 pt -96.52 -11.72 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.097 0.559 . . . . 0.0 111.687 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.97 -59.26 2.8 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -50.24 111.58 0.55 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.367 1.067 . . . . 0.0 112.966 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -70.64 116.87 11.46 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.7 mt -76.53 -30.75 57.26 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.428 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -60.24 -52.38 65.55 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -164.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.89 -22.17 63.25 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.361 0.413 . . . . 0.0 111.708 -170.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 57.1 mtt -60.25 152.02 25.9 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.313 0.645 . . . . 0.0 110.823 174.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.38 152.77 44.38 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 52.4 t80 -46.22 -52.27 12.75 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.843 0.857 . . . . 0.0 112.589 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.88 -34.81 78.17 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.92 0.488 . . . . 0.0 111.704 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -73.38 -47.33 42.98 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.842 0.457 . . . . 0.0 112.051 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -32.27 72.9 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 119.451 -0.309 . . . . 0.0 110.853 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.595 HD22 HG11 ' A' ' 9' ' ' VAL . 42.1 mt -63.24 -49.07 75.61 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 123.437 0.461 . . . . 0.0 110.377 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -55.54 -38.89 69.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 123.803 0.689 . . . . 0.0 111.313 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -63.78 -46.34 85.66 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.862 0.726 . . . . 0.0 109.625 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD11 ' HZ3' ' A' ' 42' ' ' TRP . 95.4 mt -59.79 -43.28 94.51 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.738 0.815 . . . . 0.0 110.889 178.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.564 ' HD2' ' HB2' ' A' ' 11' ' ' ASP . 28.6 mmtp -61.32 -38.09 85.63 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.865 0.466 . . . . 0.0 110.358 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -74.86 -23.11 58.37 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.228 1.011 . . . . 0.0 110.966 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.427 ' O ' HD13 ' A' ' 159' ' ' LEU . 18.5 m120 -88.74 0.04 56.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.612 0.765 . . . . 0.0 110.256 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 65.34 32.92 9.43 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.777 1.231 . . . . 0.0 110.67 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.76 136.64 46.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 125.111 1.364 . . . . 0.0 109.405 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.72 154.32 16.68 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 72.3 mt -120.13 129.26 54.07 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.483 0.642 . . . . 0.0 109.81 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -155.97 -168.88 2.9 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -133.25 170.38 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.206 1.003 . . . . 0.0 109.306 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.54 -61.2 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 166.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.401 ' CD1' HG21 ' A' ' 89' ' ' ILE . 70.9 m-85 -74.18 102.07 4.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.453 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -65.08 -28.89 69.77 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.663 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.61 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -149.15 141.79 24.46 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.957 172.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.585 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -142.44 134.39 6.05 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.328 174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB2' HD13 ' A' ' 2' ' ' ILE . 39.8 t -112.62 169.91 8.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.756 0.822 . . . . 0.0 109.275 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -134.39 119.68 18.9 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.55 -27.72 25.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.393 0.677 . . . . 0.0 111.929 -172.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.78 -161.48 11.12 Favored Glycine 0 C--N 1.342 0.861 0 O-C-N 123.27 0.356 . . . . 0.0 112.697 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.4 m -80.98 -34.62 32.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.558 0.743 . . . . 0.0 110.48 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -42.74 35.74 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -85.14 71.5 10.88 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.349 0.66 . . . . 0.0 109.387 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 71.4 m -111.63 6.13 19.76 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.67 0.788 . . . . 0.0 111.509 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -86.89 -159.21 0.48 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.935 0.894 . . . . 0.0 108.76 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' A' ' 76' ' ' PHE . 3.4 mp -82.05 83.24 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 171.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.15 61.68 4.11 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.116 172.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.585 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 11.8 t70 -176.04 153.44 1.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.445 1.098 . . . . 0.0 108.218 -172.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -125.27 26.37 6.9 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 8.3 tp10 -80.3 102.82 9.76 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.5 149.9 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.047 0.939 . . . . 0.0 108.699 -173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.453 ' OD1' ' HD2' ' A' ' 77' ' ' LYS . 88.8 m-20 -66.7 141.03 57.91 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.794 0.684 . . . . 0.0 110.117 175.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.79 116.63 26.07 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -101.45 18.48 20.03 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.167 0.587 . . . . 0.0 112.087 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.4 p -69.61 -18.34 63.6 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.37 -3.34 63.19 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 118.723 -1.043 . . . . 0.0 114.361 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 77.5 mt -49.95 -38.5 36.85 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 117.982 0.891 . . . . 0.0 113.139 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.75 -24.27 67.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.842 0.457 . . . . 0.0 111.571 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -93.56 -50.28 5.49 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.691 0.797 . . . . 0.0 111.835 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.557 ' HG3' HG22 ' A' ' 104' ' ' VAL . 24.1 ptm -70.86 -38.74 73.16 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.575 0.75 . . . . 0.0 111.942 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -122.57 89.1 49.7 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 123.375 0.67 . . . . 0.0 110.262 178.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.24 -29.5 17.14 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.826 2.351 . . . . 0.0 111.997 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 10.8 mmpt? -82.7 -8.65 59.58 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.832 0.853 . . . . 0.0 112.708 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.575 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 37.0 tp -57.54 127.95 34.61 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.604 0.565 . . . . 0.0 111.698 -172.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -134.76 -37.48 0.82 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.639 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 26.0 tp -129.57 125.34 35.99 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.054 0.542 . . . . 0.0 110.057 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.518 ' HB ' HG22 ' A' ' 131' ' ' THR . 57.0 mt -107.2 110.82 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.524 ' HB2' HG12 ' A' ' 18' ' ' ILE . 73.9 m -96.69 115.23 27.07 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 122.612 0.365 . . . . 0.0 110.606 -175.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -89.11 123.03 33.0 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.403 0.681 . . . . 0.0 109.726 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -90.99 99.27 12.34 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.05 138.88 8.13 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.447 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -52.71 -42.1 64.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.753 1.221 . . . . 0.0 112.19 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HB3' ' NZ ' ' A' ' 116' ' ' LYS . 5.1 mtpm? -59.8 -30.65 69.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.59 -38.97 64.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.286 0.565 . . . . 0.0 109.943 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.77 -9.45 62.46 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 114.779 -1.101 . . . . 0.0 114.707 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.12 -26.29 67.57 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.428 0.632 . . . . 0.0 110.562 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -102.55 14.03 33.0 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.034 1.334 . . . . 0.0 111.373 -176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.4 ' HG3' ' OG1' ' A' ' 131' ' ' THR . 41.3 tt0 -58.5 -53.19 68.7 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.242 172.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.65 -18.09 53.36 Favored 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 121.742 1.628 . . . . 0.0 113.15 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.5 tp -66.93 -46.35 75.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.501 0.72 . . . . 0.0 109.705 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.92 -18.98 31.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.168 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -69.2 -33.0 72.66 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.124 0.569 . . . . 0.0 109.966 167.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.68 -22.92 64.63 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.741 172.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 49.3 mtt -90.21 10.7 23.59 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.056 0.942 . . . . 0.0 111.401 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.3 25.56 75.22 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 113.899 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -109.56 132.65 53.94 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.282 0.633 . . . . 0.0 110.82 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -70.2 142.5 52.41 Favored 'General case' 0 C--N 1.348 0.526 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.518 HG22 ' HB ' ' A' ' 110' ' ' ILE . 32.2 p -133.65 150.67 51.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.524 1.13 . . . . 0.0 110.159 -173.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -142.12 119.22 11.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.704 1.201 . . . . 0.0 108.866 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.9 t -91.51 93.06 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.642 0.735 . . . . 0.0 109.765 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.86 154.39 94.29 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.711 1.204 . . . . 0.0 110.287 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.96 165.51 27.87 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 122.277 1.985 . . . . 0.0 112.191 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.1 t -67.35 143.74 56.19 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.0 t -74.02 5.92 3.85 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.125 0.97 . . . . 0.0 113.513 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -64.26 140.35 58.86 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.139 0.576 . . . . 0.0 110.371 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.95 -28.98 73.56 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.212 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.04 98.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.555 0.742 . . . . 0.0 110.29 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -65.93 -22.9 66.52 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.003 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.519 HH12 ' HB3' ' A' ' 149' ' ' GLU . 18.7 mmm180 -81.99 -16.74 49.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.644 0.778 . . . . 0.0 111.504 -177.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -67.0 -36.58 82.47 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -91.54 -34.14 14.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.659 0.783 . . . . 0.0 110.397 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.1 m -101.43 29.76 4.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.509 1.123 . . . . 0.0 112.038 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -57.31 -62.02 2.07 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -72.3 -4.93 32.62 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.252 1.021 . . . . 0.0 112.464 -178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.445 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 64.6 mtm-85 -88.91 -8.14 54.77 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.631 0.773 . . . . 0.0 111.84 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.519 ' HB3' HH12 ' A' ' 142' ' ' ARG . 0.0 OUTLIER -59.64 -23.99 63.5 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 118.589 0.632 . . . . 0.0 110.665 172.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -61.19 -32.24 72.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.851 1.26 . . . . 0.0 111.481 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.483 ' O ' HG23 ' A' ' 155' ' ' VAL . 7.5 pt-20 -74.34 -27.03 60.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -70.82 -37.91 73.23 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.93 -36.71 84.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.618 0.767 . . . . 0.0 110.168 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.6 -12.55 61.1 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.342 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 151' ' ' GLU . 41.6 t -95.1 -44.93 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.435 1.094 . . . . 0.0 111.157 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.44 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 56.3 m-85 -99.37 3.12 45.83 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -69.75 -34.6 74.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.459 ' HE1' HD11 ' A' ' 16' ' ' ILE . 11.5 p-80 -82.1 -9.73 59.44 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -170.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 16' ' ' ILE . 99.3 mt -51.21 -61.79 2.02 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 124.164 0.915 . . . . 0.0 111.979 -168.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.85 -60.8 2.24 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 N--CA 1.482 1.131 0 C-N-CA 123.794 0.838 . . . . 0.0 109.55 172.502 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 80' ' ' SER . 34.2 mm -65.46 101.02 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.1 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 22' ' ' LEU . 33.5 mtmm -95.51 118.79 32.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.744 -1.116 . . . . 0.0 107.989 174.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -87.82 134.19 33.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.203 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.18 171.8 48.16 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.953 170.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -98.26 143.85 27.02 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 117.353 0.576 . . . . 0.0 110.031 -174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.78 150.11 79.2 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.219 1.946 . . . . 0.0 110.449 169.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -61.96 143.32 56.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 112.325 -174.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.519 HG12 ' HE2' ' A' ' 66' ' ' LYS . 11.8 t -101.21 61.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 168.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.518 HD11 ' CG1' ' A' ' 104' ' ' VAL . 42.3 tp -98.18 146.36 25.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 113.657 -1.611 . . . . 0.0 111.162 -165.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.06 159.73 29.27 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.85 -19.32 63.45 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.773 0.429 . . . . 0.0 111.696 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -95.49 6.99 47.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.642 0.377 . . . . 0.0 111.792 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 82.6 m -66.84 114.58 5.8 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.227 0.611 . . . . 0.0 111.223 -171.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.508 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 40.6 tt0 -94.23 -35.44 12.47 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.384 1.474 . . . . 0.0 110.223 -178.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 44.9 mt -121.42 118.47 56.07 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.431 HD13 HD13 ' A' ' 10' ' ' LEU . 63.7 tp -105.01 116.5 32.05 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.524 HG21 ' HE1' ' A' ' 41' ' ' PHE . 52.6 mt -92.84 107.63 19.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 73' ' ' TRP . 96.0 mt -99.24 108.45 21.02 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.065 0.946 . . . . 0.0 109.152 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.83 179.66 12.78 Favored Glycine 0 C--N 1.34 0.774 0 O-C-N 123.281 0.363 . . . . 0.0 112.26 170.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 m -86.89 -69.04 0.7 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.486 HD22 ' HA3' ' A' ' 79' ' ' GLY . 27.6 tp -146.21 131.81 9.31 Favored Pre-proline 0 C--O 1.246 0.917 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 163.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HD2' HD12 ' A' ' 22' ' ' LEU . 18.4 Cg_endo -56.96 159.28 15.03 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.087 1.858 . . . . 0.0 112.075 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 m -60.37 136.94 58.19 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.893 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.66 -29.09 58.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.682 0.393 . . . . 0.0 110.927 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.46 -63.1 1.27 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.934 1.293 . . . . 0.0 110.549 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' GLN . 51.0 p -57.24 -28.2 62.73 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.626 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.8 mt -73.28 -28.02 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.445 0.698 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -59.9 -29.13 68.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 122.888 0.475 . . . . 0.0 111.095 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HD2' ' HA2' ' A' ' 35' ' ' GLY . 67.0 mttm -111.69 -0.55 15.98 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.115 0.966 . . . . 0.0 111.318 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 51.09 34.16 10.48 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.416 1.486 . . . . 0.0 113.832 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 27' ' ' SER . 13.3 pt20 -138.67 151.64 47.37 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.506 0.722 . . . . 0.0 109.706 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -70.27 -2.51 13.6 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 123.836 0.854 . . . . 0.0 111.433 174.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -103.11 -4.85 23.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.428 1.091 . . . . 0.0 109.843 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -72.91 -25.43 73.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 113.996 0.358 . . . . 0.0 113.996 -175.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -106.83 103.27 46.48 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.254 0.622 . . . . 0.0 109.662 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.03 -19.71 29.76 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.724 2.283 . . . . 0.0 111.791 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.36 31.07 5.61 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.655 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -115.5 116.33 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.783 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 37.0 m-20 -85.11 3.51 38.61 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.658 0.783 . . . . 0.0 112.299 -175.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.524 ' HE1' HG21 ' A' ' 18' ' ' ILE . 86.0 t80 -40.95 -51.08 3.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.282 1.033 . . . . 0.0 112.899 172.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.419 ' HE3' ' HB3' ' A' ' 53' ' ' LEU . 86.1 m95 -71.66 -23.21 61.63 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.236 -175.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.783 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 2.9 mpt_? -79.12 -42.63 25.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.957 0.903 . . . . 0.0 110.219 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.14 -49.78 16.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.957 0.903 . . . . 0.0 110.649 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.1 -31.54 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.329 0.652 . . . . 0.0 109.655 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.03 -40.54 88.58 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.485 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -62.72 -39.68 94.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.833 0.853 . . . . 0.0 109.753 172.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.63 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -72.62 -30.06 64.01 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.737 -1.12 . . . . 0.0 113.892 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.5 pt -102.75 -4.36 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.58 38.59 86.42 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.314 0.384 . . . . 0.0 113.508 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -137.15 136.26 38.09 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.111 1.364 . . . . 0.0 108.265 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 56' ' ' MET . 14.8 p-10 -74.38 87.07 2.02 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.307 0.575 . . . . 0.0 109.866 174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.419 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 92.0 mt -68.14 -51.85 41.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -46.87 -39.34 11.91 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.528 1.531 . . . . 0.0 113.258 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -78.45 -33.15 48.62 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.434 1.093 . . . . 0.0 111.343 -174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.53 ' HB2' ' HB3' ' A' ' 61' ' ' LYS . 62.0 mtt -66.01 151.58 46.51 Favored 'General case' 0 C--O 1.246 0.898 0 C-N-CA 123.103 0.561 . . . . 0.0 111.842 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.15 157.39 37.69 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.491 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.502 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 21.2 t80 -43.63 -56.43 3.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.968 1.307 . . . . 0.0 113.862 -171.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.07 -31.49 72.74 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.923 0.489 . . . . 0.0 111.668 -175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -72.53 -52.15 16.88 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.516 0.726 . . . . 0.0 111.439 -175.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 56' ' ' MET . 6.4 ptmt -61.54 -32.6 72.67 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.528 0.731 . . . . 0.0 112.491 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 89.8 mt -64.84 -42.99 94.48 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.438 0.695 . . . . 0.0 111.504 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.25 -40.75 95.2 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.936 0.495 . . . . 0.0 110.853 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.411 ' HA ' ' CD2' ' A' ' 67' ' ' HIS . 17.8 m -60.8 -41.23 95.23 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.105 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 90.4 mt -61.35 -46.93 88.16 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.828 0.705 . . . . 0.0 110.782 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.519 ' HE2' HG12 ' A' ' 9' ' ' VAL . 23.0 mttm -65.77 -28.0 68.7 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.016 0.926 . . . . 0.0 112.617 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.411 ' CD2' ' HA ' ' A' ' 64' ' ' THR . 12.2 m-70 -57.54 -43.28 84.26 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.319 0.581 . . . . 0.0 111.061 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -90.69 11.41 22.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.417 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.508 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.1 OUTLIER 66.66 39.28 3.7 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.09 1.356 . . . . 0.0 111.26 174.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 69.1 mt -109.72 131.56 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.01 152.83 17.15 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 171.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.5 mt -116.98 137.58 52.12 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.509 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.6 t90 -165.6 -169.1 1.47 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -140.59 171.92 13.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.741 0.816 . . . . 0.0 110.852 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.571 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 78.9 t -88.15 -56.96 4.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 123.841 0.857 . . . . 0.0 109.616 176.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -88.67 104.37 16.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.113 0.565 . . . . 0.0 110.22 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.736 ' HG3' ' HG3' ' A' ' 93' ' ' GLU . 17.6 ptmt -71.34 -14.74 62.29 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.758 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -149.89 123.91 9.39 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.486 ' HA3' HD22 ' A' ' 22' ' ' LEU . . . -128.7 125.8 5.09 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 2' ' ' ILE . 30.3 t -149.2 168.48 23.13 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.66 0.784 . . . . 0.0 110.315 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 85' ' ' GLN . 30.0 ptt180 -141.55 162.83 34.54 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -156.66 149.62 23.93 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.375 0.422 . . . . 0.0 110.937 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.71 -91.71 1.58 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.299 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 t -157.13 51.32 0.47 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.265 1.026 . . . . 0.0 108.552 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 81' ' ' ARG . 9.1 tp-100 -89.43 130.68 35.74 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.966 -175.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.08 -39.22 50.49 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.757 0.823 . . . . 0.0 109.948 176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.0 t -67.76 111.09 4.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 123.844 0.715 . . . . 0.0 109.398 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -65.64 -38.78 90.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.984 0.913 . . . . 0.0 110.029 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.6 mt -97.6 85.79 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.93 -59.05 1.82 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.89 142.51 1.32 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.097 1.359 . . . . 0.0 114.124 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -111.01 24.27 13.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.601 -1.636 . . . . 0.0 112.167 -161.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.736 ' HG3' ' HG3' ' A' ' 77' ' ' LYS . 9.5 tp10 -80.83 102.76 10.22 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.0 mt -110.6 153.2 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.126 0.971 . . . . 0.0 110.622 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -80.56 151.9 28.89 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.37 1.068 . . . . 0.0 110.161 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.94 119.87 24.98 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.571 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 32.5 m-85 -104.28 -19.48 14.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.655 0.782 . . . . 0.0 111.582 -175.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 p -62.89 -19.89 64.61 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.29 -19.24 53.45 Favored Glycine 0 C--N 1.356 1.648 0 CA-C-O 119.773 -0.46 . . . . 0.0 112.484 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -38.89 -45.98 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.996 1.318 . . . . 0.0 113.727 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -65.87 -20.79 66.36 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -163.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -74.25 -45.21 49.35 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.515 0.726 . . . . 0.0 110.85 174.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -90.77 -18.16 25.42 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 13.6 m -130.12 90.06 43.32 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 121.348 0.594 . . . . 0.0 110.566 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.92 -36.59 2.53 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.116 1.878 . . . . 0.0 111.17 170.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 13.4 mmmm -81.1 -9.15 59.86 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 123.895 0.878 . . . . 0.0 112.551 -171.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 38.2 tp -58.36 104.28 0.2 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 123.848 0.718 . . . . 0.0 110.791 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 106' ' ' LYS . 23.6 mtp180 -98.33 -42.89 7.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.604 0.762 . . . . 0.0 110.019 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 37.9 tp -128.93 139.77 51.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.133 0.573 . . . . 0.0 110.531 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.45 127.36 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 77.3 m -106.98 115.56 30.4 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.291 0.636 . . . . 0.0 109.717 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 95.6 m-85 -89.16 114.61 25.92 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.451 0.7 . . . . 0.0 109.819 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.554 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 11.8 t-20 -83.11 89.54 6.95 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.87 144.56 8.82 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.335 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -60.45 -37.66 81.68 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.052 0.941 . . . . 0.0 112.358 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -60.06 -31.63 70.17 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.17 -43.56 56.86 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.323 0.582 . . . . 0.0 109.512 170.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.73 -9.73 52.79 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.281 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -55.9 -35.64 66.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.326 0.65 . . . . 0.0 111.113 171.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -104.07 23.79 12.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.72 1.208 . . . . 0.0 110.945 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.485 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -65.29 -55.96 22.58 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 123.386 0.675 . . . . 0.0 111.29 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -70.6 -16.35 34.01 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.714 1.61 . . . . 0.0 112.035 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.53 -43.76 88.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.971 0.909 . . . . 0.0 109.977 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.554 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 8.1 mt -82.27 -9.88 59.32 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.813 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 75.5 mtt180 -67.56 -22.07 65.42 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.312 165.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.94 -23.28 69.29 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.823 0.702 . . . . 0.0 113.481 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.554 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -84.18 7.09 20.11 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.462 0.705 . . . . 0.0 111.094 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.1 28.33 68.57 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 116.876 -0.147 . . . . 0.0 112.738 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 21.0 m-85 -108.43 145.46 34.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.602 0.761 . . . . 0.0 110.866 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -79.72 139.12 37.44 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 51.4 p -134.85 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.914 0.486 . . . . 0.0 110.57 -174.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -140.32 130.59 25.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.457 1.503 . . . . 0.0 109.431 -174.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.13 113.02 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 111' ' ' CYS . 85.5 mt -96.49 150.8 37.49 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 166.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.35 167.42 23.96 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.118 1.879 . . . . 0.0 111.277 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.9 t -62.52 115.03 3.9 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.3 p -75.21 5.9 4.97 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.286 0.634 . . . . 0.0 112.359 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.9 p -62.23 152.58 33.01 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.854 0.862 . . . . 0.0 110.919 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.29 65.72 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.382 -0.826 . . . . 0.0 113.737 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.07 -23.64 51.94 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.814 0.846 . . . . 0.0 111.705 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -110.23 4.51 21.01 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.97 0.908 . . . . 0.0 110.314 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -59.95 -34.67 73.58 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.325 0.65 . . . . 0.0 111.152 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.85 -37.4 63.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 111.595 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.26 -25.51 15.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.699 0.8 . . . . 0.0 111.009 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -80.45 22.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -67.84 0.38 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.021 0.928 . . . . 0.0 110.952 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.48 -10.74 27.51 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.084 0.954 . . . . 0.0 113.142 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.427 ' O ' ' HD1' ' A' ' 152' ' ' TRP . 35.1 mmt180 -86.34 -18.75 31.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.301 0.64 . . . . 0.0 110.489 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -54.39 -36.52 64.01 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.244 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -62.19 -46.35 89.29 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.418 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.35 -30.67 63.48 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 119.462 -0.304 . . . . 0.0 110.471 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.427 ' HD1' ' O ' ' A' ' 148' ' ' ARG . 44.3 m95 -66.29 -43.3 86.74 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -59.13 -42.72 91.29 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.083 0.864 . . . . 0.0 109.512 176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.33 77.45 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 124.242 0.963 . . . . 0.0 111.522 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 36.6 t -62.5 -34.6 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.959 0.903 . . . . 0.0 111.936 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.63 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 83.6 m-85 -110.24 2.42 19.24 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -65.7 -40.91 92.78 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.368 1.067 . . . . 0.0 110.793 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.466 ' HE1' HD11 ' A' ' 16' ' ' ILE . 19.5 p-80 -69.84 -6.79 34.86 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 112.424 -176.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.413 HD11 HD12 ' A' ' 16' ' ' ILE . 96.6 mt -75.4 -18.11 60.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.907 0.483 . . . . 0.0 111.051 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -89.43 -3.39 58.43 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 122.434 0.294 . . . . 0.0 110.237 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 . . . . . 0 N--CA 1.484 1.262 0 C-N-CA 126.123 1.769 . . . . 0.0 111.048 177.657 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 80' ' ' SER . 42.3 mm -64.97 120.2 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.683 0.793 . . . . 0.0 111.218 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HG3' ' HD2' ' A' ' 81' ' ' ARG . 74.3 mmtt -110.11 116.28 31.27 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.398 1.079 . . . . 0.0 108.701 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -83.26 135.38 34.77 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 122.704 0.402 . . . . 0.0 110.233 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.4 150.17 44.8 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.817 0.698 . . . . 0.0 112.952 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -79.17 132.42 63.22 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.54 147.83 22.1 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.287 2.658 . . . . 0.0 112.275 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.95 133.19 50.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.039 0.536 . . . . 0.0 111.597 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.635 HG11 HD22 ' A' ' 62' ' ' LEU . 94.6 t -95.59 88.07 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.498 HD11 ' CG1' ' A' ' 104' ' ' VAL . 18.0 tp -136.58 149.54 48.12 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -163.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 13.9 t70 -128.99 163.79 24.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.407 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -72.16 -12.44 61.19 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.943 0.897 . . . . 0.0 112.567 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.3 12.44 37.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.217 0.607 . . . . 0.0 111.42 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -75.79 118.75 18.93 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -173.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 108' ' ' ARG . 56.7 mt-10 -93.49 -33.75 13.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.366 1.067 . . . . 0.0 111.366 -177.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mt -126.72 120.22 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD13 HD13 ' A' ' 10' ' ' LEU . 63.0 tp -104.57 121.77 44.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 111' ' ' CYS . 48.6 mt -99.55 109.65 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.659 0.784 . . . . 0.0 109.378 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 76.1 mt -93.59 118.49 31.44 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.81 -74.38 0.32 Allowed Glycine 0 CA--C 1.531 1.038 0 O-C-N 123.895 0.747 . . . . 0.0 113.121 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 117' ' ' ALA . 10.8 p 151.25 -92.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 -165.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.7 136.23 14.27 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 164.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 129.75 36.47 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.078 1.852 . . . . 0.0 111.917 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.7 p -69.04 140.21 54.91 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -49.84 -42.77 48.14 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.214 1.005 . . . . 0.0 112.848 -174.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 11.8 tp10 -63.38 -29.53 70.82 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.5 m -74.39 -33.26 62.99 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.5 mt -74.47 -14.18 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 124.064 0.946 . . . . 0.0 110.718 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' A' ' 26' ' ' GLU . 2.5 mmp_? -66.18 -35.28 80.04 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.62 -3.28 26.91 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.759 0.824 . . . . 0.0 111.484 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 61.48 18.98 9.91 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.008 1.323 . . . . 0.0 114.034 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -146.18 161.14 40.89 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -71.61 -12.95 61.61 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.524 1.129 . . . . 0.0 110.91 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.476 ' HD1' ' HZ1' ' A' ' 61' ' ' LYS . 85.0 t80 -87.2 -9.16 55.89 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.831 1.252 . . . . 0.0 109.731 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -47.3 -44.3 20.53 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 124.499 1.124 . . . . 0.0 115.589 -170.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -125.95 115.53 24.23 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -63.06 99.26 0.22 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.484 2.123 . . . . 0.0 108.196 154.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 156.7 -38.1 0.57 Allowed Glycine 0 C--O 1.241 0.541 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.575 -164.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -72.77 105.5 4.36 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 167.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.85 6.92 14.18 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.951 0.9 . . . . 0.0 111.938 -168.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -44.11 -43.09 6.71 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.857 0.863 . . . . 0.0 111.975 166.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.7 m95 -75.16 -21.96 58.41 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 112.158 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.71 -53.53 8.4 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.758 0.823 . . . . 0.0 110.471 170.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -69.84 -47.94 60.79 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.861 0.864 . . . . 0.0 111.535 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.45 -31.93 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.083 0.553 . . . . 0.0 109.876 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.39 -38.26 93.43 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 123.323 0.389 . . . . 0.0 112.689 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -72.22 -36.71 69.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.305 1.042 . . . . 0.0 110.198 174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -63.54 -42.28 98.41 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.573 0.749 . . . . 0.0 112.52 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -94.08 -15.17 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.642 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 35.31 61.12 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -136.14 127.69 28.76 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -70.0 89.76 0.62 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 122.014 0.911 . . . . 0.0 110.98 -173.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.5 mt -74.68 -0.44 18.02 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.76 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -84.6 -39.22 18.97 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.646 0.379 . . . . 0.0 111.18 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -99.12 0.37 43.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.693 0.797 . . . . 0.0 112.089 -166.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -90.78 141.77 28.46 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.033 0.533 . . . . 0.0 109.634 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.51 147.23 53.59 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.715 0.634 . . . . 0.0 109.373 170.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.488 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 56.0 t80 -45.28 -51.62 10.67 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.539 1.135 . . . . 0.0 113.776 -169.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.78 -46.15 90.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.826 0.851 . . . . 0.0 111.63 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -66.04 -38.89 89.5 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.652 0.781 . . . . 0.0 110.572 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.476 ' HZ1' ' HD1' ' A' ' 34' ' ' TYR . 30.9 ttmt -59.94 -40.42 88.9 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.523 1.129 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.635 HD22 HG11 ' A' ' 9' ' ' VAL . 27.0 mt -61.13 -49.03 78.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.355 174.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -65.16 -29.2 70.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.757 0.823 . . . . 0.0 111.516 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 67' ' ' HIS . 85.1 m -62.19 -50.02 73.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.787 0.835 . . . . 0.0 109.985 170.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -57.78 -40.34 79.61 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.046 0.841 . . . . 0.0 109.961 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' HE3' HG12 ' A' ' 9' ' ' VAL . 2.3 mptm? -59.39 -39.04 82.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.71 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.48 ' CD2' ' HA ' ' A' ' 64' ' ' THR . 79.8 m-70 -55.44 -41.18 72.48 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 122.72 0.408 . . . . 0.0 111.367 173.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -90.12 2.18 55.58 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.983 0.913 . . . . 0.0 111.05 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER 64.32 36.76 8.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.847 1.259 . . . . 0.0 110.868 177.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -104.05 132.93 49.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.795 1.238 . . . . 0.0 108.66 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.05 159.88 13.77 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 172.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 87.6 mt -122.53 143.87 49.45 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.839 0.856 . . . . 0.0 108.872 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -163.71 -168.59 1.68 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 171.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -125.84 179.88 4.99 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.276 0.63 . . . . 0.0 110.34 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.498 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 92.4 t -90.66 -44.49 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 109.884 175.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -99.26 133.19 43.91 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.874 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.592 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 88.4 tttt -78.56 -25.11 45.29 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.671 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.24 136.43 11.9 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.297 0.639 . . . . 0.0 110.025 172.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.672 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -145.73 130.17 3.68 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.406 ' HB2' HD13 ' A' ' 2' ' ' ILE . 34.4 t -88.39 106.21 18.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.367 1.083 . . . . 0.0 109.535 -174.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.462 ' HD2' ' HG3' ' A' ' 3' ' ' LYS . 95.2 mtt-85 -85.68 108.83 18.21 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 173.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 84' ' ' SER . 10.7 tp10 -78.79 152.59 31.31 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.847 0.717 . . . . 0.0 110.816 -172.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.59 -19.55 73.05 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 120.404 -0.109 . . . . 0.0 113.252 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.409 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 17.7 m -84.3 -173.47 4.74 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.257 1.023 . . . . 0.0 111.759 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.1 -16.97 64.66 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.902 0.881 . . . . 0.0 111.756 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.4 52.08 2.27 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.369 1.08 . . . . 0.0 110.209 170.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.9 p -83.14 29.63 0.48 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.264 -1.334 . . . . 0.0 111.7 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -90.03 -163.35 1.0 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.989 0.915 . . . . 0.0 109.723 -171.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.498 HD12 ' HD2' ' A' ' 116' ' ' LYS . 37.1 mt -84.18 79.88 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 175.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.16 62.63 4.31 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.247 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.672 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.4 t70 -175.25 156.57 2.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -120.73 21.44 11.48 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.017 0.927 . . . . 0.0 111.062 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.9 tp10 -85.39 109.14 18.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.49 137.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.077 0.951 . . . . 0.0 109.741 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -59.72 142.11 53.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.419 1.088 . . . . 0.0 111.177 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.23 91.78 0.74 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.52 0.728 . . . . 0.0 111.295 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.525 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 21.6 m-85 -80.18 -13.14 59.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.244 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.1 p -57.03 -31.64 65.35 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.736 0.815 . . . . 0.0 111.154 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.94 -4.24 69.51 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-O 118.528 -1.151 . . . . 0.0 114.134 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 97' ' ' PHE . 27.9 mt -51.67 -39.5 58.33 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.181 0.991 . . . . 0.0 112.749 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -56.8 -34.77 68.01 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.419 0.688 . . . . 0.0 111.894 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.79 -46.71 8.39 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.822 0.849 . . . . 0.0 112.031 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 ptm -72.88 -36.15 67.29 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.482 0.713 . . . . 0.0 111.804 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.7 m -121.22 85.92 42.38 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 123.527 0.731 . . . . 0.0 109.189 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.77 -32.54 7.33 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.56 2.173 . . . . 0.0 112.3 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.15 1.9 48.87 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.685 0.794 . . . . 0.0 111.577 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 42.6 tp -58.14 115.13 2.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.698 0.799 . . . . 0.0 112.223 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.457 ' HD3' ' HB3' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -107.6 -40.06 5.43 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.651 168.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 44.4 tp -135.06 131.95 37.61 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.118 0.567 . . . . 0.0 110.496 -171.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.457 ' HB ' HG22 ' A' ' 131' ' ' THR . 54.3 mt -102.54 145.08 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.601 ' HB2' HG12 ' A' ' 18' ' ' ILE . 76.9 m -124.56 116.22 22.1 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.346 0.521 . . . . 0.0 110.425 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.455 ' HE2' ' HB ' ' A' ' 131' ' ' THR . 97.9 m-85 -96.72 128.07 43.31 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.646 1.178 . . . . 0.0 110.377 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -97.25 78.86 2.76 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.448 0.642 . . . . 0.0 110.412 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.1 152.48 5.76 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.052 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -65.76 -40.25 91.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.241 0.616 . . . . 0.0 110.604 174.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.498 ' HD2' HD12 ' A' ' 89' ' ' ILE . 4.7 tmtm? -60.07 -37.12 78.95 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.163 175.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 21' ' ' SER . . . -67.82 -41.75 82.59 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.98 172.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.7 -9.85 59.78 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 114.815 -1.084 . . . . 0.0 114.232 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -63.61 -33.12 74.9 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.069 0.548 . . . . 0.0 110.566 170.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -98.87 13.59 31.95 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.968 . . . . 0.0 111.359 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.471 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -67.34 -54.64 18.11 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.57 0.748 . . . . 0.0 111.629 177.274 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.94 -15.61 43.94 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.713 1.609 . . . . 0.0 113.143 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.43 -48.64 76.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.453 0.701 . . . . 0.0 110.886 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.518 ' HB2' HG21 ' A' ' 131' ' ' THR . 17.2 mt -82.12 -9.41 59.54 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.386 -172.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -68.03 -28.59 67.53 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.812 0.445 . . . . 0.0 110.332 165.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.51 -19.35 64.58 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.53 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 59.4 mtt -94.07 12.15 27.39 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.098 0.959 . . . . 0.0 111.369 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.98 18.23 79.0 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.727 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -110.88 131.52 54.98 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 122.919 0.488 . . . . 0.0 110.706 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.61 140.97 51.76 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.518 HG21 ' HB2' ' A' ' 124' ' ' LEU . 16.3 p -132.8 151.78 51.93 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.952 0.901 . . . . 0.0 109.848 -172.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -134.94 123.58 23.6 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.044 0.538 . . . . 0.0 110.266 -175.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.6 t -83.11 98.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 111' ' ' CYS . 69.8 mt -90.88 156.88 44.19 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' A' ' 148' ' ' ARG . 84.2 Cg_endo -71.02 165.03 33.71 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.985 1.79 . . . . 0.0 110.616 177.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 40.6 t -63.93 117.39 6.93 Favored 'General case' 0 C--N 1.345 0.374 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 170.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.9 p -77.74 19.03 0.41 Allowed 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.346 0.658 . . . . 0.0 112.578 -174.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.7 p -77.26 153.1 34.29 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.895 0.878 . . . . 0.0 108.905 170.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -9.89 51.2 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 114.635 0.614 . . . . 0.0 114.635 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.06 -6.85 56.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.905 0.882 . . . . 0.0 111.795 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 135' ' ' PRO . 26.2 t-20 -123.05 -2.64 8.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.696 0.798 . . . . 0.0 110.59 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -75.6 -10.01 59.08 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 120.996 0.427 . . . . 0.0 111.727 -169.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -52.38 -26.85 13.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.674 1.189 . . . . 0.0 113.463 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -103.29 -5.37 23.12 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 0.0 110.911 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.641 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 66.3 m -88.14 0.36 56.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.654 0.781 . . . . 0.0 111.968 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -55.26 -70.96 0.09 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.63 0.772 . . . . 0.0 109.906 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.9 -12.05 59.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.112 0.565 . . . . 0.0 111.535 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.641 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 74.4 ttt180 -87.51 -11.71 48.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.395 0.678 . . . . 0.0 110.58 -172.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.49 -23.76 64.77 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.009 0.524 . . . . 0.0 111.298 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.8 t -66.96 -36.33 81.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.031 0.932 . . . . 0.0 109.85 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 155' ' ' VAL . 5.7 tt0 -67.42 -44.69 78.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.554 0.742 . . . . 0.0 110.223 175.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -60.06 -44.35 94.79 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.115 0.884 . . . . 0.0 109.184 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -60.6 -42.25 96.41 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.004 -1.453 . . . . 0.0 110.489 -178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.59 -37.95 70.95 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.4 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 151' ' ' GLU . 52.4 t -59.06 -34.88 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.115 0.966 . . . . 0.0 111.286 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.525 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 57.1 m-85 -107.98 -8.75 15.81 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -75.16 -48.59 22.91 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 118.1 0.409 . . . . 0.0 110.317 172.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -62.27 -14.56 40.08 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.03 -13.05 22.19 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.706 1.202 . . . . 0.0 112.329 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.23 -7.31 35.48 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.018 0.927 . . . . 0.0 112.304 174.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.9 t60 . . . . . 0 C--N 1.362 1.132 0 C-N-CA 125.972 1.709 . . . . 0.0 109.375 -175.165 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.773 -0.084 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 80' ' ' SER . 44.1 mm -65.07 118.73 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.837 0.855 . . . . 0.0 111.515 -170.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -104.53 116.56 32.3 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.51 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.1 mmt85 -84.73 133.39 34.37 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.498 0.719 . . . . 0.0 110.027 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.32 -179.79 34.84 Favored Glycine 0 C--O 1.247 0.96 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.739 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.448 ' HE1' ' HA ' ' A' ' 28' ' ' ILE . 20.4 m-30 -93.91 139.12 22.56 Favored Pre-proline 0 N--CA 1.47 0.548 0 O-C-N 122.504 -0.41 . . . . 0.0 110.495 -177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.97 162.34 26.18 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.482 2.122 . . . . 0.0 110.752 163.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.457 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -69.74 133.59 47.65 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.33 0.652 . . . . 0.0 112.606 -172.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.675 HG11 HD22 ' A' ' 62' ' ' LEU . 84.2 t -93.24 80.77 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 167.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.475 HD11 ' CG1' ' A' ' 104' ' ' VAL . 37.3 tp -128.24 149.41 50.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.23 -161.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.697 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 34.4 t70 -111.5 153.2 26.53 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -53.66 -48.61 69.27 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.283 0.633 . . . . 0.0 112.305 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -105.8 59.83 0.66 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.779 0.799 . . . . 0.0 111.817 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.479 ' HB ' HG12 ' A' ' 104' ' ' VAL . 27.6 m -85.9 135.2 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.37 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -91.94 -39.57 11.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.836 0.855 . . . . 0.0 111.809 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.419 HD11 ' CE1' ' A' ' 158' ' ' HIS . 44.3 mt -122.31 123.99 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.455 HD13 HD13 ' A' ' 10' ' ' LEU . 51.2 tp -109.37 117.18 33.37 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 175.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 111' ' ' CYS . 43.9 mt -98.56 113.35 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 73' ' ' TRP . 88.2 mt -106.08 122.52 46.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.846 0.858 . . . . 0.0 110.176 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 -154.71 10.84 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 164.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.6 p -119.16 -66.88 1.03 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.067 0.933 . . . . 0.0 108.825 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.8 tp -146.72 119.33 4.92 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.63 158.24 56.85 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.116 1.877 . . . . 0.0 111.053 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.5 m -67.94 146.46 53.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.16 0.584 . . . . 0.0 109.436 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 36.5 t70 -61.81 -27.04 68.48 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.14 0.275 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.91 -31.48 62.91 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.555 0.742 . . . . 0.0 111.249 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 m -86.6 -41.27 14.4 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.744 0.818 . . . . 0.0 110.489 173.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 25' ' ' ASP . 72.3 mt -63.73 -32.09 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 124.107 0.963 . . . . 0.0 112.974 -172.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mtm180 -62.7 -27.43 69.24 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.495 0.318 . . . . 0.0 111.283 177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -91.02 -26.37 19.23 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.714 0.806 . . . . 0.0 110.596 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 61.51 34.5 17.94 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 125.25 1.42 . . . . 0.0 110.728 -165.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -135.7 133.25 37.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.888 0.875 . . . . 0.0 109.672 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -60.59 -54.83 40.65 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.751 0.82 . . . . 0.0 110.547 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' HB3' ' CD1' ' A' ' 58' ' ' TYR . 83.7 t80 -65.41 -15.16 62.31 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.618 174.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.48 -30.33 49.61 Favored Glycine 0 C--N 1.359 1.859 0 O-C-N 123.249 0.343 . . . . 0.0 112.854 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -99.47 106.98 42.87 Favored Pre-proline 0 CA--C 1.55 0.981 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.14 179.61 6.05 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.303 2.002 . . . . 0.0 110.644 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.18 -11.53 65.03 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -170.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' A' ' 41' ' ' PHE . 28.8 t-20 -80.77 122.78 27.58 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.893 1.277 . . . . 0.0 109.5 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.06 -3.9 50.4 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.543 0.737 . . . . 0.0 111.986 -170.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.42 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 87.6 t80 -48.07 -45.24 32.24 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.306 1.042 . . . . 0.0 112.451 174.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -60.97 -37.03 81.01 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.482 0.713 . . . . 0.0 111.374 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -70.62 -41.64 71.96 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.616 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.03 -55.04 25.11 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.725 0.81 . . . . 0.0 111.057 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 49' ' ' ILE . 63.2 t -66.48 -44.73 90.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.68 -177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -34.44 88.61 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 124.179 0.924 . . . . 0.0 113.975 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -68.33 -43.22 78.02 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.544 0.738 . . . . 0.0 110.313 176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 153' ' ' GLU . . . -70.52 -41.35 72.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.005 0.922 . . . . 0.0 112.474 -174.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.475 HD12 ' ND2' ' A' ' 68' ' ' ASN . 17.1 pt -85.12 -14.88 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.23 0.612 . . . . 0.0 110.141 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.95 23.14 78.42 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.661 0.601 . . . . 0.0 113.933 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' HG3' HD21 ' A' ' 68' ' ' ASN . 11.6 mm-40 -115.65 142.81 46.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.012 0.925 . . . . 0.0 109.282 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.82 88.83 6.3 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.25 -47.47 34.91 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -59.88 -48.58 81.1 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.747 1.279 . . . . 0.0 112.248 -165.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.37 -32.44 64.5 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 123.258 0.349 . . . . 0.0 111.822 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.5 mtt -63.7 137.0 57.9 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.507 0.323 . . . . 0.0 110.733 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.92 31.51 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.397 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.558 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 42.9 t80 -44.1 -43.75 7.12 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -167.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.82 -49.1 78.97 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.816 0.846 . . . . 0.0 111.101 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -68.1 -34.75 76.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.862 1.265 . . . . 0.0 111.473 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -61.33 -45.5 94.15 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.764 1.226 . . . . 0.0 110.12 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.675 HD22 HG11 ' A' ' 9' ' ' VAL . 80.7 mt -63.14 -42.78 99.53 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 110.816 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -63.08 -31.21 72.3 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.707 0.403 . . . . 0.0 111.339 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -74.4 -28.05 60.91 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 122.954 0.502 . . . . 0.0 110.948 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.27 -48.36 80.25 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.697 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 2.0 mptm? -57.11 -39.28 74.78 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.617 0.767 . . . . 0.0 111.019 176.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -57.68 -40.58 79.74 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.295 1.038 . . . . 0.0 112.15 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.499 HD21 ' HG3' ' A' ' 51' ' ' GLU . 52.8 m-80 -92.15 4.76 52.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.644 0.378 . . . . 0.0 111.671 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 63.39 40.6 8.32 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.18 1.392 . . . . 0.0 111.15 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 52.7 mt -105.86 138.69 29.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 125.066 1.346 . . . . 0.0 109.065 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -121.08 154.77 16.41 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 170.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.6 mt -126.33 134.19 51.16 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.692 0.797 . . . . 0.0 108.866 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.431 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.8 t90 -160.71 -170.27 2.69 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -134.75 162.88 31.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.345 1.058 . . . . 0.0 109.236 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.0 t -73.39 -48.87 40.26 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 52.6 m-85 -87.45 133.75 33.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.537 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 1.7 tmmm? -75.17 -32.64 61.33 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.51 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -159.82 152.93 21.89 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.695 0.798 . . . . 0.0 110.817 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -146.54 128.44 3.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 174.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' ' 2' ' ' ILE . 43.5 p -89.46 119.81 30.23 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -173.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.421 ' HA ' ' NE2' ' A' ' 85' ' ' GLN . 43.4 mtm180 -90.92 102.22 14.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.017 0.527 . . . . 0.0 110.116 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -57.4 -42.42 82.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.078 0.951 . . . . 0.0 110.432 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.81 -71.91 0.18 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.444 176.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.1 m -116.36 88.02 2.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.801 0.84 . . . . 0.0 109.356 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 81' ' ' ARG . 25.2 mt-30 -115.04 -5.22 12.48 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.674 0.79 . . . . 0.0 111.375 -178.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 71.99 -64.92 0.37 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 125.736 1.614 . . . . 0.0 112.756 175.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.4 t -82.41 7.47 14.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.797 0.839 . . . . 0.0 112.157 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt 78.36 -43.98 0.37 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 125.828 1.651 . . . . 0.0 113.09 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.9 mt -73.66 139.78 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.924 0.89 . . . . 0.0 110.111 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.03 55.32 0.4 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 18.7 t70 174.77 158.57 0.17 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.577 1.151 . . . . 0.0 108.813 -167.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.86 25.56 10.44 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.953 0.901 . . . . 0.0 111.948 -171.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 6.1 tp10 -79.82 102.81 9.31 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 87.5 mt -114.81 146.81 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.744 1.218 . . . . 0.0 109.735 -173.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -68.26 141.82 55.78 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.833 0.853 . . . . 0.0 108.981 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.17 114.56 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -100.78 6.37 43.83 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.86 0.464 . . . . 0.0 112.124 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.1 t -63.73 -26.05 68.47 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 120.893 0.377 . . . . 0.0 111.615 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.83 -1.88 84.7 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 118.898 -0.946 . . . . 0.0 114.302 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' SD ' ' A' ' 103' ' ' MET . 35.9 mt -50.03 -34.84 22.65 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 117.87 0.835 . . . . 0.0 113.071 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -65.42 -22.43 66.77 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -99.33 -45.97 5.68 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.082 0.953 . . . . 0.0 111.573 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.525 ' HG3' HG22 ' A' ' 104' ' ' VAL . 17.4 ptm -69.81 -35.85 75.17 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.874 0.87 . . . . 0.0 111.314 -177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 2.0 m -132.87 88.11 38.49 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.336 0.654 . . . . 0.0 109.698 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 94.9 Cg_endo -72.59 -25.3 17.76 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.013 2.475 . . . . 0.0 111.771 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.2 mmmt -91.72 -6.65 51.61 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.553 1.141 . . . . 0.0 111.537 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.5 tp -58.82 109.62 0.85 Allowed 'General case' 0 C--N 1.356 0.861 0 O-C-N 123.771 0.669 . . . . 0.0 110.253 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -108.38 -40.14 5.23 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.659 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 130' ' ' GLU . 47.7 tp -125.45 130.12 51.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -174.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.6 mt -110.2 116.59 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.909 0.884 . . . . 0.0 108.793 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.506 ' HB3' HD12 ' A' ' 134' ' ' LEU . 68.1 m -97.9 117.33 31.99 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 123.417 0.687 . . . . 0.0 109.699 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 133' ' ' VAL . 91.2 m-85 -93.34 123.05 36.37 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.206 0.602 . . . . 0.0 110.57 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -79.95 79.62 6.46 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.166 0.586 . . . . 0.0 109.564 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.64 175.3 19.98 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.379 -0.828 . . . . 0.0 115.02 169.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 119' ' ' GLU . 73.5 ttt180 -57.31 -61.04 2.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.709 1.204 . . . . 0.0 111.52 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -54.24 -27.66 36.22 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.86 0.864 . . . . 0.0 113.316 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.16 -50.74 15.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.443 0.697 . . . . 0.0 109.914 172.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.17 -10.53 84.26 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.63 -1.168 . . . . 0.0 114.789 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 115' ' ' ARG . 96.1 mt-10 -66.24 -22.58 66.33 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.667 0.734 . . . . 0.0 110.265 173.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -103.53 19.63 19.41 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.347 1.059 . . . . 0.0 110.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 37.2 tt0 -60.68 -51.54 78.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-O 118.146 -0.931 . . . . 0.0 112.0 170.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 121' ' ' GLU . 18.2 Cg_endo -54.99 -27.56 55.11 Favored 'Trans proline' 0 C--N 1.406 3.563 0 C-N-CA 122.76 2.307 . . . . 0.0 113.571 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -62.2 -42.84 99.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.299 1.04 . . . . 0.0 110.444 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.415 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 20.0 mt -93.5 -15.04 25.94 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.633 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 37.6 mtp85 -66.85 -34.3 77.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.863 0.465 . . . . 0.0 109.975 171.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.44 -13.02 70.5 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.454 -0.793 . . . . 0.0 112.758 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 61.5 mtt -93.36 12.25 25.43 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.154 0.982 . . . . 0.0 111.292 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 72.0 27.83 69.68 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.387 0.429 . . . . 0.0 114.028 176.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -108.86 137.96 45.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.715 0.406 . . . . 0.0 111.306 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 28.1 mt-10 -65.1 129.83 41.12 Favored 'General case' 0 C--N 1.345 0.406 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 165.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.488 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 33.9 p -130.66 144.45 51.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.88 0.472 . . . . 0.0 110.16 -175.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -139.64 125.56 19.69 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.095 0.958 . . . . 0.0 109.835 -176.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 46.3 t -87.13 104.62 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 111' ' ' CYS . 74.3 mt -90.14 154.08 46.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 172.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.4 145.14 70.33 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 111.164 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 26.5 t -59.91 107.39 0.61 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.71 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.5 p -57.97 85.04 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 O-C-N 124.447 1.092 . . . . 0.0 111.04 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.7 t -129.81 161.0 31.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.616 1.566 . . . . 0.0 108.395 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -42.92 95.84 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 123.414 0.446 . . . . 0.0 112.865 167.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.21 -36.0 82.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.41 0.684 . . . . 0.0 111.23 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -65.02 -44.4 89.3 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.979 172.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -67.9 -23.54 65.11 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.417 1.073 . . . . 0.0 110.309 -172.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -56.94 -28.34 62.01 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.819 1.247 . . . . 0.0 111.684 171.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -118.17 -20.04 8.78 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.301 1.04 . . . . 0.0 111.496 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.427 ' HA ' ' HB3' ' A' ' 148' ' ' ARG . 22.2 t -98.28 31.71 2.7 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.834 0.853 . . . . 0.0 110.973 -173.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -65.35 0.68 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.77 -6.94 59.18 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.642 0.777 . . . . 0.0 111.965 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.427 ' HB3' ' HA ' ' A' ' 145' ' ' SER . 13.8 tpt180 -85.85 -14.22 45.62 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.318 0.647 . . . . 0.0 110.042 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -51.76 -23.52 4.72 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.862 0.865 . . . . 0.0 112.57 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -63.63 -29.6 70.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.619 0.768 . . . . 0.0 111.376 -178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 155' ' ' VAL . 8.3 pt-20 -73.22 -35.2 66.27 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -68.03 -35.9 79.04 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 2.1 tm-20 -70.8 -33.12 70.4 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.751 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -78.72 -11.95 60.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.858 0.863 . . . . 0.0 112.307 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 151' ' ' GLU . 53.2 t -89.61 -49.17 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.002 0.521 . . . . 0.0 110.29 175.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -99.36 2.17 45.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -71.19 -35.03 71.43 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 118.651 0.66 . . . . 0.0 111.469 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.419 ' CE1' HD11 ' A' ' 16' ' ' ILE . 31.7 p-80 -69.44 -11.77 61.1 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.803 0.441 . . . . 0.0 111.441 -176.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.39 -35.71 71.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.38 -45.81 24.78 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.601 0.761 . . . . 0.0 109.273 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 . . . . . 0 CA--C 1.563 1.468 0 C-N-CA 126.077 1.751 . . . . 0.0 112.518 -176.506 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 mmt . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 120.763 0.316 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mm -79.1 129.43 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.102 0.961 . . . . 0.0 110.085 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' HB2' HD21 ' A' ' 22' ' ' LEU . 3.4 mptp? -100.1 117.55 34.6 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -93.38 130.94 38.98 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.974 0.51 . . . . 0.0 111.766 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.87 165.05 45.63 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.942 0.776 . . . . 0.0 112.502 172.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -107.45 149.23 38.54 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 123.295 0.638 . . . . 0.0 111.544 -165.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -56.74 137.29 80.64 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.519 2.146 . . . . 0.0 110.311 171.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 142.99 56.6 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.87 0.731 . . . . 0.0 112.419 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 62' ' ' LEU . 59.9 t -91.06 86.61 2.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 171.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -132.25 139.76 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.839 -162.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.89 162.26 23.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.426 1.091 . . . . 0.0 108.353 172.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.65 -24.39 67.59 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.758 ' HA ' ' HG3' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -104.14 36.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.128 0.571 . . . . 0.0 111.075 -175.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 m -89.53 106.63 18.58 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.268 0.556 . . . . 0.0 110.334 -176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.63 -29.98 17.44 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.95 -173.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 159' ' ' LEU . 43.2 mt -123.95 121.49 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.1 tp -107.98 115.12 29.54 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 111' ' ' CYS . 39.9 mt -97.31 119.91 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.328 0.651 . . . . 0.0 109.268 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 73' ' ' TRP . 60.7 mt -111.0 115.87 30.22 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.669 0.788 . . . . 0.0 110.385 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -70.99 178.32 33.57 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 167.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 p -86.24 -80.28 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 3' ' ' LYS . 45.9 tp -131.68 122.39 18.67 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 171.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.12 149.42 44.13 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.901 2.4 . . . . 0.0 113.25 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.517 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.9 m -60.78 152.2 27.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.693 1.197 . . . . 0.0 111.12 -176.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 54.2 m-20 -58.98 -40.56 85.18 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.185 0.594 . . . . 0.0 111.35 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.04 -25.54 67.88 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.838 1.255 . . . . 0.0 110.506 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.2 m -83.36 -38.59 21.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.925 0.89 . . . . 0.0 109.718 177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 24' ' ' SER . 48.6 mm -61.34 -41.03 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.346 1.058 . . . . 0.0 110.795 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 25.5 mmm180 -58.68 -30.95 67.77 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.717 179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -106.73 -7.51 17.23 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.896 0.878 . . . . 0.0 112.33 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 58.74 30.95 20.67 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.814 1.246 . . . . 0.0 113.421 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -145.9 141.67 28.03 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.97 0.908 . . . . 0.0 109.554 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -59.69 -42.73 93.62 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 123.688 0.795 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -62.14 -12.63 20.72 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.404 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.45 -21.94 55.29 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.277 0.465 . . . . 0.0 113.615 175.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -115.77 96.69 47.26 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -85.65 131.87 4.05 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.38 2.72 . . . . 0.0 110.032 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.14 -13.38 5.48 Favored Glycine 0 N--CA 1.471 0.983 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -171.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -75.17 126.44 31.03 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 171.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.4 m-20 -82.18 1.88 34.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.326 0.512 . . . . 0.0 111.025 -169.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -46.52 -44.21 17.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.161 0.984 . . . . 0.0 112.179 170.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -71.55 -26.42 62.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.813 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -76.58 -40.12 50.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.233 1.013 . . . . 0.0 111.495 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 149' ' ' GLU . 80.3 mt -79.56 -46.71 16.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.59 0.756 . . . . 0.0 110.9 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 49' ' ' ILE . 98.7 t -72.64 -32.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.75 -40.97 93.95 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.804 0.69 . . . . 0.0 112.325 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -67.22 -36.07 80.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.421 0.689 . . . . 0.0 110.113 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -70.95 -32.33 69.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.421 HD12 HD22 ' A' ' 68' ' ' ASN . 18.5 pt -103.09 -10.93 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 C-N-CA 123.241 0.617 . . . . 0.0 111.732 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.7 40.99 44.33 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 123.37 0.419 . . . . 0.0 113.76 177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -134.02 142.63 47.69 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.668 1.187 . . . . 0.0 108.794 -178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -86.48 87.8 7.51 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.522 0.677 . . . . 0.0 109.976 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.5 mt -71.8 -31.94 67.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.831 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -62.13 -39.19 91.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.639 0.776 . . . . 0.0 112.399 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.38 -36.76 66.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.856 0.462 . . . . 0.0 110.638 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.3 mtt -57.67 130.39 46.17 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.19 -173.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.63 151.79 19.96 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.479 166.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.494 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 69.1 t80 -48.11 -49.58 31.47 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.501 0.72 . . . . 0.0 112.524 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.24 -40.65 94.32 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.767 0.827 . . . . 0.0 112.249 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -65.47 -39.49 92.04 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.573 0.702 . . . . 0.0 110.567 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -62.2 -40.59 96.6 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.011 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 28.8 mt -57.91 -52.33 65.94 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 124.012 0.82 . . . . 0.0 109.398 174.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -52.52 -46.62 66.78 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.18 0.992 . . . . 0.0 111.721 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.7 m -63.19 -54.74 32.75 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.058 0.943 . . . . 0.0 112.304 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.24 -50.37 70.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.498 0.719 . . . . 0.0 110.739 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -66.0 -32.24 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.837 0.855 . . . . 0.0 112.105 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -60.34 -42.39 95.59 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.546 0.738 . . . . 0.0 110.628 168.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.443 ' O ' HD13 ' A' ' 159' ' ' LEU . 92.0 m-20 -81.32 8.08 9.99 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.984 0.914 . . . . 0.0 110.83 -178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.401 ' HB2' HD22 ' A' ' 159' ' ' LEU . 0.8 OUTLIER 68.51 31.57 4.78 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 0.0 111.161 176.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.7 mt -111.09 136.85 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.489 1.115 . . . . 0.0 109.349 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.55 160.63 19.14 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 171.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 74.5 mt -123.6 144.18 49.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.462 0.705 . . . . 0.0 109.187 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.427 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . 5.5 t90 -167.07 -169.27 1.24 Allowed 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -137.68 -177.89 5.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.43 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 97.1 t -98.67 -55.48 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.522 0.729 . . . . 0.0 110.289 175.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -80.46 107.82 13.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.986 0.514 . . . . 0.0 111.552 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -64.53 -36.4 84.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.194 0.998 . . . . 0.0 110.519 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.44 122.95 10.41 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.713 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.89 116.26 1.94 Allowed Glycine 0 C--N 1.33 0.236 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.5 p -88.08 154.28 20.6 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.196 0.598 . . . . 0.0 110.878 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -138.97 96.01 3.05 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 84' ' ' SER . 12.1 tp10 -80.89 137.72 36.16 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.756 169.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.73 -24.26 71.16 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 123.315 0.384 . . . . 0.0 112.868 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.444 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 17.2 m -85.17 -1.83 57.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.918 0.887 . . . . 0.0 112.026 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -114.31 132.97 55.99 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.097 0.959 . . . . 0.0 109.523 175.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -81.55 2.83 27.35 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.799 0.84 . . . . 0.0 111.665 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.6 m -83.91 130.96 34.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.911 0.484 . . . . 0.0 110.066 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -76.49 -44.98 32.97 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.8 0.84 . . . . 0.0 108.999 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.405 HG23 HD22 ' A' ' 22' ' ' LEU . 29.5 mt -115.77 88.63 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.417 -1.265 . . . . 0.0 107.94 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.44 -75.9 1.13 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -38.96 137.79 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.214 1.406 . . . . 0.0 114.208 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -105.24 28.08 7.65 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.491 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -75.64 106.09 7.01 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.2 mm -97.4 155.27 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.22 0.608 . . . . 0.0 110.013 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -78.7 158.33 28.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.68 0.792 . . . . 0.0 109.868 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -78.6 121.69 24.97 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.43 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 58.9 m-85 -117.71 -0.01 11.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.545 0.738 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.2 p -74.96 -19.59 60.04 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.92 -4.13 79.1 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.575 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 103' ' ' MET . 69.2 mt -52.93 -29.43 28.63 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 123.444 0.698 . . . . 0.0 112.855 176.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.493 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 36.8 mtpt -65.09 -27.6 68.87 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -85.59 -55.28 4.07 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.196 0.998 . . . . 0.0 111.405 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.413 ' HG2' ' HA ' ' A' ' 100' ' ' LEU . 24.7 ptm -74.52 -33.82 62.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.21 0.604 . . . . 0.0 112.594 -169.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 1.1 m -127.08 90.77 48.46 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.221 0.608 . . . . 0.0 110.933 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.93 -32.54 2.55 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.512 2.141 . . . . 0.0 112.325 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.758 ' HG3' ' HA ' ' A' ' 13' ' ' ASN . 8.1 mmpt? -76.51 -9.49 58.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.947 0.899 . . . . 0.0 112.241 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 43.2 tp -59.97 112.46 1.88 Allowed 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.687 0.617 . . . . 0.0 111.218 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -101.71 -45.38 5.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.413 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 132' ' ' LYS . 40.8 tp -134.39 133.49 40.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -171.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.2 mt -105.53 115.76 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.161 0.984 . . . . 0.0 108.487 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.493 ' HB3' HD12 ' A' ' 134' ' ' LEU . 80.0 m -98.97 116.15 30.55 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.022 0.529 . . . . 0.0 110.466 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.22 127.98 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.702 0.801 . . . . 0.0 110.195 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.498 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 14.4 m120 -90.2 102.28 15.0 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.59 155.05 29.89 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.586 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 119' ' ' GLU . 78.6 ttt180 -55.84 -48.05 76.17 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.4 1.08 . . . . 0.0 112.359 178.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -56.25 -29.61 61.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.45 27.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 173.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.82 -9.55 62.8 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 114.874 -1.057 . . . . 0.0 114.597 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 115' ' ' ARG . 15.2 mm-40 -62.13 -19.97 63.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.56 0.744 . . . . 0.0 111.703 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.4 ' CD2' HG11 ' A' ' 75' ' ' VAL . 59.4 m-85 -110.13 22.11 15.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.198 0.999 . . . . 0.0 110.674 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.442 ' HG3' ' HB ' ' A' ' 131' ' ' THR . 40.8 tt0 -59.02 -55.84 42.34 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.367 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.29 -17.71 23.98 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.458 1.438 . . . . 0.0 111.801 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.7 tp -63.5 -48.1 78.97 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.562 0.745 . . . . 0.0 109.83 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.503 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 6.7 mt -84.17 -16.64 42.75 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.533 -176.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 7.9 ttt180 -73.54 -17.81 61.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 176.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.88 -16.66 78.19 Favored Glycine 0 C--N 1.355 1.637 0 CA-C-N 115.467 -0.788 . . . . 0.0 113.021 171.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.503 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -83.38 4.55 26.97 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.633 0.773 . . . . 0.0 111.197 174.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.97 14.56 72.07 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.542 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 36.2 m-85 -110.95 130.43 55.59 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.305 0.642 . . . . 0.0 111.222 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.42 139.1 58.74 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 121' ' ' GLU . 15.2 p -128.13 147.01 50.53 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.553 0.741 . . . . 0.0 109.967 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.528 ' HB2' HD11 ' A' ' 109' ' ' LEU . 51.9 tptt -140.38 124.72 17.76 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 109.164 -172.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 34.0 t -90.39 118.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 111' ' ' CYS . 79.6 mt -102.9 147.79 34.62 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 169.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.19 167.45 16.31 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.328 2.019 . . . . 0.0 112.87 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.7 m -65.46 126.55 28.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.48 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.6 m -77.12 12.75 1.31 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.028 0.931 . . . . 0.0 112.94 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.2 m -72.93 145.8 46.54 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.862 0.865 . . . . 0.0 109.975 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.57 -26.9 71.2 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-O 121.298 0.388 . . . . 0.0 112.185 173.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.97 -10.87 54.04 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.501 1.121 . . . . 0.0 112.667 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -119.17 -15.85 9.15 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.764 0.826 . . . . 0.0 109.216 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.71 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 39.6 ttp85 -83.54 -17.74 40.8 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.629 0.772 . . . . 0.0 110.705 -171.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.7 mtp-105 -61.14 -27.12 68.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.701 169.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -106.46 -28.92 10.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.233 1.013 . . . . 0.0 110.12 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.71 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 23.1 t -81.49 37.73 0.47 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.176 0.991 . . . . 0.0 111.501 -176.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 54.0 mtmt -69.82 -54.11 15.11 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 123.744 0.818 . . . . 0.0 110.626 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.39 -15.04 57.77 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.861 0.464 . . . . 0.0 110.827 174.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 5.0 mpt_? -88.44 -13.73 39.69 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.107 0.563 . . . . 0.0 111.459 -174.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.552 ' HB2' HD22 ' A' ' 44' ' ' LEU . 12.9 pt-20 -80.42 -22.66 40.97 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 120.654 0.264 . . . . 0.0 110.605 172.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -66.5 -28.49 68.61 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.426 0.69 . . . . 0.0 111.309 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 9.8 pt-20 -71.27 -21.37 62.1 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 122.848 0.459 . . . . 0.0 110.819 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.0 m95 -67.52 -42.09 83.33 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.724 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.63 -36.45 78.64 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.7 63.65 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.782 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.435 HG11 ' SG ' ' A' ' 111' ' ' CYS . 45.8 t -89.54 -45.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.583 0.753 . . . . 0.0 111.195 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.59 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 72.0 m-85 -96.46 -20.36 18.47 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -166.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -76.18 -6.13 49.9 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.85 1.205 . . . . 0.0 113.156 -171.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -73.54 -5.83 42.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.986 -0.447 . . . . 0.0 110.632 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.469 HD11 HD12 ' A' ' 16' ' ' ILE . 39.1 mt -87.57 -17.41 32.03 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.44 1.096 . . . . 0.0 108.787 177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.59 -44.29 10.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.625 1.17 . . . . 0.0 109.904 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 70.4 m80 . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 125.46 1.504 . . . . 0.0 110.771 -175.769 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.524 ' HB3' ' HB2' ' A' ' 81' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mm -74.14 125.27 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.066 0.546 . . . . 0.0 110.279 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -107.97 114.18 27.9 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 168.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HD3' ' HB2' ' A' ' 78' ' ' ALA . 15.3 mmt85 -78.69 129.73 35.03 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 123.821 0.701 . . . . 0.0 109.995 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.62 151.03 52.23 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -80.6 145.32 58.37 Favored Pre-proline 0 N--CA 1.468 0.453 0 CA-C-N 116.787 0.294 . . . . 0.0 111.269 -167.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.5 149.17 68.18 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.322 2.015 . . . . 0.0 110.248 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.62 131.93 50.68 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.247 0.619 . . . . 0.0 112.58 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' A' ' 72' ' ' LEU . 57.7 t -89.92 86.15 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.506 HD21 HG13 ' A' ' 104' ' ' VAL . 19.9 tp -144.41 153.67 42.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -160.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -128.27 168.32 15.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.433 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.47 -13.65 61.1 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.446 0.698 . . . . 0.0 112.277 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.86 38.09 2.09 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.241 0.616 . . . . 0.0 111.464 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.63 ' HB ' HG12 ' A' ' 104' ' ' VAL . 94.9 m -101.61 130.96 48.05 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.458 0.303 . . . . 0.0 110.899 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -98.2 -39.7 8.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.258 1.023 . . . . 0.0 111.21 -174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 159' ' ' LEU . 51.9 mt -120.21 119.81 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 tp -106.94 118.21 36.1 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.478 HG12 ' HB2' ' A' ' 111' ' ' CYS . 54.3 mt -94.43 109.94 22.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -98.0 109.3 22.08 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 113' ' ' ASN . . . -66.8 -168.92 3.4 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 169.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 p -103.76 -76.12 0.6 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.54 HD22 HG23 ' A' ' 89' ' ' ILE . 31.1 tp -155.34 121.78 2.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 22' ' ' LEU . 9.8 Cg_exo -72.23 151.59 54.93 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.949 2.433 . . . . 0.0 112.707 -174.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 28' ' ' ILE . 18.3 m -67.31 157.77 33.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.088 0.955 . . . . 0.0 111.092 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.17 -24.57 67.95 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.14 -45.33 95.08 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.549 0.74 . . . . 0.0 110.437 170.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 m -68.53 -41.13 80.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.307 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 24' ' ' SER . 19.2 mm -57.35 -34.96 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 124.265 0.978 . . . . 0.0 111.647 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -58.11 -38.0 75.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.116 0.566 . . . . 0.0 112.258 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -94.77 -17.01 22.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.252 0.621 . . . . 0.0 111.168 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 64.19 30.34 13.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.514 1.125 . . . . 0.0 111.264 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -145.68 143.64 29.91 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.784 0.834 . . . . 0.0 109.851 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.32 -41.68 97.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.181 0.992 . . . . 0.0 110.113 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -59.25 -24.16 62.96 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 114.421 -1.263 . . . . 0.0 112.733 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.5 -14.4 41.97 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.368 0.418 . . . . 0.0 113.725 -177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -100.25 104.59 30.7 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.851 0.86 . . . . 0.0 109.468 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.42 97.79 0.8 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.27 2.646 . . . . 0.0 109.539 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.08 -30.14 0.72 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -170.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -67.45 103.65 1.36 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.049 0.94 . . . . 0.0 108.467 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -84.83 -0.94 55.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.418 0.687 . . . . 0.0 112.01 -166.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -42.78 -46.1 5.05 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.22 1.408 . . . . 0.0 113.135 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -79.4 -18.66 51.84 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.87 0.868 . . . . 0.0 111.254 -170.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 4.6 mmp_? -72.72 -47.71 44.81 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.114 0.565 . . . . 0.0 110.12 167.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.7 -46.63 71.69 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.962 0.905 . . . . 0.0 111.413 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 90.9 t -73.68 -41.46 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.66 0.784 . . . . 0.0 109.685 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.92 91.2 Favored Glycine 0 C--N 1.356 1.653 0 O-C-N 123.793 0.683 . . . . 0.0 112.453 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -66.77 -45.1 79.57 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.288 1.035 . . . . 0.0 109.83 174.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -67.03 -36.64 82.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.815 0.846 . . . . 0.0 112.816 -173.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.2 pt -93.78 -11.26 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.164 0.585 . . . . 0.0 110.539 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 33.61 78.8 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.25 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -132.33 117.4 18.09 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.48 96.56 2.93 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.359 0.664 . . . . 0.0 110.432 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.34 -22.16 61.21 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.285 1.034 . . . . 0.0 113.035 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -19.87 59.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -168.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -85.18 -36.18 21.2 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 118.425 0.557 . . . . 0.0 110.325 169.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.1 mtt -63.18 120.55 11.73 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.553 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.0 160.07 2.98 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.087 0.555 . . . . 0.0 110.884 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.605 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 47.5 t80 -42.23 -53.59 4.02 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.708 0.803 . . . . 0.0 112.85 -177.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 37.2 mt-10 -60.05 -35.78 75.87 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.635 0.774 . . . . 0.0 112.295 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.02 -48.88 13.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.944 0.897 . . . . 0.0 112.092 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -59.6 -34.96 73.4 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.837 0.455 . . . . 0.0 112.203 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 15.3 mt -64.94 -41.35 95.59 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.54 0.336 . . . . 0.0 110.492 176.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 47.7 mmtm -56.83 -37.37 71.16 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.273 0.629 . . . . 0.0 110.835 177.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.4 m -64.35 -44.16 92.32 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 123.754 0.658 . . . . 0.0 110.741 177.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.65 -57.33 13.18 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.56 0.744 . . . . 0.0 111.538 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.36 -21.77 60.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -174.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -60.07 -40.29 89.01 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.19 0.596 . . . . 0.0 110.442 165.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -86.59 7.57 25.8 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.99 0.916 . . . . 0.0 110.676 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 68.69 29.89 5.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.495 1.518 . . . . 0.0 110.864 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.5 mt -102.29 133.95 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.518 1.127 . . . . 0.0 108.838 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.81 158.15 18.33 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.663 ' HB2' ' HB ' ' A' ' 9' ' ' VAL . 66.6 mt -126.39 143.3 51.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.681 0.792 . . . . 0.0 108.995 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -165.65 -171.54 2.12 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 171.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.13 169.71 10.26 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.412 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 52.8 t -83.93 -34.97 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 123.268 0.627 . . . . 0.0 109.534 169.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 55.2 m-85 -101.92 141.65 34.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.846 0.458 . . . . 0.0 111.153 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.662 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 6.7 tmtm? -81.1 -41.87 21.86 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.953 0.901 . . . . 0.0 108.898 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.512 ' HB2' ' HD3' ' A' ' 4' ' ' ARG . . . -156.47 150.82 25.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.937 0.895 . . . . 0.0 109.768 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -160.23 139.7 6.28 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.0 t -97.54 167.1 11.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.527 0.679 . . . . 0.0 111.935 -168.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.524 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 22.4 mmm180 -115.46 94.19 4.6 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 167.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 179.0 149.81 0.26 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.88 -5.55 83.54 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 37.9 t -178.42 137.11 0.16 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 126.349 1.859 . . . . 0.0 106.659 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -64.77 -36.88 85.75 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.933 0.397 . . . . 0.0 110.594 -177.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -105.02 22.6 15.02 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.878 0.871 . . . . 0.0 111.371 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' A' ' 84' ' ' SER . 57.3 p -62.13 99.55 0.14 Allowed 'General case' 0 C--N 1.358 0.943 0 C-N-CA 122.809 0.444 . . . . 0.0 110.075 177.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -54.19 -51.4 64.52 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.574 0.75 . . . . 0.0 110.09 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.54 HG23 HD22 ' A' ' 22' ' ' LEU . 16.0 mt -136.28 78.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.9 57.5 4.29 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.605 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.694 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 10.2 t70 174.17 159.0 0.16 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.107 1.363 . . . . 0.0 109.113 -171.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -119.38 23.82 11.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.612 0.765 . . . . 0.0 112.058 -173.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 14.9 tp10 -80.4 101.85 9.26 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 76' ' ' PHE . 54.8 mt -105.97 149.12 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.669 1.188 . . . . 0.0 110.033 -174.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -69.51 147.18 51.18 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.922 0.889 . . . . 0.0 110.008 173.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.62 131.8 34.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.412 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 50.3 m-85 -110.0 9.72 24.27 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.529 0.731 . . . . 0.0 111.779 -175.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 t -69.21 -20.62 63.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.682 0.393 . . . . 0.0 110.843 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -4.52 63.87 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 118.941 -0.921 . . . . 0.0 113.714 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.424 HD23 ' SD ' ' A' ' 103' ' ' MET . 31.1 mt -50.04 -37.3 32.49 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -63.73 -31.28 72.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.591 0.356 . . . . 0.0 111.165 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -82.01 -53.12 6.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.817 0.847 . . . . 0.0 111.42 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.485 ' HG3' HG22 ' A' ' 104' ' ' VAL . 23.4 ptm -67.24 -34.95 78.55 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.534 0.733 . . . . 0.0 111.527 -173.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.63 HG12 ' HB ' ' A' ' 14' ' ' THR . 1.6 m -129.25 84.98 60.77 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.003 0.921 . . . . 0.0 108.857 176.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.4 -23.74 20.11 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.736 2.29 . . . . 0.0 112.79 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -90.45 7.45 38.75 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.42 0.688 . . . . 0.0 111.827 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 40.2 tp -61.4 125.44 23.8 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.833 0.349 . . . . 0.0 111.397 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -132.09 -30.58 1.54 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.13 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.7 tp -130.98 129.61 42.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.047 0.539 . . . . 0.0 110.039 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.56 122.16 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.3 1.04 . . . . 0.0 108.245 176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.478 ' HB2' HG12 ' A' ' 18' ' ' ILE . 77.4 m -100.41 114.26 27.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.827 0.451 . . . . 0.0 109.881 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.412 ' HZ ' HD12 ' A' ' 124' ' ' LEU . 96.2 m-85 -89.88 115.5 27.25 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.983 0.913 . . . . 0.0 109.902 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.595 ' HB3' ' HA2' ' A' ' 20' ' ' GLY . 23.3 t30 -89.11 99.98 12.85 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.92 0.888 . . . . 0.0 109.124 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.89 156.43 20.8 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.811 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.54 -50.39 72.0 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.717 1.207 . . . . 0.0 111.681 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -55.06 -31.47 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.0 -43.91 51.14 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.037 0.535 . . . . 0.0 109.757 173.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.43 -11.43 64.85 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.007 -0.997 . . . . 0.0 114.149 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -60.43 -34.32 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.038 0.535 . . . . 0.0 110.955 170.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -107.16 18.26 21.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.12 0.968 . . . . 0.0 110.743 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.555 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 2.9 tm-20 -70.4 -48.79 17.71 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 123.631 0.772 . . . . 0.0 111.197 170.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.23 -28.77 72.88 Favored 'Trans proline' 0 C--N 1.399 3.208 0 C-N-CA 122.322 2.014 . . . . 0.0 113.192 172.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.7 -48.95 79.47 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.645 0.778 . . . . 0.0 111.12 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.412 HD12 ' HZ ' ' A' ' 112' ' ' PHE . 14.0 mt -85.61 -5.23 59.3 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -171.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -65.21 -34.44 78.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.75 -14.36 67.45 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.156 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 54.9 mtt -90.59 8.0 36.35 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.806 0.842 . . . . 0.0 111.4 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.48 0.75 89.58 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.33 0.492 . . . . 0.0 114.33 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -92.22 137.4 32.4 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 117.105 0.453 . . . . 0.0 110.331 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.43 131.31 45.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 171.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.555 ' HB ' ' HG2' ' A' ' 121' ' ' GLU . 49.5 p -120.69 136.83 54.74 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 123.303 0.641 . . . . 0.0 109.403 -176.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -134.51 115.79 14.34 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.304 1.042 . . . . 0.0 109.173 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.7 94.79 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 111' ' ' CYS . 73.6 mt -77.11 139.07 64.81 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 169.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.01 159.46 29.62 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.522 2.148 . . . . 0.0 112.505 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t -65.39 104.15 0.92 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.427 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.8 p -73.29 77.21 1.33 Allowed 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.162 0.982 . . . . 0.0 109.037 172.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 61.8 p -129.1 159.77 34.94 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -171.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.98 29.7 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.475 0.55 . . . . 0.0 114.475 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.04 -45.42 8.32 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.206 0.602 . . . . 0.0 112.143 -176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -87.82 -9.88 52.51 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.626 0.37 . . . . 0.0 111.896 -169.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -65.15 -33.18 75.41 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.633 0.73 . . . . 0.0 110.369 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -67.13 -30.88 70.99 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.836 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.37 23.3 6.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.656 1.182 . . . . 0.0 110.596 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.5 t -139.42 24.4 2.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.294 1.038 . . . . 0.0 108.818 -170.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 49.2 tptt -66.8 -55.93 12.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.941 -175.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -56.53 -25.55 52.19 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.244 0.618 . . . . 0.0 112.355 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.576 ' O ' ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -88.54 -17.52 30.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.597 0.759 . . . . 0.0 111.146 -168.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 146' ' ' LYS . 10.9 pt-20 -65.8 -19.91 66.06 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.21 0.459 . . . . 0.0 110.424 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.6 t -67.98 -44.86 75.69 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.075 0.95 . . . . 0.0 111.172 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.8 pt-20 -73.77 -29.42 62.19 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -62.68 -48.54 78.84 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.512 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 1.2 tm-20 -60.89 -38.01 84.19 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.782 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.88 -19.89 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.088 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 151' ' ' GLU . 43.7 t -68.77 -47.14 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 173.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.512 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 33.7 m-85 -91.82 2.74 56.31 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.505 -174.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -60.78 -55.51 32.32 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.475 0.71 . . . . 0.0 112.128 177.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -70.3 -9.73 56.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 16' ' ' ILE . 93.8 mt -73.53 -31.18 63.54 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.995 0.518 . . . . 0.0 109.896 -178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.4 -52.21 3.57 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 . . . . . 0 CA--C 1.554 1.134 0 C-N-CA 125.456 1.502 . . . . 0.0 111.167 177.28 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 80' ' ' SER . 38.0 mm -87.29 135.38 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.493 0.717 . . . . 0.0 110.082 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -91.31 112.41 24.31 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.06 138.03 35.21 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.019 0.527 . . . . 0.0 111.367 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.437 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -71.18 152.44 49.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.536 173.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -84.53 138.56 38.41 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.029 0.531 . . . . 0.0 110.267 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.61 154.94 11.05 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 123.046 2.497 . . . . 0.0 112.22 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 10' ' ' LEU . . . -64.83 129.75 40.92 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -167.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG11 HD22 ' A' ' 62' ' ' LEU . 97.4 t -91.12 76.54 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 170.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.518 HD13 HD13 ' A' ' 17' ' ' LEU . 26.9 tp -135.6 153.64 51.6 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -158.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.585 ' HB2' ' HG3' ' A' ' 66' ' ' LYS . 9.2 t70 -126.5 167.46 15.58 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.595 0.758 . . . . 0.0 109.09 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.26 -12.77 61.63 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.799 0.84 . . . . 0.0 111.085 170.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -119.45 73.72 0.96 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.565 ' HB ' HG12 ' A' ' 104' ' ' VAL . 99.9 m -125.15 122.63 37.66 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.508 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 35.0 tt0 -93.34 -39.27 11.04 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.966 1.306 . . . . 0.0 110.283 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.511 HG12 ' HB3' ' A' ' 109' ' ' LEU . 52.5 mt -120.11 113.67 41.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 HD13 ' A' ' 10' ' ' LEU . 52.3 tp -103.84 116.18 31.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.504 ' HB ' HD23 ' A' ' 72' ' ' LEU . 46.2 mt -94.38 114.1 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.288 0.635 . . . . 0.0 109.372 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -104.25 113.7 27.43 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 123.552 0.741 . . . . 0.0 110.424 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . -67.54 174.09 28.55 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 169.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.9 m -86.91 -79.8 0.26 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.2 tp -136.46 122.34 13.53 Favored Pre-proline 0 C--O 1.243 0.743 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.437 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 41.7 Cg_exo -58.04 135.3 67.75 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 122.073 1.849 . . . . 0.0 111.371 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.3 t -60.89 146.12 47.75 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.765 0.665 . . . . 0.0 109.58 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 4.9 p-10 -58.08 -34.3 69.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.431 0.292 . . . . 0.0 111.339 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.06 -43.01 69.91 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.272 1.029 . . . . 0.0 111.722 172.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.554 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 26.3 t -68.99 -39.19 79.5 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.011 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 24' ' ' SER . 40.3 mt -76.97 -15.62 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 114.913 -1.04 . . . . 0.0 112.27 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 13.7 mmt180 -60.63 -36.27 78.25 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.353 0.597 . . . . 0.0 109.599 176.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -99.76 -0.14 40.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.204 1.002 . . . . 0.0 111.288 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 61.93 21.87 12.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.35 1.06 . . . . 0.0 112.737 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.589 HE21 ' HB3' ' A' ' 34' ' ' TYR . 18.4 pt20 -146.52 158.69 43.94 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.491 0.316 . . . . 0.0 111.689 -173.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.584 ' HB2' ' HZ2' ' A' ' 42' ' ' TRP . 83.5 m-85 -68.6 -0.88 5.68 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.745 1.218 . . . . 0.0 112.564 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.589 ' HB3' HE21 ' A' ' 32' ' ' GLN . 63.3 t80 -105.41 1.77 28.08 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.689 1.196 . . . . 0.0 110.024 -176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 27' ' ' SER . . . -38.22 -42.42 1.24 Allowed Glycine 0 C--N 1.361 1.961 0 C-N-CA 124.917 1.246 . . . . 0.0 116.083 -174.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -126.78 146.38 56.97 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 165.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.98 -0.38 10.2 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.5 2.133 . . . . 0.0 112.762 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.9 -6.36 85.25 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.02 172.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -67.58 104.78 1.68 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.58 6.39 41.33 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.267 0.627 . . . . 0.0 111.131 -173.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -42.77 -43.24 3.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.898 0.879 . . . . 0.0 111.045 164.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.584 ' HZ2' ' HB2' ' A' ' 33' ' ' TYR . 57.3 m95 -82.71 -28.13 30.73 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.868 0.867 . . . . 0.0 111.966 -177.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -68.79 -45.81 70.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.812 0.845 . . . . 0.0 111.071 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.6 mt -87.03 -39.03 16.01 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.133 0.573 . . . . 0.0 111.96 -170.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.3 t -71.39 -36.85 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.61 -39.72 95.61 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 123.891 0.745 . . . . 0.0 112.471 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.2 t60 -67.96 -39.29 83.42 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.15 0.58 . . . . 0.0 110.496 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 156' ' ' PHE . . . -68.89 -32.93 72.93 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.022 0.929 . . . . 0.0 113.07 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.8 pt -94.74 -11.14 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.929 0.492 . . . . 0.0 111.151 175.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 33.78 72.83 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 123.14 0.4 . . . . 0.0 113.574 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -142.98 104.26 4.29 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.09 99.91 0.19 Allowed 'General case' 0 C--N 1.352 0.703 0 CA-C-O 121.453 0.644 . . . . 0.0 110.993 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 73.2 mt -67.06 -34.49 77.79 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -66.17 -21.21 66.32 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.227 1.011 . . . . 0.0 112.539 -170.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -95.39 -31.55 13.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.87 0.468 . . . . 0.0 111.229 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.4 mtt -58.1 141.09 51.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.236 0.614 . . . . 0.0 111.176 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.41 137.69 57.1 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 118.141 -0.933 . . . . 0.0 109.395 171.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.491 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 38.4 t80 -45.66 -38.82 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -167.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 40.3 mt-10 -58.79 -59.93 4.65 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.534 0.734 . . . . 0.0 110.923 175.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -60.11 -34.15 73.1 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.971 0.908 . . . . 0.0 111.729 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 53' ' ' LEU . 2.3 ttmp? -60.17 -47.5 85.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.875 1.27 . . . . 0.0 110.006 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.629 HD22 HG11 ' A' ' 9' ' ' VAL . 46.0 mt -67.5 -40.35 85.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.001 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 57.7 mtpt -60.2 -31.34 70.06 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.574 0.35 . . . . 0.0 111.736 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -67.88 -34.52 76.83 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.072 0.549 . . . . 0.0 110.58 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.55 -57.31 11.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.585 ' HG3' ' HB2' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -58.73 -36.78 74.87 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.137 0.575 . . . . 0.0 111.264 -178.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -53.51 -46.58 70.13 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.481 1.112 . . . . 0.0 111.9 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -87.06 8.41 23.67 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.0 0.92 . . . . 0.0 111.852 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.524 ' HB3' ' H ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER 60.53 37.3 19.67 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.595 1.158 . . . . 0.0 110.353 -178.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 66.6 mt -102.81 140.41 21.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 124.383 1.073 . . . . 0.0 109.225 174.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -123.35 162.88 17.07 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 170.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.504 HD23 ' HB ' ' A' ' 18' ' ' ILE . 98.0 mt -128.76 138.95 52.38 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -164.69 -168.74 1.55 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -131.29 160.98 33.35 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.61 0.641 . . . . 0.0 111.553 -175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.504 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 75.6 t -94.04 -48.28 13.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 124.204 1.002 . . . . 0.0 110.809 175.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -93.78 113.35 25.38 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.437 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 87.9 tttt -64.28 -37.29 86.95 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 124.252 0.97 . . . . 0.0 110.513 -175.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.86 134.97 17.99 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.849 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -143.66 136.26 6.81 Favored Glycine 0 C--O 1.218 -0.892 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.513 ' HB3' HD13 ' A' ' 2' ' ' ILE . 23.9 p -114.43 162.94 16.01 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.958 0.879 . . . . 0.0 110.594 -177.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -141.17 135.25 30.63 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -160.76 -163.04 1.0 Allowed 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.575 0.547 . . . . 0.0 109.824 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -74.53 69.39 1.75 Allowed Glycine 0 C--N 1.341 0.847 0 O-C-N 123.216 0.322 . . . . 0.0 112.676 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 t -127.04 176.34 7.42 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.719 1.208 . . . . 0.0 109.267 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' A' ' 86' ' ' ASP . 49.8 tp60 -72.79 169.8 15.98 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' H ' ' HG3' ' A' ' 85' ' ' GLN . 18.3 m-20 -47.49 89.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.839 1.256 . . . . 0.0 113.471 -171.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.9 m -153.14 105.94 2.95 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.752 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -87.44 -32.97 19.22 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.4 mt -101.32 66.91 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 165.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.36 65.05 4.07 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.802 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.593 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.0 t70 -177.87 153.85 0.87 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.075 0.95 . . . . 0.0 108.577 -169.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -121.62 22.07 10.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.574 0.75 . . . . 0.0 111.746 -175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 77' ' ' LYS . 10.0 tp10 -80.28 101.32 8.84 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.0 mt -94.61 153.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.18 0.992 . . . . 0.0 110.162 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -86.97 156.33 19.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.947 0.899 . . . . 0.0 109.429 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.01 122.12 34.22 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.515 0.726 . . . . 0.0 110.312 -174.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.504 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 48.2 m-85 -109.0 6.85 25.51 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.52 0.728 . . . . 0.0 112.007 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -70.45 -17.14 62.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.63 0.372 . . . . 0.0 111.048 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.94 -5.19 77.69 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.657 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.8 mt -47.89 -49.06 31.02 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.561 0.745 . . . . 0.0 112.666 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -62.0 -27.8 69.12 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -82.91 -54.36 5.14 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.444 0.698 . . . . 0.0 111.076 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -75.45 -27.72 59.02 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' A' ' 14' ' ' THR . 4.1 m -132.54 92.61 27.04 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.285 0.634 . . . . 0.0 110.851 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HG2' ' HG2' ' A' ' 106' ' ' LYS . 71.5 Cg_endo -74.19 -36.89 2.95 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.907 2.405 . . . . 0.0 111.781 172.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 28.3 mmmt -79.83 -5.93 56.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.095 0.958 . . . . 0.0 111.392 -172.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 39.3 tp -57.84 128.91 39.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.842 0.857 . . . . 0.0 111.316 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.528 HH11 ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -137.7 -22.61 1.09 Allowed 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.328 171.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB2' HH11 ' A' ' 108' ' ' ARG . 23.6 tp -129.64 126.57 38.72 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 122.883 0.473 . . . . 0.0 110.577 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.551 ' HB ' HG22 ' A' ' 131' ' ' THR . 33.7 mt -113.78 110.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.458 ' HB3' HD12 ' A' ' 134' ' ' LEU . 76.8 m -96.12 114.21 25.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.796 0.438 . . . . 0.0 110.509 -175.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -91.47 116.19 28.65 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.023 0.929 . . . . 0.0 110.742 -177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.538 ' HB2' ' HA2' ' A' ' 20' ' ' GLY . 83.1 m-20 -82.92 102.39 11.66 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.75 138.32 9.48 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -58.83 -32.1 69.08 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.144 0.578 . . . . 0.0 111.513 173.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -53.31 -42.89 67.11 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.892 0.877 . . . . 0.0 112.303 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.29 -38.72 71.8 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.426 0.631 . . . . 0.0 110.314 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.57 -9.53 55.7 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 114.561 -1.2 . . . . 0.0 114.44 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.87 -24.64 66.91 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 117.374 0.587 . . . . 0.0 110.547 172.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.4 21.5 16.59 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.198 0.999 . . . . 0.0 111.215 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -66.24 -52.16 39.79 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.17 0.988 . . . . 0.0 112.405 176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.46 -14.61 30.89 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 121.608 1.539 . . . . 0.0 112.357 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -66.1 -44.98 82.82 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.905 0.882 . . . . 0.0 109.668 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 -20.49 29.47 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.909 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 50.5 ttt180 -72.24 -29.13 63.63 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.06 -22.28 75.87 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.932 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 58.4 mtt -76.66 -9.9 59.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.195 0.598 . . . . 0.0 111.719 177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.89 14.75 16.4 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 120.175 -0.236 . . . . 0.0 113.412 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.2 m-85 -109.12 145.72 35.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.368 0.667 . . . . 0.0 109.734 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 mm-40 -70.55 137.11 49.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 163.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.551 HG22 ' HB ' ' A' ' 110' ' ' ILE . 25.8 p -128.43 138.4 52.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.0 tptt -129.33 117.99 21.54 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.785 1.234 . . . . 0.0 108.849 -173.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.8 t -82.41 103.33 9.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 111' ' ' CYS . 48.0 mt -88.53 131.92 40.53 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 172.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 148' ' ' ARG . 45.8 Cg_exo -59.57 136.3 70.24 Favored 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.687 2.258 . . . . 0.0 111.133 176.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.6 t -50.24 118.99 3.3 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.261 0.975 . . . . 0.0 111.013 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 p -83.65 30.17 0.5 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.901 0.881 . . . . 0.0 111.529 -176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 65.4 p -61.05 149.52 36.73 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.715 0.806 . . . . 0.0 110.576 165.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -53.14 -42.97 62.89 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.729 0.643 . . . . 0.0 114.4 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.01 93.26 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.329 0.652 . . . . 0.0 111.782 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -78.27 -28.51 47.64 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.168 0.587 . . . . 0.0 110.065 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.98 -36.62 77.55 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.322 0.649 . . . . 0.0 110.952 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -57.02 -20.78 26.19 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.118 0.967 . . . . 0.0 112.565 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -112.5 -33.69 6.08 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.243 0.617 . . . . 0.0 110.847 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.7 m -69.5 83.12 0.41 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -95.8 -57.18 2.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.396 1.079 . . . . 0.0 110.586 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.05 -32.41 69.74 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.182 0.593 . . . . 0.0 110.399 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.514 ' HB3' ' HG2' ' A' ' 135' ' ' PRO . 0.0 OUTLIER -86.95 -31.81 20.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.908 -172.599 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.75 -28.85 67.17 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.006 0.821 . . . . 0.0 109.01 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.6 t -65.87 -42.91 89.74 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 174.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 7.1 pt-20 -71.9 -26.96 62.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -67.52 -43.21 81.38 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -67.69 -39.12 84.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.401 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.497 -175.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 151' ' ' GLU . 54.8 t -80.73 -62.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.003 0.521 . . . . 0.0 110.407 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 54.6 m-85 -85.08 2.45 43.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -165.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -25.62 62.84 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -78.21 -8.15 57.98 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.558 0.343 . . . . 0.0 111.814 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.81 -38.8 76.72 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.815 0.446 . . . . 0.0 111.312 -173.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -77.25 -41.68 40.16 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 C--O 1.243 0.733 0 C-N-CA 125.566 1.547 . . . . 0.0 106.89 175.552 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.34 139.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -88.34 110.14 20.54 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.2 mmt-85 -84.25 136.42 33.94 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.182 174.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.538 ' HA2' ' HG2' ' A' ' 23' ' ' PRO . . . -68.22 162.46 49.32 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 123.634 0.584 . . . . 0.0 112.052 173.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -101.47 146.14 31.69 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -172.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.05 137.09 17.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.741 2.294 . . . . 0.0 111.866 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.4 138.79 58.27 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.94 0.896 . . . . 0.0 111.625 -173.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.63 81.29 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 174.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.537 HD11 ' CG1' ' A' ' 104' ' ' VAL . 40.8 tp -128.0 145.36 51.0 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.358 -163.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -123.41 159.67 28.46 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.603 1.161 . . . . 0.0 107.909 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.13 -26.73 64.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 122.987 0.515 . . . . 0.0 111.202 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -111.46 89.53 3.08 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -135.48 107.64 7.21 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.303 0.641 . . . . 0.0 109.61 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 69' ' ' ARG . 59.7 mm-40 -80.47 -35.74 34.39 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.107 0.963 . . . . 0.0 109.396 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 24.3 mt -129.09 124.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 123.461 0.704 . . . . 0.0 109.857 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.7 tp -107.79 117.4 34.02 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mt -94.15 112.83 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.52 119.66 39.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.727 0.811 . . . . 0.0 109.981 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.24 177.11 46.39 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 164.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.508 ' OG ' ' HB3' ' A' ' 116' ' ' LYS . 47.4 t -90.16 -75.7 0.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 tp -129.59 125.2 22.26 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 175.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.538 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 50.6 Cg_exo -59.28 125.0 16.78 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.033 1.822 . . . . 0.0 110.509 168.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -78.76 173.07 12.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -59.8 -37.28 78.69 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.046 0.539 . . . . 0.0 111.578 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -58.57 -42.95 89.17 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.871 0.868 . . . . 0.0 111.475 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.5 m -65.4 -41.9 93.15 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.024 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.02 -26.78 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.852 1.261 . . . . 0.0 112.304 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -63.37 -39.56 94.86 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.042 0.449 . . . . 0.0 110.892 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.81 -5.18 22.66 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.149 0.58 . . . . 0.0 111.186 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 62.5 31.22 17.13 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.688 1.195 . . . . 0.0 111.253 -177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -127.68 139.34 52.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.908 1.283 . . . . 0.0 108.887 -176.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -57.56 -40.48 78.99 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.378 0.609 . . . . 0.0 109.535 175.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.418 ' HA ' ' HE1' ' A' ' 42' ' ' TRP . 24.6 t80 -47.71 -44.76 27.98 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 113.839 -1.528 . . . . 0.0 112.422 169.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 42.39 -107.29 0.1 Allowed Glycine 0 C--N 1.362 2.012 0 O-C-N 124.043 0.839 . . . . 0.0 113.301 -170.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -122.72 146.6 48.44 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.294 1.037 . . . . 0.0 109.794 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -40.54 119.04 0.67 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 124.821 3.68 . . . . 0.0 114.216 172.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.29 -33.12 0.09 OUTLIER Glycine 0 N--CA 1.472 1.071 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.431 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -93.46 126.9 38.85 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.52 0.728 . . . . 0.0 109.245 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -81.64 1.49 33.81 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.399 1.08 . . . . 0.0 111.017 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -37.51 -49.48 1.06 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.918 1.687 . . . . 0.0 113.073 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.418 ' HE1' ' HA ' ' A' ' 34' ' ' TYR . 74.7 m95 -73.37 -24.21 60.3 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.402 -173.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.9 ttm-85 -88.29 -27.17 21.88 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.159 0.584 . . . . 0.0 111.117 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.35 -51.36 9.52 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 110.569 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.9 -32.96 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.27 -36.79 85.55 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.069 176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -64.23 -40.97 97.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.279 0.631 . . . . 0.0 109.498 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 156' ' ' PHE . . . -62.81 -50.32 71.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.585 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.3 pt -88.19 -4.98 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.49 0.316 . . . . 0.0 111.212 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.3 28.99 64.93 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.147 177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -146.15 92.28 2.17 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -61.01 101.16 0.14 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.243 0.617 . . . . 0.0 109.868 -175.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.402 ' O ' ' HE2' ' A' ' 61' ' ' LYS . 54.3 mt -68.73 -17.43 64.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.401 1.081 . . . . 0.0 112.229 -167.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -60.02 -41.93 93.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.543 0.737 . . . . 0.0 112.044 -169.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.38 -32.64 71.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.58 0.752 . . . . 0.0 112.459 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -60.37 148.85 35.73 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.307 0.643 . . . . 0.0 112.55 -175.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.78 153.72 32.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 167.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.521 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 33.5 t80 -54.45 -45.61 73.12 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -164.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -63.8 -45.2 90.75 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.044 0.538 . . . . 0.0 111.271 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.85 -34.59 78.74 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.06 0.944 . . . . 0.0 110.333 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 53' ' ' LEU . 29.7 ttmt -65.46 -41.44 93.37 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.814 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 58' ' ' TYR . 29.2 mt -58.06 -48.46 80.04 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 124.07 0.856 . . . . 0.0 109.625 173.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -55.92 -45.23 78.78 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 124.237 0.96 . . . . 0.0 111.693 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -67.41 -45.64 75.57 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 123.543 0.527 . . . . 0.0 110.691 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.7 mt -55.84 -56.56 19.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.752 0.821 . . . . 0.0 110.527 177.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -67.95 -30.65 70.0 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.296 1.039 . . . . 0.0 111.58 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -63.45 -35.94 82.1 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.815 0.846 . . . . 0.0 110.884 170.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -84.82 5.13 29.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.388 0.675 . . . . 0.0 111.254 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.501 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 2.0 mpt_? 65.36 34.47 8.19 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-O 122.25 1.024 . . . . 0.0 110.197 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.06 135.65 49.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.36 1.064 . . . . 0.0 108.731 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -119.61 169.04 13.66 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.0 mt -126.73 147.42 49.97 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.759 0.824 . . . . 0.0 109.127 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -166.18 -169.02 1.34 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 166.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -139.33 164.34 30.1 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.312 0.645 . . . . 0.0 110.565 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.414 ' HA ' ' HZ ' ' A' ' 97' ' ' PHE . 76.7 t -86.14 -42.38 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.037 0.935 . . . . 0.0 111.074 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -100.22 115.78 30.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.095 0.558 . . . . 0.0 110.625 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HB3' ' HG2' ' A' ' 93' ' ' GLU . 1.6 tmtp? -66.47 -34.75 78.64 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . . . -144.82 135.26 24.35 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.684 -0.635 . . . . 0.0 110.614 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 91' ' ' ASP . . . -157.26 148.72 18.78 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.547 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 p -116.41 173.51 6.56 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.303 1.041 . . . . 0.0 109.119 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.66 109.93 11.38 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -89.67 -61.8 1.61 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.238 -167.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 138.65 -60.04 0.59 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.069 -0.412 . . . . 0.0 112.069 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.7 m -88.18 38.16 0.84 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.876 0.87 . . . . 0.0 111.368 -177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -126.35 153.67 44.58 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.477 1.111 . . . . 0.0 108.488 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.38 -67.18 0.47 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.7 t -81.81 135.98 35.42 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -39.74 91.92 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.04 0.536 . . . . 0.0 111.204 -176.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.5 mt -63.44 89.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.933 0.893 . . . . 0.0 110.743 -176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.38 58.09 4.18 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.519 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.542 ' HB3' ' HA2' ' A' ' 79' ' ' GLY . 5.9 t0 -171.19 144.05 2.0 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -110.43 17.67 20.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.887 0.875 . . . . 0.0 111.59 -173.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 45.8 tt0 -85.01 103.01 13.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.488 0.661 . . . . 0.0 109.376 -176.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.55 154.01 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 124.809 1.244 . . . . 0.0 109.451 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -79.58 157.2 27.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.686 0.794 . . . . 0.0 109.748 175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -89.22 139.78 30.14 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.414 ' HZ ' ' HA ' ' A' ' 75' ' ' VAL . 80.8 m-85 -130.48 11.58 5.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.713 0.805 . . . . 0.0 110.951 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 99.2 p -77.62 -12.1 59.93 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.969 -0.457 . . . . 0.0 110.469 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.03 -4.87 68.55 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-O 119.532 -0.593 . . . . 0.0 112.307 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.3 mt -51.23 -49.47 61.02 Favored 'General case' 0 C--N 1.37 1.494 0 C-N-CA 123.729 0.812 . . . . 0.0 111.362 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.549 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 44.6 mtpt -64.92 -16.18 62.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -171.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -96.94 -40.13 9.04 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 111.611 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -85.44 -26.61 26.26 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.537 ' CG1' HD11 ' A' ' 10' ' ' LEU . 2.2 m -129.02 89.5 48.46 Favored Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 122.868 0.467 . . . . 0.0 110.04 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.64 -28.7 20.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.296 1.997 . . . . 0.0 110.969 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -84.61 -11.95 54.97 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 112.864 -173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 104' ' ' VAL . 32.3 tp -57.69 101.85 0.08 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.033 0.833 . . . . 0.0 110.665 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -93.21 -43.97 8.57 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.588 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 51.7 tp -134.19 135.66 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.555 0.742 . . . . 0.0 109.894 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 46.4 mt -105.08 136.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 86.3 m -117.75 115.39 24.93 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.14 0.427 . . . . 0.0 110.251 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -93.56 123.06 36.62 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -101.81 111.35 23.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.18 134.99 8.62 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -172.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -53.17 -47.17 69.02 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.304 1.042 . . . . 0.0 112.18 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.508 ' HB3' ' OG ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -60.22 -20.83 60.53 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.805 0.842 . . . . 0.0 112.641 -178.13 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.56 -46.36 17.47 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.372 0.606 . . . . 0.0 109.476 170.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.26 -9.76 68.33 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 114.582 -1.19 . . . . 0.0 114.95 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -68.35 -17.52 64.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.009 0.524 . . . . 0.0 110.636 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.79 21.47 17.45 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.183 0.993 . . . . 0.0 110.988 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.44 -51.48 59.96 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.15 -0.928 . . . . 0.0 112.357 171.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.28 -24.44 67.7 Favored 'Trans proline' 0 C--N 1.405 3.551 0 C-N-CA 122.084 1.856 . . . . 0.0 112.698 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.9 tp -65.81 -57.21 8.47 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.914 0.886 . . . . 0.0 110.181 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.48 ' HA ' ' SD ' ' A' ' 127' ' ' MET . 12.2 mt -79.18 -21.03 46.96 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -168.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 129' ' ' TYR . 6.9 ptm180 -75.22 -11.65 60.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 120.703 0.287 . . . . 0.0 110.715 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.59 -15.14 81.44 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.405 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.48 ' SD ' ' HA ' ' A' ' 124' ' ' LEU . 1.4 mpt? -81.94 10.71 5.98 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 174.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.24 19.74 79.76 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 122.749 0.214 . . . . 0.0 112.716 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.549 ' OH ' ' HA ' ' A' ' 101' ' ' LYS . 18.3 m-85 -108.79 139.59 43.39 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.304 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -73.48 142.42 46.8 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.9 p -129.99 148.15 51.82 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.401 ' HB2' HD11 ' A' ' 109' ' ' LEU . 54.3 tptt -139.37 123.54 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.215 1.006 . . . . 0.0 108.864 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.04 122.81 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.52 HD21 HG21 ' A' ' 155' ' ' VAL . 90.4 mt -113.02 150.15 42.44 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.58 177.37 4.08 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.772 2.314 . . . . 0.0 111.561 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.4 m -66.02 130.29 42.74 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 29.4 p -83.89 14.91 3.64 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.834 0.854 . . . . 0.0 112.044 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -69.88 156.26 39.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.147 0.979 . . . . 0.0 111.78 -178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -67.17 -18.61 69.38 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.693 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.22 83.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.362 0.665 . . . . 0.0 111.056 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -76.56 -2.59 33.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.7 0.8 . . . . 0.0 112.477 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.446 ' HA ' ' HB3' ' A' ' 145' ' ' SER . 20.1 ttm-85 -56.13 -33.68 65.38 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.039 0.935 . . . . 0.0 113.317 -172.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.68 -33.38 72.76 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.643 0.589 . . . . 0.0 110.606 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.01 5.94 20.63 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.774 0.829 . . . . 0.0 111.994 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 142' ' ' ARG . 13.7 t -91.07 14.8 13.05 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.151 0.58 . . . . 0.0 112.195 -175.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.98 -58.06 5.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.44 ' HB2' ' NH1' ' A' ' 148' ' ' ARG . 17.4 m120 -59.21 -15.06 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.44 ' NH1' ' HB2' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -74.96 -23.65 58.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.974 0.51 . . . . 0.0 110.101 179.481 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.36 -55.63 32.27 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.26 0.624 . . . . 0.0 110.695 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.5 t -73.93 -32.34 63.48 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 111.161 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 155' ' ' VAL . 19.3 tt0 -67.37 -56.75 8.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.165 0.586 . . . . 0.0 110.224 -177.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -69.58 -25.91 64.2 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.523 ' HG2' ' HD2' ' A' ' 157' ' ' ARG . 32.4 tt0 -59.35 -49.61 77.14 Favored 'General case' 0 C--N 1.362 1.128 0 O-C-N 123.821 0.7 . . . . 0.0 109.442 172.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.28 -40.53 77.69 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.553 -171.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.52 HG21 HD21 ' A' ' 134' ' ' LEU . 92.6 t -61.91 -32.64 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 124.173 0.989 . . . . 0.0 112.673 -174.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.417 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 44.0 m-85 -115.55 -11.99 11.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 112.909 -176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.523 ' HD2' ' HG2' ' A' ' 153' ' ' GLU . 14.4 ptm180 -74.1 -26.56 60.43 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.555 0.616 . . . . 0.0 111.591 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -73.84 -8.8 57.42 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.571 0.348 . . . . 0.0 111.906 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.412 HD11 HD12 ' A' ' 16' ' ' ILE . 80.8 mt -70.26 -12.21 61.43 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.338 0.655 . . . . 0.0 112.732 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -90.37 -1.99 57.94 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.878 0.471 . . . . 0.0 111.036 174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 . . . . . 0 CA--C 1.555 1.148 0 C-N-CA 125.561 1.544 . . . . 0.0 110.435 -175.01 . . . . . . . . 0 0 . 1 stop_ save_